<SEC-DOCUMENT>0001437749-12-003067.txt : 20120330
<SEC-HEADER>0001437749-12-003067.hdr.sgml : 20120330
<ACCEPTANCE-DATETIME>20120330112008
ACCESSION NUMBER:		0001437749-12-003067
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20111231
FILED AS OF DATE:		20120330
DATE AS OF CHANGE:		20120330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		12726808

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>govx_10k-123111.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<html>
<head>
    <title>govx_10k-123111.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 10-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings 2, serif">R</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>SECURITIES EXCHANGE ACT OF 1934.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For fiscal year ended December 31, 2011</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commission File No. 000-52091</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of Registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="45%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">incorporation or organization)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1900 Lake Park Drive, Suite 380</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Smyrna, GA</font></div>
</td>
<td valign="top" width="38%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">87-0455038</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(IRS Employer</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification Number)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">30080</font></div>
</td>
</tr><tr>
<td valign="top" width="45%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
<td valign="top" width="38%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Zip Code)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(678) 384-7220</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Registrant&#8217;s telephone number, including area code:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(b) of the Act:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">None</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(g) of the Act:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock $.001 par value</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Title of class)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167; 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.&#160;&#160;See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</font></div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="25%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Large accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings 2, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#163;</font>&#160;&#160;&#160;</font></td>
<td width="25%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings 2, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#163;</font></font></td>
<td width="25%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings 2, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#163;</font>&#160;&#160;</font></td>
<td width="25%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Smaller reporting company<font id="TAB1" style="MARGIN-LEFT: 12pt"></font><font style="DISPLAY: inline; FONT-FAMILY: wingdings 2, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">R</font></font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The aggregate market value of Common Stock held by non-affiliates of the registrant on June 30, 2011, based on the closing price on that date was $8,741,870.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Number of shares of Common Stock outstanding as of March 30, 2012: 16,850,610</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="white" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RDGPreambleEnd</font></div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">DOCUMENTS INCORPORATED BY REFERENCE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Portions of the registrant&#8217;s definitive Proxy Statement with respect to its 2012 Annual Meeting of Stockholders are incorporated by reference in Part III</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Table of Contents</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PART I</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 72px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 1</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Business&#160;</font></div>
</td>
<td width="27" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 1A</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Risk Factors&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 1B</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unresolved Staff Comments&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 2</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Properties&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 3</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Legal Proceedings&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 4</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mine Safety Disclosures&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PART II</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 72px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 5</font></div>
</td>
<td width="1146">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Issuer Purchases of Equity Securities</font></td>
<td width="27" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>
</td>
</tr></table>
</div>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 72px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 6</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selected Financial Data&#160;</font></div>
</td>
<td width="27" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 7</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 7A</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Quantitative and Qualitative Disclosures about Market Risk&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 8</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial Statements and Supplementary Data&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 9</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 9A</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Controls and Procedures&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 9B</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Information&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PART III</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 10</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Directors, Executive Officers and Corporate Governance&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 11</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Executive Compensation&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 12</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Security Ownership of Certain Beneficial Owners and Management and <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Related Stockholder Matters</font></font></font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr></table>
</div>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 13</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain Relationships and Related Party Transactions, and Director Independence&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 14</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Principal Accountant Fees and Services&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PART IV</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 72px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 15</font></div>
</td>
<td width="1146">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibits and Financial Statement Schedules&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: right; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 624px">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Signatures</font></div>
</td>
<td width="594">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td width="27">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 1218px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibit Index </font></font></div>
</td>
<td width="27" style="TEXT-ALIGN: right">36</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;SAFE HARBOR&#8221; STATEMENT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From time to time, we make oral and written statements that constitute &#8220;forward-looking statements&#8221; (rather than historical facts).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All statements in this Annual Report that are not statements of historical fact are forward-looking statements, including any projections of financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or financial performance, any statements regarding action by the FDA or other regulatory authorities, and any statement of assumptions underlying any of the foregoing.&#160;&#160;In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;potential&#8221; or &#8220;could&#8221; or the negative thereof or other comparable terminology.&#160;&#160;Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, including but not limited to the risk factors set forth under the heading &#8220;Risk Factors&#8221; in this Annual Report, and including risks or uncertainties regarding the clinical testing required by regulatory authorities for products under development; the need for future clinical testing of our products under development; the significant time and expense that will be incurred in developing any of the potential commercial applications for our products; the possibility that our products may not demonstrate adequate clinical performance or obtain market acceptance, our ability to obtain capital to fund our current and future operations; and risks relating to the enforceability of any patents covering our products and to the possible infringement of third party patents by those products.&#160;&#160;All forward-looking statements included in this Annual Report are made as of the date hereof, and we assume no obligation to update them.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART I</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">BUSINESS</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Company Overview</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax, Labs, Inc. was formed in 2001 and is a biotechnology company developing vaccines that prevent and fight human immunodeficiency virus (HIV).&#160;&#160;HIV infections result in acquired immunodeficiency syndrome (AIDs).&#160;&#160;We are incorporated in Delaware, and our offices and laboratory facilities are located in<font style="DISPLAY: inline; FONT-WEIGHT: bold"> S</font>myrna, Georgia (metropolitan Atlanta).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a treatment for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in humans -- both in those infected with HIV and those who are not.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current vaccines under clinical development are designed to function against the clade B subtype of the HIV virus that is prevalent in the United States and the developed world.&#160;&#160;An estimated 3.5 million people are infected with clade B HIV virus and between 55,000 and 58,000 new infections occur in the U.S. every year.&#160;&#160;The cost of treating HIV infected individuals in the United States is estimated at $500,000 for each infected individual over their lifetime.&#160;&#160;We estimate the worldwide market opportunity for a clade B HIV vaccine (preventive and therapeutic) to be approximately $5 billion annually.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to the availability of funding support from governmental or nongovernmental organizations, we also plan to develop vaccines designed for use to combat the subtypes of HIV that predominate in the developing countries.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Work on our vaccines began during the 1990s at Emory University in Atlanta, Georgia, under the direction of Dr. Harriet L. Robinson, who is now our Chief Scientific Officer. The vaccine technology was developed in collaboration with researchers at Emory University, the U.S. National Institutes of Health (NIH), and the U.S.&#160;&#160;Centers for Disease Control and Prevention (CDC). The technology developed by the collaboration is exclusively licensed to us from Emory University. We also have nonexclusive licenses to certain patents owned by the NIH and exclusive license rights to certain manufacturing process patents of MFD, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Vaccine Pipeline</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes key information regarding our vaccine candidates:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="TEXT-DECORATION: underline">Vaccine&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Candidate</font></font></font></font></td>
<td width="2%">&#160;</td>
<td width="14%"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Indication</font></font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="TEXT-DECORATION: underline"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Stage of Clinical <font style="DISPLAY: inline; TEXT-DECORATION: underline">Development</font></font></font></font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Trial Sponsor</font></font></font></td>
</tr><tr bgcolor="#c0ffff">
<td width="14%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B &#8211; DNA/MVA</font></font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Preventive Vaccine (Clade B)</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 2a</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/HVTN</font></td>
</tr><tr bgcolor="white">
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B &#8211; DNA-GM/MVA</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Preventive Vaccine (Clade B)</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 1</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/HVTN</font></font></td>
</tr><tr bgcolor="#c0ffff">
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B &#8211; DNA/MVA</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Treatment Vaccine (Clade B)</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 1/2&#160;</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GeoVax</font></td>
</tr><tr bgcolor="white">
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B &#8211; DNA-GM/MVA</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Treatment Vaccine (Clade B)&#160;</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Planning &#8211; Phase 1/2</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/IMPAACT</font></td>
</tr><tr bgcolor="#c0ffff">
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C &#8211; DNA/MVA</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Preventive Vaccine (Clade C)</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preclinical&#160;</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">n/a</font></td>
</tr><tr bgcolor="white">
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C&#160;&#8211; MVA</font></font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">HIV &#8211; Preventive Vaccine (Clade C)&#160;&#160;&#160;&#160;</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preclinical&#160;&#160;&#160;&#160;&#160;</font></td>
<td width="2%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="14%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">n/a</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our preventive vaccines are being tested in humans by the HIV Vaccine Trials Network (HVTN) and are funded by the NIH. The first generation of our preventive vaccine is one of only 5 vaccine candidates out of more than 80 tested by the HVTN to have successfully progressed to Phase 2 testing.&#160;&#160;In Phase 1 human trials in uninfected people, our vaccines have shown excellent safety and induced both anti-viral antibodies and anti-viral T cells. The results of a two group, 30 participant,&#160;&#160;Phase 1 trial (designated HVTN 048) are published in <font style="FONT-STYLE: italic; DISPLAY: inline">AIDS RESEARCH AND HUMAN RETROVIRUSES </font>22:678 (2006) and of a four group 120 participant trial (HVTN 065) in <font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases</font> 203:610 (2011).&#160;&#160;Our Phase 1 trials have tested both safety and dosing regimens.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The 300 participant Phase 2a clinical trial of our preventive vaccine (HVTN 205) further tested safety and immunogenicity of the two most promising regimens evaluated in phase 1:&#160;&#160;(1) Priming with DNA at months 0 and 2 and boosting with MVA at months 4 and 6 and (2) priming and boosting with MVA at months 0, 2 and 6.&#160;&#160;The HVTN 205 trial is fully enrolled and patient inoculations were completed in January 2012.&#160;&#160;We expect study analysis and completion of the trial during 2012. </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The HVTN has also agreed to sponsor and conduct clinical testing in humans of a new version of our preventive vaccine that co-expresses granulocyte-macrophage colony-stimulating factor&#160;&#160;(GM-CSF) in the DNA vaccine used to prime the vaccine response.&#160;&#160;In preclinical studies in non-human primates, co-expression of GM-CSF in a simian prototype of the DNA vaccine improved the ability of the vaccine to prevent infection. <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In a study employing 12 successive weekly exposures to simian immunodeficiency virus (SIV), vaccinating in the presence of co-expressed GM-CSF prevented infection in 70% of the animals for a 90% reduction in per exposure risk of transmission, whereas vaccinating in the absence of the co-expressed GM-CSF prevented infection in only 25% of animals and achieved a less effective&#160;&#160;60% reduction in the per exposure risk of transmission (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases, </font>204:164 (2011)). </font>In normal humans, GM-CSF stimulates the expansion and differentiation of cells in the macrophage and dendritic cell lineages that promote immune responses. The use of GM-CSF in humans is anticipated to have good safety based on its licensure for stimulating production of white blood cells after autologous bone marrow transplantation, as a treatment for fungal infections, and as an adjuvant for the Provenge&#174;&#160;&#160;prostate cancer vaccine.&#160;&#160;&#160;Research into the potential benefits of adding GM-CSF to our vaccine has been supported by a $20.4 million Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant awarded by the NIH to GeoVax in 2007 and covering a five year period ending in 2012.&#160;&#160;Clinical testing of the GM-CSF co-expressing vaccine is expected to commence in the second quarter of 2012.&#160;&#160;Pending successful outcome of this trial, we expect to carry forward this version of our preventive vaccine into Phase 2b efficacy testing. We have scheduled vaccine production and have begun discussions about protocol development with potential government sponsors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our therapeutic (treatment) vaccine is in Phase 1/2 human clinical testing that we are sponsoring.&#160;&#160;These trials were initiated based on promising preclinical data from therapeutic trials in HIV-infected non-human primates. In these studies, non-human primates were infected, drug-treated, vaccinated and then drug-interrupted.&#160;&#160;Following treatment interruption, median levels of virus in blood, measured as viral RNA, were 10 to 1000-times lower (overall median of 100-times lower) than those measured prior to drug and vaccine treatment.&#160;&#160;The therapeutic reductions in virus levels were associated with the vaccination regimen eliciting T-cells (a form of white blood cell) with functional characteristics known to successfully control viral infections.&#160;&#160;We expect to complete patient enrollment of the Phase 1/2 human trial of our therapeutic vaccine during 2012 and to generate data in 2013.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are also planning a Phase 1 therapeutic clinical trial to investigate the use of our vaccine in combination with standard-of-care drug therapy in young adults.&#160;&#160;This trial would be supported by the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT).&#160;&#160;The NIH has recently prioritized searching for a cure for those individuals who are HIV positive. Because of the mechanisms by which current oral drugs&#160;&#160;work, if the virus is in a latent phase these drugs are not effective, thus it is impossible to totally eradicate the virus. Current approaches to a cure include using an effective vaccine and oral medication together to more effectively eradicate virus. This trial has been assigned a clinical study number (P-1082) and, pending successful committee reviews and FDA approval, we are hopeful that this study will commence in late 2012.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Background &#8211; Viruses and Vaccines</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What are Viruses?</font>&#160;&#160;Viruses are microscopic organisms consisting of genetic material comprised of deoxyribonucleic acid (&#8220;DNA&#8221;) or ribonucleic acid (&#8220;RNA&#8221;), surrounded by a protein, lipid (fat), or glycoprotein coat. Viruses invade healthy, living host cells in order to replicate and spread. In many cases, the body&#8217;s immune system can recognize and effectively combat an infection caused by a virus. However, with certain viral infections, the body&#8217;s immune system is unable to fully destroy or inhibit the replication of the virus, which results in persistent and ongoing viral replication resulting in disease.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Infections caused by viruses can be chronic or acute. Chronic infections, such as those caused by HIV, do not typically self-resolve with time and can cause chronic disease. Acute infections associated with viruses, such as influenza, generally last for a relatively short period of time, and self-resolve in most immuno-competent individuals.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Viruses can also be characterized as either active or latent. An active virus can cause a persistent infection or disease over an extended period of time. A latent virus will remain in the body for very long periods of time after the initial infection and generally will only cause disease when the body&#8217;s immune system weakens, fails or is suppressed, allowing the virus to once again replicate. Vaccines have been widely used to prevent active viral infections from occurring.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Viruses that develop resistance to antiviral drugs are increasingly becoming a challenge in the treatment of viral infections, particularly those that are chronic in nature. The ability of viruses to mutate spontaneously during replication allows drug-resistant strains to emerge when patients are using drugs that are not potent enough to quickly and completely inhibit viral replication. Drug resistance occurs because viruses continually replicate making millions of copies of themselves, some of which contain mutations in their genetic material. Mutations that emerge in the presence of a suppressive antiviral drug will give rise to mutant strains that are wholly or partially resistant to that drug. These mutant viruses, while initially low in number, eventually become the predominant strain in an infected patient as those strains that remain susceptible to the drug are inhibited from replicating. Once this occurs, the treatment benefit of that particular antiviral drug often diminishes, resulting in treatment failure and the need for an alternate therapy with different or possibly new drugs, or classes of drugs. In general, viruses that cause chronic infections, such as HIV, are more likely to develop drug resistance due to the long-term and persistent exposure of the virus to the antiviral therapy.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What are Vaccines?</font>&#160;&#160;Vaccines represent an approach to broaden the ability to prevent serious infectious diseases caused by both viruses and bacteria.&#160;&#160;A vaccine is a substance introduced into the human body that teaches the immune system to detect and destroy a pathogen (a virus or bacterium that causes disease). All vaccines contain some harmless form or part of the pathogen they target. They exert their effects through the adaptive immune response, an arm of the immune system that learns to recognize and neutralize specific pathogens.</font></div>

<br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several types of vaccines:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Whole-killed/Whole-inactivated vaccines</font>: The active ingredient in these vaccines is an intact virus or bacterium that has been killed or otherwise stripped of its ability to infect humans. Examples include the cholera and injectable polio vaccines. This approach has not been applied to the development of vaccines against HIV due to the small but inevitable risk that the viruses harvested for such preparations may not all have been killed or adequately inactivated.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Live attenuated vaccines</font>:&#160; These vaccines use a form of the targeted pathogen that is highly unlikely to be harmful&#8212;one capable, say, of multiplying, but not causing disease. Examples include the measles vaccine and the oral vaccine against polio, which has been widely deployed in global eradication efforts. Such vaccines can be very effective because they closely mimic the behavior of the targeted pathogen, giving the immune system a truer picture of what it would be up against. Due to the risk that attenuated HIV might revert to its disease-causing form, this approach has not been applied to the development of human AIDS vaccines.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Subunit vaccines:</font> Vaccines of this variety are composed of purified pieces of the pathogen (known as antigens) that generate a vigorous, protective immune response. Common subunit vaccines include the seasonal flu and hepatitis B vaccines. This approach was employed to devise the first AIDS vaccine candidate tested in humans, which failed to induce protection from HIV infection.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">DNA vaccines</font>: These vaccine candidates are also designed to train the immune system to recognize a piece of the targeted bacterium or virus. The difference is that the active ingredients are not the purified antigens themselves but circles of DNA, called plasmids, that carry genes encoding those antigens. Human cells passively take up these plasmids and produce the antigens that, in turn, train the immune system to recognize the targeted pathogen.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Recombinant vector vaccines</font>: These vaccines, like DNA vaccines, introduce genes for targeted antigens into the body. But the genes are inserted into a virus that actively infects human cells. The viruses chosen as vectors are safe to use because they do not ordinarily cause disease in humans and/or have been stripped of their ability to proliferate.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview of HIV/AIDS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What is HIV? </font>HIV is a retrovirus that carries its genetic code in the form of ribonucleic acid, or RNA. Retroviruses use RNA and the reverse transcriptase enzyme to create DNA from the RNA template. The HIV-1 virus invades human cells and produces its viral DNA that is subsequently inserted into the chromosomes, which are the genetic material of a cell. HIV preferentially infects and replicates in T-cells, which are a type of white blood cell. Infection of T-cells alters them from immunity mediating cells to cells that produce and release HIV. This process results in the destruction of the immune defense system of infected individuals and ultimately, the development of AIDS.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several AIDS-causing HIV virus subtypes, or clades, that are found in different regions of the world. These clades are identified as clade A, clade B and so on. The predominant clade found in Europe, North America, parts of South America, Japan and Australia is clade B whereas the predominant clades in Africa are clades A and C. In India the predominant clade is clade C. Each clade differs by at least 20% with respect to its genetic sequence from other clades. These differences may mean that vaccines or treatments developed against HIV of one clade may only be partially effective or ineffective against HIV of other clades. Thus there is often a geographical focus to designing and developing vaccines suited for the local clade.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">HIV, even within clades, has a high rate of mutation that supports a significant level of genetic variation. In drug treatment programs, virus mutation can result in the development of drug resistance, referred to as virus drug escape, thereby rendering drug therapy ineffective. Hence, we believe that multi-drug therapy is very important. If several drugs are active against virus replication, the virus must undergo multiple simultaneous mutations to escape, which is less likely. The same is true for immune responses. HIV can escape single targeted immune responses. However, our scientists believe if an immune response is directed against multiple targets, which are referred to as epitopes, virus escape is much less frequent. Vaccination against more than one of the proteins found in HIV increases the number of targets for the immune response as well as the chance that HIV will not escape the vaccine-stimulated immune response, thus resulting in protection against infection or the development of clinical AIDS once infection occurs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What is AIDS?</font> AIDS is the final, life-threatening stage of infection with the virus known as HIV. Infection with HIV severely damages the immune system, the body&#8217;s defense against disease. HIV infects and gradually destroys T-cells and macrophages, which are white blood cells that play key roles in protecting humans against infectious disease caused by viruses, bacteria, fungi and other micro-organisms.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Opportunistic infections by organisms, normally posing no problem for control by a healthy immune system, can ravage persons with immune systems damaged by HIV infections. Destruction of the immune system occurs over years. The average onset of the clinical disease recognized as AIDS occurs after three to ten years of HIV infection if the virus is not treated effectively with drugs, but the time to developing AIDS is highly variable.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIDS in humans was first identified in the United States in 1981, but researchers believe that it was present in Central Africa as early as 1959. AIDS is most often transmitted sexually from one person to another but it is also transmitted by blood in shared needles and through pregnancy and childbirth. Heterosexual activity is the most frequent route of transmission worldwide.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The level of virus in blood, known as viral load, is the best indicator of the speed with which an individual will progress to AIDS and&#160;the frequency with which an individual will spread infection. An estimated 1% or fewer of those infected have low enough levels of the virus to preclude progression to AIDS and to not transmit the infection. These individuals are commonly called elite controllers or long-term non-progressors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIDS is considered by many in the scientific and medical community to be the most lethal infectious disease in the world. According to the 2011&#160;World AIDS Day Report&#160;published by UNAIDS, the Joint United Nations Programme on HIV/AIDS,&#160;at the end of 2010, an estimated 34 million people were living with HIV worldwide,&#160;with approximately 2.7&#160;million newly infected in 2010 alone. Approximately 25&#160;million people infected with HIV have died since the 1981 start of the HIV pandemic. The United States currently suffers about 56,000 infections per year with the highest rates found in Washington, D.C., where an estimated 3% of the population is infected, a prevalence rate higher than in some developing countries.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">According to the International AIDS Vaccine Initiative (IAVI) in a model developed with Advanced Marketing Commitment dated June 2005, the annual global market for a safe and effective preventive AIDS vaccine (all clades) is estimated at approximately $4 billion or more.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At present, the standard approach to treating HIV infection is to&#160;inhibit viral replication&#160;through the use of combinations of drugs. Available drugs include reverse transcriptase inhibitors, protease inhibitors, integration inhibitors and inhibitors of cell entry to block multiple essential steps in virus replication. However, HIV is prone to genetic changes that can produce strains that are resistant to currently approved drugs. When HIV acquires resistance to one drug within a class, it can often become resistant to the entire class, meaning that it may be impossible to re-establish control of a genetically altered strain by substituting different drugs in the same class. Furthermore, these treatments continue to have significant limitations which include toxicity, patient non-adherence to the treatment regimens and cost. As a result, over time, many patients develop intolerance to these medications or simply give up taking the medications due to the side effects.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">According to the IAVI, the cost and complexity of new treatment advances for AIDS puts them out of reach for most people in the countries where treatment is most needed, and as noted above, in industrialized nations, where drugs are more readily available, side effects and increased rates of viral resistance have raised concerns about their long term use. AIDS vaccines, therefore, are seen by many as the most promising way to end the HIV/AIDS pandemic. It is expected that vaccines for HIV/AIDS, once developed, will be used universally and administered worldwide by organizations that provide health care services, including hospitals, medical clinics, the military, prisons and schools.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Vaccine Candidates</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines, initially developed by our Chief Scientific Officer, Dr. Harriet L. Robinson at Emory University in collaboration with scientists at the NIH and the CDC, incorporate two vaccine delivery components: (1) a recombinant DNA (deoxyribonucleic acid) and (2) a recombinant poxvirus, known as MVA (modified vaccinia Ankara), both of which deliver genes that encode inactivated HIV derived proteins to the immune system. Both the DNA and MVA vaccines contain sufficient HIV genes to support the production of non-infectious virus-like particles which display the native trimeric membrane-bound form of the viral envelope glycoprotein that appears authentic to the immune system. When used together, the recombinant DNA component is used to prime the immune response, which is then boosted by administration of the recombinant MVA component. However, in certain settings the recombinant MVA alone may be sufficient for priming and boosting the immune responses.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our initial work focused on the development of a preventive vaccine for use in uninfected humans to prevent infection should they be exposed to the virus. Later,&#160;&#160;based on&#160;&#160;encouraging data in preclinical primate models, we undertook the development of a therapeutic vaccine for use in HIV infected humans to supplement approved drug regimens. For both preventive and therapeutic applications, our current focus is on a vaccine for use against clade B, which is common in the United States and the industrially developed world. However, if efficacy is documented against clade B, we plan to develop vaccines designed for use to combat the subtypes of HIV that predominate in developing countries, including clades A, C and an AG recombinant.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Induction of T-cell and Antibody Immune Responses. </font>In both preclinical and clinical trials, our vaccines induce both anti-viral antibody and T-cell responses. The induction of both antibodies and T-cells is beneficial because these immune responses work through different mechanisms. Antibodies can prevent infection by blocking viruses from infecting cells.&#160;&#160;In preclinical vaccine studies using repeated rectal challenges with moderate doses of virus, the avidity, or tightness, of antibody binding to the surface envelope glycoprotein of HIV correlates with the prevention of infection (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases, </font>204:164 (2011)).&#160;&#160;In high dose challenges that infect all&#160;&#160;animals at the first exposure, the avidity of the antibody for envelope glycoprotein correlates with reduced levels of virus replication (<font style="FONT-STYLE: italic; DISPLAY: inline">Journal of Virology</font>, 83:4102 (2009)).&#160;&#160;These results likely reflect the tightly binding antibody both blocking infection as well as tagging the virus and infected cells for destruction.&#160;&#160;Our vaccines elicit CD8 T-cells, a type of T-cell that can recognize and kill cells that become infected by virus. CD8 T-cells are important for the control of the virus that has established an infection.&#160;&#160;In our therapeutic vaccinations, our vaccines elicit high frequencies of CD8 T-cells with the functional characteristics of CD8 T-cells associated with control of viral infections in individuals termed &#8220;elite controllers&#8221;.&#160;&#160;Elite controllers, who constitute less than 1% of all HIV-infected individuals, enjoy years of disease-free life without the use of drugs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">DNA and MVA as Vaccine Vectors. </font>Both the DNA and MVA vaccines produce virus-like particles containing the three major proteins of HIV.&#160;&#160;The virus-like particles cannot cause disease because they were designed with mutated or deleted enzymatic functions that are essential for virus replication.&#160;&#160;The virus-like particles display trimeric membrane bound forms of the HIV envelope glycoprotein (Env).&#160;&#160;This is important because the natural form of the envelope glycoprotein elicits antibody capable of recognizing incoming virus and blocking infections.&#160;&#160;Expression of multiple proteins by the vaccine is important because each protein provides targets for cytotoxic T-cells.&#160;&#160;Elicitation of a multi-target T-cell response limits immune escape, just as multi-drug therapies limit drug escape.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><img src="fig1.jpg" alt=""></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 34.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 1. Electron micrographs showing the virus-like-particles (VLPs) produced by GeoVax recombinant DNA and recombinant MVA vaccines.</font> For the DNA Prime, VLPs are seen budding from a DNA-expressing cell.&#160;&#160;For the MVA boost, fully formed particles as well as a budding particle are shown.&#160;&#160;The VLPs display trimeric membrane-bound forms of the viral envelope glycoprotein (Env).&#160;&#160;This is an important feature of the vaccine because display of the normal Env means that the antibody elicited by the vaccine can recognize the Env on incoming viruses. The VLPs are immature and are rendered non-infectious by deletion of essential genes and introduction of inactivating mutations in essential viral enzymes.&#160;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MVA was selected for use as the live viral component of our vaccines because of its well established safety record and because of the ability of this vector to carry sufficient HIV proteins to produce virus-like particles. MVA was originally developed as a safer smallpox vaccine for use in immune compromised humans.&#160;&#160;It was developed by&#160;attenuating the standard smallpox vaccine by making over 500 passages of the virus in chicken embryos or chick embryo fibroblasts which resulted in large genomic deletions. These deletions limited the ability of MVA to replicate in human cells, which can cause safety problems, but did not compromise the ability of MVA to grow on avian cells that are used for manufacturing the virus. The deletions also resulted in the loss of immune evasion genes which assist the spread of wild type smallpox infections, even in the presence of human immune responses. MVA was safely administered to over 120,000&#160;people in the 1970s as a smallpox vaccine.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The availability of DNA and MVA vaccine delivery vectors provides GeoVax with the means to use combination vaccines that induce different patterns of T-cell and antibody responses. Specifically, the use of DNA to prime immune responses and MVA to boost immune responses elicits high levels of T-cells and thus could be particularly well-suited for therapeutic uses. Alternatively, the use of MVA to both prime and boost the immune response elicits higher levels of antibodies and therefore could be well-suited for use in prevention.&#160;&#160;The DNA prime also facilitates expressing genetic adjuvants, which are co-expressed by the vaccine vector with HIV proteins, at the site of immunization.&#160;&#160;This has proven to be particularly effective in our work using GM-CSF as an adjuvant in which a single DNA expresses both virus-like particles and GM-CSF.&#160;&#160;By co-expressing GM-CSF and HIV proteins in the DNA vaccine, GM-CSF is present at the site of the HIV vaccination where it enhances the ability of the vaccine to elicit blocking antibodies for the HIV virus.&#160;&#160;Blocking antibodies can stop a virus before it infects cells.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Pre-clinical Studies. </font>During the development of our preventive vaccines, preclinical efficacy trials were conducted by vaccinating non-human primates with simian immunodeficiency virus prototypes of our HIV vaccines and then testing them for resistance to simian immunodeficiency virus. The experimental data produced by these trials documented the ability of the simian prototypes of our vaccines to induce immune responses that can prevent infection as well as reduce the levels of viral replication in those animals that become infected.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax&#8217;s research pipeline includes the use of adjuvants together with our DNA/MVA vaccine.&#160;&#160;Adjuvants are additives to vaccines that improve vaccine efficacy.&#160;&#160;One of these, GM-CSF, a normal human protein that stimulates the first stages of immune responses, has shown particular promise.&#160;&#160;When GM-CSF is co-expressed in the DNA prime for the MVA boost, the vaccine achieved 70% prevention of infection with a &gt;90% reduction in the per exposure risk of transmission in a study employing 12 successive weekly exposures to simian immunodeficiency virus, whereas vaccinating in the absence of the co-expressed GM-CSF achieved 25% prevention of infection and a less effective 60% reduction in the per exposure risk of transmission (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases 204:164 (2011))</font>.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Survivors from this first series of exposures were rested a year, boosted once with the MVA vaccine, and then exposed to a 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of challenges (Figure 2). Greater than 90% reduction in risk of infection per exposure was achieved against the 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of exposures. Survivors of this 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of exposures were again rested for 6 months and are being exposed to a 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of challenges. Again,&#160;94% reduction in risk of infection per exposure&#160;was achieved.&#160;&#160;The 1<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> two series of exposures were to SIVE660, a virus that has neutralization characteristics like viruses undergoing transmission in the current epidemic.&#160;&#160;The 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of challenges is with SIV251, a virus that is considered the most potent SIV used in nonhuman primate studies and is an outlier in its high resistance to neutralization.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt"><img src="fig2.jpg" alt=""></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 2.&#160;&#160;Schematic of serial exposures testing vaccine efficacy.</font>&#160;&#160;Heavy vertical arrows indicate vaccinations, clusters of thin arrows, serial exposures.&#160;&#160;Exposures to virus were rectal to mimic mucosal transmissions.&#160;&#160;&#160;Protection against the 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of exposures is shown in Figure 3C below.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To our knowledge, the level of protection achieved by the simian prototype for the GeoVax GM-CSF-adjuvanted HIV vaccine is unprecedented and far better than has been achieved with simian prototypes of other vaccines currently in, or slated for efficacy trials (see Figure 3 below).&#160;&#160;Figure 3A shows prevention of serial infections by the vaccine currently in efficacy trials that was developed by the NIH Vaccine Research Center.&#160;&#160;This vaccine consists of priming with a DNA vaccine and boosting with a recombinant Adenovirus 5 vaccine (DNA/Ad5).&#160;&#160;When challenged with SIV251, vaccinated animals were infected more rapidly than the unvaccinated animals.&#160;&#160;Figure 3B shows a Johnson and Johnson (Crucell) vaccine developed at Harvard and tested in conjunction with the US military.&#160;&#160;This vaccine initially provides some protection, however only 13% of the animals remained protected after 6 exposures to SIV251.&#160;&#160;Figure 3C shows data from serial exposures to the simian prototype for the GeoVax GM-CSF-co-expressing vaccine. This vaccine has provided&#160;a 72% per exposure reduction in risk of infection over 12 serial exposures.&#160;&#160;We are very pleased with the reduction in risk of infection per exposure that the GeoVax prototype vaccine&#160;has achieved.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><br>
&#160;<img src="fig3.jpg" alt=""></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 3. Comparison of protection against serial exposures to SIV251 induced by vaccines undergoing or slated for efficacy trials.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A. Vaccine consisting of priming with a DNA vaccine and boosting with and adenovirus5 vaccine (Ad5) developed by the NIH Vaccine Research Center and currently in an efficacy trial in North America.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B. Vaccine consisting of priming with an adenovirus 26 vaccine (Ad26) and boosting with an MVA vaccine developed by Harvard and the U.S. Military, owned by Johnson and Johnson (Crucell) and slated for an efficacy trial in South Africa.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C. GeoVax vaccine consisting of priming with a GM-CSF co-expressing DNA and boosting with MVA..</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preventive Vaccine &#8212; Phase 1 Human Clinical Trials. </font>All of our preventive vaccination trials in humans have been conducted by the HVTN, a network that is funded and supported by the NIH. The HVTN is the largest worldwide clinical trials network focused on the development and testing of HIV/AIDS vaccines. Figure 4 below summarizes our clinical trials conducted by the HVTN. In our first Phase 1 clinical trial, HVTN 045, our DNA vaccine was tested without MVA boosting to document the safety of the DNA. Our second Phase 1 clinical trial, HVTN 065, was designed to test the combined use of DNA and MVA and consisted of a dose escalation as well as regimen studies. The low dose consisted of 0.3&#160;mg of DNA and 1x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">7</font> tissue culture infectious doses (TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>) of MVA. Once safety was demonstrated for the low dose in 10 participants, the full dose (3 mg of DNA and 1x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">8</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50 </font>of MVA) was administered to 30 participants. A single dose of DNA at time 0 followed by MVA at weeks 8 and 24, a DMM regimen, and three doses of MVA administered at weeks 0, 8 and 24, an MMM regimen, were also tested in 30 participants each. Participants were followed for 12 months to assess vaccine safety and to measure vaccine-induced immune responses.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Data from the HVTN 065 trial again documented the safety of the vaccine products but also showed that the DDMM and MMM regimens induced different patterns of immune responses (<font style="FONT-STYLE: italic; DISPLAY: inline">Journal of Infectious Diseases</font> 203: 610 (2011)). The full dose DDMM regimen induced higher response rates of CD4+ T-cells (77%) and CD8+ T-cells (42%) compared to the MMM regimen (43% CD4 and 17% CD8 response rates). In contrast, the highest response rates and highest titers of antibodies to the HIV Env protein were induced in the group that received only the MVA using the MMM regimen. Antibody response rates were documented to be higher for the MMM group using three different assays designed to measure total binding antibody levels for an immune dominant portion of the Env protein (27% for DDMM and 75% for MMM), binding of antibodies to the gp120 subunit of the envelope glycoprotein (81% for DDMM and 86% for MMM)&#160;and neutralizing antibodies (7% for DDMM and 30% for MMM). The 1/10th&#160;dose DDMM regimen induced overall similar T-cell responses but reduced antibody responses while the response rates were intermediate in the DMM group.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="fig4.jpg" alt=""></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 4.&#160;&#160;Overview of GeoVax human clinical trials supported by HVTN.</font>&#160;&#160;The efficacy trial is indicated with a dashed line, because it has&#160;yet to be assigned a HVTN trial number.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preventive Vaccine &#8212; Phase 2 Human Clinical Trials. </font>Based on the safety and the immunogenicity results in the HVTN 045 and HVTN 065 trials, the full dose DNA/MVA and MVA-only regimens were selected for testing by the HVTN in a Phase 2a trial (designated HVTN 205) which commenced patient enrollment in February 2009.&#160;&#160;Because the Merck STEP trial had recently shown the Merck adeno virus vectored vaccine increased patient susceptibility to HIV infection, HVTN undertook the trial in low risk individuals to gain additional safety and immunogenicity data. The HVTN 205 trial is fully enrolled and patient inoculations were completed in January 2012.&#160;&#160;We expect study analysis and publication to occur during 2012. Preliminary analysis of data for neutralizing antibody responses have shown elicitation of unexpectedly high response rates for tier 2 isolates of HIV.&#160;&#160;In the DNA/MVA regimen, of 46 tested vaccine recipients, 50% responded with neutralizing activity for tier 2 clade B isolate RHPA, 26% with neutralizing antibody for tier 2 clade B isolate SC22.3C2 and 20% with neutralizing activity for 9020.A3 and CH77.&#160;&#160;In the MVA-only regimen 72% responded with neutralizing Ab for RHPA and 40% with neutralizing Ab for 9020.A3 and CH77. Neutralizing antibodies can block virus from infecting cells by binding to regions of the virus that mediate entry into cells. The elicitation of neutralizing antibody for tier 2 viruses is an important result because tier 2 viruses represent viruses that undergo the most frequent transmission from an infected person to an uninfected person.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preventive Vaccine &#8212; Adjuvanted Vaccine &#8211; Phase 1 to Phase 2b Efficacy Trials </font><font style="FONT-STYLE: italic; DISPLAY: inline">. </font>The HVTN is also sponsoring and conducting clinical testing in humans of a new version of our preventive vaccine that has substantially enhanced prevention of infection in non-human primates (see above).&#160;&#160;This vaccine co-expresses GM-CSF as an adjuvant and achieved a much higher level of prevention of infection than our unadjuvanted vaccine in non-human primate testing.&#160;&#160;Prevention of infection is seen for serial challenges with tested animals being protected against more than 34 challenges administered over&#160;two and one-half years in a &gt;3 year vaccine trial.&#160; The co-expressed GM-CSF enhances antibody responses with the enhanced prevention of infection correlating with enhanced tightness of binding of the antibody to the viral envelope glycoprotein that mediates HIV entry into cells. Commencement of Phase 1 clinical testing of the GM-CSF co-expressing vaccine in a trial designated HVTN 094 is expected to begin in&#160;April 2012.&#160;&#160;The study will be conducted in 48 volunteers and will assess safety and immunogenicity of the adjuvanted vaccine at low-dose and full-dose regimens.&#160;&#160;Pending successful outcome of this trial, we expect to carry forward this version of our preventive vaccine into Phase 2b efficacy testing. The Phase 2b trial is anticipated to have approximately 4000 participants equally divided between placebo and vaccine groups and to be conducted&#160;in the Americas. GeoVax is currently manufacturing product to support the Phase 2b clinical trial so that progression through the development path can proceed as soon as results are available from Phase 1 testing in HVTN 094.&#160;&#160;We have begun conversations with the HVTN regarding protocol development for efficacy testing of the GeoVax vaccine.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Therapeutic Vaccine &#8212; Phase 1/2 Human Clinical Trials. </font>To help treat those people who are already infected with HIV, the Company is testing its vaccine for the ability to supplement, or even supplant, the need for antiretroviral therapeutic drugs in HIV-infected individuals. Antiretroviral therapeutic drugs, which are taken for life by individuals once infected with HIV, have side effects and are expensive, costing $12,000 - $15,000 per year (drug cost only, not including physician visits and related costs).&#160;&#160;And according to a 2010 study by the CDC, of those individuals in the United States who are diagnosed with HIV, only 35% ultimately achieve stable viral load suppression through drug treatment.&#160; Thus, even in the United States where the availability of drugs and treatment is good, there is still&#160;a compelling&#160;need for therapies&#160;that complement drugs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2007-2008, data were generated in three pilot studies on therapeutic vaccination in simian immunodeficiency virus-infected non-human primates. The vaccine used in these pilot studies was specific for simian immunodeficiency virus but with the design features of our HIV/AIDS vaccine. In these pilot studies, conducted at Yerkes National Primate Research Center of Emory University, the immune systems of most infected and then vaccinated animals were able to control the infection.&#160;&#160;This control resulted in median levels of viral replication following post vaccination treatment interruption being 100-times lower than the median for viral replication prior to vaccination.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have received permission from the FDA for a Phase 1/2 clinical trial in HIV-infected individuals and are currently enrolling patients. This initial trial is being conducted in Atlanta, Birmingham, and Los Angeles and will enroll individuals who began successful antiretroviral therapeutic drug treatment within 18 months of a negative HIV-1 antibody test. The primary goals of this clinical trial are to document the safety and immunogenicity of the vaccine using the DDMM regimen in patients with well-controlled infections.&#160;&#160;However, vaccine efficacy will be directly assessed through a brief period of anti-retroviral drug cessation. We expect to complete patient enrollment for this Phase 1/2 clinical trial during 2012 and to begin generating data in 2013.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are also planning a Phase 1 therapeutic clinical trial to investigate the use of our vaccine in combination with standard-of-care drug therapy in young adults.&#160;&#160;This trial would be supported by the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT). The NIH has recently prioritized searching for a cure for those individuals who are HIV positive. Because of the mechanisms by which current oral drugs&#160;&#160;work, if the virus is in a latent phase these drugs are not effective, thus it is impossible to totally eradicate the virus. Current approaches to a cure include using an effective vaccine and oral medication together to more effectively eradicate virus.&#160;&#160;&#160;This trial is planned to have two groups of 20 participants, one of which will remain on drugs while being vaccinated and the second of which will remain on drugs but receive placebo.&#160;&#160;The participants will be monitored for vaccine-associated reductions in viral reservoirs. This trial has been assigned a clinical study number (P-1082) and, pending successful committee reviews and FDA approvals, should initiate before the end of 2012.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Support from the Government</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With the exception of the Phase 1/2 therapeutic trial, all of our Phase 1 human clinical trials, as well as our ongoing Phase 2a clinical trial, have been conducted by the HVTN and funded by NIH.&#160;&#160;The HVTN will also support Phase 1 human clinical testing of our GM-CSF adjuvanted vaccine, and we anticipate their support for the Phase 1 therapeutic trial with IMPAACT. Our responsibility for these clinical trials has been to provide sufficient supplies of vaccine materials and technical expertise when necessary.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2007, we were the recipient of an NIH <font style="FONT-STYLE: italic; DISPLAY: inline">Integrated Preclinical-Clinical AIDS Vaccine Development</font>&#160;&#160;grant to support our HIV/AIDS vaccine program, which was subsequently amended such that the total award now totals approximately $20.4&#160;million. The project period for the grant covers a five-year period that commenced October 1, 2007.&#160;&#160;Only meritorious HIV/AIDS prevention vaccine candidates are considered to receive an IPCAVD award. Candidate companies are highly scrutinized and must supply substantial positive AIDS vaccine data to support their application. IPCAVD grants are awarded on a competitive basis and are designed to support later stage vaccine research, development and human trials. We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production, including the GM-CSF adjuvant program.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulations</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Regulation by governmental authorities in the United States and other countries is a significant factor in our ongoing research and development activities and in the manufacture of our products under development. Complying with these regulations involves a considerable amount of time and expense.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the United States, drugs are subject to rigorous federal and state regulation. The Federal Food, Drug and Cosmetic Act, as amended, or the FDC Act, and the regulations promulgated thereunder, and other federal and state statutes and regulations govern, among other things, the testing, manufacture, safety, efficacy, labeling, storage, record keeping, approval, advertising and promotion of medications and medical devices. Product development and approval within this regulatory framework is difficult to predict, takes a number of years and involves great expense.&#160;&#160;The steps required before a pharmaceutical agent may be marketed in the United States include:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pre-clinical laboratory tests, in vivo pre-clinical studies and formulation studies;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the submission to the FDA of an IND application for human clinical testing which must become effective before human clinical trials can commence;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">adequate and well-controlled human clinical trials to establish the safety and efficacy of the product;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the submission of a New Drug Application to the FDA;&#160;and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA approval of the New Drug Application prior to any commercial sale or shipment of the product.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each of these steps is described further below. In addition to obtaining FDA approval for each product, each domestic manufacturing establishment must be registered with, and approved by, the FDA. Domestic manufacturing establishments are subject to biennial inspections by the FDA and must comply with the FDA&#8217;s Good Manufacturing Practices for products, drugs and devices.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Pre-Clinical Testing. </font>Pre-clinical testing includes laboratory evaluation of chemistry and formulation, as well as cell culture and animal studies to assess the safety and potential efficacy of the product. Pre-clinical safety tests must be conducted by laboratories that comply with the FDA&#8217;s Good Laboratory Practices, or GLP. The results of pre-clinical testing are submitted to the FDA as part of the IND application and are reviewed by the FDA prior to the commencement of human clinical trials. Unless the FDA objects to an IND, the IND becomes effective 30&#160;days following its receipt by the FDA.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Clinical Trials. </font>Clinical trials involve the administration of the HIV vaccines to volunteers or to patients under the supervision of a qualified, medically trained principal investigator. Clinical trials are conducted in accordance with Good Clinical Practices under protocols that detail the objectives of the trial, the parameters to be used to monitor safety and the efficacy criteria to be evaluated. Each protocol must be submitted to the FDA as part of the IND. Further, each clinical trial must be conducted under the auspices of an independent institutional review board at the institution where the trial will be conducted. The institutional review board will consider, among other things, ethical factors, the safety of human subjects and the possible liability of the institution.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Clinical trials are typically conducted in three sequential phases, but the phases may overlap. In the Phase 1 clinical trial, the initial introduction of the product into healthy human subjects, the vaccine is tested for safety (including adverse side effects) and dosage tolerance. The Phase 2 clinical trial is the proof of principal stage and involves trials in a limited patient population to determine whether the product induces the desired effect (for our vaccines this means immune responses) and to better determine optimal dosage. The continued identification of possible safety risks is also a focus. When there is evidence that the product may be effective and has an acceptable safety profile in Phase 2 clinical trials, Phase 3 clinical trials are undertaken to evaluate clinical efficacy and to test for safety within an expanded patient population. Phase&#160;3 trials are completed using multiple clinical study sites which are geographically dispersed. The manufacturer or the FDA may suspend clinical trials at any time if either believes that the individuals participating in the trials are being exposed to unacceptable health risks.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">New Drug Application and FDA Approval Process. </font>The results and details of the pre-clinical studies and clinical trials are submitted to the FDA in the form of a New Drug Application. If the New Drug Application is approved, the manufacturer may market the product in the United States.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">International Approval. </font>Whether or not the FDA has approved the drug, approval of a product by regulatory authorities in foreign countries must be obtained prior to the commencement of commercial sales of the drug in such countries. The requirements governing the conduct of clinical trials and drug approvals vary widely from country to country, and the time required for approval may be longer or shorter than that required for FDA approval.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Other Regulations. </font>In addition to FDA regulations, our business activities may also be regulated by the Occupational Safety and Health Act, the Environmental Protection Act, the Toxic Substances Control Act, the Resource Conservation and Recovery Act and other present and potential future federal, state or local regulations. Violations of regulatory requirements at any stage may result in various adverse consequences, including regulatory delay in approving or refusal to approve a product, enforcement actions, including withdrawal of approval, labeling restrictions, seizure of products, fines, injunctions and/or civil or criminal penalties. Any product that we develop must receive all relevant regulatory approvals or clearances before it may be marketed.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Strategy</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our immediate goal is to bring both our preventive and therapeutic HIV/AIDS vaccines into efficacy testing, with the ultimate goal of becoming a leading biopharmaceutical company that develops differentiated products to prevent and treat serious infections, focusing on unmet medical needs. To achieve these strategic goals, we intend to employ the following strategies:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman, serif; FONT-SIZE: 1pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Focus Our Resources on the Development of Our Therapeutic Vaccine Candidates</font>.&#160;&#160;In the near-term, we plan to focus our resources on developing our therapeutic vaccines to show initial proof of efficacy in humans.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Leverage the Support of Federal Government Agencies for Trials of our Preventive Vaccine</font>.&#160;&#160;The NIH and HVTN have been very supportive of our efforts to date in developing our preventive vaccines, and we intend to continue to solicit their assistance and financial support for the efficacy testing of our preventive vaccines.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Seek the Support of Nongovernmental Organizations</font>.&#160;&#160;We also intend to solicit the support of Nongovernmental Organizations (NGOs) toward the development of our vaccine candidates for the versions of the HIV virus prevalent in the developing world.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Seek Strategic Collaborations to Accelerate the Development of Our Vaccine Candidates to Optimize Economic Returns while Managing Risk</font>.&#160;&#160;We intend to establish strategic licenses and collaborations, partnerships, alliances or enter into other transactions in the future with pharmaceutical or biopharmaceutical companies with greater clinical development, manufacturing and commercialization capabilities that we believe can accelerate the development and/or commercialization of our vaccine candidates.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Seek New Business Opportunities</font>.&#160;&#160;We plan to seek out new business development opportunities to potentially expand our technology and product pipeline or to otherwise provide additional revenue sources.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Manufacturing</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have the facilities or expertise to manufacture any of the clinical or commercial supplies of any of our products. To be successful, our products must be manufactured in commercial quantities in compliance with regulatory requirements and at an acceptable cost. To date, we have not commercialized any products, nor have we demonstrated that we can manufacture commercial quantities of our product candidates in accordance with regulatory requirements. If we cannot manufacture products in suitable quantities and in accordance with regulatory standards, either on our own or through contracts with third parties, it may delay clinical trials, regulatory approvals and marketing efforts for such products. Such delays could adversely affect our competitive position and our chances of achieving profitability. We cannot be sure that we can manufacture, either on our own or through contracts with third parties, such products at a cost or in quantities which are commercially viable.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We currently rely and intend to continue to rely on third-party contract manufacturers to produce vaccines needed for research and clinical trials. We have entered into arrangements with third party manufacturers for the supply of our DNA and MVA vaccines for use in our planned clinical trials. These suppliers operate under the FDA&#8217;s Good Manufacturing Practices and similar regulations of the European Medicines Agency. We anticipate that these suppliers will be able to provide sufficient vaccine supplies to complete our currently planned clinical trials. Various contractors are generally available in the United States and Europe for manufacture of vaccines for clinical trial evaluation, however, it may be difficult to replace existing contractors for certain manufacturing and testing activities and costs for contracted services may increase substantially if we switch to other contractors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Development of Improved Manufacturing Techniques for MVA &#8211; </font>The MVA component of our vaccine is currently manufactured in cells that are cultured from embryonated eggs.&#160;&#160;&#160;This is cumbersome and prone to contamination during the processing of the eggs required to make a large batch of vaccine.&#160;&#160;GeoVax has explored a number of approaches to growing MVA in continuous cell lines that can be grown in bioreactors. In this process we have identified a duck stem-cell-derived line (termed EB66), that is proprietary to Vivalis, Ltd, Nantes France. We are currently working with Vivalis on the use of EB66 cells for the growth of our MVA vaccines and are pleased with the results the collaboration is obtaining. We anticipate that by the time process development is complete we will be producing at least 10-times higher titers of virus per ml than we currently achieve.&#160;&#160;The U.S. FDA has reviewed our plans for transitioning from MVA growth in egg-derived cells to a continuous cell line.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Competition</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There currently is no FDA licensed and commercialized HIV/AIDS vaccine or competitive vaccine available in the world market. However, the market for vaccines that protect against or treat HIV/AIDS is intensely competitive and is subject to rapid and significant technological change. We will have numerous competitors in the United States and abroad, including large companies with substantially greater resources than us. These competitors may develop technologies and products that are more effective or less costly than any of our future technology or products or that could render our technology or products obsolete or noncompetitive.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several small and large biopharmaceutical companies pursuing HIV/AIDS vaccine research and development, including Novartis, Sanofi-Aventis and GlaxoSmithKline. Other HIV/AIDS vaccines are in varying stages of research, testing and clinical trials including those supported by the NIH Vaccine Research Center, the U.S. Military, IAVI, the European Vaccine Initiative, and the South African AIDS Vaccine Initiative. Following the reported failure of the vaccine developed by Merck&#160;&amp; Co., Inc. in September 2007, Merck&#160;&amp; Co., Inc.&#8217;s vaccine program and the NIH Vaccine Research Center vaccine program, both of which use Ad5 vectors, were placed on hold. Since then, the NIH Vaccine Research Center product has moved into an experimental Phase 2b clinical trial to learn more about immune responses and AIDS control. This clinical trial has been restricted to individuals who do not have high levels of antibodies to the Ad5 vector used in the vaccine (approximately 50% of U.S.&#160;citizens) and to men who are circumcised.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In October 2009, the results from a Phase 3 community-based clinical trial in Thailand using a recombinant canarypox (designated ALVAC and produced by Sanofi Pasteur) as a priming vaccine and a bivalent mixture of the gp120 subunit of Env from HIV clades&#160;B and C (produced by VaxGen, Inc. and currently licensed to Global Solutions for Infectious Diseases) as a protein booster vaccine were reported. In this clinical trial, protection against HIV infection at the rate of 31% was reported. This level of protection was significant in a &#8220;modified intent to treat&#8221; analysis in which the seven participants in the 16,500&#160;person trial who had become infected by the day of the first inoculation were excluded. The results of this clinical trial are encouraging because they represent the first success of an AIDS vaccine in humans and demonstrate that a vaccine can provide protection against HIV infections.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To our knowledge, none of our competitors&#8217; products have been tested in large scale non-human primate trials that have included experimental infection through the rectal site and shown to induce levels of protection or duration of protection comparable to that achieved using experimental prototypes of GeoVax&#8217;s vaccines. Furthermore, many of our competitors&#8217; vaccine development programs require vaccine compositions which are more complicated than ours. For these reasons, we believe that it may be possible for our vaccine to compete successfully in the marketplace if licensed.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overall, the biopharmaceutical industry is competitive and subject to rapid and substantial technological change. Developments by others may render our proposed vaccination technologies noncompetitive or obsolete, or we may be unable to keep pace with technological developments or other market factors. Technological competition in the industry from pharmaceutical and biotechnology companies, universities, governmental entities and others diversifying into the field is intense and is expected to increase. Many of the pharmaceutical companies that compete with us have significantly greater research and development capabilities than we have, as well as substantially more marketing, manufacturing, and financial resources. In addition, acquisitions of, or investments in, small pharmaceutical or biotechnology companies by such large corporations could increase their research, financial, marketing, manufacturing and other resources. Competitive technologies may ultimately prove to be safer, more effective or less costly than any vaccine that we develop.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA and other regulatory approvals of our vaccines have not yet been obtained and we have not yet generated any revenues from product sales. Our future competitive position depends on our ability to obtain FDA and other regulatory approvals of our vaccines and to license or sell the vaccines to third parties on favorable terms.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Intellectual Property</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary rights are described by valid and enforceable patents or are effectively maintained as trade secrets. Accordingly, we are pursuing and will continue to pursue patent protection for our proprietary technologies developed through our collaborations with Emory University, the NIH, and the CDC, or developed by us alone. Patent applications have been filed with the U.S. Patent and Trademark Office and in specific international markets (countries). Patent applications include provisions to cover our DNA and MVA based HIV vaccines, their genetic inserts expressing multiple HIV protein components, composition, structure, claim of immunization against multiple subtypes of HIV, routes of administration, safety and other related factors. Patent claims filed for our vaccines include provisions for their therapeutic and prophylactic use against HIV and smallpox.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are the exclusive, worldwide licensee of a number of patents and patent applications, which we refer to as the Emory Technology, owned, licensed or otherwise controlled by Emory University for HIV or smallpox vaccines pursuant to a License Agreement originally entered into on August&#160;23, 2002 and restated on June&#160;23, 2004, which we refer to as the Emory License. Through the Emory License we are also a non-exclusive licensee of four issued United States patents owned by the NIH related to the ability of our MVA vector vaccine to operate as a vehicle to deliver HIV virus antigens, and also to induce an immune response in humans. The four issued United States patents owned by the NIH expire in 2023. All of our obligations with respect to the NIH-owned MVA patents are covered by the Emory License. In addition to the issued United States patents owned by the NIH, and a recently issued patent owned by Emory&#160;University, there are six issued and five pending United States patent applications, 29&#160;issued or pending patents in countries other than the United States. The Emory License expires on the expiration date of the last to expire of the patents licensed thereunder including those that are issued on patents currently pending. We will not know the final termination date of the Emory License until such patents are issued. The Company may terminate the Emory University License upon 90&#160;days&#8217; written notice. The Emory License also contains standard provisions allowing Emory University to terminate upon breach of contract by the Company or upon the Company&#8217;s bankruptcy.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Emory License, among other contractual obligations, requires payments based on the following:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Milestone Payments.</font>&#160;&#160;An aggregate of $3,450,000 is potentially due to Emory University in the future upon the achievement of clinical development and regulatory approval milestones as defined in the Emory License. To date, we have paid a nominal milestone fee upon entering Phase 2 clinical trials for our preventive HIV/AIDS vaccine.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Maintenance Fees.</font>&#160;&#160;The Company has achieved the specified milestones and met its obligations with regard to the related payments, and no maintenance fees are (or will be) owed to Emory University.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Royalties.</font>&#160;&#160;Upon commercialization of products covered by the Emory License, we will owe royalties to Emory University of between 5% and 7.5%, depending on annual sales volume, of net sales made directly by GeoVax. The Emory License also requires minimum annual royalty payments of $3&#160;million in the third year following product launch, increasing annually to $12&#160;million in the sixth year.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Sublicense Royalties.</font>&#160;&#160;In the event that we sublicense a covered product to a third party, we will owe royalties to Emory University based on all payments, cash or noncash, that we receive from our sublicensees. Those royalties will be 19% of all sublicensing consideration we receive prior to the first commercial sale of a related product. Commencing with the first commercial sale, the royalty owed to Emory University will be 27.5% of all sublicensing consideration we receive.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Patent Reimbursements.</font>&#160;&#160;During the term of the Emory License we are obligated to reimburse Emory University for ongoing third party costs in connection with the filing, prosecution and maintenance of patent applications subject to the Emory License. The expense associated with these ongoing patent cost reimbursements to Emory University amounted to $249,907, $193,674, and $85,673 for the years ended December 31, 2011, 2010 and 2009, respectively.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may only use the Emory Technology for therapeutic or prophylactic HIV or smallpox vaccines. Emory University also reserved the right to use the Emory Technology for research, educational and non-commercial clinical purposes. Due to the use of federal funds in the development of the Emory Technology, the U.S. Government has the irrevocable, royalty-free, paid-up right to practice and have practiced certain patents throughout the world, should it choose to exercise such rights.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are not a party to any litigation, opposition, interference, or other potentially adverse proceeding with regard to our patent positions. However, if we become involved in litigation, interference proceedings, oppositions or other intellectual property proceedings, for example as a result of an alleged infringement or a third-party alleging an earlier date of invention, we may have to spend significant amounts of money and time and, in the event of an adverse ruling, we could be subject to liability for damages, invalidation of our intellectual property and injunctive relief that could prevent us from using technologies or developing products, any of which could have a significant adverse effect on our business, financial conditions or results of operations. In addition, any claims relating to the infringement of third-party proprietary rights, or earlier date of invention, even if not meritorious, could result in costly litigation, lengthy governmental proceedings, divert management&#8217;s attention and resources and require us to enter royalty or license agreements which are not advantageous if available at all.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are also the exclusive licensee of five patents from MFD, Inc., which we refer to as the MFD Patents, pursuant to a license agreement dated December 26, 2004 with MFD, Inc., which we refer to as the MFD license agreement, related to certain manufacturing processes used in the production of our vaccines. Pursuant to the MFD license agreement, we obtained a fully paid, worldwide, irrevocable, exclusive license in and to the MFD Patents to use, market, offer for sale, sell, lease and import any AIDS and smallpox vaccine made with GeoVax Technology, as such term is defined in the MFD license agreement, and non-exclusive rights for other products. The term of the MFD license agreement ends on the expiration date of the last to expire of the MFD Patents, one of which expires in 2017. The license granted also extends to any and all current or future customers of GeoVax the right to commercially practice the GeoVax Technology, as such term is defined in the MFD license agreement, or any portion thereof. The license also extends to any and all current or future GeoVax Users, as such term is defined in the MFD license agreement, the right to use any GeoVax Technology, as such term is defined in the MFD license agreement.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to patent protection, we also attempt to protect our proprietary products, processes and other information by relying on trade secrets and non-disclosure agreements with our employees, consultants and certain other persons who have access to such products, processes and information. Under these agreements, all inventions conceived by employees are our exclusive property. Nevertheless, there can be no assurance that these agreements will afford significant protection against misappropriation or unauthorized disclosure of our trade secrets and confidential information.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We cannot be certain that any of the current pending patent applications we have licensed, or any new patent applications we may file or license, will ever be issued in the United States or any other country. Even if issued, there can be no assurance that those patents will be sufficiently broad to prevent others from using our products or processes. Furthermore, our patents, as well as those we have licensed or may license in the future, may be held invalid or unenforceable by a court, or third parties could obtain patents that we would need to either license or to design around, which we may be unable to do. Current and future competitors may have licensed or filed patent applications or received patents, and may acquire additional patents or proprietary rights relating to products or processes competitive to ours. In addition, any claims relating to the infringement of third-party proprietary rights, or earlier date of invention, even if not meritorious, could result in costly litigation, lengthy governmental proceedings, divert management&#8217;s attention and resources and require us to enter royalty or license agreements which are not advantageous to us, if available at all.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our expenditures for research and development activities were $4,276,375, $4,793,956, and $4,068,682 during the years ended December 31, 2011, 2010 and 2009, respectively. As our vaccines continue to go through the process to obtain regulatory approval, we expect our research and development costs to continue to increase significantly as even larger human clinical trials proceed in the United States and foreign countries. We have not yet formulated any plans for marketing and sales of any vaccine candidate we may successfully develop. Compliance with environmental protection laws and regulations has not had a material effect on our capital expenditures, earnings or competitive position to date.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Properties and Employees</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia under a 62 month lease agreement which began November 1, 2009.&#160;&#160;We believe this space is adequate for our current needs. As of March 30, 2012, we had thirteen full-time and one part-time employees.&#160;&#160;None of our employees are covered by collective bargaining agreements and we believe that our employee relations are good.</font><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Background and Structure</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our primary business is conducted by our subsidiary, GeoVax, Inc., which was incorporated under the laws of Georgia in June 2001.&#160;&#160;The predecessor of our parent company, GeoVax Labs, Inc. (the reporting entity) was originally incorporated in June 1988 under the laws of Illinois as Dauphin Technology, Inc. (&#8220;Dauphin&#8221;).&#160;&#160;In September 2006, Dauphin completed a merger (the &#8220;Merger&#8221;) with GeoVax, Inc.&#160;&#160;As a result of the Merger, GeoVax, Inc. became a wholly-owned subsidiary of Dauphin, and Dauphin changed its name to GeoVax Labs, Inc.&#160;&#160;Unless otherwise indicated, information for periods prior to the September 2006 merger is that of GeoVax, Inc.&#160;&#160;In June 2008, the Company was reincorporated under the laws of Delaware.&#160;&#160;We currently do not conduct any business other than GeoVax, Inc.&#8217;s business of developing new products for the treatment or prevention of human diseases.&#160;&#160;Our principal offices are located in Smyrna, Georgia (metropolitan Atlanta).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available Information</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our website address is www.geovax.com.&#160;&#160;We make available on this website under &#8220;Investors &#8211; SEC Reports,&#8221; free of charge, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports as soon as reasonably practicable after we electronically file or furnish such materials to the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;We also make available our Code of Ethics on this website under the heading &#8220;Investors&#8211;Corporate Governance&#8221;.&#160;&#160;Information contained on our website is not incorporated into this Form 10-K.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">RISK FACTORS</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We face a number of substantial risks.&#160;&#160;Our business, financial condition, results of operations and stock price could be materially adversely affected by any of these risks.&#160;&#160;The following factors should be considered in connection with the other information contained in this Annual Report on Form 10-K, including our financial statements and the related notes.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Financial Results and Need for Additional Financing</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have a history of operating losses, and we expect losses to continue for the foreseeable future.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have had no product revenue to date and there can be no assurance that we will ever generate any product revenue. We have experienced operating losses since we began operations in 2001. As of December 31, 2011, we had an accumulated deficit of approximately $22.6 million. We expect to incur additional operating losses and expect cumulative losses to increase as our research and development, pre-clinical, clinical, manufacturing and marketing efforts expand. Our ability to generate revenue and achieve profitability depends on our ability to successfully complete the development of our product candidates, conduct pre-clinical tests and clinical trials, obtain the necessary regulatory approvals, and manufacture and market the resulting products. Unless we are able to successfully meet these challenges, we will not be profitable and may not remain in business.</font><br>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our business will require continued funding. If we do not receive adequate funding, we will not be able to continue our operations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To date, we have financed our operations principally through the private placement of equity securities and through NIH grants. We will require substantial additional financing at various intervals for our operations, including clinical trials, operating expenses, intellectual property protection and enforcement, for pursuit of regulatory approvals, and for establishing or contracting out manufacturing, marketing and sales functions. There is no assurance that such additional funding will be available on terms acceptable to us or at all. If we are not able to secure the significant funding that is required to maintain and continue our operations at current levels, or at levels that may be required in the future, we may be required to delay clinical studies or clinical trials, curtail operations, or obtain funds through collaborative arrangements that may require us to relinquish rights to some of our products or potential markets.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The costs of conducting all of our human clinical trials to date have been borne by the HVTN, funded by the NIH, with GeoVax incurring costs associated with manufacturing the clinical vaccine supplies and other study support. This includes the cost of conducting the ongoing Phase 2a human clinical study of our preventive vaccine. We cannot predict the level of support we will receive from the HVTN or the NIH for any additional clinical trials. We are currently not receiving any governmental support for our Phase 1/2 therapeutic vaccine human clinical trial.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operations are also partially supported by the IPCAVD grant awarded to us to support our HIV/AIDS vaccine program. The project period for the grant covers a five year period which commenced October 2007, with an aggregate award of $20.4 million. As of December 31, 2011, there is approximately $3.9 million of unused grant funds remaining and available for use through August 31, 2012 (the end of the original project period). We intend to pursue additional grants from the federal government. However, as we progress to the later stages of our vaccine development activities, government financial support may be more difficult to obtain, or may not be available at all. Therefore, it will be necessary for us to look to other sources of funding in order to finance our development activities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current working capital, combined with proceeds from the IPCAVD grant awarded from the NIH will be sufficient to support our planned level of operations into the first quarter of 2013.&#160;&#160;In order to meet our operating cash flow requirements we plan additional offerings of our equity securities, debt, or convertible debt instruments.&#160;&#160;Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could have a material adverse effect on our business, operating results, financial condition and prospects.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The current economic conditions may adversely impact our ability to raise capital.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The recession and adverse conditions in the national and global markets may negatively affect both our ability to raise capital and our operations in the future. The volatile equity markets and adverse credit markets may make it difficult for us to raise capital or procure credit in the future to fund the growth of our business, which could have a negative impact on our business and results of operations.</font><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Development and Commercialization of Product Candidates and Dependence on Third Parties</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our products are still being developed and are unproven. These products may not be successful.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To become profitable, we must generate revenue through sales of our products. However our products are in varying stages of development and testing. Our products have not been proven in human clinical trials and have not been approved by any government agency for sale. If we cannot successfully develop and prove our products and processes, or if we do not develop other sources of revenue, we will not become profitable and at some point we would discontinue operations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Whether we are successful will be dependent, in part, upon the leadership provided by our management. If we were to lose the services of any of these individuals, our business and operations may be adversely affected. Further, we may not carry key man life insurance on our executive officers or directors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Whether our business will be successful will be dependent, in part, upon the leadership provided by our officers, particularly our President and Chief Executive Officer and our Chief Scientific Officer. The loss of the services of these individuals may have an adverse effect on our operations. Although we carry some key man life insurance on Dr.&#160;Harriet L. Robinson, the amount of such coverage may not be sufficient to offset any adverse economic effects on our operations and we do not carry key man insurance on any of our other executive officers or directors. Further, our employees, including our executive officers and directors, are not subject to any covenants not to compete against the Company, and our business could be adversely affected if any of our employees or directors engaged in an enterprise competitive with the Company.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulatory and legal uncertainties could result in significant costs or otherwise harm our business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To manufacture and sell our products, we must comply with extensive domestic and international regulation. In order to sell our products in the United States, approval from the FDA is required. Satisfaction of regulatory requirements, including FDA requirements, typically takes many years, and if approval is obtained at all, it is dependent upon the type, complexity and novelty of the product, and requires the expenditure of substantial resources. We cannot predict whether our products will be approved by the FDA. Even if they are approved, we cannot predict the time frame for approval. Foreign regulatory requirements differ from jurisdiction to jurisdiction and may, in some cases, be more stringent or difficult to meet than FDA requirements. As with the FDA, we cannot predict if or when we may obtain these regulatory approvals. If we cannot demonstrate that our products can be used safely and successfully in a broad segment of the patient population on a long-term basis, our products would likely be denied approval by the FDA and the regulatory agencies of foreign governments.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will face intense competition and rapid technological change that could result in products that are superior to the products we will be commercializing or developing.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market for vaccines that protect against or treat HIV/AIDS is intensely competitive and is subject to rapid and significant technological change. We will have numerous competitors in the United States and abroad, including, among others, large companies with substantially greater resources than us. These competitors may develop technologies and products that are more effective or less costly than any of our future technology or products or that could render our technology or products obsolete or noncompetitive. If our technology or products are not competitive, we may not be able to remain in business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our product candidates are based on new medical technology and, consequently, are inherently risky. Concerns about the safety and efficacy of our products could limit our future success.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to the risks of failure inherent in the development of product candidates based on new medical technologies. These risks include the possibility that the products we create will not be effective, that our product candidates will be unsafe or otherwise fail to receive the necessary regulatory approvals, and that our product candidates will be hard to manufacture on a large scale or will be uneconomical to market.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Many pharmaceutical products cause multiple potential complications and side effects, not all of which can be predicted with accuracy and many of which may vary from patient to patient. Long term follow-up data may reveal additional complications associated with our products. The responses of potential physicians and others to information about complications could materially affect the market acceptance of our products, which in turn would materially harm our business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may experience delays in our clinical trials that could adversely affect our financial results and our commercial prospects.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not know whether planned clinical trials will begin on time or whether we will complete any of our clinical trials on schedule, if at all. Product development costs will increase if we have delays in testing or approvals or if we need to perform more or larger clinical trials than planned. Significant delays may adversely affect our financial results and the commercial prospects for our products, and delay our ability to become profitable.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We rely heavily on the HVTN, independent clinical investigators, and other third party service providers for successful execution of our clinical trials, but do not control many aspects of their activities. We are responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with standards, commonly referred to as Good Clinical Practices, for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. Our reliance on third parties that we do not control does not relieve us of these responsibilities and requirements. Third parties may not complete activities on schedule, or may not conduct our clinical trials in accordance with regulatory requirements or our stated protocols. The failure of these third parties to carry out their obligations could delay or prevent the development, approval and commercialization of our product candidates.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Failure to obtain timely regulatory approvals required to exploit the commercial potential of our products could increase our future development costs or impair our future sales.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None of our vaccines are approved by the FDA for sale in the United States or by other regulatory authorities for sale in foreign countries. To exploit the commercial potential of our technologies, we are conducting and planning to conduct additional pre-clinical studies and clinical trials. This process is expensive and can require a significant amount of time. Failure can occur at any stage of testing, even if the results are favorable. Failure to adequately demonstrate safety and efficacy in clinical trials could delay or preclude regulatory approval and restrict our ability to commercialize our technology or products. Any such failure may severely harm our business. In addition, any approvals we obtain may not cover all of the clinical indications for which approval is sought, or may contain significant limitations in the form of narrow indications, warnings, precautions or contraindications with respect to conditions of use, or in the form of onerous risk management plans, restrictions on distribution, or post-approval study requirements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State pharmaceutical marketing compliance and reporting requirements may expose us to regulatory and legal action by state governments or other government authorities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In recent years, several states have enacted legislation requiring pharmaceutical companies to establish marketing compliance programs and file periodic reports on sales, marketing, pricing and other activities. Similar legislation is being considered in other states. Many of these requirements are new and uncertain, and available guidance is limited. Unless we are in full compliance with these laws, we could face enforcement action and fines and other penalties and could receive adverse publicity, all of which could harm our business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be subject to new federal and state legislation to submit information on our open and completed clinical trials to public registries and databases.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 1997, a public registry of open clinical trials involving drugs intended to treat serious or life-threatening diseases or conditions was established under the FDA Modernization Act, or the FDMA, to promote public awareness of and access to these clinical trials. Under the FDMA, pharmaceutical manufacturers and other trial sponsors are required to post the general purpose of these trials, as well as the eligibility criteria, location and contact information of the trials. Since the establishment of this registry, there has been significant public debate focused on broadening the types of trials included in this or other registries, as well as providing for public access to clinical trial results. A voluntary coalition of medical journal editors has adopted a resolution to publish results only from those trials that have been registered with a no-cost, publicly accessible database, such as www.clinicaltrials.gov. Federal legislation was introduced in the fall of 2004 to expand www.clinicaltrials.gov and to require the inclusion of trial results in this registry. The Pharmaceutical Research and Manufacturers of America also issued voluntary principles for its members to make results from certain clinical trials publicly available and established a website for this purpose. Other groups have adopted or are considering similar proposals for clinical trial registration and the posting of clinical trial results. Failure to comply with any clinical trial posting requirements could expose us to negative publicity, fines and other penalties, all of which could materially harm our business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will face uncertainty related to pricing and reimbursement and health care reform.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In both domestic and foreign markets, sales of our products will depend in part on the availability of reimbursement from third-party payers such as government health administration authorities, private health insurers, health maintenance organizations and other health care-related organizations. Reimbursement by such payers is presently undergoing reform and there is significant uncertainty at this time how this will affect sales of certain pharmaceutical products.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Medicare, Medicaid and other governmental healthcare programs govern drug coverage and reimbursement levels in the United States. Federal law requires all pharmaceutical manufacturers to rebate a percentage of their revenue arising from Medicaid-reimbursed drug sales to individual states. Generic drug manufacturers&#8217; agreements with federal and state governments provide that the manufacturer will remit to each state Medicaid agency, on a quarterly basis, 11% of the average manufacturer price for generic products marketed and sold under abbreviated new drug applications covered by the state&#8217;s Medicaid program. For proprietary products, which are marketed and sold under new drug applications, manufacturers are required to rebate the greater of (a)&#160;15.1% of the average manufacturer price or (b)&#160;the difference between the average manufacturer price and the lowest manufacturer price for products sold during a specified period.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Both the federal and state governments in the United States, and foreign governments, continue to propose and pass new legislation, rules and regulations designed to contain or reduce the cost of health care. Existing regulations that affect the price of pharmaceutical and other medical products may also change before any of our products are approved for marketing. Cost control initiatives could decrease the price that we receive for any product developed in the future. In addition, third-party payers are increasingly challenging the price and cost-effectiveness of medical products and services and litigation has been filed against a number of pharmaceutical companies in relation to these issues. Additionally, some uncertainty may exist as to the reimbursement status of newly approved injectable pharmaceutical products. Our products may not be considered cost-effective or adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an adequate return on our investment.</font><br>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may not be successful in establishing collaborations for product candidates we may seek to commercialize, which could adversely affect our ability to discover, develop, and commercialize products.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect to seek collaborations for the development and commercialization of product candidates in the future. The timing and terms of any collaboration will depend on the evaluation by prospective collaborators of the clinical trial results and other aspects of our vaccine&#8217;s safety and efficacy profile. If we are unable to reach agreements with suitable collaborators for any product candidate, we will be forced to fund the entire development and commercialization of such product candidates, ourselves, and we may not have the resources to do so. If resource constraints require us to enter into a collaboration agreement early in the development of a product candidate, we may be forced to accept a more limited share of any revenues this product may eventually generate. We face significant competition in seeking appropriate collaborators. Moreover, these collaboration arrangements are complex and time-consuming to negotiate and document. We may not be successful in our efforts to establish collaborations or other alternative arrangements for any product candidate. Even if we are successful in establishing collaborations, we may not be able to ensure fulfillment by collaborators of their obligations or our expectations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We do not have manufacturing, sales or marketing experience.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have experience in manufacturing, selling, or marketing vaccines. To obtain the expertise necessary to successfully manufacture, market, and sell our vaccines, we will require the development of our own commercial infrastructure and/or collaborative commercial arrangements and partnerships. Our ability to execute our current operating plan is dependent on numerous factors, including, the performance of third party collaborators with whom we may contract.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our vaccines under development may not gain market acceptance.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines may not gain market acceptance among physicians, patients, healthcare payers and the medical community. Significant factors in determining whether we will be able to compete successfully include:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the efficacy and safety of our vaccines;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the time and scope of regulatory approval;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">reimbursement coverage from insurance companies and others;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the price and cost-effectiveness of our products, and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the ability to maintain patent protection.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be required to defend lawsuits or pay damages for product liability claims.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Product liability is a major risk in testing and marketing biotechnology and pharmaceutical products. We may face substantial product liability exposure in human clinical trials and for products that we sell after regulatory approval. We carry product liability insurance and we expect to continue such policies. However, product liability claims, regardless of their merits, could exceed policy limits, divert management&#8217;s attention, and adversely affect our reputation and the demand for our products.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Intellectual Property</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We could lose our license rights to our important intellectual property if we do not fulfill our contractual obligations to our licensors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our rights to significant parts of the technology we use in our vaccines are licensed from third parties and are subject to termination if we do not fulfill our contractual obligations to our licensors. Termination of intellectual property rights under any of our license agreements could adversely impact our ability to produce or protect our vaccines. Our obligations under our license agreements include requirements that we make milestone payments to our licensors upon the achievement of clinical development and regulatory approval milestones, royalties as we sell commercial products, and reimbursement of patent filing and maintenance expenses. Should we become bankrupt or otherwise unable to fulfill our contractual obligations, our licensors could terminate our rights to critical technology that we rely upon.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other parties may claim that we infringe their intellectual property or proprietary rights, which could cause us to incur significant expenses or prevent us from selling products.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our success will depend in part on our ability to operate without infringing the patents and proprietary rights of third parties. The manufacture, use and sale of new products have been subject to substantial patent rights litigation in the pharmaceutical industry. These lawsuits generally relate to the validity and infringement of patents or proprietary rights of third parties. Infringement litigation is prevalent with respect to generic versions of products for which the patent covering the brand name product is expiring, particularly since many companies that market generic products focus their development efforts on products with expiring patents. Pharmaceutical companies, biotechnology companies, universities, research institutions or other third parties may have filed patent applications or may have been granted patents that cover aspects of our products or our licensors&#8217; products, product candidates or other technologies.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future or existing patents issued to third parties may contain patent claims that conflict with our products. We expect to be subject to infringement claims from time to time in the ordinary course of business, and third parties could assert infringement claims against us in the future with respect to our current products or with respect to products that we may develop or license. Litigation or interference proceedings could force us to:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">stop or delay selling, manufacturing or using products that incorporate, or are made using the challenged intellectual property;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pay damages; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">enter into licensing or royalty agreements that may not be available on acceptable terms, if at all.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any litigation or interference proceedings, regardless of their outcome, would likely delay the regulatory approval process, be costly and require significant time and attention of our key management and technical personnel.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Any inability to protect intellectual property rights in the United States and foreign countries could limit our ability to manufacture or sell products.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will rely on trade secrets, unpatented proprietary know-how, continuing technological innovation and, in some cases, patent protection to preserve our competitive position. Our patents and licensed patent rights may be challenged, invalidated, infringed or circumvented, and the rights granted in those patents may not provide proprietary protection or competitive advantages to us. We and our licensors may not be able to develop patentable products. Even if patent claims are allowed, the claims may not issue, or in the event of issuance, may not be sufficient to protect the technology owned by or licensed to us. If patents containing competitive or conflicting claims are issued to third parties, we may be prevented from commercializing the products covered by such patents, or may be required to obtain or develop alternate technology. In addition, other parties may duplicate, design around or independently develop similar or alternative technologies.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may not be able to prevent third parties from infringing or using our intellectual property, and the parties from whom we may license intellectual property may not be able to prevent third parties from infringing or using the licensed intellectual property. We generally will attempt to control and limit access to, and the distribution of, our product documentation and other proprietary information. Despite efforts to protect this proprietary information, unauthorized parties may obtain and use information that we may regard as proprietary. Other parties may independently develop similar know-how or may even obtain access to these technologies.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The laws of some foreign countries do not protect proprietary information to the same extent as the laws of the United States, and many companies have encountered significant problems and costs in protecting their proprietary information in these foreign countries.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Neither the U.S.&#160;Patent and Trademark Office nor the courts have established a consistent policy regarding the breadth of claims allowed in pharmaceutical patents. The allowance of broader claims may increase the incidence and cost of patent interference proceedings and the risk of infringement litigation. On the other hand, the allowance of narrower claims may limit the value of our proprietary rights.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Common Stock</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The market price of our common stock is highly volatile.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market price of our common stock has been, and is expected to continue to be, highly volatile. Certain factors, including announcements of new developments by us or other companies, regulatory matters, new or existing medicines or procedures, concerns about our financial position, operating results, litigation, government regulation, developments or disputes relating to agreements, patents or proprietary rights, may have a significant impact on the market price of our stock. In addition, potential dilutive effects of future sales of shares of common stock by us, and subsequent sales of common stock by the holders of warrants and options could have an adverse effect on the market price of our shares.</font><br>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our common stock does not have a vigorous trading market and investors may not be able to sell their securities when desired.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have a limited active public market for our common shares.&#160;&#160;A more active public market, allowing investors to sell large quantities of our common stock, may never develop. Consequently, investors may not be able to liquidate their investments in the event of an emergency or for any other reason.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have never paid dividends and have no plans to do so.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Holders of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid no cash dividends on our shares of common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future. We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any potential return investors in our common stock may have will be in the form of appreciation, if any, in the market value of their shares of common stock.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to reporting obligations under the United States securities laws. The Securities and Exchange Commission, or the SEC, as required by the Sarbanes-Oxley Act of 2002, adopted rules requiring every public company to include a management report on such company&#8217;s internal controls over financial reporting in its annual report. Effective internal controls are necessary for us to produce reliable financial reports and are important to help prevent fraud. As a result, our failure to achieve and maintain effective internal controls over financial reporting could result in the loss of investor confidence in the reliability of our financial statements, which in turn could negatively impact the trading price of our stock.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to remain current in our reporting requirements, our securities could be removed from the OTC Bulletin&#160;Board, which would limit the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">United States companies trading on the OTC Bulletin&#160;Board must be reporting issuers under Section&#160;12 of the Exchange Act, and must be current in their reports under Section&#160;13. If we fail to remain current on our reporting requirements, we could be removed from the OTC Bulletin&#160;Board. As a result, the market liquidity for our securities could be severely adversely affected by limiting the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We expect to need additional capital, and the sale of additional shares or other equity securities could result in additional dilution to our stockholders.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that our current cash and cash equivalents, combined with anticipated cash flow from the IPCAVD grant, will be sufficient to meet our anticipated cash needs into the first quarter of 2013.&#160;&#160;In order to meet our operating cash flow requirements we plan additional offerings of our equity securities, debt, or convertible debt instruments. The sale of additional equity securities could result in additional dilution to our stockholders.&#160;&#160;Certain equity securities, such as convertible preferred stock, or warrants, may contain anti-dilution provisions which could result in the issuance of additional shares at lower prices if we sell other shares below specified prices.&#160;&#160;The incurrence of indebtedness would result in debt service obligations and could result in operating and financing covenants that would restrict our operations. We cannot assure investors that financing will be available in amounts or on terms acceptable to us, if at all.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our directors and executive officers beneficially own a significant amount of our common stock and will be able to exercise significant influence on matters requiring stockholder approval.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our directors and executive officers collectively beneficially own approximately 14.3% of our common stock as of March 30, 2012.&#160;&#160;Consequently, our directors and executive officers as a group are able to exert significant influence over the election of directors and the outcome of most corporate actions requiring stockholder approval and our business, which may have the effect of delaying or precluding a third party from acquiring control of us. Furthermore, Emory University beneficially owns 27.4% of our common stock as of March 30, 2012. If our directors and executive officers move to act in concert with Emory University, their ability to influence stockholder actions will be even more significant.</font><br>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The exercise of warrants or options or conversion of our Series A Convertible Preferred Stock may depress our stock price and may result in significant dilution to our common stockholders<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are a significant number of outstanding warrants and options to purchase our stock and we have issued Series A Convertible Preferred Stock that is convertible into our Common Stock. If the market price of our Common Stock exceeds the exercise price of outstanding warrants and options or the conversion price of the Series A Convertible Preferred Stock, holders of those securities may be likely to exercise their warrants and options or convert their preferred shares and sell the Common Stock acquired upon exercise or conversion of such securities, as applicable, in the open market. Sales of a substantial number of shares of our Common Stock in the public market by holders of warrants, options, or preferred shares may depress the prevailing market price for our Common Stock and could impair our ability to raise capital through the future sale of our equity securities. Additionally, if the holders of outstanding options, warrants, or preferred shares exercise those options or warrants or convert those preferred shares, as applicable, our common stockholders will incur dilution in their relative percentage ownership.&#160;&#160;The prospect of this possible dilution may also impact the price of our Common Stock.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our outstanding warrants include warrants to purchase up to 8,799,999 shares of our Common Stock that were issued in March 2012.&#160;&#160;Of these, warrants to purchase up to 2,933,333 shares have an exercise price of $0.75 per share, and warrants to purchase up to 5,866,666 shares have an exercise price of $1.00 per share. These warrants contain anti-dilution provisions, which may, under certain circumstances,&#160;&#160;reduce the exercise price (but have no effect on the number of shares subject to the warrants) to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the exercise price of the warrants, or if we announce plans to do so.&#160;&#160;This potential reduction in exercise price could reduce the funds the Company receives upon exercise of the warrants, and increase the likelihood that a dilutive issuance will occur.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Series A Convertible Preferred Stock provides for an adjustment to the conversion price if on specified dates certain conditions relating to the ability of the holders to sell the Common Stock issuable upon conversion of the preferred shares pursuant to either an effective registration statement under the Securities Act of 1933 or Rule 144 are not satisfied, then the conversion price shall be reduced to the lesser of (a) the then conversion price, as adjusted and taking into consideration any prior resets, (b) 85% of the volume weighted average price of the Common Stock for the 5 trading days immediately following each such date, as calculated pursuant to the AQR function on Bloomberg L.P., (c) 85% of the average of the volume weighted average prices for the Common Stock for each of the 5 trading days immediately following the date and (d) 85% of the closing bid price on the last trading day of the 5 trading days immediately following each such date, which shall thereafter be the new conversion price. The adjusted Conversion Price shall not be lower than $0.32.&#160;&#160;This potential reduction in conversion price could increase the number of shares that could be issued upon conversion of the preferred shares and the resulting dilution to the other holders of Common Stock.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Common Stock is and likely will remain subject to the SEC&#8217;s &#8220;Penny Stock&#8221; rules, which may make its shares more difficult to sell.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Common Stock is currently and may remain classified as a &#8220;penny stock.&#8221; The SEC rules regarding penny stocks may have the effect of reducing trading activity in our shares, making it more difficult for investors to sell. Under these rules, broker-dealers who recommend such securities to persons other than institutional accredited investors must:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 14.4pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">make a special written suitability determination for the purchaser;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 14.4pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">receive the purchaser&#8217;s written agreement to a transaction prior to sale;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 14.4pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">provide the purchaser with risk disclosure documents which identify certain risks associated with investing in &#8220;penny stocks&#8221; and which describe the market for these &#8220;penny stocks&#8221; as well as a purchaser&#8217;s legal remedies;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 14.4pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">obtain a signed and dated acknowledgment from the purchaser demonstrating that the purchaser has received the required risk disclosure document before a transaction in a &#8220;penny stock&#8221; can be completed; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 14.4pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">give bid and offer quotations and broker and salesperson compensation information to the customer orally or in writing before or with the confirmation.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These rules make it more difficult for broker-dealers to effectuate customer transactions and trading activity in our securities and may result in a lower trading volume of our common stock and lower trading prices.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certain provisions of our certificate of incorporation which authorize the issuance of additional shares of preferred stock may make it more difficult for a third party to effect a change in control.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our certificate of incorporation authorizes our Board of Directors to issue up to 10,000,000&#160;shares of preferred stock. We have issued 2,200 shares of Series A Convertible Preferred Stock.&#160;&#160;We believe the terms of these preferred shares would not have a substantial impact on the ability of a third party to effect a change in control. The remaining shares of preferred stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our Board of Directors without further action by the stockholders. These terms may include voting rights including the right to vote as a series on particular matters, preferences as to dividends and liquidation, conversion rights, redemption rights and sinking fund provisions. The issuance of any preferred stock could diminish the rights of holders of our common stock, and therefore could reduce the value of our common stock. In addition, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with, or sell assets to, a third party. The ability of our Board of Directors to issue preferred stock could make it more difficult, delay, discourage, prevent or make it more costly to acquire or effect a change-in-control, which in turn could prevent the stockholders from recognizing a gain in the event that a favorable offer is extended and could materially and negatively affect the market price of our common stock.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certain provision of the warrants we issued in March 2012 may make it more difficult for a third party to effect a change in control.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The warrants we issued in March 2012 contain provisions which permit the holders to require the payment&#160;&#160;to them of an amount of cash equal to the value (based on a Black-Scholes computation) of the remaining unexercised portion of the warrants on the date of the consummation of a fundamental transaction (as defined, but generally a change in control of the Company) that is (i) an all cash transaction, (ii) a &#8220;going private&#8221; transaction, or (ii) a transacting involving a person or entity not traded on a national securities exchange.&#160;&#160;The prospect of making such payments may discourage a potential third party acquirer.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">UNRESOLVED STAFF COMMENTS</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">PROPERTIES</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia under a 62 month lease agreement which began November 1, 2009.&#160;&#160;We believe this space is adequate for our current needs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">LEGAL PROCEEDINGS</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are not currently a party to any material legal proceedings.&#160;&#160;We may from time to time become involved in various legal proceedings arising in the ordinary course of business.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">MINE SAFETY DISCLOSURES</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Not applicable.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART II</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY,RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market Information</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock is currently traded on the over-the-counter bulletin board market under the symbol &#8220;GOVX&#8221;.&#160;&#160;The following table sets forth the high and low bid prices for our common stock for the periods indicated.&#160;&#160;The prices represent quotations between dealers and do not include retail mark-up, markdown, or commission, and do not necessarily represent actual transactions:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">High</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Low</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2012</font></font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter (through March 30, 2012)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.24</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2011</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fourth Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Third Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Second Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fourth Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.63</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Third Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.52</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Second Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 3%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Holders</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 30, 2012, there were approximately 1,000 holders of record of our common stock.&#160;&#160;The number of record holders does not reflect the number of beneficial owners of our common stock for whom shares are held by brokerage firms and other institutions.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not paid any dividends since our inception and do not contemplate paying dividends in the foreseeable future.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Sales of Unregistered Securities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no sales of unregistered securities during the period covered by this report that have not previously been reported on Form 10-Q or Form 8-K.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issuer Purchases of Equity Securities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We did not repurchase any of our equity securities during the fourth quarter of 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Authorized for Issuance Under Equity Compensation Plans</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the caption &#8220;Securities Authorized for Issuance under Equity Compensation Plans&#8221; and is incorporated herein by this reference.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SELECTED FINANCIAL DATA</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following selected financial data are derived from our audited consolidated financial statements.&#160;&#160;The historical results presented below are not necessarily indicative of the results to be expected for any future period.&#160;&#160;The information set forth below should be read in conjunction with the information contained in Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, and our consolidated financial statements and the related notes, beginning on page F-1 of this Report.</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="18" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2007</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Statement of Operations Data:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total revenues (grant income)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,899,885</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,185,257</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,668,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,910,170</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,004</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,241,796</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per common share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="25%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="18" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As of December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="25%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance Sheet Data:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,357,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,315,597</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,056,241</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,246,404</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,744,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,709,819</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,647,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RESULTS OF OPERATIONS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following discussion and analysis of our financial condition and results of operations should be read together with the discussion under &#8220;Selected Financial Data&#8221; and our consolidated financial statements included in this Annual Report.&#160;&#160;This discussion contains forward-looking statements that involve risks and uncertainties because they are based on current expectations and relate to future events and our future financial performance.&#160;&#160;Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many important factors, including those set forth under &#8220;Risk Factors&#8221; and elsewhere in this Annual Report.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax is a biotechnology company developing vaccines that prevent and fight HIV/AIDS. We have exclusively licensed from Emory University vaccine technology which was developed in collaboration with the NIH and the CDC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current vaccines under development address the clade B subtype of the HIV virus that is most prevalent in the United States and the developed world.&#160;&#160;Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a therapy for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in human clinical trials -- both in those infected with HIV and those who are not.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have neither received regulatory approval for any of our vaccine candidates, nor do we have any commercialization capabilities; therefore, it is possible that we may never successfully derive significant product revenues from any of our existing or future development programs or product candidates.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect for the foreseeable future our operations will result in a net loss on a quarterly and annual basis.&#160;&#160;As of December 31, 2011, we had an accumulated deficit of $22.6 million.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Critical Accounting Policies and Estimates</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates and adjusts the estimates as necessary. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our significant accounting policies are summarized in Note&#160;2 to our consolidated financial statements for the year ended December&#160;31, 2011. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment of Long-Lived Assets</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by such assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the discounted expected future net cash flows from the assets.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenue in accordance with the SEC&#8217;s Staff Accounting Bulletin&#160;No.&#160;101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition in Financial Statements,</font> as amended by Staff Accounting Bulletin&#160;No.&#160;104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (&#8220;SAB 104&#8221;).&#160;&#160;SAB&#160;104 provides guidance in applying U.S.&#160;generally accepted accounting principles to revenue recognition issues, and specifically addresses revenue recognition for upfront, non-refundable fees received in connection with research collaboration agreements. Our revenue consists solely of grant funding received from the NIH. Revenue from this arrangement is approximately equal to the costs incurred and is recorded as income as the related costs are incurred.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for stock-based transactions in which the Company receives services from employees, directors or others in exchange for equity instruments based on the fair value of the award at the grant date. Compensation cost for awards of common stock is estimated based on the price of the underlying common stock on the date of issuance. Compensation cost for stock options or warrants is estimated at the grant date based on each instrument&#8217;s fair-value as calculated by the Black-Scholes option pricing model. The Company recognizes stock-based compensation cost as expense ratably on a straight-line basis over the requisite service period for the award.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2011, we had cash and cash equivalents of $1,167,980 and total assets of $1,645,142, as compared to $1,079,087 and $2,357,834, respectively, at December&#160;31, 2010. Working capital totaled $476,468 at December 31, 2011, compared to $1,080,584 at December&#160;31, 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sources and Uses of Cash</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a development-stage company as defined by Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 915,&#160;&#160;&#8220;Development Stage Entities&#8221;&#160;&#160;and do not have any products approved for sale. Due to our significant research and development expenditures, we have not been profitable and have generated operating losses since our inception in 2001. Our primary sources of cash are from sales of our equity securities and from government grant funding.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Operating Activities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash used in operating activities was $303,621, $2,007,169, and $1,425,150 for the years ended December&#160;31, 2011, 2010 and 2009, respectively. Generally, the differences between periods are due to fluctuations in our net losses which, in turn, result from fluctuations in expenditures for our research activities, offset by government grant revenues and net changes in our assets and liabilities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The costs of conducting all of our human clinical trials to date, except for our ongoing Phase 1/2&#160;&#160;therapeutic trial, have been borne by the HVTN, funded by the NIH, with GeoVax incurring costs associated with manufacturing the clinical vaccine supplies and other study support. The HVTN and the NIH are bearing the cost of conducting our ongoing Phase 2a preventive trial and have indicated their support for the planned Phase 1 clinical trial of the GM-CSF adjuvanted version of our vaccine.&#160;&#160;We are also having discussions with the HVTN and NIH with regard to the conduct of a planned Phase 2b clinical trial of our preventive vaccine, and we expect the NIH will support this trial as well.&#160;&#160;We cannot, however, predict the level of support we will receive from the HVTN or the NIH for any additional clinical trials.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operations are partially funded by the IPCAVD grant awarded to us in September 2007 by the NIH to support our HIV/AIDS vaccine program. The project period for the grant covers a five-year period which commenced in October 2007, with an aggregate award of $20.4 million.&#160;&#160;As of December 31, 2011, there is approximately $3.9 million of unused grant funds remaining and available for use through August 31, 2012 (the end of the original project period).&#160;&#160;The funding we receive pursuant to this grant is recorded as revenue at the time the related expenditures are incurred, and thus partially offsets our net losses.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are pursuing additional grants from the federal government. However, as we progress to the later stages of our vaccine development activities, government financial support may be more difficult to obtain, or may not be available at all. Therefore, it will be necessary for us to look to other sources of funding in order to finance our development activities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Investing Activities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our investing activities have consisted predominantly of capital expenditures. Capital expenditures for the years ended December&#160;31, 2011, 2010 and 2009, were $11,896, $4,706, and $270,246, respectively, and during 2010, we received $5,580 in proceeds from the sale of equipment.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Financing Activities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash provided by financing activities was $404,410 for the year ended December 31, 2011, as compared to net cash used by financing activities of $430,402 for 2010, and net cash provided by operating activities of $3,020,000 for 2009. The cash generated by our financing activities during 2011 relates to the sale of our common stock to individual accredited investors in a private placement offering initiated during December 2011.&#160;&#160;During January 2012, we received an additional $310,160 from stock sales pursuant to this offering (including $36,800 received in payment of a stock subscription receivable from December 2011).&#160;&#160;The net cash used by financing activities during 2010 relates to costs associated with our previous efforts to raised funds.&#160;&#160;During 2009, we received $1,500,000 from the exercise of a stock purchase warrant and $1,520,000 from the sale of our common stock pursuant to a stock purchase agreement.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2012, we sold shares of Series A convertible preferred stock to certain institutional investors for an aggregate purchase price of $2.2 million, and five-year Class A warrants to purchase an aggregate of 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The preferred stock is convertible at any time into shares of our common stock at $0.75 per share (2,933,333 shares in the aggregate), subject to adjustment as provided in the certificate of designation.&#160;&#160;We also granted to the investors a one-year additional purchase right, evidenced in the form of Class B warrants to purchase up to 2,933,333 of our common stock for one year with an exercise price of $0.75 per share, and five-year Class C warrants to purchase up to 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The Class B warrants are immediately exercisable.&#160;&#160;The Class C warrants only become exercisable at the time, and to the extent, that the Class B warrants are exercised.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our capital requirements, particularly as they relate to product research and development, have been and will continue to be significant. We anticipate incurring additional losses for several years as we expand our drug development and clinical programs and proceed into higher cost human clinical trials. Conducting clinical trials for our vaccine candidates in development is a lengthy, time-consuming and expensive process. We will not generate revenues from the sale of our technology or products for at least several years, if at all. For the foreseeable future, we will be dependent on obtaining financing from third parties in order to maintain our operations, including our clinical program. Due to the existing uncertainty in the capital and credit markets, and adverse regional and national economic conditions that may persist or worsen, capital may not be available on terms acceptable to the Company or at all. If we fail to obtain additional funding when needed, we would be forced to scale back or terminate our operations, or to seek to merge with or to be acquired by another company.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current working capital combined with the proceeds from the IPCAVD grant awarded from the NIH is currently sufficient to support our planned level of operations into the first quarter of 2013.&#160;&#160;We anticipate raising additional capital during 2012 or 2013, although there can be no assurance that we will be able to do so. While we believe that we will be successful in obtaining the necessary financing to fund our operations through grants, exercise of options and warrants, and/or other sources, there can be no assurances that such additional funding will be available to us on reasonable terms or at all.&#160;&#160;Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could have a material adverse effect on our business, operating results, financial condition and prospects.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have no off-balance sheet arrangements that are likely or reasonably likely to have a material effect on our financial condition or results of operations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Contractual Obligations</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future payment.&#160;&#160;Additionally, the expected timing of payment of the obligations presented below is estimated based on current information.&#160;&#160;Timing of payments and actual amounts paid may be different depending on the timing of receipt of goods or services or changes to agreed-upon terms or amounts for some obligations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table represents our contractual obligations as of December 31, 2011, aggregated by type (in thousands):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="MARGIN-LEFT: 9pt" align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="25%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="18" valign="bottom" width="73%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payments Due by Period</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="25%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Obligations</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Less than</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1 Year</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-3</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4-5</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">More than</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5 years</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating Lease Obligations <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">376</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">254</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Firm Purchase Commitments <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">478</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">445</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="25%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Emory University </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211; License Agreement <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="25%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">567</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operating lease obligations relate to the facility lease for our 8,430 square foot facility in Smyrna, Georgia, which houses our laboratory operations and our administrative offices.&#160;&#160;The lease, which was effective November 1, 2009, expires on December 31, 2014.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Firm purchase commitments relate to contracts for production and testing of our vaccine products, conduct of clinical trials, and other research-related activities.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 9pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the Emory License, we have committed to make potential future milestone and royalty payments which are contingent upon the occurrence of future events.&#160;&#160;Such events include development milestones, regulatory approvals and product sales.&#160;&#160;Because the achievement of these milestones is currently neither probable nor reasonably estimable, the contingent payments have not been included in the table above or recorded on our Consolidated Balance Sheets.&#160;&#160;The aggregate total of all potential milestone payments included in the Emory License (excluding royalties on net sales) is approximately $3.5 million.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December&#160;31, 2011, except as disclosed in the table above, we had no other material firm purchase obligations or commitments for capital expenditures and no committed lines of credit or other committed funding or long-term debt. We have employment agreements with our executive officers and a consulting agreement with a member of our Board of Directors, each of which may be terminated with no more than 90&#160;days advance written notice. The table also excludes budgeted expenses under our two Research Agreements with Emory University which are fully reimbursable to us pursuant to the IPCAVD grant from the NIH and cover a period of less than one year.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Operating Loss Carryforwards</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December&#160;31, 2011, we had consolidated net operating loss carryforwards for income tax purposes of $71.3 million, which will expire in 2012 through 2031 if not utilized. Approximately $55.8 million of our net operating loss carryforwards relate to the operations of our predecessor, Dauphin Technology, Inc. prior to the 2006 merger between Dauphin Technology, Inc. and GeoVax, Inc. We also have research and development tax credits of approximately $764,000 available to reduce income taxes, if any, which will expire in 2022 through 2031 if not utilized. The amount of net operating loss carryforwards and research tax credits available to reduce income taxes in any particular year may be limited in certain circumstances. Based on an assessment of all available evidence including, but not limited to, our limited operating history in our core business and lack of profitability, uncertainties of the commercial viability of our technology, the impact of government regulation and healthcare reform initiatives, and other risks normally associated with biotechnology companies, we have concluded that it is more likely than not that these net operating loss carryforwards and credits will not be realized and, as a result, a 100% deferred tax valuation allowance has been recorded against these assets.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net Loss</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded net losses of $2,346,826, $2,747,328, and $3,284,252 for the years ended December 31, 2011, 2010 and 2009, respectively. Our operating results typically fluctuate due to the timing of activities and related costs associated with our vaccine research and development activities and our general and administrative costs, as described in more detail below.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grant Revenue</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded grant revenues of $4,899,885, $5,185,257, and $3,668,195 for the years ended December 31, 2011, 2010 and 2009, respectively.&#160;&#160;Grant revenues for all three years relate to our IPCAVD grant, except that 2010 includes $244,479 related to our receipt of a Qualified Therapeutic Discover Program (QTDP) grant.&#160;&#160;During 2007, we were awarded the IPCAVD grant by the NIH to support our HIV/AIDS vaccine program.&#160;&#160;The project period for the grant covers a five-year period which commenced in October 2007, with an aggregate award of $20.4 million.&#160;&#160;As of December 31, 2011, there is approximately $3.9 million of unused grant funds remaining and available for use through August 31, 2012 (the end of the original project period).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and Development</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research and development expenses were $4,276,375, $4,793,956, and $4,068,682 for the years ended December&#160;31, 2011, 2010 and 2009, respectively. Research and development expense for these periods includes stock-based compensation expense of $179,400, $206,501, and $304,654 for 2011, 2010 and 2009, respectively (see discussion under &#8220;Stock-Based Compensation Expense&#8221; below).&#160;&#160;Our research and development costs do not include costs incurred by HVTN in conducting trials of GeoVax vaccines.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research and development expenses can fluctuate considerably on a period-to-period basis, depending on our need for vaccine manufacturing by third parties, the timing of expenditures related to our IPCAVD grant from the NIH, and the timing of costs associated with clinical trials being funding directly by us.&#160;&#160;Our Phase 2a clinical trial for our preventive vaccine is being conducted and funded by the HVTN, but we are responsible for the manufacture of vaccine product to be used in the trial, and we are not currently receiving any government support for the Phase 1 clinical trial of our therapeutic vaccine.&#160;&#160;We cannot predict the level of support we may receive from HVTN or other federal agencies (or divisions thereof) for our future clinical trials.&#160;&#160;We expect that our research and development costs, including costs of conducting clinical trials for our therapeutic vaccine not currently being supported by HVTN, will continue to increase during 2012 and beyond as we progress through the human clinical trial process leading up to possible product approval by the FDA.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our inception, all of our research and development efforts have been focused on development of our HIV/AIDS vaccines, which we have managed and evaluated to date as a single project.&#160;&#160;Upon receipt of the IPCAVD grant in late 2007, we began incurring additional costs associated with the grant, and reallocated personnel and other internal resources toward activities supported by the grant.&#160;&#160;The table below summarizes our research and development expenses for each of the years in the three year period ended December&#160;31, 2011. The amounts shown related to the IPCAVD grant represent all direct costs associated with the grant activities, including salaries and personnel-related expenses, supplies, consulting, contract services and travel. The remainder of our research and development expense is allocated to our general HIV/AIDS vaccine program.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="MARGIN-LEFT: 9pt" align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">R&amp;D Project</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPCAVD Grant &#8211; Vaccine Adjuvants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,015,812</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,385,193</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,772,397</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA/MVA Vaccines &#8211; HIV/AIDS</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,260,563</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,408,763</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,296,285</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total Research and Development Expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,276,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,793,956</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,068,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccine candidates still require significant, time-consuming and costly research and development, testing and regulatory clearances. Completion of clinical development will take several years or more, but the length of time generally varies substantially according to the type, complexity, novelty and intended use of a product candidate. The cost of the ongoing Phase 2a clinical trial for our preventive vaccine is being funded by the HVTN, but we cannot be certain whether the HVTN or any other external source will provide funding for further development. We intend to seek government and/or third party support for future clinical human trials, but there can be no assurance that we will be successful. The duration and the cost of future clinical trials may vary significantly over the life of the project as a result of differences arising during development of the human clinical trial protocols, including, among others:</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the number of patients that ultimately participate in the clinical trial;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the duration of patient follow-up that seems appropriate in view of the results;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the number of clinical sites included in the clinical trials; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the length of time required to enroll suitable patient subjects.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Due to the uncertainty regarding the timing and regulatory approval of clinical trials and pre-clinical studies, our future expenditures are likely to be highly volatile in future periods depending on the outcomes of the trials and studies. From time to time, we will make determinations as to how much funding to direct to these programs in response to their scientific, clinical and regulatory success, anticipated market opportunity and the availability of capital to fund our programs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In developing our product candidates, we are subject to a number of risks that are inherent in the development of products based on innovative technologies. For example, it is possible that our vaccines may be ineffective or toxic, or will otherwise fail to receive the necessary regulatory clearances, causing us to delay, extend or terminate our product development efforts. Any failure by us to obtain, or any delay in obtaining, regulatory approvals could cause our research and development expenditures to increase which, in turn, could have a material adverse effect on our results of operations and cash flows. Because of the uncertainties of clinical trials, estimating the completion dates or cost to complete our research and development programs is highly speculative and subjective. As a result of these factors, we are unable to accurately estimate the nature, timing and future costs necessary to complete the development of our product candidates. In addition, we are unable to reasonably estimate the period when material net cash inflows could commence from the sale, licensing or commercialization of such product candidates, if ever.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and Administrative Expense</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our general and administrative expenses were $2,972,555, $3,162,134, and $2,914,845 for the years ended December&#160;31, 2011, 2010 and 2009, respectively. General and administrative costs include officers&#8217; salaries, legal and accounting costs, patent costs, amortization expense associated with intangible assets, and other general corporate expenses. General and administrative expense includes stock-based compensation expense of $593,597, $544,031, and $994,011 for 2011, 2010 and 2009, respectively (see discussion under &#8220;Stock-Based Compensation Expense&#8221; below). We expect that our general and administrative costs may increase in the future in support of expanded research and development activities and other general corporate activities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation Expense</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded total stock-based compensation expense of $772,997, $750,532, and $1,298,665 during the years ended December&#160;31, 2011, 2010 and 2009, respectively, which was allocated to research and development expense or general and administrative expense according to the classification of cash compensation paid to the employee, consultant or director to whom the stock compensation was granted. In addition to amounts related to the issuance of stock options to employees, the figures include amounts related to common stock and stock purchase warrants issued to consultants and non-employee directors. For the three years ended December&#160;31, 2011, stock-based compensation expense was allocated as follows:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">593,597</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">544,031</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">994,011</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304,654</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stock option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">772,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,532</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,298,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Income</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest income was $2,219, $23,505, and $31,080 for the years ended December&#160;31, 2011, 2010 and 2009, respectively. The variances between years are primarily attributable to the cash available for investment and to interest rate fluctuations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impact of Inflation</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three year period ended December&#160;31, 2011, we do not believe that inflation and changing prices had a material impact on our operations or on our financial results.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-Balance Sheet Arrangements</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not entered into off-balance sheet financing arrangements, other than operating leases.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 7A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our exposure to market risk is limited primarily to interest income sensitivity, which is affected by changes in the general level of United States interest rates, particularly because a significant portion of our investments are in institutional money market funds.&#160;&#160;The primary objective of our investment activities is to preserve principal while at the same time maximizing the income received without significantly increasing risk.&#160;&#160;Due to the nature of our short-term investments, we believe that we are not subject to any material market risk exposure.&#160;&#160;We do not have any derivative financial instruments or foreign currency instruments.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our consolidated financial statements and supplemental schedule and notes thereto as of December 31, 2011 and 2010, and for each of the three years ended December 31, 2011, 2010 and 2009, and from inception through December 31, 2011, together with the independent registered public accounting firms&#8217; reports thereon, are set forth on pages F-1 to F-19 of this Annual Report on Form 10-K.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND FINANCIAL DISCLOSURE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no disagreements with our accountants on matters of accounting or financial disclosure, or other reportable events requiring disclosure under this Item 9.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We maintain disclosure controls and procedures designed to ensure that financial information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized, and reported within the required time periods, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding disclosure.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">An evaluation was performed by our Chief Executive Officer and Chief Financial Officer of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2011.&#160;&#160;Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December 31, 2011 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management&#8217;s Report on Internal Control Over Financial Reporting</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act.&#160;&#160;Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2011 based on criteria established in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.&#160;&#160;As a result of this assessment, management concluded that, as of December 31, 2011, our internal control over financial reporting was effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control Over Financial Reporting</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Limitations on Controls</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud.&#160;&#160;Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met.&#160;&#160;Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;OTHER INFORMATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART III</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the captions &#8220;Directors and Executive Officers&#8221; and &#8220;Corporate Governance&#8221; and is incorporated herein by this reference.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Code of Ethics</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have adopted a Code of Ethics in compliance with the applicable rules of the SEC that applies to our principal executive officer, our principal financial officer and our principal accounting officer or controller, or persons performing similar functions.&#160;&#160;A copy of this policy is available on our website at <font style="FONT-STYLE: italic; DISPLAY: inline">www.geovax.com</font> under the heading&#160;&#160;&#8220;Investors &#8211; Corporate Governance&#8221; and is also available free of charge upon written request to the attention of our Corporate Secretary by regular mail, e-mail to mreynolds@geovax.com, or facsimile at (678) 384-7281. We intend to disclose any amendment to, or a waiver from, a provision of our code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions and that relates to any element of the code of ethics enumerated in applicable rules of the SEC.&#160;&#160;Such disclosures will be made on our website at <font style="FONT-STYLE: italic; DISPLAY: inline">www.geovax.com</font>.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the captions &#8220;Corporate Governance&#8221; and &#8220;Compensation Discussion and Analysis&#8221; and is incorporated herein by this reference.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RELATED STOCKHOLDER MATTERS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the captions &#8220;Security Ownership of Principal Stockholders, Directors and Executive Officers&#8221; and &#8220;Securities Authorized for Issuance under Equity Compensation Plans&#8221; and is incorporated herein by this reference.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND DIRECTOR INDEPENDENCE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the captions &#8220;Corporate Governance&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8221; and is incorporated herein by this reference.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2012 meeting of shareholders to be filed with the SEC under the caption &#8220;Ratification of Appointment of the Independent Registered Public Accounting Firm&#8221; and is incorporated herein by this reference.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART IV</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents filed as part of this report:</font><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statements</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Page</font></font></font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reports of Independent Registered Public Accounting Firms on Financial Reporting&#160;</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;F-2</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Balance Sheets as of December 31, 2011 and 2010&#160;</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;F-4</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Operations for the years ended December 31, 2011, 2010 and 2009 </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2011</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;F-5</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the Period from </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inception (June 27, 2001) to December 31, 2011&#160;</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;F-6</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2010 and 2009 </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2011</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;F-9</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes to Consolidated Financial Statements&#160;</font></font></td>
<td width="5%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;F-10</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statement Schedules</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The following financial statement schedule is set forth on page F-19 of this Annual Report on Form 10-K:</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Schedule II&#8212;Valuation and Qualifying Accounts for the years ended December 31, 2011, 2010 and 2009</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All other financial statement schedules have been omitted because they are not applicable or not required or because the information is included elsewhere in the Consolidated Financial Statements or the Notes thereto.</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="80%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See Item 15(b) below. Each management contract or compensatory plan or arrangement required to be filed has been identified.</font></font></td>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block" align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibit</font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="TEXT-DECORATION: underline">Number</font></div>
</td>
<td valign="bottom" width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Agreement and Plan of Merger dated January 20, 2006 by and among GeoVax, Inc., GeoVax Acquisition Corp. and Dauphin Technology, Inc. (1)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.2</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">First Amendment to Agreement and Plan of Merger (2)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.3</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Second Amendment to Agreement and Plan of Merger (3)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Incorporation (6)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs, Inc. filed April 13, 2010 (10)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1.2</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs, Inc. filed April 27, 2010 (11)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Bylaws (6)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock filed March 20, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Stock Certificate for the Series A Convertible Preferred Stock (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.1 *</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax Labs, Inc. and Robert T. McNally effective as of April 1, 2008 (7)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.2 *</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax, Inc. and Mark W. Reynolds Amended and Restated effective as of January 1, 2010 (9)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.3 *</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax, Inc. and Harriet Robinson effective as of November 19, 2007 (9)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.4 *</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc. 2006 Equity Incentive Plan (4)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.5</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">License Agreement (as amended and restated) between GeoVax, Inc. and Emory University, dated August 23, 2002 (3)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.6</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Technology Sale and Patent License Agreement between GeoVax, Inc. and MFD, Inc., dated December 26, 2004 (3)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.7</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office and Laboratory Lease between UCB, Inc. and GeoVax, Inc. (8)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.8 *</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of the GeoVax Labs, Inc. Director Compensation Plan (9)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.9</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Warrant dated December 30, 2011 (12)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.10</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Securities Purchase Agreement dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.11</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Registration Rights Agreement dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.12</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series A Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.13</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series B Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.14</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series C Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Code of Ethics (5)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21.1</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsidiaries of the Registrant (5)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1 **</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2 **</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1 **</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 74px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.2 **</font></div>
</td>
<td width="1171">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 74px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101**,***</font></div>
</td>
<td align="left" width="1171">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following financial information from GeoVax Labs, Inc. Annual Report on Form 10-K for the year ended December 31, 2011, formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets as of December 31, 2011 and December 31, 2010, (ii) Consolidated Statements of Operations for the years ended December 31, 2011, 2010 and 2009 and for the period from inception (June 27, 2001) to December 31, 2011, (iii) Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the period from inception (June 27, 2001) to December 31, 2011, (iv) Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2010 and 2009 and for the period from inception (June 27, 2001) to December 31, 2011, and (v) Notes to Condensed Consolidated Financial Statements.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">___________________</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicates a management contract or compensatory plan or arrangement.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">**</font></div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Filed herewith.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td align="right" style="WIDTH: 36pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">***</div>
</td>
<td align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed January 24, 2006.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed July 13, 2006.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed October 4, 2006.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s definitive Information Statement (Schedule 14C) filed August 18, 2006.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Annual Report on Form 10-K filed March 28, 2007.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed June 23, 2008.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(7)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed March 24, 2008.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(8)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Quarterly Report on Form 10-Q filed November 6, 2009.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(9)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Annual Report on Form 10-K filed March 8, 2010.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(10)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed April 14, 2010.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(11)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed April 28, 2010.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(12)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed January 5, 2012.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(13)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed March 22, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Robert T. McNally</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;&#160;March 30, 2012</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been duly signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="30%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Signature / Name&#160;</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Robert T. McNally</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="top" width="20%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally&#160;&#160;</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Mark W. Reynolds&#160;</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="top" width="20%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark W. Reynolds&#160;</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Financial and Accounting Officer)</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Steven S . Antebi</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="30%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="top" width="20%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Steven S. Antebi</font></font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ David A. Dodd&#160;</font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David A. Dodd</font></font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dean G. Kollintzas&#160;</font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dean G. Kollintzas</font></font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Harriet L. Robinson&#160;&#160;&#160;&#160;</font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Harriet L. Robinson</font></font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ John N. Spencer, Jr.</font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director&#160;</font></font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 30, 2012</font></td>
</tr><tr>
<td align="left" valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John N. Spencer, Jr.</font></font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibit</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Number</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1 *</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2 *</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1 *</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.2 *</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101*,**</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following financial information from GeoVax Labs, Inc. Annual Report on Form 10-K for the year ended December 31, 2011, formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets as of December 31, 2011 and December 31, 2010, (ii) Consolidated Statements of Operations for the years ended December 31, 2011, 2010 and 2009 and for the period from inception (June 27, 2001) to December 31, 2011, (iii) Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the period from inception (June 27, 2001) to December 31, 2011, (iv) Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2010 and 2009 and for the period from inception (June 27, 2001) to December 31, 2011, and (v) Notes to Condensed Consolidated Financial Statements.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">___________________</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*&#160;&#160;&#160;&#160; Filed herewith.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">**&#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INDEX TO 2011 CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reports of Independent Registered Public Accounting Firms on Financial Statements</font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-2</font></font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Balance Sheets as of December 31, 2011 and 2010</font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-4</font></font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Operations for the years ended December 31, 2011, 2010 and 2009 </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2011</font></font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-5</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the Period from </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inception (June 27, 2001) to December 31, 2011</font></font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-6</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2010 and 2009 </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2011</font></font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-9</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes to Consolidated Financial Statements</font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-10</font></font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="71%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statement Schedule:</font></div>
</td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="71%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Schedule II &#8211; Valuation and Qualifying Accounts for the years ended December 31, 2011, 2010 and 2009</font></font></td>
<td valign="top" width="16%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-19</font></font></td>
</tr></table>
</div>

<br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ON FINANCIAL STATEMENTS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the Board of Directors</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the accompanying consolidated balance sheets of GeoVax Labs, Inc. and subsidiary (a development stage company) (the &#8220;Company&#8221;) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2011, and for the period of time considered part of the development stage from June 27, 2001 to December 31, 2011, except we did not audit the Company&#8217;s financial statements for the period from June 27, 2001 to December 31, 2005 which were audited by other auditors. Our audits also included the financial statement schedule of the Company listed in Item 15(a).&#160;&#160;These financial statements are the responsibility of the Company&#8217;s management.&#160;&#160;Our responsibility is to express an opinion on these financial statements based on our audit.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).&#160;&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&#160;&#160;The Company is not required to have, nor were we engaged to perform an audit of its internal control over financial reporting.&#160;&#160;Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion of the effectiveness of the Company&#8217;s internal control over financial reporting.&#160;&#160;Accordingly, we express no such opinion.&#160;&#160;An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.&#160;&#160;We believe that our audits provide a reasonable basis for our opinion.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of GeoVax Labs, Inc. and subsidiary as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2011, and for the period of time considered part of the development stage from June 27, 2001 to December 31, 2011, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/S/&#160;PORTER KEADLE MOORE LLC</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">March 29, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ON FINANCIAL STATEMENTS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Board of Directors</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the statements of operations, stockholders&#8217; deficiency and cash flows of GeoVax, Inc. (a Georgia corporation in the development stage) for the period from inception (June 27, 2001) to December 31, 2005.&#160;&#160;These financial statements are the responsibility of the Company&#8217;s management.&#160;&#160;Our responsibility is to express an opinion on these financial statements based on our audit.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).&#160;&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&#160;&#160;An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.&#160;&#160;An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.&#160;&#160;We believe that our audit provides a reasonable basis for our opinion.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the financial statements of GeoVax, Inc. referred to above present fairly, in all material respects, the results of its operations, changes in stockholders&#8217; deficiency and cash flows for the period from inception (June 27, 2001) to December&#160;31, 2005, in conformity with accounting principles generally accepted in the United States of America.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/S/&#160;TRIPP, CHAFIN &amp; COMPANY, LLC</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marietta, Georgia</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">February 8, 2006</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="white" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RDGXBRLParseBegin</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED BALANCE SHEETS</font></div>
</div>

<div align="left">
<div align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ASSETS</font></div>
</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets:</font></div>
</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,079,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant funds receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">183,515</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">474,275</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,508</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,830</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,418,003</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,602,192</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net of accumulated depreciation and amortization</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">248,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Licenses, net of accumulated amortization of $208,933 and $184,047 </font></font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">at December 31, 2011 and 2010 respectively</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,923</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,809</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred offering costs</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deposits and other assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total other assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,933</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">507,201</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>2,357,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>138,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>96,892</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125,869</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241,736</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts payable to Emory University (a related party)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">677,327</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">182,980</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">941,535</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">521,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitments (Note 4)</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217; equity:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $.001 par value, 40,000,000 shares authorized; </font></font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,442,611 and 15,654,846 shares issued and outstanding at </font></font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011 and 2010, respectively</font></div>
</div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,655</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,319,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,105,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit accumulated during the development stage</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,285,176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities and stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>2,357,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS. INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF OPERATIONS</font></font></font></div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="40%">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From Inception</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="10" valign="bottom" width="43%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(June 27, 2001) to</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant revenue</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,899,885</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,185,257</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,668,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,311,692</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,276,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>4,793,956</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,068,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>25,630,676</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,972,555</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>3,162,134</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,914,845</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>17,647,659</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,248,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>7,956,090</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,983,527</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>43,278,335</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from operations</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,349,045</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,770,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,315,332</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 6pt"></font>(22,966,643</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other income (expense):</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest income</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 23.15pt"></font>2,219</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 20.95pt"></font>23,505</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>31,080</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 32.3pt"></font>340,310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 53.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36.75pt"></font>(5,669</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 23.15pt"></font>2,219</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 20.95pt"></font>23,505</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>31,080</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 31.55pt"></font>334,641</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss per common share</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average shares outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,735,541</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,651,308</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,191,278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 15.65pt"></font>10,704,803</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="17" valign="top" width="92%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIENCY)</font></font></font></div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">during the</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subscription</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid In Capital</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Receivable</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Deficiency)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capital contribution at inception (June 27, 2001)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period ended December 31, 2001</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2001</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 39.8pt"></font>10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.1pt"></font>(170,582</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,789,954</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>2,790</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.25pt"></font>(2,320</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 37.65pt"></font>470</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for technology license</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>704,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>705</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>148,151</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>148,856</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2002</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(618,137</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(618,137</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2002</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,494,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>3,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>145,841</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(788,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(639,393</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,229,278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>1,229</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,458,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,459,609</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2003</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(947,804</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(947,804</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2003</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,723,766</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>4,724</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,604,221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,736,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.95pt"></font>872,412</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash and stock subscription </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,482,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>1,483</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,988,436</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>239,919</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for technology license</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>49,420</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 34.4pt"></font>49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>99,951</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>100,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2004</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,351,828</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,351,828</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2004</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,255,791</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>6,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,692,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,088,361</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(389,497</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2005</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,611,086</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,611,086</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2005</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,255,791</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>6,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,692,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.9pt"></font>(500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,699,447</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(500,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversion of preferred stock to common stock</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,550,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>3,551</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,071,565</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,075,116</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued in connection with merger</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,359,891</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>4,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,708,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,712,849</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for cashless warrant exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>56,825</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 34.4pt"></font>57</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 30.9pt"></font>(57</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 53.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2006</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.5pt"></font>(584,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.4pt"></font>(584,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2006</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,223,358</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>14,224</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,472,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,283,613</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,203,216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>406,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>407</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,162,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>3,162,950</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock upon stock option exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>2,471</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.05pt"></font>2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 23.15pt"></font>4,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.65pt"></font>5,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,518,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,518,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2007</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,241,796</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,241,796</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2007</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,632,558</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>14,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,158,642</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10,525,409</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,647,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Continued on following page</font></div>
</div>

<div>&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIENCY)</font></font></font></div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">during the</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom">&#160;</td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subscription</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid In Capital</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Receivable</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Deficiency)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2007</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,632,558</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>14,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,158,642</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10,525,409</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,647,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash in private </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">placement transactions</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>176,129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,364,824</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,365,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transactions related to common stock purchase </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">agreement with Fusion Capital</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>130,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>405,961</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>406,091</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation:</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock options</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,798,169</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,798,169</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consultant warrants</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">146,880</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">146,880</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for consulting services</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2008</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2008</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,948,977</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>14,949</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,948,466</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,253,596</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,709,819</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transactions related to common stock purchase </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">agreement with Fusion Capital</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>216,261</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,519,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,520,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash upon exercise of </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">stock purchase warrant</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>462,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,499,537</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation:</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock options</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221,764</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221,764</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="TEXT-INDENT: 27pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consultant warrants</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for consulting services</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,632,564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>15,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,266,447</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17,537,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>3,744,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock in lieu of cash payment</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>12,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 34.4pt"></font>12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>89,988</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 20.95pt"></font>90,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation:</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock options</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%" style="TEXT-INDENT: 27pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consultant warrants</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,057</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,057</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 27pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for consulting services</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,803</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,813</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fractional share payout upon reverse split</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.85pt"></font>(218</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.25pt"></font>(1,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.75pt"></font>(1,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="28%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,654,846</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>15,655</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,105,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,285,176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Continued on following page</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIENCY)</font></font></font></div>
</div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">during the</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subscription</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid In Capital</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Receivable</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Deficiency)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="34%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,654,846</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.05pt"></font>15,655</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,105,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,285,176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="34%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash in private </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">placement transaction</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.4pt"></font>658,520</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.75pt"></font>659</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.8pt"></font>440,551</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 52.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.3pt"></font>441,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="34%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="34%" style="TEXT-INDENT: 27pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock options</font></font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="34%" style="TEXT-INDENT: 27pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consultant warrants</font></font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="34%" style="TEXT-INDENT: 27pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued for services</font></font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">149,871</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.3pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="34%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="34%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,442,611</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,319,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>
</div>

<div>&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS. INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></font></font></div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From Inception</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="10" valign="bottom" width="43%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(June 27, 2001) to</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from operating activities:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td colspan="2" valign="bottom" width="13%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments to reconcile net loss to net cash </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">used in operating activities:</font></font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>109,017</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>119,773</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.95pt"></font>89,776</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>565,637</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion of preferred stock redemption value</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>346,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>772,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 3.8pt"></font>750,532</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,298,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>6,359,739</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Write-off of deferred offering costs</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant funds receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>290,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153,954</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.75pt"></font>(8,953</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(183,515</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.2pt"></font>19,122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.75pt"></font>(4,215</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>254,671</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 24.1pt"></font>(29,708</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deposits</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.9pt"></font>980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 3.1pt"></font>(11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 24.1pt"></font>(11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>419,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.95pt"></font>39,033</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>224,943</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>1,030,325</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total adjustments</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,043,205</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>740,159</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,859,102</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>8,508,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash used in operating activities</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(303,621</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,007,169</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,425,150</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.75pt"></font>(14,123,459</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from investing activities:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.35pt"></font>(11,896</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>(4,706</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(270,246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(538,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.65pt"></font>5,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 39.65pt"></font>5,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided (used) by investing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.35pt"></font>(11,896</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.65pt"></font>874</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(270,246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(532,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from financing activities:</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of common stock</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>404,410</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,020,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.65pt"></font>15,526,308</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of preferred stock</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>728,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred offering costs</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by financing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>404,410</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,020,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.65pt"></font>15,824,349</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase (decrease) in cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.2pt"></font>88,893</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,436,697</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,324,604</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at beginning of period</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,079,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,515,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,191,180</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 65.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at end of period</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,079,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,515,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental disclosure of cash flow information</font></font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest paid</font></font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,669</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#c0ffff">
<td align="left" colspan="9" valign="top" width="50%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental disclosure of non-cash investing and financing activities:</font></div>
</td>
<td colspan="2" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="17" valign="top" width="90%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In connection with the Merger discussed in Note 5, all of the outstanding shares of the Company&#8217;s mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years Ended December 31, 2011, 2010 and 2009 and</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Period from Inception (June 27, 2001) to December 31, 2011</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nature of Business</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc. (&#8220;GeoVax&#8221; or the &#8220;Company&#8221;), is a biotechnology company developing vaccines that prevent and fight Human Immunodeficiency Virus (&#8220;HIV&#8221;) infections.&#160;&#160;HIV infections result in Acquired Immunodeficiency Syndrome (&#8220;AIDS&#8221;).&#160;&#160;We have exclusively licensed from Emory University (&#8220;Emory&#8221;) vaccine technology which was developed in collaboration with the National Institutes of Health (&#8220;NIH&#8221;) and the Centers for Disease Control and Prevention (&#8220;CDC&#8221;).&#160;&#160;GeoVax is incorporated under the laws of the State of Delaware and our principal offices are located in Smyrna, Georgia (metropolitan Atlanta area).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current vaccines under development address the clade B subtype of the HIV virus that is most prevalent in the United States and the developed world.&#160;&#160;Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a therapy for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in humans -- both in those infected with HIV and those who are not.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As discussed in Note 2, the Company is a development-stage enterprise and we are devoting substantially all of our present efforts to research and development.&#160;&#160;We have funded our activities to date almost exclusively from equity financings and government grants, and we will continue to require substantial funds to continue these activities.&#160;&#160;We anticipate that our existing cash resources, combined with the proceeds from the NIH grant discussed in Note 3 and the financing events discussed in Note 11, should be sufficient to fund our planned activities into the first quarter of 2013.&#160;&#160;In order to meet our operating cash flow requirements, we may plan additional offerings of our equity securities, debt or convertible debt instruments. We are also seeking additional funding for our research programs through government grant funding mechanisms.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basis of Presentation and Principles of Consolidation</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our primary business is conducted by our wholly-owned subsidiary, GeoVax, Inc. The accompanying consolidated financial statements include the accounts of GeoVax, Inc. from inception together with those of GeoVax Labs, Inc. from September 28, 2006 (see Note 5).&#160;&#160;All intercompany transactions have been eliminated in consolidation.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Development-Stage Enterprise</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are devoting all of our present efforts to research and development and GeoVax is a development stage enterprise as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 915, <font style="FONT-STYLE: italic; DISPLAY: inline">Development Stage Entities</font>.&#160;&#160;All losses accumulated since inception (June 27, 2001) have been considered as part of our development stage activities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use of Estimates</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results may differ from those estimates.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash and Cash Equivalents</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We consider all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.&#160;&#160;Our cash and cash equivalents consist primarily of bank deposits and money market accounts.&#160;&#160;The recorded values approximate fair market values due to the short maturities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair Value of Financial Instruments and Concentration of Credit Risk</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial instruments that subject us to concentration of credit risk consist primarily of cash and cash equivalents, which are maintained by a high credit quality financial institution. The carrying values reported in the balance sheets for cash and cash equivalents approximate fair values.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and Equipment</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment are stated at cost, less accumulated depreciation and amortization.&#160;&#160;The components of property and equipment as of December 31, 2011 and 2010 are as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other furniture, fixtures &amp; equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,789</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">520,394</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated depreciation and amortization</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(271,953</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">248,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expenditures for maintenance and repairs are charged to operations as incurred, while additions and improvements are capitalized.&#160;&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets which range from three to five years.&#160;&#160;Amortization of leasehold improvements is computed using the straight-line method over the remaining term of the related lease.&#160;&#160;Depreciation and amortization expense was $84,131, $94,887, and $64,891 during the years ended December 31, 2011, 2010 and 2009, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Assets</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other assets consist principally of license agreements for the use of technology obtained through the issuance of the Company&#8217;s common stock.&#160;&#160;These license agreements are amortized on a straight line basis over ten years.&#160;&#160;Amortization expense related to these agreements was $24,886 during each of the years ended December 31, 2011, 2010 and 2009 and is expected to be $19,923, $10,000, $10,000, $-0-, and $-0- for each of the next five years, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment of Long-Lived Assets</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by such assets.&#160;&#160;If we consider such assets to be impaired, the impairment to be<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>recognized is measured by the amount by which the carrying amount of the assets exceeds the expected future net cash flows from the assets.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued Liabilities</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of the process of preparing our financial statements, we estimate expenses that we believe we have incurred, but have not yet been billed by our third party vendors. This process involves identifying services and activities that have been performed by such vendors on our behalf and estimating the level to which they have been performed and the associated cost incurred for such service as of each balance sheet date in our financial statements. Examples of expenses for which we accrue include fees for professional services and fees owed to contract manufacturers in conjunction with the manufacture of vaccines for our clinical trials. We make these estimates based upon progress of activities related to contractual obligations and information received from vendors.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net Loss Per Share</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic and diluted loss per common share are computed based on the weighted average number of common shares outstanding. All common share equivalents (which consist of options and warrants) are excluded from the computation of diluted loss per share since the effect would be anti-dilutive. Common share equivalents which could potentially dilute basic earnings per share in the future, and which were excluded from the computation of diluted loss per share, totaled 2,798,801, 2,013,522, and 1,866,550 at December 31, 2011, 2010 and 2009, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenue in accordance with the SEC&#8217;s Staff Accounting Bulletin No. 101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition in Financial Statements, </font>as amended by Staff Accounting Bulletin No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition, </font>(&#8220;SAB 104&#8221;). SAB 104 provides guidance in applying GAAP to revenue recognition issues, and specifically addresses revenue recognition for upfront, nonrefundable fees received in connection with research collaboration agreements.&#160;&#160;During 2011, 2010 and 2009, our revenue consisted of grant funding received primarily from the NIH (see Note 3).&#160;&#160;Revenue from this arrangement is approximately equal to the costs incurred and is recorded as income as the related costs are incurred.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and Development Expense</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expense primarily consists of costs incurred in the discovery, development, testing and manufacturing of our product candidates. These expenses consist primarily of (i) fees paid to third-party service providers to perform, monitor and accumulate data related to our preclinical studies and clinical trials, (ii) costs related to sponsored research agreements, (iii) the costs to procure and manufacture materials used in clinical trials, (iv) laboratory supplies and facility-related expenses to conduct development, and (v) salaries, benefits, and share-based compensation for personnel.&#160;&#160;These costs are charged to expense as incurred.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patent Costs</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our expenditures relating to obtaining and protecting patents are charged to expense when incurred, and are included in general and administrative expense.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Period to Period Comparisons</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operating results are expected to fluctuate for the foreseeable future. Therefore, period-to-period comparisons should not be relied upon as predictive of the results for future periods.&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year financial statement presentation.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Taxes</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;&#160;Deferred tax assets and liabilities are measured using enacted rates in effect for the year in which temporary differences are expected to be recovered or settled.&#160;&#160;Deferred tax assets are reduced by a valuation allowance unless, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for stock-based transactions in which the Company receives services from employees, directors or others in exchange for equity instruments based on the fair value of the award at the grant date.&#160;&#160;Compensation cost for awards of common stock is estimated based on the price of the underlying common stock on the date of issuance.&#160;&#160;Compensation cost for stock options or warrants is estimated at the grant date based on each instrument&#8217;s fair-value as calculated by the Black-Scholes option pricing model.&#160;&#160;We recognize stock-based compensation cost as expense ratably on a straight-line basis over the requisite service period for the award.&#160;&#160;See Note 6 for additional stock-based compensation information.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There have been no recent accounting pronouncements or changes in accounting pronouncements which we expect to have a material impact on our financial statements, nor do we believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on our financial statements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Government Grants</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NIH Grant</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2007, the NIH awarded us an Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant to support our HIV/AIDS vaccine program.&#160;&#160;The project period for the grant covers a five-year period which commenced October 2007, with an aggregate award of $20.4 million.&#160;&#160;As of December 31, 2011, there is approximately $3.9 million of unused grant funds remaining and available for use through August 31, 2012 (the end of the original project period).&#160;&#160;We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production.&#160;&#160;We record revenue associated with the grant as the related costs and expenses are incurred and such revenue is reported as a separate line item in our statements of operations.&#160;&#160;During 2011, 2010, and 2009, we recorded $4,899,885, $4,940,778, and $3,668,195, respectively, of revenue associated with this grant.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">QTDP Grant</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In November 2010, we were awarded a one-time grant of $244,479 pursuant to the Qualifying Therapeutic Discovery Project (QTDP) program enacted as part of the Patient Protection and Affordable Care Act of 2010.&#160;&#160;The QTDP program was intended to provide incentive to smaller companies who are focusing on innovative therapeutic discoveries.&#160;&#160;We received the full amount of the grant during 2010, which is recorded as revenue for 2010 in the accompanying Consolidated Statement of Operations.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease Agreements</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located in Smyrna, Georgia (metropolitan Atlanta). Rent expense for the years ended December 31, 2011, 2010 and 2009 was $119,255, $118,988, and $63,350, respectively.&#160;&#160;Future minimum lease payments pursuant to the 62 month lease total $121,560 in 2012, $125,180 in 2013 and $128,920 in 2014.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Commitments</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the normal course of business, we may enter into various firm purchase commitments related to production and testing of our vaccine material, conduct of clinical trials, and other research-related activities. As of December 31, 2011, we had approximately $478,000 of unrecorded outstanding purchase commitments to our vendors and subcontractors, of which we expect approximately $445,000 in 2012 and $33,000 in 2013.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2006 Merger and Recapitalization</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company was originally incorporated in June 1988 under the laws of Illinois as Dauphin Technology, Inc. (&#8220;Dauphin&#8221;).&#160;&#160;Dauphin was unsuccessful and its operations were terminated in December 2003.&#160;&#160;In September 2006, Dauphin completed a merger (the &#8220;Merger&#8221;) with GeoVax, Inc. which was incorporated under the laws of Georgia in June 2001.&#160;&#160;As a result of the Merger, the shareholders of GeoVax, Inc. exchanged their shares of common stock for Dauphin common stock and GeoVax, Inc. became a wholly-owned subsidiary of Dauphin.&#160;&#160;Dauphin then changed its name to GeoVax Labs, Inc. and replaced its officers and directors with those of GeoVax, Inc.&#160;&#160;Subsequent to the Merger, the Company has not conducted any business other than GeoVax, Inc.&#8217;s business of developing human vaccines.&#160;&#160;The Merger was accounted for under the purchase method of accounting as a reverse acquisition in accordance with GAAP. Under this method of accounting, Dauphin was treated as the acquired company and, accordingly, all financial information prior to the date of Merger presented in the accompanying consolidated financial statements, or in the notes herein, as well as any references to prior operations, are those of GeoVax, Inc.&#160;&#160;In June 2008, the Company was reincorporated under the laws of the State of Delaware.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholders&#8217; Equity</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Common Stock Transactions</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2010, we issued 12,000 shares of our common stock in settlement of an obligation accrued at December 31, 2009 in the amount of $90,000.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During December 2011, we sold an aggregate of 658,520 shares of our common stock to fifteen individual accredited investors (including members of our board of directors and management --see Note 9) for an aggregate purchase price of $441,210, $36,800 of which was received in January 2012 and is therefore reflected as a receivable (Other Current Asset) in the accompanying Consolidated Balance Sheet as of December 31, 2011.&#160;&#160;We also issued to the investors warrants to purchase an aggregate of 987,783 shares of common stock at a price of $1.00 per share, which expire in December 2016.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we issue shares of our common stock to consultants or others in exchange for services.&#160;&#160;During 2011, 2010 and 2009 we issued 129,245, 10,500, and 4,500, respectively, for such services; and we recorded general and administrative expense of $150,000, $53,813, and $31,500 during each respective period related to these issuances.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock Options</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2006, we adopted the GeoVax Labs, Inc. 2006 Equity Incentive Plan (the &#8220;Stock Option Plan&#8221;) for the granting of qualified incentive stock options (&#8220;ISO&#8217;s&#8221;), nonqualified stock options, restricted stock awards or restricted stock bonuses to employees, officers, directors, consultants and advisors of the Company.&#160;&#160;The exercise price for any option granted may not be less than fair value (110% of fair value for ISO&#8217;s granted to certain employees).&#160;&#160;Options granted under the Stock Option Plan have a maximum ten-year term and generally vest over three years.&#160;&#160;The Company has reserved 1,200,000 shares of its common stock for issuance under the Stock Option Plan.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of activity under the Stock Option Plan as of December 31, 2011, and changes during the year then ended is presented below:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Shares</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (yrs)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at January 1, 2011</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,137,356</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.33</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,000</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>0.91</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(439,114</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>2.81</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">928,242</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>6.5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">578,231</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>4.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional information concerning our stock options for the years ended December 31, 2011, 2010 and 2009 is as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average fair value of options granted during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.79</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic value of options exercised during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total fair value of options vested during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">540,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,143,326</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use the Black-Scholes model for determining the grant date fair value of our stock option grants.&#160;&#160;This model utilizes certain information, such as the interest rate on a risk-free security with a term generally equivalent to the expected life of the option being valued and requires certain other assumptions, such as the expected amount of time an option will be outstanding until it is exercised or expired, to calculate the fair value of stock options granted.&#160;&#160;The significant assumptions we used in our fair value calculations were as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average risk-free interest rates</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life of option</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7 yrs</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7 yrs</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7 yrs</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based compensation expense related to the Stock Option Plan was $463,752, $575,662, and $1,221,764 during the years ended December 31, 2011, 2010 and 2009, respectively.&#160;&#160;Stock option expense is allocated to research and development expense or to general and administrative expense based on the related employee classifications and corresponds to the allocation of employee salaries.&#160;&#160;For the three years ended December 31, 2011, stock option expense was allocated as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284,352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369,161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">917,110</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304,654</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stock option expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221,764</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2011, there was $515,697 of unrecognized compensation expense related to stock-based compensation arrangements.&#160;&#160;The unrecognized compensation expense is expected to be recognized over a weighted average remaining period of 2.0 years.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensatory Warrants</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we issue stock purchase warrants to consultants or others in exchange for services. A summary of our compensatory warrant activity as of December 31, 2011, and changes during the year then ended is presented below:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Shares</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (yrs)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at January 1, 2011</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,400</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,400</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>1.40</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,400</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>7.00</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>0.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,850</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>0.7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional information concerning our compensatory warrants for the years ended December 31, 2011, 2010 and 2009 is as follows:</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average fair value of warrants granted during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.75</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic value of warrants exercised during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total fair value of warrants vested during the period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,780</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,238</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,413</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use the Black-Scholes model for determining the grant date fair value of our compensatory warrants.&#160;&#160;The significant assumptions we used in our fair value calculations were as follows:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average risk-free interest rates</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.98</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life of warrant</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.0 yrs</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.0 yrs</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115.46</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expense associated with compensatory warrants was $7,119, $121,057, and $45,401 during the years ended December 31, 2011, 2010 and 2009, respectively.&#160;&#160;All such expense was allocated to general and administrative expense.&#160;&#160;As of December 31, 2011, there was no unrecognized compensation expense related to compensatory warrant arrangements.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investment Warrants</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to outstanding stock options and compensatory warrants, as of December 31, 2011 we have a total of 1,806,159 outstanding stock purchase warrants issued to investors in connection with financing transactions.&#160;&#160;Warrants as to 987,783 have an exercise price of $1.00 per share and expire in December 2016; warrants as to 818,376 have an exercise price of $16.50 and expire in December 2014.&#160;&#160;During the fourth quarter of 2011, we recorded general and administrative expense of $152,126 associated with the extension of warrants which were due to expire in 2011 to 2013.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retirement Plan</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We participate in a multi-employer defined contribution retirement plan (the &#8220;401k Plan&#8221;) administered by a third party service provider; and the Company contributes to the 401k Plan on behalf of its employees based upon a matching formula.&#160;&#160;During the years ended December 31, 2011, 2010 and 2009 our contributions to the 401k Plan were $56,928, $52,632, and $25,057, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income Taxes</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2011, we have a consolidated federal net operating loss (&#8220;NOL&#8221;) carryforward of approximately $71.3 million, available to offset against future taxable income which expires in varying amounts in 2012 through 2031.&#160;&#160;Additionally, we have approximately $764,000 in research and development (&#8220;R&amp;D&#8221;) tax credits that expire in 2022 through 2031 unless utilized earlier.&#160;&#160;No income taxes have been paid to date.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the Merger discussed in Note 5, our NOL carryforward increased substantially due to the addition of historical NOL carryforwards for Dauphin Technology, Inc.&#160;&#160;However, Section 382 of the Internal Revenue Code contains provisions that may limit our utilization of NOL and R&amp;D tax credit carryforwards in any given year as a result of significant changes in ownership interests that have occurred in past periods or may occur in future periods.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&#160;&#160;Significant components of our deferred tax assets and liabilities included the following at December 31, 2011 and 2010:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 4%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net operating loss carryforward</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,875,119</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,116,958</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development tax credit carryforward</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">731,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,991,769</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,779,950</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,630,578</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,628,198</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38,587</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,945</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38,587</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,945</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="76%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred tax assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,991</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation allowance</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,591,991</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have established a full valuation allowance equal to the amount of our net deferred tax assets due to uncertainties with respect to our ability to generate sufficient taxable income to realize these assets in the future. <font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A reconciliation of the income tax benefit on losses at the U.S. federal statutory rate to the reported income tax expense is as follows:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S. federal statutory rate applied to pretax loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(797,921</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(934,092</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,116,646</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permanent differences</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 32.15pt"></font>3,536</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 21.8pt"></font>169,469</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development credits</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 25.45pt"></font>32,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,959</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 21.8pt"></font>169,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in valuation allowance</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.8pt"></font>761,985</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">951,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 21.8pt"></font>777,510</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reported income tax expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are obligated to reimburse Emory University (a significant stockholder of the Company) for ongoing costs in connection with the filing, prosecution and maintenance of patent applications subject to a license agreement for technology associated with the vaccines we are developing.&#160;&#160;The expense associated with these ongoing patent cost reimbursements to Emory amounted to $249,907, $193,674, and $85,673 for the years ended December 31, 2011, 2010, and 2009, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have entered into two subcontracts with Emory for the purpose of conducting research and development activities associated with our grant from the NIH (see Note 3).&#160;&#160;During 2011, 2010, and 2009, we recorded $1,172,758, $1,391,203, and $816,651, respectively, of expense associated with these subcontracts.&#160;&#160;All amounts paid to Emory under these subcontracts are reimbursable to us pursuant to the NIH grant.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through November 2009, we leased office and laboratory space on a month-to-month basis from Emtech Biotechnology Development, Inc., a related party associated with Emory.&#160;&#160;Rent expense associated with this lease totaled $43,112 for the year ended December 31, 2009.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2008, we entered into a consulting agreement with Donald Hildebrand, a former member of our Board of Directors and our former President &amp; Chief Executive Officer, pursuant to which Mr. Hildebrand provides business and technical advisory services to the Company.&#160;&#160;The term of the consulting agreement, as amended, began on April 1, 2008 and ends on December 31, 2012.&#160;&#160;During 2011, 2010, and 2009, we recorded $24,000, $57,600, and $57,600, respectively, of expense associated with the consulting agreement.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2011, members of our management and Board of Directors participated in the private placement offering of our common stock and warrants described in Note 6, whereby they purchased an aggregate of 335,954 shares of our common stock for a total purchase price of $225,089 and received five-year warrants to purchase an additional 503,932 shares of our common stock exercisable at $1.00 per share.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected Quarterly Financial Data (unaudited)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of selected quarterly financial data for 2011 and 2010 is as follows:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011 Quarter Ended</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue from grants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,753,033</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,297,006</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,844</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(606,282</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211,344</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(375,852</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,153,348</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010 Quarter Ended</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue from grants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,338,560</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,737,169</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,163,288</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">946,240</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(690,789</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(933,089</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(644,666</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(478,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="52%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent Events</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Private Placement of Common Stock and Warrants</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During January 2012, we sold an aggregate of 407,999 shares of our common stock to twelve individual accredited investors (including 45,000 shares sold to members of our board of directors and management) for an aggregate purchase price of $273,360.&#160;&#160;We also issued to the investors warrants to purchase an aggregate of 612,001 shares of common stock at a price of $1.00 per share, which expire in January 2017.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Issuance of Convertible Preferred Stock and Warrants</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 21, 2012, we sold shares of our Series A convertible preferred stock to certain institutional investors for an aggregate purchase price of $2.2 million.&#160;&#160;The preferred stock is convertible at any time into shares of our common stock at $0.75 per share (2,933,333 shares in the aggregate), subject to possible adjustment as provided in the certificate of designation.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the terms of the securities purchase agreement, the investors also received five-year Series A warrants to purchase an aggregate of 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The Series A warrants are immediately exercisable.&#160; We also granted to the investors a one-year additional purchase right, evidenced in the form of Series B warrants, to purchase up to 2,933,333 of our common stock for one year with an exercise price of $0.75 per share, and five-year Series C warrants to purchase up to 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The Series B warrants are immediately exercisable.&#160;&#160;The Series C warrants only vest and become exercisable at the time, and to the extent, that the Series B warrants are exercised.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE II &#8211; VALUATION AND QUALIFYING ACCOUNTS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Years Ended December 31, 2011, 2010 and 2009</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of Period</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged to</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Costs and</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expenses</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged to</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deductions</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">End</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of Period</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve Deducted in the Balance Sheet </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From the Asset to Which it Applies:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowance for Deferred Tax Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">889,322</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(873,584</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,991</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,160,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(675,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,674,882</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,416,456</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deductions represent the effect of expiring NOL carryforwards from prior years.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="white" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RDGXBRLParseEnd</font></div>
</div>

<br>
F - 19</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
    <title>ex31-1.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 31.1</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) or 15d-14(a)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Robert T. McNally, certify that:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K of GeoVax Labs, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 30, 2012&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Robert T. McNally</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
    <title>ex31-2.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 31.2</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) or 15d-14(a)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Mark W. Reynolds, certify that:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K of GeoVax Labs, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 30, 2012</font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Mark W. Reynolds</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark W. Reynolds</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
    <title>ex32-1.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 32.1</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 906</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December&#160;31, 2011, I, Robert T. McNally, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 30, 2012&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Robert T. McNally</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
    <title>ex32-2.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 32.2</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 906</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December&#160;31, 2011, I, Mark W. Reynolds, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 30, 2012&#160;&#160;&#160;&#160;&#160;</font></font></div>
</div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Mark W. Reynolds</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark W. Reynolds</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>govx-20111231.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:govx="http://geovax.com/20111231" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="govx-20111231.xsd"/>
  <context id="c0_AsOf31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c2_From1Jan2011To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c3_From1Jan2010To31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c4_From1Jan2009To31Dec2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c5_From27Jun2001To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c6_From27Jun2001To31Dec2001_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c7_From27Jun2001To31Dec2001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c8_From27Jun2001To31Dec2001_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c9_AsOf31Dec2001_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c10_AsOf31Dec2001_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c11_AsOf31Dec2001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c12_From1Jan2002To31Dec2002_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c13_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c14_From1Jan2002To31Dec2002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c15_From1Jan2002To31Dec2002_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c16_AsOf31Dec2002_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c17_AsOf31Dec2002_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c18_AsOf31Dec2002_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c19_AsOf31Dec2002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c20_From1Jan2003To31Dec2003_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c21_From1Jan2003To31Dec2003_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c22_From1Jan2003To31Dec2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c23_From1Jan2003To31Dec2003_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c24_AsOf31Dec2003_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c25_AsOf31Dec2003_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c26_AsOf31Dec2003_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c27_AsOf31Dec2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c28_From1Jan2004To31Dec2004_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c29_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c30_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c31_From1Jan2004To31Dec2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c32_From1Jan2004To31Dec2004_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c33_AsOf31Dec2004_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c34_AsOf31Dec2004_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c35_AsOf31Dec2004_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c36_AsOf31Dec2004_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c37_AsOf31Dec2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c38_From1Jan2005To31Dec2005_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c39_From1Jan2005To31Dec2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c40_From1Jan2005To31Dec2005_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c41_AsOf31Dec2005_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c42_AsOf31Dec2005_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c43_AsOf31Dec2005_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c44_AsOf31Dec2005_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c45_AsOf31Dec2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c46_From1Jan2006To31Dec2006_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c47_From1Jan2006To31Dec2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c48_From1Jan2006To31Dec2006_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c49_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c50_From1Jan2006To31Dec2006_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c51_AsOf31Dec2006_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c52_AsOf31Dec2006_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c53_AsOf31Dec2006_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c54_AsOf31Dec2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c55_From1Jan2007To31Dec2007_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c56_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c57_From1Jan2007To31Dec2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c58_From1Jan2007To31Dec2007_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c59_AsOf31Dec2007_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c60_AsOf31Dec2007_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c61_AsOf31Dec2007_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c62_AsOf31Dec2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c63_From1Jan2008To31Dec2008_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c65_From1Jan2008To31Dec2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c66_From1Jan2008To31Dec2008_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c67_AsOf31Dec2008_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c68_AsOf31Dec2008_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c69_AsOf31Dec2008_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c70_AsOf31Dec2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c71_From1Jan2009To31Dec2009_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c73_From1Jan2009To31Dec2009_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c74_AsOf31Dec2009_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c75_AsOf31Dec2009_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c76_AsOf31Dec2009_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c77_AsOf31Dec2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c78_From1Jan2010To31Dec2010_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c80_From1Jan2010To31Dec2010_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c81_AsOf31Dec2010_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c82_AsOf31Dec2010_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c83_AsOf31Dec2010_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c84_From1Jan2011To31Dec2011_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c85_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c86_From1Jan2011To31Dec2011_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c87_AsOf31Dec2011_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c88_AsOf31Dec2011_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c89_AsOf31Dec2011_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c90_AsOf30Mar2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2012-03-30</instant>
    </period>
  </context>
  <context id="c91_AsOf30Jun2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2011-06-30</instant>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPerShare">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="ftnt_0" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities: In connection with the Merger discussed in Note 5, all of the outstanding shares of the Company&apos;s mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.</link:footnote>
    <link:loc xlink:type="locator" xlink:label="_CashAndCashEquivalentsPeriodIncreaseDecrease-c2_From1Jan2011To31Dec2011" xlink:href="#_CashAndCashEquivalentsPeriodIncreaseDecrease-c2_From1Jan2011To31Dec2011"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_CashAndCashEquivalentsPeriodIncreaseDecrease-c2_From1Jan2011To31Dec2011" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_CashAndCashEquivalentsPeriodIncreaseDecrease-c3_From1Jan2010To31Dec2010" xlink:href="#_CashAndCashEquivalentsPeriodIncreaseDecrease-c3_From1Jan2010To31Dec2010"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_CashAndCashEquivalentsPeriodIncreaseDecrease-c3_From1Jan2010To31Dec2010" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_CashAndCashEquivalentsPeriodIncreaseDecrease-c4_From1Jan2009To31Dec2009" xlink:href="#_CashAndCashEquivalentsPeriodIncreaseDecrease-c4_From1Jan2009To31Dec2009"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_CashAndCashEquivalentsPeriodIncreaseDecrease-c4_From1Jan2009To31Dec2009" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_CashAndCashEquivalentsPeriodIncreaseDecrease-c5_From27Jun2001To31Dec2011" xlink:href="#_CashAndCashEquivalentsPeriodIncreaseDecrease-c5_From27Jun2001To31Dec2011"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_CashAndCashEquivalentsPeriodIncreaseDecrease-c5_From27Jun2001To31Dec2011" xlink:to="ftnt_0" order="1"/>
  </link:footnoteLink>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1167980</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">1079087</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:GrantsReceivable unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">183515</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">474275</us-gaap:GrantsReceivable>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">66508</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">48830</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1418003</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">1602192</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">176206</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">248441</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">39923</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">64809</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">208933</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">184047</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:DeferredFinanceCostsNoncurrentNet unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">430402</us-gaap:DeferredFinanceCostsNoncurrentNet>
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">11010</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">11990</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">50933</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">507201</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1645142</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">2357834</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">138339</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">96892</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">125869</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">241736</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">677327</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">182980</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">941535</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">521608</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf31Dec2011" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Dec2010" xs:nil="true"/>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">16443</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">15655</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPerShare" contextRef="c0_AsOf31Dec2011" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPerShare" contextRef="c1_AsOf31Dec2010" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2010" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">16442611</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2010" decimals="INF">15654846</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2011" decimals="INF">16442611</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2010" decimals="INF">15632564</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">23319166</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">22105747</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">22632002</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">20285176</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">703607</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">1836226</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2011" decimals="0">1645142</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2010" decimals="0">2357834</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">4899885</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">5185257</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">3668195</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">20311692</us-gaap:RevenueFromGrants>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">4276375</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">4793956</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">4068682</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">25630676</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">2972555</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">3162134</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">2914845</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">17647659</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">7248930</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">7956090</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">6983527</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">43278335</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-2349045</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-2770833</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">-3315332</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">-22966643</us-gaap:OperatingIncomeLoss>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">2219</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">23505</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">31080</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">340310</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">5669</us-gaap:InterestExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">2219</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">23505</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">31080</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">334641</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-2346826</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-2747328</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">-3284252</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">-22632002</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c2_From1Jan2011To31Dec2011" decimals="2">-0.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c3_From1Jan2010To31Dec2010" decimals="2">-0.18</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c4_From1Jan2009To31Dec2009" decimals="2">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPerShare" contextRef="c5_From27Jun2001To31Dec2011" decimals="2">-2.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c2_From1Jan2011To31Dec2011" decimals="INF">15735541</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c3_From1Jan2010To31Dec2010" decimals="INF">15651308</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c4_From1Jan2009To31Dec2009" decimals="INF">15191278</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c5_From27Jun2001To31Dec2011" decimals="INF">10704803</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception unitRef="usd" contextRef="c6_From27Jun2001To31Dec2001_AdditionalPaidInCapitalMember" decimals="0">10</govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception>
  <govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception unitRef="usd" contextRef="c7_From27Jun2001To31Dec2001" decimals="0">10</govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c8_From27Jun2001To31Dec2001_RetainedEarningsMember" decimals="0">-170592</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c7_From27Jun2001To31Dec2001" decimals="0">-170592</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c9_AsOf31Dec2001_AdditionalPaidInCapitalMember" decimals="0">10</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c10_AsOf31Dec2001_RetainedEarningsMember" decimals="0">-170592</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c11_AsOf31Dec2001" decimals="0">-170582</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c12_From1Jan2002To31Dec2002_CommonStockMember" decimals="INF">2789954</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c12_From1Jan2002To31Dec2002_CommonStockMember" decimals="0">2790</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c13_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember" decimals="0">-2320</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c14_From1Jan2002To31Dec2002" decimals="0">470</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets unitRef="shares" contextRef="c12_From1Jan2002To31Dec2002_CommonStockMember" decimals="INF">704534</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c12_From1Jan2002To31Dec2002_CommonStockMember" decimals="0">705</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c13_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember" decimals="0">148151</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c14_From1Jan2002To31Dec2002" decimals="0">148856</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c15_From1Jan2002To31Dec2002_RetainedEarningsMember" decimals="0">-618137</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c14_From1Jan2002To31Dec2002" decimals="0">-618137</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c16_AsOf31Dec2002_CommonStockMember" decimals="INF">3494488</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c16_AsOf31Dec2002_CommonStockMember" decimals="0">3495</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c17_AsOf31Dec2002_AdditionalPaidInCapitalMember" decimals="0">145841</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c18_AsOf31Dec2002_RetainedEarningsMember" decimals="0">-788729</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c19_AsOf31Dec2002" decimals="0">-639393</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c20_From1Jan2003To31Dec2003_CommonStockMember" decimals="INF">1229278</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c20_From1Jan2003To31Dec2003_CommonStockMember" decimals="0">1229</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c21_From1Jan2003To31Dec2003_AdditionalPaidInCapitalMember" decimals="0">2458380</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c22_From1Jan2003To31Dec2003" decimals="0">2459609</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c23_From1Jan2003To31Dec2003_RetainedEarningsMember" decimals="0">-947804</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c22_From1Jan2003To31Dec2003" decimals="0">-947804</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c24_AsOf31Dec2003_CommonStockMember" decimals="INF">4723766</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c24_AsOf31Dec2003_CommonStockMember" decimals="0">4724</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c25_AsOf31Dec2003_AdditionalPaidInCapitalMember" decimals="0">2604221</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c26_AsOf31Dec2003_RetainedEarningsMember" decimals="0">-1736533</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c27_AsOf31Dec2003" decimals="0">872412</us-gaap:StockholdersEquity>
  <govx:StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable unitRef="shares" contextRef="c28_From1Jan2004To31Dec2004_CommonStockMember" decimals="INF">1482605</govx:StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable>
  <govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable unitRef="usd" contextRef="c28_From1Jan2004To31Dec2004_CommonStockMember" decimals="0">1483</govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable>
  <govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable unitRef="usd" contextRef="c29_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember" decimals="0">2988436</govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable>
  <govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable unitRef="usd" contextRef="c30_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember" decimals="0">-2750000</govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable>
  <govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004" decimals="0">239919</govx:StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c30_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember" decimals="0">750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004" decimals="0">750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets unitRef="shares" contextRef="c28_From1Jan2004To31Dec2004_CommonStockMember" decimals="INF">49420</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c28_From1Jan2004To31Dec2004_CommonStockMember" decimals="0">49</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c29_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember" decimals="0">99951</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004" decimals="0">100000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c32_From1Jan2004To31Dec2004_RetainedEarningsMember" decimals="0">-2351828</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004" decimals="0">-2351828</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c33_AsOf31Dec2004_CommonStockMember" decimals="INF">6255791</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c33_AsOf31Dec2004_CommonStockMember" decimals="0">6256</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c34_AsOf31Dec2004_AdditionalPaidInCapitalMember" decimals="0">5692608</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c35_AsOf31Dec2004_StockSubscriptionReceivableMember" decimals="0">-2000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c36_AsOf31Dec2004_RetainedEarningsMember" decimals="0">-4088361</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c37_AsOf31Dec2004" decimals="0">-389497</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c38_From1Jan2005To31Dec2005_StockSubscriptionReceivableMember" decimals="0">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c39_From1Jan2005To31Dec2005" decimals="0">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c40_From1Jan2005To31Dec2005_RetainedEarningsMember" decimals="0">-1611086</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c39_From1Jan2005To31Dec2005" decimals="0">-1611086</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c41_AsOf31Dec2005_CommonStockMember" decimals="INF">6255791</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c41_AsOf31Dec2005_CommonStockMember" decimals="0">6256</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c42_AsOf31Dec2005_AdditionalPaidInCapitalMember" decimals="0">5692608</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c43_AsOf31Dec2005_StockSubscriptionReceivableMember" decimals="0">-500000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c44_AsOf31Dec2005_RetainedEarningsMember" decimals="0">-5699447</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c45_AsOf31Dec2005" decimals="0">-500583</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c46_From1Jan2006To31Dec2006_StockSubscriptionReceivableMember" decimals="0">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c47_From1Jan2006To31Dec2006" decimals="0">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="INF">3550851</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">3551</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">1071565</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c47_From1Jan2006To31Dec2006" decimals="0">1075116</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="INF">4359891</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">4360</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">1708489</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c47_From1Jan2006To31Dec2006" decimals="0">1712849</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <govx:StockIssuedDuringPeriodSharesCashlessWarrantExercise unitRef="usd" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">56825</govx:StockIssuedDuringPeriodSharesCashlessWarrantExercise>
  <govx:StockIssuedDuringPeriodValueCashlessWarrantExercise unitRef="usd" contextRef="c48_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">57</govx:StockIssuedDuringPeriodValueCashlessWarrantExercise>
  <govx:StockIssuedDuringPeriodValueCashlessWarrantExercise unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">-57</govx:StockIssuedDuringPeriodValueCashlessWarrantExercise>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c50_From1Jan2006To31Dec2006_RetainedEarningsMember" decimals="0">-584166</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c47_From1Jan2006To31Dec2006" decimals="0">-584166</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c51_AsOf31Dec2006_CommonStockMember" decimals="INF">14223358</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c51_AsOf31Dec2006_CommonStockMember" decimals="0">14224</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c52_AsOf31Dec2006_AdditionalPaidInCapitalMember" decimals="0">8472605</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c53_AsOf31Dec2006_RetainedEarningsMember" decimals="0">-6283613</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c54_AsOf31Dec2006" decimals="0">2203216</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c55_From1Jan2007To31Dec2007_CommonStockMember" decimals="INF">406729</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c55_From1Jan2007To31Dec2007_CommonStockMember" decimals="0">407</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c56_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">3162543</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007" decimals="0">3162950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c55_From1Jan2007To31Dec2007_CommonStockMember" decimals="INF">2471</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c55_From1Jan2007To31Dec2007_CommonStockMember" decimals="0">2</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c56_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">4998</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007" decimals="0">5000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c56_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">1518496</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007" decimals="0">1518496</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c58_From1Jan2007To31Dec2007_RetainedEarningsMember" decimals="0">-4241796</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007" decimals="0">-4241796</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c59_AsOf31Dec2007_CommonStockMember" decimals="INF">14632558</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c59_AsOf31Dec2007_CommonStockMember" decimals="0">14633</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c60_AsOf31Dec2007_AdditionalPaidInCapitalMember" decimals="0">13158642</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c61_AsOf31Dec2007_RetainedEarningsMember" decimals="0">-10525409</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c62_AsOf31Dec2007" decimals="0">2647866</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="INF">176129</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="0">176</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">1364824</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">1365000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="INF">130290</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="0">130</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">405961</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">406091</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">1798169</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">1798169</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">146880</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">146880</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="shares" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="INF">10000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c63_From1Jan2008To31Dec2008_CommonStockMember" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c64_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">73990</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">74000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c66_From1Jan2008To31Dec2008_RetainedEarningsMember" decimals="0">-3728187</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008" decimals="0">-3728187</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c67_AsOf31Dec2008_CommonStockMember" decimals="INF">14948977</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c67_AsOf31Dec2008_CommonStockMember" decimals="0">14949</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c68_AsOf31Dec2008_AdditionalPaidInCapitalMember" decimals="0">16948466</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c69_AsOf31Dec2008_RetainedEarningsMember" decimals="0">-14253596</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c70_AsOf31Dec2008" decimals="0">2709819</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">216261</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">216</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1519784</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1520000</us-gaap:StockIssuedDuringPeriodValueOther>
  <govx:StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant unitRef="shares" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">462826</govx:StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant>
  <govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant unitRef="usd" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">463</govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant>
  <govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant unitRef="usd" contextRef="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1499537</govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant>
  <govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1500000</govx:StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1221764</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1221764</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">45401</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">45401</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="shares" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">4500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c71_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">5</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c72_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">31495</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">31500</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c73_From1Jan2009To31Dec2009_RetainedEarningsMember" decimals="0">-3284252</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c74_AsOf31Dec2009_CommonStockMember" decimals="INF">15632564</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c74_AsOf31Dec2009_CommonStockMember" decimals="0">15633</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c75_AsOf31Dec2009_AdditionalPaidInCapitalMember" decimals="0">21266447</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c76_AsOf31Dec2009_RetainedEarningsMember" decimals="0">-17537848</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c77_AsOf31Dec2009" decimals="0">3744232</us-gaap:StockholdersEquity>
  <govx:StockIssuedDuringPeriodSharesInLieuOfCashPayment unitRef="shares" contextRef="c78_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">12000</govx:StockIssuedDuringPeriodSharesInLieuOfCashPayment>
  <govx:StockIssuedDuringPeriodValueInLieuOfCashPayment unitRef="usd" contextRef="c78_From1Jan2010To31Dec2010_CommonStockMember" decimals="0">12</govx:StockIssuedDuringPeriodValueInLieuOfCashPayment>
  <govx:StockIssuedDuringPeriodValueInLieuOfCashPayment unitRef="usd" contextRef="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">89988</govx:StockIssuedDuringPeriodValueInLieuOfCashPayment>
  <govx:StockIssuedDuringPeriodValueInLieuOfCashPayment unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">90000</govx:StockIssuedDuringPeriodValueInLieuOfCashPayment>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">575662</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">575662</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">121057</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">121057</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="shares" contextRef="c78_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">10500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c78_From1Jan2010To31Dec2010_CommonStockMember" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">53803</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">53813</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits unitRef="shares" contextRef="c78_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">-218</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit unitRef="usd" contextRef="c79_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">-1210</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-1210</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c80_From1Jan2010To31Dec2010_RetainedEarningsMember" decimals="0">-2747328</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c81_AsOf31Dec2010_CommonStockMember" decimals="INF">15654846</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c81_AsOf31Dec2010_CommonStockMember" decimals="0">15655</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c82_AsOf31Dec2010_AdditionalPaidInCapitalMember" decimals="0">22105747</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c83_AsOf31Dec2010_RetainedEarningsMember" decimals="0">-20285176</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c84_From1Jan2011To31Dec2011_CommonStockMember" decimals="INF">658520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c84_From1Jan2011To31Dec2011_CommonStockMember" decimals="0">659</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c85_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">440551</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">441210</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c85_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">463752</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">463752</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c85_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">159245</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">159245</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="shares" contextRef="c84_From1Jan2011To31Dec2011_CommonStockMember" decimals="INF">129245</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c84_From1Jan2011To31Dec2011_CommonStockMember" decimals="0">129</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c85_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">149871</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">150000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c86_From1Jan2011To31Dec2011_RetainedEarningsMember" decimals="0">-2346826</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c87_AsOf31Dec2011_CommonStockMember" decimals="INF">16442611</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c87_AsOf31Dec2011_CommonStockMember" decimals="0">16443</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c88_AsOf31Dec2011_AdditionalPaidInCapitalMember" decimals="0">23319166</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c89_AsOf31Dec2011_RetainedEarningsMember" decimals="0">-22632002</us-gaap:StockholdersEquity>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">109017</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">119773</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">89776</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">565637</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">346673</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">772997</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">750532</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1298665</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">6359739</us-gaap:ShareBasedCompensation>
  <us-gaap:AmortizationOfDeferredCharges unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">430402</us-gaap:AmortizationOfDeferredCharges>
  <us-gaap:AmortizationOfDeferredCharges unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">430402</us-gaap:AmortizationOfDeferredCharges>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-290760</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">153954</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">8953</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">183515</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-19122</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">4215</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">-254671</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">29708</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-980</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">11010</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">11010</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">419927</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">39033</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">224943</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">1030325</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">2043205</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">740159</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1859102</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">8508543</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-303621</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-2007169</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">-1425150</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">-14123459</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">11896</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">4706</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">270246</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">538490</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">5580</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">5580</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">-11896</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">874</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">-270246</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">-532910</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">404410</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">3020000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">15526308</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">728443</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">430402</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">430402</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">404410</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-430402</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">3020000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">15824349</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="_CashAndCashEquivalentsPeriodIncreaseDecrease-c2_From1Jan2011To31Dec2011" unitRef="usd" contextRef="c2_From1Jan2011To31Dec2011" decimals="0">88893</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="_CashAndCashEquivalentsPeriodIncreaseDecrease-c3_From1Jan2010To31Dec2010" unitRef="usd" contextRef="c3_From1Jan2010To31Dec2010" decimals="0">-2436697</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="_CashAndCashEquivalentsPeriodIncreaseDecrease-c4_From1Jan2009To31Dec2009" unitRef="usd" contextRef="c4_From1Jan2009To31Dec2009" decimals="0">1324604</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="_CashAndCashEquivalentsPeriodIncreaseDecrease-c5_From27Jun2001To31Dec2011" unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">1167980</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c77_AsOf31Dec2009" decimals="0">3515784</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c70_AsOf31Dec2008" decimals="0">2191180</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c5_From27Jun2001To31Dec2011" decimals="0">5669</us-gaap:InterestPaid>
  <dei:EntityRegistrantName contextRef="c2_From1Jan2011To31Dec2011">GeoVax Labs, Inc.</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c2_From1Jan2011To31Dec2011">10-K</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c2_From1Jan2011To31Dec2011">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c90_AsOf30Mar2012" decimals="INF">16850610</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c91_AsOf30Jun2011" decimals="0">8741870</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c2_From1Jan2011To31Dec2011">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c2_From1Jan2011To31Dec2011">0000832489</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c2_From1Jan2011To31Dec2011">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c2_From1Jan2011To31Dec2011">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c2_From1Jan2011To31Dec2011">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c2_From1Jan2011To31Dec2011">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c2_From1Jan2011To31Dec2011">2011</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c2_From1Jan2011To31Dec2011">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c2_From1Jan2011To31Dec2011">2011-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:NatureOfOperations contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Nature&#xd;
        of Business&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;GeoVax&#xd;
        Labs, Inc. (&amp;#8220;GeoVax&amp;#8221; or the&#xd;
        &amp;#8220;Company&amp;#8221;), is a biotechnology company&#xd;
        developing vaccines that prevent and fight Human&#xd;
        Immunodeficiency Virus (&amp;#8220;HIV&amp;#8221;)&#xd;
        infections.&amp;#160;&amp;#160;HIV infections result in Acquired&#xd;
        Immunodeficiency Syndrome&#xd;
        (&amp;#8220;AIDS&amp;#8221;).&amp;#160;&amp;#160;We have exclusively&#xd;
        licensed from Emory University (&amp;#8220;Emory&amp;#8221;)&#xd;
        vaccine technology which was developed in collaboration&#xd;
        with the National Institutes of Health (&amp;#8220;NIH&amp;#8221;)&#xd;
        and the Centers for Disease Control and Prevention&#xd;
        (&amp;#8220;CDC&amp;#8221;).&amp;#160;&amp;#160;GeoVax is incorporated&#xd;
        under the laws of the State of Delaware and our principal&#xd;
        offices are located in Smyrna, Georgia (metropolitan&#xd;
        Atlanta area).&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
        current vaccines under development address the clade B&#xd;
        subtype of the HIV virus that is most prevalent in the&#xd;
        United States and the developed world.&amp;#160;&amp;#160;Our&#xd;
        vaccines are being evaluated to determine their potential&#xd;
        to (a) prevent HIV infection and (b) to serve as a therapy&#xd;
        for individuals who are already infected with&#xd;
        HIV.&amp;#160;&amp;#160;These vaccines are currently being&#xd;
        evaluated in humans -- both in those infected with HIV and&#xd;
        those who are not.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
        discussed in Note 2, the Company is a development-stage&#xd;
        enterprise and we are devoting substantially all of our&#xd;
        present efforts to research and development.&amp;#160;&amp;#160;We&#xd;
        have funded our activities to date almost exclusively from&#xd;
        equity financings and government grants, and we will&#xd;
        continue to require substantial funds to continue these&#xd;
        activities.&amp;#160;&amp;#160;We anticipate that our existing cash&#xd;
        resources, combined with the proceeds from the NIH grant&#xd;
        discussed in Note 3 and the financing events discussed in&#xd;
        Note 11, should be sufficient to fund our planned&#xd;
        activities into the first quarter of 2013.&amp;#160;&amp;#160;In&#xd;
        order to meet our operating cash flow requirements, we may&#xd;
        plan additional offerings of our equity securities, debt or&#xd;
        convertible debt instruments. We are also seeking&#xd;
        additional funding for our research programs through&#xd;
        government grant funding mechanisms.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:NatureOfOperations>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Summary&#xd;
        of Significant Accounting Policies&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basis&#xd;
        of Presentation and Principles of Consolidation&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
        primary business is conducted by our wholly-owned&#xd;
        subsidiary, GeoVax, Inc. The accompanying consolidated&#xd;
        financial statements include the accounts of GeoVax, Inc.&#xd;
        from inception together with those of GeoVax Labs, Inc.&#xd;
        from September 28, 2006 (see Note 5).&amp;#160;&amp;#160;All&#xd;
        intercompany transactions have been eliminated in&#xd;
        consolidation.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Development-Stage&#xd;
        Enterprise&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        are devoting all of our present efforts to research and&#xd;
        development and GeoVax is a development stage enterprise as&#xd;
        defined by Financial Accounting Standards Board&#xd;
        (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification&#xd;
        (&amp;#8220;ASC&amp;#8221;) Topic 915, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Development&#xd;
        Stage Entities&lt;/font&gt;.&amp;#160;&amp;#160;All losses accumulated&#xd;
        since inception (June 27, 2001) have been considered as&#xd;
        part of our development stage activities.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Use&#xd;
        of Estimates&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
        preparation of financial statements in conformity with&#xd;
        accounting principles generally accepted in the United&#xd;
        States of America (&amp;#8220;GAAP&amp;#8221;) requires us to make&#xd;
        estimates and assumptions that affect the reported amounts&#xd;
        of assets and liabilities and disclosure of contingent&#xd;
        assets and liabilities at the date of the financial&#xd;
        statements and the reported amounts of revenues and&#xd;
        expenses during the reporting period.&amp;#160;&amp;#160;Actual&#xd;
        results may differ from those estimates.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash&#xd;
        and Cash Equivalents&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        consider all highly liquid investments with a maturity of&#xd;
        three months or less when purchased to be cash&#xd;
        equivalents.&amp;#160;&amp;#160;Our cash and cash equivalents&#xd;
        consist primarily of bank deposits and money market&#xd;
        accounts.&amp;#160;&amp;#160;The recorded values approximate fair&#xd;
        market values due to the short maturities.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Fair&#xd;
        Value of Financial Instruments and Concentration of Credit&#xd;
        Risk&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Financial&#xd;
        instruments that subject us to concentration of credit risk&#xd;
        consist primarily of cash and cash equivalents, which are&#xd;
        maintained by a high credit quality financial institution.&#xd;
        The carrying values reported in the balance sheets for cash&#xd;
        and cash equivalents approximate fair values.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
        and Equipment&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
        and equipment are stated at cost, less accumulated&#xd;
        depreciation and amortization.&amp;#160;&amp;#160;The components of&#xd;
        property and equipment as of December 31, 2011 and 2010 are&#xd;
        as follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Laboratory&#xd;
                equipment&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Leasehold&#xd;
                improvements&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
                furniture, fixtures &amp;amp; equipment&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;16,789&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                property and equipment&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;520,394&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accumulated&#xd;
                depreciation and amortization&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(356,084&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(271,953&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
                and equipment, net&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;176,206&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;248,441&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Expenditures&#xd;
        for maintenance and repairs are charged to operations as&#xd;
        incurred, while additions and improvements are&#xd;
        capitalized.&amp;#160;&amp;#160;Depreciation is computed using the&#xd;
        straight-line method over the estimated useful lives of the&#xd;
        assets which range from three to five&#xd;
        years.&amp;#160;&amp;#160;Amortization of leasehold improvements is&#xd;
        computed using the straight-line method over the remaining&#xd;
        term of the related lease.&amp;#160;&amp;#160;Depreciation and&#xd;
        amortization expense was $84,131, $94,887, and $64,891&#xd;
        during the years ended December 31, 2011, 2010 and 2009,&#xd;
        respectively.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
        Assets&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
        assets consist principally of license agreements for the&#xd;
        use of technology obtained through the issuance of the&#xd;
        Company&amp;#8217;s common stock.&amp;#160;&amp;#160;These license&#xd;
        agreements are amortized on a straight line basis over ten&#xd;
        years.&amp;#160;&amp;#160;Amortization expense related to these&#xd;
        agreements was $24,886 during each of the years ended&#xd;
        December 31, 2011, 2010 and 2009 and is expected to be&#xd;
        $19,923, $10,000, $10,000, $-0-, and $-0- for each of the&#xd;
        next five years, respectively.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Impairment&#xd;
        of Long-Lived Assets&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        review long-lived assets for impairment whenever events or&#xd;
        changes in circumstances indicate that the carrying amount&#xd;
        of an asset may not be&#xd;
        recoverable.&amp;#160;&amp;#160;Recoverability of assets to be held&#xd;
        and used is measured by a comparison of the carrying amount&#xd;
        of the assets to the future net cash flows expected to be&#xd;
        generated by such assets.&amp;#160;&amp;#160;If we consider such&#xd;
        assets to be impaired, the impairment to be&lt;font style=&quot;DISPLAY: inline; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;recognized&#xd;
        is measured by the amount by which the carrying amount of&#xd;
        the assets exceeds the expected future net cash flows from&#xd;
        the assets.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Accrued&#xd;
        Liabilities&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
        part of the process of preparing our financial statements,&#xd;
        we estimate expenses that we believe we have incurred, but&#xd;
        have not yet been billed by our third party vendors. This&#xd;
        process involves identifying services and activities that&#xd;
        have been performed by such vendors on our behalf and&#xd;
        estimating the level to which they have been performed and&#xd;
        the associated cost incurred for such service as of each&#xd;
        balance sheet date in our financial statements. Examples of&#xd;
        expenses for which we accrue include fees for professional&#xd;
        services and fees owed to contract manufacturers in&#xd;
        conjunction with the manufacture of vaccines for our&#xd;
        clinical trials. We make these estimates based upon&#xd;
        progress of activities related to contractual obligations&#xd;
        and information received from vendors.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
        Loss Per Share&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basic&#xd;
        and diluted loss per common share are computed based on the&#xd;
        weighted average number of common shares outstanding. All&#xd;
        common share equivalents (which consist of options and&#xd;
        warrants) are excluded from the computation of diluted loss&#xd;
        per share since the effect would be anti-dilutive. Common&#xd;
        share equivalents which could potentially dilute basic&#xd;
        earnings per share in the future, and which were excluded&#xd;
        from the computation of diluted loss per share, totaled&#xd;
        2,798,801, 2,013,522, and 1,866,550 at December 31, 2011,&#xd;
        2010 and 2009, respectively.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
        Recognition&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        recognize revenue in accordance with the SEC&amp;#8217;s Staff&#xd;
        Accounting Bulletin No. 101, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
        Recognition in Financial Statements,&lt;/font&gt; as amended by&#xd;
        Staff Accounting Bulletin No. 104, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
        Recognition,&lt;/font&gt; (&amp;#8220;SAB 104&amp;#8221;). SAB 104&#xd;
        provides guidance in applying GAAP to revenue recognition&#xd;
        issues, and specifically addresses revenue recognition for&#xd;
        upfront, nonrefundable fees received in connection with&#xd;
        research collaboration agreements.&amp;#160;&amp;#160;During 2011,&#xd;
        2010 and 2009, our revenue consisted of grant funding&#xd;
        received primarily from the NIH (see Note&#xd;
        3).&amp;#160;&amp;#160;Revenue from this arrangement is&#xd;
        approximately equal to the costs incurred and is recorded&#xd;
        as income as the related costs are incurred.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
        and Development Expense&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
        and development expense primarily consists of costs&#xd;
        incurred in the discovery, development, testing and&#xd;
        manufacturing of our product candidates. These expenses&#xd;
        consist primarily of (i) fees paid to third-party service&#xd;
        providers to perform, monitor and accumulate data related&#xd;
        to our preclinical studies and clinical trials, (ii) costs&#xd;
        related to sponsored research agreements, (iii) the costs&#xd;
        to procure and manufacture materials used in clinical&#xd;
        trials, (iv) laboratory supplies and facility-related&#xd;
        expenses to conduct development, and (v) salaries,&#xd;
        benefits, and share-based compensation for&#xd;
        personnel.&amp;#160;&amp;#160;These costs are charged to expense as&#xd;
        incurred.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Patent&#xd;
        Costs&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
        expenditures relating to obtaining and protecting patents&#xd;
        are charged to expense when incurred, and are included in&#xd;
        general and administrative expense.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Period&#xd;
        to Period Comparisons&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
        operating results are expected to fluctuate for the&#xd;
        foreseeable future. Therefore, period-to-period comparisons&#xd;
        should not be relied upon as predictive of the results for&#xd;
        future periods.&amp;#160;&amp;#160;Certain prior year amounts have&#xd;
        been reclassified to conform to the current year financial&#xd;
        statement presentation.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Income&#xd;
        Taxes&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        account for income taxes using the liability method. Under&#xd;
        this method, deferred tax assets and liabilities are&#xd;
        recognized for the estimated future tax consequences&#xd;
        attributable to differences between the financial statement&#xd;
        carrying amounts of existing assets and liabilities and&#xd;
        their respective tax bases.&amp;#160;&amp;#160;Deferred tax assets&#xd;
        and liabilities are measured using enacted rates in effect&#xd;
        for the year in which temporary differences are expected to&#xd;
        be recovered or settled.&amp;#160;&amp;#160;Deferred tax assets are&#xd;
        reduced by a valuation allowance unless, in the opinion of&#xd;
        management, it is more likely than not that some portion or&#xd;
        all of the deferred tax assets will be realized.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-Based&#xd;
        Compensation&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        account for stock-based transactions in which the Company&#xd;
        receives services from employees, directors or others in&#xd;
        exchange for equity instruments based on the fair value of&#xd;
        the award at the grant date.&amp;#160;&amp;#160;Compensation cost&#xd;
        for awards of common stock is estimated based on the price&#xd;
        of the underlying common stock on the date of&#xd;
        issuance.&amp;#160;&amp;#160;Compensation cost for stock options or&#xd;
        warrants is estimated at the grant date based on each&#xd;
        instrument&amp;#8217;s fair-value as calculated by the&#xd;
        Black-Scholes option pricing model.&amp;#160;&amp;#160;We recognize&#xd;
        stock-based compensation cost as expense ratably on a&#xd;
        straight-line basis over the requisite service period for&#xd;
        the award.&amp;#160;&amp;#160;See Note 6 for additional stock-based&#xd;
        compensation information.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Recent&#xd;
        Accounting Pronouncements&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;There&#xd;
        have been no recent accounting pronouncements or changes in&#xd;
        accounting pronouncements which we expect to have a&#xd;
        material impact on our financial statements, nor do we&#xd;
        believe that any recently issued, but not yet effective,&#xd;
        accounting standards if currently adopted would have a&#xd;
        material effect on our financial statements.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <govx:GovernmentGrantsTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Government&#xd;
        Grants&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;NIH&#xd;
        Grant&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        September 2007, the NIH awarded us an Integrated&#xd;
        Preclinical/Clinical AIDS Vaccine Development (IPCAVD)&#xd;
        grant to support our HIV/AIDS vaccine&#xd;
        program.&amp;#160;&amp;#160;The project period for the grant covers&#xd;
        a five-year period which commenced October 2007, with an&#xd;
        aggregate award of $20.4 million.&amp;#160;&amp;#160;As of December&#xd;
        31, 2011, there is approximately $3.9 million of unused&#xd;
        grant funds remaining and available for use through August&#xd;
        31, 2012 (the end of the original project&#xd;
        period).&amp;#160;&amp;#160;We are utilizing this funding to&#xd;
        further our HIV/AIDS vaccine development, optimization and&#xd;
        production.&amp;#160;&amp;#160;We record revenue associated with&#xd;
        the grant as the related costs and expenses are incurred&#xd;
        and such revenue is reported as a separate line item in our&#xd;
        statements of operations.&amp;#160;&amp;#160;During 2011, 2010, and&#xd;
        2009, we recorded $4,899,885, $4,940,778, and $3,668,195,&#xd;
        respectively, of revenue associated with this grant.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;QTDP&#xd;
        Grant&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        November 2010, we were awarded a one-time grant of $244,479&#xd;
        pursuant to the Qualifying Therapeutic Discovery Project&#xd;
        (QTDP) program enacted as part of the Patient Protection&#xd;
        and Affordable Care Act of 2010.&amp;#160;&amp;#160;The QTDP&#xd;
        program was intended to provide incentive to smaller&#xd;
        companies who are focusing on innovative therapeutic&#xd;
        discoveries.&amp;#160;&amp;#160;We received the full amount of the&#xd;
        grant during 2010, which is recorded as revenue for 2010 in&#xd;
        the accompanying Consolidated Statement of&#xd;
        Operations.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</govx:GovernmentGrantsTextBlock>
  <us-gaap:CommitmentsDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;4.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Commitments&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Lease&#xd;
        Agreements&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        lease approximately 8,400 square feet of office and&#xd;
        laboratory space located in Smyrna, Georgia (metropolitan&#xd;
        Atlanta). Rent expense for the years ended December 31,&#xd;
        2011, 2010 and 2009 was $119,255, $118,988, and $63,350,&#xd;
        respectively.&amp;#160;&amp;#160;Future minimum lease payments&#xd;
        pursuant to the 62 month lease total $121,560 in 2012,&#xd;
        $125,180 in 2013 and $128,920 in 2014.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
        Commitments&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        the normal course of business, we may enter into various&#xd;
        firm purchase commitments related to production and testing&#xd;
        of our vaccine material, conduct of clinical trials, and&#xd;
        other research-related activities. As of December 31, 2011,&#xd;
        we had approximately $478,000 of unrecorded outstanding&#xd;
        purchase commitments to our vendors and subcontractors, of&#xd;
        which we expect approximately $445,000 in 2012 and $33,000&#xd;
        in 2013.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:CommitmentsDisclosureTextBlock>
  <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;5.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2006&#xd;
        Merger and Recapitalization&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
        Company was originally incorporated in June 1988 under the&#xd;
        laws of Illinois as Dauphin Technology, Inc.&#xd;
        (&amp;#8220;Dauphin&amp;#8221;).&amp;#160;&amp;#160;Dauphin was&#xd;
        unsuccessful and its operations were terminated in December&#xd;
        2003.&amp;#160;&amp;#160;In September 2006, Dauphin completed a&#xd;
        merger (the &amp;#8220;Merger&amp;#8221;) with GeoVax, Inc. which&#xd;
        was incorporated under the laws of Georgia in June&#xd;
        2001.&amp;#160;&amp;#160;As a result of the Merger, the&#xd;
        shareholders of GeoVax, Inc. exchanged their shares of&#xd;
        common stock for Dauphin common stock and GeoVax, Inc.&#xd;
        became a wholly-owned subsidiary of&#xd;
        Dauphin.&amp;#160;&amp;#160;Dauphin then changed its name to GeoVax&#xd;
        Labs, Inc. and replaced its officers and directors with&#xd;
        those of GeoVax, Inc.&amp;#160;&amp;#160;Subsequent to the Merger,&#xd;
        the Company has not conducted any business other than&#xd;
        GeoVax, Inc.&amp;#8217;s business of developing human&#xd;
        vaccines.&amp;#160;&amp;#160;The Merger was accounted for under the&#xd;
        purchase method of accounting as a reverse acquisition in&#xd;
        accordance with GAAP. Under this method of accounting,&#xd;
        Dauphin was treated as the acquired company and,&#xd;
        accordingly, all financial information prior to the date of&#xd;
        Merger presented in the accompanying consolidated financial&#xd;
        statements, or in the notes herein, as well as any&#xd;
        references to prior operations, are those of GeoVax,&#xd;
        Inc.&amp;#160;&amp;#160;In June 2008, the Company was&#xd;
        reincorporated under the laws of the State of&#xd;
        Delaware.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz25guzh7wiyZM7qQcGd4aYjo=] CSR-->
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;6.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stockholders&amp;#8217;&#xd;
        Equity&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Common&#xd;
        Stock Transactions&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        February 2010, we issued 12,000 shares of our common stock&#xd;
        in settlement of an obligation accrued at December 31, 2009&#xd;
        in the amount of $90,000.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During&#xd;
        December 2011, we sold an aggregate of 658,520 shares of&#xd;
        our common stock to fifteen individual accredited investors&#xd;
        (including members of our board of directors and management&#xd;
        --see Note 9) for an aggregate purchase price of $441,210,&#xd;
        $36,800 of which was received in January 2012 and is&#xd;
        therefore reflected as a receivable (Other Current Asset)&#xd;
        in the accompanying Consolidated Balance Sheet as of&#xd;
        December 31, 2011.&amp;#160;&amp;#160;We also issued to the&#xd;
        investors warrants to purchase an aggregate of 987,783&#xd;
        shares of common stock at a price of $1.00 per share, which&#xd;
        expire in December 2016.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;From&#xd;
        time to time, we issue shares of our common stock to&#xd;
        consultants or others in exchange for&#xd;
        services.&amp;#160;&amp;#160;During 2011, 2010 and 2009 we issued&#xd;
        129,245, 10,500, and 4,500, respectively, for such&#xd;
        services; and we recorded general and administrative&#xd;
        expense of $150,000, $53,813, and $31,500 during each&#xd;
        respective period related to these issuances.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock&#xd;
        Options&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        2006, we adopted the GeoVax Labs, Inc. 2006 Equity&#xd;
        Incentive Plan (the &amp;#8220;Stock Option Plan&amp;#8221;) for&#xd;
        the granting of qualified incentive stock options&#xd;
        (&amp;#8220;ISO&amp;#8217;s&amp;#8221;), nonqualified stock options,&#xd;
        restricted stock awards or restricted stock bonuses to&#xd;
        employees, officers, directors, consultants and advisors of&#xd;
        the Company.&amp;#160;&amp;#160;The exercise price for any option&#xd;
        granted may not be less than fair value (110% of fair value&#xd;
        for ISO&amp;#8217;s granted to certain&#xd;
        employees).&amp;#160;&amp;#160;Options granted under the Stock&#xd;
        Option Plan have a maximum ten-year term and generally vest&#xd;
        over three years.&amp;#160;&amp;#160;The Company has reserved&#xd;
        1,200,000 shares of its common stock for issuance under the&#xd;
        Stock Option Plan.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;A&#xd;
        summary of activity under the Stock Option Plan as of&#xd;
        December 31, 2011, and changes during the year then ended&#xd;
        is presented below:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;of&#xd;
                Shares&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Price&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Remaining&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Contractual&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Term&#xd;
                (yrs)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Aggregate&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Value&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
                at January 1, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,137,356&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.33&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;230,000&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-291&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;0.91&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-292&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
                or expired&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(439,114&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-293&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;2.81&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
                at December 31, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;928,242&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.43&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-294&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;6.5&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
                at December 31, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;578,231&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.59&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-295&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;4.8&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Additional&#xd;
        information concerning our stock options for the years&#xd;
        ended December 31, 2011, 2010 and 2009 is as&#xd;
        follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
                average fair value of options granted during the&#xd;
                period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.79&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.95&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.15&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&#xd;
                value of options exercised during the period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                fair value of options vested during the&#xd;
                period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;540,339&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;499,557&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,143,326&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        use the Black-Scholes model for determining the grant date&#xd;
        fair value of our stock option grants.&amp;#160;&amp;#160;This&#xd;
        model utilizes certain information, such as the interest&#xd;
        rate on a risk-free security with a term generally&#xd;
        equivalent to the expected life of the option being valued&#xd;
        and requires certain other assumptions, such as the&#xd;
        expected amount of time an option will be outstanding until&#xd;
        it is exercised or expired, to calculate the fair value of&#xd;
        stock options granted.&amp;#160;&amp;#160;The significant&#xd;
        assumptions we used in our fair value calculations were as&#xd;
        follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
                average risk-free interest rates&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.4&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.6&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.8&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                dividend yield&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                life of option&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7&#xd;
                yrs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.7&#xd;
                yrs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7&#xd;
                yrs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                volatility&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;111.2&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;112.9&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;112.3&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-based&#xd;
        compensation expense related to the Stock Option Plan was&#xd;
        $463,752, $575,662, and $1,221,764 during the years ended&#xd;
        December 31, 2011, 2010 and 2009,&#xd;
        respectively.&amp;#160;&amp;#160;Stock option expense is allocated&#xd;
        to research and development expense or to general and&#xd;
        administrative expense based on the related employee&#xd;
        classifications and corresponds to the allocation of&#xd;
        employee salaries.&amp;#160;&amp;#160;For the three years ended&#xd;
        December 31, 2011, stock option expense was allocated as&#xd;
        follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;General&#xd;
                and administrative expense&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;284,352&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;369,161&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;917,110&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
                and development expense&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;179,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;206,501&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;304,654&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                stock option expense&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;463,752&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;575,662&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,221,764&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
        of December 31, 2011, there was $515,697 of unrecognized&#xd;
        compensation expense related to stock-based compensation&#xd;
        arrangements.&amp;#160;&amp;#160;The unrecognized compensation&#xd;
        expense is expected to be recognized over a weighted&#xd;
        average remaining period of 2.0 years.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Compensatory&#xd;
        Warrants&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;From&#xd;
        time to time, we issue stock purchase warrants to&#xd;
        consultants or others in exchange for services. A summary&#xd;
        of our compensatory warrant activity as of December 31,&#xd;
        2011, and changes during the year then ended is presented&#xd;
        below:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;of&#xd;
                Shares&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Price&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Remaining&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Contractual&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Term&#xd;
                (yrs)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Aggregate&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Value&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
                at January 1, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;59,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.00&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-296&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;1.40&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-297&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
                or expired&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(2,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-298&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;7.00&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
                at December 31, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;64,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.00&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-299&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;0.6&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
                at December 31, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;58,850&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.00&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-300&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;0.7&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Additional&#xd;
        information concerning our compensatory warrants for the&#xd;
        years ended December 31, 2011, 2010 and 2009 is as&#xd;
        follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
                average fair value of warrants granted during the&#xd;
                period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.96&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4.75&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&#xd;
                value of warrants exercised during the&#xd;
                period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                fair value of warrants vested during the&#xd;
                period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,780&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;19,238&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6,413&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        use the Black-Scholes model for determining the grant date&#xd;
        fair value of our compensatory warrants.&amp;#160;&amp;#160;The&#xd;
        significant assumptions we used in our fair value&#xd;
        calculations were as follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
                average risk-free interest rates&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.98&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.54&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                dividend yield&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                life of warrant&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;3.0&#xd;
                yrs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;3.0&#xd;
                yrs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
                volatility&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115.46&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;112.1&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Expense&#xd;
        associated with compensatory warrants was $7,119, $121,057,&#xd;
        and $45,401 during the years ended December 31, 2011, 2010&#xd;
        and 2009, respectively.&amp;#160;&amp;#160;All such expense was&#xd;
        allocated to general and administrative&#xd;
        expense.&amp;#160;&amp;#160;As of December 31, 2011, there was no&#xd;
        unrecognized compensation expense related to compensatory&#xd;
        warrant arrangements.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Investment&#xd;
        Warrants&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        addition to outstanding stock options and compensatory&#xd;
        warrants, as of December 31, 2011 we have a total of&#xd;
        1,806,159 outstanding stock purchase warrants issued to&#xd;
        investors in connection with financing&#xd;
        transactions.&amp;#160;&amp;#160;Warrants as to 987,783 have an&#xd;
        exercise price of $1.00 per share and expire in December&#xd;
        2016; warrants as to 818,376 have an exercise price of&#xd;
        $16.50 and expire in December 2014.&amp;#160;&amp;#160;During the&#xd;
        fourth quarter of 2011, we recorded general and&#xd;
        administrative expense of $152,126 associated with the&#xd;
        extension of warrants which were due to expire in 2011 to&#xd;
        2013.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;7.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Retirement&#xd;
        Plan&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        participate in a multi-employer defined contribution&#xd;
        retirement plan (the &amp;#8220;401k Plan&amp;#8221;) administered&#xd;
        by a third party service provider; and the Company&#xd;
        contributes to the 401k Plan on behalf of its employees&#xd;
        based upon a matching formula.&amp;#160;&amp;#160;During the years&#xd;
        ended December 31, 2011, 2010 and 2009 our contributions to&#xd;
        the 401k Plan were $56,928, $52,632, and $25,057,&#xd;
        respectively.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;8.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income&#xd;
        Taxes&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;At&#xd;
        December 31, 2011, we have a consolidated federal net&#xd;
        operating loss (&amp;#8220;NOL&amp;#8221;) carryforward of&#xd;
        approximately $71.3 million, available to offset against&#xd;
        future taxable income which expires in varying amounts in&#xd;
        2012 through 2031.&amp;#160;&amp;#160;Additionally, we have&#xd;
        approximately $764,000 in research and development&#xd;
        (&amp;#8220;R&amp;amp;D&amp;#8221;) tax credits that expire in 2022&#xd;
        through 2031 unless utilized earlier.&amp;#160;&amp;#160;No income&#xd;
        taxes have been paid to date.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
        a result of the Merger discussed in Note 5, our NOL&#xd;
        carryforward increased substantially due to the addition of&#xd;
        historical NOL carryforwards for Dauphin Technology,&#xd;
        Inc.&amp;#160;&amp;#160;However, Section 382 of the Internal&#xd;
        Revenue Code contains provisions that may limit our&#xd;
        utilization of NOL and R&amp;amp;D tax credit carryforwards in&#xd;
        any given year as a result of significant changes in&#xd;
        ownership interests that have occurred in past periods or&#xd;
        may occur in future periods.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
        income taxes reflect the net effect of temporary&#xd;
        differences between the carrying amounts of assets and&#xd;
        liabilities for financial reporting purposes and the&#xd;
        amounts used for income tax&#xd;
        purposes.&amp;#160;&amp;#160;Significant components of our deferred&#xd;
        tax assets and liabilities included the following at&#xd;
        December 31, 2011 and 2010:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
                tax assets:&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 4%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                operating loss carryforward&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24,875,119&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;25,116,958&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-LEFT: 4%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
                and development tax credit carryforward&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;763,690&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;731,290&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Stock-based&#xd;
                compensation expense&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,991,769&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,779,950&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-LEFT: 4%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                deferred tax assets&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,630,578&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,628,198&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
                tax liabilities&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Depreciation&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(38,587&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(51,945&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
                deferred tax liabilities&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(38,587&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(51,945&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                deferred tax assets&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,991&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,576,253&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation&#xd;
                allowance&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,591,991&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,576,253&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;76%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        have established a full valuation allowance equal to the&#xd;
        amount of our net deferred tax assets due to uncertainties&#xd;
        with respect to our ability to generate sufficient taxable&#xd;
        income to realize these assets in the future. &lt;font style=&quot;DISPLAY: inline; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;A&#xd;
        reconciliation of the income tax benefit on losses at the&#xd;
        U.S. federal statutory rate to the reported income tax&#xd;
        expense is as follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;U.S.&#xd;
                federal statutory rate applied to pretax&#xd;
                loss&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(797,921&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(934,092&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,116,646&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Permanent&#xd;
                differences&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-301&quot; style=&quot;MARGIN-LEFT: 32.15pt&quot;&gt;&lt;/font&gt;3,536&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(77,200&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-302&quot; style=&quot;MARGIN-LEFT: 21.8pt&quot;&gt;&lt;/font&gt;169,469&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
                and development credits&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-303&quot; style=&quot;MARGIN-LEFT: 25.45pt&quot;&gt;&lt;/font&gt;32,400&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;59,959&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-304&quot; style=&quot;MARGIN-LEFT: 21.8pt&quot;&gt;&lt;/font&gt;169,667&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Change&#xd;
                in valuation allowance&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-305&quot; style=&quot;MARGIN-LEFT: 18.8pt&quot;&gt;&lt;/font&gt;761,985&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;951,333&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-306&quot; style=&quot;MARGIN-LEFT: 21.8pt&quot;&gt;&lt;/font&gt;777,510&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;64%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Reported&#xd;
                income tax expense&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;9.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Related&#xd;
        Party Transactions&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        are obligated to reimburse Emory University (a significant&#xd;
        stockholder of the Company) for ongoing costs in connection&#xd;
        with the filing, prosecution and maintenance of patent&#xd;
        applications subject to a license agreement for technology&#xd;
        associated with the vaccines we are&#xd;
        developing.&amp;#160;&amp;#160;The expense associated with these&#xd;
        ongoing patent cost reimbursements to Emory amounted to&#xd;
        $249,907, $193,674, and $85,673 for the years ended&#xd;
        December 31, 2011, 2010, and 2009, respectively.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
        have entered into two subcontracts with Emory for the&#xd;
        purpose of conducting research and development activities&#xd;
        associated with our grant from the NIH (see Note&#xd;
        3).&amp;#160;&amp;#160;During 2011, 2010, and 2009, we recorded&#xd;
        $1,172,758, $1,391,203, and $816,651, respectively, of&#xd;
        expense associated with these subcontracts.&amp;#160;&amp;#160;All&#xd;
        amounts paid to Emory under these subcontracts are&#xd;
        reimbursable to us pursuant to the NIH grant.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Through&#xd;
        November 2009, we leased office and laboratory space on a&#xd;
        month-to-month basis from Emtech Biotechnology Development,&#xd;
        Inc., a related party associated with&#xd;
        Emory.&amp;#160;&amp;#160;Rent expense associated with this lease&#xd;
        totaled $43,112 for the year ended December 31,&#xd;
        2009.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        March 2008, we entered into a consulting agreement with&#xd;
        Donald Hildebrand, a former member of our Board of&#xd;
        Directors and our former President &amp;amp; Chief Executive&#xd;
        Officer, pursuant to which Mr. Hildebrand provides business&#xd;
        and technical advisory services to the&#xd;
        Company.&amp;#160;&amp;#160;The term of the consulting agreement,&#xd;
        as amended, began on April 1, 2008 and ends on December 31,&#xd;
        2012.&amp;#160;&amp;#160;During 2011, 2010, and 2009, we recorded&#xd;
        $24,000, $57,600, and $57,600, respectively, of expense&#xd;
        associated with the consulting agreement.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
        December 2011, members of our management and Board of&#xd;
        Directors participated in the private placement offering of&#xd;
        our common stock and warrants described in Note 6, whereby&#xd;
        they purchased an aggregate of 335,954 shares of our common&#xd;
        stock for a total purchase price of $225,089 and received&#xd;
        five-year warrants to purchase an additional 503,932 shares&#xd;
        of our common stock exercisable at $1.00 per share.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;10.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Selected&#xd;
        Quarterly Financial Data (unaudited)&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;A&#xd;
        summary of selected quarterly financial data for 2011 and&#xd;
        2010 is as follows:&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&#xd;
                Quarter Ended&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
                31&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
                30&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
                30&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
                31&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
                from grants&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;893,002&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,753,033&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,297,006&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;956,844&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                loss&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(606,282&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(211,344&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(375,852&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,153,348&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                loss per share&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.01&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.02&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.08&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&#xd;
                Quarter Ended&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
                31&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
                30&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
                30&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
                31&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
                from grants&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,338,560&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,737,169&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,163,288&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;946,240&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                loss&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(690,789&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(933,089&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(644,666&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(478,784&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;52%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                loss per share&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.06&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.03&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;11.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Subsequent&#xd;
        Events&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Private&#xd;
        Placement of Common Stock and Warrants&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During&#xd;
        January 2012, we sold an aggregate of 407,999 shares of our&#xd;
        common stock to twelve individual accredited investors&#xd;
        (including 45,000 shares sold to members of our board of&#xd;
        directors and management) for an aggregate purchase price&#xd;
        of $273,360.&amp;#160;&amp;#160;We also issued to the investors&#xd;
        warrants to purchase an aggregate of 612,001 shares of&#xd;
        common stock at a price of $1.00 per share, which expire in&#xd;
        January 2017.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Issuance&#xd;
        of Convertible Preferred Stock and Warrants&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On&#xd;
        March 21, 2012, we sold shares of our Series A convertible&#xd;
        preferred stock to certain institutional investors for an&#xd;
        aggregate purchase price of $2.2 million.&amp;#160;&amp;#160;The&#xd;
        preferred stock is convertible at any time into shares of&#xd;
        our common stock at $0.75 per share (2,933,333 shares in&#xd;
        the aggregate), subject to possible adjustment as provided&#xd;
        in the certificate of designation.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Pursuant&#xd;
        to the terms of the securities purchase agreement, the&#xd;
        investors also received five-year Series A warrants to&#xd;
        purchase an aggregate of 2,933,333 shares of our common&#xd;
        stock at $1.00 per share.&amp;#160;&amp;#160;The Series A warrants&#xd;
        are immediately exercisable.&amp;#160; We also granted to the&#xd;
        investors a one-year additional purchase right, evidenced&#xd;
        in the form of Series B warrants, to purchase up to&#xd;
        2,933,333 of our common stock for one year with an exercise&#xd;
        price of $0.75 per share, and five-year Series C warrants&#xd;
        to purchase up to 2,933,333 shares of our common stock at&#xd;
        $1.00 per share.&amp;#160;&amp;#160;The Series B warrants are&#xd;
        immediately exercisable.&amp;#160;&amp;#160;The Series C warrants&#xd;
        only vest and become exercisable at the time, and to the&#xd;
        extent, that the Series B warrants are exercised.&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c2_From1Jan2011To31Dec2011">&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;SCHEDULE&#xd;
        II &amp;#8211; VALUATION AND QUALIFYING ACCOUNTS&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;For&#xd;
        the Years Ended December 31, 2011, 2010 and 2009&lt;/font&gt;&#xd;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Additions&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;&#xd;
                &amp;#160;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Description&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Balance&#xd;
                at&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Beginning&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Of&#xd;
                Period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Charged&#xd;
                to&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Costs&#xd;
                and&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expenses&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Charged&#xd;
                to&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accounts&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deductions&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Balance&#xd;
                at&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;End&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Of&#xd;
                Period&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Reserve&#xd;
                Deducted in the Balance Sheet&lt;/font&gt; &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;From&#xd;
                the Asset to Which it Applies:&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Allowance&#xd;
                for Deferred Tax Assets&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;40%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-307&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year&#xd;
                ended December 31, 2011&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,576,253&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;889,322&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(873,584&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,991&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;40%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-308&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year&#xd;
                ended December 31, 2010&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,091,338&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,160,405&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(675,490&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,576,253&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;40%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-309&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year&#xd;
                ended December 31, 2009&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;25,674,882&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,416,456&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,091,338&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;table align=&quot;center&quot; border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; id=&quot;hangingindent-117&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr valign=&quot;top&quot; style=&quot;LINE-HEIGHT: 1.25;&quot;&gt;&#xd;
            &lt;td style=&quot;WIDTH: 18pt&quot;&gt;&#xd;
              &lt;div&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td style=&quot;WIDTH: 18pt&quot;&gt;&#xd;
              &lt;div style=&quot;TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;(1)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td&gt;&#xd;
              &lt;div align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Deductions&#xd;
                represent the effect of expiring NOL carryforwards&#xd;
                from prior years.&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;</us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>govx-20111231.xsd
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<xs:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://geovax.com/20111231" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:govx="http://geovax.com/20111231" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" elementFormDefault="qualified" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20111231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20111231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20111231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20111231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedBalanceSheet" id="govx_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals" id="govx_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedIncomeStatement" id="govx_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ShareholdersEquityType2or3" id="govx_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedCashFlow" id="govx_ConsolidatedCashFlow">
        <link:definition>005 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note" id="govx_Note">
        <link:definition>006 - Disclosure - Note 1 - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0" id="govx_Note0">
        <link:definition>007 - Disclosure - Note 2 - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00" id="govx_Note00">
        <link:definition>008 - Disclosure - Note 3 - Government Grants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000" id="govx_Note000">
        <link:definition>009 - Disclosure - Note 4 - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0000" id="govx_Note0000">
        <link:definition>010 - Disclosure - Note 5 - 2006 Merger and Recapitalization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00000" id="govx_Note00000">
        <link:definition>011 - Disclosure - Note 6 - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000000" id="govx_Note000000">
        <link:definition>012 - Disclosure - Note 7 - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz238wd1Zi8dVNOlrsKcfp8ss=] CSR-->
      <link:roleType roleURI="http://geovax.com/role/Note0000000" id="govx_Note0000000">
        <link:definition>013 - Disclosure - Note 8 - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00000000" id="govx_Note00000000">
        <link:definition>014 - Disclosure - Note 9 - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000000000" id="govx_Note000000000">
        <link:definition>015 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0000000000" id="govx_Note0000000000">
        <link:definition>016 - Disclosure - Note 11 - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Schedule" id="govx_Schedule">
        <link:definition>017 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-types-2011-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="ConsolidatedBalanceSheetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedBalanceSheetsAbstract"/>
  <xs:element name="CurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CurrentAssetsAbstract"/>
  <xs:element name="CurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CurrentLiabilitiesAbstract"/>
  <xs:element name="ConsolidatedStatementsOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfOperationsAbstract"/>
  <xs:element name="OtherIncomeExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OtherIncomeExpenseAbstract"/>
  <xs:element name="BasicAndDilutedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_BasicAndDilutedAbstract"/>
  <xs:element name="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
  <xs:element name="StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable"/>
  <xs:element name="StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable"/>
  <xs:element name="StockIssuedDuringPeriodValueCashlessWarrantExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise"/>
  <xs:element name="StockIssuedDuringPeriodSharesCashlessWarrantExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise"/>
  <xs:element name="StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant"/>
  <xs:element name="StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant"/>
  <xs:element name="StockIssuedDuringPeriodValueInLieuOfCashPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment"/>
  <xs:element name="StockIssuedDuringPeriodSharesInLieuOfCashPayment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment"/>
  <xs:element name="ConsolidatedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
  <xs:element name="CashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
  <xs:element name="ChangesInAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ChangesInAssetsAndLiabilitiesAbstract"/>
  <xs:element name="CashFlowsFromInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromInvestingActivitiesAbstract"/>
  <xs:element name="CashFlowsFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromFinancingActivitiesAbstract"/>
  <xs:element name="SupplementalDisclosureOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SupplementalDisclosureOfCashFlowInformationAbstract"/>
  <xs:element name="NatureOfOperationsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_NatureOfOperationsTextBlockAbstract"/>
  <xs:element name="SignificantAccountingPoliciesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SignificantAccountingPoliciesTextBlockAbstract"/>
  <xs:element name="GovernmentGrantsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_GovernmentGrantsTextBlockAbstract"/>
  <xs:element name="GovernmentGrantsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_GovernmentGrantsTextBlock"/>
  <xs:element name="CommitmentsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CommitmentsDisclosureTextBlockAbstract"/>
  <xs:element name="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
  <xs:element name="StockholdersEquityNoteDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
  <xs:element name="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
  <xs:element name="IncomeTaxDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_IncomeTaxDisclosureTextBlockAbstract"/>
  <xs:element name="RelatedPartyTransactionsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
  <xs:element name="QuarterlyFinancialInformationTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_QuarterlyFinancialInformationTextBlockAbstract"/>
  <xs:element name="SubsequentEventsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SubsequentEventsTextBlockAbstract"/>
  <xs:element name="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
  <xs:element name="PrivatePlacementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="govx_PrivatePlacementAxis"/>
  <xs:element name="PurchaseAgreementwithFushionCapitalAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="govx_PurchaseAgreementwithFushionCapitalAxis"/>
  <xs:element name="StockSubscriptionReceivableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockSubscriptionReceivableMember"/>
  <xs:element name="PurchaseAgreementwithFushionCapitalMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_PurchaseAgreementwithFushionCapitalMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>govx-20111231_cal.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrantsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_GrantsReceivable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz25mpQ59336GYcl46Qlh8N3w=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromGrants" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfDeferredCharges" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>govx-20111231_def.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ShareholdersEquityType2or3" roleURI="http://geovax.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note" roleURI="http://geovax.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0" roleURI="http://geovax.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00" roleURI="http://geovax.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000" roleURI="http://geovax.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000" roleURI="http://geovax.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00000" roleURI="http://geovax.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000000" roleURI="http://geovax.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000000" roleURI="http://geovax.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00000000" roleURI="http://geovax.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000000000" roleURI="http://geovax.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000000000" roleURI="http://geovax.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Schedule" roleURI="http://geovax.com/role/Schedule"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#DocumentAndEntityInformation" roleURI="http://geovax.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentAssetsAbstract" xlink:href="govx-20111231.xsd#govx_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="govx_CurrentAssetsAbstract" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_GrantsReceivable" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_Assets" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="govx_CurrentLiabilitiesAbstract" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_StockholdersEquity" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="5"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3"/>
    <loc xlink:type="locator" xlink:label="govx_OtherIncomeExpenseAbstract" xlink:href="govx-20111231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_OtherIncomeExpenseAbstract" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5"/>
    <loc xlink:type="locator" xlink:label="govx_BasicAndDilutedAbstract" xlink:href="govx-20111231.xsd#govx_BasicAndDilutedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_BasicAndDilutedAbstract" order="6"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1"/>
    <loc xlink:type="locator" xlink:label="govx_StockSubscriptionReceivableMember" xlink:href="govx-20111231.xsd#govx_StockSubscriptionReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="govx_StockSubscriptionReceivableMember" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20111231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="5"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" order="6"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" order="7"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueInLieuOfCashPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment" order="8"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" order="9"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="10"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="11"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="12"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="13"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" order="14"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="15"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="16"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="17"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="18"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" order="19"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" order="20"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="21"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="22"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="23"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="24"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="25"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashlessWarrantExercise"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise" order="26"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" order="27"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" order="28"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="29"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="30"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="31"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="32"/>
  </definitionLink>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz20G5Ij4/ayu7CtfgrTTTj+o=] CSR-->
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDeferredCharges" order="3"/>
    <loc xlink:type="locator" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5"/>
    <loc xlink:type="locator" xlink:label="govx_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="govx-20111231.xsd#govx_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_SupplementalDisclosureOfCashFlowInformationAbstract" order="6"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="0"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NatureOfOperations" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlock" xlink:href="govx-20111231.xsd#govx_GovernmentGrantsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_GovernmentGrantsTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Schedule">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="1"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityRegistrantName" order="0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentType" order="1"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityPublicFloat" order="4"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentFlag" order="5"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentDescription" order="6"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCentralIndexKey" order="7"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityFilerCategory" order="10"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>govx-20111231_lab.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedBalanceSheetsAbstract_lbl" xml:lang="en-US">Consolidated Balance Sheets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedBalanceSheetsAbstract" xlink:to="govx_ConsolidatedBalanceSheetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedBalanceSheetsAbstract_lbl0" xml:lang="en-US">Consolidated Balance Sheets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedBalanceSheetsAbstract" xlink:to="govx_ConsolidatedBalanceSheetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">ASSETS [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentAssetsAbstract" xlink:href="govx-20111231.xsd#govx_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentAssetsAbstract" xlink:to="govx_CurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentAssetsAbstract" xlink:to="govx_CurrentAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Grant funds receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">Other assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl0" xml:lang="en-US">Other assets: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Licenses, net of accumulated amortization of $208,933 and $184,047 at December 31, 2011 and 2010 respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Total other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="govx_CurrentLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="govx_CurrentLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Amounts payable to Emory University (a related party)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&#8217; equity: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.001 par value, 40,000,000 shares authorized; 16,442,611 and 15,654,846 shares issued and outstanding at December 31, 2011 and 2010, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US">Deficit accumulated during the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Licenses, accumulated amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract_lbl" xml:lang="en-US">Consolidated Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:to="govx_ConsolidatedStatementsOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:to="govx_ConsolidatedStatementsOfOperationsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromGrants_lbl" xml:lang="en-US">Grant revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating expenses: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_OtherIncomeExpenseAbstract" xlink:href="govx-20111231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OtherIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="govx_OtherIncomeExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OtherIncomeExpenseAbstract_lbl0" xml:lang="en-US">Other income (expense): [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="govx_OtherIncomeExpenseAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_BasicAndDilutedAbstract" xlink:href="govx-20111231.xsd#govx_BasicAndDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_BasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and diluted:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="govx_BasicAndDilutedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_BasicAndDilutedAbstract_lbl0" xml:lang="en-US">Basic and diluted: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="govx_BasicAndDilutedAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl" xml:lang="en-US">Consolidated Statements of Stockholders&apos; Equity (Deficiency)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Stockholders&apos; Equity (Deficiency) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20111231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl" xml:lang="en-US">Represents increases in additional paid in capital attributable to capital contribution at inception.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl0" xml:lang="en-US">Capital contribution at inception (June 27, 2001)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Sale of common stock for cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of common stock for cash (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Issuance of common stock for technology license</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Issuance of common stock for technology license (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable_lbl" xml:lang="en-US">Value of shares of stock issued during the period for cash and stock subscription receivable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" xlink:to="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable_lbl0" xml:lang="en-US">Sale of common stock for cash and stock subscription receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" xlink:to="govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl" xml:lang="en-US">Number of shares of stock issued during the period for cash and stock subscription receivable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:to="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl0" xml:lang="en-US">Sale of common stock for cash and stock subscription receivable (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:to="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Cash payments received on stock subscription receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock to common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock to common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Common stock issued in connection with merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Common stock issued in connection with merger (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashlessWarrantExercise"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise_lbl" xml:lang="en-US">Value of shares of stock issued during the period for cashless warrant exercise.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise" xlink:to="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise_lbl0" xml:lang="en-US">Issuance of common stock for cashless warrant exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise" xlink:to="govx_StockIssuedDuringPeriodValueCashlessWarrantExercise_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl" xml:lang="en-US">Number of shares of stock issued during the period for cashless warrant exercise.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:to="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl0" xml:lang="en-US">Issuance of common stock for cashless warrant exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:to="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon stock option exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon stock option exercise (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Transactions related to common stock purchase agreement with Fusion Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Transactions related to common stock purchase agreement with Fusion Capital (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock-based compensation - Stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Stock-based compensation - Consultant warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation - Issuance of common stock for services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation - Issuance of common stock for services (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant_lbl" xml:lang="en-US">Value of shares of stock issued during the period for cash upon exercise of stock purchase warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" xlink:to="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant_lbl0" xml:lang="en-US">Sale of common stock for cash upon exercise of stock purchase warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" xlink:to="govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl" xml:lang="en-US">Number of shares of stock issued during the period for cash upon exercise of stock purchase warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:to="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl0" xml:lang="en-US">Sale of common stock for cash upon exercise of stock purchase warrant (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:to="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueInLieuOfCashPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment_lbl" xml:lang="en-US">Value of shares of stock issued during the period in lieu of cash payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment" xlink:to="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment_lbl0" xml:lang="en-US">Issuance of common stock in lieu of cash payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment" xlink:to="govx_StockIssuedDuringPeriodValueInLieuOfCashPayment_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl" xml:lang="en-US">Number of shares of stock issued during the period in lieu of cash payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:to="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl0" xml:lang="en-US">Issuance of common stock in lieu of cash payment (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:to="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit_lbl" xml:lang="en-US">Fractional share payout upon reverse split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Fractional share payout upon reverse split (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl" xml:lang="en-US">Consolidated Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xml:lang="en-US">Accretion of preferred stock redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz2zcggBJ2mWvghtEFhmw+aCk=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDeferredCharges_lbl" xml:lang="en-US">Write-off of deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDeferredCharges" xlink:to="us-gaap_AmortizationOfDeferredCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Changes in assets and liabilities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Grant funds receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Total adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from investing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided (used) by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from financing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from sale of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from sale of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="govx_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="govx-20111231.xsd#govx_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="govx_SupplementalDisclosureOfCashFlowInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental disclosure of cash flow information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="govx_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_NatureOfOperationsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_NatureOfOperationsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NatureOfOperationsTextBlockAbstract_lbl" xml:lang="en-US">Note 1 - Nature of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NatureOfOperationsTextBlockAbstract" xlink:to="govx_NatureOfOperationsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl" xml:lang="en-US">Note 2 - Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAccountingPoliciesTextBlockAbstract" xlink:to="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_GovernmentGrantsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_GovernmentGrantsTextBlockAbstract_lbl" xml:lang="en-US">Note 3 - Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlockAbstract" xlink:to="govx_GovernmentGrantsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlock" xlink:href="govx-20111231.xsd#govx_GovernmentGrantsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_GovernmentGrantsTextBlock_lbl" xml:lang="en-US">Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity&apos;s treatment of any unearned or deferred revenue that arises from the transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_GovernmentGrantsTextBlock_lbl0" xml:lang="en-US">Government Grants [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CommitmentsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_CommitmentsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CommitmentsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 4 - Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommitmentsDisclosureTextBlockAbstract" xlink:to="govx_CommitmentsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl" xml:lang="en-US">Note 5 - 2006 Merger and Recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 6 - Stockholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 7 - Retirement Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_IncomeTaxDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 8 - Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_IncomeTaxDisclosureTextBlockAbstract" xlink:to="govx_IncomeTaxDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 9 - Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl" xml:lang="en-US">Note 10 - Selected Quarterly Financial Data (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_QuarterlyFinancialInformationTextBlockAbstract" xlink:to="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SubsequentEventsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_SubsequentEventsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SubsequentEventsTextBlockAbstract_lbl" xml:lang="en-US">Note 11 - Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SubsequentEventsTextBlockAbstract" xlink:to="govx_SubsequentEventsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Statement, Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Statement, Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PrivatePlacementAxis" xlink:href="govx-20111231.xsd#govx_PrivatePlacementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PrivatePlacementAxis_lbl" xml:lang="en-US">Private Placement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PrivatePlacementAxis" xlink:to="govx_PrivatePlacementAxis_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PrivatePlacementAxis_lbl0" xml:lang="en-US">Private Placement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PrivatePlacementAxis" xlink:to="govx_PrivatePlacementAxis_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_PurchaseAgreementwithFushionCapitalAxis" xlink:href="govx-20111231.xsd#govx_PurchaseAgreementwithFushionCapitalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PurchaseAgreementwithFushionCapitalAxis_lbl" xml:lang="en-US">Purchase Agreementwith Fushion Capital [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PurchaseAgreementwithFushionCapitalAxis" xlink:to="govx_PurchaseAgreementwithFushionCapitalAxis_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PurchaseAgreementwithFushionCapitalAxis_lbl0" xml:lang="en-US">Purchase Agreement with Fushion Capital [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PurchaseAgreementwithFushionCapitalAxis" xlink:to="govx_PurchaseAgreementwithFushionCapitalAxis_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockSubscriptionReceivableMember" xlink:href="govx-20111231.xsd#govx_StockSubscriptionReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockSubscriptionReceivableMember_lbl" xml:lang="en-US">Stock Subscription Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockSubscriptionReceivableMember" xlink:to="govx_StockSubscriptionReceivableMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockSubscriptionReceivableMember_lbl0" xml:lang="en-US">Stock Subscription Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockSubscriptionReceivableMember" xlink:to="govx_StockSubscriptionReceivableMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_PurchaseAgreementwithFushionCapitalMember" xlink:href="govx-20111231.xsd#govx_PurchaseAgreementwithFushionCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PurchaseAgreementwithFushionCapitalMember_lbl" xml:lang="en-US">Purchase Agreementwith Fushion Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PurchaseAgreementwithFushionCapitalMember" xlink:to="govx_PurchaseAgreementwithFushionCapitalMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PurchaseAgreementwithFushionCapitalMember_lbl0" xml:lang="en-US">Purchase Agreement with Fushion Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PurchaseAgreementwithFushionCapitalMember" xlink:to="govx_PurchaseAgreementwithFushionCapitalMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_DocumentAndEntityInformationAbstract" xlink:href="govx-20111231.xsd#govx_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DocumentAndEntityInformationAbstract" xlink:to="govx_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:to="govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_GovernmentGrantsTextBlock_lbl1" xml:lang="en-US">GovernmentGrantsTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesInLieuOfCashPayment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:to="govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:to="govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesCashlessWarrantExercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:to="govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Stock Splits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Deposit Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0" xml:lang="en-US">Development Stage Enterprise, Deficit Accumulated During Development Stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>govx-20111231_pre.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 29 00:44:50 UTC 2012 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ShareholdersEquityType2or3" roleURI="http://geovax.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note" roleURI="http://geovax.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0" roleURI="http://geovax.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00" roleURI="http://geovax.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000" roleURI="http://geovax.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000" roleURI="http://geovax.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00000" roleURI="http://geovax.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000000" roleURI="http://geovax.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000000" roleURI="http://geovax.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note00000000" roleURI="http://geovax.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note000000000" roleURI="http://geovax.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Note0000000000" roleURI="http://geovax.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#govx_Schedule" roleURI="http://geovax.com/role/Schedule"/>
  <roleRef xlink:type="simple" xlink:href="govx-20111231.xsd#DocumentAndEntityInformation" roleURI="http://geovax.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentAssetsAbstract" xlink:href="govx-20111231.xsd#govx_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="CurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_GrantsReceivable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_Assets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="CurrentLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfOperationsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfOperationsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="OtherIncomeExpenseAbstract" xlink:href="govx-20111231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherIncomeExpenseAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedAbstract" xlink:href="govx-20111231.xsd#govx_BasicAndDilutedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="BasicAndDilutedAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="StockSubscriptionReceivableMember" xlink:href="govx-20111231.xsd#govx_StockSubscriptionReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="StockSubscriptionReceivableMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20111231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueInLieuOfCashPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueInLieuOfCashPayment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesInLieuOfCashPayment" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesInLieuOfCashPayment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodValueCashlessWarrantExercise"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueCashlessWarrantExercise" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesCashlessWarrantExercise" xlink:href="govx-20111231.xsd#govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesCashlessWarrantExercise" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfCashFlowsAbstract" xlink:href="govx-20111231.xsd#govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<!-- [WMV3][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCg9bVmJBkpG0p9Weoty0FgIB6TmIINIPVOJYJHlp2mrcMSbjWjnDb9i/IxkHtESS3G81PzaGYBlAIag4YGoTebk6tz+NjNNe43kam7GRb5b52qusfbhjM5XZpy695L6Kz2ydxDlJ7WgRwCYPMM3euZ60=] CSR-->
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDeferredCharges" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20111231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="ChangesInAssetsAndLiabilitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20111231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="govx-20111231.xsd#govx_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="SupplementalDisclosureOfCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note">
    <loc xlink:type="locator" xlink:label="NatureOfOperationsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_NatureOfOperationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00">
    <loc xlink:type="locator" xlink:label="GovernmentGrantsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_GovernmentGrantsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GovernmentGrantsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="GovernmentGrantsTextBlock" xlink:href="govx-20111231.xsd#govx_GovernmentGrantsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="GovernmentGrantsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000">
    <loc xlink:type="locator" xlink:label="CommitmentsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_CommitmentsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="QuarterlyFinancialInformationTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="SubsequentEventsTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_SubsequentEventsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Schedule">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:href="govx-20111231.xsd#govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="govx-20111231.xsd#govx_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="15.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>fig1.jpg
<TEXT>
begin 644 fig1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`.$"
M[@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/J#_@C'_P`$9/V'_P!M+]AWPG\=/CKX3\:ZW\0-:\<>.]#OM0T;
MQYJFBVC6&@:DEIIP6RM80D<AC=S<LS.DY?)SP:_5U?\`@VP_X)=YPWP]^)IP
M,\_%#6>@SP?W&/S]NV:?_P`&V*X_X)<_#UQU/Q.^*1)_[C</MC.:_<SQCXQ\
M,^`?#.L>+_&&KV>@>%_#]E<ZKKNN:G.MOI^E:=:QF2XN[N=@0D:*.%`+NY"(
M&8@5\7DF2Y77RK`XG$8'#5*E7"Q4FEHM8_JNCT_$^@S/-,QCF6-HTL=BHTXX
MJ:4>?25FT^O33IVMN?AI_P`0U_\`P2X''_"O?B7^/Q1UC\_]1GT[YZ^M'_$-
MA_P2WS_R3SXE_P#ATM7^O_/#\.GZ'G]25_;9_94.X'XQ^&059E(-OK98%200
M0-)&.G&>H]J?_P`-K_LI_P#19/#'_@/K?_RJKT%D7#__`$+L-==HR\O^!Z'#
M_:>9[/'XKTYO\/\`>\OZY3\LO^(:_P#X);X_Y)[\2^O_`$5+6/I_SPSC^E+_
M`,0V'_!+C_HGGQ+_`/#I:OUZ_P#/#';']<5^IG_#:_[*?_19/#'_`(#ZW_\`
M*NFG]M?]E7C;\9/"X]<V^M__`"J-/^P<@_Z%N'_\!EY>7^$%F>::?[?BNGVO
M\/\`>\OZY3\LS_P;9?\`!+4,J'X??$O+=!_PM+6,G''7R/\`/X4H_P"#;#_@
MEN>?^%>_$O&./^+HZQ_\8Q^GIVYK]2O^&U/V4R0W_"Y?#.X=/W&M\>N/^)5_
M3FGC]M?]E,#'_"Y/#'_@/K?_`,JZ7]@Y!_T+</\`^`R_N_\`VNH_[3S/_H/Q
M73[?^'S_`%TU[*WY9_\`$-A_P2W_`.B>_$K_`,.EJ_Z_N.?\]::?^#:[_@EN
M6!_X5Y\2\CI_Q='6",G_`+8@?E7ZG?\`#:_[*?\`T63PQ_X#ZW_\JZ/^&U_V
M5.WQE\,CZ6^M_P#RJH60Y!I_PFX?_P`!E_=_^U_JXO[3S3_H/Q73[3_N_P![
MR_KE/RE?_@VZ_P""7D;E%^&_Q18@@97XI:N5VM]X_P"HQP.HYZBG-_P;;_\`
M!+I"P_X5U\32B@G)^*.L!3CZ0Y[<?I7ZI/\`ML?LKIC'QD\--DGGR=<'X<:2
M>>:SO^&TOV8%::5?C3X;:25N(7MM=,21CH5_XE.<[<9..><]:?\`8?#UE_PF
MT/\`P&5NG]W?RZ:%+,<T_P"@_$O_`+??3E[/[O\`@(_,"+_@V[_X)>.B2-\.
M/B2/,)0X^*>O$JGJ?W'3_/>IT_X-L?\`@ETQ8-\._B4`#M7'Q3UK)'4'YH./
M3`_E7Z>R?ML?LP*8FC^,_A@[B!*AMM<P0<9*_P#$IZ@="?ZU8/[:7[+'S&/X
MT>&D9MI^:#7#@\YP?[)[\=/2C^PL@?\`S+L/T^R]_N[_`'=0_M+-.N/Q/3[=
MMN7I?\?SLC\N_P#B&Q_X)<*V3\/?B5C&,CXHZP?Q_P!1GOU__72_\0V/_!+<
M_P#-//B7D_\`54=8^I/^HZ9]^^*_4)OVT_V6?F/_``NCPUN*%01!K>`2,%O^
M05U]./>I(/VT?V6XT"R_&?PRR@#!^S:Z#P,?,3I0_$_RI?V'P_\`]"[#]/LR
M7IT!9CFG_0=BMNDG_=MU_KY)GY;R?\&V7_!+=2/^+>_$O)(4`?%'6.I![>1U
M[CCMU]&-_P`&VO\`P2\3E?AU\3-W0`?%+6!UZ_\`+&OU//[:O[*A8'_A<GAC
M@YQY&M@9P1_T"O?/UIH_;5_97^7/QF\,'&=W[C7.?I_Q*J%D.0:?\)V'Z?9E
MY>773^D)9EF>G^WXGH_B].G-OI_5D?EL/^#;#_@EQCGX>?$O)Y/_`!=+6.YY
M_P"6'7G/;UZBG?\`$-A_P2WX_P"+>_$O_P`.EK'Z_N/YY]*_4S_AM?\`93_Z
M+)X8_P#`?6__`)5T?\-K_LI_]%D\,?\`@/K?_P`JZ/[!R#_H6X?I]F7]WR_P
MB_M/,_\`H.Q73[7^'^]_PU_(_+/_`(AL/^"6_P#T3WXE]_\`FJ6L?T@]_J<?
M2C_B&O\`^"7!Y_X5Y\2^/^JI:O\`KB#'_P"NOU,_X;7_`&4_^BR>&/\`P'UO
M_P"5=!_;7_93Q_R63PQ_X#ZW_P#*JC^P<@_Z%N'Z?9E_=_X'I\@69YII_M^*
MZ?:?]W^]Y?+_`+=/RL;_`(-L?^"6_FJO_"O/B66PQ&/BEK'3U_U'_P"H#US4
M_P#Q#8?\$N._P\^)><?]%1U?J?\`M@,_YYP:_4@?MJ?LIYW'XR^&=VTK_J-;
MQ@G/_0*IP_;6_94SG_A<OAGM_P`L-;/U_P"853_L+(?^A=A^GV9;Z6_-#_M/
M-/\`H/Q6EOM_X?[WEOM]R/RT_P"(:_\`X);\_P#%O/B7U_Z*EK'Z?N.G/Z'/
M:E_XAL/^"6__`$3WXE?^'2U?_P",=??W^M?J9_PVO^RG_P!%D\,?^`^M_P#R
MKI#^VQ^RIG_DLGA?'_7OKG]-)/\`*E_87#^G_"=AE=I+W9+5VM^FXO[3S3_H
M.Q73[3_N_P![R_KE/RS_`.(:_P#X);_]$]^)?7_HJ6L>W?R/<_Y%#?\`!M?_
M`,$N"./AY\2L_P#94=7QU]X/;_.:_8WX;_M!?!;XO:EJFC_#7Q_X=\7:MHMI
M;ZAJFEZ7=/\`VE8V%W,]O;7MQ87$4%Y%:37$4L*7#0"(R(R[LU[0(T/.T5<.
M'LAJ1YH9;AI)-QND]XVNM>JT^[T%_:N9*W^WXKI]I_W?[WE_5C\"Q_P;8?\`
M!+C`!^'OQ+X_ZJEJ_OSQ`?6C_B&O_P""6_\`T3WXE?\`ATM8]NWD?Y_G^^GE
MI_=%'EI_=%7_`*MY+_T+,/\`=Z>?S_X(EFV9:?[?BNGVG_=_O?\`#?\`;I^!
M+?\`!MC_`,$ND&5^'OQ+.,]/BEK&>GKY&?7TQ[\5&/\`@VT_X)>%1GX=?$M6
M+$X_X6CK!//4_P"H(P1Z_4U^^[0JWMSQCCCTII18\';N4`EB<D\#M_/'X"C_
M`%;R7_H68?\`3ITOY#_M7,=/^%#%>G,_[OFM=/P\DC\$!_P;8?\`!+CC/P]^
M)7_ATM7_`/C'/^(SZ4?\0V'_``2W_P"B>_$K/_94M8_^,>W^>:_>E+B&90\$
M32@OL;`VE?4D-S@>U3&*/>2!@X'!)`/Y$?\`U\>U+_5K)/\`H5X?^K>?DA+-
M<R_Z#\5_X%Z?WM-5Z_<C\$/^(:__`();_P#1/?B5_P"'2UC_`.,<TC?\&V'_
M``2W_P"B??$H$]/^+I:QS_Y+_P">>#DU^ST'Q>^'ES\3[OX20ZXC>/++2H]7
MGT;8Z[;*3"K)YC80G_9Y/:O3#!O!27<NUPP=>`<$8'7G/3_]9I_ZMY)_T*\/
M]WI_DON'_:N8Z?\`"ABNGVG_`'?-]OP]#\%5_P"#;#_@ER1EOA[\2\_]E2UC
M_P"1P#^7ZT?\0V'_``2W_P"B>?$O\?BEK'K_`-</;]1ZX/[Z"-`?NYX[]/\`
M]?KGFE\M/[HH_P!6LD_Z%F']7?R_'1?=H+^ULQO_`+_BM_YG_=ZW_KY'X%_\
M0V'_``2W_P"B>_$K_P`.EJ__`,8_S^5)_P`0V'_!+?\`Z)Y\2_Q^*6L>_7]Q
MTX_SFOWU\M/[HH\M/[HH_P!6LD_Z%F&^Y^7^2^[[S^U<RT_V_%?^!/\`N_WO
M+Y7\C\#/^(;#_@EO_P!$]^)7_ATM7_\`D?\`S^5-_P"(;#_@EOQ_Q;SXE]?^
MBI:Q^O[CV_4=><_OKY:?W11Y:?W11_JUDG_0LPWX^7^2^[[S^ULRT_V_%=/M
M/^[YZ?I_VZ?@7_Q#8?\`!+?G_BWGQ+_\.EK'Z9@]^WI]*!_P;8?\$M_^B>_$
MO_PZ6L>__3#V';W[G'[Z>6G]T4>6G]T#_/OFC_5K)/\`H68;[GY?U\O0/[6S
M+3_;\5_X$_[O][_AO^W3\"S_`,&U_P#P2YZK\//B6?;_`(6CK!Y^OV?/X=/:
MOQ3_`."\?_!'W]BG]A[]B+4?C'\!/"7C#2/&?_"8:1X=>;7/&FHZ]9-INJ6U
MV+I7T^Z18&E9HT(FQN555>=O']SQ3;R.GZ\]>GU_G7\U/_!T\G_&LZ_;/)^)
MGAD#C/(M]0/?C_/&*YL7D.6T,+4J8?`8:E4A.ER/J^6=.3MOJE?\;=SIP6:X
M^>+HTYX_%.+=M9/K;1:NW7MOTW/\FY&_?`OGYG8G'UX['J<=NO;-?W!_\$-/
M^"(7[*?_``48_94U'XM_&'6O%V@^(_#OB'3_``Q;P>$K'PNEI>6DFB6^HB\N
M6U/2;JXDNC).RR.)<-@$C`K^'MAEQV_>-DCZ]OS_`,FO]1?_`(-,B4_X)^>,
M;@)'*(/B'I8Q+.("@7PE9;MK'A^.-IY)_,>IF%&.*JY72JRE&E%XCFC%M<T?
M9QNERM.Z^2_`Y<-.M26*JQGR33<>;M-SNOFUIY]R]_Q"A_\`!.\B8OXW^+2-
M;E793;^!\RJ#R1MT`CL=W.[`X&:RI?\`@U>_X)QB5E_X3KXN#RU>0$6G@DI,
MJ?.R+G0/X.GS8Z5_25XM\:^'?">A>(?$_B/6+;2?".G63ZKJFLWLK6]EI$%G
M/'&SWEZL9CCB:67!(+$C"X)9:^./'W[:'P`\/>'[_4]$^)%IKEU!:RS6]CH?
MA_Q;K#ZA=RRNL-I$]KX?D$T<VT%I8F9(`?WA`%0\IRR#2G*K%\MU>577X=?C
M_KYFD<;F+LUB?O=ULEU^=O+7??\`"'XC?\&WW_!,/X<^';_Q'K'C7XR26UO:
M3S0V]M9>`VDNY(P0T-I$VA!Y&4G+LH(B"ER1MQ7Y>^+_`/@D?^Q#9ZO<CPQ;
M_$"XT-I3%87<DW@N^NHKAD0)%?01Z$KB,LREY!D+DI7ZL_M%?M0>+_BYXB:9
MM'\77>G:C'':I9Z)X2^(5G::+HUE<23R(]S'X<V&_O'?9<-:IF>(;6/2OB7Q
M_P#$'5O#VA6VN>'_``+\6]6O([W[!+H.E_"CXDW^IR6TK-&SQV]MX760VZIL
M>.]D8XVY8"H_LW+HM*,JS5N\_P"[?XFWT^^P/&9JGIB8M>;7E\_E?_@?!VM?
M\$ROV3=.U'5M(M[+Q=J%YX:=U\2SVUKX45HI)+=+FW_LNP71_M.H1/&S13O;
M.OD26[GG=BN%T_\`X)[_`+).MP.-.NO$EO<"YW13WNB^%X8[>VC48CU>VETP
M2VYNIC]DLKE!Y1EYN5-?KMX"?0=8NO"%YXI\)^*/#^I7=@\6J^()?A]\0X+R
MTS]HGM[36XI_"KONCDN(]TZJY(:2)FQ'@M\0>'M`T+1?$>K16FKZYK&F/]IM
M(].^''C"9M==9GE%IICKX7073.2A>SGC"Q@;@0QK18++$DG[>^B;<GY:M>>]
MO3S)^N9L_P#F(C]_>WGTUT_X-ORPU7_@FM^R[HNHVT>HV'BJ2VNYH9)!%%X1
MAEBMOLR--:02)I#V4LMF^ZZEG558QR]#TJ^W_!-_]C#S8;Y3XNGTM9+<W=A#
M8>&+F^DMWF6+SK6\BTB.V\E0Z-(RQMM)8M\HK]B_ANGAR_\`AI?W/BFUDTC4
MM<U"YU^\TJY\!>,'UYH+O3X;2/2+;1IO#;_9[BU:,M))"\1D;^';G/QW\0/A
MSKM]8R>*O!]KXDAO4EEFTCPE=>%_&9>WM+%#')'.O_".1Q6,]ZL8DBL9"T;L
MP!/!J_J.6+?VSV32YO+S^]K_`#NEB\W_`.@F/3K;I'S]?R/$=-_X)K_\$WED
M@AU:'XOW,EQ=Q>3)91>!EM)-+NX!Y%ZEU_8<D!C65I8':;<5,!`P5-?3.@_\
M$9/^"6/BW3?+T#QM\49?$T0A:[T>;_A`YFBE;;Y$5N$T#?,DJDAI]_E!L%\(
M*\$UW3?&":#I$Q\)?%JPUFSATZ/6%\*_##XBZG;+H:H;A+;3((/#,D`O8VGD
M@U:VA#-$VVX7Y)E-:^EZC\3M#CT/Q3H'AGXHZ/):RFV;3U^&'Q-BU.\TIP%_
MTRW@\+F&21%)=$G\MT8X=@<X2P66?]/H=;MO6W+?^MNVP?7,WT_VF/W_`.%O
M=^O;\R;XD?\`!'+]AJRU*T\.^`;WQV-<N]0N-.G'B.#P@575;55,VDV5E8Z.
MD\EP@/FB5#Y,B_,G'3I==_X(9_LKV=KIC^'KKQ3K,<EHTVM:F[^"8;+3+MD\
MN:.Y@DT:2\BBM;AD+"9^,<`<U-X'^+/Q%U+XW:1;>+/A5\7K'0HC9_8_&4WP
M@^(;2Z)>F%HY)[C4?[!8`W,3[YKHQM]GC.QF.VOMOPQ\7+SPI<>.-`?0O%VI
M6>L7LCZ>Y\!>/ETN3+J\DDE[-X95[U;H@&=(2Q5UY&&%+ZGE:_Y_/SOYK;?S
MT_2X?7,WM_O,=+)Z[K397]5_6GYJVG_!(?\`8P:ZBT.Z@^(*ZF88HKC4;6W\
M)W-C+JT<CQ-%;6RZ'YT\$K*+A?*92R-QC->Y_!__`((<?L0ZO<7VC_$^/XI:
M=K2AUT@:/9>"[6SOHFE^2YN'U'1'>&5HR%6W)#J2,^M?8/[/_P`7M0T_XC>)
M+'7/#C>';;5)9[ZR\4Z]X&\?7=E8("0T%H+GP\(;:1@0L1B&8@`0<\C[6E\>
M_!S4[F'0CXMU?3+DM%J^H^*6\*>-[C3_`+;YH-Y#I[1>'0/.GACC"1R.V\97
M:K,*?U#+79IUDOGY/O\`UV>X?6\W6OMX]'HU_=\[]9>>OH?F-XY_X-U/V/\`
M3=,AO/!^J>.M5FNO*:**:/P7(UF@.^87D<&@J&E>+,<2\AI.,G-=W\+?^#;_
M`/84\<6UE<WVI_%&$36QBGB>/P3I]S#JHE$0M_)ET`Y#-O;#$GRPIYYK]88/
MC_\`#'1--N)-!\8VU_/ID$8L3K'A;QE:7%Q<1KC>81X>:2Y8D?NHB/O''7BN
M8^#W[3.D-J5Q-\1/%$&@Z'J>JW6IZ7<Z-I7BY[[3=4D5XHGU33I?#GVJ*QDB
M#[4;$0)+*1SF7E^6M6<JZ6FJYD]&M=[]^W43QF;/1XE6[I_X?/U]#XZ@_P"#
M7G_@GB;V#39_$?Q=%Y/<>5^XC\!3VR1@`/()8]!5,(QV'ONQC-;/_$+3_P`$
MY&DNPOC#XM[+(A%F:V\")%<$??6`_P!@YE>/D;"/F;CFOT;\=_M1_#J6;PO/
MH_Q+2>"'58WU.WL/#OC"&&-(5W1R;8?#WF-$TJI*\>_;(<@YR*]7T/\`;A^#
M5_;2QZEXC@M;J"$1W&_PSXLM5N&5B6GLDE\/[5DF3^('>'.5YYK-99E/_/RO
MT^*57^[M:7K^/02Q.:_]!*_\"MV[OU_+O;^?+XN_\&ZW[`/@^ZET[P=K_P`3
MM:OHUFAE6X7P(;@WO*K:QP)H2[6SNY8KPI(!KB_A_P#\&]7[%>NPW\WB$_$W
M_0=3L[9TTO\`X0IUFBEC8R"5WT$P136\D8$B9/).:_7;XB_M*?!;PG\1X_&F
MC2:_XPTOQ)<M:7.E:/X/\874NEF2/%WJ%\HT1_F+9,%P_EO'N)7FO;='_;"^
M`VB^#[]=-LM0EO+JUDFL=&N/"WB5KD"V65Y(W+:"";V99#()9@2S)@L>*/[-
MRY?#*LUH[IS\K[O?3;?8J.,S=))5XZ^:W=OGW_%=4?AS9?\`!OC^P#J/B.;1
MK27XRVUKIUM.=2O)X/`<K02Q(QMS"8=`*S;V9!(OW@G;O7D&L?\`!"?]A3PU
MXKCTK7/$?C&VTE(+Z:]9W\$6NI06Q'F:?>+9W&B-+((4!BN=J$'I@BONWXO?
MM0ZQHZ:WKWPML/'EEJ!>]U*/2]-\`?$/5-1U^:X@<1:7<36_AB6TM[>5=R1S
M0-YT+E>F,U^0.MZW^U[\6/&&F:S<0>._#%E?:3='5K[Q9\-O'O\`PD6FW.J/
M)#=:!;ZK-X<5!IUG`1)$[H3\Q(<$5M'`9;9+EKWVOS?X?._?[P^N9M?_`'B-
MM]]]%^*W[^ECGO'_`/P39_X)M:=XP7P;\-]9^)'BC54MK@O;2Z;X8EF%[`I\
MJ-F@\/1PA&FVD'>`8]V.E=+\-_\`@D)^Q5XK;2QK/B'Q)82KI=A=ZK9+;>$H
M7.HRSM#?Z;#+/HQ1+N(_ZF*<>4S`X!.*^R?@Y\%M`T^VOQ%XVGT?Q^T2M?VP
MT/4+O4KK35#!KV)]?AL)88WO(VMX[I$$;,)%1B!QW7@_X*?'32;[5=2B\.VD
MEA=6<6JO-K/E79E%I<.FEZGI3V@D@DDF<J;JT=UD20_,IQFFLMP$XMQ]M+EM
M>S;MM;=[7_1&;S#-(NTL3&^F]_[O9^K^2['@@_X(7_L'Q2ZQ=QWWQ)O[&W*K
MIVG^5X,MM1OKARB"`R?V`T:2&Y=-IC^1K?>P.*\7UC_@BU^Q_;:IXATV'7]:
MTJZTF<,(M6_X0Z64`)YM[:+%#H\;7+0H1Y,T(\I."4&,5^D_@>T_:Z\0>,K?
MP]INC_\`"/>()VCNGU;Q'HA&AV^EP.8X+N2*Y=(KI2Y&8X]I:`G:V[%>YQ?L
M%?$WQ%KUS\0?BUXO\/:EXHU2]N5UB#P_:2Z9X6TR9F$EGJ>CPM*\J2:E'B&X
MMY'V>83M&VB&5X+M65UU?:WFGT#^T<S=KXJ'W/\`N_<]_P!3\1(/^"2/[#6L
M:TFAZ;J7Q$M;R00V$=O)HWAB[$NH/&#*\5W'HJPI`PS);RR!F0`(<&OL#P7_
M`,&^'[&VM1.=?O/B+;W'VQ(8(]/@\')#>P-&<RD76AR-;29()R6&\EAP17W-
MHOA+5+;Q_JFAZ,TCZKI=Y<:?!?1:<DFEZ6MM;+$NHE6C6*1)I`\4CO)EF5@.
M",_6'PC\(>*=(U;2H7N+[6I5FU(MJ<NHLWAV*[C2,/':BY`)>XD9MMG)N6(X
M\H[<5;RS`;.G7=NJEZ;:O97MV!9CF?\`T%06W1_W;_/=:6_4_*?_`(ASOV)`
M=/EFOOB?IEI*T\4ZC_A`;Z2(LIBMI6F70$>/R9<7+8S\H.,XK(O_`/@WA_85
MTKPWXWO]2UGXG0ZIX4\+>(M>6:.U\%3:;,ND6_FVTFZ30$E,4\N5G*,"QX4\
MU_4'X?\`AW#J,6GV]]=W44<Q$T\,2PPM),`#):6;29D>8,3LBC7+`X7KSD?M
M!^$8;;]G7XX:I936C7<?PG\6:9IMS?6]K`8V6RDEQ/"S1;5WHJDS,IR?;%9_
MV7@KWY:^]_B_X/;3[^[#^T<SV>)AV;]YWO:]OZ_"]_X`O$O_``3>^``N([GP
M;9ZWK&GV=I%=7M@=-\.W&J7%H)9K:86__$MC@ANS.L4<5O<,SPJXEX'-?(DW
M[.'P.LO%<WAF;PM/)>P7022PB_X1P7MC9R-LGN+JYGL6L)9+2;,=VJ,7B8X1
M#D5]]WWQ9\9:-H&IZ5KFEV_@G4M+U*&[\3:]IFHR6%OXC;3YUN;+3[:ZLFOH
M)K>^MXF&LS`PK+YB02,C*37A7Q:\)^`+GP_#XZBUC2KS3)[F*?7+[0[N1+S2
M8-187'V9I(U^S730S^6P>:49E4!@0*T669?I^[KZM?:_P^?35!_:.9_]!4.B
MV>RY?EWZ=_,^</'_`.S+\+?#6D0>(]+T*QN-,OX=0LK&TMX=&U"X35D-W;:;
M*TUMI:M<V[74,#3Q6\<;[I@N2,XFTK]DSP#9>%],U;QQHUCINH:B)(X-+M++
M0OM,TXM1)%^X>S-S:V[.Y!:3,BJ#LY%>JZW\7]#\-:;INB/H5WJ^C>'K)GTR
MX%I);:S<ZG;SB[NK]=0MH(M/N&M4<7S6:RL[2%L!T!KS#7-#\=>+)HM>UNWA
M\3:5J%N-3TGQ#?\`B`^&['PT6V/;7HU"!K;[3<1QC,]K+;F-1E0.E']F8%_9
MK1V5N;?X;]?)_GN+^T<ST3Q47][ZQO\`+RZ6N4_^&7?A/=^'9-2TF"UU2\2T
MNC_H_ANPAM+75+>>W1I+YKFRCN'T6UM6NH[JZM&+-=)"V0"U6-0_9U_9\TJ;
MPW8W>F7$DVL6EW+<W$>EZ&L-K);A&C$`&GN;B2>+?)!$6R0!NRQ.>STCQ%\1
MM(^'.HPW7BKP?I\^F:M)IUA'IUU;ZM;^+='O6\Q[E=2#SEHF9_\`2;=9(4=A
MNV!JZ/X9ZWI7C/QK'H7B"RTUM7FTF*'39+^[GL+,V\<3++>Z;-/&+-/*?`C(
ME$BXV8VFLWE6"YM(U[:=?1]WU6W_``1K,LS_`.@J/3O_`';Z??U[Z:$4'[&'
MP&?3X;^WTC6+YM8N+6VTQ9=%\,:;<V%I>L'MM0U.QN[$F6-X2%B^RJLK,/G7
M.17U!\,?^"7'[-7BF^T?1]=;Q!)J&KW,R"/3-'T&VN%6&50^V"XTQ]SG<%C\
MH!&)Y.*]Y\":5I7B_P`4Z*E]:7MQ;^$H[*ST_4I8;>+[;JMFTJ0VP@53!JJD
M3%O,$IVA5?CO^N7[/7[/DUCXSM/%>BW`N]1B&FWEZT\,MTH@4'^T/L8D#VMA
M<QML3RXI`CE22`U:+*L#HG[;2U[M^77F\M6KB_M',[W^M1W71VWCWU[[]O(^
M*-6_X(&?L7Z!X4FU_5KOQ\;FYLA=Z=8[?!-C,DN`%L[N-]":2&0.48DY#([9
M.17%?"+_`((L_L`_$FP\0O(_Q2AU?PM:7;ZI9V8\!2VTE_;HQ2*VG?0</;,J
M@E@.),K7[?\`QO:[/P\L;I5UK^V[G58391/82F^%I+<%;@W,:2!&MIHUC5'(
M8$X\O&&SV'PB\$V'@/P%J=U9:%)=ZUK5Q=1W.K6+QD0QSQQR)9W&G!6EWH\@
M2>4Y"\EL5,LKP5KKVW3KZ>=_ZL]K#699GM]:C^*Z1_X-OFC\V_@M_P`&VG_!
M/CXH>%+36M0USXO:-?>4DUW;R_\`"O?-1)@"A,:^']R@%L*#CVSUKFOV@O\`
M@W!_8.^&?AC^U/"NO_%/4[M/M#W+7MGX)GMDAL8!))&@M]#61)'S@29VIR6!
M'3]?OAOXL\8:'+=ZA<Z?$FG*DB:G)"Y@%G<"4B"V"0G=,I@42"8ILCQUSQ7V
M1X1U+PU\6?!^O6KV=Q<"#2;@D7L4>Z>_N(9;:-(I7*J8Y`PZ$&16!D&1BL_[
M*PFFE?MH^FFGQ76V_7U#^T<S_P"@M:Z[ORTV=NO3U\OYH?`W_!O-^P%K^E>%
M;_5_^%SV1\1:1!J;7<"?#^72K<W!5/*>8Z"61TY<(YW$9P#@YE\7?\&YG[$>
MEDW?A&#XS>);+3[R2'594M_`MNAM1M2:>VD?P\89D@5O/<[?-`!$9Z5^X^L:
M'=VFG?V):7YTF&TAMK>]T5-+OY;"VU&Q_=116TQV1PPHG+-')LEDE+<@9'I_
MP_\`$HN;ZXT=_$:Q6&CRVG]LPK!Y4J9@$-S`T,QV"*:4IA@SEE(;J<4_[+P?
M55W_`-O=K=+_`-?-C699GI;%1Z;I_P!WT7?^KH_G=U;_`(-\/^">.E1:5;KJ
MWQ?EOM3,$*JP\!>6E]*<"&4_V#N$0!`YVD?,3BOQ+_X*I_\`!.3X'_L.>)OA
M3H?P\MIM7M_'FB^(]6OFU^/P]?36YTG6/[/MD4:?IMJ\+20L'=9O,#$94@#G
M^T[XA2"3Q5JUK!:)H]]=ZC;012O=.MO'IQG(CU247<2K:W4K'Y&L@WF+@'(`
MK^=G_@X_\$V'@_Q#^R%>PK;G4O$/PX\97>I7D,KRF^-OXECAMYG+$J"(S\Q5
M5#,Y.,U\_P`6X&AA,FJXG`K$TJCQ$$[5YJ25XZZ/L_+1[=5[W#V88G$9E0IU
MVI2="=U;7O\`<UM>WW6/Z*O^#;%B?^"6_P`/?^RE_%(_^5NW_P`37ZD_MM''
M[*WQI(R"/"@`([;M5TY"?3.&/4&ORY_X-L,?\.M_A\>/^2F?%//_`(/+<$#/
M0]/?\:_4?]MO!_93^,_OX6C_`%UK2A]>A_*O1R-_\8_E]M&\-%7_`.WET_K<
M\7,_^1IC9+IBZOK[TN;\$M3ZEB@1%(!8Y)/+'Y1S@<$<<?T&*D,>><]>G+#]
M*$ZD=L?U_P#KFI:]N$%!))1<W&[;V:NM/77L>>^92=W]WRZ_\`A\H^O_`(\U
M'E'U_P#'FJ:JUR6"C:9!D,OR!N,[3DD?*N,8#/@#=]Y<YK2T^U/[GY?\'\`Y
MGW?WC_+]_P#QYJ/+]_\`QYJ_F7_X+\?MK?M?_P#!/_PG\'?B1^SQ\<[_`$5?
MB?XRUS0-4\*Z]X-\">(=)T^VT[18[VT_LF:Z\/3ZE&[3YWBZO9A(6P7Z8Z?]
MJ#]HO_@I/^PW^RWX%_;/M/BWX9_:L^&5K8^#/$'QG^'_`(L^&^A>!O$N@>'/
M%T&GPG5?">M^#Q91W%CIE]J4*7G]H6%S=Q*$N6_T6*\)\*KGE*CB<7AI4&W@
MZ<:M62Y;<CY4VKM-6NWK;1/?0].&68BI0PF(C./+C*\J%.-Y<RE%;RZ6?2UV
MS^D'RCZ_^/-1Y1]?_'FK\0/BO^WGXG_:%_X)?:U^V[^R-\2-2^'GBO2?#$6I
M6NC3Z?X8UZ&V\:?VOI>AWW@_Q-%XATR[MXX;.]O@#<6HM9!%+'<C*.0/D7_@
MDS_P5J^.GQ>^*_Q._8-_;^U6W\`?M8Z#>ZH/`_B,:5H7AY_$\4%L9;C0[.TM
M;9M#N-8L+5X]9\/W<5M+;>)=,,A@BFGMY4%3SS#0K4*;BO98BGST<2DO93T3
M45K=-[*^EVOG*RW$NE5J7]ZA5]G6I>][2%G9R::2:OV;/Z>?*/J?IDX_QH\M
MLYSSTSDYQZ=/PK\LOV0O$/[0/C/]HS]K+PS\0OVA?%?C'P9\!_B5X>\&>$?#
MEQX6^'^D+J>GZ[X-L_$,T^O:CHOARSOKFYM+J\>&%[6XL"4B42*S`DW_`/@J
M]^WF?^"?O[(_B;XS::;*^\?7NJZ+X6\!:-<A9UO_`!!J5PCW,LEH,E[33M,B
MOKVZW858X0"P+K7:L=3C0GB*\84*=.+G-S6T5:TKK^;IUO9/;7E^KU)5H4(/
MVE2I;DC'F]YZ-I72V5F_/3<_3WRC_>/Y_P#UJ7RCZ_\`CS5\Y_LF?M`^'_VH
M?V>OA+\=?#-Y#=Z9\1?!NDZZ_D-\EOJ$UM&FJVCQGF.2TU%;F`Q\;=G3!%1?
MM97'CC2O@7\1/%7P^^(&M_#SQ-X+\*>)/%.GZKH^G^'M3%U/I&C7MU!8ZA9^
M(],U2TDL9)41I?)BBN`5'ERK@UK#$PJ8:.+I^SG2G2=:+BM90BDWUWM??;2^
MFIG*%2-9T)<T:D:D:4D[^[.32L[7V;UL?20CXZ_S/ZYHV'U'^?PK^1;_`()1
M?M9_\%.?^"B?PQ^/OCZ3]L#2O"?BCX/Z^ND>&O#MS\&?A]?^%?$ERVF37]M#
MXBN8--M=6MK1YHQ;W$NDW'G^7(KA590M?H!_P1\_X*UZW^W3X/\`C1H'Q_T[
MPW\/?BM^SMJ\&G>-]9TNXETOP+KFEM?W^DG7+:;574:0\6IZ;<VMQ97=T&,;
MQSHFS)7@P><X?%JA)15%8B_+[3ETLDW=QDUM\EUVU[L1EN(H.NE)5OJ[A&I[
M/FT<G%)>\DV[M>K5D?O1Y1]?_'FI?*]2?S;_`!%>9VOQA^%5_I,6N6?Q+\$7
MFC3ZE%H\.K6WBG1)M-DU69ECBTV*]COFMY;Z5Y$5+=',IW`[<<GXQA^(O[1^
MK?MY0Z%HWQ<^`MY^RG#\.KF'4?`-KK>G77QFC^(MO.&ED:PAEDU!;.&`;]RE
M;80"020NYB9.^6(M;D5*I=I+EE'6_+M=^?\`77DC2JRYE:<7%2;O&2MRJ_;1
M^I^C/E>A_5O\31Y1]?\`QYJ\OTSXP_"W5+_4M(TSXE>"M0U+0[:\NM8T^U\5
M:--J&DVUE((;NXU2T6]:XM(K25TBN)+F.-8I659"&(!VX_B'X'D\.CQ8GC7P
MVWA@Y`\0C7--_L8D,48?VF9_L0=7R"IDR#\N,UHZJ5E>@WIS)3C>+LG)/7>*
M=W:^Z^<\E6R=IJZ36^SVVO\`$]%WL=KY1]?_`!YJ/*/K_P"/-6?9ZE87]I!J
M%C?6]YI\\*7$%]:W,=Q:3PN@9)X;B)FAEB93OWHVPK\V[%9&E>-/"FMW]WI>
MC^)M#U74;#'VRST_5K*\N;;@G_2+>":22$D`GYQCBE.LH<KDZ7+)I*2?,G>V
MJ:;WO_5M9M4UTEIOOH^WJNO;J=/Y1]?_`!YJ/*/K_P"/-4JG*CO[TM;+F:32
MIM.S3L]4[?\`!_`F\N[_`!(?*/K_`./-2%=N.>>>YZ?YS4],?I^/^-)Q;Y>:
M,+)I^ZM;Z6WZ7O\`*WF'-+NSY0AC'_#:FH*22'_9GL92#S\Z_$ZZ0'Z!)"H!
M!P``,5]95\H1?\GJWW_9LEE^OQ2FKZN'0?05A@E:G.VSK5&OO6@Y7T;ZI?DA
M:***["0I.@[G]2?\_P#ZZ6D)P,T`4]KQR,^4C1@0!@`9['@^I[]^<]:(PV?G
M;<_3C(&.@Z^H([U+(Z?*&3=N;N.F!U]OJ>E3!5SNVC)`YQSCM^5`'R%X_P#V
M9)=?^//A#X[^$?$TGAGQ#I")IWB2$P^=#KVC(5'V(!<;'..6<D`'.*^MS&[`
M(S?*`IR/O%@>0?\`9^GYT_S!Y@7T_GR.?_UU+0`@&`!UQ2T44`%%%%`!1110
M`4444`-?[I_#^8K^:G_@Z>_Y1F7W_93O#7_I-J%?TJOT_'_&OYJO^#I[_E&7
M?_\`93?#7M_R[7]<.8.V$JOM.'_DW+'\#?!?[_0\Y?K%?H?Y-G_+3_MJW\Q7
M^H'_`,&H4Z)_P3Y\9V[.!CXCZ3,Q$;.5"^%+,C+,%B4$_*=SXYK_`"_1_K!_
MUT?^E?Z?7_!JE<P6W_!.CQ[]HG$*2_$328T`927<^$K3:NU,L<MC/88R>Q$X
MO_>,M_[F?_2(&Z7[C&_]?U^#3_$_>?\`:L>^?X#?$F63[-+IO]BZ8Z1+B*Z@
MGD\6Z.DD(%N-DL$T;1.QWGYD49X.?O328E_LS36/4V-J3P!U@CY'=<_[)Z<=
M*_-_]KC5%TWX">.Y$MGE$]EX=M)[>!B'MI+KQ9H,*7+8^7[.?E8CC$I8^AK]
M)=)_Y!>G=?\`CRM>O_7%*WG%2KQ4EI[)+3N^3U_!^OGS2O[.'K^B+AB0XZC'
MH2..X].>_'--$$8Z`#/!P`N1G..,5-4$[.$RF<C)X'I_M'"K[;C@]*U]E#M^
MGY?UKZ6SN^[%\A.<9&?0XQ[9'\/L>,DFE\F/&`#TQG)Z=N_:OY:_^"X'[7W_
M``4'_8F\<^`[W]ECXU7]YX6UOX:_$'XG_$'0/$?@3P'XA_X1?2/"OC+P+X9M
M+G1IO^$?BOFTR*3Q@J:B+RZF9(Q'*LAR0GZ]?L,?MQZ!^TA^P9X!_:N\3:Q9
M0W-K\.[G4_B:8A'!!8^*/#-C(/$,8@15\C[3<VQFMK>-0,W<<4:D``^7#,\%
M+'5L`UR5J--3O-KEJ:)N,+:N26^AVU,%6AAJ.)4U.%;[,;\T-;>_I;?U_$_1
MH0H/7IC\Q@G/7GZ]>:3R5^7DY7.,\_C[X[9SC^?\;_[-W_!3#_@H7\=/^"M,
MW['?CWXQGX>_"W7[[6?$EAX?\.>"/`1\1^'_``MJ?@BT\>^%M`DUC4]%U2<:
ME9Z=JUE#JSW0:YA<;.!AAZG_`,%`?VV_V^OV#_V^?@+\-?''[2>KC]CSXSZW
MH4/_``FLWP[^'!\2:58W-\FF:Y8G68_"_P!@^TZ;<SVEV9Y(&863.S1/NXXE
MGN$="KB71FJ5'%_5*DVHVC.Z7,VI?"Y-+^:[VVMTO*JT9PIRK4HU)T?;P@^:
M\HI*R5HM.6Z^3/ZSO*7MD'L<Y*\D_*3DCDGZ]^@I1$H&.>A!)QDYZY..<_UK
MXB_:_P#'GBKP/^RWXI\<^`?BMK7A3Q=I_A^U;P-XATS2?#NMWWBSQ=JJPZ=X
M6TJ72M3TJ^T^]37]7O;.,PZ?!;LS2[8#$OR)P6I_&#XF?L9_L&^)OC1^U9\2
MI?B'\4/`OPTNO%7BK53HFCZ+:S>,YM,1K+POI6E>'].M8/LXUJ:#38"UO)++
MMDEGE`):O4GBJ%%OVT.2G&@J\JKMR*#2MK??T[_(\]4JDHJU^=U?91I:J<I7
M6JTY>6_6]_(_1GR(^F,C.=I^Z?JO0_CG\J%A1>@(_+CKP..!STK\R?\`@DQ^
MW4W_``4`_8[\`_&G6I+"#XCV-QJ7@SXLZ/IVR*VTKQOH<P$[P6ZX*6FK:9-8
M:K:@#:GVN2!3F!@/T-\:Z/JNO:%=:9H_BK6/!E_<)BWU_0K?3+O4K&1'20/#
M;ZO8:GITH(4HZ7%E,K(S`;<Y.E"OA\1AZ>)I)2I5(3J1DK.ZAOL_,BM"I0JS
MHU$U4ISC"4=6U*3C9:KS3T1U7EKWY/X_RSC]*/+'J<$8(]3Z_7M_,U_'U^PI
M^VE_P4@_;*_;P_:[_90N/VP9O`OAK]G[Q/\`%?2_"OB&T^#7PVU?5=6L_`7Q
M+O\`P1H\>M"_T"TM<ZAIMI#?WLMOY,OF.[1JA(%?9W_!.O\`X*8_M,^.O^"@
M?QS_`.">?[3(\.?$;6_AC#K]SX>^,O@#0'T:PNE\-O;&[A\4:;:3W.G:>M_;
MW4"V=SFS`U,/9Q1NMQ$:\NAG.%K>P<J,Z<<17G0IM\M1\T':[5.3:3U\UJVE
MT[Z^65Z#JQE.$O8TH5)*+EK&=K6NEM?7IH?T;F)2NW&1U&>2"/0]:3RESGD?
M0GMTYZ^O&<<URM]XX\(:7J<&BZEXJ\/Z?J]UQ;Z7>:Q8V]_-QN!CM)9UG(8#
M<#L`(.1Q6U?:I86%K->WE_;V5G#&SRWEU/';VL*#`,DEQ*RPJ@RN&9@#T!.:
M]I1HWWBWV<MWIY[NZMYO[O-<IV=E*371;]$_NW?SZFB(D4_*`!_=`P,^O%*8
MU(QC@]?4^V3DXYZ5S7A_Q7X=\46PNO#OB#2==MAN5KC2M0MKZ,.C%"KFVE?R
MW#J5*M@@YR/2A=>.?"EM?W6E3^*M!MM2L6M8[VSDUBP2[LI+^98+);JW></&
M]Y+(D5NLBAG=E"J<BF_9*UU'62CO>TF]G;LM6"<VU[LTW!RO:VB6B[7?J=B+
M>,'=@YY)/3=_O8`W8[9Z4&"/WX!`YX&?;O\`C7Y_?M2_\%!_@I^R_P#$KX(_
M!SQ3XMT%_B5\:O&]GX?TWPW<:S;V=QHOAPQ33:IXMUAI&"6.FV2Q+%$UV\(N
MI7`AW;2:^[=%UC3]=TRSUG2-1M-5TO488[JPO["YBN[.\M95#17%M<P,\4T,
MJG>CH[@J00>E81K82K.M3A*,IT)*$X1EK=VV]+V;Z?<:RI8B%*E5G"<855>+
M;[6]$_UML:@@C&<#&3S@#GK[<=>U-D@C*'Y1PN,]^.^>N1ZY_3-6/UH/0YZ=
MZZ?91Z+7IU=]/Q_S]#)2>CN[;[]#\R_C'X0\-^*/VM=5/B;0AKNFV'P,\+?N
M9XUEM$-QXUU_=*R-PTD91"`<#:#DXKO+F'X?Z39OIMW!I.D1V<2P01[[2WLK
MI`FZ-KA%`C=_+`5(TW'`^4@UB_$_7(]$_:R\0R)"TMQ)\#O")4R%_LD-L/&?
MB$3S2(.'=58*B,#N+8(P<UX;\3M.USQ9'JS26T-E#8%KBT<6LD-RVG3)^YGU
M"!`3`S*<VAMR9XT*SC`K/#*WMEUNO3=%S32A)_;5TNJ5K_>:OB_XF?#K2EDB
ML9K&/76!@%S+IULWV*)2/L\L!E$<[6V]>1*OEL!P_>O"_%_BOQ1XGL=0MO\`
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M:3*&/`/%<5\8/A9I_C_0;1=&TO1/#6MZ3:2_9K5O-:PU33;3,\UI-ITBG9+*
MJ%TF/^DA@&7Y<YP?V:?$%SXCT]O`&J2RW-]X9O!+HMW'J(34[FSG,@GTB]\.
MW;><EO%'\L5R`$>-5?'(R`?H!\/_`!;%?Z=]JN4T^^OY8M\MY&K;+::1%^SW
M"IN:5;J#&5DB6/<V,@UU?QF6/5?@]\3M.DM'NDD\%:X6^W1(AN'^P%)H2D&2
M02Q$NXDL>5(Q7S+J\C^`9=-\0:*]H6FO[*+4HUDEMK>*VCNE66:9XL^=,RY1
M[55*<=AT^K?&=QH^M?`_QA=M.UO)K/@S4G80S@7)@>Q`^T2QC!MYL_Q9#9SW
MH`_B"^,OP7U6^OM0U*QM[K3-'GU*:.32K2[CO(#;P-*-45+*=7$;-9^;+&@5
M<R!22<$'PE?"6F>%;7Q3+X$M=2D@DM-/@?PAXKTNVDB6&>T7SI[6",E+@23!
MV5O+!A`!&6&!^XOBGX&^+=&M-8OVT_4-9L9[HWT-Z]HKVEOIMU9E434#$3,8
M[I9&CEU5%+0;RS_*":^%_$7P;7Q-HUAK=GH%S#<)K-R+M+/43%+:10,4MS%.
MA#7=H)`0)$.QD)!&0U`'Y`^-OAA\0+P2:E)J.FV4=[J][JTUA<:=?ZF;30["
MV,%SIUK=EE-C"B,L'%EM1%`P2-PD\`_L]ZW9WVE7.J7,^H^"=46-)=0U%H]0
MGT^R="\6FZ<49WEBWKEA.H=8F&YE8XK]$/&7PQOO#RQ:_&VOZD][<#1[B\6*
M[N].4R1F..*6=X&M[%'0'[5=/F17&QF).:W?!'P<F\22:)ID>M:G9Z1IB-?7
MWFVD<%K#M!A\P6<NV4PEB1NC!-UM60@YH`^4_"_[-OA/07UW4[VWBTOPYJ9N
M#H4-IX?-Q:P7,L*&-;NW59FGGPDL\**%9WFP6`7!]1\+?LTWUQXV\&ZG#]@T
M+P_H>D_:$GTJPT^RD\075Y)C3UO8;J21XF53F[MC;IWR,X(_0S2OA)#HEC8>
M$M"MSKVJ7WER6POY9X-1A41L)]5B20M9Q@A5>W,N,)PF"*^SO@5^PCX@\?ZW
M!KGBB74-/@L;FTU&$3Z;(VGWUO!"%ELVNK<^4[_\]"!@ELY/.`#Q3X%?LWZA
MXSNX=*M]'2.WLY'GMTC^SPQV&K-E)YUEBM_LSS749>2-)&<[2&!%?M5\&_@1
MJ/P\\*Q^$[33K6TL";=WU.:X8^?-<N)&B:#9B<QMGSB&5.00HZ5[A\'O@;X5
M^'EI826VFK+J2I//=7S_`#6Z0,VV"TAA8?9R%B.YFD'GY'/S9%>^26IDDMIF
MA\R&9G@@"J([52K9^TNN,"0`#G`.1^8!^07[3/PSL/"7C/PU?S7]\="=EN;O
M21:M+I]J=&D$MW?>;AGAAF208@C!5W"\@)S[[X1\&Z9K7@2QO])LK:2SGGNM
M4M-1=FM3(J*L@W>0N65<(K(R9<##"O5_VBOAG-XOT>XN[2201Z&T[27VUYQ*
MDJ8N86QGR[=&">>S+@+("!UQ\_?"OQNS^&8?!ME-;V]WH-VT,T<]Y##:WV)0
M9H[!WP&7R_WC>3\[*"#DXH`X_P",D,.F:1X>2SU.+2M5FU""PNY=.EEM[".S
M(%S*^HY3<#/NV)L5F&=OR]*[#X<>,HO#S:!X?T:]TO6);VXD74/LI:3[1%*C
M2P1S;%8!X0#"9)'#KO4[5.:^4OVJO&ESX:\26\D;M?Z9K>J^9?VD*K<VETMN
ML2QRS<>98Z;;J3-YP"R2-\AYYKZ.\`6.E^"/AW#\4-,:)#?QVU[/I5K937YG
MBD,:23Z:@&[?L9F501GGO0!]0^*9;^*%+FYM;:TL;VW\B2VWF[,;LBLD;6>U
MA++;C>QG<!!E=SCO\_W'@;Q-J]U<:9:^/-$.FSW6J&UMXK&UEUVXDNT$UK&S
MH0L:VTJJH`)V\@'L-/Q-\0-1BT;3GTJ>.ZFUAR9;B[M[EKJUTRY215E4S_*D
MV2MO*''EPDQAATKQT7'B+X5?$:WO[/PA>^+[K6-/MKS2M*L+^WNO[,:1#]IO
M-9C1O]!LSS,UW&?F?$:C%`'=ZQ\*/%VI?\(7XF\<MI<NI>$]1FB(N/W%W=11
ME6M?,D9MDZX`:)65RCD@-P*_F5_X.1]8GUGQ?^RF9=/N=.CL_`WCJVBBN9_M
M*NH\4(3)$P.$0GH@`&,>E?U<:+KFH^-]4L;;QG)9VDFIVJ11Z386TDHMV\V-
MHYYIG.PR0JVT.3GC//;^73_@Y\\.Z7X:^(?[)]OI4ZSQR?#WQMY^)FD"S1^)
MH@3L/$;/NRVWCC':OF.+_P#D15K:?[5'[O=T^7=H^BX::_MFDNJPSO\`^`[_
M`*'[[_\`!MINC_X)<?#\$8'_``LWXIC.>`#K=OC';FOU!_;3F+_LM_&M-IVP
M^%%!8=&)UG2N1^''I7Y@_P#!MHH?_@EKX`5R,?\`"R_BEDYY_P"0W;C]>WXU
M^I'[:Z(O[*/QHVKC'A-5SU)_XG.E'G^GI5Y%_P`B#+_^P>*]-5H<&8_\C+,/
M^PJ7Y/\`K_ACZMCZ_A_A4M0Q=O\`=_PJ:OH%\<?^O?ZQ/-D_>?K^6@4UF51E
MC@9QGG%.J&:-I``K*H&?O+N&>-ORY`..>^02"*T$?R&_\';4L<GP'_95,3!P
M?BAXM.5.Y3_Q2\8QE<CCJ?3![9K](O\`@IOKNCZ+_P`$.OBTVLWEO;)??LP>
M#=#LH[F1(OM.KZSIGAVRTJWA+D;YVO)$\J,?,S9"]#7?_P#!3#_@DW+_`,%+
MK;P=X>^)'[0&I^!?!?P_UW4=?\*:+X5\!Z/=7T-YJ6GKI\W]J:KJ>H3?;U2-
M69`;2-22`5P":C\3_P#!)*Y^.7@SP)\+OVM_VJ_BA\?/@]\.[W1+O1_A5;:#
MX9^&GA76_P#A'+:WM]$A\8MX3MTU'Q)!I\EM%<Q6]U=QVSS@,8AFOC:V78Z>
M8YU5IX3GHXS!QP].3DK<^BE9;W2=][[_`"]VCC,'##97">)Y*N%QLJU2"C)M
M0TDK:6NVO3OT/P\_X)J^`O'/@W_@@3^TYK/BM[U-$\?^.(?$/@K3[N%XQ;:-
M!XL\'V,UW;*RX>VU"^B>17QM8(W/>ONS_@L[_P`$S_$/Q=^'G@#]N?\`9>%W
MX<_:I_9_\/>'M?N5\.Q"VU'Q]X=T6VL=0&V>#;++X@\.Q133:9,_F?;+,36#
MKS&1^NG[0_[$$/Q4_9UB_9<^$OCFP^`?PG_L/3]!FTKPSX%TC6[BWTS2;ZQU
M#3;?2&U"\M[;3Q%/8Q&=C;W#S99BZN2U?4'PS\%^,?#7@C3?"OCWQ=8^/M1L
M+:+3IM<B\.0^'TU#3H+2.SCCO-+@O+VW>XDCC)N)5E$4I<[8D``/33R.,\'3
MR^MI*GAH1I5-%[*HG&2:T?G;KJM3.IF+G6EB:,[*=>4ZJEO-2Y8M2Z-)>]I;
M74_##_@W]_:8\4?M9>#?VKOC;\0-)&B^-?$?Q>\&Z9XGLP6(DUKPQ\.],T6_
MORC(KP27L]JUQ+;NNZ&1V0Y``'/_`+=GCOX:_M1?%K]I7X6>./A3\9OB/X!^
M'_PMUSX*>`=2\`?#J]\6^&[?XN^)8(M3\<^)AJ,6+6#6O"R6>A>&DV`RVJRZ
MHID1Y6`_63X3_L.>#OV>H/VC3^SWKA^&%]^T'XP3Q].\&B6>J:9X-\63:5%I
MFI:EHND3R0VTZ7SQG4/LEPPMX+MB55D)6M;]C[]ECQC^RY\*YOA?KGQDN/BW
M&FHZYKEIXLUOPAIFA^)[S7O$VLZGKNOZOXENM,O&@UZ^O[_4!(]TT%K<$1;7
MD<,-MT\KQ+P+P->?MKN<9RFTW*G9<NJLK+?8BIB\/#$O$TKIPC3=*VG+.\>:
MV^ZTU?>_4_GR_P"#93]IK6-#T7XU?L#_`!(&IZ9XI^#?B?5/$_A+2O$$<UEJ
M]MH&H7AAU33)-/N3YUF]C>JEPUJ,^4+D_P`/7^E;]JJ:)_V:OCPH<$CX6>.U
M(!!PQ\.:AM!]">."`<'.`,5^3\/_``13U;0_VY]3_;X\#_M5>(?`?Q4UO56O
MM9\.^&OAKX=MO!6L6=S;1VFHZ7JNF2:E+/>0ZG%&AO9&N%DDN%6Y0HXQ7ZU_
M'CX4^+/BU\+?$'PV\.>/+?P-+XLTB^T#Q!X@D\,V_B*5],U/39["^&GZ9<WU
MG:6EW(TWF132M<+"%V&-\*0\JPF*PV6XG!5$N:BJU/#+>]*2CRIJ_3771:]1
M8^OAZV+H8FBFN?V4\1?=58N\I+2VNFFK7X'\9?\`P;M_#K]J7XE?"3]JGPU\
M!_C3X&^#OA?5?'4>D^+M7UCP/>>+?&=O=W^A7,%OJ'A.X&I6>EV5Q:QN"JW\
M,^)@LJ#=@'^@WX!?\$R/@?\`\$_OV-/VD/`_A.ZOOB-X@^(W@;QEXA^)/CCQ
MM964VH>,-8MO#FKR6IET_P`F>TM;.UFN;F>"VC1U6:X>>5C)M*Z?_!-?_@D[
M<?\`!->3QEIOP\^/VJ^//"/Q"U^+Q#XMTCQ;X%T>WU":ZMK"6TMAI6KZ;J*/
M8*LCI(Z-;W$;(A5!$2N/T^^,7P\U/XF?#3QIX`TCQ$GA:?Q?X=U7PZ=;;2XM
M8.GP:O:R6-S/%87$\$,LJ6TTPA#R!$<JVU@,5CEV4.EEB5>%\13I5(TUTO4A
M;;>]GIK>_P"&V-S%5,<Y4I.-"I.E*HXIIMTW&5WYZ.^G:WE_'?\`\$.?^">O
MP)_;?_8?^(MA\;CXJGL?"?[4FHZ[X3B\-:[>:`VAWF@OH>I73V?V.3[.6UH6
MZ:??S-"]S!;9^R2VTF"/5[?PQH/A/_@YQT31=!TVRT^QM/@EHT7EPP1(9@G@
MFYMOM%U+D37=Y-Y(^TWESNDN-@DF>1V=C^Y7_!-/_@F_;_\`!.'X?^-OAEX;
M^,&K_$OPGXQ\67?C41Z[X7TK1-1TK7M1BAAOVCN],N)([NUF2VA*136X>)@Y
M#L"*\YN_^"4TMY_P43B_X*'GX^:NGC>*P@\/IX#7P5I7_",'PQ:V<NGPZ>US
M_:7V[[>;24B34UPQE56$&T;3STLMK4\MR]*E_M$<7!5G>6E&G*+NO>>K6ZVL
MNC+EF"GB<;4G5<J-2%14U9)<S2<5HD_B2_SW/PR^!_P!^%_QI_X.#O\`@H#\
M)?&^BK)\/]2^"WB6XUGPIH=W+H&GZTJWWPONA9ZD=$EL;J:QEO@E_J%KYL45
MW=00?:3-&TD<GS[_`,$_/A3X7^+/[+?_``5N^%OCV?7=?^&W[.GB'XAZW\(O
M`\VOZK'H'A#4(X_%<5K?6EG;7Z><;5="M#;07)>VA>)Y!!YLKO7](/PR_P""
M4&J_#']N_P"+7[>FD?M$ZG=?$7XP^'/$/A3Q)X9N_`&C?\(O:Z-K4>C_`&=-
M-B34UO([S3KGP_I,_P!IDF<W@@E28!9?E\Z_9^_X(N7/[.WA7]KCPKX6_:8U
MS5+?]L2'6A\0KG6?AYH<LFD7>NOJC7MUX>CAU-(H@R:S>QK%<"5`3&^-RG."
MRK$QE*4</.KS5<PEI4:]VM"@J-[NVDHRLDM-M#>6/P7)"W+S*GEW-=.W/1G4
M=9*R5DTXW;WV[V_$/X?_`+9GQY^%W_!ME=^,_#'B;Q#'XQ;XU#X`Z3XTM[VZ
MGUGP9X&UCQ!.)KYM4N)&N+86MC;2^'[&?S!]EDU6QAB*L(ROZ8_#3]E_]J;X
MHWW_``3I_:8^"5_\*_A1X2^&'@OPNWQ'N[?QI>7=]\9/!_B/3=.34XM=;3[-
M+?5-6D9KBZ@.L37CKJ),1D7+5]K?LX_\$=OA1\'?V)OB-^P7\1?'.I_&SX)^
M/=4U+61_;7A_3=`U_1]4U.]MM4-_!>Z;-+%+>Z;JUC:7^D730+)9S0*?G!8-
MU7[&/_!+*/\`9"%CH)_:C^.OQ<^%_A6^DN_AQ\)O'&I6$?@[P<AE,T`:#3XH
MKK6IK25I)+=KV=+>*23*VH*(1T8/+L?&6"^L1E"A1H4H2HN3<G4@VYRD]?BN
MONZWN<^*Q^%G]9]C"'[S$U9PDH_\NY<J@EJMK/?Y]3]7[,YMHNG`QQTZ\_KG
MZ=*LU'#'Y4:1]=@P.2>,G')))^I.3U-25]BK65E965EV5M%\MCPV[MOS"F/T
M_'^AI],?I^/]#0^GJOS$?*<7_)ZM]_V;)9?^K2FKZN'0?0?RKY1B_P"3U;[_
M`+-DLO\`U:4U?5PZ#Z#^5<N#_A2_Z^U/S+EM'T_1"T445UD!5#5=4L=$TV^U
M?4YQ:Z=IMM->7MRR2.L%M`ADEE*1*\C!$!8A$9L#@&K]5[J-)K>6.1%='4AT
M=-ZLIZJ4_B!&01WSBC7IOY[?,3=M7MI^?]?\$^2_"7[>W['OCWQ1%X)\$_M`
M?#[Q5XOFN/LB^&]"U.74=92X$WV=HYK"UMI)[8QS`QS&X2)86XE*<UZG\5_V
MBO@G\"["RU7XO_$;PY\/=+U%D2SU/Q)<R66FRR2SQVL,1OS$UK'-/<2I#;Q2
MRH\\I"1!V(%?Q]_MA>%[+_@D_P#\%N?A'^TYI&EV>D_`']J>\6'Q6(;9(]/T
M76?$5Q#H_C9$CAB*6L:W4FE^(8/EC`DGU%D(C0U_1C^U7IWA']J;XD?`?]DE
M;'2?%'A/5K[1/VCOC1/)"ES:67PI^'&JVNJ>`]"69X9$6[^(?Q,7PW%%!&RR
MS>&]"\23A6A!S\U@<XKXN&*I5:<:6+PN(=)PUCSQ;:ISA%MMIK5OTL>KB<#3
MIRP]6G*<L+B*:G&;MS7BE[1)V2]UO31]F[GT1XK_`&XOV1_A]::?J?C;X[>!
MO".GZW;P7NDW_B*\N=(LM2MKN$7,$ME=WUI#!<B2W*R[8I&=4;+*.WM/PW^,
M7PU^+VCMXA^&WBS3_%VA@PA-5TM+IK&<7$/GP26MQ-!#'=12Q89)8#)&P(PW
M-?RV?\'5^CZ3I'[+'[/*Z=865F(?BC):0+;V=K`(+6+0YECMXU2$".WB`4+%
M'Y0PBCCK7]$/[#ME:0?L@_LV&WBBA\WX+?#F5EMXDAW.WABR+,XA53(SL23N
M9MQQSWKIP688BKF6,P-6,+8>A"JFE+FYI1O:3;M;LDK_`*95\+"G@,/C(N;]
MOB)4K.UN6+5WMJ[/T.J^*G[8'[,_P/U$Z5\7OC'X.^'5]N1$C\67LND12R21
M^:L<%U<P+:3R>7\Y2*=V4`DBLGP!^W#^R)\4M6AT+P#^T/\`"OQ+K%R8A:Z;
M9>+--CN[PSL5A%E%=2VYO#*RL(_LOG;BIQ7\]?\`P=:6=HG[(GP4NA9V_P!J
M;XS;7N(HX8[EH8]%F;9]KV1R@A5P(S+AFP,-7S%_P5#O/V=M1_X)*?L;:?\`
M#-_"-Y^UI-9?!"+X70?#6.UN?B:FHP:)IZ^+T:;PDLVKP!K"9C<)?O&?[0\H
MH'N5.SS,7G]>AC,QH0IQG'`87#5W%<WM)RK5(QDHZI-*+NK+?<ZJ.5QJT,+4
ME4Y7BJ_LHR;2ITU>UYW7ZJY_:JLT;D!&#9Z$<@\`Y!Z$$$8(Z_2I:^./V"K?
MXS6/['W[.-G^T,]TWQFA^%_AI?'8ORYU*'4_LJF&#5W=Y6;5H[`V46I.\LCM
M?).&;<>/L>OJJ51U:5.I9Q<XPDTUJN9)M>JO]ZL>35A[.I.G=2Y)2CS+:7*[
M76^CZ:[!1116I`4444`,?I^/]#7\U?\`P=._\HR[_P#[*;X9_P#2>_K^E1^G
MX_T-?S5_\'3W_*,N_P#^RF^&?_2>_K@S'_<J_P#CI?\`I43?!?[_`(?U_5'^
M39_RT&?^>K?S&*_T[?\`@U=:V3_@G/XWDDX>+XEZ+Y,SQEX49_"=F6$^WYUB
M&,,T9W#KTR*_S$A_K1_UU;^8K_3J_P"#55KE/^">GCN7?$8O^%A:4L,:%I;Q
M)CX3LU\RVM2N)Y57.%R!W'2EBO\`><NTZ8G_`--Q_(Z(_P`#&]/WWY6T/UX_
M;9\0PZ=\%/$U];V+_P#$VUWP3X<O&LKXM8-'>>,=$D$IC.W.UK9GP4!(P.>M
M?KQI.?[+T[/)^Q6N3C&3Y*9/XGFORQ_;&T&QU+X%^.K>\CN;A+&7PAJQOUL(
M($DU"U\4Z&]KYC-MD$T(D(EV+@$[,Y4BOU.TG_D&:?\`]>=L>_>%#W^O3MTK
MIG_O$?\`!'_VPY9?PX>O_MJ-"FLP498X_P`_YZTZHIHS(FT$`GC)!/!ZX]\=
M*W,C\;/VS?A)X9^/_P"WK\*?@YXLMEO?#OQ'_8,_:R\*W\;H&"KJ7C;X.113
M1,P*":WN?(N8F&YDEA1^``:_G*_X)(ZC\9_#'Q/^/'_!'W7M'UF?3Q\9;?7/
M%WB`O-'9Z!\-O!>L"[\6JS(5\M?&4%IH4%FHVQSPZC=JZD"OZR?&'[(?Q:\3
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MU^UG_!?O]D)?VJ_V#?%^L>'K![GXB?`FZ;XI^$GM(0U]<6NDV\B^(],A=/WP
M2ZTP/>;4.[S]/A/.*RM&_P""+^K:)^WQK7_!0^#]J/69?C;KNHSZC>Z9/\-=
M#D\$@3^%;'PB;:#3&U@WD$2Z5IUNH9;UBLJJV"`5/[=S:!'JV@OHOB,VFL)?
MZ6^FZSOLDBM-2CN;9[;4$:T+2I%!=K+(IBW/MC=DW$<E87**L\#FV&JTX*.)
MQU2O26MG!)2A)Z_SQBV]/QN7B\PH_6,MJTY\SHX2$9WYKN6BDMDMI/R3[=?Y
MI_\`@D?^TUXF_P""C_PD_9.\,>*X]2FMOV1=/DU#XX7]Q#,-.\6?$/PW+<:/
M\'H&FES%?2MX<:S\6ZLC,_DZO:J73YXVK[5_;P^.G@SQ#\?/AQ^S]XM^'GQ(
M^*'PP\%Z1J7Q%^+NA_#OP5=^-;?4-:U.RFT;P-X3\16]MM@AM3!<:GXB>.1G
M8RPV#A$95-?8_P"Q9^PE\+?V%_A%XJ^%?P<FFC_X2WQ_X^^(FI^(=0LK4WTN
MK>,-9N[_`$VTDCMQ$)-.\+:4VGZ'I=KO51:6&XE7GD-4_P!F7]DOXD_`?Q_\
M6O&_B[X_W/Q?'Q?\3W/BS7;?7?`6CZ-J>GWIMX+/3=-TK6M-OVE30](LX/(L
M;&>WF9`?]>H&#O3P6(6$PN%Q#>(J5Z<HUW+6,86M&,7IHM];ZI:ZF.(Q>'J8
MF5>C&5)4W!T]?>C4YHRD[M=5=[72V=S^6[_@B#\9Y/V+/^"F/[0/[$/B73_&
M'A'X8_&WQ#KFM?"#3?'^F7'A[5D6SNKO4_!-W>:1>.QM;O6O#,LFG%D9Q++8
MQIG<=H_MW:XBF0,C@KG'<'//8@'GMQV.*_#_`/;)_P"","_M<?M5>"/VM/\`
MAI+Q'\)/B)\-)+!?!4_@+P)H27%M9Z1JIU?28M=O[W4'EUZXL9Y)[:.XFBA5
M[*:2&2%BYK]=(/"OQ'MOA]:>'X_B#82^.X+"UM9O'%WX4AEM+N[A*"XOY?#<
M>I06Z/<(&/D1WJ1I(V0=O`>48+&8'#XO"UO9NE3]M]34;O\`=SBK1EJ]4T]K
M;ZIZ#S7$87&U:&)HWC4G3I?64W?]["5Y3VZJW='\-G_!,+X':Q\>?^"M?_!2
MOPAH?QD^)_P3O+?QY^T=<GQ)\+M2T[3=5N5E^.VNVWV*^?4M.U"&>S660.\*
M"WG\U!B=<$5[]_P3=_:@UO\`8E_X*1?M"?L+>)?`_AKXN>)-2N_B2MG\>;31
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M"%%033]M#EYE)O70_#K]AWQYX@_:/_X)=_\`!2?]I+XPEM;^,.L^.?BQJMIX
MGU<%_$'@I]%TM;O0-%\-Z@_^D:#;^&I2MI8Q:9)9HCP,2&R<^!7_`.VU^T5\
M</V<_P#@B?\`"SX@:AXD/A[X^?M!Z3H?QCUV2XFB/Q,T3P%\1]#\.Z/HNLW,
M+PR7MIK%I*NJZA;R2*E]%'NF$@5PW]+X_P""7'P[\/\`A7X^_"SX:>.M;^'7
MP6_:6\3ZSXM^)WP]TG2=+N/L^J^)%QXC7P7K,J1W'ANUUQMQNX##?1P>9)]B
M2WR,=K\1_P#@F9^S?XV^"WP.^"^CZ')X%L?V:O$WA;QK\#?$GAP0IKG@'Q1X
M1N8+K3]2LVN$DM[Y;UX"-9MKZ*:#45EED=5FV2)Z\\HS%NDUB9:5J,I6E]E5
M(.?RY+W_`.'..CF.`C4DW0^)32_NN5/D5E9;-[/;U1^4_P`8OBGXM^`G_!=[
M]G+X8?"6`Z+\/_C=\%KS3/B%X)\/00V?ANXG@FU=['Q5<:-;^79P7VD/#%+)
M?V]K'+*LI65W5MU?FHGQ?^(7["_[>'Q%_9R_X*#>!M2\8?!+]I;]J'PS\9O`
M'[0MM)-#K.D>)=+\4Z1?>!]0L-<1I8[WPIIK:3I5EKGA0SA-*1Y9H;22.661
MOZI/#'["?@V+]HRZ_:R^)&OR?$7XYIX`D^&_AKQ!<:1!H^C^"_#$[3R7D?AO
M1H;BY^RZAJ#38O;^2[DE=5$48BC.VO'?&G_!+WP?\5/#7P+^'WQB^*7BCXH>
M`O@?\4H/BWH=EXBTC15\2:GKNG:G<:CHWA^_\36T27(\&:=)<F)M&2!I[Z""
MUM[N]DBB`ISRK,HJ4Z>(G*<<U]K"$G[DL--14VTE&Z6K6J2>MGH*AC\)SSA.
MBG"6&=-R:?-&4=8N#VNVTG=;/='X8?\`!4GX:_#OQ7_P7;_8-T/7O"'AW7O#
MWCO0=+_X2_2=5TN"^T[Q'`;O4XD75K.Y62*_C$:Q@"9=J(%P.,5_7MX+\,>&
M_!?AG1/"/@_2-,T#POX>L+;2M!T31K6&QTO2M*M8ECL;"QM+<+!;V]K;".&&
M*)0BQHH4#I7YL?MK?\$KOAI^V1\9/@M\?9/B1X]^#WQ8^"\WDZ'XP^'4UG#J
MEWH[2M))I\DU_%,+:<(\L=OJ$*F:U$SLBEMN/TO\(>&+;P?X>TCP[:75Y>VV
MCV%I80W6H3O=7UPMK`D/VB[N9/GGN9RAFN)FPTL[R2'&[`]+`8">&QN/G4C[
MM>ISPDM[)1M^*???3N<>-Q,*^'P<:52;]G3Y9PEJE[V]TEJUZ['2J<CMP2..
MGX4I/!XSP>/7B@<?K^IS0>AXSQT]?:O:C>ROO97]3SWV6VROV/S-^.<=W_PU
M1K-]!)$+.P^"GA*:_@E;8LT+>,M?79)N!5U(/W'QS\V?E%87C.*\U"?1--M+
MA=&TNZNXYSJ89K6*2)8S+]GN+V4,KP0KF.-=O*\1G&*B_:0U3Q-IO[4VI#0(
M+/48+[X)>&+?4M,N9X%>>-?&6O2I-!;R@M=R0,G,`*@INYSP:EU)<75EIWAZ
M_AMDN-8F\Z.$/>3Z7$)$,\]Y]G$3RZ7<POA?(+/;M]Q-HK##WYJ__;OYFU;X
M*'^%_D>)_&'P_#%=^#3J>JPMH=B97EM-'$5[->W%TVR*\GN9%9XXHQM,9C7"
MOZ'BN[\+>(H-"L[1);1EBNV%C+)J"^;;BV;`A^\2K31`#:2,9QQ7B'Q(UN]B
M\9:3H>@ZH+G5-)TB&">^@T_S]/*6E^MS<?:(&?\`>"&W5H6V*I`.YNXKK?&/
MC=H=2@N8;>RO$U"V6.WM?L<<D$",T:RO=6L<R&WFC5RZ7*(4,D;1CYA708GJ
MNK:M;0VNKW$.L0OX7O8+D0Z5J1BLY1=>4\4D-S<`*_D2R_ZE8F5U!4'@\_G%
MH_B*V\)?'$>,?#5[J1UJ[DTD:;:6FGM!80:9<@VNH:<@S_Q,8E'SN\Y,JECV
MKM/CQ\>-*^%^C3Z)XL6'6-5UO2+B73K"&WDU#2+*"X#,US>76FI<S6]T\4:^
M242*6.5PI9>6'RW\(+GXD_$#7/#VG^&_"^O7#^(/L]Z\4<MN-2T_3KNX#Q&\
MO9[LKILD"KA1;2-<R6ACWQAR:`/V+T.VTOQ+<:IKBFYN=5TFVMKZWMXMS:>U
MU,/W<3A"_EQ6K$BYCDC9E(]J^C;32M6C^"_BBPU'48]3>;P7K`D-QEP9D@;=
M"UVJK(JGT89]*Q_@%\&;3PCH1U>\B9?$EY%!!>O%+<2VHL;:017NGJ'W)<7\
MYR6E90\K9PQKW'Q\UCIW@;QU?PLL.F-X:U)X`\2008-OO:ZF2388XR2`ZF,D
M#-`'\\.K>,_$_@^^M[:\L]1N=+U.TDTZU>02WFG6\D)FN88[@239$`:$1PW$
MKJ%!`(`KW#PC;>#];\,Z9I4FFV&DVFI2M=):V&G6LWFS7*LRBY>X1EC>YD=F
M\MG;:"K*3UH\6:%;:SX9O[IM+L-45[(M*897+M)YSI/:V5M"Q\\30OA"0G7<
MG(KB_AI)'X>U>33-<M#::-`@70;%'E22"\2%?L_F+LD222*)RI\]E+%0$.5Q
M0!]2VO['WP7\<>'=-:;2[ZUE,$KR1WDDDHQNVNPM8RD<4ZRC]U.GS;.,CBCP
MU^QUH$%TDM_9B]L[>3[%9SO:LK?8H6,=J(0^U)$B4`-'<%F9^0YKUWX#>)T_
MM.>)M4GO+>UA:&7[;(Q@='F\T&V1HQ)''&#M.X%P!VZ5]N6D-E?VQ.Z-[)[2
M.2)U9A"LRL79[:0H&49.0Q&&P,@YH`^1?#W[)GP]T"Y@N].T*QCEMY89/[6N
M@J2HSI_I<7G*SRS*QVJEK(WE1G*HH!Y^N/#GAW2]!M[>RM-\:^5Q%&"RQ>I:
MW4`*C\856VXJW;2M:NL.R)O,*&T-VJF*2-V`>YG#*J(X`S$-K,^W(.,4S5_%
M=EIL<C7+6T-Q*6BMDV[':0L567(<2['"[QL210O1/4`[*QCBA55EB>*"WD(,
MT:;$1P!LC",<$>@.1@XSQ5QTC1W*DSK+:R7$=D@"EY%.<R=$C))R`#@XKYA\
M>?'W3/!]SHT"7#WZZPJRS7>W&D6T<"8DEN9659+=F8$*)X(P.NXUYZ/VQ?AO
M)J-PIUNW%U:%8[G[-'<WUDL$.%9C*J+%LW-AW)"#JC2<4`?5GBF..32+FT>1
MH);ZUFB$T.'VS7D+8=Q]UQ^[$1'5<$XP>?RRU"X\,>!_B!<174>HK<?OG^S7
M:1BPN;PPLL15G;,D3S`/A<K'TS7NNH_MI?#_`%:RU/\`L"80ZAISS:?<0ZQ:
M3"!9F:14:QVF11]H81F&5E4;&8``@U\1CX@6/C?QE9:OXAT.Q9#+]H+WHN(K
M=K`7$D3W.F23E(V'VD;90_EK'SSM.:`.2^+/@J+4M!T_7I]=NKGQ%KEWJ=P;
M"4-)'!+<[8DTVUDA`$-DT4BE,G"\<9!(^T-`UO1/AW\&M/FU`R7E_I>B6T4F
MDVUJ]TUE-%$KI)$DH=9'`#;PR%,,6(X&/FV_T>_U[QGI<&GWEI::3#>Z=J!A
MB,HL5<1$K9F1=Z2QW%LL<A6'<ADY61Q@U^E\_AG1QH,,&IZ=IJVMSI\+QK&B
M^?<-);B)B9G15B0!W*A^-JD$YH`^&]7TWQ3XV\,^'?$6B64-_J$EU%-<PW+R
M0VVE:?)*;BW2"VBPC.2$WSL"&.5PNT@]]H7C31]`U>2WU6PO+GQ8EK]EOFEM
M!>6T#7$6Y[<2($D^QQ)F94)^3;N[9K`\7:EXF^'>I0:KX7T'5+[0KFX%JVD6
M,D4<4:6KK%`"';=Y**TDV(@PDR,D;1GAOB'XH^)6E^);*75/#.GK9^)X[7RB
M)Q)JLEI,GER&01B)[3,+?++'*\R,!NCD`VD`^C6NO"NKV=MK6G:AHTL+JS"#
M3K]5_>Q@)*LRJ^4GB="[(6#(#CWK^4/_`(.,/$T7B?5_V1;B(3#[#X)^(NFS
M),WFQB>T\8^6[P3,6ED60;2=QQPNTD<U^Y&E^%-;M+WQ)J'@I]>6&6ZD>?P_
MJ[0#2I(H59-3_LUIY+0N\O\`JS-@+*S`Y!%?S5_\%M1J,^O?`74;JZOC;7FD
M>.OLFGZC(HN-&6#Q#'%)IJQC#^7"ZEP[[B?,&V60'(^8XN_Y$5;_`+"8JVO]
MW5_\/\MCZ+AK_D<T]O\`=GZ_"_/]/P1_6%_P;8_-_P`$M?A\#W^)GQ2SCWUN
MW_S_`"K]2_VV8YG_`&4_C6D$,\YA\&W-T\5K;SW=RT%E>V5]<&.WMXY9Y2L%
MO*["*.1PH)5&QBORX_X-L`/^'6WP^X_YJ5\4S^6N05^]C0Q3JT<T231L"&CE
M171@>"&5@58$$@@@@@X/!K?AZ'/D671[X=/\5_D_O\CSLT;CFN.>Z^M5G;I\
M5DON/FR+]KO]GC'/Q/TA3A<!M-\0!L,`PW*='!4XQD'D9Y%2_P##7G[._P#T
M5+1O_!;XA_IHY%?00T+1!G&CZ6,G)_XE]IR3W_U-,.@Z+G/]DZ;GVTZV^HZ1
M8->Q[.LM8SBG:WO)O331;_TO,X>:#^)6]+[_`"5_^#^/@'_#7G[._P#T5+1O
M_!9XB_\`E-1_PUY^SO\`]%2T;_P6>(O_`)35[]_8&B?]`G3?_!?;_P#QK_.!
MZ"C^P=$_Z!.F_P#@NMO_`(U^'TXZ4<N)_P"?M+_P&7EY>OW!S4O/_P`F\O+^
MKKY^`']KK]G4]?BCHQ_[AOB+_P"4U)_PUS^SK_T5+1__``6^(O\`Y3?SS7T!
M_8.B?]`G3?7_`)!]O_/RO<T?V#HO_0*TWG_J'V_U_P">53[/$]*E+?F^&6DG
M:[M;^K/OJ7HN^FZ2>CU6EK^[_5U\_`?^&N_V=/\`HJFB],?\@[Q!T_\`!31_
MPUW^SI_T531?PT[Q!VZ=-)';_)KWM]$T-`2=)TOCK_Q+K7C_`,A4Q-%T.0\:
M1IO`R/\`B76V#GG_`)XX/3\.E2Z6+:UK4'>V]/5VY=K]>WIV6J4Z.F_IKY7T
ML_Z]%?PC_AKS]G3I_P`+4T7_`,%WB#_Y4TS_`(:Z_9SSD_%31O4XT[7_`,?^
M817O::)HO(?2=+#;CP=.M2<=ND5-71=%:21/['TX8`(/]GVN&R0>/W/MGZ=O
M1\F,_P"?]#_P6_[OE^7_``XJE':SWULM>EW_`$^U_/PD_M>_LY_]%3T?V/\`
M9OB'(]>FCBF_\-=_LX]_BGHY_P"X;XA_^5!KWW^P=$P/^)3IO7G_`(E]KD<]
MR(O\BHAH6C&0C^R=-`P<?\2ZVZX_ZXYZCH:/9XN_\>CZ\C\O*^['S4'U:VZ/
MR_X*_$\(/[7O[.><CXIZ./;^S?$)_P#<13C^U]^SD01_PM+1N?\`J&^(?_E1
M7NAT+1P0HTG3#C[SG3[?N>W[K''3\NG6G)H6C$D'2--QG@FPMB<9//\`JN_'
MTS3]GB]/W]'I]C;96M;?7YBO0VN]>EGK\-[Z-]^^_D>"_P##7?[.7_15-&_\
M%OB'_P"5'^<TH_:[_9S)S_PM31N/73?$`^G_`#"/\]^:]^_L#0_^@3IO_@OM
MO_C5`T#1!_S"=-/UTZV/_M*ER8MV7MJ'_@OO:_373\NUKOFHV6CLK/:5KWC;
M=?/KT^?@/_#7?[.7.?BGHQ/MIWB'O_W"#2?\-=_LY?\`15-&^G]F^(?_`)45
M[V=$T4DK_8^F\'@C3K49_P#(/^-/'A_1,<Z3IO\`X+[8_G^ZZTG3Q6B=:ATM
M[FUK-:6TM?1=/S2E0ULGKJ]'N^6_1O5Z?=\_`A^UW^SF#Q\4]'/M_9OB$?C_
M`,@<_K3C^UW^SLW3XI:,/^X=XA'\]&']:]\&@:)_T"=,_P#!=;'^<5+_`&%H
MH_YA.F#U_P")=;?_`!JFH8I?\O*3N[W47;HGVUTWUV^\<J&BMLE;1[:>7;U^
M_?P'_AKS]G?_`**EHW_@L\0__*:C_AKS]G?_`**EHW_@L\1?_*:O?O["T7_H
M%:=_X+[?_P"-4O\`86B_]`K3N/\`J'6__P`:Y_&JY<5_S\I>G*_\K?\`##YJ
M7GT_F\O+^KKY^`?\->?L[_\`14M&_P#!9XB_^4U(?VN_V=R/^2HZ,?\`N'>(
M!_/2!_*O?O["T<-_R"M-(QQG3[?V_P"F1--.BZ2LJ*-'TMD8?,?L%K\IY_Z9
M<\=Z:CB/MU*=O[J:=[JVZ74?-3Z:OT?EW7S_`*9\8_#[XC^#_B=^UWKWB'P)
MK*^(]%TO]GK2=$O=4M+'4K>QMM4N/B)>7ZV,MQ?6=M&;E[5%N$CC+-L5BR@8
MS]TC@`>@JG;Z;I]H2;6QM+9FX9H+:&$OCIN,:+NQGC.<=JN9'8BKI4_9II;-
MWMYO=_/K_3<RE>UE:P$XY--+XZ?X_P`C63KFJZ9HVGSZGJ^IVFDZ=91RW%W?
M7MS%:6MO#%&S/+/<3.D<:1J"Y9F"C&6.!7\_/[6/_!<W0;;QM=_LR_\`!.?X
M7Z]^VA^U+>7$NBH?"T,P^$_@:^8F!K_Q5XL2,07K63D3F"R:/34\LIJ&J6BL
MI;JH8:O7FU"/N=)/17TO>3LM/7\CFK8FC17OR]Z_PK5V=K:?\#J?M1\>/VD/
M@Y^S/X$U;XD_&_X@>&_A[X0TF&6274_$&H6]G]IDC!86FGP2R+/?WLF`L=K;
M1RRN6&%%?E[^P]_P5H\6?M_?M*ZOX2^#'[-?C:W_`&1](\.:ZW_#2WB5)M&M
M-8\7:=-"=.L]$TNZB1;_`$G4(5N$6XMI)I8IWA:0(JN!\F_`O_@BC\9/VE_'
M^C_M,_\`!7WXSW/Q^^(RS0ZKX?\`V=_#=Y>6OP2^'D)=;F#2;BUMW%GK-Q`S
M^5<06<$5BYB(FNM5!,Q_HY\'>"?"GP_T#2O"O@OPWHOA7P]HUG%8:3HF@:;:
MZ9INGV5LHBBM[:UM(888D5%4`*@X%==:.!PT)48R^NUYQY>>G>,*,Y):/1<R
MA+1NR3U:NM'RKZUB'&<FZ---248NW/"Z<;^L=]_GN?C=_P`%[/V-!^U5^PMX
MUU#0+"2[^('P467XF>%)+>(/?S0Z-$TVLZ=;NL;2_P"DZ>)66.,[V:%0H+8K
MJO\`@BQ\+_BKIO[)'@3XT?'V^FU;XP?%CP?X3@>ZO;5[;4-%^'OA736TWP+H
M,@FS,KPZ>7O[D,%+WU]/*Z*S&OV/FMX;J&2"Z@CGMY8WCEBEC62.6.1=KQR(
MX9'1U)5E8$%20>,TVUM;6SBAMK2VAMK:*,1PP0Q)%##&@VK'''&HC1%55`10
M``!@`<5\U/+:/]HQS#FM+DY*E);5'[O+*7=QMHVM$W979[GUZM+`PP;25.FV
MZ4_M04DN91[*6\D?R,?\'6?BSPS>?`#X'^$[;Q-HEYXFTKXI3WFH>'+74[&Z
MUVPM9M$E:.YO],BG>^M(I<_N9+F&))=PVL>*_4W]F[_@IM^PK\+_`-CGX*KX
MD_:<^%%IJG@GX*>#+;6]`3Q%;SZ['J&E>&K(7>E+ID>^Y;4%>*6W%MMSYK*"
M>*_6W6/AQX`\0WTNH:WX)\*:O?RE6FO-3\/Z5?W,IC01QM)-=6LLCE4543+'
M:H`'`K(_X4Y\)1P/AC\/_?'A#0.0!@?\N'.`._;\*Y5EV)I9AC<?3K4U]8II
M-U%S/W59)>23VU1JL71EA,)A*M.K-8>;DO9R27-)Q;;3ZZ:/6RZ6V_C+_P""
M['[4?AW]J+_@FO\`LQ_$^#Q+I,FK?$+XQZ_XQT/P<U_IJ^*-(\%-)K.F^&VU
M+0XIVO[<RV5G!<22W%N@9YQT'%?T._\`!-#X)?LH-^S#\`_&?PX^'_P=OO&+
M?"OX>7?B_P`1^'=*\+ZCK]EXI/AJU>Y;5KJW2YO-.UB:=KEI/-:WN"T;%0"&
M)_2*;X5?#*Y6%+KX>>"KB.W@CMK=9O"^BRI!;Q9$<,2/9,L<48+!$0*JYX&*
MZ70O"WAGPM!-;^&_#^C:#;W#1O/!H^FVFFQ3/$OEQM+':0Q(S(A**64E5)`P
M.*C"Y-.&8U<PKN%5UJ=*$K)6E&"BU%^2E[UNCU0Z^80JX2&#I1G2A"<I6DUS
M<S=[O;57T[FTD2;$`&``N%Z8Q@@=`<`]!Q@@5-2+@``#``&`.PQP/PI:^B_K
M[CSE?KKYOKY_,****`"BBB@!C]/Q_H:_FK_X.G?^49=__P!E-\,_^D]_7]*C
M]/Q_H:_FK_X.GO\`E&7?_P#93?#/3_KWOZX,Q_W*O_CI?^E1-\%_O^']?U1_
MDU_\M!_UU;^8K_3I_P"#5MKL?\$^/%TBR0QP6_Q*T>9G>)\ML\)V9VM,A#1*
M/O;ER<C'M7^8L?O\C(\QOYBO]/?_`(-4+9[S_@GIXPBCRR?\+*TD2.H)>V9_
M"5F/,4G&5`)R,'K]33Q'^]99=7_WK_TW'?R-4W]7QO\`U\N^FNGXG[@_M2:B
M^I_`KXN6SQM]GL-%T?6Y)K1);Q)8K?Q+H]U<R0^3%+<.8;>"2::()N"+N4$F
MO=K?]MK]ERPT_3%O?C9X/L3-:V\4*WCZA;,\J6R,\:K/8(6D7!S'D,.1CCC?
MO=`M)HM0M+N;S;:-4NIWOK4/`5B78JI':K%)Y@*[P9-R@,"0:\+^)?P+\"?%
MWPPNB>(K#Y;&\EO].U*TMDM]6M)GBW&Y@N&4`1+NWRSGY'C;RV1F5B=70KNJ
MZD*L(I^ZE5U27N_"K;K3Y*QS1:Y(\VO;RT7?^NC/1Y/^"@/['$,CPR_M&_#*
M.:(JDT4FM;'AD8;@DJM;@HS*"P!P<`GH.*]O_P`%#/V++QB+/]IKX37>)?(/
MV;Q'%<8G/2W_`',,A$V<CR_OY'2OYO\`]H;]E3QA\+I-=O='T*PU6QU>ZBA?
M6+0Q22ZE<6NI2365QJBW@9=-N9+1S!%?6&Z&6-2LL9P!7P'XP\":EKD\6L>&
M;:;3K'3[B*[U6=+FQ\.7.D7UM*J6\4C06[0WQ^TJYCU"VC262+!N`5)%7['&
M:?[1AO\`P%_W;]?7[@O#L[?\-_6_YG]JDG[<G[)\49ENOCMX&BC8X5Y+F^C4
M@=U+62@@'*Y&02O4]*K3?MY_L>0Q&2;]H3X<Q1;02\FI7$:[?7<]HJA>O).!
MS7\G?@KX[>/;5=#T[Q7>2ZW:Z5=6VCWML)M.NHKB[BMGFL_,NOLQM[MM10QQ
MO.85AD:/RSB59&;"^)?Q(O=0T.1#I>KV_BJTUJ79:ZII=E:^&5L57,>G7UDA
MFD=93@1S0$Y)\P)CBLW3Q=W%XC#6:2:Y.UNNO75?\.->S^?FF_\`@']:<'_!
M03]BZ\7SK3]I/X5W409X6DM_$"SQB1&VM&6BB8!PW!&>]/;_`(*!_L90W#6D
MO[1_PPCN$@:=H&UIED$*_>E93;[A&`02Y&WT.>*_BQO-)UZ>XBL;Z74O!$.M
M:9=>*;"T:XT\0:5`I,.KPV;6]D!>?;I%:72;IVB2!&%O<1B7$@R-6TW5?%E]
MH\O@GQH][(UC;VGB7>]C!<66BVL;+=Z;J$4J7$44EX4C\^XLII)';(>-:OV.
M+LH^WPMDN6W*[*/NZ;_>]+V%>&CL[I)7TOI\S^V>3]O[]C5"JR?M&?#)-T:2
MJ#K3*&B?)64,;<*489P20&P0,XJ*7_@H/^Q9`ZQ2_M*?"R*1HA*J2:]LD:(\
MAU1H,E#SAL8/8G-?R#V^@>+?$_A>_P!*TK0C;^'[2_BM=1O7M%T?4);6V"/!
M):7)CFCGL[1BY2.!81<0/'(5!8DZ">$/#^X:[K4@U37UL8M$M-.;1K:]RL!/
MV>Y>XOD@DA,$6)9HH"T;Q#).XK1&CBTDO;X56T7N/1/E[^ORM8=X=NSV6K6G
M]=#^O&/_`(*`?L:RF(1_M%_#1WE`\E4UAW:56'RNBK;992,],XZYQ6[;?MJ_
MLNWD:2VGQI\*744G*2VPU6XBD&<95X=-=2,@C.<$CKD5_-=^R[^S=K?Q*\67
M5QKEKJ1\,01Z8;+4)UMX+,:7/$8G;2((K=;F16<N&NBT9MG"JR2A=Q_:W1W\
M&?"K3-.\)0V4LNEZ7;M8Z3;6EK;ZA-:^7M+37FI/&IG822>9Y9`(W,N2<@3*
MEBTU_M&&Z/X;]O77=?CLF"</^'7^6A]1R?MJ_LN02F.7XT>$89`.4E.K1/Q_
ML2:<K8Z\XJN/VX?V4#(T?_"\_!'F)'YSI]IO@R19P9&!L<A.Q8CWKY"^)&CW
MM_\`V9>Z1X8?6X;R&X.IZC/IME#;6%O=1?Z-?"6-EFV(!()(`HV/@]<UX_-I
M?@[4+5;R&RM[:6V1M/N+NRM()GU"W`\N;375XEDE,4F9)DE<LL.Y8R3@T_8X
MNS?M\,^9*]XMW2Y;7U]7:R%^[3TCL[IVV;W??7KUW/TA_P"&X/V5"F]?CEX)
M(W^7N^TWN/,P#M_X\,9P>!UJM=_MT_LE6+,M_P#'OP#:%5W$7=]<VY"XR3^\
MLX\A1\Q/0`Y.`>?S,TK0(-8U6[M=(F6'3HE>\=WT&WGL'U)T$"6YM7Q=))%\
MK(8R8PX!?*DU\\_MF?"R]E\%^7:ZU;2ZW/;V]WJ>K62KIVH06T$L:ZG:WEG+
M!)#`KVR(@$#A)HG8-DY%2J>+;M]8P[[^X]597WV_#739![FGN[--:+I;S\E_
M3/VD_P"'@W[%Z103-^TC\+1;W3%+>8Z[B.X=3@B.1K?:YSV!)STK5B_;C_9-
MFC%S%\=O`TL(`(FBNKV2(J3P1(MB5*GH&!P3TK^(S4/$/@K0;.QTS689=;TS
M0M;N;.WAT8Z=+JD@L-U])_9-O<O!`]Y&"KRH1;NT(81R2?<K[2_9L_:#U;QQ
MX.U;3/!4]YXOMKNXE>TT'5AI&D:OIL5GN,5I:!BS1P;H]TD<WF`MEHR.#5.G
MBXV:Q&'3>FD7MIY/:_EM]S4HW?2_=>G;^MS^J.Z_;D_9-L=C7?QV\#6F\D(;
MBZO85;`R<,]D`<#GTQWP:8/V[?V26=43X^^`&,B"1-E]<OO4@MN4K9LI4J"<
M@\8K\)?$'BGP]\5_A,^C_$`)HWB"2UDM]/O-*FTJXN[:<AH#%/#"JL#!MQ*7
MR&&25(KXO^%/B3P#\'=3L_!VLW&H>--":2]M9[^]M[[^W);B\>:."VL+R";[
M-Y]MYLTD$#M'$8(5B"AB'5JGC&D_K&&=K+6.MM-+:?CYW%^[6T?Z^;_K7N?U
M8?\`#<?[*919%^.G@<Q29VS?:;PQG;UVLMB58C^($C:!SBK,7[;?[+$Z;H?C
M=X-DRI8-'+?NI4=6&VPY`[GIWZ5_.!H7C_18+.^'A#58],\.3&;45N?$MK%%
M#;1*#9K!<Z;+([8EE):2."]8N!N8[CQ[!X/_`&HOA]HN@3V^H?V7:ZAI/EZ?
M%K=E;6-UI6JW9)/D0[F,129ODEC4*X&4+Y&:S<,6K_[10LKW2B[^B?SLAKDT
M_5>F_3^GYGV?\9_BOX-^)O[2M_XS^%^OVWC70M&^#7A^POK_`$99TM(-1;Q=
MK<YL?MMQ;P&*]-DPG14+X+)N&#FO"_'?QO\`&FEWDUMI$=O=:M'`ALKN>[DL
M!:02CR]-M-;^<CS'9Q!(\+`2RA78`5XOX\_;'\,6_ASQ"UV_AFWLI;2:"SA\
M)7MHE]<ZM-98@@,\"*FFHK!6N%O$*H@)5L8K\4=8_;$\2_$KQCINFZ7H-_8V
M^JI-HC62W=QK$-PLTGV6SUVWUO3FCAC:RGB:X<.5\D?*@QS6U"E*$')RWW7?
M:WY]/\QS?NI/6VB\O1?HON/VYO\`QIXF\*Z5<^+_`!AJND:#XW@#V*Z7I\J7
MBVUS<OYD'VB9MT<UKJ*ND-W<$_NRP+!:^8_BI\:_%NIS:3X4\%VMC9^*M=L+
M:SU;5OMLD,.B06\J2FR@BE;?)'<S7,DJ2"1968+U`(/SEX.^'OQ"\7ZG+X9\
M->+-;\>>+Q97-PMSFXA\#EIHU,.AZOJ-S#+&]YYB#>8$,VU0?-SBOL']G#_@
MG]\8?B9XU@G\;>([_P`,:=H]M!=746JO87UUJERWG7<>H2ZC;*R:I=0S(L%M
M%`8XH(%1-J@`5J9&%X.^%EUXCU6WA>XF^)OC."'R-=U+3XI[RSMY[A<G3MT,
MDEM;30P(5DED7*H7(RU?MW^SI^S5HGANQTO7;S2H+76[.U@OK"&`3-%:SDAB
M(4$F6,:G8'ERA`QM6N^^"G[.O@SX5:=;Z>D>GVE_<SR:AJE_:VKV3:A<QQJ(
M]0D=_G-R6^;!<1I)^[08.*^L],T>PLX)YG226#S)I'OKJ-8GN69OD2:.%@JD
M<,K+PZX/WCP`5SI8ATV)+26ZBE\P,[)&Y4&202K*]JC;91`X)/ER(=O4YS7*
M?%;2+V^^$GQ`!DLKB\N_#>M?99Y(Y)+<*;0-M>$E28N#A0<_I7HEBTR02Y7[
M7:1Q/(LL+%72=_O6T>[,D9`PI)(.,=C7"?%*];3_`(8_$*5)+JT@A\*:E<6U
MU*%GV@VK@MME)\M3P&A8;3_%QC`!^,%MHFI66A:/!9K/)=2,)KJ2SBDCBO)X
M4,J-(DBAHH(K?C`*H[%1G)YYK6M$N[Z>WU?2M(O+:YEV7<MA=&Y5,!BCS)\A
M"RP$,^Z0F/YA@XZ,\/>-/'&L)9PK!IEII$]K?Q2+<OYBOY,:+;SR6UM!)+-%
M<NJEHP4%NV`IV#%=3\0KV633-/3^VKW3+JZT[[`NL,\LMO;7$9$]SIUI`5C9
M4EC#G;,,J,<G.*`/8_!&J6_@ZSLVCNDA$LDTUU?3`.RQL`C6IF&Y9Y8[C<KD
MX4*&Q7V9X/\`$\.NV]I+;ZBXL9@R2B.??!+;@*RM$,*OD@'<?+[=\5^9/PW?
M7+GPI'X7DOV\07D\-V&O_*E@:1([_P"W6\EE,[!@[0G;,DVR(CY<XKZ5N_B5
M/\&?!$LO]D)KMZFDW%_*8[Z&QO694/D+)NC-M';HFU9[9""X'R`&@#VKX_\`
MQC\(>`-`L9M?\1MH\M[<%--U-I6784B=45BV%6/8A^9EQ'E2-QK\A/CI_P`%
M&;.;PY;Z"=6EM]89]7M-(N=-"WUQJ45O;&".XM[Y?+>.Y*LDD((C&=SH3C%?
MF]^U!^V3\2/CQXXD47/A6#1?#&I75I?6EC]LA:"*WLY;J>_OKB:13%86\*30
M0-:B2*66)U"@%<^&_#KX7:K\49XI]+76%M]:UA=0L-9TFU?Q%8^(K<']UY@U
M&.WN=(@\D-%&(1L#("6Z4`8'Q`_;#^.>I3G0V\3ZSI)FU:ZM[#2[[4+A9M4T
M^50D%Q;F3S)KMI)EE>>WED1&21?)*``UF6'Q&^..DZO::Z5U3PY#?Z5!9_9G
MW31WX>X7S`6N)#+9W<NP!8Y2\)5U"DFOT_\`AE^PYX64ZU\0;+0]*O=5EN+:
M'4;K63=S:Q$T$2VIM-0M)7G$6H1XS&+(1(VWS)78BOM[P7^R/X:O+RROKC36
M$.GZ9_R#-4:&YT_59&_>-&Z744CD*ZK(CY.PA03P,`'XT>!_&/Q#77KS5/$.
MD>(X2T,MU<:+JT5U))KFI22(;,VXM4(BC*LI2$9+/#N#*"P/[-?`#X9ZUXBM
M++4-1T#7XI+C1KF%;S6XEMFL#J<(F-GI^]5B=8I6S''.N[><@9-=!X4\!Z-K
M_B2_T>;1M/FO(=1A^SZ,;F/[3"+9H_*O?.CC6=V@+28CCE7$;$$$5];>)]:U
M[X8^"]1U>UL%E.D6%TT8-W!;1-J28BMX[TNC.MJ9?($;*S2&$R'L:`/#M/\`
M!VO:#XD^V>-Y+.UCTB"T_LJ]CMXK6\EDA_T*UM;BV)6&22*$*Q<#=M7/(Y/U
M'9ZEXJN+.\TK5KRTUW3Y=)2&$0+/)>Q1W(8,7E4JEOY4;#:Q`6,D$,17QI%\
M9_$UUXHTO3/&/P]L=<T?4M.M]9BN-.DD\17']KW.Z,Q1;X84^S1H<M'([/$J
MA4!VBOH+P!J%I<R+97<]W::9<7%X6L6LY["13O4I:!9Y618<E8VV)N*XV$"@
M"UI7Q=\,:]XXB^'=MIS7#:&+>QOFE2&22Q1D6![J,DL"D;(OVBX+,%9AD#?7
MKGQ+\%Z!J^D1"QNH+Z22,)YLC(6CTY$W2BT=$:6.0X)2:$@K_`17G6M?#CPA
MX%\7:9XATG2;;3M5UZWGOK^:*SFN6O6AV2O"]X9`S(BX/E9P68<9`SY9\5C\
M7?#M_-XZ\':Q;ZOH'V%+ZXT8P,R:!IX<"20V+2`E)+>3$03+&X'S`**`.&\0
MZ7XHC3[9X>U/1-/L]+>;1M%U'4K>6YC^Q2+B>PD25RMQ/-+D-+)F0R?-P17\
MTO\`P<'>&]7T#Q!^RK/K2Z;!=:EX`\7R/8V"J3`\?B*,M/,XR<W1D,BJ78JH
M`X``K^FK6(/B3;Z#IB06L=[IWB&.34WUF1$\^UBD0-,DFG0Q37<$R[XQ'(ID
M(;>8U.,U_,C_`,'`^I-<:[^ROIKM<SG3_`?C!C-*\DT1DN/$2&9(YKI8KIF5
MD4,DL8\H@J,9`/S'%Z7]@U=_]ZCY=(Z+7SMZ?A]%PU_R.J?_`&#-/_P&]]_E
MMZ/<_IJ_X-KO^46_@#_LIGQ5_P#3Y!7[Y)_\5_[+7X&_\&UO/_!+?P`/7XF?
M%0?^5R"OWRSM"GKD']<5T<-W_L;+7VP__P`B>=F__(SQ_P#V%UW\G-V_K_@D
ME-!;+9``S\N#G(]3Z4SSDW!"<,>W)X]:EKWSSANX'H<G\?\`"D+A?O8'3'/7
MV'2H2T,3@9(;].1[X%?//QO_`&B/!OP9%K'XCD"7=S$US!NEC6-K.,$SLF]E
M9I]H(2/;UQAN:`/HPNH."0..<^I['MG\:#(B8#';S@9[_3KFOQ*\<_\`!93X
M&>%VNHM#T_6]4FMYY$_?Q1I`CH2N9&+D'#@8503M-7?AQ_P6`^'7B&32!XLT
M-;"'4;DJU];3$Q6<#*6C-PK`,)",`#&"QQF@#]G6\VX9D;]TJ-C@\2*?_K=J
MD6=$+1N50I@!0<G:.-V!T]_3BO*?A7\:?`_QC\/Q>(?`^L6^HV\FY1!YB?:(
M&QP)TW9&[@CCCIZ5Z9#`&Q+<A1<.A#E6.!NZI_M$`9SQC/3U`+8>%CYV[K\H
MYQGG`/7D9Z'_``IQ9O-&!E<<'J/SQP?SJ'[-#A-PPJY5=QX_V2>>_;TZ>]31
M1&.,H6+9)/(QC/.,\GKWX_"@">BF)O``8#COG^F/ZT^@`HHHH`*:S!>3FG4U
ME##!Z4`*#D9%+44DHCVC!.>/I_.I0<\T`%%(3C'N<=<?S_E61JFOZ1HL/GZI
M?VUE'_?N95C4\XZG/.>,>O%`&Q2,P4$GH/\`]5<_;>*M!NPCP:E;.DG$;B0;
M7.`?E)P&X(Y!/T%:INHYHV,#)*",@I(I&.N>">?;C/8T`7*JSW"1,`_7;D#`
M)(SC(_$@>[$#O4D.Y8QO.23Z8]/Y?T/X?G-_P5$_;T\%?\$^/V5O'?QJUY[6
M^\92:;=Z#\*_"\LP67Q'X[U&VEAT=9(BX<Z3ID[KJ>LR1QLZ6-M*D?[YXJTI
M4:F(JTZ--<TJDXQM:^C:OT?W]#.K6IT*<ZM5I0@KMMV2_(^W_#OQ(\&>+=8\
M8:'X>URUU;4/`6M6_AOQ7%9R)*FD:]<:58ZT-'N9%8JE_#IFI:?=W-L<20QW
M<&Y<O@?G[^WC_P`%7?V5/V#='>P\=^+O^$O^+FIQ^7X3^"O@/'B/Q_KFHSNJ
M64$VD:<+F;38;F=T427J1O*I;R8I3C/\??\`P37_`&[/V_\`]J/P-XG_`&0?
MV8?%OP[^$GQ/^*WQ1\<?&#]HC]JKXJ>*M.7Q!->_$"]@6.#P#H#2FYAN-)T:
MTM;&V%K#J-[LM8EM)[*/:$_JF_8)_P"",'[,_P"R3J<7Q=\97FH_M,?M-ZVQ
MU3Q1\>OBLT?B/4YM8N@TEY<>%+&^%S!H5NTK/]GF4S:B8CA[TY(KUL3EM++*
MKCC)-R2BX48)J<[J]^:W+%:*]W?5:'E4L;5Q\7+"I>R;M[12CIMNF^;37H?F
MWI7P!_X*B?\`!96_M/$G[3_B#7/V'/V+[V=;S2/@GX2GGT[XK>.M!N&$\,WB
MJ^REU8F]MGVM#>)$(E<K]B;`(_?W]DW]A;]FC]BCP18^!OV?OAEHGA"SBMH8
M=3UP0I=^)M?N8\-)?:YKEPKW]_=32+YK[IEB$C?+$%``^O8K5(>(\*N,;0BJ
MH'R\*%`VCC)'0G!["K(4#M_7].E<&(QM:M#V=/EHTDK1IP5HK9-NV[DEJ^^I
MW4,)&#52K^]JZ7F][:67_;MN^J]1L?W$&,84#'7MWQCGU]Z?117&M$K[Z7?=
MV.OT5EV"BBBF`444$9X-`#%D5F91G*]<C`Y]#WI](!CL/P&*6@`HHHH`****
M`"BBB@!C]/Q_H:_FJ_X.GO\`E&7J'_93/#7_`*3W]?TJOT_'^AK^:O\`X.GO
M^49=_P#]E-\,_P#I/?UP9B[8*N_[]'_TJ)O@O]_P_K^J/\FP?ZP?]=&_I7^H
ME_P:;1"3_@GOXV,CND:_$;2&+0C]XN/!]E\Q!X95'+`@^M?Y=H_UF?\`IJ1^
M9K_41_X--X%O?^">OC"$NT*GXF:.7G63RWA$7A*R.1G*N'QM93P5...M+$22
MQF6*^K^L+Y^RYOR3-UI0QGG72^9_3==W"10(;7RM2+EVGFF90(X6.V+Y3RXW
MAB\;J"RD?PX%9^IZ;,JRSO;/-=W$<?D6T:CRTVQIMF*@@,,Y*0'Y)%(1QQ76
MVMO86U\PCMT::X1A(SPMY9D+O^]F>-GC5!$%"1%`Q/S;QD57U`F7352.-1"D
MLSR.6FM[YA"[>4(@4D,:,X;;RX,87@9X]`X3Y>\?_!_0/B1I-UHNM6$.HVL\
M+WUT$B^S?8+NWX1HUA=6M9K?)Q&&=&SC`)K\W?B1^P-IL>F:MX@\/74TFIV,
MYN8TGL+A1%:NC))ILEO;[[>Z@V$.'FC$I=L[^37[-W)2YLI9EFAM;?SHXXDN
MHI(99#<.OVJ42PP,+M&4$([%65ACR\'<,V\TF6U6[@MRBEYS,L,X>82VDZK&
MIED,;1^81\T<4L!!/RDJ?FH`_E1\9_`[7]"T"VFMO#%UIM_IFI,R6$EC>Z,U
M_++)<+%?1+)#))<O;A"\5NS-'Y0$J$%R!YIJ/@R[U;6)K>_U"ZGCO-.M;R70
M;FSB\]+ZVC\L7FDW$3I=^>[@_N;I2C#/`!!K^J[6_`FEW4%Q->V2ZG/%>QW"
MG6T@,5O#!"8]]LT($:JPN)H0F(Y%"`&/Y`\GSMK_`.RSX4U#7[_7V\,>$=0U
MB^-F^FPPP2::=*AME^5I=256%TLP;+;A&<Y'S8H`_G'M/@+%E9?$<U[]ED@>
MP&GZG%<O?^;>S"6$&?S&CT^PFC.TP1]6._J:N:5\/](TV6ZET?PY#':ZG>-:
M"+4(H[0VJ*WE7!L[BV;S)E8Y<B099-K$DDU_2IHWP`\`:!=@'P?9WDUTOG7E
MM>:A!J$%W<",K+<)YEN/)MK9\+`OF%U5<GCBN)\2_`?X6:/;7%WJ6@:3;1+'
M<2.]K8VGVB=6^=UTX^=Y<<JC:OFEY"VT_(IP*`/PBTGX::\+[0M+U#7M?TNV
MTK[3K(N;58#HNJ"61[.&QG-RIFDMQIT,$9E;$2.H6++EC7U7\.O@]\%/`"W?
MQ!^(WBFPN+ZV5FTG2!?Q@20NR!@+5GD^W33NRP-"!O51L*D-BO<?CU\7OA/\
M//"%Q9_V3IT>LKN;0I8+%M1NM7TNT@C:2Q$)B3R6A=0;Z"X98U9C+#*HD+5^
M`'QQ^,/BSQAI.J>,_#5]9Z+H.G:_:K8^&4O$5-%OVF2<W5O'%<W5U!<WR(1#
M/<-<6!^>-_*9`2`?LUK_`/P4R^%7PEDGLTU"SMUFU)+6+1IH#I-]HFG64>%U
M*!K>$P/;"-?^/.3YB>JYKXK\4?\`!7OPGXMU?Q5-X:U35-0L(IDLM(_L:>T*
M:IK$\B>5<07/ES"6:$J#-;C`7.'&>!^:VA:8OBSQ'J#?$CQLD.D>*=-CUIM(
MM=`MET/6%8+;7D.G^(+T-J4&KPNP6Z$"+!-+OD@PF`=V#X(_!GP[J^CSZ3I6
MI?#[PAX=U9[W4F>RCBO-1GO?DM+K3'M7-J\;$.[W$EOYF\!G3+9H`^ZE_;#_
M`&C_`!KX(N`FI>(_["3Q#]FU*6SUC[!XB6=I(VLX8WAMF@-LZ,3+:$`3!"J[
M2U>B2?M0?$/0=.M[:_CUW^R[=;'^TWCT^1[:]6*;SM3OXS;KYL&K3QB)%GE"
M;Q'(BQ,&KY6T#5K'PWJNOV'P?O=;UO0+C4K:XGN=3U".ZGL6CBBFO'^R&VBM
MI4D,/F"\:2":-F$:;>9#SOC+QS9W7C&>Q\9:KJ5M87HM]:L[315FT>]LI;*/
M]R-1$4ETFL20S8FC8S1QS.4C#!AD@']`7PE_:5^%-UX7L-;^WR2?VCIL5\-3
M2*W\F*[R`;%IT9D^V%E,=TLWER1-P^#FO2?$&B^&/B_X#UOQ!<8U74M0L9[?
M18+0+.MU]I5HXDN`@DP+=UC\^2-7$0D!8'-?RS2^,M6TRWTG4_"2:Y'<ZAKE
MWIOV2U@NCHEPJR&2YU2[L9+BRL!')(`;Q=GVB;+!)`WSU^@_[#?[7T]OXIA\
M+ZUJ5OX8M(?$-W_:?AX37\D5QJ4-NQNKS0Y9;B8V4-RBP3_V6)W1"C$G!!(!
MB_%[]GI_AUJ=MX6M/"&F7^I>)=3;5=1NK?0FO#9//#M)LKR+`FN%1MC_`"QO
MGDJ.E97P&^!.H6UOK":>NK^'M=M&U^RLKJ6WMXWMM3FMY8H;F-E>)U"6DAD^
MR.9!D8";S7[D:CX6\+_%+PQ)XD:YO;6VOM/:.'4C90R06^H(P:-A;W"H6:]^
M4274+O)&I^5#7QE\6_`6K>`-!L-7N]9CTC2K"_M(#X:M--BC^U:C=R%[;7[F
M_60SW%TN`XB;[/&L.#(X`-`'S/X4^%-GJ%R;+7=0@TG6K2Q-WIEU,9-.L"^5
M6XFU^\$C!S<&*23[H+;BNX$5XOH/AU_$7C>:;Q"EG;:-I\>L^'_">LP:7*FA
MZWK\LSK;ZK920+Y]W>6L*SQ63;O-=\%=P)`]IL/BAX=EUC7KK0M6T3QYI<*?
MV5J-I:)G5(9;8,4,>GW<Z-*MO(6:5G'D2(7)8;0U>/:G\?\`1-'7PW;_`.D>
M#O[!U6^U*&WO=.?5?#$MZDCM;ZC:)#;BXL+K>YSHUS++#*Q$BRQQLA8`Y32?
M@SXDUGQ&+*">\GLM+U".W@.I3Z@EM+9"XWI<ZIITD:FXC0JX\ER-H7/S#BNE
M\;?L^^/_``M;26-_J-K+?:C)J]QH>EZ?YS6L?]K74QTEX+:R#)'=0V;_`&N/
MSHSY2@>8<`@=WIOQW^(4^I7VI:';Z-!;P06^K0W]UIMM.FH+,=\\]RAG+6:V
ML1=HX'9HE$@8[0FT^Y7_`(8\>^.?!L?Q8\*>)M(1UMH-2TRWU2]^QS:3?K;L
M]Y)IJZ?!+)=(63;;:?.60Q'R!,`^Z@#\G_$'[/WQ`T7P+XYU75KF^M;YD`FN
MU@\J;Q-9/8S0M?36Y1;<36K*5F:!?-:(?/C.:G_90^&NH>/]<T#P'IED+&R\
M12Z#-HJ:*D%KH^B:?I%M%!.[7,6V[&K:O<QS&>R?S!#-+ERRFOT8^.=EXZ\7
M^!?#,%[:ZC/?:'>:;JM\T+P6EGK]_?$07:W5HB-(+.3)F:TADM6=5QAF.UL+
MX0>`/"_P2UB+;=:;JFN3ZW;7,?B/28;PVES/'(+];=;F1K--$DTA)'MKB..W
MW7$D(BF.\[R`?N/^S%^S3X%^$/@2ZT>?2XEU*YA>^N&O"=2NA/,<&[BN&4)]
MJMW)C**Q5%)!48KZ_P!%LM/TRPB\/Z;H]IHUK^XCMI+=$%S-*QQ(L-P!N5R!
M\J*<D9Q7SO\`"+XQ>%/%FB1QW'B71+K5+".`^6919";[=&LMQ<I`)IX0]L`5
MDW,5<DR$!B<^_>&_%%EXHU][.UO';^SELKRU7RXXH8@.4OF=(I8YDDZX@F9U
M'+!:`/4&^PFWO+65([J62T@MFMFW21F*,JF0&194D(.9F!`9^O:NOL(8Y[=]
M.N8E>V61IA!N9=MOD?9@Q.&50P.<DXQTKC[6>-KFZNEM40W4DSV[//(6NIHL
M&0,)/]3:R$;T4S*#C*C/%=A,MFOV5;U9(;B^5#%LF8VHF">8(T8JLOEJ>SC!
MYP,<D`L6<MN;>*.VCA!ENFB>**;)`!(\QE89D;@9/I^%>8_&)'N/AMX\L0I:
M8^'-4BNA$W%PS0DB.-61]O.`3R!G!&,FN]GEDL+8W;_8ENTXDO&@=DBWG$,4
M=O&=S.W0S[U]=E>9^,M6MO\`A%/&=G<7L\VI+X>U6[6U>-DCCBD@*S*DB*[/
M)N'".JX'&>.0#\7;FS;1+2WGL=%%Q>I<F*73DGF2/[/Y1DFMC<H,0-(,2,R$
MY9?+"@$5E7VN7OB#PQ96MY976J:S#K,7V==*BBA6SDN(S!&H\V-C*\<##SY)
M`Q++C@FO3]7TJXU&P@BT.SU:_L+9Y)=6LPR)J-Y=3`&.+2B@C4Q1%DD)D'FL
M$=<'%=;\//@_J-YLCEO5@MH-,,3&>6?[8NJSS&6$PD6R*P$HV[V1F"JPW-D8
M`.K^$/P>M_#MCIZ+<W6NZO+#+JMXEW>>5'L@027FYE&%@W'(C3Y0PV@8XKXY
M_P""E_Q2G^'GP8\21Z.=.L8;Z,6SS>?MF$AC_>M;SDQX?RE="$<Q^9SZ"OU<
MT;P9/IEDJW=R8K@Z?':S/:Q'R8V^S""=;5FAWJ9B-]UN25),G`3J/Y^/^"K=
MCI5AI^D:$/$^E:[=V4MQ?0Z,;6U%O+9>;LN-.C2_NQ']N*N?+F:':A&3"PXH
M`_)3X;>&]/UW5/AUHFK?V63\2M6U.SUUK^9[&\31X[22Y@M+0P22)-<-'<KL
M,C&-]Y+`Y%?TW_LZ?!_P!H'@O28=#TVWAATB"UTN&ZCC*PQ@QIY4"B--\D@'
M^L94(W-R0.G\_/[.-E;^/_C#X)_M&QM;U_A_I7VO^S;\VVG7TEE*"8I";&/^
MRS/IT;+`LL4B2W4>"P38%;]_OAKX\/ANZL--U>33[*+R)9+/2;:\G:9HH3YB
M%[I%MTNF6/:JK:D2@DB7A1N`/JI_!6B^']'UN_TJ""TE0QS:KY-KY-U-.%#-
M<;FRLI0-@`AF;J<$FNF\*^(_#5[I<6M6SVEUH>D1"QOD:3;)'=MQ(\RABZ,'
M;+`XC//`YJ[JWBR+4=!\,7L>G"Z344.IQV7FQ0>1;S#[,_GO,!)(L3K^^+).
MTC96.(CYSC^";CPS8OXMT&T\)QZ=<ZK,L]Y;26Y:SO9;C!6;<47=#(PZ(L;`
M'.T4`96N?"JRN=;TGQ/X$O8M.U@Q?:;R55MB-0+SY,;Q,K#RI$_<K<(RM&K,
M<-FO>-3\&:5J?A-M-\7:>NJ9@G:[LRWVBV:]D@S;QH411,$D`.9.!T-<KH-M
M;^"[:5-0TEIFNY`\4]JSPP6*RRLS6<1G\UF$8="@&S//`QFO:I[UKOPHTVF7
M=JE[+(\`MKA!^^C"8"LH)<W#K]TK@@\C.>`#P'P/X0O=(M%EU31].D2TN7_L
MB'RTAFALVAV*6A"$*T&T8_>$G><=*\R\1V^GI\2HM/+:C'J,L<E]974V$T>U
M9A&SQ7$80[IE0,8U+#H#CICTEO$>LV`EMKF^CL;"RN6M[D'YY8Y)5\Q3#YBM
M-+*JD#R@C*),IG%=/IJZ9J"KK#:?J5Q*(95@DDBMXKR^E$31BZNK.XB+)&RN
M>4`)`7#+0!Y?XLU7P#X9T\?\)[XCN6F5)A!)=7$D$6DVE[!F&_6=ML8C:150
MX))!5<5\MZ-XSL/$3>-M(EO=61M1MY/"^CWFR8Q7=K<0.MA=:;'(@%V(V>.X
M>4!E*`@D"OK7QYX=\*7=E`?$<27UA#$D\NG>(#:E&CB0F*S@,Q*3.C+F./RF
MR,+\IY/RH?`_A3Q@/%OB;2=5U?PMXAT-=1OK*..3[UE80/+:Z9IUG/$8(&OU
MB,*"`Q;488DY!`!8U2#Q##J/A?X?>&_&VJ:GXJDT:$WL-PT4,<FG6>X/<J%C
M'V<1N"&9L%A\O:OYN/\`@XF\+2>&=2_9$EN[>WMM3U;P-X_NK\6[.\$DL?BF
M*+S8Y"S[_.8-+(25^=^%P*_HA_9EU[6?','B/XF1:#?Z5JD=S=:%IFI^)GM+
MG[2MDGDRPF"W+;(]RDK;-*N3G?(3R?Y[?^#CF'5+?Q+^RC!J5O+$S^"O'EV+
MG/EP7<USXH1YVL[3=)]DMHWRL<0EE'5LC=BOF.+_`/D15>E\3#7?^1=?\NJZ
M6/H>&O\`D=4NG^S.S[^YT_#OU^7]&W_!M;_RBX^'_P#V4WXJ<=O^0Y!7[X;E
M;CKM7D?D!T]Z_`S_`(-LCM_X);>`,\'_`(67\4R,\<_VW;_Y/6OW=BO9%E:&
M>#8'W*LR992.<#=ZGZ_RQ73PU_R)<N_[!U^AP9K[V8X^7;%3_%MFI&R.QVK]
MWC/?/^3Z5*P8CY3M/J1FH+8QJBJK*3SZ;CSW[FK!/!/;G/X=:]X\T\%^//QR
M\*?!#PG>>(/$IGW&VN/L"PQEEFNXXRT2.X'R!I,#)Z"OY$?VG?VB?B-^T'\1
M;B77?$MU_;TVK[/"?A/3F>6&WT0RL56X:+*K(T+)@N!D\8R*_<W_`(*L?&W1
MM$\!1_#6*PENO%5_Y]W;OMQ;V]D(R!<R2`'KU()`SSVK\$_V8M#$FK:S\1=3
M2WO=8_M&TB22\M%DL[*"VF*Y\PX*"0#;NCSVR,<T`0Z1^Q;\1=9T6YU_XB7N
MG^'?#,EU'J-I:2E!K-_,2N!#&2)'0@C<FP@D<^E=?\0/V&]9TGP['XJ\(:GK
M%QI,FBKK#L\4H(NH"B_9$X`P-W`5>@].O[8^/O@CHOQ:\)_##QOX>MKM-4TB
M2SN[Y[.\:;1KNUBC$D\/DIM5<E2`C@XR>3787E_8?$#X?7L>F+IUE'HCW&D:
MMIMIY2SQR6Q,:BWM>!+)*T9R53IEL<4`?AE^Q+^T[XO^`OQ%?2?$^L:C910W
M,4DVB,942\AA;;N$;'&"H.Y@.E?V#_##QQIOQ)\#^&_'&E>7)9^(=,M]114<
M/Y+2H/,0G)^8..>XX[YK^,OXQ_#V\NOC4]W96;V%[9R_9KF/;MNXK.27$4[X
M41JKDA9`0"%/RU^W7[!W[5:^&'L?A'XQNK(6>E(MBMU;/LMK:Z=?W,(4D*C%
M-A9.F[)4#-`'[7+&TI*%7,8?=O9BIW`]`/[H]!5H^9S^\4'Z`X_#UJB=1LA9
M?VD;N);!HA-Y^]?+\M@")&?(0`@YZXYXS7@/C3]I#P-X'\1?V/JM_:);1VD=
MW)>&Y#!TE1741JGRYPP[D#D9]0#Z*$X+>6`69<9."!_^OKC_`"*D$BEV0,"1
MCCTS_C_GMG\WO&/[>_A^RUNVT[PO;6%W;SL&$TUPJM+&'4,S<G:`,X_'TK#\
M2_M\^"(;^*S37+;1+IWB#)'Y=P)9`%>:-)"3D%00N#QNYQ0!^H`(/3GG%5WG
M\L#S?D)?:N/FSSQCZCGBOR_\/?\`!1WP)JGBO4-.NIK'2M!L['S+>\N;H>9J
M%R%`8&/[T?S9Z'IZ9KW_`.#W[9'PB^+FK-X<L-?LTULWDL%E!+-$J7@B/SF%
M]P.5((49R1B@#["\UBBM&N\EL$=,#N?Y=:G!R.>#W&<X/X5D$PRW<<ZRL$A1
MPR;BJG)7)"C`<>K8/;GDUIQJB+\IR&._).<[NG)_2@"3`/4#\JBEF2!&DE=(
MD7DN[*JX')Y8@#CU(^M39KX"_;B^*^M>#/!O_"-Z/)J.FWNN.B0ZM9_(D<8/
MSAI3@IC.6((&,T`<Y^U)^V?_`,*VFL=*\&R6;Q3O>V>K:I<LH>RN(XW$1M1D
MB4[_`$SGU'?\C?%G[7_CSXCZ!X@T>U\0WNHWUK?*VRYF>WNI$9SO:R4X+)']
M\JN1P.?7Y&^+'B_Q/-J-SJM_XI_X22PT+45AFM7Q.8KR<L?.E48#Q$\9Y+,0
M1G%>?7VG>)KV\368I9]+U2YLC<:.MK&B07WF`91-G^KX.T[_`)LX[=`#[=A_
M;'^)7A[3=$T:?6Y;E-,E$%JHE8S2"4#S'NMF3^Y(.02>,9Q7U?\`L\?M\?$.
M'Q>;/6WL]8\*F^1-7F?(DL8!&&=X2Y#.J9W<`]Z_*U-"N-.E\+V5YITTUSJ%
MO-<:X%2.:<[DW2,9E.Z`Y/)^7(QGW\I\0^+[;P/JE[JND^(;JRM5O8K>?3HD
MQ*C/(L1\Z0Y38RG!VCE<@Y%`']NG@GQSX>^(6@6?B+PSJ5MJ&F7BYC>&1696
M&TF-P"2C(01M8<CKT-?"G[:O_!+G]ES_`(*`^(O!^M_M*6/CCQ59^![>Z@\/
M>&M,\9ZCH7AJ"2]8&YO)M+LALN+Z10(A<LX81_(,$9'&?\$R_&6AWOP]O/#K
M:T+_`%IV@U6*TWY:&SN8D;S%B&%50S*/D'0GCK7ZGIR,E<')ZCG@XS^/M6E*
MM5H352E.5.:O:4=&K[V(J4XU8N$X1G!M<T9JZ:3OMW['XW>!?^"!W_!+?X=Z
MA8ZQH/[.=L=9TQQ-8ZK=^,/%O]H6TXD$@FBN+/5[-A*"``QR`ORJ`*_6CP5X
M)\/?#[PWI/A+PQ;7%KH>AVL=EIEM=7UYJ4MM:Q#;%#]KOYKBZE"+PK332/C@
ML:ZS&>HS^%%.K7KUYN=>M4K3?6I+F^XBCAZ.'3C0I0I1;O:"M?U_KJ%%%%9&
MP4444`%%%%`!1110`4444`%%%%`!1110`4444`,?I^/]#7\U7_!T]_RC+U#_
M`+*9X:_])[^OZ57Z?C_0U_-7_P`'3W_*,N__`.RF^&?_`$GOZX<Q_P!RK?\`
M7RC_`.E1-\%_O^']?U1_DV?Q_P#;;^M?ZC'_``::?NO^">_C.54+M_PL?1U"
MEU6/YO"%BQ9U8$-R3QQVK_+F_C_X&]?ZC/\`P:9)&_\`P3Z\722R,H7XEZ0-
MF=JR'_A%+/`8]`.^<CT%9XB'^V99*ZWQ+:=^E#EZ>J:]&;/^!BO^PE?H?U%0
M+(TL\(FAM!<$K(7=C]H9E7$<9PJK(HQMQT``Z<U%?:'J#S6MQ/+,T<)CB,<+
MXD=0Q$4DC'C:@QOX^9?O9/3<>);KRHF:-G1I6M[CRED2(G*O&XW`"38%\IC\
MV>5]*>69I$!S)%;%8IQ,7VB.557;A2=[9Y^8D@Y&:](XCF[H01321J386R7$
M37$ERP6*Y=&5D6V$H9`S*",1;=Q.1SUQ]1ACCMYYK3S'GFN/M$8"33R3F1_W
M*L0<1+"3W&$')[UU5SE%C@(D6,7<DB1W<$,^T+_J[B&0$K'$F?D0@2YP,X-6
M[BWNIW0P/;J!;2[F*X7<Z8WS9ZK)]\*/N-QT%`'G>IV<DND)"8(DC9UFO;FZ
MA8)#?0$2XD4$R,MT'6+<!C]T&(&:Q]5A-X(8/LDMIITWD/)=VKI/-(R+EA-"
M,F)%8?NXP%WJ`2*Z\VI87:3WUXCVJQB0-$AMR`7+SP)"4DE5E819EW*!$!DX
MP,BY6UTZ`7=G!</)J%S$GW4RDL8.R:9=^&MW'7;S&<9.*`/,!;PH)KG3[I+B
MX9[HB*X1H&C:,E983"1NC:>+>[!6W,N<#->4?%'Q%H?A#PU=3W>I6UJMII]Q
MJ%Q8ZEY<]O'$5#O*(ILR;=Y2.WAA(WLP!.[@>W:G`;NUU61Y;2TO=-FDN;6.
MR`$DTLJPJMS>$E4E$;,?EYQ@U^27[?7CC3]'T74=6CFO`VGV?V.6%)5N+!H0
M/.N[R^EG0PI;1RYN$AW%,X!`VK0!^.'Q9\;0>(_''CO7_&U]>OX&\07NIWQU
M"5[N&5FA$>G6V@Z=:($&EW!F@0?9%=9)8G#R;E<5^95_\#M<^,>N:QI?@74%
M\/>&1<S#77N7A5K*.&1C9'4E9HREL%#!)=\C)*YR#DX^O[:\_P"$\\6ZK))?
M7=WX8EU'2-0LK\L\6GQ10K;WLVKPQP9MY+F>Y\ZW$:QY*Q!\G<17VIJ7[.FB
M_$[P2G]DZQ_PA\FJ7]E+=:OHNRVU22)9GEN!-&T6'>:((5,L8;!;C%`'Y0VO
M@K0-.\&>%-`T7QC->36MY<:?=76H!;N._P!4T:Z9)DTN<9-E_JB@1&5)D`9E
M(YJQJOQ"\9'5;/3'T:P\0>&('87Y$TT!AF,GE0@038GNYH$19!;VX,$GS_,"
M1GWWXH?"VP^$;7'ABVM=1\1Q6NJ7^OVNL6T=M;VMI!"R_O46ZW">YD7S6U&-
MUB,CNWE@J0*QM*TGPY?:1IVLZC8VTVH17L&H6=W<P@?8[":'8MH1;R1"2&24
M;[M))%6)`GE#):@#M?A#:6.B6VF^-+/3?$S64Z;/%%GIVGXT7Q'>R23Q+;PK
M.YELH&@8!E&2IB<8YK?^*G@*SU#2[R3P1X4:]O=8T[4&_L\3275_INF3VANY
M%MQ,RS"_M9D%Q9Q02X21%.`I(JO;^%3X<\$2%W;1O"5M)<:K#"OB"ZWRW1!N
M%>PL9E:6!&DD?[/^^9=K(&)7%>&Z1XTU'6=3?3-6TSQ%>WD,D&J^'M1EGD@O
MEM6E$!MK.U@6)+ATMP9)[B=)5D4,K;D."`<!J[:A?Z9HGP_U'5]6T*\AFM8[
MVV,D\YE'V5)9Y]6O+,,ND7M\I,`0L460J=VX&NNTK2YM+OX-+\):%:KKL<EQ
M?WVJ3_:-0G@L;&"2`WGG(8W34FT]V@FN(@5D?R97)<`5[%XNUGPEX/T^ZUA=
M-T&T\1^((Y=,>[^R/J*SWL-IYELT%G*RVL<4N!&SQ1!H[GYAP..+\*>.HKW1
M[R773''XHNM'_LO[3\NG7FCV]TZ1W$;((]LK30,'0QMRN&4%E-`'W;\'/VSK
MX^$O`'PLM/%]X]W'>V]GK*ZCYL#VDA_X]F,UM"YAM+M`(K9GD$C3+M)!-?HI
MXYM]8^,?PX%CJ^E-<-"@NK1[?SH=7GETZ-UC:[CE(+B\4>3"KG=/N7:03Q_-
MW\!?&'B"V^+UUX+TK6?"EMX6DM[/2Q?Q7-_=ZR\R:DOV%M66[B,,D%NQ9Q+;
MN)9')1V*+BOZC_!T&M:;X?T]UMUN[K1;6*?[;]H^UPZ[!/"D?V2U@`A@<%S^
MYWE%M79258C-`'X,>-]"C^&^MRZC?>%=7\(:/::G;W,MC8QQKJVLS7*&&"*]
M@`,EI%)*VV2!"&E8`G()KBO'7ACQ'9^!-:UV[GTB6;6$M-7.EZ_=-`^GHEZ8
M[:*.&*5[FUU2:.:)=V$BEV(&.U>/NO\`:0A\/WGB#4M=M]0UJTU"\OQ9:DFO
M:I`MXNJV[%]0L-&AE@9(TM(/WD*7!?+8\N1"!7YQ>,_$?AG4]3OI8KA]7T]M
M/@T`)J%^T&JW5K&`[O+YZR0B_BN%(6XC8IM/&,@4`>W_`+-'AWQ])97F@>)/
M#UR]C>^%;R;2]=O))KN>.!YAYVG7<L;OYID0[(R0R^20,CBONC1_CQX-\`P>
M'XM*T6"UU?0-)L]-/@B19[C2I3<Q/&VKWT@A:*7S.<;"9[;&60`<_D!HWQN\
M2>$;^V\!V_BF]LKUKF:^T>PAU=M.EM+"-X?(L4UWR91*D\7#:=<1"WGDW;)5
M!X^^OA9;Z_\`$&VM-<UC77N=?LKJU73K=[Z"UMKE3*$N[<7%O;;8M5"_NYGD
M#1X(\L9H`]F\;_%#4M0NM1TCPV;"VTG4)5UOQ!<37JE[14*32VMLQP4AC3=]
MF6,J^0#P17Q%\2_B]X3\,^$M&O\`3=>O-9L]*\4W/DWMQ=3VLUCJL]R[.NI2
M3R)]JMXRYB2%8Y7E^5G!7!'UMK7P1T[Q;XHF\):M;ZCX7T_7WCD34EN[F+5M
M/N_E\VU=PR6U[:2`LT=P"%V\!>:IS_L,:-8ZQIFE:O:V/B;0XUEDTRPUEI[C
M2K^_8.LFIB12TZ:PT'"3.Q`/W6Z4`?&/A+]L[Q!I>K7=QH.=7L6^S1WL>@7$
M.Z"SDDVR7,TKR+;I&L)DDO%$B3B)<I'Q7ZT_L^?MZ:]H6P>)+&RA1;:SCM)X
M+J5(/LH=9$MQJ#.\#ZAJ%LRB6%<(#G[M?GCX\_9K^'?A7Q3'9Z!J/A_P586%
MI/(GAFYM;B4SZH@+F82S20R7B!-\1W-)AI-G`.*^5_&0TWX?Z<\&GW>LZAX<
MFU5XYK6\74H;N;!\N#4;&=[B**S%E]T6>V2.4``R$#%`']Q'PV^+O@;QCX>M
M_$>G:O9->O;QF;1X;Z%[N&XN$3?:QVTDC?:,"50TB`F,$L!Q7JTMQ;:G<6OV
MIEBL;9(G1EO@EU%*?N0JC'>&R.H/S#BOX[_V:_VFM9^'S^%2E[)?Z5#-!)_:
MFJ>7IPL)9=RVUU,T[NVLS6T0Q<^2JAXQB17P#7]&'A'XNVWC&ST:Z;487U&Z
MM(KC5+S39G>T6(0K)'=):#:ENTFX3+,\3A494&%&:`/L/Q/XZ33WM5M;BZ2%
M\VUVI@7R[95/E2-)(^7EN8U_TC+#RPHR#BOGQO&U]-X_?P+.ZK#XD\)Z\8KO
M,4M]BWMC-+)YX=UF9PRLORJ%Z],UP@\5RRZOJ#2:H;V(?:+&<7J+<2W?VNV,
M<7V*"!1"AN<A5DRS1GH>HKRWP?%<MX^UK4ULYF70/`OB9;>XO]25Q#+=6&UD
MF(B$]P&Z.4?RXQ\BE30!Z_X9\'>'[W54U.RU-K>:TD%A<V;SJS&_B15^UM;P
M$A;MUYBD0E06)88)KZ/M=-TVS7>CR273R0"4SVJ(;4PJ!!M\O"*F=W3.223R
M*_+3X:Q^/?%>H:E?SZY9^#=%\-7K3RWNFV\L:K?Q+F$W$,D\KW=C."J7:RR)
M*8SF/GBF7G[1?B#P5JNJ^&-<\1?VG8)=13W5]+/=VYD)<RA8IXX?/L[,H=UM
M$@F)R0[8Z`'ZB>(S=ZGI][8VU];Z=>;[BVMK\F0&$K"7@F^7<JA_X^,,,]!7
M\U/_``56_9UU.S\.1?$/7I+KQ3,^H_V>]MH4,\GD7$CJ([VU>#,Z)DB6YD*^
M2BABQQ7ZV:%\8X?%=HEWX?\`$?D"_M9;NTBM[U9I7M[%3#J<ER542/(9#F$3
MY?'!'6OD3]IO0#\4_!FG^`_$$_B:XM[BZO)?[;TNX2Q2[B:/"Z/>S)&S1"<%
M6_=D!,[<J#0!_/-\&?BGJ_PY\4>%_$-U%;Z9J^N>%[S0;+3M4US3K.T34H;N
M;3=/MKJ.XF2\EU.9E2X^6-O+0QDC$@K^AWP%X1TKQ'\)=`N[V.?6_'$:_P!H
M%K*^G\Y-1D9%N%6[576.`,2&2#",$R0:_G;_`&A/@=K?PQ\4_P#"*ZWY>M:7
MJ#1W6@>)+P1:=<>%)K.ZANK=))UMKF7SD\I+>ZDA=)[F-5D?[]?H'^R+^V-:
M^!K>#PQ\2]6BTG5DNK9M"U6:[VZ7JEF[I&Z6F8=KN^0R13R12.22P^84`?T4
M>!_#R7>B:8GB":*ZN=-L+&S>%IS(MI>B4[6$X52P`4Y&%#XW$;C5/QA;^+#;
MW*>"9[6.X2_190JQRS[(LLSIYLAD,FT'8O3)X6O#=.^,=OKNKV]OHWB9XM+N
M].BE:"&"WCCN;NU09DG,9,D;R@%UPS(H8D9'7J/#::;-)<:S?ZQ9Z-J$UR9(
M;6376NY)K=79EOO+D*K$9&X*[3Y:G`!QB@#<\+V/Q:U74--TKXA:@LEI?:I-
M='48G:RCT^T9HS:6LH<+YMZT>PN.$3&<_.*^B+FX&A7]M9_;M1U"QM1=M+:1
MPQ--Y\$8$5W'*CY?:GSLJ$[R!M'->-M\8-%FLK&QU/4()K.]>3[5?1M%,<V^
MZ"VM(KT!#\T@`\P1$OQ'N(C`'H/@+7O!6M:MJ/V@BX:S$(\B:Z6W-O(L&)%C
M3SA(VT%9C=!X]N/]6>A`.K\(/HOB^>>74[%+?3=*OY;:"]OY46_O7),BSK',
M$D\U%PVV8;T^X,D9KJK?489->UOR)4O+&PMX[:TO+L+;W0"(6>.*(D/(J*/D
MD<!9#P,XKR[QU8:+/'9I8ZQ=P3_:GU"R>T47\6J"U38;34Y9W4I([J9([E`7
MV,%;/(KR?5O$EQ:!-;U&`Z=?2/B)+QKQEFT^$")TG,.<`G<\0N05`!$6%/(!
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M7/B?1=46*_T&)X-/TXV\WE6\`$VV2W+1M+=R>>1$!A2XQ&.PV[17\JO_``<W
MW=MJ7BS]CZ\@B^S//\//'CS1&Y6[</\`\)3$,M,N!D]TP-N1CO7S'%Z_X0JM
MO^@F%_\`R1VO?[^VQ]!PW&^=47VP[:_\`U^?Z>5C]_?^#;13+_P2U\``GG_A
M9GQ2.?0C6[?I7[VP1K&,$;B?8$?AG%?@K_P;7_\`*+?P!_V4OXJ?^GJWK]\$
MX(]P?PY_^M^M=7#?_(DRW_L&7YGGYH_^%',%WQ,_O37Z-@4C5S)@`A>G`'?D
M]O\`"H4D9M[MC8#E1D8*]GY/`QW/>DDED+[(L-C[X(Q\IZA23VQ^/KT-<OXP
MAANO#.M6D>H2Z4;FQN+>.[MMWGV\I4D21E6&2AZ*&7CC(KW3SS^=+_@K'XKB
M/Q&O4A"NT6COIBW<DL0@,KC`C1W9<,IY(4=>F>*^4_V,QIEQH::9K^C7^H6F
MGRK>ZI<FSE&@W4499UM;F]\L1[GY'4?[Q!S7AO[8&OWWC[XQ:EX0US6M8U`>
M'O$$EE9O*S-=:I-'-B,M"QR`Q&&+;CC\Z^MO@)\1/&$'AR^^!.G>!E:#78`M
MWJMY#Y$6GS+&H@7S8PCR2.W(Z<YXH`^B[WXJ_&35'U[PK\$+";0/#IL;JXM]
M)F;R;6VM;9<7+V4KL0=RCY0K*6'3%>7^$=4^)9TFP\1^$[:6;Q?IVI7-U?64
M<KBPO&A8K>/>;F,,K<2$%@>>1TKW#P+X7\8_#W6I_!?CO4EO+'Q-8B2QFA"1
M'0;6.(^9$+E06'G=-A8LW?K7/^%-5\1^%?$?B+0-%T?^T]+EM+VUT'2IH&M)
M;VY:9C]LFE=<OYB*&X_U@).`30!Y$FK^'_C1J'B)(]#O=*\5W6+36?$%O;,+
M*TN%^62%YR`J!)CM!4GU%<`OP[^(7PF:]BC\*75[I\MZ-1E\2P.QFN+A&VC=
M<9YW*BF,@].W.#[IXL'C?PIX?CTRQ\/7%G?^+];BU'6;+2;)$BL1`RL(;B8(
MK0QR.N)-S#?DDBOO;Q5_:?Q+^"?@'3-:\,6GA.^U&6TM7CL-DSSV<+11S7T[
M0#S(VD5.&8%0<LSK0!Y3X4_;(EN_@7<Z=KLMW;1V%O)I=RI0O=DHNV*!I=VX
M%2,;R><U^4/Q%^./B'Q-J&L6VG1ZC>:GO%GHMI>R/Y4=@!\]Q).Y^>.$=AD@
MC:!Z?8/Q/^!'B/PE;^-C8ZPECX<N5VZ;82E;E[^9$RMS$P/RDOWP>G6OD?X;
M?#CQ-K'C*QC\80P0Z9%%)917%P/)LIWO!YH:2Z&T+(=V_P"\2"2I`[`'B4/@
M/XB:K:0>);;5-<-VUP+9D+R1PW5SOP18Q;BWV.-<J[`8(!/K7&ZCX;\2ZQJE
MYH\<FN.VBZM&TFLQB<JEU)M1[:V0LTDZ,Y8%P-HVDG'?]>-#_95\=Z]IT,7@
MC3AJ<FFWL\D&I"_=H+"T(8>39Q([))O)&7)#<]*[6#PGIG@+P5=IJ/P_M['Q
MWX5$O_"0ZC=Q[D.US(MS"LD9$\TC)DD\G^]T)`/S&\-?LH>(_$%[*EQK.K0^
M(KBWC&G6D\LT"SB2,;5>)L>89-PZ$$9QGK7B_C'PI\7_`-E_Q'9ZCK<6J>%'
MM-6$VD:Q!)<)OEW`(7&_<(I"`2S#!^E?L]X%\:7_`(E\4^&M5\<6FG:?YLMG
M?:!=6MLL%W=6%E(CRQRQ)AE)AC(WY;=Z"O'?VP?^$7^(?CCQ'KU]<276E:E;
M-::+H^KIN@%O!"<S6D+859(R`ZR`!B0/2@#ZG_X)N?MQ^(OCAKS_``[^)%W-
M>>(]/TUO['UDY6SN561%`N.0IF92",EBP!/%?MLLIC\MI!(2BK$PVC#.V?FQ
MG&WC(/OT[C^'+]D7XG^(?AS\6!IG@R_FGMH/&5N@01$78@CNDBD7<,L(4#-P
M&(''7K7]MWA2^DUKP_X>UF:3;=7NCVLIC9CL9Y(49V88P65B0.`0">1Q0!V2
M\+^9_G7X^_\`!2K7M2AM;?2[G54L-'DMU6W\@++>!W.)D$:AI5WH2%;@9/)&
M*_7S++"1"%D89R"Q4$GKC@GJ?I7YV?M[?!_3_$_A"'QMI]E=R>)-*`BW6R&>
M%X6'S":,G:=O.&"9'7'6@#^;CQ'K/@[P_IM_H%OI[W?]K&VDDEEA8W;M`_F(
M]S.-ZKY9RW)W2$A3M%6TU^'Q"FF6'A^[6RTS3X5CU+4+Z!K>&&64#>(;N0%`
MP(V[590..N:Y_P")%W=R'5="N)+;2OLEU%,&@ME:241NPF^U3C#1^6S#]UP6
MZ9&*YF?7++3[?3H-,U5M=TK5XT&L:4(HA;V7V<KYEW!&QR9'()"%3TSO/2@#
MZ8L/[$\)^'IKUG>^>Z#QZ[=SS^=/;%0?LAM)26!@NP%!,1/N`*^6_'L6ASZ;
MJT>GQ6VKVNJ7,.K79:#9<6<H<+]E@)R[@`EAP`6XKO\`Q%X_TC3O#5PT>HV^
MJKJT<">&[2XB"3:7;68VW<=\L2LH:1U9;/<G4CFN4\,>$+WXAZCINJZ98ZCI
M,.IO;VZP7`)^T3;P@>"!54%78\'`Z^M`'[N?\$H?#MA%!J^M2VLL=\='L+>R
M:0,)/L?EP_?R>B-A2,8!(Y[']M5)`.<\']#TKY0_9$^%5O\`#;X2^&%O=,MK
M/7YM*@%]<"-8[EHBD;1QS<9PQ56Z]A7K/Q3^+7A'X7:-/J/B+Q%I&DSF/S+6
M#4;E(FEVCYPB,=QW`$#``)[\T`>LY]C]>/\`&HY)EC`+!R"VW*KG!]\=![U^
M3_C+_@K7\!O"]S);6R7FLF&WFWRVJ*L3WD/'DQ,5=61VSARX(!X0U\_0_P#!
M;SP`DCI<_#_565;CYGBD.$M`PPX8QD,VWYL%>V!ZT`?O*&!Z9P1G/]/K2U^<
M?@K_`(*>?LV^+K+2YCK4NE76H627;6EYY:O&255HQ@C<ZD\@@<`GBOLGP1\9
MOAU\0=-AU/PSXDTV^@E1'VK<Q^9'O.%61020Y.`%YS0!ZG135;<JL!]X`C)[
M'I3J`"BBB@`HHHH`****`"BBB@`HHHH`****`&/T_'^AK^:K_@Z>_P"49>H?
M]E,\-?\`I/?U_2J_3\?Z&OYJ_P#@Z>_Y1EW_`/V4WPS_`.D]_7!F-_J5>W\]
M'_TJ)O@O]_P_K^J/\FP?ZS_MHW\P/YFO]1G_`(-,BW_#O;QFRQ&95^).DL\9
MV!65?"%D#DN1P&&<+ECC&.X_RYOXS_UT/_H:U_J2_P#!I8B3?\$]_&J,%5?^
M%CZ42V0&&/"=GDKD<D^F1U/-+$?[WEWE]8_]-Q_S-EK0QO\`=KPM_P!O-I_^
MDH_J+TN9Y([D3PY0$381?(C=O-("989:0*%^YE2,8;.0.D2WMI(_]6R>;L9D
MY."O*C]>??(YS6<LJJQB@M$E98@\1D?#XQ@O\V0%W=N@()[\RVY)LRTLLL33
MOL7#^:%8,?F1U[9&".F>,UZ!Q$7V<HMQ!)<1A9)P4(`4(RD-L=#D%"!G).,X
M[T7T,,CX=)93Y3';`Q2%Q&F?WO*#![!2>>#3YC,?-VP;&7`%VWEON8<9$66Y
M.,?-D<Y[4Y0S1@W&8IWC*EX_0#.&7!&&_P!A`1[T`<IJ$$D5GYRL\5V(6>,Q
M(LPA@<X6&10PD>+AB%^?#LQ*\Y;G;XO);VK*$GMA$?M#R0[)+4'`>8019)"O
M@E(]S8P2O6NVN[>=0-@-Q-\NV=76*6"(\^7"`.7`^:0LARK*.U<]>6$7VP,;
M.)+:*>.XBNH9F^TRW2H1(NP2!41N1,&/[SGY%ZT`>6ZY82S&XDN!Y,HLI8[!
MT:-8-1W',<BM&P5)),A)()@LR(20,X(_GG_X*;V_C+3_``1XMU>]GET^QBN]
M/TO5_"%B\8DOUBBFD:"P@`DN+J"_B*+,^Q9=_P`@8AB:_H,\5>9HT6K6J:;$
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M);E697\JXX);^@;1-??5+*V;4]/N+:9M*DL;"*]M(Y#YEL/DDN!#Q)"-JR`C
MR)7."7(P"`?,_P"T7\&=#^+=A8Q_"N75]1\2O;ZF\JR3QJEQ!*"S65W&\BS6
MXN75D67[,SVX8.-X''R9HOP+UZ[MH?!.NZ+=6^JPV]O<#0OM8E,5[IA%RE@=
M2BD$.KVM_%E&2/\`>VNQMRJQP?T]^&7PQTKPWX[\4^*-3U*\O_%NO_OGGMFD
MBT=8/)588X-,$CR6<C1.(\0L<RX=CR17KWCGPC?6'A%]=L-,M?.FN([?<+:U
ML+G0Y)L&XU2.:2-7DN5MP]O/Y9@,@DA<X9#N`/B"X^&^C>+/`T&@^)?#-]HM
MNAABTZSE9VU-I(Y5MI[=Y'?S4TY77$%WL&Z'R^,5SNN?#KPYX!725EM9?#5_
M=V<EFLL"I?:Y-IUIN$T>GR/!<J9'CD#M(LD<C0[U6/>!GM/C3X(UF/PYI=QX
M4U_7_#MIXF@DN=1NIM3GNM5MA9I'%;11ZB\<IL[>XO%^TS00HZE'V(S;BU<Q
MX?\`$9TFVM/!OQ!\2VWC+QY>6FG0^'K[6+?^Q]3@MKMV2YL[02/M83JWEC4U
M'F+]]D!!H`_/SXQ^%;7X@^)$U6.?6+BPTR6;3Q:6MFEC<65R8RZL(+E[62*>
M.,%Y+J..1&4DHV>*\1U?3->72IM!TFPMX1=16]I:Z[J-XNIRR"">3_B9SW<;
MSS2-;Q+S;O'`(V4C+@5^N6H>#-$NM*\0:_X?TO0Y+R98M$N9_$&KNUYH>IZ<
M"NJV^GZ@B[+Z!P3'%((UD8O\QP,5^7OC#Q=\._A7=^,(_!VG7TNJ6T]_J]SI
M]S+>:_9I/;HL^I6$@9-Y@NHEN)+6&V51$ID,G5<@'EOP;@8?%'PP^A7MMJ=Q
M:ZU8V'B;Q#XBM;C3[S[983L\0CTY;>(RV+S9VW2J(F3:Y<U_7]X#\7:;HGPF
MT"\UJ\T]?M>A/#=,US9_9K:Y\B9I8K2Z+F)[AW\J6*#S!(J?[0P?Y/\`P7\2
M_&7QE\?:!-X>^'.FSWFLII`MXX+BQM+34K7>AC2&91"]LUO;[E\N682)M.Z-
MS7]$OQ#\.K-^S3<^%M3M+*S&EZ,USI4MLWV>6QU>WL7DD@CNX%,<MXD@VK=&
M(Q_+RWWA0!^!'[8/QD\>Z!\5_'-K]NDUY]NJ2^%(M1L(6LM,NKR1W@U,W$+A
MI7E0_9DF59?+!0MC@'X2\`?%6X\=^,/!/PT\1W-I?6=[!J%UXCM[![B.2UOK
MA6_T:[U206LTF+E028EV+M\H'<55O4?C-K%UJEC?ZAXDM=-N]"DU.\MGN[^\
MNK/5;.;3Y";*YLIF;?L:6/,B>8+<M@LC*>.#_8UL[77?BUXEU.[T"WUI=0@M
M]/T"\UJWC\M+=9R'G@O+?=;P&[N'"-<(TI7RT95=\L@!^K7PL^`VB:LKQZ]:
MP^([DVEKI^D>?8QV-Q;K(,Q6&J><J3R*J%5MKHL6<8+E22:_0S]GKX`:]X%G
M\<^(-7/V[1KR\T98O#MS#BWLM2M541S:=9JQFLGAC"V\C)L@O)B))7&<U!\'
M]#L;WPGX9LKC55:_M)"E_,+!3/$PRGV=[J;=<W5M$!Y:2/N\L*'#]J_1+X61
M^&?#FHWECKE]8O>!(;>74-0)NH%BGA^T2R,/.#7$F[$D,@:3R]H5T1>:`.)7
MX3:WKUKH/B5[J2WL+&__`+7NM)U;[*8KJZMC^YT.X)#W-C;`?*7AN!E&W%"5
MKO?&?ASQ3I<-MJGA_2_#VJVMO+;ZHEM)YR#2;&$*\T-M-/&JW@LF=UWHY+0J
M"0>E>R:C::1<66K)X9OHKC2C+%%=7EI<F6.>66-98;B"190+=YBRJRR1RJ,$
M,K8KEO#/CG6;%]<T#Q)H=S<6]@TEC!`]I931ZA936S"+4([Q$1EGVD(X6!E9
M5((SDT`?G/\`&3X*^&O%/CBT^)3>&%\1P+8ZAYD<;7.H16.K!,27D5E#B*2R
M#/O4"1/F3!0&OFKXM?L_>&?B_P"!]0T7QI)J.E:C?:5<_P#"&:AIUFMH^F:]
M9!KBUC@-H#]M^W,$$EC=H#C*[CUK]%M7\3SZ-X6\46=O8V6D-IV][:,7+VM]
M?VVIW0021E5$3RQD[6MXU)X'(KB;:RTN7PFEYK>C+H@G>WEM+]]1*BRUR*(1
MEWBVL5O9'^99E?:A.)%&:`/YPO%7@WQA\,?^$0\+^.Y].\77>D:K;:R;K[3/
MIFBS33&2VL+)X_E-M+;R1^5<IY@0S,0\>SFOU?\`V)OVLK>?Q[J]AJ][J-D(
MXXK**PU>WC?^S]"U`V]AI\<A#F"\6RD;?;7-O+L>U(>4!@5KP+]KK0=#O-%\
M6RKK+S^*]-2[N;:U:.UM+R^^[+-'9&ZA:R=%CCWPS;7E:4EE7<U>%?`/Q2MU
MXD\(7LVL6VB++);WUYK,<-O>O:)<1I;Q:7J4,<*Q1VRRHOE01>9'#,"6,>>`
M#^K;3K*>\N)AJ4^FL+VS>T2+2[5Q:O%"H,%S)?Q2(4AG7#>=%*CQ$G&2./*]
M7U=-"T[XGV&F@:?9Z=X+\6/</;-=7D\,!TD,)+2ZND;-L)M^W=(>,.C.,UZ;
M\)=3CO?AUH4IU.WNMVF,=7BN9;9)RBQ`13I#&?G2Y7#QQ*\:J#C/6N:^(5Y#
MJ'P]^+NI>%])MS%IOP\\96KM!<A3=+!I;&VAM(KJW*.TXYE9V:-?NV[JIH`_
M&'6/VQ$\&?9]-CUWQ!8Z)Y-C*-4&D7']D:\%C>0V][J,4;:?>WT3VTEGL\Q3
M/)*B3%<G;Y5XH^(OQ'\:$>,&N3X<A_M%KB/5)7G@D;2KB7S#;+_:$SVF1"YB
MD",%3(BCXY'@^F?$[5/&>M36FLV<'AWPMH'AV22UT1K`:O-'JUNTZ3:E;:;>
MB:TL;>YDS)+$?/$SJ9;8JQ`'T1H&HWVL:!)X<\3Z[I]IX;O=!9],6\TS2(_M
M4D<ZRLEQ:*ZW5LEP[F8,ERKV^U5YS@`'MWP"\;>(=)MK'5K/5M-OC/!>/.+5
M;=T,US(P15T\R22VI8\SN$^S.?F5B`#7O%W\4]8M+K2+'5!+%+=P326]^\UK
M):_:I6:2.!K0B3;YD>Z/S(TP5`PWI\R?"_X::)K5O/XETJ#3X]7T]K32(;FT
MEOK`7NE6[_N[*XC>4-$D7R[;F6.1KM5RCL&S7V'I/A?2]/L(YM;TNRO/$FA0
M++97[(LR3VI#;H6M2N8H8BQ$,V7DP`-M`'EWQ4^`OAG]I#PL-&CU:QA\8R7D
MVHRWHN?*EFC.G^5#!N$?^CW=J-OD[$9;E%!<!C7XR_$OX$?%WX%:CK2ZYIFE
M>--%B%O_`&:]_:R+)NM&$+P_9_+\RPNW1?-CN3`?-*EG=,@C]O8-7MM%U*>\
MM+6RL(;B6T@N@DAFGU"2178`6G^CW,43VYBC<0.)?W>Y7!^6OH_P_P""?"'Q
MZT40>,]"N%^P^7`D,"SV8U"%>([E;S$MS<);K\O[\[P3LD#*0:`/YO?!/Q3\
M=>#O%&G:IX0\:7ML3IED]GH>JSI/H$,]W>3B9WN(KF>96CE\VV2UD(3RK=5#
MD8![KXG?M,_&O3F?5K#Q+HWB(I9177B.72S<VL5G"+@P6P5'3Y;2Y`D$MON2
M0.H.X@@U^LOQC_X)]_`,ZM/?W?A7Q#J5E=YB6R-S)I4+6QE\YV1=*BL)@;:X
M`:WG#EHI-Y)<.37CFN?\$F--^(QE\7:9XCUK0]'66QL[72-,W?:Y=&\A4FMK
MB*\%R;F?@AI93,9U;<IB<AJ`/B[X8_M'>+[/QSX5@\8?$SP\=/O-.CU4Z2EE
MJ(33]%#FZ5Y]B.T$MH[8VRQ^:XDW`,F#7Z_^&=?O?&0LO&GP_P#%FD>)Y]52
MV74K72M6MH;M;69`S/9),\6^58E5V@N51R@*,%R0>!\"?\$A/A5X-ADUWPGI
M@N?$2;1J2^(['^UM,U2U>!D?1[ZQU&::7:I;S4DAN('A<NJ;E*B/S76?V./%
M?PR\0SW_`(7AG\)W4-];:A;R62L;&*&.3'EV5E/<.196ZKY<5LQ($1**S<&@
M#]0?"7Q#\16NBZ;'?:>-5U.PWR7V%MMR">4^3*T'S0AS&58A)2K,2`O(J"&T
M\1^-?&D]UKS70\'V\;72,EO'96B7:6S((KEUN/,*LQ.0L7EH1G<,XKX@\(?'
M>'5KN\\":[K-E8^)[.>WTV]UFQL+D:/J4NY1%%<6D:POIUU;(`+@AW42D"%&
M4@U]B:[XCU&^\%:SX9T@6NISII"V\T>GR/$OG1HDDLYU!PLUI^YW-C9(Y8[3
MCK0!%XVU;P':>&;+5;`W.G3W.I2:1=31W;6VD0_853S;FYNX"Z'[2=J(LT8,
MAX&1N(YR[\2>';7P[97&GRW-W:76IV6E7USI6=1CU6)I%,6FW%J(SB*2ZQON
ME0NJ?ZML8-?.7Q5\2:MX@\.Z?X1AGDT'2M&*Q7?AC0]9CU/4KV6:WQ)=7*W:
MLHS"3*CK&K*^6.=@(^@_V1M+\+V6J0Z-IZWNJ:)I6B>>BZ[M=5U+FX@66XD=
M&N;JUSM\^%&1G7&46@"'Q#\8_BKH^D713X=2?#70IK@Z?JFM:I<1W'V_3X79
M(KF"WMXIFCC,`#6\+H'?*JX5\X_F1_X+L?$2+XAW/[+EY#(;NTTOPEXZTVWO
M9X'M+B^>+Q,IGNWMY%CDB$SXVJT:@J@(K^TWXBZ)_P`)-X5G2WBT_P`Z\C$T
M1O+5)(6-NZJ6MYE#I!-;YW_O5)8C!!'-?Q^_\'%WAVQT#Q3^RRT-LT5_?>"O
M&[ZC?_9DMX=1DA\211I+;QPXA,2`LH=54R$EB/7YCB[_`)$-;_L)C^+BOQM8
M^BX9_P"1U#_L%[?W?Z^X_I(_X-L!_P`:N/A]@=?B9\4\^P_MR`<5^^*\IQU(
M./U[U_-%_P`$`_BK%\/?^"6OP[VK:2S/\1_BO</#<2A/,`UVW*K`,Y<NIR!U
MQZ]:_=;PA\?O"?B+3?M6HZA;:')OC2)9I!'&\CD;D+,<?>X/<#L!77PXFLDR
MS_L&7Z?Y[^IYN:)_VCC_`"Q4O6S_`,_ZU/>%86ZR37`\I5;D\'<#TZGIU^M>
M0_'+XB>&/AI\/?$/B[Q#?Q6=AI&E7]\3YBB1V6V+Q.%_B`?#$$<\"JWBCXP^
M"O#FYM0\0V2"Z@:[5]Y>T9(P?DCESL)R,D9&">*_`;]O+]H_QQ\:O%T7PX\,
MSQ6O@^:^MK2^2W5G&JZ*'47"S$$[`ZJ.2!D''2O<///C:Q^"OB7XW>,-?^-=
MA>,+?5_&3Z]I>HS$6YGT6.Z9W>WCDQN5D&.!QUXK[C_:C^(NF_#?X?>"/^%=
M1:39ZIJFEV$>O^(88E.I021JD=W.CQ@E9QDE78YSTK<_X1KP_K\OPV\"IJ3>
M%=%T+P^L5C#HC"TN+N80*)4GBBR',K@[$?@L2/6OD_\`:$\-7+:Y-9QW%];Z
M#IXCM+FTGA674KV.!]I,=HN5BDG^7+IABIYH`]Z'QT5_ACH_B&6+4==_X12Q
M4W^JWG[RZO9YRLD=S.3\S1H4V!03E>HKZO\`@E\:=`_:,UGX=:[?:!9Z#'I5
MNT%QJRVRZ?9W&HQ0A+2"X#*C22S8W#KDG/>OS^^&EGJFJ:?HOA!O#,XM#=VZ
MWOG*R6_V%L&!+\$"/_5Y9E/S#/.,U]Z>!K+X1?#E=2FU*=+MA+%=:7::3=%-
M(T#4(5\MRZ1D[W63Y%R>H!%`'6_'/X0?%;XK^)]2\._#/5HO#]S'=6W_``D"
MWEN]O!<VSRH!)8S[,;?)Z[,;B<U[/\1/A7\0?@[X*^'UYX2N$U*\T22RMO%]
MQ=3![6ZTZ0I%=VT"2[U#LHDV[0"6.>M<3XW^)_QPTCP1IGB#P'IL&I-JTR/;
M:M<VQEO-D3KL*EMKO"D(SGD$CIFO7O\`A;7B[Q)X/GT[QF+*/6+KPVE[H]BL
M2?\`$VGBB#32;"2-ZS(VW=@Y#`>P!\\?M!7_`(4\1^%]!TW0/#VNZ3?W5W:H
M9F@=+=))I%%W)+-)D"T4LQ7G;MZ`5V-]\!O"/A_X??:?'EYI7_"`+IUM(ESI
MI22_O-9N8D?=%<)C;L8L`JN.,#T`\)G\1:UXVU/7+/Q;IVLP$>'WLM)MG8Z=
M9(S`@2Q%5\II`1\CAMS<<9K#\>Z5XRTGX,:=HL/C,7UGI%NEXGA&YG#ZI`FW
M?YKNS$L$3A=X)XX/-`'N_A;Q[9_!+3X-/\.:Q;67A74;BT6QFU&[$ERL=PR\
MR1EO,.<@`DX!(''2N#_:/^*5[>_$FQT6QG\/WEGJ>E6DMYJ<H5-/21HD=;75
M4'S-<29+'(.T+EOO5^=EWXZ\0^(Y="L]'T:_U:_2,R32:@KO;V\-L_\`J53&
MSS`Z?*W.,BNM\-^*_$'B'Q)#J9\+6FGZC#=))=Z;K)>XT^^FC_=-)(';Y&18
MS(%+!<X%`'MWBGQAX7\+ZAX7UC4;JQ/BF$S06]K`1_8PLGC*NUN5P(UB7]YP
M!N`.>*^2OVCOB%;^-O!$^F^$IXO$'B"RU#RX-4TF-G6S^V'#1ML&^-`6`9CA
M>,BL7XC?\+&U_P"(UG=2:$D^ER:O);Q:A!;Q_8(+>0>5*B01DK''&NX)GJ!D
MX)KL]/\`A3H_@/QI!>1:BVD:;=:69H[:-7<Z_JMVO^D,(G0H5M@3Y:J"%`&/
M6@#R[]E#X'-8:JOB37[J"TUC2=2L"LMN5S=2SW"23I*IY+XX.[N,U_6G\.)-
M.B\&:&8;PM&FG6Z1M-,LA5Q&GF*N#D#)&5/KCM7\ZOPWNM%T.<Z+IVGS->ZA
MJOVZYDOXS-<WT<;,S26VWB)8B1P!NP#Z5^J'P%\3GPY8B[2?5_$3WLQW6K/)
M+IMD)&Q%`GF@+$`-V[!X*`4`?I#YJQ(C'+EP"H0<<CKGKSZGCK7*^)M1T9=+
MU"'6XX'LUMFDN([I5,"H00J2;_E$C#.`>3^5><>.?C_\//AGHAU3QAK5GI1@
M2Q\^!I446SWKI&BD[L87S%'!//XFOPQ_;U_X*"MXCUV[\!?"7Q!->Z+:VPN]
M3U72HYEC,^W=%#+<1@IG&,`MCVZ4`<Q^UK\*?A<VK>*-+\'P6]E>>(C+K4MR
M]W;6K")G9[JW3>V8PN01C`V\]:_+WQ=X&\.:+H\;V6LHFO>;%%IY@N5:"&T!
M_>)<2*VV61L'!&[(ZG--\,V/Q8_:.FUQM0U#5(Y+:("&?SK@2-"Q*E0ZC*!N
M"6)V_+@\D5[9H7[)>O!8=*U&^N;J[AL8KI;2[4N%5!G<DT@`D9NPC))Y'7J`
M>!^"X+O5[R2WL)=,U2:SGMX[^&YV1P"SW`,T<LHV-(K9^Z1USG-?O3^R);_L
MV>!O`\WC/QE<V-WK^@Q27/V*\BBEACN((S*J6>X;2`1U4=1G-?G!X;_8H\0:
MWKDL>J7FI^'/#UOIBFPO;"WCMY+R_G(_T:=5_>3@,6VL5PHZ5T>E?L]ZGX'U
M#4?#_B?Q3JNII#%<16NA%Y8YEB>,M%-<M&NR3?E<JV/D)[T`?I=XS_X*Y^`=
M.TC7K/PSX9DEU>QL9)-.#R1FWD,1\N#*!@57;\P.,<8/6OP>^+_[1?QC_:E^
M)%SJ,HU/Q'J&IR)'IWAS3I9Q9:;&7VA-JN(@%7DA1DY]S7I^I?L>:X^@ZA\1
M=;FFNM/U"^^RV%CH[M$MA9I,<M<+@O+^Z63>?NAA[5]3?#JQ^%GP2\#VFJ>&
MO!YN_$E[)%#IVI1[9[ZZU$84)(QSY?[SH,#..>*`/F#PM^Q-XMU_PY>ZUXUU
MBY\(V=I>V>-+EC*W$D]W@'$3C?Y(;DENO7IS7>>+?^"8_BFSU*.73M:U?Q'9
M3Z?;:G"NB,LD:120I^ZNXD&[<&D!9<<8SC`X^M?AGXZU_4[[QCJOQMBG@\.0
MK;SS?;W6";2WY^Q2P)%\TBHIZ.ISCZ5]7^!-'^(>HZ=8^(?@/XWTP^`=1627
M6O$WB*_1[IB2%\FVMW8&"*!#Y*I@!E;.,T`?@OXB_8V\?_#ZSU'6O#NJ)XBN
M],=I=0L'G+7&D!LYM6B4YB=5R#N&`1ZUTO[.7Q:\9_#GQ:B:MK.H:%IDP$1:
M>[E>T6\5AY:K&'V[O,&`N,?2OVCO_@=X:M/%/C2ZU?QR-&N9M+FU#6;Z-3+I
M^NW,ELTK1B1AY*,[GY=IZ=*_"7XK/HJ>*4T=+.2/3/[=GNQ]G;=+=_8+EFMW
MC*<JDCJI;:`-O6@#^P/]E_XGGXH_"_2M7DF>ZN;-4L9[Q@?]*,,:@3\\Y?J<
MY/3K7T;7XL?\$V/C+JUXP\*:E++'!J$$4L&GM:O'#;I&BK&T3X"LS*!N()SC
M)Z5^T]`!1368`<D>P]3VX^M>1_%;XO>%/@QX.USQSX^U:RTG1M&MGFV-,JSS
ML,^7''&6RY<X4X!VGTH`]:>18U)=U0<X9R`/Y]!WSVZUYIK?Q<\!>%[J?3]>
M\4:98ZA`AF-G<W,,<SPD?*Z`N-R]"3Z9QFOY[/VF?^"KVL?$/2[C0/A987FF
MVIN1)9ZC:7,EO>7*Q2DH@[NDFP!MO7)`ZBOS(\3_`+0WQD^)&N6^M>*KB^&J
M6*-:I&SR;C"Z%8DE:,DY;(`W=3Q0!_;-X?\`'?ASQ-IL6K:7JMC-8S,5BF6[
MM]KG)'4OU/I_]8GKD<NJ,N'5N0RD8(.2"""00>,$'!S7\1.A_M8_%/X:0_Z;
M?>(=)LEN(H;;3EGN722:5@//\MQF.,9#9P!CO7[9?L3?MC>.?B-X@T3PWXR\
M2FSTE8(9Q=7,B$2*4.R`.YS\V5#8^Z3@\XH`_<FBH8)HYH8I8W62.5$='4Y5
M@PR""."#V/0]JFH`**0G`R>!2;U_O#IG\#WH`=11FB@!C]/Q_H:_FK_X.GO^
M49=__P!E-\,_^D]_7]*C]/Q_H:_FJ_X.GL_\.R]0Q_T4SPU_Z3W]<.8W^IUK
M?\_*/_I<3?!?[_A_7]4?Y-W\0]Y?_9__`*PK_4?_`.#2K=_P[Y\7,KJDG_"R
MM+V^9G:['PI9J%/;/IG@GK7^7`?O#_KK_P"S&O\`4C_X-*(RW_!/7QF1-Y)3
MXD:6=_&`5\+69Y)X''3WK'%MK'Y2M4G/$Z;)KZHG\]=?4Z%_N^-T_P"7ZZ=K
M6^[6W;4_JE26Y5V\R`JI\N+<J"1V)8JV0I&V,D?=QTR>O%#Q2HZQJ(TBV,F0
M?+97WLP**WRD\C.#US]*N(W#QMCR7"1K*S<RR-D@JP]2<#IC'K6=J/D1HR&9
MHXXU8@'+%I?EPJ$`DG=Z<Y]Z]0X"1G`=$DNXT(<3/DJ"ZC@1,>A))!R<\TV[
M8R07'VF&2*,$#=`[&5HVXW1F/+J2#GY<9'3VJ1K:+-:I+N\RY'FJI3=%-+@C
M!;D"3^+9GMTK8",94.!N/$<H/X;"H.,#'6@#GY"T2-<Q>?>1PJOE0PVS_;"'
M`0-)+-M#;<9<#Y]O)."*Q#`BR2W8O+B5+7S?,L(H@D<T[IN=9&()VJ"`7!R"
M#BNYOHMR`ERQA`<Q!F"O(^5`=@<J`%!&#U!]:Y1B\*W!,,<LD[,B")R3)``2
M3M<A25YRR@].N:`/)-:\JY=94A+VUS,D"1S1-)/'<M$=UH)&VI)`R_.DD:L%
M&4D.XU\!_M&?">[\6^&]2GM;2TDU^Q$R6FGZE!/)87VF22[;F/R;<@QRA2JP
MSX"1N"6(!Y_2*YN[FY4V6P211_Z2_FQLTCO&?W45LT2YM@B#+$'+MG<>:X>X
MT,:^?M%S:FTEL?/B%RZ^3)<03Y(MY`V3)#O`,@(!*<]:`/X5_P!L3]G?4_@?
M\28[KPMIC:#XAGUA+F\O?[.N[Z1Q+#_:<.DV!T=)WD$[3R>2JB.(NC&616!S
M]I_LS?%D:^GAPZ_KR6^J7>FYO=*OM1DO-2Q8DK)=OIO[N32I4*'-O-(]Q*!Q
M&<$G]:_VQ/V1]:^)KPZIHVI6=I%:?:]1T>V59+/4O#VL0.PNWMKN)'>XTG4H
MXW_T&[#[=P,3J)"!_.5XQ\#?%+X3^.O$.K>)7M=#72Q<:WIM]H>C00:A)!#(
M((-3UJ!V!NI(6WF,A8HY(&8RAB<T`?N1J#:R=#U#4O">N6A\2W%C!J6A7M]&
M!=W;S#<K"VVATMUVA/F!.%;`)XKY>\=?%WQX-&T_PQXWU][R!;PQ27%A=I:3
M:CJLNZ66)YI2D]I9&4QPR7?DL(T4@9`Q7RI\*_VDO%":YI4E_P",O^$@U[3[
M1/LEY-90:/((F3SH[-(Y#+#,3&P6!`AC4L"AS79^*O'_`(1\>M>WOC*_0:E)
M?1QW$$!M!+:@3$G_`%`C:)FD91(L_P`N[+)PQ%`'K_@WXHG6;RS'BRV&FR:?
M:MITD5R]Y>>&XUM)&E%S;W<D0M]26.!1YUW&$R2&",17A_[5_C7PI<II^I^'
M-1M+KQK?:/-IWA#6))3%:AK19)(IM&U7RRZM%=;8I;6X197CYR$Y'`:]^TI;
M:`VF>')HVT^#1[,6MK%>:>EYIVK/=7DD*!X;;^*6)$#/D,PZG%>*?&;Q1X#^
M(/AS7/MFI#0/%+6LEMI6CZ9-%9:=#),T<5MJ&C;B9K6]^=UEM8V:5G*MUXH`
M^?[GXM_%&:*QL=3.OQ2Z5)/#?7RZG<7&G2:K+N=HH]/T_?&LTC#=)>R,5D4C
M?@YQXGXB\/>+]>\5:$QURZO-8\3WEI>Z/H>EW2PV[7GFO!JUOK%U;^<9;UK"
M0_9MRK&96$+D%L5VB&WT.S34[-+S2O$-Y%;V5SH(L9KRZN(H8_LT-^UY$)&A
MO[WB.5(8BL3R>8^237VE^P_^Q=\1?'.H07FI67B7PMIM_)K.I:QK5]'++<:$
M9G:73=/TC2YX52X@>0"65[61F=WC:7;M"T`?1W_!/GX):1XKU*\U2:V?PK%H
MU[<>&--U&=)B)=1ME1Y8K&YN+<27&I!-\<@CB:,$MY<N.:_=7X^^`XKOX,26
MEY977V;PK;PQ6-GI[QV^J:O>R1;!'-M`*PSQLUR^\,F%9B,9KIO@K\`?#'PG
MLO#=_96%U-<:7IUFUA::C;6B#4-3N%"76H3VEN2XO9FW2-*H4H"`V>E?0?BW
MPK8^(=#L[!KN?3==GN+RY6T^T^9YDDL3JOFLZD12PAO]%C<XQ@8(H`_A@_:5
MTN6;Q'KWAW2-.M-1U&W>^O98;A;"/19U@B9T$:32(9K[<WERVENRSE\MY35X
MW^RWXUUC16TBY@L)(SH6K:AHFI>');2*PU'2X+F02QR6;N%%V+>??+:6<Q\U
MHV+QL`M?II_P4/\`V;!9^.KB^U?39UT^TU'4;^T?P^MPPN-04,6N9-)B*R7,
MQ8AFEAD&0K$<9%?FCX1EG^&FM:.WBBQTC7-1O+NUETN:6SD-U!!=RM;1W-UI
M\10+?+!*&M;N=3Y)B99C*S!@`?IK\,_CQI[^.]9\+ZEJ?BZ[UB)5@T+1K.VN
M(Y9DO&2&YNI)558XKFV1B88G;8<!Q*S?+7Z;?#U]4\!1SBYU%-2T.Z>,:;-X
MCO8SJEI%+#EW8QF><W"RLUJXFQ;W)(59U.<?G%X'\-Z!I_A&Y\47?VR+Q+</
MI]I9>*].NA:7D5I'<"6.RN(RCJN96`GQ\I;J5K[0^%_B^UUO3=/LUTOQ!XBU
MA[#4-/N;:01N]W;V]SN@LS>2JEL=/F<_(K?/*Q(#]Z`/M3X.>,]2U+4M1\-:
M=_95CHMS=P75U!=:FL/B">8DOYK:8K[+.QBQ^Z1F:4J5)`!X^HSJESI][>Z1
M-9P`V]BMSIFO12?:8@A3:GVU'B+2[6D*A$W-@YXQQ^66E>.[7POKVL7_`(ZT
M.Q\)K9ZM;6::]';>=<3VTL:#^SKY+!GEAN[4[$-U'R^0"N":^P_#OQ6M?&'B
M;4/!@FO[&RL+*2\T_4+EU@6[T^*VCN9H9I1FX3=$V^V8*&P0&^;-`'"^._",
M=IJ`UCQIKEU;M;SZC<6NFW-G)=:)<>>=UK<VDD>)%D1L%()ON'.!7#WOC+P%
M%%!JWB7Q-?:7H\]K);V7]IR1V^E#4;D8N&DBF"[+F9N=J>:XSPN14?Q]^(,,
ML^GZ'J'B.TNO#]]9W46D"SBDU![)8+=II+K4;]B'4*ZB/RU7<K<$C-?S9?&G
M]H7QQXHU0>$@^NZ=X5\!>([RXM&O=)OO*LFM[Z2SCNKN'599/[5FGGC\]C:/
M^ZC*N-J8R`?JE^T-I%AXVSK=K+HMTNBLNG0V%MIUU>0:@)%DDAN#>O'$8;EH
MF282`%2JE`3D"O@#X>6FG>%?B7;K:Z%"6N[>SOUM9TO$;3]1^9KEM/M&9&,]
MW@-Y=P5@)(:/DXKYF\)_MH_$O3(6_P"$SO=2U3PJ=;%O(EMI\VK74VCV&R;[
M?>B)HWLXK&52C/!S%;$@YVBO>]"^*)^*&M6?B&\M[C4))];@ATV/2([BSGFN
M9V`75(=4#NYTX6VU8H=75+</DQ8/-`']%W[$ESJGQ7\%7]C=W]\\45_=Z7IM
MI=:=<V.HVMPK%;R#5VF<1R6Z&6(690EU"C8<<G](O$G@@V'PU\?:$UB\EH/A
MKKRB^@E1K^:/["L!2:57WW$;LKB*00JT`;]YR*^$_P#@FYX8NM2\.6>I:GJ.
ML//I>IW0N!.X72KN^AG4B*9!(DLUZ;4"+[2/W3.`5[&OTP^.MK!IGP<^+FNV
M5U_9::3\,O$WV6>0)!):CR3(Y%ZN7FDCG^:1)0`5;UQ0!_*7X^T74O#_`(DU
M;4/!.@ZK_:^F65C_`,([H-O:V<?VK3;J\C6\EFU&\9+6_L(I6F9K61EG4R-Y
M:9Q7H7P@\"ZSJ^O:+;WGAV_UJ[U&"_GEGN;-!I6C3:A(?MT=L[!EC6)AY1AE
M9HU:,NF`17SK;?$3QSJVJ:GI%\\FK[I9RL=I&+6TN]+U*>%I91)&LDTFI6TB
MK-#%(#'@$Q!'.:]<\*_&7Q)\.)H=(6SEFM-3M4\[1[V^-M>6\,$X6_U6)W5G
MF9^"8C*S<-NXX`!^F=O\,XM!\+Z,EM>1V-_!J"VEY&B+JMSJMJB$-<2);L(K
M5K0KBT51\L?W:Y4L]AK6H:!>75[>Z??VML\4E]J;VC&4ABB6.Z,R_P`(`M&8
M-G@C)X^;+KXU^(+2\MY?#URL.GO8I#=8N[1].M9;\J+6PN\MYTR7RGS"IV/:
MR#"OCBMUM5\7:-!%JUNMO+!/="2>[M)I+SS6"<&>&Z9HTGME(4!-AR=W)H`^
MA/A+\-_$7B37+ZR\7:/>PVT.KVM_8:U<NQMQ92[FMXWB9/-26-\P(T+E8]I+
MJ,BOT'MM/LM!N8-%LS+$MO9O:#5ECDFM=K,K21"6`!$G=B`I(.<$DYKR/X07
MFL6_A[0;S6[QKEKRRL+N2%W1X$WQN5@@"?ZMVRC3DG&1@'BO1-0U.:"46L6L
M0Z?=:G<N]P+HPS6FS.(H5`8.+8@CS"N'+C*G@@`'KLFGV\\%E<:E:7&I7%K(
M[7()>YEM[9T,,0MHV!%S$Y;<\*9,9.7Y!QZYX3TNPL;2*WL+&ZAM[)(YEF9?
M+N53;OD9;+);"N2@E5BP48`KQ?PSHGCRVO=*M[O58+6".!M/*+%YMM=33#SC
M*^6+C+9*R*P#`CL:[!/%/B31=;MF9+F6WBE>POYYXYHXGM(R#_HL2IA55\E7
M);([]:`/>3ID>H6ZS0,AN)F25&,A$+6JA@7D:0)*TX;*R>8@Y90&KP?XS^%-
M&FT6ZUJ2WO+._L[&XC$\,8N&\N)6S%%_K&9!+B28[,K'G!P*^FK*'S[4:C8P
M+*KVJSM+,8DE,>"5$&.RDDR"1>>,<YKS;QVIM/#6H:C?31`26E]O!1Y,QS0N
M`K1Q_,N4R"X`WCG-`'\U/C?3='TKXFW&K:!/8SZIIUW!JVN06UY)-!J5S>S"
M!)[*.1$22Z2-A,]KDHFU6ZJ#7Z#VWQ,T3P1)9:O<VFI:C#=6^BZ/=W&F6Z7!
MFMIHX9+N[U)I1##;)"T@AF;]X0#_`!5^9WQHTS4W_:>$-K>V\6CW%M;Z]I.F
MQ74P436(ALMZVMG'#OB>68!UN"^UN)-Q!-?H7+X5UKQSX9\,^%==T2ZM9([N
M-M):)&L]&DO%@207NHR'#W5MSO,6_P`MF4(1@F@#Q3Q[9Z=/\1=/U[X7VX\0
MZO?ZW*=6;1]4L9;G2+1%EG-H1<S1Q7<DL>^)XMNV)`8R>1GW/]FKXJ^'/$EC
MXI\1:GJVB0II>O7VARZ3:G['>Z#?Z:[[M,G9DCB2XE>(F9(?.CW,PC+)BO"O
MB]^SPWA:Z\/16^O76G:KK&L)*UYX:LX-/CDO"I#0W-I"7FM[6]4-&3;LT;;=
MQ8,:[7POX/\`%NCVUGX;F\`^"M!O?$<MU#X>OK#4%:ZU5$B47.IW^G,[!M;M
M7W7'VBX8"0#RVY)!`/T-O?%6B^-M#T>WA\8-;V]X99ETZV#(^HI=`)Y<31@$
MM:%=I*``D$D8K^3W_@XGMM=T[QY^S=I&KW,4^G6/A#QI_8,9GDFNX+&;Q(K,
MMT[?+EF"LBJ<IR".]?T#>%_B[X(^'=Y%H'B.#^S=;T:"[DN'UIK.SO[BXBF%
MK%J=I$Y&W3[IRSI]G4I@]<@5_.O_`,'`UUXEU;QG^S;KFOM$]MJO@CQ7<:0M
MO)&839MXA#),D0;?&)E92I<_/@D>_P`QQ=_R(JNW^\Q]?L]O7K?\[?1<,_\`
M(YA_V"_^V_Y'Z$?\$B)O&?\`PPE\)9-,\-ZG/X7TKQ_\2+K4-;B$KVC3#5[3
M="D:9$A'1U.WKW'-?J)XR\<:K-96/A;1;"U\V_,MVT]XPM?LBR?-)(6+_NO)
M&2N<L`/N\9KP+_@@SJL<O_!-/X?Z)JD:VFA6?CCXKS-)(JB2_O[G6K9((;4[
M2967H!R2>HZU]*?$'P;:Z+8^*;"VU"SOM6\31WMV\NJ3+:WOAZS!.Z"-';>D
MDD1(3:%!R,')KT.'_P#D195_V!1_]*@<&:_\C',7;7ZSTVV7_`/G7XH?&WQ9
M%\.;/P.]O;3HTTT,/BBWF:]>T@#;)96>/>0L;#C)`(XKQ32KW1_!]I8WMQ::
MKXXN]1"OX@\0VB&06MB`K#[)'NVQR'("H&&/[W:OI7QYX"\(>&?A9IFJ^&1-
M+I5M8B75XIF%Q>7.H"/<8XLLSFV=SN8$`'/M7B7P@T[6["#3-6NM4MF\/>*M
M0;[)X8BMEF:U8SF-!*Q#/'%@C*XVCMVKUSS#UR#XR?#C3H=+32M%U?4-;U*>
MVFLM3N(FAO=#TYB`XF+X^9,]!WP>O%?2/_"L?"OQ2U#11X3DFU+5+:33_$6L
MW][&9VGTZ*,SWZ-<(7$"JH(*NF,X!(ZU\\?#CP+X,\._M"Q6_P`6KEM1T.\L
MGUA(H%:ULOM$CY32(R2BL8R1\JCMR*^QKOQ=X4\)KXL@\,:E'X=TW6K"[M=#
MTS30)-6O(=I$EK)*#YD4;1GG:3Q0`SQ'H^BZWX3MO!OPPCM_^$GUC5I!<7%Q
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M&J1Y+75M$<`LA@*I'CD?-@<T`16?C#PO\:=#F^'5_I4'AY/#(@B767,<-WJD
MNF8\UH+J,;\3%#@]&)P0!S7SC\<OAU<>)/%/A_4?#^EWFE>%;/19HM4N4NFE
M:_-DJQJUY(A*)YH&_P`H%LY()!JO\:/!'C6UO=)U[PIIFJ>&KC7Y8[`P1^>5
MLY&<1RW?D*N!$&8N=V./6OI+X>+KGPW\(M\,?&4=CXE76I[."Y\57DD2B#^V
M8EF:6`2$L&C=MRQ+P.G:@#\>+WQ9X@^#GQ=(UBRAO_#VKV_G>'[:QVR&-67R
MB)4R`H#D.X8D$9R1T/U'X9\0:-::!#J6L^'+;4=;F::\FOH7C-G);W1<P((U
M("-$'V`D@L^>,#->J?M!_"+P-::F+"$6^L:OISQ1Z)J.3`]Y+*!*]N%52LA`
M.P)G##&<5UO@?X8:'!\+O$>N>,M&TB+Q"ML+;PQX:.H"TEEM8T<QWEW;[U=&
M24(R@H=W..IR`>$^*O!=UXFT?P]<^#/#FJ:+:27EM<:I>LLLD)O!*)(X'A//
MD3/M1B#M*'[Q&:[34;#4M6TYYO$GA?2+O6_"EO+:V=GIL<<+V\3(!<W!DE)4
MR;2"@!#!N/EKW_X?66M7>@:-91Z&^HG4[86VLLMS)!!HUK#D?:;8,%2<HH&'
MR"`"0:^>-0^&GBG2?%VNZFK:IJ/A6?7I8K&U^V2[[BYF;YDDF#'-J@``RVWK
MGB@#SV\T'5=#T#2/'.@VROJ^DI>K!HD$:RZA:6[[B+O5$`8LCGY5(9P<CV`]
MF\/ZS^T5XL\%Z%/X8L++2/#S6LRW\SP'3IY]4D91%%M9`\Q8EO+93A0#G!:N
MCL-,U/P/8>)#I'A>R_M[5A!=:V^L:@M_86NBVRM,R"=RPM#L4%8TY9_E/`K1
MA^*/B/\`X1SQ2ESI\VH^'])2`Z==:/"UK8V.I3P[[1TG5=DD43$,=F=VT[O2
M@#RCQ)^R9X_\0>%YK[X\>)KW7=2NY[C4-*\.V4LWV<):QFXM(+Z;*!T1U4D$
MD*1@9P:\@NO"_P`&_"_P_L?!4FC:/;>+?%EZ\4ZK#!/-'J$S_9[=+FX8>8L:
MG!55+8SSBOK*X^*/Q)\;?#2#1?%]T^FV@E.FMX@LK0M?79FR5BMI(8RX/DE4
M=P>2"6YKQOP3^S7I.DZE)\2]?U]-3\/>$_MNJ_8=5D8ZD9+=#<(QCD)=W9ER
MH/?U[`&=X4^%VM_!?P7K'@;PMX;T;5?B3J\<%]KVI--;PIH_AV1FD>6-'7<Y
M5!%B-4&=P.[`->[7&I_"V+P_X(L?LFH>)?B%H\((M+*U>.RN9)@KB-[Q/W<G
MEN#F-O3`R*\I\4>*?$/QLT>U\:?!Z=O/U&9/#.NZPR!+C3["1F@(O(U4D!%*
MJ.AV[3D#-=9X)\$?%GX"1Z3J>OZEX9M]&LM6C9+W78HKB+6[(E7N);>2<EHY
M41F$9##K@"@#Z#T[PGX<U'PU%X[U;Q-=^&M=EU6%[VUNP2EC:V((CTZRTU@I
MD$C(`\P53W`(//F7BGPS9W_Q#L/'$;&XMM0MIEGTR2,27%];K;-%%>)"JLT0
M=L,-VWKS@9KZ*\0ZO\)_B?\`#K7?&VAE+&2RE@C@U&>1DM9=0+K%,+.+_5-&
M'+,V-V!]2:^5+3QQ=_"FXU[4M>O+7Q,?L:O/J\L2/9QV+K_R"X""PM95B/RL
MN&/4\F@#J/A_I'A2\T;Q;X1\0ZWIK:B^EZI+I-B)8@^F^:SND;)*8Q)*BR99
M0"5[$D#/EOP<_9D\!^&K#3_&'C?XJ6,^EVGB(ZC#I$X\VW25+IG\AV)4(Q``
M"D=QTS7E>LZ#X>\5>-_"OCKPCXDU:T\):]=R[X[,%EL]2:/S?L-S.K;I(_-.
M0I))50NW&33OB%I/Q*T_Q-I_A#2M/2?P'XCN8I)KC4VCM$26W99+R[4R%716
MP2!D*1QZT`?;GQ]^%GP/\9^&%\2Z1K-GHEQXBU+3;6_BMW5HM4M;8!(4M[8L
M`%=>7).`2.O&?F[XUZ+X;_9B\,Z9H7AZ:]U#3?$5I:S0Z3!J!>2/[3MF>ZCB
M@D58T4`EQY;8Z8/!KR/]H+1_'/C>/1=$^'TSC4="LX$AGTZZ$&EZ8MK&F;V6
M16\N4DCDD')!YKD]<TW4=%\'Z%K'Q*\8W'B#QE;:5)9I;WB":TDD08MH(902
M%WMM1"/O`X-`'W5?>*O#E]\#(;MA'J&E:UI(FOHK]5;4+"[,*P1A@")!$I)`
M8RG(Y*\BOQ)\1P>'8?$6HV6AZ2VO:G-.]E]N:(K%I<LLVX1VDDAV<J>1E2.>
MIP#T]U\?_B&FH67AC7],FTNPUJ"5+#1[(.':&WE$:BX.`JK+@.HZG.>37:_!
M3X8>+_%/Q#C2_P!(ECT76M4METU_+<RV4RR*QGF`R7&"5&\8YH`_7+_@GCX2
MT^ZD^W/-BY\):=##]E%MM47%XBL^;K`$QBP0",J.Q(K]<G&5(SC..>>N1C]>
MM>5_"7X:Z+\.?#-GI^FVL45W+:VO]H7"PI')<RI$H^?:!T(S^->IR,$C=F("
MJI+%CA0H'S$GL`,DGM0!Y/\`%_XL^&/@WX&UKQQXKO(H;#2;2:6*/S$2:\N4
M1FCMH1(R%C(R@97.,\8K^/7]IC]L?XI?M8>/]7T2[2XA\/:Y?RV?A'PO9O-*
M4B6X\J*6\6(F,DQ@.>7]3BOJ3_@JS^T7XH\:_'^Y\!>$_%H_X1GP991:>^B6
MUP?L=]JDA?<US"#L=@QP,YZ9XKK_`-C?X-^!?`OPSUOXQ^.M$TK5/%FEV0U7
M2]-E:/[5?3W!*R):JV2I1&,V(T.T)TZB@#R;X9_L7Z1H>DZ-K?CA-6U;4+(Z
M?<3V=@DB;/M$J,+.)=H#NF_:^2`H!)/&#]MW_P`'_P!G/X.:E;:1XITBTU#6
MO'UC;:CI4!OK9[O0C$HGBDOH]V1L8`,G)X(P36_X%\4:'\1["Z\4V@N%MM.A
MN!I>A6%V\5^U_E@UPZ'_`%OD-]U7&/EZ5A>"?V7/#6I>)O$/QT^+GB34-4BT
M[3I;BS\,ZUJ+VKVL<+EX&!:3]Z)GV1K&JA>O7I0!\U_&+X2V/C'P_P")_'-Y
MX?M-+TJU5M+\.W4-NC1:K<6X*6[H`@42.5&2.W(YXK\]?@WX[\4^'_'47AO4
M/M>C7=E?"UM9T>01^1-<(R^4HVM(\C@$C:`B'ALY%?LOJ.H>,_B1X<U_5?LN
MFVGPATJRNX?"FAVMNOG)JJ*R).\JJ&F=)!\I.0>2:_!V^UK5X_CI82W8:UU'
M0_$4-LUC*X1OLTUVN;ED'WP,*5##@=.O(!_<O\"[[4KSX4>"+K669KZ71+-I
M7?)+@Q+Y3G=\WS1LK8QP?7'/G'[0O[8GP._9KT^*?XC>*H;;4;LR)8Z+IYBO
M=2GDC[/;Q2[XD9B%!;!YY`KXE_:$_:SE_9H_9'\(W^AZVEQX_P#%>@6%OX=R
M4EDLO.B027"P/ESY()`PN%"Y!S7\^5AI'Q,_:K^)8CFU&[UO5]5O5>^\3ZG=
M.]E83SCS66*-SY<"Q$G*+@'`&*`/V-\:?\%K-)>\N)/!_P`/M232-/F;?>:H
MZVPNX\[4V>8Q4;^&QD'^5=;X4_X+4?#:0V%OXN\#ZWIMY,D4NISVVRXM$@<#
MRWMBLHWEUP[#Y1EB20<@?(<G_!*2XT+P`/$NO>)+CQAX@\TWG]F0W+Q:?*B_
M,BB$.%FQCL,#'?O\Z>.OV'[NTL+37]"N+W3/$%Y$\']C3R-):VOE$@,L3/@*
M=H91MP00:`/Z4/@E^W'\"_C?-!9>'-=DL]2N-GE66J)':L3(,HH9I<;FZ+R<
MDCGN/L=95;&,E2"0_!0X./O`D'/48X(.<U_"(^K_`!*^"7B^VL?$-Q+H^L6%
MW:R:;<6I>);D0[3'(#'M^4\,5/';%?U`?\$Z/VH+[]H3PA-:^)-8^U^*?"EH
MFGWL;/A[M!)B.[:'`PQ4!6;GIUR:`/T\?I^/]*_FJ_X.G_\`E&5J'_93/#/Z
MV]\*_I3=L@X_AY_$<8K^93_@ZCU*%?\`@G!-IWVI5N)OB-X=E-J,,[1K;ZAF
M0C[P`(Z]!QCO7!F&N%K16ZE3F_\`#&4;_<VO.WS.C`J^/H>6OW-'^4+_`!_]
MMOZU_J2?\&E`:3_@GWXSB79A_B3I3.'Z%/\`A$;$@`;6!;V.!QUK_+</#^N9
MO_9B/Z5_J2?\&DA'_#OWQF-Q0M\1-*PX7=M*^$;/J.,`A>>>]98NWU_*._/B
M/_437]#>+MA<7%_]!'Z17_#G]5'G*8XHDDCC<[]AV_+OCR5)&/E3/'`)R.E*
M[-''^^9))9$`A3:&VS,.G*_QG<06P2#TZ`TUW$3R131G8@15V#Y/-#EBI)'[
MTLN[;TVGBHK..Z1+<W5PK228E8&+)G4("K-G'E%`0OR<$C.>37J'`7A`R(L`
M=5E&)RQ4.89<CID`;3]WKD9Z5(99$C"2D&X<L=\2?)%W&]C@J#QR`>3Z<TZ,
MM--.7DW(F%("?*,8(&X?,S`CIC'O5AR<%I"C1,NP*B8<L<`,3U]CQTH`R&\V
M9VA$,F0/GNHKB/R?-"AT5R&W;"""`4!)W#'3.5>2FX0FVD*_9CY?F0+"RW,O
M`:VBD)WQLO(<%<$9PQS6G<K=0LC^>B6ZW*FY5T$F8VC1(%C*!2?*96;D'F1L
MG`K.E$IN(=/=A"C`S22VZ+!%-,S$J4^7[V-OF<CTH`R_LU@+A;JW+1W$6);N
MU@D<A3WR1A#(P)RFTC&2I)XJI'9)J*W3:DC0$AIX&MY'N!/;1,2KQPA8IB3G
M8^(SA@1T`)Z$3&1C#*QMI#*JE(94C#+"0A;?LS)YH'SJ2,@D#%1O;Q$S64<$
M<=J()(HYHFP0TLBM)&L:MYR."=Q;S`K9&`.`0#SO5O"\DY:$V5J\-Q,+AUF<
MPE;$1`-@F.0K*^?]5)L/!)QD9_/#XV_L4>&OB-<:W>ZF^A7=MJ(N4M;>;3%E
MN["W\ID:!M1&3<6D[2!3')!((GR_E8&:_4#4<2?9K=%6(VI>,B52DMV]L'"(
M9MQ*HQ"9W;F(8@;@N*_"?_@H?_P4V_:*_87L-1\=:Q^QGK/B?X8VMUY<WQ`M
M/'V@2>'O,D/E6_FVI6/4=-FD*H"HMY@Q))Y%=&&PU7%U84:*O.;M&]DF[KJ[
M);[LPQ&(IX6G[6JVH7M>SOM?:US\P/BW_P`$W=8^%_AW5ET;2BCIK4?AG1-<
M:XNI988=4N6O[8Z<1;DS30NWV*1X7+VTC1*K>5D+\M>*/V,OC9J/C&:WMO#=
M_K6BWFE1Z-J]OX;U%+?59K@KLD@OY;UA#'J$JAIXY!<QE3&098F(KZR_9`_X
M+4_'G_@H_P#M+>'O@Y\._P!F'0/#/A.XD36_B!XEU+Q#>ZKIG@_PG:2Q3ZAK
MDD/V-H$U*=9(+6W">49[N7",J@D?T<:1X)\'Z;%?26EIIFHG3+^1EB32_,GU
M#<%DWO*-I>.!I)U;>7D5B!N.!6F-P5?+ZWU?$**J**DU&2FDG?K%M7TVW%AL
M32Q5/VM%MP;MJFGLGLTGU/Y$M4_8I^+>FV,6LPZ!XETS1M.NK?R[G6H+S5[I
M(=/6.%)=-%N\\-T\:+@P73H[3!V&],.>^\`_\$R=3^-7BRP\8:[KS1ZG;Z98
MR^'M.N;GR+'^T(;QY?M&JZ?:&0:3),#^\><G#!2R*`6']7MWX<\(7MM)96-A
M::7I5W+'=[6!66^.UB+6:6:&80,)"PC6(+\A*L3Q7GM[KWAGPC>V=M8^'K+3
M/+C:&Z@TVQLEL[IK2;>]Q(_DJUU<@,KK'*P5W7!1N0>,Z#\2?!W[#T?@#QP9
MKC2O$'C+4+2X>R%A%X>M9%L]154<*;P2R!+:$CS8KQHIHY4P5D\P[:_:CX!?
M#"[\/^"=$AUR/3XM2S>+?0RSM=7%M;>:)H(X+I(HIDEB&8V78%.7CP``3UGA
MO4].FC%T+K2['4;F:*ZN)[:6RD!1W)DC9XF62%5!$<T#$A6)``QBNRO?'_AC
M0U=KS4M`LK6PC^W.9&B4P]5D5<.KN)`3([L&4'8I.6`(!UUOICZM:3W']FQ6
MD*7D:V]X;1PR&W3(:!U`:")PO.68AO7(K-U33]$UJQ\17,$3?:(8K:YEU2.3
MRYK6>$!/+M1EDN'?&7$:ALG#NI)(X>V^-O@N_:&&S\1VAT2^2ZFF03%4`@!D
MEG<ALVZ.,@!L%1T!Z5@6/QB\(:Z9(EUW38TN;D65GI\-Y;S0^6K[2\*(8Y4A
MD0[IIW4L&+$9[@'Y[?MZ?`R]\7>&]%\0:-I<^H3Z)=L=0BBLYVDT\3PNT=U)
M<0[)387",RSHA+QDDKNP:_EA^,'PX@^$OB;5M1!U/6[:QU@ZTFE7BWU[!9W\
M3+/-I7A_4Y7^T75E")09K.\,<.GF5#A\X']V>I)INI:?=Z5J=[F&59%,=KNG
M86%PQ\M9I,&-N7581(1E<XP<`_SZ?\%$?V5?$.D6.MZOH^H7EQX7\6->376D
M36+2SW>IO$MJT%O>6ZJ+.6>R'EV\*('9\.X.T&@#\]OA)^T'9>(="$VN:1_P
MKN[N=,EGM(]5M8[^QC^RJ793I^[[+/>RL$,<JRC>WRCYA@^__"_XSVOBR6YL
MKG1=;TNZMBD&D:WICR2SZK.UZR6]Y/#9S+96.EF9,[G8"T7YWW8('X^^+?AC
M-96$=OXHN==L=/TO48YM$M;K57CGTW40RQV6D7Z6KQXG^16@DN`H4D&16.2;
MGPF^)7Q9\.7%O&^KQ:;I%CY]G97]M/<2S?VP][+/>_\`"5PW-Q+--,UI)MGN
MK7;:/&JI#&C9H`_4'XM_\)58>&M=L+#Q#='Q%-J33ZS:V^K-'9WUK<S+)<2V
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MTKQ+J^F:=J.KW]GJLVFZ7+.-6@5+*5H8R!:0I"L<-QYMNKN\`D"[I&`]/F_:
MS\:K902:'+I5ZNC_`&ZZE\,ZA//<V]U:QJ"^L:*+MD2*QVAWCN`Q"M@'FOF#
MXJ?'70?$\%AH&A:C!XEU6\L[F'Q%&D3:IJ$L<ER[1ZI'J4$D=S&VDW#?9(;$
M&4/LR5P*`/B"VLM'\,6WB2PU77M%T:[O=5CO;.;09AJ$\&F:_*EK>6<MK'%<
M0:AI,@!68P!G7>?E5NGT'\&M&LM3\8W8L-+NPUG)'I*Z)X;M_(^VZ8CX2^>:
MYN(8[(649#RQ7"&9UD6.%&*C/DOP^^#-YJ>H6.J^,H9-1L&U.X74='&F2'7H
M;&&Z9XCL1Q=7]LT;1SQ1P.DL$J@O&57-?JW^S'^S[XJ\6^.[+_A'-(O/[)FU
M2&QO)M0F@AO=0T02E@-2L9E,JF8K&3?E$GM@H3S"`#0!^S__``3;^%FIQ^&;
MW5[FZU>WT*&[CBT0ZC&\+M:;_+O1<1736XD$!R$N8S(S`9(7BOTE_:-T73K;
M]G#XT07!TRZM6^'WBA7LH9FNM]L+$.)`QP&!QF9R?*!'$C#!K6^!/PSB\!^"
M-(T%K>$0PVTL#V]LT\\ENS[9)565C*57/R[F8\<BM/XZ>&Q=_!CXIV,%K:SZ
MOJ7@'7(=-%U&\5NT;6+1FU94*_N)SC>AQ@GC-`'\/NF>/]/UOQ]+HFCZ!J,S
MZ#;07JV,=N]C92RVQ,CYU!'1Y8O*7S6CM_-DFC1A"-V,_7FE^%[/X@6$NN3:
M38>1X;BEU".2*.UU?,MR25L8O)O%N8K9FP6CE6.Y3.9D<G%=!HG[,W@#P=HN
ML>(/$UW%;>(KNQO;]?L$<E[K.C70;#BVGMPDL]O`&9;"/RY5MU;YLE:^BOV<
MOAA\-9==@N1KUT]FUA!'_944KFW1&P1<:BJI&;V>1V8R2*&9&RCX*4`?(/@C
MP+/XJU[3[Z?0-6TB+2M;C6_2$BZM]:N[*V9&$-BD4+R1R*5B2UN=K6Z#?YSR
M#%?I3\-/V<M:\4+I;^(;==-\/6ODW-QH[K)9S7%VDSR/*\3KY_[Z,(#$TK@K
MD;EX)^\?AE\'O#>FW,5Q;^'](N!8W4MQIQA@C,DQ\ED:XNV9OGDG4>8C;B23
MR0>G?V=GHB27T5\L1N;K,IMT26)H%7E`^QF,95>1L.-@.:`/.O#/A5?#>HVJ
MVF@"Y\/7MG*S$6WFQZ9>VX$5JSJ\N[[#&H+-`H63<S$*P(JY9^&K\^(IY&TC
M2[K0;J6":[C33&0V(A?]S<62WL!G17D/SK'*R8.0,\5Z3IVHZ)<+=KX?N+;7
M$TR_A&NPP7CHDDKQA(XC&A9E1<;2B#EHV+8)KHO[/>YDGVVJ"^>.-87A^TI;
MK`"9A'\K,4;HI=P,$9`[4`5Y;0?9[:#2+34YKR-RD+SQ.7EV1[&$J*Y:W2)!
MM$GED@CE0*[OPKH_]N6<9GN-2DU"W8036#I*\6UCM&VZ:`(I7'4C#^M8EOIL
MOB.UM8[B.[&HV0BCO&L;BY01)&BMC[>@0^<-NUT(;?WKZ#\+VJV=O$]E:JLN
MR!8G:8S2AVCRWV@'"DY!X=02<]^:`)+6R6W@ALHX"6,(41AB6`A5BP:3"Q,4
M'+*'.-RYZ\>(_%;Q#HGACPUK.L>(A-;:1:Z1J%U=3PF.1E$4$A56MD?SK@G:
M5$4'F')P`.37OT=U+,CQX<W*W-Q,&BC/V41N55TXQY;/L`49(;!'&*^??BGX
MD\,3:;>>'->FTM8=0L]5@6.>..0PDVDJ'SE`81`;B%:5T4MAMU`'\TU[XPM;
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MB&W*^:VW;ZY)Q\WZ[\-_`$GA6PTWP]-JSFTN-476;E+^\CLKV2XCFCF_MLNT
ML5U:1JY%NBLH60!U`QP`?/#>!]*^+'BS3OB=XBTB3Q=9Z>9=#L;G2IH6F@GL
M[D7,S2VMT,K82(N63SVB5.,,>:_$;_@X*U'3]4\5_LS3V")"EMX(\5696&19
M;-$36X3#!;1@1?9_)1=LL8,BES\K*!AOWY\"#0=#\(2>'M#\4W%I/9:S=Z5>
M2WT\</E6]PN#:P/.(5=Q%GR9"263:"QQS_-O_P`%SOL\'Q%^"6E6CS-:67@_
M7'MDED5T"3ZQ\THFC9HY))V3>X4L$X&>>?E^+O\`D15?^PJ'_MN]_P"K[,^B
MX9_Y'4/^P5K_`,EO9?G]_P`_UM_X)0?$V7P!_P`$PO`.MOJ=M,^A_$OX@7&F
MZ2&,5S'<3:W92+-)U%Q"7)^4<Y/08KZEO/$T'QTUK6M<\8Z['X;\52+97<=K
M8L\;ZGIJ!)/LK.2(D$ZKAB5[],U^7'_!-!H&_8I^&\FJW>DV&AZ7XN^(M]>R
MZC=.9+J,ZM!(L4=@Q*^9$N!@`@G&*]=\7^+I/B=</<^$M?DT-M,OQIAO[:`6
MC2:<#@7`DQATB48]1UZUZ7#W_(ARK_L#7YP\O3^M3S<SG?,LP5O^8COY*^A^
MAGQ#\,ZK'\/]4\4>#[X:A::E;)I2^'T=Y%TF2.,(;E\ML9S]XL`,CCZ<+^RA
MXZT+X?IKECXTN],DN].M;B:35-<MC*MA.SF5%L;=L^:J2?=D0<X[YKY*\/>*
M_'&A65GX8M/%&N:D4G:+[&TH6/4Y9&Q%=E@3YD0&,K_=P?I^DNE^"/!+_LV6
MFK^-?"<,WC^:Z:$7T5NT:O`<-Y-T5'S1D?Q<CJ>*]8\\Y;6/%5IXVOV\3S:-
M)XJU.5GFT#4K8+'I2QPMC>D:@/"^T?QYS['..%TO5;C1=0\5^+(+'4=;UK1D
M%TEC>R>9IM@DX"W-K:]0LF.F/8>U>;W7C2Z\+SZ+<>%;/4=,\+ZG=76F:I9*
M0RZ:PC";K9/O+;'D!L9'<CK7J'PT^/W@S3_[6T2XT>'4;+2%CAO3(!)=:YJ%
MQ\D.>O[J($;GSC)].:`.V\,>%]`\53ZEXR\;:GJSZ5-I/VVUT2-V+Z7J4R;X
M(+!=P\MW;.[;C^'/I7I_P"\4V&BZQ)::UH&KFUO+J6W\*^+[IUCFT!#N(CEE
M<;BT@V+@GENE>7>([C2]4N+[6-$2\\/V=M-IOVW3GN=IEN;P`Q+I\&?WJHIP
M2N1CZ5]O_"33_AO<^$[SPYJNFZMK&J3Q12Z5IZQ%)))]GFR2K<?P[7`)3.[^
M5`'T=X/^(GCW3=+TJUO[JQ@M3K#P027.V;5-6MF.89)&C;[D@(5.._-3?%/X
MW^/-.N!I^@>"[^YU*V%O/=:G%'Y6FV3)(=T5ZS#YPT14DY.1D>E>9:WXXU3P
M)\.OMUQX-$;BY>VM-7B'VVXTV%/W:H>6\NXC7[K8RK8:KFC:EKFK>`H;'3O%
MEI86^IV]SJ>IMKMPMW>2Z5)&CR&>0Y<,DC.T<9PR`X''0`L:=\;HF\9P2_%;
M5O#,5O#H-QJ5II>G0F2.?;%NCM5F8,@N2P(EP!M8CD\"O#=7\2^'?BFWB+Q/
MIMTVDII=PE^MKJNHB+38&@+-;+`HP7F5,+&@R,_*.U'P]\>_LX^&M6U*P\<:
M_P"'_%7BZ1+G3/#Z/:S7,<4SEEC+1`>5'O8C#XYZG%<5XR\,_"'19M2U:?Q%
M;V^IWUC+)<^'H)W.FPEV9BZV>0%E4DB/&2#@``8%`'77FN>)O%?@W1?'%QI>
MEW>EZ9J0A2*WAV:A)):N(C>+<-E0=OS*.K?A7.V7V#QO\61JNN1:S::)H.G)
M.)AN,6M;(]_D,00F]6`4C;C/:OAWQI^U4_PB\)7GA/09KKQ5:ZC/+/I6F#S&
MFT]-Y)^V2`'&2<QQD\)[UPW@+]L;QIXSGO-"U:6Q\.6?V6%HI[3Y;RS4G]ZI
MRH;)``8,.WO0!^W=S\3?"FKV%IH'PWN[W5O&6L6#Z-!HMO$LEKH%O""9YKWR
MU&)G12AXSSGK7F/B/5?&>N>$+[PQHOP\U?3M5T&*:&,1S+%8:M<Q!I+JZDNW
MY1V()1,[E#!>HS7SC^S5\1]-^%#^,/$/AC2]3UB^U'RM2G\1ZK`KVL,MQ(HE
MF25\G9+EE4)GKP,<U]M67Q"\6^)8D\4S^%KNQT^69?-C>Y%KI]TEP`!?[>#Y
M?)=N.AX&.:`/SM^!H^//Q(^+&M>%M9\$ZWI.@6EKOU*VO)'6PO--MF'GLLDG
M_'PYPH7YL%2V..*^U3/XV\(:XNG>*=+T31_AOJ6F2VV@:;*D*K<W,,;@"YA^
M_-(2%\M\-M&<GFMKXP?M&/X*TJ'3?#O]DV>L-IDZV]_I2I<W-S$(R)T,@7<0
M-Q4`_P`97%?FJ?C+XN\?^)+6_P!7U?4M4M+2.:UT2+51*D>GZ@SA54QE,!%D
M&X$\%1WYH`_0OP69]'\#ZCXZM_$&F-=Z/J]S-HW@K4K95L;U!(ZW,8:?!\Q8
MBTL)"C```XKP[XG_`!`N=7\(>*[K0;:TFU3Q)83,VB0N$_LJ9HF5IP20HME8
MEB2=N!C/&:Z"Z\9Z/\1_A7?>$8[G2K3XC>"+.:35?L#)']MC>+*W38P"T3.&
M/<X/I7Y^:5\2KC2M.U73[Y+S7O$$<M_HNKF-&M7&D2(R0R17.`)#&22-I+-C
MC.:`/IOX:)\2O@/\![>%(M$6Y\;23W^KW8N[8LD4FUXFM@&/[Q^2=H7&PXQT
MKUCQY\8OA?J'[/>@Q_$+Q(?&/B6XN!I\6DVEX)+K1(&98W=HXU;+!22K'#<8
MSZ^(_"[1O"?PT\'6'Q$\<ZVNNZ:EFRZ/X>\5ZFUQ#Y$[-RNFRM^Y:'+!,_,Z
MD]CBOHSX!_"'X'_%J_\`$=SJ/A&WTV6>!-?T?58@R:7+$S>>T<2,VT%"-H4#
M)'04`>S_``IT[X2>/OA[X;^%'A#6DT#PCIL`U*>37'\KQ#JE_=`27:6D9V^9
M!`6."X^4*O2O,/BWIOPYU9]3_9Y\.Z6='\.ZC-:IJ?Q`OM0A5[J]8B-I;=L;
MRJ$@%=P'4$#->O\`Q0^%W@/PAX@\(?&/PM?20W7A_3)=%TSPQ8)L2[NA&!+,
MUO\`*6$RH0#M/)/3I7GFJ^!?A]\0)-'UO6!J]OK7B@RW$F@V:[!X>U"$YCEN
M9<C;$[J)`A.0<9&,4`>93?`*'X'_``6UKPE;ZO+XEU#1O$=MKNF:U#"WEV6F
M`,\DQ8L26ECP%D!V[]HQAB*\R^(,^B_&O0-0U*74_%6E6_@[2+>'3+L2&"75
M;VZ18I(3&I7,3OQO')7`S7W>_A'6K>?POHGCV^CA^']Y8W6G7[1N\ESXA6",
MFT67R=S!8P@)R5Y4#O7S-J_AWPYXH\/Z_P"";#Q)9Z5#<^*(]-TW3H`MIJ"V
MD-S_`*/=-=2E6\FW7#NN3D`D<T`?/VB>$/$^D6-MX;L+R^?5+O1`);1]Y1+2
M<`PW&H7(;]RI&.&.3SGFO2/#G[.7B7Q3:>(O^$GBGU>[6PMVTNRL+B&6.SGM
M(B86MUW$@2*"PP-S.`#UKF/&'@CQ+\,O$;6EMXVN+M+ZWAA\27ZW'VB>32[0
M`6S:>,$'RE+;@N"3VKVSX,_&633_`!`[>'Y+S5['1]&N?,N&AVW)*1N/M5XD
MFT"5&.Y%/5@N!TH`\AE_94TK6-$\)Z]K$.MVTMEJ?FZLYM5.L6S64A5XHX3\
M[PD`[MI`P.AXK[D_9]^%"CXD:?XE\(SZ;>^`],M76[FOE']HSW.SRX_+LL;H
MI(I!M)/`()ZUS7B+X@V\O@/P5J\,FIZG)>Z[-=ZA*F+?4$2>[)E:<'!^SJ"5
M9<891CI71_#7XF7?AK7M<\2:;IB-X/BO=LK6@VM=EE&[,1^YL<G?P!NR?H`?
MIJOW!@8XZ'G]:\^^)>JPZ9\/O%U]>:BND)!H>I%;]B0(&^S2+')QSG>5`QSD
MCKS7E%E^TYX,>PL[O4(KVUCOFE2.1(6D2,)G#M@9VGH.#S7RK^T-^T%_PF>@
M2>#='@2"'5[C$+R*3(;*$Y=[E2,!7*!QGN`30!_,W\7[,:G\?K;Q'?I<7-M?
M:\TUU<2`K_:$BW#K%*2^?,CE7!'N<^M?K#X>\/>$?'?@;2YKO6-4\*77ACR+
M/[)I4;S-<Q7?R%Y8XR%8'<$&1D9X/.:\.U[X"S>+/%\M[KTR0VNA74-UI2VT
M"K-J<*-N;[&%`\P(20P/IT.*^\/@VGPM^'E];WOBC2]:U:UN4CE@MC9RD-=1
M)NMQ-"5!9%E55.`V<C(H`\NU,6G[-5KH$^IZ8MGI/C2X:WLM?NH]DD-I.I)N
M[B(<V>=^_+_?[9S6U/X`BO\`7=!UN7Q3XE^)?A3QC9O:3:38>>MKIR2#S(;U
MW4E1;Q2E%`*D,%P.2#7:_$[X3>(/VE=5OO$OQ->3PE\/8[D#PE:7I^Q6\TD6
M19V\R`H1&0(U*N,%3@DYY\V\?:O#^SI\/;'Q:)_$$?B[3-570]/L-/EG70)-
M'M%$D$@M%S%+'*J@;MIZ@@T`<MX[T[7O@IK47@JV\9V\'@;2[>X\0W=AJ:';
MY=P&N7LD8-GSE4D+O"C(P!S7XUV(\,_$3]H'5]?TB*5XO$7B.UM]#NKE\"[D
MAO0LB0J>-J.-N.!C'M7U_P#M#?M/>+/VE[9?#7A_P;Y&JZO8);:AJ=I88GEV
M(48(57Y1C.XY![D"OJ7_`()E_L.Z3/K$_P`1?BEIMO>7'@^&(^'/#\S!F-XZ
MRLVH/"IX:-D5B2>#R?6@#X+_`."@GC'Q;/X\\*^&;ZZ@5_AWX9TVVTS3)RPM
MI99HHQB=!A`0#M!"GKG-?6G[!GA"_P!,^'6M:UJ,&C+>Z]?17-F%)\Y9!&C2
M+;N#D*@SD\?+P>.OS)_P4Q^&FOS_`!P\4WJP!;'5'1+'5+><>3%-;'S/LS%2
M5&V)?*V]L8[5]&_L;'5?$'PQ\/1Q7MO!8^&M5D;5M+MYF&I7+R0I`[KM^=T*
MKN\O(#4`?JSH7A+Q=XM\4^&[.7XC:5=>"=4MTMYK"PU2!=5T:>.+]ZGDB4MD
ME2/G')]ZO?M"?#'P/X4\!R:UX8BUG6/&D,MQI>C6ES=HZ7UQ'L7[5<!&.T",
MB1<8!5@2/3Y0T3Q1\.O@EXW\)ZEI<FI7S:SXAE?59-0:YBDMY)V.RV\AND$3
MMEB`0=O!YK[\\9_#/XA?$#0[:+2[NSATS7XY==@UZ$^6;.WO$WB`2,<JVQOD
MX'RD=*`/YZ_VV?ACXCTKPKI'Q`598[U8X#=-?%)VCU50#):VI&<1+@C!'0+7
MNG_!&'XA6MO\:/$&F:EJ/V:^U[3%ABTR52LC2(6)D(Z8+KE<`9':O5/V\?!V
MCVWP7TWP#H6J7WBKQ)93LFISVY,P5DW^>^[L\1!RQP.,UQ7_``28T?P#X?\`
MBMK7B#7],07]GIL4%EX@O)0JV<J1%)4E)/\`K`X(``S^%`']-]]J%OIUE=WU
MTWE06J/)*2.JH"6V]SD].?3%?QP_\'+WQ)L_''[,VN+I<]X]KIOB71(WBE<_
M95)M+X+M7IYF<D<<YS7];OQ!\2>%8?`FKZOJ^H1#1ULOM(GAF4/*BJ65XP2"
M<X.,@9'K7\,W_!>CXKZ+\0/@-XEA\+/YN@KXDLXR\,6%@N;2"\#&[;@[Y,K@
M@$'=P2,XXL>O]FK^=%OMM5I+[K+\T=.`;_M"@O[LON5O^&/X"6^_])C_`.AF
MO]2#_@TJ13_P3Y\:F1WCC'Q%TC<RD`8;PA9GYSS\N>3CG\*_RWCS)_VU'3\*
M_P!1W_@TM=!_P3Z\9B4?(/B-I+`M]S`\'V6_<N,-D':%/4GBL,5KF&4_X\3_
M`.H2?Z&D?>P^+?\`U$7^ZQ_4Z^FK<2RR+)F`BV;?'/M5R@V$?+W/.2!WP>U*
MVUW6-(B9$B<`OYA6*('RSMD4%93M0?N0=V><U4@NK1I;6"S0007!EC\EE8QN
MZ,2\8*-^YE'WPC8X*G/4#6>,(H"3%%#&(C=F-E<;F..3)*@.`#\P`&,CIZAQ
M#DNH+5=@::,11;A&RA$ESQYC.YX.3CYCU`S2-(WF+.[7$,+!!L/EF'E<[@P+
M9!]!W-5;@VIAV*86-JRE?.>0%&D=?+WAP.'/*@\'MFI]T_D(DS0O,)C(\@\K
MR[>(8P/G!QE>`0#Z4`67\UY8O(V/:JCM(KQD-)(`I5T<\;1N``XY!Q5%59F:
M-K4+LCF"3LQEC220JS;L<HS`XZY7`Q4QNX!=V\:%W$Y8PMM?:K@*K[>,!#M&
M#PI)X.:2]MX+^WDMED:+#[G\F9X90`>6;RF!()SR>#GT)I74;\]UK[J2<FUI
MJEIKY!KTM\W8K2HJI$T=N&\M'C"L-RI*!N+LS9;RSU!S][\JP9[EK2T>X:6-
M9+?Y[QIIXXX0H;<95ED*Q1+$BYS-A7"D%T"DU\1_MM_\%'OV5OV$/#L&H_&O
MX@6?_"53VI/A+X:^'Y/[;\?>*M2D\^**"Q\/6+27<7G-Y4(O;Y([5=^Y,N@%
M?B(NB_\`!4O_`(+'2O-J5UK_`.P#^P[JTN^/3HIIK/XS_$[0)VPRWDRM'J&G
M:9>VI?S+<26-O+YG,<Z@*?0PV75*\/;XFV%P;LXU*SY:M3;2-%M-N]KVE^IR
M5,9&F^6B^>N](16SEIN[=FWL]NS/M']LW_@MO\'/A!X\N/V=_P!D?P-K/[9G
M[5NJ7#Z?8>"?ALTNH^$/"FN2YA$OC7Q79PWMF/L=P?,GT_2Q<20!&6YO+4-7
MPSJ?_!,+]J/]J+P]XY_:L_X*O_%G4?%%SX9\(^*/&7A#]D3X7WEU;_#KPO>:
M;HEWJ>E:?XEGL99!J^H22I;6R:3I\,\DEV`)[S+,@_</]C/]@C]ES]A/P9:^
M%/@!\.-,T[4[VWC7Q)\0]1MQJGQ#\8:L\LDMW=^)?$%\7U#=+,Y,%K:):VD4
M.SRXR[RS2?6VJQ37QN--NTMIH;J$ADN=S1S88$PR6I#;W51\OF85B`"<9K>.
M-A@YP6#BUR--U6TI322LDDO<VOH_NT,?JM;%1E+&2O">L8)?"]&VW>STT6GF
MC\.O^"-__!/+P[^PA^RU!<^/M+L],^/_`,<8(/%WQ!=IX'NO#VC:AMO=!\`V
M-PF_R8=#TZ6W_M>5G*MK$EU;/'Y=K&Y^X_'GQ6TKX4PZOKUU=P-;1VES'H^B
M7DT,,NLM&H82VJ0,TUI+N4J;B:/[/-\I;&17I_Q=\1Z5I&CI>W=Q]@FT[(:U
M>#R9Y%1_+MAN3,5O#.57(?(9.S9Y_FW_`&\_VAYM5N_%.A6FKZ9+XJM+B'4-
M8^RQWD$V@>$MWR6=G,"#-?SY+LL)6&1`HE["N'%8FIBJTZ]5WE-WWO;RN=M&
MC1P].-.C#D@NE[W=E=['N7QF_P""DNLV=XFI-KME96FK>9'9>'-%2^EM;:59
M&%O'JNHI')!IVIK(FRX@6)DVX9)&#\?G]X\_X*.?%;Q99/\`;[2>QU"WU/3+
M6Y_X0^\AU>)+"XFE@DU"T>62%A?00'SKN&>%'#QXB5VV@_"WC+7M;U^31Y]#
ML-:U_P`/'23_`&I/ITGE7TMS=OLC/V-%,T,B1KD2PKD$$`X.:]E\!^%+RSTC
M6=:D\&6OA[2+]Q#'J\D8&L"".UAFU*\N@ZF7[062-HVNE+"4`K@YKG-#T?P%
M^V3?:7J5GX9L/&%UK]EH=W?:E)_;NI:K;:WKFC7K-+/=M;Z=;O-:71N'/V:W
MO"MPKQ9\LQ<GSGXK?M:?'GQ/X]TK3O`/BSQ1<Z/%9K8:[%XAO[22UGM6OY,V
MVGJ)EO0QMW53.RFX4VR%H2>*Z7XB?LZZY/IFB^.-)U&73/!FHI917]Q;6B)X
MKOHM3_T=8)#$B32L[N)(]0!7R4YZ"KW@C]DOQKK.J^%((=0ET0:7<7%OJFI1
M:;'>ZD^EE<V%S<7]U%+*EQ<($22XC=PQ.TD'.`#R3Q+\>?B9:W,&G6'Q'\50
MWD=FT>I:7;ZKJ.F3SPF1O*N8[F:"2%8;50JS74D.)1\A7FL7P9^V'^T3X9GF
MEO@=4#68%QKVM7NE2:=9Q1SE;6&VOM.DCU:YN)(1Y=S/);0QPW+Q[I%`S7ZH
M^&_V,=!A\<:3<:W>6FM0F5-3U!=1\A=2WVBJJ6]U:.%3[)=$[1%MV\$]37&?
MM&?LI^"-(O;O6-1\,V^E6DZR:(MOHA@%K-IU[/%=92!@<Q"<)]I:7&T%A$X4
M#`!UW[/O_!47Q=<6MC:>/--\0Z;8%K.TN;B__LZ[M]0@AAW_`+NYL)3*MON0
M-;BZC:1L#<V[K^H>@>./"7[2/A72=3;6X;;0]22[N]-U?S!)`)+)7VFXTALR
M6FH(#<(;UOW;"('!K^97XC?![6/#1;4/#%JFJW.@ZG9VJZ78WT,C6=B(5>(L
MER3$B8(,WG,5`!V$#-;?P"_:2\=>`/%ET+.^LGL5U-M/\2^'IKPKI=W%*%AN
M/+N=/DGM[62UCED:58UMA<D^2)#O8@`_5K]HO_@G]%XF\+Z[J?P_T[2O&45S
M8G4M6N;*WC&J#]\TT=V;?S/+UF:0?NPP:&XMQ\RAEQ7X6_'']E_6_#6O:IHV
MHQ:U:Z7+9Z6\2Z9:1PM*TZ^?J"K=P?O=/U.VG40O:WX"WBXBB=2V3_8I\%OB
M+X:\3^$-`C^T:)'?&R,Z)HUPL'VBQ^S*;8F$M(5"`K"R88JZG)))-4?$_P"R
MI\/OBW'XC/B;P4EK-K*;Y==L)GDN"KJ5>?58K<FW:(*=UO.Z?:D89`7`H`_C
MR\.37'A"UU"P\.:#)_9FA:597%Y+;:E>6,FK:7=1D7\RZ;=,MQ93A!(LT4(D
M#&,LN`U,T+QEXF6*::U\07=GX)U6Q30['39;5X9M3@DW/)]FN9/,FLKNUC81
M0SWD&VXD&W>%=A7](OBC_@E?X?UW5-7U'P_XB6;0[&PMH+2VFAMXM1'V8&'4
M+`EU+7UG?VWS[960B3(4@]?-M<_X)U>.-%@M[?\`LFTOM.T:"WN](M-.T"SN
MM^CYRDL#231,EWY(\IX;F66.0*0%`(H`_"*W\(>.[K28+JPUNQO)(GETNYN+
MQ7T>:3P^6$UQIEM>7CS6-UYT.U9(HE&]PQ0*#M'JGPD^!4^FS_V_9^'-%MO%
M.II+/&7U-=2L?L-RYBM]4@CA^R&ROI(@6%BJ21V\OSR2%N:_<;X=?\$_M=^)
ML%O?ZAX?&CZ';RS++IUU]BTFQ:YM1Y=C?7FEM#NA?!)9;5RA`Y)/7[.^$?\`
MP3,^%O@>?3]2\9-)J]\MLESIGAO3K9I+#1].E<QLKZKA9-266Y!DG,KLX4_*
MG2@#\1O@+^P=XT^,'B33;O1;?5GAT_4)+^ZD34YK9-*O)28Q+=:E.T,B&]MW
ME%O;JTJ,^U1V(_I3^"G[+:_!OP]I]QI&L:;J.MQVL$.H2QZ45MKN)SLENA>7
M>9;RY2`".Z@C.SSU:08SBOI#X=?#/PQX3T6-="TB+3X(X)+0V5O$R6[F`[+.
M0!/WC_91\T;."-PYKV:WL;NPB\F;3X[ORX8OW`8(1N&YKB%``I=B2\F2&W9'
M2@#,T#29[K3HG%R]G%%#+:I''^Y^TH%Q-*P@)?S%/-N&&3T.*Y/XP0:BOP9^
M(LGV/[=K4?A+6EMHTNB@DC6!O(7<4*I+/C('`R>,5Z=:-)Y]Q<HRQLJQO(X_
M=@1=XFP/*V+R#)M$IYR]<5\6C'<?#7QM:Q712:?PUJZ11VA<S/(L),0B(&28
M0>0#R,XR.:`/Y3]1TOX@#5]:\0ZKI]Y;1Z@+)%T.X,6ZTL5C>"]ET>ZC+S/M
M8)//`$S-B0#D&LGX/_$?6?A=XMATWQ-I-[>7TPOTL#:6\VJ6%C:^8TEO"Y,$
M*L+L.)8U+$P@G>Q(-?7VLV5G-?V5MJ`$>NJ)%:`3NA-M$YD,4'F%=UQ=(/,F
MCC)9P60#.!7R!\6-;\5^'-4BUVWMK72-'DFO$^T0W<DSS(I)0OIUTK31AHVV
M&)%4@J>>10!]U7_[7UEX0T;2+?4[];#5I-.N]2N;*QL9;H79:.X>*VCGM[@K
M&^`I$:C*[=B@5Z%\%OVH?!'Q:EGATP26FM6I4R/<K<6<MRMS`HVF"[C22+EB
M1NSM'`XK\8+^RU666V\87%Z3H&H10_VK&ADM(1:[?]'M+>V^_!>07/[R4$B6
M09&ULD'ZC^$_B>SN;2UU^QMI%D%A`FFB1H5N0UD666Z0QQK<1QLNT>3.VX8H
M`_<[X>Z1X5\F73-)B@TR]EEOKG4(HW</>S(ZR;EU&)6/G[B?*1B!R0,\X^B-
M*T?S(G,CQ2R2^0\DED)/M,:`;5#EPK7#*H^8*,$Y[FOAWX)^-K'1-/@\7:[J
M$.G:7<V:QWTVHA%9KV,1,?)\TEI`V["F`-DY&<C%?1&E?M&>`KV2]FBUAG13
MMA6VCFS<P&4*I55&2@8@[A@*!SB@#Z&2"RLX+FVA+B.68)Y,UNMG()XCM:Y;
M8[MNFQO828(R01D<7;>+[.+><3S10I.KM^ZD";EX7S.?WZD'$;C@=_;PU?CK
M\-VOIK2]\8Z!#>R3;K.TO;PPRW$T"!ITC20#,L>X9!^4MQDUR_B#XWF\DM[+
M09H3-<7:VS0WCR/)=H[[<VJ[F3R^0%>(A1WP*`/IV]\R17E4&/RY%>)P_E&9
M9"WR*@P#\QRQ))P1@U\O_'C2[2UT7462WC?4-7TZXMIKN(0.HBP3<I.9P$6:
MWA_>1;6!;H<U[;HVKKJVB0W<L*PB$_9B))&V)-"&\\HK'<K1X(!X4[N#QQ\[
M>,Y]8\32ZE>30V^M^#;&*^M8;".XCB>.]V,MO+-T>X59L;HL[<X8F@#\%/B3
M923^*M6DTV\&C66BZG%;6K&XN[/[5<R6CSMK5W+'`T1N[26.....(E/)?:A9
M0,_H!^S+))\2OAO:76HQMI6IZ([Q27T1\Z'6ULE$XO8KW;'._P!J*.)+;:#;
MJ6<_>%?G;\;-6%A\4DE\=!M$TN>?5K*]-I>RM?\`VS3@R6S2P0PM%-!'"(HP
MY4,@*_,Q.:]V^"'Q!\5Z+\.M-UK36CO++4M1NH4)BN-QMY;KR+2P^RE@%U*Z
MMOGFNF4[DV\>@!^B>HK,[V%O/=7%I;M$)]2,"2-8W>]U:*W5YOD98XV4H7."
M=^>,X^8OC!;ZIX5OI_%FFZ]>Z9X4\-6<UU)I]FUI::9J6M3E%L[G5;L2F*.(
M1R"/[*8VBEE_UC(2:];T"Z\;VVH&RUZ*T?2IUME;3DWW1TW39BLT!GEN/G25
M&R"01Y6<*N&P/'OCE^SOXH^,?BVVFOO&<NE_#RP*.^C6MY)86#7L06:&>ZLH
M/^/QT90WFL.V2N:`/E.Y^(^B^/;O4O#WC31I[70C<1SW.NV#V]XVI:I@36]N
M;:RDM;FV+':@GB$@VXVAUXK\8_\`@NLFA+XG_9Q?0]*.F1-X$UU'#:@-2,FS
M5(`HD4N)+.9!S);R#.7&3D<_T::G\"?!VGW/A_PUJFKZ#KSZ[/9_Z1):6T5V
MYTG:(<385EE\MSMF?#RJH!'0U_/-_P`%[?A[IWP]\6_L\6&D745QI=YX7\97
M,&V%TD27_A((UFCE>8OO,1P@V';CMC%?,<7+_A"J_P#85%O_`,ELOD]?P9]%
MPS?^V:>KTPKTZ-<JU^_^KGWM_P`$F?V>(/$?[!_@[XI^(R^I>')_%WQ$T7^R
MW+-;Z<8-2MX+F];*@%]PW(%WY!&X`\5[2W[/]G:ZCKXT;4YAX=B2X<V81([V
M:&0-)&EG`D1=F;[L;=SCIUKZ?_X-_P#[+KW_``34\+^&=6T.#5+!/%OQ<N(`
M[AUO+N;6[?:A0_<$9(#,V,]17ZX?!?\`9A\"Q7Z:[KMK:7VK1F>Z_LYH5=-/
M8$^3$[,#YL449^4'(].:]+A[_D0Y4_\`J#2V\XGDYE_R,L?_`-A+_)?T_4_$
M']F7]G7PGXU\;I;^,+_Q/X3FM[5KKP1-JKQC^U6@D19+786QO9@RHOU.0"*_
M0+]K#Q9:^#/@Q)HFCV^EP^)_#5HUI-I"O#YUWIJP@_;Y%4_)=2(N0'VX8G+#
MK67^T59Z58?&"YF\,Z8^F1>`K:74XY[.13]I=I!YT5A;*5*.2=PVKUSZ5\"_
M%6[\2>.=6OK'3K+7KIO$S)>7FKWPEDO(;=DV269C;=N0+\N1QZ8KU3C/%/V=
M?$6C>.?$&KVOBU;^XFO?M%QI^F_:?-M?+D8H0`K`B4$X^4$$X.ZNKN[S2OAU
MXD\1>&K3P3#J?_"0QFTTR^M"[WFGH3ME=U.7DN8CCRU"\$?>'0=[\)OV0O&>
MKB_\0Z"W_"+);W$=I9:GS'-!,3G:8CC<&DP6(X[U](>"/V.M3\$^-]&UCXL3
MZGKNKWFHI-I9TZ<S07$LYS'<S-&YV1R';YBL`!@YQUH`]`\$_!X:OX7\!ZA<
M6<6L>(8S;ZK!I?VU;>Z^P6L?SSZG'*P""'`W*Y+<_*IKM=4^,ECX#TS78M-\
M/ZDOQ"C6ZO\`0[2VM'FL+:*&5H'F6[&T-;A"<LH.>"!CFNKUSX77'@!/$'C+
M4]=N]+O89%%ND;,UK%9`;A9@JX#+)@"5",$\'(K'\":9!^T5++/JTKZ5XHTF
MSGTKP['ICI$NM64C8(N((#A5:,"4JV#V]<@'#_#"\^(OC?PKJ]]XNN=6CT+4
MKR6ZM;"SNT$UQ?L-\WD-,7A55SAHS@_2OIGP1_9OB7P1K.G>#?"TMC-;?9-%
MUS7M?NDB>-1*PN3&\CM"^5)R(<#CD8(`RO$?G_"WP0OPQLO"TUS/H$LFH-?K
M&QDN+N<9DC60`N>3C`.,5Y7XNL?$NM_#[3=`%_J>B+JD\&H7]KI2368T[3]Y
M?4;N]N(MAE,4&&(9BPV].>0#U"W^&G@[2+W7([#P5X5OQIWDZA)XN\A9)9GM
M8Q++;VMR8MGF,<J3&3@G)/2ODK]IR;PUXBU:R;^R1X9^VK8&YO=$(OI(;39&
MP-T(06C>889B0<D]CQ7T5XP^+WPF\-?!:T^'7P6\:6WBSQ;<0RZ?]MU"Y'GS
MS-%Y=W'%YK$RW/FY"X.20/K7YH?#2S^*UOXA\:Z/XLT?4YFU2Y6-;ZZ9YHHX
M"Q,`C9BZQ>6I4*JX(Q@\B@#SGXD_#>.#XC/IND>(8)[#5]&MKO31]FV7L>R)
M68SH5(#S.N%!(W9&34W[.O[)7C7QKXTNM>U'4+6R\%7]TXU2^U!5MKI+F.0K
M_9\*A63YU5FW;@H`&2"0*^MO#OA&>\\6V>FZ]X6\[7#9QZ-%K7E;W-G.=L4W
M"G:\*D?/P1^-?>OPO;1O#>IZ!\$IOA[/=:*Y:&^\1H&+3:A.#ON6D4;_`#$W
MYR3Q@#UH`ZOX6?!K1/*TWPW%I`U'PS!+!IDMPG[N*9K("59)OE"W$<;+G&X[
ML>O7VWQ]X?\``.A>7#XKUB?1M/\`)B&FKI=RJ6FL1PXVV"6+2%E8@>6[!4]O
M2O;]4L/"/PE^'D3RRO::3X?(O'F8@W;AF)<%C\TCNI*8.3@\>_Y=?M=W=[\6
M+_PAJGPUUI[2&[<16"21R*;34IMHMHF@XVI(Q7]Y]2.]`'`_&_XD?".#7[&T
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MZ<T44MU:W4'^K9(DVR/&'R'9@1CNW6O"_#FO>/\`1+'6(K[2[+P=:^)KIK8:
MU)9)+-;V76YTZ1F0.NT!H@6Q\H'4<5Y/9?$*Y^&OC2*^\"^(F6RDN1:7,.GP
M");N=W_?2S!<"5'8G&03GVH`_1/Q9^P3X>^*WBO3/$J>*7L/AMH-Y->:SINI
M22*MZEOB6*WABV;;>#*X._8,!@,L0#[)8_%GX!>$/#5UX.\$:1<7?B#2C+:6
M-K$OV6SCEL1M$JW1=1+:DJ&,9R6&<@5\76W[7%W=>+I/AMK%_?QQ^*=)6"&>
M%66UM[S9&<7"IA1O8\Y/)X-:E[HG@>WM=&\3>)M3N;37-)FG@MK&S/D6FN^8
M^WS9BA"_NP?F!!W`D^E`'L_C#QG9)J'@_P`9>)+F?Q!;+#=7FH6VC,5M[1HE
MS!;Q6:'+RA@8W?8$;;G>&.*ZK2]*L_'^CZ/J5B/$?AK3-6N+SQ(;C3K9I]35
MK<-)9Z=>,"3!;W3QJC*#]USQ7EWA;X+Z3XUOF\4Z?XZ_LBV:2UM[&SN9#!;3
M6DA!OEL[=FVS^4P9=ZKRV[-?<WP\T"Z^%ADLY_$^BZMX6U0O--++.HN;"VBB
M.U8U/5]X`$?`8G&.*`/._`WQ#B\,^'/$&J_%^]L(+M8[F+PCX<(-S+!;"-UA
MF=73S8YI]NY@5(!;`8XK\O\`Q%X?O/C)\=-'L]`U"]CTW4KF1FATV0V,UC<D
MEQ*TJ[5V1G#.K?-@?E^G.M?#;X>?$/QGJ?B+6O%\5E;/;2P*)T2.*[M2/W7E
M*2$CFCDV-N4!SC'<BO,9OA]\,/A[J,_]C^(X=$G2![G3/$/E&6YNK@YRB[<M
MF0_(">N>*`/DCQ]I6N_#+4[74WU;3_&6D^'IGL_$0U>\C^W0D%52&&($F96Y
M`+$?-U%>Q^"(/#M_K]AXEN=0\.Z'X>\5V$3W7A>T<0:M+&L9E#&<;!$I5-TN
M\8(!4`Y!J2V_9QT'XQ^*GCB?6Y=0CCEU+7;V[^T6NGR0??BN(XB1',W5U`#9
MS7GES8>$OA9X\GT-KT:Y<:QOT"Q@N+%9XO(B1D<PS-DVMP",;%VMMW=B:`.F
M^.-M)XWFN8/A;<:AI"V$45FMC;NOV:2UC*H;BQ<MLGF;@O\`=4G)W&O$7D^-
MWP[AU2#6H]=O=%?3HFTEK,>5#+=!5)EO4*A9!_ST*D]#GUKVSPO9?$O5[:^O
M--\,VE_9>%M3DL;&RLIEM+YK(98BY;C]VJ?,\C%B.!6KX_\`'^E:;X4U"#Q-
M;6^B:[>);6.D1C7&U"%&ED"W,8C#,HF*Y0)C@]^]`'SOHWQI^,EE`(YM"TJX
MM;NS*6%S=R(UM;7<@^;S.-D;(3N,:%F7'((.:U=!@\;?$635=9O?$.A6K:'#
M$BZU:AA9VUT"/.6=<[&MX6SO4<OC;CG=6-X_L]#:3P[X-CUE_#6B:I&+V*.=
M)/[4N=3N4'VBYCC4;Q;2,<IV4'-36NE>#=(N;/X7>'VUL6T\UE/K^MVT\ZZ3
M=;G1YH99LA6>9EQ*A/1NF,T`?2WPD.EZ-HMSXDUG33\0)/#T[?VKK"0M:V$D
MV[*16#./*CC8$$H#@@YS7N/P]\=)\:=1\0:7-X0TG1;RSEAM_"D**DGD;F!D
MEN=J`L0F,%68$^@YI-%^&EW\6;1OA_I,L?@_P[X>CL6U1=$VK%JD4<*K&998
M=JSS2@JS[BS=CS5[5/B#\,?V4?$^A>!K/1;_`%OQ!J%K,-6\1PVIGO-/B\HF
M!U@`8N<E?F')`H`7XR?!GQW)?^'K7Q-XJ>3X=17%G/K%M82)#,DR-&5BBA^9
MMJL-I*E0P'!K._:RT7P)+X"\&3:=/I.N#0F2*^TV>:*.>:T-JL4(97`!E0'<
MYDVY&2"2:\X\0?%'XK:MJ?GV>BW_`(G\+^(]3MT%S-%+]HM(!,K1N+<*S0F8
M8P,`)N]J\8^*WB&P^(WBZ+X8?$#_`(M;+IMW:7/]J2PR))?6LV$@C+`*LQ=M
MJLNXL-V?:@#>_9^\!>`[:[\6^,!HOAWPQ%>64UGX9L+Y(KG[1<SQ[9KNU;D*
MZMT"$D-T%?97PX^(WP8^$GA"_N]2D-EKB6M\;VZ17C^W;$D6000N0&P,XQ@D
MD;>E?&&H_!7Q.OB33M"\/^)B^@>&-/;4-.>&V9S>;+;S89'4`%8Y"-QR>2:\
M#7X3?$CXMWUSK_C+Q?;P^%M#GN+1;&*Z>TN&N$F9$6:V3:Y5O+"'(P3UR#0!
M\Q?M&?$CP=\:OB=I&B_#K3]8N_#R:_->ZXVII+N=WN29'\W+A(=V4C`8`<`X
M%>\?"#PI;^&/&-R^B7J>"_#L7V!KR,JLUW>RJ-TDMG`"1,C<!LD''85]!Z!^
MSQ>6?AZ^U.#P-H\46G0>?]N)6"?4XD;S!`"RK+)--&`Q*[BS,3R2*^=?%_C#
M1]%\5V%WI'AV]T2\GCM].GCU$L]O9W$<QCN)H&E(S&8SE2!D'%`'U_<:7X9^
M-_C2_P!0T>^TB)_"EE':R0:G:_8Y[F0J(DU"WAVMYD^_$C8Y')^OUCHQU/PK
M\.]2M-6^)%YJ]IHU@T<EKI2F&\BE1#%!`I;`$"X6,,,<+\P[5^4O]I:5?>(I
M_&O@WQ7=V:^#8EN=?M?(<()5V9>1T.V:.YE)15DR`""*^]/@EXKU;XB7^OP6
MHL=>\,:CX4CN;_3+:)$N;II5):W6X`RDZ.68E&#*W3L:`/./'7@>?6O`EA>7
MVG7=A%JUU.;^[^SFXU5TN0WV;RKG:L7^D!E&TDMN;H:\4^&OP:\'_"E+?Q$=
M=N="N[J2ZG7PQ=VTG]I:L"YVRWF'"P*<F10X7<.17Z\^#?"6E^']$NK&_MIH
M?`MK:6U]=1:^?M)LYMH)CM;J<L1]F.=@4Y#+Q7D/BRZ^!/BW7-/T)&M];!D:
M.2."$+JA=<F..XOU`>*WS\N0>%-`'Q9\6H[G6/!4/AB3XQP:!+XK@E.F37$Y
MNH?LY1F&GF)&S$4`*YP2!T)/%?S\?\%FO`/A_P`'?L-WG_"-Q03W1\1Z-%XD
MU`@N]S=):W:1WEN_(\FZPSOEE895=F00/WR_:=^%/@.^\=^%3I7AC5[NVL/+
MEU)M(NYVTS0;:!6R)70^7ETP'/WB3S7X@?\`!;G0Y-"_87\21R6TD-O)XYT2
MZTN1I9&6XTN:SNA!"`V,F#G(QG@DUR8]?[-6?_3B7_IVG:__``?T.G+_`/D9
M8;TGW\OZT/\`/7'$GKB8_IFO].G_`(-4M6CM/^"?_BVSEU**P27XC:8P#[XY
M)"/"-EM.3&5**P+'G)Z<U_F+#F3US.?Q&>>OM7^A7_P;F?$Z#X>_L9ZO-YXF
MO/\`A*[*=-"F9@FH0?\`",6@'EL595E(7@8#$9QZ5AB7S8_*$]N?&?\`DN!T
M_KJ;0BOJV-[*O=>MXV^X_MFT_7K&66*V#K/L?[;-=V3K]G1HP$\R1]@*QNP3
MS\#?F0!58<U<M[];J]N%DMP$:-YC)'<$V@VN=YW%5,,R'CS2G08R1S7PY\#/
MVBO"_P`0_$-_:V]UI]CJ=[96\4.A2[2%B&3=>2[B(I*A"LRR85GC&UB<@?5B
MZS"TUU"));CB*&XEC,"[X7;:0-W[R`''[X*K@GD-@\^BG?8X#O%:"*]>%9?.
M9H1<11W#>:B0J5\US.N_S\_\NZRB/R><9S6\MSYL*F%(%BFD58S+^\WJ6P2Q
M("\=E!-<E8-%%,(K8VLT%Y;27$9)\TE+4!9X7+XV[257'`8D$=*N0QWL\,+0
MVWV>-LNMBP55"JWS.A5LJ2,D8YY[TP.8^*?QI^&OP1\):M\1?BMXTT#X>^"?
M#EO<7&L>(/$VHVFEV<45O&S,J/=R1^8SJCFWM[03SRL"$C+<5_.+\0_^"K/[
M7O\`P4,\8:O\!_\`@D'\(]0MO"7VN;3?&'[:7Q4T^XTOP5H.FR/Y=U<>#K&6
MWVW$JJ?,L[J<7U]*N&M=,7/FK^W/[7'[%_P!_;E\'>%?`7Q_\)3^*?"7@KQG
MIWC+3-+74KO3EGU>R1XC:Z@\6!=:==HQCN;5CMD0`;AN->_?#[X3_#_X2^#=
M)\#?##PIX;\!^"M"@AM=.\.^$M,M-%L+".!0@3RM,6V1P5&&>3S))'+/*78L
M:[*&+PF&@Y.E[;%7]R,O>C'6VL-G9;7_`#5CS\10Q&)KPBJWL</'X[6BY;;2
MU>^FA^1?[%W_``1'^#/P#\41?'+]I/QCK7[7_P"UGJLPU;7/BE\3$DO](T*Y
MF83R6?@OPSJ;WD5E865QN%K=W$DVH3`B1!9,%0?M"T<=ND%E9;$EMTPD*VX\
MIH54`K';!]EMA>`'ER@`(!SBK%Y'-YMJ\C[%?"Q2+*7D=6/RPA!\^]5)9SG@
M#(Z5GRMY;3BZ>/#N]M9^0[?:)"4+D%EPS,,`LS]JSK8JOB9<]:;F^BE\,?*,
M;67;8ZJ-"E1MR1U3OS2]Y_>SG'U15=RDT@,LLB2ML47*S%6`:X$8==L2Q8\Q
M9\^64`C!5JX;5=5>W1HX0^HV;Q&ZU)[.5Q?2J&VQ1V=R5,J.[C:(BA4D?,V#
MSV=P[(CV%S:_9#;%+BWN;:7*RRR0X"W;H#DR%B'1C\HVG@&O,]4GU*QG:YU!
MQ81I97ACAM_DC(CPJ'S0-A7YR_.2&)/%<UES.75JWE]VQNVWN[GY>?MN_$31
M+3PO+I.C^(M374)+Z9[U)("TVGQ6%M)>%KIX8R$NK9D$:2R2M%E0Q@S\I_D7
M^/7CR]UB\N/$7B'Q>Z^(/$<ALKS5M*G%\T5Q=W;Q64L]H\,,^H&WLD??;&"*
MV1P3+(JE&/\`0O\`\%/Y='MO!GC2XT+Q&VFO<0-I2V\7V@/JVH:JI^U3W9BV
MR06RJS1)=H<[L.N>*_EL\*+)X[^*WAWPA9+:7XL;R'3K^WB)FNM&$\!6*XM-
M3E!GE,\@\ID59968$2E,(2Q'Z4?!ZT\#Z]:V/_"++#?^)K31=EK<1-/I]QK;
M6ED(_M%J26LE-S.I>6-B0")%C*[1GZ5^"'PO\<^/;J_3Q#HT<$-CIF_4K+3[
MRYO$:^N&D@A4Q7,444ER'$+-"K%6'!;:219^&7P%7POX=T!M%U.+PEJ^C0K>
MV/\`;Z"[L8F4.MQ;7FX%X"6WLY1\)N1B,`BOIG]G.TO]4O\`6_+\7ZOIVLZ=
M>:E+JD?FQV^@W>L0&.2";3EWE+^QEB*^1.NU$8E6PPH`Y-;[4O"\FAZ=KGA?
M6]9L=)U^TL]3LKJ-&M_[&M'599[.95$$K0CYOLBG>F"HS7U!<ZQJE[JU]-I/
MPYND\*WFD6=OHNEV6KVNDZPK&<;=934&W16:2+L,EE*)2L`<(-[Y7@O%/Q<\
M.WLUEI<E]'&UQK']FSWMQI/EZ1:SLI2]S'.@,HE(;?)'O#'E3W';Z3XC\"16
M6EZ!JTD-[+=:MIVD:/'I$UQ;0:TTEQ)(DLDI;;$@$@C$"MY:HN%Y)%`'DWCW
MXJ^!O"_BFVU+5EN;GQ"]A/;?VAI#R)I^A-`ZP'3;HKYQU29<F7SQ&<.K$X&*
MHS^-]2U[PK=:QXEETZ?P_';W%CX=U^`-Y^L26N]X_MT!CNF6VD$AM[BYVQL&
M7A!U&M\8/`G@KPW-9OXN2#PWI^FW^HZS-:Z&PBU*1DD)M)'(9YI82S%+@(KB
M4CIS7&^$?!?AS2-&$_A[5-2\1Z+XDU*.ZE$22)]D76B696M;DK$\T4:%988P
MIAW"8(&XH`\JN/AG'K/AEM8U5-,EL[Y[N]\RV-U'*?)ASOA;<B7T;Q@%$NBD
M;+PI0J17YL^-_A!?>!?$5_K6@W,UAX;U2QO->N[BV-II^H:=JMDR30PS0-%+
M;#1Y('8W<\)OUN(VPCI(AK]IXX?#6FWFK>&[C43J3:F@3PS-=/:BWLDE39-9
M"$.([9T4"-/-7R@2/4Y_,CXZ:]X77Q&N@Z[X(US^QK"PU;28K%[N*X.K>4&C
MN($M$D22YC$\JW$`0"$(S*NY>``?=G_!.SXHZ=K]UIO]JNZ67AR33[2QU*T9
MM?GU:WU2;;J5I9);3VL<-A')LD>9TDN;2-B##D8K^EO0;)ML5[IUK:P:5=6U
MS+)>+*OV6;2_+PIAV2>;&T7/F1SPNS'.V3/`_D0_8K\0:79_$O1_#RZ;I6G>
M&_#_`-BEBBOK6X\.+;O*`&AM?("1O>G*,K!G,Q0J:_K7^&]]%K6@V)MO).E7
M6FZ?]FM098KFV1I-DK2C;MCW8)",29`023UH`Z[2=,L9?*:QTJ&R@N+O9<7C
M[A#++\VV>TNF5HF(P0X*$#."N<5W=OX.T4_:K>YE-P[,UI*S7*2S?Z5&&1W=
M?+18HQM:U6)",DAU7%7M$T,13-931VC62W"RV:>0]Q!'%&N]TQG;$\H!RP`R
M<5V>F6EG,LL6H1++=_:&>UC9?(^RVDLN;>)W`4.R+CR\@E5P"10!QECX>^Q+
M!9O:+I[%3"PG>*5=0B5L*T<9&(=ZX+?,3GFNTM5200O+"D$:"/3[;=&A@950
M;6$2DLA\X%A\VT@GH<BNJ>UB>UDMY3%+'+.(0SHK$)A1\QY+$=B".G;LPVEJ
MC2[8K>5I1YL:C:@0XPOE\_B7'3MUH`S+?3[HR7#206MJ\<@2S$(>-I(5&Z0N
M$5T9I#]WG`'7%63Y\<B"3Y6W[+E(F:5+?<I*_O)%0EBH`91D`GKWJ2*!K2!4
M6=U0,9%F:5I&BRV7A.22P+?*`.O\KS,1;H65HW5O-43/N9B00=XZD8R0#GMZ
MT`<SJFRVLIA:BZ>5,O'8(%!N<\[$=@!<)_TPSL&2-_IXYX\^('AS0-&\5QZM
M/]FOG\*ZAJ4$-\R*JV]II^^ZDCMQAH/(&1<!]HST)'3UO5III+:>4V;7:[Q'
M8C>L"I(/]9=_:.&MH@3PY.T>E?'_`,7M%_M#0/B"TGV-KNX\$^,--T#49EB%
MQ*KZ:PO"$<E[B&-_O,%VOT`YH`_!WXH_&#X??%+QE!-X<U^W,UA?2:?!?V\,
M]KIS7,4H\V07$)D+O;,F[?&I#IE'=*I:5X&E\0^.+BWP?$?DQ))!?7=PPT21
MIK4R7L&FSA;I(X5$GS_:$,[296,\''%_#;]F>YM?$JP74L\>DW]Q/+ITUC:G
M[&-6EG::X>1E13;.THW20N/+\IBV#FOIA+R]^&)FMI])2(P2.NRV826UV7$B
M1M8.R[&E+M\ZJH`)XQ0!\\ZW^S]JVHWVL6&G7\_AO1;6>QN]-EEN)9[13;R&
M35+J>R/VKS(I3D6]R8P\1VYAP>/*O'OQ:\)?!+38=6GGNIM/DDM=%T1GT^.<
MW6JB4175RT.G-;O<1E\M();5`L69&4*,CZ\B^)LNI/K]M);OH<=CIK6?AJ\D
M*M*-3O'VR6]_*JF,[)021=,R[",*#BORE^.?P9^*WCCQ?X+MK_2-'\10GQA#
MJLUQ/JWD[1<S-MG:(O&;/[/&Q,OD1.CX(RW%`'Z1Z'\2_&_Q-\'^&KF\,$?A
M.>_E%E&^E3F*"SC=%DO[)P\$MI")LB&5TGBN1N,)*)O;V'P+HVKZ;>W5S;ZZ
M)[&5UL[/3UU+)FR3(T$-S<1V\D3W?$@C2-XPR[?-)S7J'@WPCX,^'W@#P\;O
M5[+4-0&G:?I^E:7=&.2P$T<'V6_$`*YF@@/_`!Z[<%EP=@/->P>"_@]X.UW3
MK744N3=W+7D=]:6'SVL<0MRSNT4C.S*B,3L#D9&`%'<`^0O$G@/7[\OJUV]]
MINKVJ23V%Q###),D$C++;RBYG+QQRR`O'>2@,87P$61AMKWCX6I=R01W^HW4
M\^J6%M$NG7+W::I<0AI!YDLRAK5)(T<'S%D6WEW_`'4V\UV?Q`L+>]U"7P[>
M?:$@N5CDM)UN=T\?D0'>JPIM2&UE8"7]X"LK?.!DYKE_"6G:3HLEEKB/IUIX
M;EBF@+WL0BU"]O+,[+FZ12_G;%=>,Y65N5%`'T'X<T#XC^*9M%ATW7;O2?"E
MMJ=U<:XQAF2SU:9W#++8F:4$/'O8/:?:#&Y<8)P#7UU<:'I]EH,%DD"SQP+&
M)UNS!&+TXR\FV':R,W4PEV*$X+-7AOAKQ?/#I=KI<7D7EE?6%S?:7=(WVBSA
MNW,7EP23+S%=!45@H3*;B"<UT>I7VO>'-+N+SQ)-]ICDCDFL@DPCBMS.`SM.
M-P+",<F7/`^\!S0!^)G[:VDZK:_M$I>ZA+::1X-U7P]J<-G/IVGRR6-C?6$\
M#?9=8GOUN;."[UN'RX8)+6&29V@)+)OS6O\`LW:CH5MI6M77A_2!+JFK7BNN
MCZI?DRQ:C8QKLU#2[1C-&D5R(B0_EVX."%7<0*YC]OS6%\;36GAS1O%GE:QK
MNHV<-LLKF2"*-G$1NXKK*I<);1KN@"E"&QANE<OX4AT#X<^"+;3M1\5>(+VX
MTS12T?B:3;;3WFJ6X!B07=FR7$:&]\M5>YE8-`F&RH((!]Y>!?C-X2\0>)I+
M;QO-;^$];UK4ETRYM;V1FLTU"W1@B%X9)9#%)'B8M-%"L<@2/J6QZ[KVH:7X
MCTR\BTJ:37SH-W=^6=(O/[-EO]02TD6W$,ZK*<P0('>&2)TG9<QY)K\VOV;O
MAQ)\7O%7C#7/%GB6QM->^T*MBR30PW&H6AB#*)(5+1S>3-(['4(B)#OP_0"O
MIS3/A=XO^'M_KT3>()M<UR]U*&8)]L$>E:7;.?)MY[2&-L2F&%E#RR[69@<$
M@\@'D&H>+=)M-(MW^(-KXCF\0V^MS2:.UB[SW&F`2[85NDM;99[J(J5,ID2'
M805`'2OPR_X+S7$MQ=_LIO+KLNO+<^!_&FH1&?3GTZ6SCO/$<;K;[92))5`4
M#<ZJP93D<@G^ES3?"A\:>)-.TJTGA>^T.-X[O4UMX9)[J[616E7S2O[Z-V4H
ML@SY8.#DU_/5_P`'&GANR\-^,OV78+<745Y=>!?&5QJ5A<,7:SG_`.$BCC41
MYP$BF56D1%PJC.!7S'%S_P"$*K_V%1_]M5_^!ITUN?1<,_\`(YI_]@K_`/2>
MOW>OR/UL_P"#??QEH&G_`+$_@'P>VL7FD:OX@\:?$:*^NIH3):BW?6[(0Q6*
MXVI<RAOF*D\DDU^P'[4/C3QC\%X-.N/AY=W;:B+-('VQ;UELW;%Q=ZA&&&T(
MI+B3.<#'/6OR>_X(7WWA.P_X)>>`-:UK2X/[1\-?$WXG3:5J,,"R7T]T=9M3
M;P2G:)%@C<8+.[)CKZU]E?$+]LCP;XXURX\'ZMX<O;?5M4A31KW5GWBUMT9/
M*DC55!#"=2"&3*9Y/K7H\/+_`(0LJ_[`EIZ.+[^9Y^:?\C',7;_F)_16_4^:
M?A-XM\8^/_CU;ZYX\TR6_P!%DNA9ZMJ%O<LT5W;3-F-K>W^=,(3E@2>0<X[?
M6'QVF\%?#,7&K:#I=\-.MC:&/4SI\D\DD4MTHEM;81H`I\LE6QGCVYKY\_9G
MB\?6/Q.U'P+X<\."Y\,QZC+J=EX@U&WC!CMU9R$2:3_EDN0.O/.`:_6+XK7&
MAQ>`]$TWQ%8:1J/BW38GU$:+;1P^7=VR`$RG<@1E[]><\`UZQYI\K?`GQ+I7
MQ@\4ZWJMK#-X7\">&-*%U'HU["]A-J\T4"L=2<3XRAY;A2V<YKDO$WAKXJZA
MK/BKQSX:\76%MX?_`+'U&7P[;WUPEQ>*]N#Y7]D1;_FF89$:@90@$5ZUI5MK
M7BGQ7HWBQ?#0\*^'[309%N=%C5(+35[3:5(7:H$A8'A5RW3@UY;H.GCP+X^U
M3QWJVG:K/X$BDDU+1M$F,ES!I?V3=YUI%;/\J)<%A@87(/<4`?*OC#QI\>?B
M*GA#X8^'O#>NZO'?31G6M;U.&<F:-F`O))'0[3Y6&*@D[0!SQ7UW\)?A?\._
MV<O'?AKQ%K'Q*DL]=O["34I?#3%IXF:"+;<H7+9@D9RW[H#.?EXYKT+0/B_J
M6D>*I?B%)H5A%\-)[*>YLX;)%^W633*?,B:$1\%20757&,].]>`76D2_'SXG
MQ>+O"FAW%[;Z/J9U">S9<1R:87(E7R\XY!W%>03[9H`^YM._:N^$?C?QA=^%
MXO!MS?\`B"2V2XLI+RT\N&_5IO)0+-(F%+=0"22.A[U]%:GI7@,>'9-'\566
MC:-!XDMYM-5$DA$\#7]N(Y;2.7:=LR+(O0XRW&*_+3XV6]Q\)/&&@>)+'0-0
M^P:M?6L37D49A?34:.-2%C50!%"^>>@`)%?5OQ(^&%_\7O@?H&G>"?%UK+K2
MW]GJNI>)+N_\HV:OY,UQ_I"MNCFCB"H`<'(`H`^!OC[^R!^S5\(K_3-&\->+
MM?LO',=_/XDT""&\2?\`TZYE:2&.98QGRB[@8)'RU!X+?6?@GH>M6GQFUS3+
MV+Q!"FM6NH>1YNHZ8UPWF1Q2L[,S1KO"^6I!QP.];WQ;\!1_LY6;?&&__M#X
MA:Q8I;V/GZJ'U!6M1M%S<V^\,'B3GRF^]CMS7F_Q9O-!_:P^&UCX\TS^V?#\
M6@PVUG=6\%E)"MXY"B#I_P`L!P3@?*G!Q0!]+>`_B;HMKJ.@WUMX5;5-.\07
M5K"GBJ"!IO)D9T5,1R+_`*-&4PQ^8[3WKM/B%XX^(/P_^/\`#X<^%NAGQ;;Z
MUIMEK<]Y/I\EQ:Z)`YB-[*D\>`9UC=RN6&PQXQUKY[_9U\?>#/"^EZ=X2\9>
M(TLM7T#4(&M;9&2>UU&S=!%&DB<_OE)&=P#`Y[U^L^EZ?J]EI^C7GA'2+&]7
M5+6&*74KH)'/]FN")#/&W):+RR44#\10!RUKXB\"?&6#6=$O]1O]4_LO2X)-
M0L);6:WMUO(XV9W>1CAB+H;%7G"@<=*^#_B#-XFTW0'UVP@BT?1_"7B(S3W*
MZ5)<7<L-N?W7ER?+^ZB"`].>N*_5VP\)>&/"UCK.HW$-I;1WD9N]7G=(XHE6
M)?-?<V%!`P1D\DU^-?[0_P"U+X*TSQGXF\/KXAAC\"6K)<WUG(46&^5F)N(H
M)3\TA(W*L>#VH`LV7C:X\6)8^+O"_P`1VTRX\1W4TVL7SV%PUGYEOA?LLQ=P
M(FD8Y:/.&*'`XXMZA\=?&'@](_#TWBA&O;Z]0SW6F:5%Y-U;RN$B+>:PC#;&
M;#L3M!-?G!\2OVTI/&FC-X#^#'@>7PYX!L))))=6^R[9KQMZ@NLF!N)D8LN#
MD$^]9FI>+/&WB'0=&OVUJ^MDTZ.);R*2T#WC2ML$:M&?F>/:I/F#(`/?N`?K
MO%X+M?C!::IH%K"/LTT"Q:KJES+;R26VI7L2^7>0B!?+C4%AN"#()P3G-?%,
MW[.OB_P]\0-2^&\NB:-J8M+B!=/UM[D"X2VW[A?;%&6EY)`)R3CK6=\,OB/K
MG@X26^C^-M/FUO4;>REG:.Y9K:V0NCF&[B.`EPJX&W'##%=AK&B?%_Q'XM'B
MOPE<ZE=S75Y:MK'B%2PLI8@5/]GV46<$CG[HQ@C)&:`/IOQ'^Q[X2TWP"?%6
MGQ7D_B""2""YUN8)%J2ZHRE8UMA(A!M_.*HS@@[<#(S7,Z7^RK\6K;0H[O6=
M)3QQ?)'/-;QWDH@M[&&Y^=5;&X2,J!26X(/I72Z)XY\8^';/6+WXF7'BJ/PQ
M]IAT_3]/O+1H[9-0(54FCD)^9%822`J#V].-3QK^VSH_PH\+77A?Q#X@L],%
MW;YT:[GNQ+?2Q2)D[@&S&02-BMS@=J`/=/#G@S48/"/AC4+OP!H<$^B6,^G2
M:?)J`C>UF65(S/9A5_?,PW$,0,!B#D\"'Q7>1>&]^A2:#9V9OA!=PWFO7S7%
MC;7+G,<#2Q[5AA+$'Y^^*^'M(_:0MO$OA>QU_P`(?&#P]=/:7W_$XTK5[I5N
MXH99UES$"^X@JAP0,#@'%=YX8^*GA3]H*V\:Z?=ZS]@L[6_M1)>/*9VU3^SM
MKO#9QMP(I7CV#;U#=Z`/0M94^+_B=X.^'^OZCX>\/22V4NJR/H]T7TC49K?Y
MK=);H%1'%)N570$\@'VK1_::^*'@+X+:+HAUI/!&J^=);6]]$C&ZN+=HS@?9
MBO)&0/FQG)K,\,ZA\+M:N[WPYXMT0:)JOAFV2^T/68(F43Z8RA$A\W.\RF1E
M8H`1@$G.*_'K]J3Q)ILGC'Q9-K7G)9P7)M_#!F9IA<!_D28HQ8*,G)((.,]Q
M0!]Y?\/`+RZ^SR^![>ST^/3+F*UU2>.)8S_8S867:^1(X2/`0-G&:SG\4^!/
M&WBG_A/[6[O(8-&E&K"SN+.:YBNY)P1=7<;@97$SJRX^\P`)VFOQXT^Q\;2O
MH^A:/"MY<7#"^N%TYFD@FTR1@6^V38`B,8QN0GUXK]>_V>="\6>%%T+Q)XML
MM(7X<SO;Z1J(B$=T[V]RB(Z%6&699=K=.&7.<B@#V[]GD>/_`!WJ?CN+P09[
MS3->TR]CUK6M9D-C%HMS?I(MLUK:KACB'#;BW4#N0*V_AK^P]I'P]O8=%^*F
MKWGQ"BU!M0U^36YYY7_L2YR]W;)9AS()55\+M!Y'<<U]+>+?%5KX0A\.^%_@
M;8:))=:E-;W6KQRPK#/?6-Q(HCM9`H"M*L#[@I)QCUXKUO7?$ND_#2^T_P`1
M?%+6;"RT4:64L;!2'\JX>%6EBN(R,A$+,B`KC(STZ@'Y7W^EGX@?%R6X;0=1
MMX?#%M=:7X?OSI+E=2^Q(4A2WW*51G"K@]\]*G^)EG:S_#6V\+Z-&O@SQCIF
MMQZU=6MY$G]HZI<)<(R)<@[2EO*1M<%MJJ20.,']3X_B=\,]4^%^H?$70K:U
MNM)TV[>ZM%T>W@>_E>)P5"JBE\GC=@?7G%?!7BKXH_`3XS_%O3_#6O3W2>/?
M%-@(=+TW2X&*:4'C94:_O8OF6YEY\R-TPA)Z,!0!Z1\$?CMI.@Z#8>$GO-,T
M*\.G+'J.K?:8)I)M5=0Q>.7()C67Y?+);:,J*^>_&GQLU%OCOX4NM:\,6>J6
M-CKJZ7J7B:0J;_5H[E=D2VJ,K6XA4$<ODG\:XK]I[]D_Q[\,/#YM?ACX;U#6
M--)CNC<V,DEWJL%Q/,'D^SMD2;6D;<0!A?4=:Y_X5)K'@J$+\=='NM'O;N]T
MJ6PFUB`2-#$FP`EY"VR>08W%,MGGH#0!^M_B[QYX/\(^"FN=*N-,TR[$MK?R
M:1:-:3:V\<K1O$H@10`'8C)0<$_+P!7ATWP]M/C)XUT#XA^)=.T*?P;IUW:2
M7T6MI';ZO+J!4"VLXV8<Q^;L?:01D#'/3EK+PM\%-:^)\.OZIK]_#J6HZ5!_
M8EN=\FFM';0AP#EMK;=JA<=#@8%;'Q#T[QIXIT/6IO!FE7GB&PEM;;3](^P,
MUK-;:I9,52^O+4%0L,>`(YNLAQQC-`'SQ^U?=_%SP[\7(-'\"ZQ::-?Z_:Q6
MWA[0M(C$\T]H(UCLH+J4.HC4IP<``CT`XUKCX*^*O"6GZ9KGBG79XO$-[I=O
M)XMBL=KVNE3ILO&5[)"4,[(2=Q^9F!)JC8>$/$FHZ'=7EQKS7WQ<T!H8M;UN
M6;S'\,E@HM;>><DF'RUVJOS8&/K6;%X@U;1?B)X;\'Q?$0>(/$VM6DJ^+='O
M#]HM9+^;8MM<W%^Q=(HV@8H@&2!D#-`'T_\`!?QI_P`+(77+/1M.U3QKH]NW
MDP3W5N]@^ESP6?V9IX)GS%))N7S(XBNTG`;&:\=^.7P6@TVRTG0-5\,6LSZK
M%>7<FMZM-C5+&2:5G$L<T2B%3`,;?,.P8YX!KV+1_`?Q#^']I>Z1X;UC3[/7
M]2O&U*W\+:?=!+=+95,QG+HH:3SWZ#^+=T`Z>8_&+5/%OQ*^'NL66JRWW_"R
MK)/(DTB(>7%80(X2-0Z$EHY`"\DHSP3U/0`^6-"^#U]I/A.]TZWL[Z'PYK6I
M"SUW5+22RU#4M6M4?(RT"X$0[8'RKUY%?HM^R[X.\/>$_#W]D^!]-D40PWZ?
M;HYD^U(1@QK=+*OF;@6(8,0,Y"<<5\9>!=4\4?!/P?HFBZW8:=XBU76;P-%%
M8ZD9TLX[@J'M[Q\,R^66S(A&!_+ZST[Q)XJ\->&M6M_!VG6]UXYUZT2\@32$
M'V:&":/%O:AE"Y:,;#(>,ONSST`/8_%GPO\`B/XS29/%_P`2K70_"<L;H/#V
MG+%:++%""8WNKF:0EY7(VN%`YR![_FOXA\$>*]*\5W_]G:G>:):V.JS"XN;&
M)+K6=?LUREN]M:H5>!$4`@\B1?F.*^J_#FC?%K4_A[J2_$34)UU2WO%U+6S,
M\GEZ7IBW'[Q+0GF25E.WRUR-W'?-:'BRU\)^&/B=X5\=^$VU34]7AT2S>2VG
M8MI%W(;?R@',I/E>9_$H7@T`>(C2Y)QX?T+POXXN[6R\0:=Y&MMXCM5:[U;4
M'+&X@,3D-"UF!O(Y!537Y-?\'!_A#2](_P""95U++K5AXAU70OB/H&G0WD&R
MVE^S2V]^S?NT!\Q`[$+GC:JCM7[63-%\0+VZUK55TSPGXBN=<N;318$B'D6<
MT";Y7@G**A-RA\KKG)].:_"3_@OMX,UOP]_P3D\176I>9=&7XJZ7)?74VZ`I
M%+#?"QAMDZ21`*I.,Y8L<\YKCS"WU6HWHO9./_;SJP:7K97V>VQT8"_]HX;;
M:>_:\;[_`-?(_P`UH??X_P">Q]O7UK^^?_@WY\-^'_%?['U]IFKWC:?=0^-M
M(GM+F"2>SO)9QX9MC;[+@'RYESE5MP").00>:_@9',O//[_T]_3^8K^P#_@D
MC\0?&GA3]GK2]/\`"MQ:7,BZQHU_:Z+<FXA&HW,>@PL_FSJ%MCY.QO(#R^8K
M`!E`-<^):6.RER3:53&MI;O_`&):+S9T1:6&QS;LE6O=^L>I^D/_``4V\=_M
M/_L#_%#X3_%?X1?%W6[3X3_$35H-+\4+=>%_!NKWOA+6M+N[:ZN;+3[FZT6>
M)[6]T:2YO+'^T8VF;4;2]MF+1A,_N]X+_:B^U_LV7OBV\^*_B>[6X\%-K>D_
M&2PTCP=:^*/L1L#J=GKC6#^'=2\)3-?RR1VAA?0(H%^6(@SJSM^(OQI\1^%?
MVK/V7?C=\(_BC.MIXYETZ7QKX*\5:K',+.V\2Z&CW=EI.FA8WV7,AA>P96*F
M0R`CY22/E;_@FY\<-;^.OP@\(_LGWYU*'4_AQXQ$_C/4I_M$5M=?#3PU>_VI
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MY8-?M+?S!B6)D)%=S^TEXW&H?\$]OVI](:!'N3\`/B=.E\+AS':V$7AN6!=*
MA8DF*2,J"(L9$2[L;<-7R#_P:_:H-/\`V(/'8DC\QY/C7JL5O&DBBX:8Z)9A
MI%W.A981DGJ!V]MY.K1S_+:$*U64/JW/4A*<G&[FU><6[/1)*][VM>VIFHQJ
M93B,1*%/F>+<82C".WLX:1DEIOLGMTU/V^_;HU/XF>"OV7_C%\4OAG\5O%/P
M\\7_``I^'?C/QWH]QH&D^"=1L-:OM!T*_O[*V\3:?XP\+>(X)],BDM5:1-*3
M2+II69VNY%>,+^!7_!-7]J'_`(*<_MP?LE_%_P#:1M_VRM%TGQQ\*]4U^'2O
MAOKWP`^&=[\//%0T/1!K8C\0ZMHUMX>\4V7VQ(Y(EETF^A,3.BLA4G/[=_MV
M^.=(E_9<_:^^'T=Y]I\367[*7Q$\3W=O$(G^P:%KNB>(M,LI;Z9',D$VH7FG
MWLMO!)"IDBL6D21AG;_-%_P0*^"W[3?QP_8H^,_@SX3?''PK\(OA[XQ\::OX
M9\4W#^#I=;\=Q3ZIH,$-W=Z)JD]]%96L-Q:2/&-UO+)"V)8_FZ<V:5:G]NX*
MA0JU5.>'Q_-"$I)<]H^RYHIJ/G!OSMMK>`II93B9UX44E4CRRJP@Y\MULY1;
M:M=?Y'[K_P#!'?\`X*9:[_P4=^#'CW5/B1X2TGP;\9/@SXPM_"7CBR\*+>MX
M0UW[58&XT?Q#X;_M/[1<:<FH-;7UO>Z7<:A=M:W-A.;=C#,M?K;>7LDLMP+:
MUA662,9D,J"X550B:7"CY-KY&1@D$_C\1_\`!/K_`()__"G_`()Y_".Z^%GP
MSN;_`%Z?7M=?Q=X\\::R1)KOB[73:QVYO;I(_E2UM8(_LEI`JB../(.XG=7V
M7JHNX;MFMEAD@;S+F2:\C)AEC>,&%+>Y#CR70!@T3H\:G&,-7TV5T\92P%*&
M82C/$)OWH._;XK7T2T2?J>/C/8O$R>%NJ6CUVZ7MTWOY_<95OI5S]GGNF7R)
M[I'B=A<EK0E1B`Q1GD2NH&YN<G'<5X7\0;<W&@:EI6H6.H7D:1R6\UU%=-#'
M!)-F1AO)^U*,+AGC/E@<]!7KUY<V%]##;1))-.%*S22O)9):(@\\"!ED7S77
MS2T,B+E@Q&.@KQKXA:9K%S#=Z;)]KNM,U"VC-SY4Y^V[L;8_L[2LL[8!!>16
MCP.3NQBN\YS^8+_@HO\`V+KNK^+=/O;A=*ATNVT`QM+JFH7:75J\9M'@N8HV
MCAM8V;`-UN5\[6W(3D?B-\$='\+^$/'_`/;UGK.G>$T>[U&U:*_E?5KW3M4C
MN8A8ZAHZBXGF^UW3([)'+/(I41D*I9J_H9_X*'?LXV7A_2O$6J65IJ&IZGJ6
MB:I9V-FT3WS+?R2+?6^JZA.SO)=11!?+\C:Q0J2`!S7\N>M:+J_@[Q9H6K7M
M];V4-QJ&G:H^J06\WG6EY%(X>"TM#L6*UAN5\Z[GVD1A4R<XR`?T#RZEX[\1
MII6D:3KUCK_A[4+:!]?FMIOLLMG;SJ#-?ZV\JSO!J,[!XVTU/LX8OO\`,XXB
M_P"%?^(-`NDM?`&L->:MJ`M/[0T1[N\74O#^@37)6\OK%(WO+<R%MHADN-L7
MS`RE4!(^8OV>_&FKMX"U?6+2_@O-7U6&XU5KJ.[=+34[Z&5@TRR21A)WGBS+
M;,?,9&.W;S7IFH_M,'X6/J6I:ULM-2OM+\BQUWPM);ZKXEC6^1&D;Q'I<:K+
M!:'#PPW*.JHW3:P`H`]O\9ZG%<_$J\\%W.@Z[>ZSH\.C)IHN;RV6:SN1!%)J
M$]G9P(+&6-4#VMS.Y)6:19!SQ7L>I:K=^"/`\'B32?"^@2>';.^_M>XL?$6L
MRCQNVOV\ACLX=,FA'V:.!)I5#6L"+YFQ]QSBOQ[\8_M<ZG\5_B/8Z;X9OE2'
M3]031+K56>&TUC=M2;S"@)N_F8Y!,ZQRN#'N+<5]._!ZX\2_$37]1TCQ7I6J
MZ7HNES6\=KJ6K7@=]:U%9T6.^M]/9IS:3QL#,DTN8VW@OC`R`?1(N]9^*_BW
M3-=^(,=SX.U]K6&V>PN;E=8T;[!YYGB>.VD\BX@FE8C-NURP8KC@&OIK2M*\
M1:D^I:#X6U#2H;'3+9;W2+^9&LK*816T46H-=VODM,#<-(5CM[>7S86'GQ2D
M\UYQ\4?#7A30E\.WL.I%K:VF\G6;Y=)N#J<LNQ=S3JS&WO'?!`+>2J`!TYP*
MS/#OQLMO"5[J=G8Z-'J=C=VJBQU*WBD\]T0BP:WOX9'EBMKB&U87$2AE60_+
MD$X`!YK\2X?$/@WQQ8^([.]TJ[EU"&W\-WVFV=M<Z@ED)$$\.L618B/[5%,S
M1S0RKYD\6W!RIKY/^.MI<ZQ#=3:E>30^*H72[\+:IJ-C+:VFA-,3#)?IY1*W
M=I<[&#Z9(P*.3(&^7`]L\<?&];"76X+6[TE-4GFLKBPU&]DVKITUHQ6V58G(
MD5U'$B0JS8R/2OSP\1_$_P`9>/\`7Y_#&H:_=ZY>1727%I::+I\I+ZMJ%Q<K
M<75G+/)&TD5C'MF(FVVR@ERK.%%`'OW[/FI?$[4/B3\-K1_&'AO58M$UO3S/
M;Z7H\M]J-P"S02^?81O_`,>Q5P8II"S))\V*_M7^`6@2>'_!6@07>L3W5Y!H
MED"T]IL75+F>4O&KQS,TI5&81[0<X&%Z5_,Y^P'\#;J/5QXTE1-*OKG^S+/2
M/[2LDEUK7O[*N5.JZA#96\87[+<MA7O\AUV_+P,U_49\.[&ZU#055=*U/2A;
M^1%Y<T<=S'(L.&=EGCD_=0YRT`/SQG.0*`/<K&0Z?#;)+'<Q$R2&Z!AFDDN9
M#\QA$>1MMD7.T@\9`/4"NHM;9O\`1IE1Y+22.65G=7:8-(V(;;[.QR8HQR'S
ME<8^N3I:2A(F82W=V854,K>8MLCD*\+>82C$_*Q7.X8)P3C/2I%+`RIMD2X;
M]V3&3<K"@.5;YBH4$8^7:VP\#@4`23P&"U/V=%W0"-A$?-?:S-EI`D1W!^O!
M)Z'BJ+1QK-]FD@GE&Y9C<.^UGV\[D?\`@A!R=A[8%;,H&%(;.UX6GYP"JGER
M>@X^]CH..U<_KU]<0PQ21#:S0NJJ$WLTX_Y9JNXY)[=1SF@!\UUM2-+Y2("\
MN^W8M^_C!Q"\;Q\EF')4_P`>#7)ZSJVI6UI+?03*(8!(D$-X7$V_;E+9G))+
M>668,1T50:YK4/%XTR]M;UTN'M+23S-62V07<5O%;Q_-);Q"0,+E7=!/"%+?
M-D*>:Y#6-?A%\^(0':*?4[@W%YY$%LD<!1QY<)*O-)&R`Q#<5R&%`&!?^*?%
M=Q)JVCBYLK5)+.YEL#,ES-<J)K<LB)<O=QV,[!N1;2HH!Q]#POBZ5(O#?BS4
MT,6HFT\%^(6WW$*QW%K?&P3SQ`[,XA:0DEK8#:W/-9<GBRXU>T^V[[2/P]";
MNUGMI;=YYK:6(G-Q&;M(Y9\@96(KM;.$)'-<Y#XAM]=B\36?AY8=02Y\"^(4
MN[BY3[/%]IM;8CFU4DF*;!+-(@D'1U!H`_/'PUXZO]3*I:Q-%JMA/%=VUAY4
M-O;WD\.2RW,@_P!6US$#%L&=W!)-2_$58/$\$-_>R26T^EQ,U];6ML+NYTM[
MB1&%R#$0C6\+DKYA&]5.>PJY->Z;]KTVXLET:ZUFWDETV^CL;B);.+SIL/+*
MAB21;B"(/%#*FYXB05YKT'PEH]BND:UKD&AQW.C7`D2:X>\\V\F".P\K:2Z%
MXV!1?F!8`9&30!^8/Q2OO$.A64WAKPEISZOJFH27FH6,EQJ:6^@"4JX6ZO=1
M>U\ZXO1%_J=+=AYS$$R@C->,?!OQ'>:UXQT'1?$&G:L/$-G91Q:KK.LWDD]N
MMQ+.QBLK;3XTGDM2`08IH[O[IVO@<5^IEUX9\">,9+]]0TVWL[6&28VJ7LC&
M^F\ICN\E%5?+O%QB/G:HXW=J\Q\<^%[/3/!$=UX2T/3]-U3[<5>ZU":&QU./
M3IY-H2W_`'>[;(45S()`TC_+WH`].U#PC;>)_"=KX>T)+J==)U;3[N>^DM;R
MXB748[:1Y;'1M2F8'RH[I8X9NR-(5;(6O8_A5I.K_8X["]U2\M((;26&^@@G
M(N4U@O\`+#<RB"161,_(L+#`XE[5\N?#WX[:/X-T"STKQ=J=I9W.DRI,+:V8
MM+J<;DH][!;9:59[A^L#XB<H\IP:^OOA]\5_!7B_[!I]O>65Q%?R$'R;<QF)
MWD5E>15=7^T*<(79><G!*@4`=OXH\-76EBQNKVYAU1'BC6>=-L]_)$4"P11M
M"BJC1KA;E4`7&X*H&`&>%_!VF^)X;2*[T*V:"VN'6S1[6YAB2&20AY@)MUTC
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M`KQ/O,91URI&-Q!YH`_G!_:;U?QK'X@L3>:UHEQIEC)?6!U"WCL8I6EMY1<:
M==7$2LKVB2PL\:1PNI9P,D8%=%\$_&5Q>?#JSCU?2D\3>#+2]O\`5O$+WZ2Q
M6Z6EK=%;6*Z>YS+J+[]S0I;PPQ1J`&,W##N/^"@GPE>RUZ37=`N-#@T[58HK
MZ>"]9#&+6W^<LT:R+Y9:(>2=J.';.0:[/X!^&M/\>^#]"@T[2-.;PW9V\-QJ
M;Z.7:-19B%S;1I(D3RAW5F4,,J^4QTH`]"\`?#O0?$?B#1K_`,,IJWAMM4OK
M.^M6T);B*[?3M0DV70"?+&T*IY9"-@*!]W!-?J+HOPZ\):?;3^'#J=WX@U)=
M/NQ-?7=U''J*"%%EM?[1B4$7):7`\L,"%P.#S7P7X-B\5ZWXZU6*SO=4\-V^
MF.JZ3)81AV\J&$NN8ED(MYDCBV<KC=)@X(Q7M8'B;P;#=^+WU[79I-5^QI'-
MJ%M;RFTNGF7(F"!V072Y#;AD!OFQ0!]+Z1)9>#-2MC;:7HD%N5^QW>HP&U2Y
MMI9`&*R6SX7=YF2I+?7.*_E%_P"#CWQ39^*/BK^SS<6D_P!IEL_!/BJTNF`G
M0+(GB$;<+*3'\PR1Y/R^G%?T$:EJBZS!XGU.]O/MNJ6EJ+C_`(1^2ZC2*=IY
M`PFCC1RRR$*=I5?DS@XXK^63_@M?JVMZW\1/A)=ZQ8-IT#>'_$(TJ!H_(FAL
MDU5(A;2P@X/DR1MLG.'F#$L,`$_,<7/_`(0JO_85#_VU=O7\O7Z+AE_\+5/O
M]5??LG_7H^Y_0%_P1DN_#,'_``2H^%]GJVIS:<=7^*7Q-T_48K2,2W:Z7+X@
MM4>Z8D,T3JIR'X9:^V/CAK_P@^&%KI:_"_P*GQ0\:V\ME!IUA>VCR27U@^U;
MN[NY1MWW21LS1,#U7')KX[_X(C^'_!U__P`$N_A5%KFK6>A7VO\`Q7^*]O\`
MVE?3CF"QUJUD:WMT8\S3$[4"\L>@K]$-5^%6HS_$^Q\=Z%<6,7@GP9IR37X8
MK%=L+)4+WC1N`2K`,Y&,/D"N_AVHI9%E25_]S2MMK>/]/[M#S\T?_"AF/_82
M^_;;M_PW4\R^`?Q$O;76_$&M>+;<:!HEN%Q8<VXMYI'$BZ4LG'S*&$>"W48/
M-?5GQ=NO!'Q_T?P['X'O[C2?&NF:8]QJ2V-ZMO+8Z%;KN-O=NS;6\Q0>^[UY
MK;@^'?PD^/V@Z_;:'X<UA;:VNXI/MMC"UC9:I=E#(;H2+MW.LO4C<,`GVKFM
M9\+V7P-^'6MVFE:#;>)_$E[IUY+J,=L`-4T[2$4[!)=+NDF`1?F3KG.:]@\T
M\_\``?[4O@VWN5L-5AFU#2?AF(M+O[EUF:U@@A8QRW=Q*<),/E+')Y[<U[1X
M5^)GAGQQIWC37/#?]D>)]-U&5VT_2+^#9&MM/DQW=FKJJ&*,-N(!.1C`X)KX
MK_9)?X5?%2P\7W/C?19-`\$:QJ5QH-^;N=K8SZJCL9([@D*3&>0<\'VKGOV@
MI[SX17(M?A?JMG;>';.[M[+3]+LYU`U+3HFPMI:2H22\B?ZQB1A<<4`>^?%:
M]\5_#;X;7'ARUT33?$M_XLNO[2TVSTY?.DTG3"=UU"Z0DA'8'"CL,`U=_9,@
M\:?#G1_$OQBURRM=#\-MILEA8>#K\"WO[V8;G\]6D8'`&,KN'H5S7@'P9T#X
M^^+O#7B;XK+K6F1:)IL37$>CW;&ZU".UA!>>V5'!8-@8RHP<#'6K?PO_`&IM
M:_:&\=V?P9UWPK(?#-J\EBEM`CVUQ<WT2M')>37"J@BCDV&159AUQSC%`&S)
M^V3;?M:^)]6^#,?A5K?5I]7GTVVN[/+2:;'&6V.K([CS"1P3\HP,\5YAX&^(
M7Q#^'/Q4\6_"7QSXLMK?X8641M);&&?R=4FNH%9H%DFC*[)7DVB8H0'7`Q7U
MY\/_`(#?"KX%>/O$_B;X>^'KG1/$]G*MWJ.KW,XU/3KVYD.9K:&1LA+I49@R
M+]T_G7AWQC^#/PG\::^/BEH&K:MJ=UK/B.WA\2:-:1R27-QJ,,\?GP``YB3+
M']YP,$]<&@#]$M.L?AW\0?AWH<?Q`U6PBT&6PCCLK*^>.)IXAQ%"WFC,T;*!
MODR6;).:\7^.,7A;P;X":T\#V.EZ-H.FQ*$LM%MHC;:A%M,:GS2&6:4I@Y#9
M!QQFO#_C]<>/?$L7A#PWX5\%16/A7P7864M[:S7?D7?V"&-<Q-*-K&:4`CDM
MC/Y\#XN\5?&#7/!&G:%%X8L;#P;`"]CX:WK+K<MNP)$S3D><Y*E2,\9]J`/A
M76=#U/1?B+IGC+1=)O+JY-RNH65D[^;"X)+B"_3E`'<Y&,;1@<5^Q/[&G[1'
MCOXOV&H^#O&LMEX3\3>%BRV($WEQ-IH9UBA5)&V,ZJ`01GY<C/-?FGXTTC4M
M"\+:=J^BB;1TNR;CQ5)KDPAFT5('*F.TW$M*2@)`4#Z5Y+\.+/XP_%3QI=:G
M\-9]9T'P/INH0V>J^,42=)M3\L[9%3&&,1PS;LXVMGF@#^A'X^_&+X8_#GX:
M^+-*\;^*XM5U:XT"[1[:VN@9YF\EVB.R%\HID(4]&*U_+?XN@'Q3\76OB37'
M23PC:32&RTNQ;'VE9)L0'4"P)D$1P#N;@`Y)ZC],Y_@_X@OO^$@?7[.]UZ^,
M<]A'<ZH\D\-Y:/"56\9I<^6B,=^!TQZU\4W?[-GQ1UOQ`FA>%;W3?#UAIL=T
MTUX[;;.XC?<)6WR8WF+ED`&`W.>E`'.>(=:\+^`(M;@&O^&$\(RZ';K_`&3&
MD?VO3M695.VV>)=[/N`&,E=S?-7#Z#XE^(WC^^CNO!,B(L5I!#/>ZI;I;Z9#
M%$0%C4LJI+-)%D@X).#7J_PR^"?P&\`ZJL_QB6_^(M^VIR/Y-K<2"UN)H)0)
MT:')1P6Z'H<#`KZ/\16/P+^(46H^$_`,6KZ-J5J8+C2++18A%!I,)Y9-2:''
MFRIM4'?SZ8YH`[#X%?!#PX=<\):KX^-N_P#:NI1/)#I4FQ'NS&?FO=J[?(:4
M%MK'&",<#%?K#KNE>$/#^HZ%X-T#PZE\L-O)KL:Z.TJK+-#&&6*X5&\L"3:`
M"<<@DXKX$^"7PNMO$6M^%=`C\07>G6T5JL6M7,]Q@O+;(66ZB9G'E,[*$"@Y
M)R,^OZ?:G\*[+1/#T=GX8O;U_$-S#:V;7YGD:XFL-P61H903M+IN)*GVR*`/
MR$_:;\=?'#XE^+8+^^O='\-?##PVLT$F@Z;M>9ID<*KWX7>WVF!D^:4\#?@&
MOQ[32].\=?%#Q+9?%G7FET@:G')INMW=RTMI;6$<FUTMB&V"1(^-G8]<&OZG
M/C#^R#H&N?#3Q1H/P_NQI7B_5-/,MVUW.]Q--(ZF2Z8%F+"29L?,.F,^M?R\
M>.OV=-9^$?Q5NO`>N:E-KC:W*84LR[W"V,]ZYR$?#8DW<XXP0!QQ0![5%^S)
M\&;[6)M*\)^+KH0:M:C4X9XKPVMQ<K;C*QVXC.P+*,$;L^_6L/PA=>-/A3KO
MVKP]XDEE\/:/?KI]QH=YY4U^U\TH$+31QKOEB?@EO3DGFE^*7P@A_9CU7PK9
MVOC#4O$6N:[H4.IM-()8T\-172*?L<@W'!CW``''`SWKR_X?W&I^#/'LGC/6
M=5.JVLDK3_:;N%Y;6[\T;DEE28&)GA)`7@$`9'-`'Z@^)OC3XZ\6:986#Z'X
M<TO5[C3<1:W!`Z7-LD4>^431;MKLT89D!4[<<]*^+?%6C7?QE\:1Z';:5*NF
MZ!I\MWX@\27@!BOVB0^:+(?<#.05C"H"K>]7/$OBN3Q[KLFL>%_'$>EO;:9,
M\T*694+))$PE,"*-K90F-0./F]JO?L[:1\3O'UMK6A>"+>V3Q/\`:EMX[W5R
M42_M3.RR2Q1.=O[P'/\`3O0!ZS^RE\*_#MA\7X_#.F-)K.D:[;0P75G>MY]_
MI]H^1?NC@[D&>8VZ+P.>E?HO\3O"OA3X<>%]8\%Z5?6]MH"ZC:3>'K34Y734
M#<^9&9WWELM&L@X8`@#.:^'/A]\./BS\`/B=J>L>);:"_P#'%REN+>+3#(+6
MWL,[R)2BE8U;=\_(!QVK]15^&L?Q[\*67C3Q%%8/KL,1M4LXE=RL\<38B@B(
M7+2D;2^.I+=L``\KOOAW\8+?PYX*\5:?JVD1O?R6*Z1=:7'#/*_00M+*?XP#
MMD!.`N[H1Q\S?'7PU\9]0\87<OBWQAIFJ6>D-]K\16%W<*UE:6IC"E8HB>;@
M\?(O&>F.M?3FF^$/CAXJ\$7OPTLM0?PD/".LR-:V%P3%J<^F+,2\^FL2)'$4
M+'&P]<>V/&?CY\&#IWA>_M_AUK^HZSXIFMX+O5)]>N9)+J^FB"^=:&&5F8I)
M*K*JGD]/2@#S+X+?$:Y\,ZE;>$Q->1>']?NIK>PM7B:+2YHIB4,UN!D!U+`X
M(ZX('6OI7X7>!/"GP$^(5WX_\5^'M+U_4-1N+B3PT]M#Y^J/%*WF23F;!8-#
MOP`0,D87FOEKX(_#/XRZ2^C^)OB/9VFC>'8+I]0M%U:W2)=)2#!F.Z4*Q68?
M,BJ,``<U^HGA#PYX.M?(^+VIWB>-+*]B-MID$3^9IND.,;CY390"4J""!D+S
MVH`]+D^,%]X[\):YJFG>%]0T$64%Q;7.H7\;,;7S8RT<L%NX'52K9P<=.PK\
M_/&WAG2/%^J?#F+Q5X^L_%$%IJ%WJ.NZ?A%CF@4.(;"Y1?W\=V&9=A0@<8QG
MFOT_\`?$30/&>CW\]QH5MI>EAKA;ZY;[/_9TR0XC0$\9;:-NW;VZYKYC\7?L
ME^`)_'6H_%W3-;CLK"U$6K1:5;3D6LLRR(Q::$N%6!`2Q(7!]QQ0!\YV?B'1
M8O&\>C:[X='A7PEHUJ(/#>I3EHKN986WM'!+/ASYJJ%#-GY#7B/BG]HGXS:=
M\9/#G@KX6/>2>'?%E]-8W>II92-)86(1U6..8A;=I'8#]\1N5<E3NK[:^+OA
MWX)?%#Q+X3L/$7BQ;V\NFB_LB'P\Z.D-Y;QC,,YB8#"LN'##YL$8KV8:#\.-
M%\*2^$-$\/"\\4:3IEK/;W]O9QB]MYKABMM/+,1YD0,@7=ACGF@#RB'PIX`_
M9_\`@7X[\9^,C?ZGKWC"SN[OQ#87U[]HN-4U4(WE1QM'B2-3@,J[OE(%?+_P
M%F^$G[07@-KS2/`6H^!_$U_<W"CQG/+-)-%)ISRR01W5U*S"-<1#:%89C&*^
M\_#WP;M/&W@_6_#/Q3C.H?VG'N-N\I:6UWD;)$?/[MBO`Q[CIFNY@^"_A3P?
MX&TSP!X$M--T#P]:3(=7?]VEW<*P.Z3S5_>/*X=P>0.:`/CG]G[Q3XH\=_%2
M2'6-(UBYTKX<6UUX=E\1Q+,MIXC*LT"W2W(&YXXE4>6H(QCKBO2/C#I>A^!?
M$TIT2UO]:\;^([!H])@NHYI()5<LT5O(8=I>2(N0&DZC&37V)X.@\$^#;-?"
M?AF)1]CA^TSK;P[V9I%\QI)),`RR.23M)//![XYK6]6\)ZAJMCXIN=#:;5=%
M>:*"21HTF@=<B-Y8R<HI8C#8&!STYH`_,;0?#_P@^$MW?WGQ.\77MQ\5O&SN
M=-\$JXN++PU?SDNCF%PQ@WG`.\C<ORKS6/#>?$?X1>*/"/BV^\:F:3Q9JM];
MIH)LT\G3=!DN)#'=(@7SE`!Q"6^X,9XQ7GG[:VN7U[XIE^(GP^\)Z5_PGF@7
M-N/%=X;A+VW@T^.4F":50'"3,=IPO/8^M>L?!7XJZ+\0_#&F^*/B0NF:9XJL
MX5TF*74XMT4T,Z[3);0R*!%&&.5P.OXT`?3E]XD\8>)[#^U;/5_MFJWBKIUE
MX&BCB$]W9^8KC5+@JA8EX4::,2':0>170+H;?$K7(/#6A>#?[!N/#]I9QZWX
MDU22;<ERH61XH(-P4J6#*6"8`X&*['P5=^$3HL\FBS:?%KFG0QR7>O$Q"=%B
M.8+=F<CRHY8UVQ*A.8VQWK-T[XI0Z?XHU"UL[F._UK6)H$"1PL"D/DKN>YPI
M54+?,'/5<8H`ZO6OAY;W=FNBW&E:/J>F::OG7%Y86Y@OK:\8>6+BUE0AFE!&
MYRV2<XK^?O\`X.8F_LC_`()KMX>^S1SQ3>//#AMKXR#SV%G;7V5E3(<R`'!)
M&,J1[U^SVM_%#XH0:GJ%EI#OH]K/J:V<<UW8C[/=LLF9A:3$9963[IP1GH:_
M!3_@XMB;Q#^P#XR\4376I7,EA\1/">EF"ZADMK:"Y>RO?M<MLK85M[)DLH^;
M<3W-<.9_[C)/;VJ[]H_U=;'3@/\`D989^4O_`&WT7X_?U_S'1_K.F?WWX]?Y
M]Z_M5_X(WV=IJ'['T\%GX>T/Q)?OXDTF#4(-6O'TVYTRQN?#EO`E_872[&B=
M;@R.WSX+XP-A./XJA_K,?]-CWQW]?>O[C?\`@BK\/O'>N?L0ZAXH\+16[Z=;
M>,=#TW4TU%C;P3QOX?M<1I<&*16D5F:2*)@$9S\S*,FLL0KX_*%_T\QO_J$C
M914L-CHR6CK?K$^X_B)X$M1=_P#"+Z#`MAJ>FVD>O,MK)--)+;P,L%V?[021
MM*983/YIBNX7EGWD>8<A5\S^'OPN;]FFZ^(?Q`\&1";4OBUK=SK7B:_T^2-K
M&U>V6.5_#L/AV"W2>U:YO1->_;H]LLDDLR)\FPGZ0\:^$=3\`:=#X@66*6_N
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MPWX)TOP_K^@Q:!X&T;1_%FCZ#X:CV^(;R0S2VE]"F(7M[2*=))9>S_X)O?\`
M!-;4?^";_A'5/ASX"^/<_P`4/AUXCU^Y\3:IHOB7X9V.EZ]<:G]BBLX7TSQ1
MI?BR>*VMQ!$K/!-I%T78D"51@#]'XX)(].M+5K:&2W>&+9#N>3SV<;V>:6(?
M+;/D;%89+JX;C&>FM3'IMK&]XSI';J5DMP_[R/?@CR8EYV!<`/QM7!/2LEE6
M'AB*6+A=UZ&E.4G>5G:_-+OZ=O)$SQF(JTYTJCCR5&I345:+:V25M/T]32CG
MLY)DM4@N8)IK-RDCO(DQCWY-NJL"(S$X_CXD7ID&J5[8W$JM%)>V]Y]J,4<=
MG(1&+>!0P,:PHH();EG_`(FS@XZ7)KFW?3TG6XF<>7+)"\C@VT@?/E1M=H/D
MD1B$0OP#P1GJ:9(C.J27$<FK2QK).\6QH[:';A$67&',?5R,9;/X>H<YQ>HV
MFHL)%CTV-A<72+<*XC%O;VEO:);-+ORLBQL(@5$9\P.7+#D9Q=2M(+))X-UM
MYKQIN=\7(CCVCRS:3S/N$H!R8W'.`"!7JALC-BU5XYK>%)3=RLQC^T74H<#R
MHVR5^0IN(QDJ".E84NBQR0PQ3VI(MY/,EE?#S2E5VK'%&0-RL."Q.<<^]`'P
MA\9OAKI'Q&T2^%UH5M=:E$MS';3/"VF/;2V\3&.Y@MHI?+NIIL;KAPYCFC+!
MHP#BOY3_`-MG]DW6],\:2SBUT&/5-4G-IH$HLUM+./4V(B31[&XD?^S['[1O
M1Y#<(4GN)0LS;47']GGCK0;[4+51:)%80QM/*T$,P6_M53/ERMD967(#(F<.
MAVMN!K\T/VO_`-FJW^+?A>V74([2WEAE?5]-U&Z$7VG[?;QL+<_9$P&DFF_>
M)G`+1`MG:*`/XR/"?BWQY\+]7O/AWJGA?65L]"\1-:N==OH;3SKVT):\@EL-
M*D"W`@D+>5]AQ:31A<Y!K"^//Q`\106=K:ZOH5KX>.LI=Z38Z]I\Z6VI7?AW
M5G$D<NJQVQNI_(TRX\QPES"C[,(K=:_2[XP?L5Z[X$@&M>*[F;4+B_LR/M&N
M?Z7:Q7UQ=2[M1T^9?+OK=KH;(WCPRQ,H*'&:_+OQY\+/'_@3Q-K>I/\`#[4M
M=U,Z3$&$)N-6M+?1_.817EM)=S(7O%D87#VNU5>%=JDD\@'G7PT^&OC'5+W1
MYY)H]4\+Z;J-P=)\6::+1[UA%*@M[Q]6M;6*>2))CDPWZN8Q\KL,9K]]?V:]
M$TS0KC0O$FI>([76;?4;ZSAG@LM:6]N[_59E^R2VUS'-%"+01`>9+"N0KQAX
MS@-7Y%_"+XPCX2Z'8VWBW0K9X=7MK^QSI<);3[J[B9I_LEN)]T4=XT.9+NT$
M99F0K'O.*VM&_:T\3>,O$!N/"WA+_B46TS1:7J]S87&EZ3X:?3XV0":S\M)I
M[N3S1(S!20"Q&`*`/WP^+7[05O;ZLW@.-_#L,VK&>S\0V=U]E6X73X,K&]I>
MRPLGVM@%W(A02ID!\FO*;:^^'O@SX=>*H;FPT&PU#6/[2U)=0WW"W4D!MR;=
MM*9I)H);V%U#+#L$0D`WC;FOQ-U+XQ^([KQ?+J7BV[-IJ.JZZLMM:7\TYL[:
M.U0+'<VL_E2.D%\Z[[:&?$>R0<XS7U=9:WXR\=>$$U/4]-N=+U/7+F>'1-&C
MF$TDS:/%%-+>V;A$ECLM0L?,DE'D-;!AY;$[AD`XKXB?$+3/$,MAH^F75LNI
M1W4K6%W<06<FLQ1-"[K=GSK6"-YGB).5\V)`06&0#7M'[,_P2\4_%*^\/Z2?
M$/ANQEM9=&GU#7/^$9M?M6M^&8]5>>[T>:_@;,6J'[C7=EMN+E"R.``!7IG[
M(O[&7B#XUW0U3QOHEQ:^%I+U]1\.ZMKSP?VFURKF.XT[1+%HDNH;/R]@WWVV
M#Y?ER#BOZ6OV:/V,?#7PHT73=+B\/PQ#2U;4SJ"65A]KU2YEGCN4G7RDP(H3
MMC=4)!<-LQEJ`/6OV<_@EH'@?0=,DT"""]FE2VBAU1--AN%LM,DA$=QIUI/)
M%#?Z:P?!D3S3D@G))S7V+HUK96]A';Z<EQ)+!+-'>7BQR0LVH0S;/LS!6,4:
MI\I:5E;*GG)K#TO3F\/Z-<FVAOY#8_:M7>'3(`EQJ;0123K9-#*RJ;FX,?V>
MV4$!I6!.!S7Y`_`/_@K/\1_C7_P4\N/V$M1_9I\:?!3P39_!'Q!\69=<^*L4
M.D^/]<U*RU"&"#4K#3--GNM/M_#UWYABMI;B5YYV@D)$?W:`/W.@GG40_P"@
MW<>+IIF8!9RS\(0T4`">7SG<Q#+C..35L2:BFH2S3&`6S;A!;)*D<4VTC>[R
M?-)YT?.(P<;1@\\U_.+\9_\`@LE^TH?$/[8OCC]F?]GSX<>-_P!FO]@_Q/8^
M&?C7J_BGQ;JVD>/_`!O?HL5UXBD\"V6GP/IEL-%LY/,!U.11=/&5R,UVGQ'_
M`."O7QC^,/Q;^%'P6_8$^%/@7Q_XG\<?LH>&OVP/&7B#XM:_>Z-X<\(>`/%6
MB6^LZ-X5MH]&26XN/$^HB7[&T[D007#*'R`30!^]VJ^*;:SOUM)-D,.Q7:\N
MX)%@1)N#",$+.I_O-]WDM7@FL_%"22YT]8&M;6VC6\;3H#%->0S&U5@+D7S.
MLJ+==8_,8E#C.:^"?V)_V[KK]NWX`Z/\78?#]MX+U&;Q9KWPU\:_#B[U#[=%
MH/CGPE?MIOB!+#5RH:XTN21/.MRP5A"ZYP0:^6_C9_P5^_8@^'7C3XH_"SQC
MXUU2PU_X*^++SP;XOT;1_!/B;7+OP;JEM)LU">^?2;.>W@T6R;+QZC=SI`81
M@_O010!^N.D^*M-U6SNKJ_>2(:5*VHM91Q&S2Z:4?-#Y[G?=QE\2R-@LS*J`
M["17#:IXAN[B!IFD%]Y[CR[O3;I;*6Y,$6Z%)X)T$<=S'A0RY$=R%&\'K7Y9
M?%7_`(*I?L?_``HTWX9WFO?%237A\9_#\GB;X>WFCZ5J>I)K^CZ:2MP;"*U@
MFF,RD>0FG)"TTMSB(`,1CP6^_P""\W_!/^[\/0WN@^+]>2]N-:N-%UHZSX,\
M17*^%Y-QBBU+7K1+4+X?\B3<#]N92&#)(%*D``_6C7_BEJ/A^!+Z6]M9(KZW
MN4M=/U*TM;W?>2Y159D5(#<Q,#L"-MC.-V<5QOP?NI_^$TN9K^?48&U?P1XE
M8:.9(8X%861D:^DB@#@+.2\<L<SY20#H&`/QE9?'5/$/A>^\<>&H;'7K`Z;]
MM2>*W^UZ7/IVJ1B:UUFQ53+;PI<QNLCI&BNN[&0<UUG[-'QH\7WVNV>L^)_!
M\FFSZ7X$\=:I?N\;6\5K!!IDC[Y&8B.>RNV6+RHW(ECFZC!(H`]ULOA1X*\/
M077B34-3N(+6V275+S3YU58=1EN7DDD6R<0^8\[M(L=IM?\`UH^8`<UI:9XP
M\O2)-.T#07THW,"M!I$EM&\EDD<QF@EO0V8B;CAW=2TA+,&``%?**?M0OXK\
M6_\`",7BOH7A^XTR'4KA-2"SV<TEUEK.*PF23S(K@&,^5&`59R`5QG-KQA\1
M_$@5H?`NH"_CN686\TJ'#"&-'\@[(UD28*<,O*O@X)R<`'DO[37Q<U#X,/X?
MU9M,UK7[[7_$HT[_`(1CPY8G4+G39;\/=3:I?10QEHM-M8OWCM%(R@?*1Z>>
MZ_\`'7_A+M`GMYHK:YUF]TZ$Q6EW96UO9:GI4+[C#=2W;-'IY8XC,FR.9?OQ
ML"`:\I_:`^)WC32_#-[K&NV]JU^][:0:-<Z7"\=QI>H3@F=KC(:>1=27*K':
MK^Y3Y7X!K\P-)\7_`!>UGPW\3M5GU^VO)+K6(;?1?"M_#>6NI2QQ3*+Z*>Z:
M``VL,3(]N+=B)`W(XH`_4KPAX>T;7TOO%^N^+)-,TN3^S=+M+&ULK5K/PUJ$
MT5W%+H$FM"*2368+VW5Q:7&T7%H\>Y6(*L?JGX&:#H6F6L6EZ3(=4U*WU:TN
M]#C2*]2^M=.C<N\-QJ9"?:3R)%:8,2&*DG@5Y!^SLMUX@\$ZC8:GX2M[:2PT
MKPK+:7$]KY.G"]DTYD,D4#Q.MQJ6\21I(2A\O#E]S$5]PZ#96?@O3M)2^AFL
MY-6\OS[V`-,=,6!-S29CW2M$QP%0$8YZXH`^G_"^MZU8*?\`A(IFBM[=8H+/
M4(YWAD#3H'C7RU`5PH(60L"^02?6F77BS5-.US3[&&2XU&PN6>#5I8RBQI%=
M'>@F6/\`>7A[H[#`Y!!/%?.FK_&"`FUDL(I+F#>87O#$Z&/[%&;=KN*"8[V2
M1UP\A7:&))85N6GQ.M_#WA#Q'XYD\/:IXUUK0M&AGT[PAX8@M;SQCKLMS.$M
M[+0K&YFABN;^4.?(".I^4_,!F@#[<TKQ>9],>TTF[ATJ]@N3:"VU6`6]O>EP
M%A*R(I`@`W!VC!+F15<@@`_!/Q]^)%SH_C'5GU>YL+?48)([:SL;>=39744L
M`AN4;[3(!;M"5+QM$%E=/FP3T^#/V9_^"EM]\>/C%^V;9_$/X8>(_@GI/[-&
ML:-I&@>#?%ISXQ2RN-)NM1U!_%]G:RRZ?::K$]IYRQ6DDFU9H1)*Q7C\T_$W
M_!1OXN>,=#\,?M7>-?@_X(OOV5?&?QWL_A9;ZX?$5W<_%#3(+O7QH$7BB^TH
MP#2$TXE9S'`T@G$`&#N'(!]T_&K7]'\<:]H5Q;WUYBZCN&O8[(VE_IEU9V8%
MM;Q3-+#*]NBS_O&970R,K-(37T5X*BUSPYX<,6FW5R;F[M+%)(=!T^$>7(T7
MVE)8-1B2.VDNF=88Y#.%!B#QXXS7X[?$W]L3QYI6J_M.?$OX`_!_P7KO[,_[
M,OB^P^'GCC4?$6N3Z5XN\17ELL;ZY-X2LHHC;106@:XG<W+.9%"'!-?LU^SK
M\7?"WC;X7>&OB>J6EA\/-2\$P>*6F$IF-OI,NF?VE<LX8(MX]C;)-YL4:-,/
M)W0[B=M`&G^SMXRN['X@>+M!UK0_$-MXB#2O'J3)/I:7/RM->O';N\D1#-)'
MF6`%+H[=H`3!^[X/%7A9O#DPULZ9`+ZXC2>+4KR*VU%P%V+<212LH$RRC;$0
MJ;_E:OP,\&_\%*?V1YOBUX6UOPU\9M3UO0O&GB#^R-+\0:OX;UZVT"#5KBZ%
MO;Z9J>O3V*VFE3R[8X;73I9BVTQRN%WXKZQ_:6_:N_8?\.>+_'O@?XP?%[Q/
MH'C?P3H.AZUXLT'PCX6\0^)=6T;0]7MUN_[1AMM&MIHKFPMK.2+4)]0<K:6D
M*OYTBDB@#[)U*#P3;7C7OA(2:=YDE]9:S.'BOC>R2#S(I7DNF:6!UF`,*6Z^
M00"!D$5_.G_P<`^";+PMJ?[*.I1-=2:CXF\#^.=2U.\O)S)+<R)XFB2/$8"I
M%'&K$*J@<'\ONW3/^"C7[&=GXG\#:=X-^,">*M&\56^G:3X3N_\`A&=>@T#5
M;G9$L=NWBW4[2/3QXF8F,76CB5WMBS(S!PJGX._X+^>.[?QUJ'[)FIV\[F-?
MA]XN!L7B:,Z>TGB)&$2D_*ZNFUPR\$8KYCBY_P#"%57_`%$QM_Y+\]O\M#Z+
MAG_D<T_^P9WV_D^__+T>G["?\$6/V=-8^,'_``31^$'B$^*/)L/"'Q8^)6K:
M5HJ1SAX;N/6K1[BYVQ/FZ0.,>7+E>N1VK]_1X5^%&LZ/J>F>*_%46D^+-9TN
M#2]3M8=0-C)/"L*PQ-'IX9'5)E"^<`A#G)?M7\W?_!%O]OC]E/\`9U_8)^'O
M@7XD?'_P?X%\<_\`">_$1KSPYJNK/:W>C66K:Q:7.E:A>6OV=U%OJ$#AXFW,
M"<JVT@U]YG]M?]@[Q9\=[?XM^+?VM/@=%9:)9F!+7_A*YD:^BMDVF18H[,QB
M=^6Y&>.?2IX?Q^`H9/EE*KCL)3K+#)<KJ]^5ZVU5UMIZ[G+F6'Q53,<6X8>K
M.%6K[2ZC[W;E2ZZ:W\C]6%^*/@[X)V_@_P"%^C&'6DU"UDMXKK2/+<K+\ZQ+
M=20#*O\`,=QDP>>N:Z)/A[X>N])U+Q1IU[J,6M6]K=/JEK-(;@W-O(I>2R*3
M$AD"DJ(P"H'05^87CS_@HW_P3C\,VTE[\/?C?\&=0U^YA>;3;T>,&GDBNY'$
MP-PC67[I2>HX('I7FGPZ_P""D_P+\=^%/%<?CG]L[X#_``]UF^U6:#1%A\4S
MS.+(Q%/-:);0;1V.2<YS7LK,\O?_`#,<#_X-]/+^KHXOJ.,_Z`\3_P""_3_@
M_AYGZ)?#WX0^'O'7P\\?VD?A.RTK3=7U26YTG1F8V%Q;:BTK[M8E="A"8PY[
MM@<DU\^ZU^S#X/"'PO<>*K/6O$^D2+J,T$]R_P!F$%O^]EL;:Z=MBS3*/+CR
MV05)7DUP4'_!13]C/0OA??::W[8_P.O?&5I;2V275GXPF5-7MD0[+@[;-622
M0CA&&0>"!7S]I'_!1+]C_1/!VM7>O_M+_!SQ'/JDL=S:Z1;Z[(^K27T98PPO
M<_91+';E^&;D,.HH_M/+_P#H8X'_`,&O_(/J6,_Z!,3T_P"73ZV_X/X7ZGV3
M\(OB[X1^'/CV_P##NIV#?\(.VERV6K)(/.MX+P9C6.3JK$@G)8?,1G)ZUZ%K
MNL_`C3]/U?3_`-GOP_YWC[Q),VHR^(-/MBC:0I<O++-/QMA0,ZY'R*N0.`!7
MY<?#;]KC]C;Q3J6N:UXD_:?^"7A73_$JN]]I=[XJD^TQ7$6XPI`CV9V*0N-X
MY)R<UN>'_P!N_P#8WT#1/B!JGAO]I;X.Z#JUF\>EZ1:'Q+++<:Y9K(8YVM0+
M3)@ND_?;ACY31_:>7?\`0QP/_@U^7E_5P^HXS_H#Q/3_`)=OR_X/X>9^HNA?
M$7PQH/@9_"^O:+>^(/$U]')<W^N6@,MK]K92C:@LZXA`1OD88R6_VJ^7KSQI
MHWP6\0%;^UN;IM9_XJ1],2`9O(HV,HF&%)20YS(P`8C!8G''G=Q_P4._8=N?
MAKHMO'^TA\$-+U&ULU-UI]KXJD-]=7(Q*\<B_8LJLTPSM9QUYS7RUXT_;I_9
M2^)%H/%,/[2GPIT7Q-X?BD@%IJ&LN/M>FP@)-IUJAM-TGVF%`JN,@DCG/0_M
M3+O^AC@?_!K_`,@^HXS_`*`\3_X+]/\`@_AYGWEXJ^/\OCW1$\;K::=X.T2_
MNX=-CL;I]]SK$<<BI$D0ZJP/#<<FMFR?QSXP\>^$-2\`^%+.Y>QT&XAU6YU2
M>=-,*(0B@6K,(C+M'RR;`>X-?EF/VY/V0]?M-"TZ;XP?#.PAM=0LI;%;S6YD
MM+.5I09KJX46>$B#@R?-@XKZST#_`(*-_LNZ9K'B-[S]I_X)65KX5T@VVE2Z
M3X@D5O%L[QXCAM$CM-L@A.!(YP>"2<FC^T\N_P"AC@?G5?\`D'U'&?\`0)B?
M_!;\O^#^!]+7OA'PEJ&I>,-$^+WA"^\2:T%>_P!)\/6$EQ:Z9<AHR_GPR1.$
M9$?A@WW@.<YKZ7_9$U_P1HW@V_T2ZM=*\+2F[G)TVXL8Q$MJCM&I!="#A66,
MOU)&<\BORO\``_[>W[->OSV=_P"-/VN?@?I/]KQWZ7L]WXID%UIME+(ZV\*1
M"S8B5(V'&[&1[5YYKW_!07]G/2?$T/AFR_:4^$&K>%-.(ME\1:=KTT-YK%ND
MZS1&9EM!M7(`D)_A!]J/[3R_IF.!_P#!K\O+^M`^HXS_`*`\3_X+]/\`@_@?
MNO<^+?@GXY\2W_A[3_$-G8ZIHEPMLFE1#9<ZIY&);I1%CYH)$W!!@H0<#KBO
MDO\`:(M='U#7M"\3^"O"^J:3X9T,7=EK\,:_9HKQ7^4/-'#LRK@%AN&1GM7Q
MQJG[57[`VFWT7QD\+?MD?!FV^*$&F)(^@?\`"0R2VLEP\0@$0D^R;=Z<.ZX'
MSY%43_P4%_9;L]+DOK_]K#X/>*_[1TZ^G\2:)<^)I8#+J$L;"."SA^Q'<8'+
M;"<9P!Q1_:>7_P#0QP/_`(-?^0?4<9_T"8G_`,%OR_X/X>9]"Z%??LR^-KC_
M`(1*]M=+\/W]K!'>R>(5?RKW3W(+S+&LA(DE8X(."6*]:[G]G[P'^SE\-;CQ
MIK&G^)M.\4W?B34)&M=6U"]MUNXHU\T21F-^(^2N%XZX-?@)8?M*?`;Q!KOB
MCQ.GQY^%&A2C5GATP7OB&96FTI]ZR-%!Y(,KP_(4R,<<52\??M)_LY>']!TV
M'P/^T!X&U*[OY9O[7$>O7)FDG.UWO$`B40J#N")_%D9Z"G_:>7?]#'`_^#7_
M`)>8?4<9_P!`F)\_W?I_P?P/W*^+WP1\5Z-:ZQ\3O#_Q*U+0-&U*:'^P].TI
M3):H[S+Y,K/;8C:.,_-@C:M?H7^S5\6=<D\%>"O"WBZ^_M[Q`;-K9O$DR*K7
M?3RV!^^F.A)(S@U_-G\!O^"H?@+2?"=OX&\3_'7X?7?AWS&LQ:^)M38RP6LF
M8FNHBUNXQ"3YT0)W,NTCD\?8'A+_`(*+?LJ>#)8;+PM^U'\(;Q8_*-UJ&M:[
M+:K:2L^]HK2/[(28T)*@CC@4O[4R[IF.!_\`!K_R#ZCC/^@/$_\`@M^7_!_#
MS/VE\3_$^TTKXVKX337;:PW:)>2:Y?W<B0I9K]F/EM`)?]<Q8JJ+&-V2"O2O
M`?#/PJ^'$]S\0?BWXD\&IXHNM*GN)?"]]J5K,UQJU^N7AFM1(&+P^:`P=0`.
M,5\2?&']K[]@WXI^+?`/B9OVT?@78:N(K%O$^J#Q7-&]JMH`S6D<,=K^_6<@
M*0P(P,MTKZSTG_@IW^P7I,RZ*?VP?V?K[P_;V%O;V<ESX@P;>2)%1@+=;/:Z
MOC<21UI_VGE__0QP/_@U^7EYK[R7@\8M\'BO/]WYI/?^M4<%\.?AAH'[0GC+
M6+KXV^#4T5%62[:ZN(%M[=],M'VVUE;R.H<@J$$N#@XYXQ7`?M7?L;VK>`=4
MM/`FEZ;!X;U..>;0YK<1PO80VT3.#+*%5VR4^1@?O$8/K]$^-/\`@HQ_P3>\
M26$-OIW[7OP#L9WAAM9KI/$+0&.W,L<ET((X[,`M,%(RXX'!KY>^(O\`P4,_
M9/UWQ3<64?[7_P"S[=?#;3[6UTG2-/7Q;(E[<+MQ//<8M=L8ZY)QD'WH_M/+
M_P#H8X'_`,&^GEYK[PC@\7)V6#Q73>DUVOOZO_,_,#X;ZY#\.+)])UGPI_PD
M4VC-!9S3R*AO;F2:<6R0J0"6B+N-[,3\JX;@FOIWX%^/?".E_'.PTJ=#X1UN
M[=)]/TU[DQVQF8!UM`BL(U#M@*2,`M7QM\8_VF?V8=`_:!8^$OC]\)]7\$:Q
M:QW+7^E:S)<:9I]QO4.LUP+3:'7<S^N1GH*\M^+WQ<_9ID\6-XL\*_M*?#6]
MN+:RMKJRU'2O$$SZDNHP[9#`BK`K!004'88R*7]J9=_T,<#_`.#7_D5]1QG_
M`$!XG_P6_+_@_P!)G]8/AKQ7X6\4'4=*N=,M8/BOJMA<6VGZ888[[[990$".
M]FG=7Q'C!1"WR#.T5-\3#\4/AY\([B_\$VFD:QXU1H(-,TJ!XH([%]R&:Y*<
M1B6,;B&QG@@'I7X=_L@?\%-OV;/!MQ9Z[X[^-WPW75)TMM%&HZUX@EBU*RMV
M`2[F<26Y90``00<$8(]_K7]I/_@H5^Q7XN.E:#\-_P!KOX0V9CM!JEWJW_":
MS11SWGG1YLY66S('4@Y!XX]Z/[3R_P#Z&.!_\&OR\OZNA?4L9_T!XG_P6UV_
MS?X>9]L?#CX>>-_BMXGT'XB>-_B"^B^//!ED8I="TF[BMK5[RX@218KV"-D2
M97)*OO5MY.3GFO5/BC\.8==\,ZMKL*V'_"R]!TZ?6[Z:WF".R::'FBB2QM]J
M2^85!*O&0[,,YX`_&3P1^U#^SG:?%/1_$6M?\%!_@#I?A..RMKS5K73O%UW)
MJ=[JD"+Y4-PSV2H\,;#:Y!.1@`=Z^I/#7_!0[]C?2OC8/&>L_ME_L_7OA[4-
M)FT_798/&$X,L*_+`BV#6C)N=0/,(4@DFG_:>7_]#'`]/^7K\ME;S\]T2\'B
MU_S!XG_P7IT\]=;_`(,R/V8_$&M?M?>+O$D7Q\\1ZIHVE>#;J6.R\/RN-*CU
M"!9#'&)+>+RPT6U.$*X`Z#)K]D/"WPZ\`:+X/GT"Q\F3PE+&J16,[I':PA0(
M_,CE)5@Y&,/E2>['//XC^)/VT?\`@G;/\0-5U[PE^UA\#](DU^5RUY!XD>&S
MAABD=F,BQ62KO.[[O?Z<U]`Z[_P4._X)WZAX#U'1H/VV_A!_;-SID-N(X_%\
MJVJSVR+F6(+:@*9-A?&<Y`'.:7]IY?\`]#'`_P#@U^7EY_UU;P>-BUS8/$^]
M:W[OO;U_K[C[^\"?`GPEHUUKJQZE=:EIK:B9[;18]1FDTZVMY,.(FA#F&3+]
M05((Y/K4'Q'^%UO=)<SV-MJR_;+0Z;)IUG=21Z=!;3XC9_+5PN4CY5<84\KB
MOSS^'W_!67]@OX6^%])T2Y_:<^%GB;49())]4U&'Q,\CB0$K!"-UH?,^51T.
M`#7D=S_P6Q^`%_\`$RTM[;XV?!V#P7-]K:6XN_$TR0QV\0RNYC:_/<N!\J$;
M0QXH_M/+_P#H88+U]KOMMUZ_BOG2P.-W^IXFVG_+OKI?];?\.?:'@3]B*[\*
M^-YO$<GBQH/#=LZ7VEQW#F6>UGE82-LE<MY9YVDC&1D'(KH_C7XMT?X=:I"-
M"\4V]YXF\3+!IFL7]U<QB"QT^Q4-;101I@1.9``2I&2:^7[K_@M!^Q-=:'#%
M<?'CX5B"74'M[B%_$,KSR6@)!N$5;7<L:_>S@''X57/[8_\`P2?\32_\)%XM
M_:N^#5U?7L2W`M9?$LNVW/$B1",VH;S8VQGH3C&,T?VIES_YF.!_\'/R\NXO
MJ6,T_P!DQ.K7_+I^7_!_JY[;I_QF^(]C'H7AW5[G^VG\177EC4M!M7NKC3K#
M.+>:ZF4,-H'+A\]"?>OH'1-*\1^$+;4M<U6ZN_&>FW%C)<27BW4ABM9'+1VR
MM;@A!-$Y"NH4%=N.@K\E_#O_``55_9$^'7Q,U_2/!WQG^"]_X$NIXX+'5M2\
M32E[6,C:\MONLFPA4D\X"\9X)KN/B3_P5M_99U>R?2OAE^T[\&]'72[9VO\`
M^TM<<6&KWUR0?+MB;3]X(FWMN'RYP.M']IY?_P!#'`^7[U^7E_5T/ZCC/^@3
M$^?[OT_X/X'Z$?#7Q-\3/#'C#5+GQC<:+I_A0J]_+/<B,W<6FO&;B%5?&Y9"
MI5!D^W2M_6/^%2>.]*UCQ9IGB?5[+^UIY;:0Z??2R23S*QC4>3"V4A,A'4`#
M.5S7XL2?MK_L\^*K47NN_MW?`^TBGC`\1::/$-P;BXC"[A;6:&U"@H?W4<><
M?='`YKIXO^"CG['OPU^#7B*S^&_[2?P9U3QSJ-^T5G+J&M/&;:S.Q"]O#]D;
M?*GS2\#&[J11_:F7_P#0QP/_`(-?^0OJ6,_Z`\3T_P"73_N_YO\`#S/T7^$'
MP:\(>$I?&NH?%/24L-/UN_>/3K_7;]3#XIA+;[6&6.X+;]WRY+`X/H:]*F^!
MGP9\6:YI4^H1:7;POOABT'2/,>WD6!=UNZ36V(@5AV%\8^?<3DU^2T?[??[,
M/Q2\'Z'X!^)_[7_P0DM84BU%?%+>*I[?4M-O7CR]H(%L]PCA8[1V``QQR/>_
MA)_P4-_8%_9Y\$:IH^H?MG_"CXD>(+RXO;K1Y[?6IKAM*MG1H88%DDLR<E`N
MY>#N)'2C^T\O_P"AC@?_``;Z;:>8_J.,_P"@/$_^"GY?YO\`JY]=^-M-^$6F
MZ]INGQ3WD.B6.HP)J45I=RQV92S9!]FNIHW$DY(3:RN6VD_C7JVI^+?#=S,E
MKX"\%""XN;.QGD\46MNDH&DP*B0XF;<[3.@V?>W8..!7XH?$']LC]B#Q5X#U
MGQ;H7[:'PWT[Q!)=W.H-X0N-9G%[=7LUPTABB`M/DBE&0#SP0*U_A9^WC^RU
MI/A&^NX?VX/A=H,AT@&/P_J'B!IM12]AC9OL5NSVOW'D4;<<#=BC^T\O_P"A
MC@?_``:_+R_JZ#ZCC/\`H#Q/_@M^7_!UU_,_5OQ[X]N;FZAMQ9:M+I336YBU
MV6P6)]$NK/$EQ;6EN8P)&N,%%F4;LD\\BOP\_P"#B/6+K7?^"6^KZC]J=X'^
M+>@R"&XL8[6],1M=0CB2X*JI8KM;86R2/FZDU]7^.O\`@HS^RQXL^#'A"71O
MVP/@Q9_$2.[6/7+>_P#%1C:'3IPT0N!%]C"+<J/G'S$Y'TK\&/\`@KA^W-\,
M_B[^PYXP^`WA3XK^%/B3K6G^/-(UJ/4M*U9KRXOK6RM]09Y[6)H8V>WB>62*
M1E&$9.>&!KDS#,LOJ825.&.PDZCK4K153?G:CI??1=K/\3?`X+%1QU"K/#U:
M=.*=W-6:;M=M6TMTZWML?P6@CS,'_GMVZ]:_OR_X(!:]<P?L.>(-`AUBZTZ#
M5/&.CM<+%#;R0F0>';7$3PW(:&03+\IW+D$@@@BOX"%($Q5OE^<\\?AG/^>:
M_LU_X(^_M9?LK?!/]EB+P5\>?B==^`=;NO$N@^(]/2STO6+V:[TZ/P_;1()#
M86D\)M6N`N\2,)<@%1BML=5I8;$Y77K5(4H1K58\TW:"]OA_9WE+HHI<RWNW
M:R'0IU*U+%PI4Y5&Y.;C%7E926B77;KM9W5C]V_&7PGL/B!\1[W3/[>OK#2Q
MHD=[8^']6^R746J:O;D^?)9I*@DE8+$',<+1F$0P$-A(\?!/Q-^'.FR^.YE@
MUGQ)JMSX%U&UUB[T^U\27#N+%4Q,=3AE9IX9@ZJL8CRUHF#"P)+'VCQU_P`%
M#/\`@G-XTO+&YOOC_J4.L>'=->WT;4-%\*^*+4+YTD<[I<W!L5FG+_,)%)VX
M`&,8KX0\/_MK_LQ:;\0_%/B#4/C.-3AUW4[ZW369/#/B&&9]-WHVGI*O]GLY
MCCA41LQ).2V4%=,LQRY)6S'!-MI:UK+7MIYWMV.?ZCC/^@/%=/\`ET_+_-_A
MV9]Q_$_X;Z3\<O`A&C^$I+77?"&A6NKZ7=3K<6EA>6FHH8(XKS4XKDWNKS/E
MHI)XV%ZK.H+*.GUK^Q5\>?BK\'HK;P'X[\,:@?#VAPZ5):2:WLO5TB">%819
MIXDA;SKJ*,*IC;5?M5W#"4CFF8I7Q+X7_P""DW[#GAVTT;0&^-UW<"VL+N]U
M2]/@GQ`MG?M/,632(X_L2E?LL198)54AF;+?-C&#X6_X*9_L0ZGJ7]GZ]\3-
M9TC193>IYA\-^(5=[;S)5AMI#'8%PFQE*N^XJ#MQ2CF.7M7>8X+RM5?EY/\`
MIKYKZEC/^@/$_P#@M^5_U_I,_J5^%G[3W@SQAXD&@:?JTD.JS+-+/IL+0SW$
M0,<:176FW,1\F>W!4AS*,O@KSM&/K+1KM+JWN;NY9RK2>2#*/,FN5!'G3M,H
M\R%E)'R1$*O0#GG^3;P!_P`%,O\`@G/X"\5:9XIT[XRZ=:7D%M#97<=OX/\`
M%B,T,+1M;.9H;!1)-$1(\A9"&9C@G(%?H]X&_P""\G_!-C[,+G7/V@)+.\M)
MI<K-X.\5-#.<?N9(8TTK:(B`"ZOER3GFJ_M#+O\`H8X+_P`&^GE_5U\SZEC/
M^@/$_P#@I^7^;_I,_=&S>XC:7RO*E@>16;3O+A_X\XDP;@^<GFL[N`P0/EG`
MW9%:Z)#<E)(8(8'4?N\Q`E86Y/G)MVQN3_RS7Y>XY)K\49O^"^/_``2_N&BE
M3]HB..X$,@.[P7XM,1N)&(W/C2PQB"DD*&ZC'?%;,'_!?G_@F`MI$D_[1ELM
MR8]MQ)#X)\5K'*P^[M7^S]RC`X!Z=R#4O,<O6V8X)_\`<33I\^O;L'U+&?\`
M0)B5YNDTNF]_5_U<_9F>..`$S.)KIHRUJ$3&[9C#LW8C)5<_=`P,9J&999HD
M(\U]N)Y?F&(YN`L3'JT>W+NO?`)YK\<6_P""_/\`P2S?S/-_:)+YB$2^5X+\
M5KC`!W9_LTY.2?3I[TQO^"_'_!+-$`C_`&BFB(&\N?!GBEPSH``'3^RP>1UP
M3Z4HYEE[WS#!=/\`E[Z?UU^?46"Q?_0+7?\`A@WVW^3/UAOM+2YN+M[BXE9+
MB4(UU(BI*UF8]K;98QNA,+96VD4K*Q"@\9KR?Q5\/K#Q&L^BW[@6C>;!<2!M
MP2Q6/S(I)KE@TL=Q`098PA'G2LV_)`%?G1>?\%[/^"6MW$;6T_:.%@T@+7$L
M?@CQ4P<OU:-6TTA7YX.TX)'?I$O_``7D_P""6MM:^5'^T:&NC$4-W+X'\42,
MY/R[GC7351B!ZYQG(YJUF&7NW_"C@D_^OOIY?TF@^HXS=X6M'RE!IZV6UO/Y
M'V'KW[.WPW\1VIL/%_AS3?%K72K#<3ZFIFCC\NW6.VCMDC4H@:$1S2PJH03,
M6(WDFO@W]H'_`()U>!O&_@C5C9Z-<ZUXDTB*]B\/6T-R-&O8-&N$$+Z3;-IC
M6D^H64:,S1+=2MY$N)%97&X=`O\`P7:_X)60QQF/]HN*&[5'B:>+P-XN&XSL
M&FF\HZ:4\U@H`)^9.JU4U#_@NK_P2LO9H6MOVATBE6QEL$N9_`_BHR1>:QRX
MD72RVXYW;N<'&>F*7]H9?I_PHX+_`,&^GEU_RT']1QG_`$"8E^:IMIK39^C>
MNWRN?FS??\$>]:FTNWTV*"._T7[9%?Q:5>V,C2VTUI"'AD6>(O>7E[9D&/[1
M8WD-RJAA))(N17SG?_\`!+M=%^(\MMIFHPWNN^(;F*6VTZQ_X270M;TV>VAF
M>[LK'2OM$NG7T6HVJ3P+J=S&\LDQRV&4EOV??_@N-_P2XMY=-8?M'0(;'S-Y
M'@?Q7,969<9B8:8A0N?OD^I!]:C3_@M;_P`$FEU$:S#\>[2WU&Z1A<WJ^"/$
MQN(Y<'$]J[:4SP81V7:I&XN<^[_M#+]/^%'!:]?:^ENGY>0OJ.,?_,)B%YRI
MM+9=?6_]7/QLT[_@D_XRU_4O#D`N/$OB9=2NKF?=J&D6VHS6]F)?(73=0GOK
M:%8VLX?]&C@\KS!Y?FPN'`:OT[^#G_!-C6OA[XKT236=(T35]/T?2[]=&\1:
MM-'+XRT#[1Y$=SX8TC3+E)(9-"F1`?MC#SH)@-IP@KW)_P#@N3_P2?,-O"O[
M0EI%-:R*Z7'_``@_BB.8E3DO*T>F+NE;DA\9SUS4UU_P7-_X)1SO<W1_:*=[
MN8QF.YD\&^*)IK0!0LXLV.F;HTE0':.2LIW<\Y/[0R[3_A1P3OVJ^GE_5U\S
MZCC/^@6N_P##"_57OVZ]S[B\!?L]Z3X*+ZWX9TK2;?5KRQCMU>YBBA^Q211X
M\J/RE$#7.W)!"!FXYXKZ6T;PW=VNA6\5W>-;V<-LLMU$8G%S(4D,S-++++Y9
MM3^\9L815.2*_)J#_@O9_P`$JUMXK-?VAYQ'#Y;;V\$^)\RE8RK>9NTKJ2?O
M`9]*COO^"[O_``2GU3P_J7AW4/VC9'L=6T^]TZZQX2\5PRK:W\$MO<1P2KI2
MR(QBE8+(K#RVPRFLY9GEZ?\`R,,%:RU]KZ?Y_P!:7?U'&?\`0+6CY2@T_P"O
M^&/U-C^+WP8MKJ5?^%L?#E?*9XS:?\)GH9:&:1/+D64/J8$(AQQ&@4*X/`-?
MBQJWP?U%O^"Y&D_MK#X@?"=OV?K7]C<_!FY\1-\3O"(U0^-9=3O+QK=-&.I2
M:C):LMU&[WACC@1]Q8$AF/XVZA\%_P#@U\U;4+_5[OXS_&*2\U&^O-0O##XN
M^*\<4EQ>SR7,Q1!"`J&25MB#`48'3BN>E^!W_!L`ET\8^,/QD<J-B,WB[XLM
M#(K#[T<GV<D2KGHW.1[U4<RRY_\`,?A.G_+Q6Z=?R^6@?4,9:_U>IZ*,OPTU
M/H/XK?`#]IGX'?\`#R3]FO\`9^T7X%_%CX1_\%!?&TOB_0?C/>?''P-H-M\*
MG\16L6G>*;;QAHU_JWV^Y%K`'FT_^ST`FF8<DL:?<?`SXG?L*_'#X;?&?]EM
M/A3^T?HB?L(>#_V-/B-X9_X6[X/\(^(-#\4^!-%@T_3O'-C<:QJ217N@ZE=P
MI<74<,KN;?.Q><5\=Z[\%/\`@VO47MOI?Q5^+J-&;>.*9O%7Q8G67YLR221_
M9EX(X.>1V%<CJ'P+_P"#='S+B6+XP?%&-V@Q;VL?B3XJRP(5"_,TDEN)`TZA
M@4;(4\=!5?VAE_3,L%_X,?\`E_5P^I8S_H#Q7_@I^7^;_I,_=G_@EI\$=$_9
M2_9#7X?_`!+^*GPKC^)?BSXB>-_BQX^LO#WC_P`-:C8^']:\=7K7W]C6EP+Q
M7\S38GC26ZB8VTA7[I`%?FWX?_9FU+P5J_\`P5KUGQUXL^&VM']KGQ3XAU3X
M(ZC8^/O`VL:EX@LUT?4-/L)=<=+Z.7096F,;^1<+:.IPPCW#)^+[/X,_\&]%
MO)>?:/BY\5Y;=[R"6T5-?^**3K;&/%S:SL%"/AA_HT@PW:3Y15.]^#?_``;Q
M@W]O8_$'XLSR!72TG;Q!\3TC9F7*SDLI#%3SLP2<4?VAE_\`T,<%T_Y>][>5
MOS^8OJ6,_P"@/$_^"WY>7]?)FY\!?V0/%%I\3?\`@FMKOCO4OA;=^$_V5O"O
MB2T^,5A>?%+PNHTZ?4;B\O;"[TJTCUO^T=7$<DEK),]B_P`L@(9",FO0Y?V0
MO%,_PM_X*K^#4_X4OIM_^T]\6[CQ!\"H8O&?@J9;O2YII#:I]M^VF30+(9,I
MCGDB0;L-"6.\_("?!?\`X(0I=VES/\0/BW<01S6]M?VMMK?Q#2>2W,KK+-;R
M-""05*M(KXRN0.>*LZ7\&/\`@A<;G5;/4/B7\3HH[%5:TOEU[XE@74DY+B&&
M$1EF2U0JLKN5\QP0H*X-']H9=_T,<%_X-?EY>?XH?U+&?]`>*_\`!3\O\W_2
M9^T?[.6E>#O@Y\.?A!X'^(?C;X7RZYX'\$^'O#>NZ?H/C;1KBQG\3VFE1POI
MNJ36NKK8ZY:R3)MAMIUEL)&_UB5]T_#3QGX1\0-XOA%O)_9^H?#;QY=&YT^0
M36FFVHT]I?,L;V#$;6\RD(-/YM89AYL*#(:OY))_@I_P1H?Q/<W</Q$^(3>'
M[>9!9VDVJ?$/SKR%F'FRS2&V9X+F+&;;&]3QYA]/V=_9X_X*(?\`!.+X5O;^
M$T^+^KP^"8OAYK?A2V@OO#GBJ:>QM5TA-+TFUGN9+)C=O=1(%EG.Y@V"QZT+
M,,N_Z&."_P#!OIKL_P"FOF?4<9_T!XKI_P`NGY?YO^DSR[XC_$"P_P"$FT^U
M\'ZY>/8VTVF3:-JE\7:2WUVPN09M,U*XN3++Y(7>$AA"PI&V1Q7L'A'X[W%[
MJ-M#X(OXF\1V<I34;HMY>EV5S&[.UFEK(&L6\^,.PENH61RVU<$9KY/\0?M?
M_P#!/G6$U*2/XA7VFF757CL5@\(:^9(;>21T%ZUS]A$TA5%C9%7<`6R5(%<[
M\.OVK?V#O!%W<:/;_%75);;4+HW6NZS?>$/$1GOWNI#(X%W#:B01VJ[8T185
M(P"JX)H_M#+O^AE@O_!K\O+S_%?,^I8S_H#Q7_@I^7^;_I,_3#6/%7P2UR^T
MO3_$&IP>(?$]XXEU426#P6>ERMRMTJHJV,.J6\F8K,PA$D4D\5F?#?\`92\*
M^(_B_#K=['=2Z5J%TVLZ#97L<YT^..,XNWMY9+N7:]W]Z:+'V<DB1(@P!KXZ
MD_;3_8-N-:;3;'XR6=KX1O+B!]8NKSPEXJEUBZMK>X\P01H-.\L$$`Q.&C=5
MX))R*^Q=`_X*8?\`!.2.'1K"?]H=K#2M+55^S0>#/%$=T4#)O\J:/3C(K.`1
MQQ@X/%']H9=_T,L%_P"#?3R\_P`5\U]2QG_0'B>G_+I^7^;_`*O;]?\`P%\-
M/"GAC3WTZTGM7TIK=)(XK2'S))1'<Y6TN;QPTI%FY(6,G:$=EQBI_B7X'DU)
MM&^S:E-I\DEK>O>6MM8VJ%CMQ9[6$7[N)8N%E!W`DG/K^<^E?\%?O^";6C72
M1Z=\<IX[2$@6@E\+^+FDG"D^9]M!TUHR'!!0CG(.3@C'>-_P6?\`^";-XDL5
MS\?`DS",>8_@_P`5.!'R)889!I?20$#:_`*\T?VAEW_0QP73_E[Z:[;?UKU/
MJ6,_Z`\3_P""WY>7F_3Y,^P[;X%VGB/P_IL?AY(;]]-M]0MKN&2=)+M8&9FF
M@MGM?)F@E>X_>!KB2163Y4QWY_X;_"^U\,^*M'U:Y-]JFKZ?C?$UO)$&,4KQ
M6L2P@2M)/9(62)`&1B-V-S&OF:P_X+*?\$P]#N4FTW]H&Z:W@B;_`$1?"7BB
MW::>5"')DBTK:0C$]<A@.N:FT/\`X+/?\$SH[I[V_P#V@3&[,^VVC\&>*L+L
M82HQ==+`=7*A6Y1@WS"C^T,N_P"AC@NG_+WT\O/_`(?J_J6,_P"@/%?^"GY?
MYO\`I,_-?PK\.?A7X%_;(_X*8ZU\6OC5\%?#GA_]I'Q_9S_#*:+XL>#4U8QV
M^@SZ'K,>OV-CJHF\/WMM--()[+5H8Q(\,BR6XD4&ORQTOX3>,=2^%?@;_@GQ
MK_Q!_9MLO@OX<_:%TGQ_K7[0L'QR\!RVD_@"U\4/KL>GP:"FH+J*^(&MY9[=
MS)&1'(!)&QP#7US\:?@A_P`&V?Q)\4>./B5>?$GQI>>,?&GB37/%.L21/X^@
MCGU?7KZYU"ZG@A.G`1P^?,2(-W[O/#$=/C?6/V7?^""%T^F6FD>/_&.G[[E)
M[W4)U\;3K(B'/D&/[(/+5Q@&4!V`.<"C^T,N_P"AE@O_``8_+R\Q?4L9_P!`
M>)_\%OR\O-_TF;_Q^\'>*?A!HO[;7P*^#OBWX`?$WX/_`+3?Q*U7QOX5\?P?
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M_P`'TT\SW_P%^S%IOB7_`()F^$O@<WQA_9XTWXP>'_BMI_BH:%J7Q<^'UE&^
MG1^+DU.]UF'79]8A22\.EAHTM&D$\@5(T8!<5][?"[0_!/A[]JS]M_X@:E\=
M?V?KWP9\9?V2=+^$/@75-0^*_@:ZU+4?%VE^$H;%M+9'U1YM/LOM\+6\]\TS
MP26ZC<)$(!^:+']EW_@VZTRPNI-0\8^.-=U57G%K9PZIXYM+(YV"%C)_93,B
M+N=E#C<=OS$$BO';O]G'_@@1:7\<8U_QY=6ES=77VJ6WNO&;BPM2N(%BD-FA
MN"2/GW(,8.0`*J.8Y:[/^TL%9[6JW[?+_AT+ZEC/^@/$_P#@I^7^;Z_DSV&/
M]GWPU#^PG^PG\!8OBC^S]-\7_A9^T5I'CSXAP:9\7O`DUI#X6;6[RX;^S[N*
M]D@U'5+I'1?LL22S3%8HVC(`%8?_``7!TI-,\2_L_K`9IK6?PMXKDM;^4Q%K
MVU77(TMI/W($`V1`*!`D<6W:0O-<;X0^#?\`P01TSQ1+=+=^/=*_X1R]TW5_
M#>NO<^-6-U=P31S0M-;&QD0BVGA21EP-X.!QT\I_X*D_M-?!G]H/Q#\)+'X+
MZ[J'B/P]\./#VM:#+J^HVU]9F[^V:DMY:O#%?00RJGE!AL*DH1G)WFOE^+,=
MA*F35J5'&X.I-8F#<55][>.UEV5[._9GO\/X;$T<U]I4HSC&-%4U=;WC^%NW
M?=K8_*"TZVW_`%SNO_2B&IX_O#Z7O_H3445^-Q_A4/\`KPOS@?6P_P![7S_4
M#_Q]M_URB_\`0*6W_P!8WX_UHHH6Z]5^9Z_1>D/S$A_U_P"!_P#0:@G_`-6W
M_7U%_P"A-111T7J_R0_LK_MW\T21_P"KMO\`KL/_`$)Z'_U$'_7Y)_(444A+
M;YQ_*(A_U'_`Q_Z$*FDZ2?6V_G115?8_[>_0I;+T7Y$5I_Q^O_O2_P`J99_?
MN/J/_9:**DB/Q?\`;J_)%NT_X][C\?YTQ.D?T/\`*BBFMUZK\PC\7_;J_)$U
MW_JD^I_F*C;_`%\G_7(_^@BBBF]Y_/\`]*0WO\_U@9R?\L?^NDG]:M7/0_\`
M7-__`$$T44U\#]?\A]_\4?\`VTK6'W8_^N2?^@BM1O\`6K]?Z"BBJ>T/6/Y#
M6R]%^167[C_]=E_]`EI[]?P_J:**SZ+U?Y(QG\?R?_MHRF1=6^A_DU%%5+:/
MI^B,X[R]?U8@^ZG^\/YFKDW^K_X#_A114&RZ>B_]+(H.K?\`7(?SI(/]7_P)
MO_0C115K?Y1_.)72/HOSB22]!_P'_P!!J`]#]#_*BBJAM\_T1S2_B+_MS_TF
M)+%_R[?]MOZU$>A^A_E114PW^7ZHJ6U+Y?\`I,!J_?C^@_K2777_`(%;_P#H
M2T44OM+_`+=_)&RZ?+_W&:)^_#_U\M_Z,%,?H/\`KXE_]!:BBD]_DOR02^U_
M7\A4;K+_`-<G_G3(_P#4/_NP?RHHI_:7_;OY(G[2_P"W?R19;_5R_P"Y%_Z"
M*AM_]?8?67_T&BBG#?Y?JBH?_)?^VD(_X^)O^NK_`-:NR?\`'LO^?^6C444E
M\+^?YP&]_G^L""W_`.0?_P!M9/YFHUZ-]/Z&BBCO_AC_`.V@OC?I_D6_^72[
M_P"N*_\`HVL_5?\`D7=4_P"P?J7_`*2M116]'^+0_P"ON&_].Q/&Q?\`$?\`
MA7_MI^5L7_'ZO_70_P`C7Z<^"_\`DGOA/_L`:1_Z06]%%?K7'?\`R+L'_P!?
M:?\`Z1$^6X8_W^KZ/_TM&[+][_OC^2U$W1_]S^C445^45?A7^*/YGZ(]OFOS
M1$W2S_ZY_P#LZU:'^JN/^NW_`+*:**,/\"_Z^/\`*`R[:_</U_QI)OX/]VBB
MMN_^&/\`[:`R/[Z_6KG<_0?S-%%<E39^D?R1AB?X%3T7_I2*T_WQ_NC^9JM-
M]W\!_P"@T44H?:_PP_0X\#_$G_@_]N06_P#KA]!_,U;G_@_X%_2BBMX;?/\`
M1&>._P!XA_@_S*]%%%6>CA_X-/\`PA4\'5OH/YT44&>,_P!WG\OS0X]3]3_.
MG'_5'Z'^=%%1+>/K^J.;`;R_P1_,J5)'W_#^M%%<L]_E^K(QG\9_X8EE.GX_
MT%0C_CWA_P!^BBO0P_PK_`O_`$EG+3_B?]O0(Y/O3_1/_0:;%_5?_0***@^@
M)?X_^`_UJ@/N0?5?Z445I'XO^W5^2`E/^N3_`'7_`/06JI;_`.HM_P#?_P#9
MJ**(?_)?^VBZKT?YHEN/]=)_O46W^LA_ZX_^RBBBI[_X8_\`MHQ\G^N;Z?UJ
M`=4_#_T(T44?:7_;OY("R>J?1?YTZ;[_`.`HHI+9^GZH`A^_^!JO+TE^I_D*
M**%NO5?F+JO1_FA4^XO^ZO\`(5/#]_\``T44+=>J_,9>3K^']15*X_U8_P!X
M_P#H5%%'1>K_`"0"M_J8_P#<7^2TQ?O?\!'\A117-7^Q_P!O?H3W_P`4?_;2
M2J\OWKC_`'?Z"BBM*'\-_/\`]*01^U_B8C_\>T7T3_T,UGS=?Q'\J**X<P_@
15_\`L(7Y1/)PW^\K^NLC_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>fig2.jpg
<TEXT>
begin 644 fig2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`#!`E`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HJIKVMVWAK0[W4;R016FGP/<
MSN>B(BEF/X`&OA#]CC_@H#^T)^W/X(MO%_A/2OV?-"\/:IJEQ:Z?8:YK6HC6
M)[>*0KYOE1(RY(#8&1DJ3@#%=%'#3J1<ULN_G_PQC4KQA)1>[/OJBO'[O]OC
MX0:59?$":]\=Z19CX52I!XL$\<T+:1(Y945E9`S[F5@NP-N(P,U0\:?\%(/@
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M?"K7?`'CKQ5:>,].G\/?#2\FT_Q+?K%-Y6ESP@&2-CLRY7(^YNZC%#P]5;Q?
MW/KL"K4WM)?>>JT5XMX__P""B?P4^%7A?PCK7B3XA:+HFE^/-.?5]!N+Q98D
MU&U2-9#*N4RHVNF`V"Q95`)(%9_B[_@IY\!O`W@GPWX@U+XCZ3%IWB^V-[I"
MQ6US<75Y;AF4SBVCC:98MRL-[(%R,9IK"UG:T'KY,3Q%);R7WH]YHKEO@O\`
M&WPG^T3\.=.\7>"->T_Q+X<U52UM?6;[HWP<,I!P592""K`,",$`UU-8RBXN
MTE9FJ::N@HHHI#"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHKX?\>_\%%OB=XW_;I^(7PB^%UC\(+73_AM8VDNI:QXVU6[LUFN
M9E5C!&(%;)&X]N-C9/(%;T,/.JWR]%=_D95:T:=N;KH?<%%>.>"OVH[+P5XD
M\&?#_P"*OB'P;I?Q;\86L]Y::9HANWT^_CC,C$V\TT8W8C3)#$'(.!C%4[C_
M`(*0_!"T\`3^*YOB'I$/AFWUX>&6U62&=+-]0.?W*2F/:^-I)=24`!)8"CZM
M5O91;]$'MZ?5I'M]%>0?!#]OCX/_`+2'Q%U'PEX)\=Z3KOB/2XFGFL8TEBD>
M)6VF6+S$431YQ\\99<$'."#7->(?^"K7[._A;XAOX7O?BMX;CU6&\&GRNGG2
MV4%P3CRGNT0VZ,#P0T@VGKBA86LY<J@[^C#V]*U^96]3Z$HKQ_\`:$_;Y^#_
M`.ROJFG6'COQUI>B7^JVYO+6T2.:\N)(!_RV,<".RQ?[;`*<'GBMOP[^UI\.
M/%WQ5TCP1I7BS3-1\4:]H:^)=/L;;?(;G36QMN@X79L;(QE@3V%3["IR\W*[
M>@_;4[\O,K^IZ+17CA_X*!?!P?#/QAXR/CK3/^$8\`ZL=#U[4/)G\K3[T,B&
M`_)EVW2(/D##YAS6=I7_``4R^`NM^!_$GB6T^*'AB;0/"5S%9:E?"5_)2>4,
M8X8B5_?R,$;"P[R<<"J6&K;\C^YB]O2_F7WGNE%>.?!W_@H)\&?CUH'B74_#
M'Q`T2[L_!L(N-<-T)=/DTN$KN$LL=PD;K&0#\Y&W@C.:L?LY_MV?";]K76M0
MT[X>^,['Q'?Z7`MW<6Z6\]O)Y#-M$J":-/,CW<;TRN2.>12EAZJNW%Z;Z/3U
M!5J;LE):[:[GK=%%%8FH4444`%%%%`!1110`4444`%%%%`!112,P09)`'O0`
MM%!(`SGBD5@Z@@@@]Q0`M%%%`!16;XK\8Z1X#T274]<U73=%TV`@27=]<I;0
M1DG`R[D*,GCDUH03I<PI)&ZR1R*&5E.58'D$'N*=G:XK]!U%%%(844V658(F
M=V5$0%F9C@*!U)-9_A/QEH_CS1DU'0]5TW6M/D9D6ZL+E+F%F4X8!T)4D$$$
M9X-.SM<+]#2HHHI`%%%%`'C/_!0S1/&WBK]BGXD:-\.=)FUKQGKNC2Z9IMK%
M<1V[,T^(G;?(RJ-L;NW+#.,=Z^8/^":'[-=O^SMX:\#:=K'[(5SX:\9>$]$<
MW?CB9]!N;NYO5@;S"DD5PT^Z9F9%)P`K@$A0:_06BNNEC)0HNBEHW?KZ='^9
MS5,,I5%5;U7I^J/R2^+?_!.KXZ?&3]J+0OVE=>^'.D7.I:CXRL?[4^%Z7ULR
M1Z+:JR175W,91!<72X#;1D#CKRHV_`OQ(\8^.O\`@KY\>/BOX3^#D_Q@MO`$
M,'@72FL]9LK.;1KJ.+<[J+ET4J[K,C,A+)NX!#&OU2K!\#_"OPQ\,6U-O#?A
MW0_#[:U=M?Z@=.L8K4WUPWWII=BC?(>[-DGUKL_M9N+4XIZ<JW22NM-[]+=^
M]SF_LY*2<9/>[VWL_+S_`,C\OOB1_P`$DOC''^P_=`6>F>(_'OC#XI1_$CQI
MX4M=1CBM]0MLN?[-BFDQ&Q4E6.\[2<X)VC/LVL_LZ_%O]K[]LOX??%G7_AK%
M\,?"_P`#=.NY/#?AN]UBTDU+Q#J#Q#8CO:F2*WM@RHH.XD;6.W#8'W-XJ\::
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M%V-Y\'/@]X$BTWP]+=/!+;7.IY`!%ON+?NU/&]-N8U(.0*\4^)?[`_Q1\)_M
MP_&#Q=<>`_BUXHT7QDT$?AO4?AS\0K3PTEMIZQE/[/N8I)8G"+A,!<J.3@YK
M]46<(N6(`]2:6LZ>:58]%:UNO>_?=O<N>`IRZ];].UNW8\V_9'^`>@_LU_L_
M^'O"OA[PE8>"+2V@$]QI%I>O?):W,GS2@W#@-,VXG+D#..@&!7I-%%>?.;G)
MRENSLC%12BN@4445)04444`%%%%`!1110`4444`%%-$JEL!E)],TZ@`HHHH`
M****`"BBB@`HHHH`****`$=MB$@%B!G`ZFORC_9H_9'\6Z'\6/BMXE^-/['<
M_P`4?$'Q#\83ZK::E>7F@7D.FV+'$<:BXN=ZXRQ;:.0%&.,5^KM%=>&QDJ,9
M1BOBMW6WHT<]?#1JN+;V]/U3/SB_X*D?L0?&'_@H_P"-KK1]#\/P?#WPI\)=
M)NKKPOJKW4']H>+=4E@VBVA\J3-K:84(QDP2<'&#\OCG[4&C>*/$FH?L7_`_
M_A35C+KWA*SE\7>(OA[;ZE:V\-P+(>7M$NXP_O=EQ(-[88OM8@DFOV`KCM!T
M'X?^-?B5=>*M,M/"&K>+]&1M'N=7M8[>XU&Q3.3:O,N9(QDDF,D=>E=E#-)0
MC&+BK1O;?=IK77SOZ[6.:K@(RDY*6LK7VV33_2WYW/BA?V,_C#^U;^T1\3/C
M-KVAQ_"'5)/AW>>`_`.B3ZE!=WEK)-'*#>W,EL7CC&YSM5&8@-GJOS>6Z%^Q
M=\=OBA_P3K\*?LII\'K;X;645S'_`,)5XTU#6=/N;.XCBNQ,\UM#;N\TD\I"
MD&15PJE2W0C]6J*SCFM16M%:6MOI;;KKO?6^I3R^#W;UO?;6^_3\K'YF?M5?
ML=_%[5?C[I.K?!KX>^,_`OQ%\*6MGX5TOQ_'XNT^3P]K.BVZ@`ZA9R9F8E<Y
MC$+?.B\L`#6]J'P4_:$^#O\`P49^+?Q#T3X6:=XV?Q1X0L?#_@[7(M6L[#3=
M&$,"F47$3OYX!F0D)&AS\HR`2R_HJ2%&20!2*P89!!'M269SY>5Q3TMU[I[W
MOTVVWT']0A?F4FM;]//R\_78_**;_@F7\7KS_@F1\)_@]=>%#<ZSXR^(2^)/
MB4PO[:,Z=:-</(^]A)B1MOE_ZHL1LKTS_@I1_P`$]/$WB3XU_!35OAWX&U;4
M_AI\/X;F*[\/^"-<MO#6K6-V4"V]Y!)(40E`B+G<'`!`(W9K]$J*K^UJW.IV
M6\GU^UOU^X7]G4N7EUZ?A_6I^?7A_P#8U_L3]E[X@7=[^SIXZ\2^(OB9>1Z1
MXBM=<^(T&H>+M4TL#Y;EKR20P*\4BILA67E$#%L@)7#_``<^-?Q@_P""8'P=
MOH_%GA_7O&4OBK7K3PY\(OAYK>LVMWXJAM`7\Y)[VV213"BB,JHW*@"Y*9K]
M/:QK[X=Z!J?C6Q\2W.B:3<>(M,MWM;/5);2-[RTA<Y>..4C>BL0,@$`XYI1S
M&Z<:L;IN^[Z;+5Z=M-;:#>"M:5.5FM.G^6OY7U-/3II;C3X)+B$6\\D:M)$&
MW>6Q'*Y[X/&:FK,\+^-=&\<6L\^BZOIFL06L[6TTEE=)<)#*OWHV*$@.,C*G
MD9K2\Q=VW<-WIGFO-:L]3M3%HHHI#"BBB@`HHHH`****`"BBB@`KY!_X+O?#
MQOB#_P`$NOB7Y1G%QH4-MK,1B<JP,%Q&S'CL$+G\*^OJYKXR_"?2/CO\)_$?
M@O7XYI-%\4Z=/IEZ(7V2>5*A1BC8.&`.0<'!`XK?"U?95H5.S3_$RQ%/VE*4
M.Z:/SJ^/?QVNO^"BW@KX0_`?PSK,UEX;N_"6E^-_B[K=I,5;2=*2VBF%EO'2
M69QDCJ`$)&W>*A'_``4P^,/AK]A+6_CSX'T?X1^%O@OX9G;1?"GAK68+Y]6U
M.UAD%I%+YZ2JBN7^81>6<B-@7&0]?9'[&W_!.'X8_L-?#'7_``KX.L-0N[/Q
M1(6U6ZU:X%S=WJ>7Y2Q,ZJH\M4R%4`8W-W->2W'_``0A^#&H?#BV\'7FM?%"
M_P#">F:B-1TG1KGQ,\EAHK&1I'2"$IL"N6PQ<.^.C`EB?7CB\'?D:]U-6NM[
M_%UT;T2[)=SS7AL3;G3]YKOMV^2U;[LQH?\`@H/\7_B-\1/A;\&/".D^"+7X
MP^(_!EMXQ\8ZKJMO<OHWAN*1$;RH[>.022R,6"@&4!=RG)R<:OQ5_;:^-'@+
MXL?#KX!Z?I_PWUCXZ^-([K4K[6(UNT\.Z-I4+/MNGMR_GM,Z(W[D28#+]\[A
M7IGQS_X)F^!OC5\<[3XE6GB#XA>`/&UMI:Z++JGA'7#ILMY:*05BERC@@8`X
M`/`SG`Q#\9/^"7GP_P#BYXQ\&^)[;7/B%X+\6^!M*.B:=K_ASQ#);:E)9D,#
M%-+()#+]]R6;YB7.2>,8*MA+QTZ/I]K7SV\C5TL3KKU[]-/Q\SQ']N?XF?$+
M3_#?P:^#_P`4/#/P@^)7B;XJ^/TL)H(]/O1I;Z1"$D>Z$#SB2.YCWD8\QT^7
M/.<"MXI_X*(?&?Q1\8OVC=%^'&F_"[1_AW\!+1!_PD&N074X6:"W,DUL(H95
M$C,4=`<HL83/SD@5])Q?\$]O`?\`PM_X9>-KBZ\5:CK7PFL;BRT3[=JK7:.T
MX;SKB<R!GEF8L26W@=.,`"L;0_\`@E[\./#_`,"/BE\/X+SQ6=+^,.J3ZMXD
MO7U!&O[B:9E:0))Y>%0[<8*GAF]:<,5AE%*2O\M+N6KM?^5(4L/7YFT[?/6R
M6BOZMGAZ_P#!6#QWXH_9?_9Y&A^%_#:?&K]H5W@TVTO7E&DZ=%$2);^1%;S#
M%M*,L>\$AC\QQS>^%7[;'QZU7]O#Q=\$=?N_A%?1^!O"%QKVJ>(](TZ]6&"X
MD1#:1S0/<$Q["X+HK,63!#(3@>P_%K_@EW\-_BMX1^%^FI>^+_"M_P#!ZV%I
MX7UOP_J@LM4L8O*6-E\W8P(8(I/R]0<8!(-K]G?_`()E?##]F7Q1\1-7\/Q^
M([R\^*%LEIKKZKJLEZ\L81U;;(W[S+[V9F9V)8\$8``\1@^27+'5WZ=6]-;[
M*/3ON-4<3SKFEIIUZ6UT\W^!\(_L7?M2_&+PC^P-\<_VDO&7BWPWXN\)>(I]
M5GL]$U.RO&:2Y#BVMXX"USL@LF=R#"JEB/XZ]B^#_P"U-XL^&MA\%/V=_A#X
M$^'/A#XD>+?"*>-?$`DM;E?#_A2"8F1]ENLOG32.Y<!3,,$KD\X'K6D_\$:/
MAAI?[+>I?!M_$?Q,OO`&H:C!J*Z==Z\LJV1BE:40P_NL)$TC;F&"20#D8KLO
MCW_P36\"?'3XHZ!XY@UCQSX"\:^'=+_L2WUSPCK)TV\EL1G%O(2CJR#)(^7/
M/7IC:KC<+.3TT;=M--%:-UUMK?\`R,J>%Q$8JSU2777>\K/I?0^?O"O_``5<
M\>_#O3_VH-!^(6G>#=6\1_L^:4M_;ZYH45Q;:5JLTR?N+62&21W23S2BD"0Y
M.X<;<G*\._\`!2+]HKPWKO[,MYXS\._#&&R^.]Y%92>'=/ANSJT,)17:^$S2
M^7&"LB/Y6Q]HP"Y).WW_`%+_`()(_""\_9:UWX26]MXCT_0?%E]#J?B'48-4
M9]8\07,<@E\RZNI`[2%G4$C`'7:%S7;>*OV%?`WC#X_?#7XC7@U;^V?A/ITN
MF^'K2.Y5;&".2,QEFCV99PN`"&`^5>.*R^LX+6T-[]/[MEUTO+7R-/88K2\N
MW7SU];+3S/9:***\8],*^*_^"E'_``4&\>?LH?&[P;X8TJW\/>"O!NO6KS7O
MQ`\3:)?:MH]M<[F2.R*VCIY3,=I,DCX"G.,`FOM2OG3X\_\`!-#PC^T;XSUF
M_P#$?C3XLGP_XDFAFUCPE:^*IHO#^IF/9\KV^"RJWEIN6-T!VYP"23UX*=&-
M3FKJZ_K^M=#GQ4:DH6I;GS[\;?\`@K7XYT#XN:'\*O#-CX=NO%>G^'[76O%W
MBK2?#FK^*M%LY+A`\,-I:V0$[K(C*_F2.JJ'Q\Q%4/B-_P`%2_CY\(/V#="\
M6^)?AGI6E_%;Q9XWM_#/AK2[JRGMD\0VLN'6X%F\OG6TCKE!'(Y(8@GC@?0?
MQ`_X)5?#_P`2?%M_&_A?Q%\1_A7XAN-*M]%O)O!.O'3([^U@54A25&1U.Q41
M00!PHSD\UT7BG_@GAX%\:W'PDDU6_P#%VI?\*:OSJNB_;-7:Z:\NR0QGNWE#
M/,^X;L[EP20,#BN]8C!)1M#S?>_^3>GIV9QNCBGS>]Z?UW2_$^5OC=\6OBUX
MU^/'P,^#GQS\`_!7Q/JWQ#\6SZX--L;>\OH/#VCVD`8RF1Y4S=KOG7?M:,A3
M\IS6'XQ_X++?%CXUZ]XTG^"?@]'T;PYJ,FC^'H+OP+K6NR^,;B-PC,+JV,=K
M91[N!YCL0.6V\`_<FN_L:^$?$O[7ND?&N^FUJX\7:%HDN@6,#W2G3[>"0N78
M1;<^8=[`MNY!Z=*\L\)_\$B?`7PZUJ__`.$6\<?&/PIX7U35'U:Z\)Z1XNEM
M=$EE=E:1?+5?-5'*C<%E''&0.*=/%X1I<\=4NVE[N^GI9?U<4\-B$WR2T;^=
MK*VOK=GE_P"U]_P4K^+OP"O?A-8:QX9\.?".U\8Z%'?^(_%/B32[W7=&T/4G
M&!IA-HZ;&#X)DD?`4YQ@$U]J?!?7-9\3_"?P[J/B"?P[=ZS?V$5Q=7&@RR2Z
M9<,R@^9;M(`YB8$,N[G!ZGK7C7QZ_P""9_A']HWQEK%]XC\:?%G_`(1[Q'+#
M+K'A*U\531>']3,00!7M\%E5A&FY8W0';G@DD^_>'O#5CX1\-6.CZ7;1Z?IN
MF6T=G:00C:EO$BA$11V"J`!]*XL34H2I1C35I=?ZW_X9>9U4(554DYNZZ?UL
M?FI_P5M^!EO\3?\`@H/^SKX.'BGQCJ-]\0?%::I=Z7=ZH[:1IFFV"(TL4%H@
M5!YF)&:23>^<@,%.T?IR!@5\B:M_P1W\+Z[\8=/\?7GQ?_:!N?%^DQ/;6.IO
MXNC,]G`Y8O!&WV?*QMN8%1U!KZYAB$,*("S!`%RQR3CU/<U6,KPG3ITX._*G
MTMK?_*WW"PU*49SG)6YG^@ZBBBO/.P****`"BBB@`HHHH`****`"O-/VS/C+
M'^SS^R?\1/&TDAC;PWX?N[R(CKYHB81`>Y<J/QKTNO-_VM/V7/#W[9?P)UCX
M=^*[O6[30-=:$W;:5="VN'$4JRJN\JPVED7(QR.*UHN"J1=3:ZOZ&=7FY'R;
MVT/P\TKX%WWPN^`?[-FI^)_AMJGPTU7QUXPM+F;XO6VOC4-6U#[0TDT4*6L,
MBO%O1E_UF<>7G!.0?TRM?VW?BY^U)\:OBIX>^"I^'OASPG\%[AM)U;Q%XQMK
MF^;5M016,D<44$L0BB38^Z1F8]#MP>.Z^&?_``2=^'O@CQMX5US7O$GQ*^)4
MG@38WAJR\8>(#J%AH+H%"R00*D:!U5%`+!L;1@`@&J7CS_@C[\,_&GQ`\9ZU
M:>(OB?X5T_XC7?VWQ5X?\/\`B:2QT?Q!*23(9X@I?]YN8/L=<ACC&:]S$9AA
MZSO/=7L[76KOLW?;3MV2/)H8*O27N[:7UL]%W2[_`#\V>(?#O_@MGXJ^*7[*
M'PHOM&\"Z/-\8/B]XDN?"FC64ES*FB&2V9%FU!GQYGD#S%^0'=G<-V%R?0_A
MC^W#\7_AW_P4&C^`OQ)M?`7C6]U7PE+XHL]0\(6ESI\EBT?F_N)XIY90?,,>
M%?<N"Z9'/'JGQC_X)B_"GXM_#KP%X<M;#5_!"?"Z?[1X3U#PK?MIU_H;';O\
MJ3#9WE5+%PQ)&<YYJ'X=?\$POAQ\.?#WC-8[[QQJWBOQ_;?9-9\9ZCX@FE\2
MS1@@H([Q=IA";4PL:JIV+N#8KFE7P3B^6-KWTMM=Z.]]DNG5F\:6*35Y7M;\
MM=+=7U['SU^Q]_P4K^+W[3WCGQ+IVK:G\)_A_KVCVFI7%[X$US1-5M_$'A^&
M*,FWNR[R+'>Q[MAD6-8_E<X8$#+_`/@A#KOQG^,_P_\`$?Q6\8^.-,U[PC\0
M=>U&\BT^YL[LWMM)'+Y2?9G><QP6OROB(1D]/GKZ$^%'_!,WP%\./&.O>)=6
MUGQY\0_%7B#19?#LNM^+M=?4+VUTZ0$26T+*J+&K;B20N[)/S8XKI?V+_P!B
M;PY^PO\`#RX\*>$]?\::KH#2^9:6>O:H+V+2QEF,=N`BB-&9F8CG)/6C$8K#
M^SG"BK7MT];V>_;ST'1P];GC*J[VOU]+?J>QT445XYZ04444`%<?^T%\0M8^
M$WP/\5^)O#_AR[\7ZWH6ESWMCHMJV)M2E1"RQ+@$Y)'8$^@)P*["N)^/_P`#
M;/\`:$^'K>'[S7?%GAHBYBO(-2\.:J^FZA:RQME625<@CJ"K*RD'D<`BZ?+S
MKFV)G?E?+N?"'P4_X+,>)-+_`&=_''Q0^(.L_#;6K?PCIL0O_!FBZ7J.D^)-
M!U>:<0P6,Z7+.LD3,64SJJ@&/A3D@;O[+W_!0?\`:.^-7QW\!V<O@.RU;PIX
MD9I/$L,?@K6=!_X0Z!MI0_VA?.L5XP!(Q'$-^TXQD5[-;_\`!(3X/W_PT\=>
M'_$4?BKQK??$=K=]>\1:_K,EWK=VUN0;8B<!0GE$#:%4#CY@U=7\#/V"M,^"
M&LR7S?$GXQ^,94TZ33+)/$WBI[Z'3(Y%"LT,:HB>9A5`=PY&WC&3GUZF(P7+
M)PCJ]KKRZ6[.^NCV\T>;"CBKQ4I:>7K_`)>O4^:/@A_P48_:"_:1\7_$CQ1X
M=\/?#+2O@A\,_%-_;7NO:K]K%_J.FV89I8[:-'*-/L4,9&*I^\48.#7F_P`(
M?^"D\W[-'[%O@+Q)H?PL\)Z1\5?VD?$.HZG::=H6EWTMH+>.8J^I7$$1FN)W
M";6,<1!<L<;0#7VO\./^";OP^^%7[%^M_`K1[KQ/#X/\11W<=]=/?JVIS?:F
MW3-YVS&2/ESL^[Q65\0/^"57PP\=?#KX8Z%;W'B[PQ??!^V%IX5U_0M6-EK&
MG1[%5U\X*5;?M!;*<G.,9.:6*P?,XN/NWZ=4D[7UZNS?H)X?$V34O>M^+:O;
MY7L>5_LZ_MT_M">(M'^+.J:Y\,W\9>'_``AH+ZCX9U.Q\,:AX5F\0WZ(K-8I
M97SR3L,D_O%`^X0`Q(K:_P""6_[<OC[]LO4]3F\3>(OA=<_V=9!M8\,Z9I6H
MZ5XA\)WQD(%O<1W+LLT>`X\U0@W(,`Y./5++_@G_`*-;?"#4_"LWQ%^,MY?:
MKJ,&J/XFG\7SG7(9H<"(1S`!$C5<CRQ'M;)+!C@UK?LN?L-^#?V4M=\2:[I5
MYXG\2^+_`!>T9UKQ)XEU-M1U745C&(HVD(50B#@!5';.<"L*M?#.$^6-F[6T
M_K\+:]+&M.E74XW>G77^OQN<S_P4GU'X(>'?@O;:Q\=I6N_#.G3N;/0Q>SK_
M`&]=,N$@6UB=?M<G=58%4/S?+C</$_\`@@[^RMX[^`GPI\<>)/%5GJOA+P_\
M0=8;5/#'@N]N9)7\/61:0IO5^8Y'5D&W[VV-2P!.!ZS^TS_P2J\%?M3?M$Z9
M\4=9\9_%+1?%>A0I#I$FBZY';0Z.%7!:W1H7\MF)+,0<ECGL,>S_``$^"Q^`
M_@9M$/BWQMXT+7#W!U'Q3J8U"^^8`>7Y@1`$&.!CN?6H>)A'">QA)MNU[[+T
M_5]2E0E+$>UFK);>?K_D?/WQR_;*^)'CK]N3_A0?P5MO"%IK/A[0QXA\5>(?
M$UM/=VFFQ2$"&VB@ADB9Y7+QL6+@`-T.#7@7A/\`X+'?$^V_8]_:,^)WB.R^
M'3?\*OUF'PKX6DTN&Z:PUK4=XBED+/+ODB)9)%4;#M8C)QFOJOXR?\$R/A]\
M9OVA+_XE3ZMX\\.Z_KNF)HVNQ>']?ETZU\0VB8`BNE0;V&`JG8Z$A1[YYW3?
M^".GPBTG]ES2/@_!)XL7P7I/B4>*C#_:,9FOKL'(6=O*P\0&!MP#A1SD9K>E
M7P2A&,HW^&^FO>6M^NR\C*I2Q3DW%][:_=IY;OS/,O!W[?7Q_P#"W[8/P"\"
M>/\`P]\.A;?&;2KB_O-&T:*[;4O#J0V^_P`^2X>0Q,"0Q*"/Y<,NYB`QY_QM
M_P`%/?B_\5?AA\;?BI\.+?X;^'_A#\)+BZTBWE\117<NJ>)KB!0)9(7C=4MQ
MN>,1ADDW,0#C)Q]?7W[&7A#4_P!L#3?C;/+K,OB_1]"?P]90-<K_`&?;6[,Q
M9EBV9#G<PSNQ@]*\1\4?\$-_@WXK\+^+/#LNK_$NW\(^+=3DUJ3PY;^)'32=
M/OG=6:Y@@V$;\+M'F;P`>`"`04\1@VU*4;:*^FF[OI?M9)^O4)T<2DU&5]^O
MDK=.]VT:O_!$'X+R_!?_`()J_#M+Q)%U7Q5!+XFOFD7#R27DAE0GW\HQ#GTK
MX-_;W^#=KX9_:U^#^EZM\+=5^`5WXO\`'#R#XG+XH?Q'K&M,LF$BQ%+OBWF6
M,YD)\L;`!M1A7Z[>)?@AHGB3X*GP$'U32]"&GQ:;"VEWTEC=VD4041F*:(JZ
M,NQ<$'M@@@D5XO\`#[_@E=X!\,_&G1?B!XH\2?$GXJ>*/#`_XD=QXV\0-J<>
MC-DDO!$J(@<D@Y8-@JI&"`:,-F$85JE>;=Y7T];VZVZ]4PKX.4J4*,5M;7[K
M]+_<T?2L,?E1*FYFV@#<QR3[FG445XQZ84444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%5M:NK
MBQT:[FM+?[7=0PN\,&[;YSA253/;)P,^]6:J>((;ZXT&]CTR>WM=2DMY%M)I
MXC+%#*5.QG0%2RAL$J&!(!&1UH`_-G_@G1^V1\9/VK/C5I<GC/\`:&\%^#?'
MMKJDO_"5_`+5/`\6GW^C6H>5?)MKJ65;NX<1(DJW"AXFSDC80*[#Q5^U/^T!
M\3M:_;G\._#G7--7Q3\$]2T<^`K:728)5=6TJ"_N+.3</WIG/F(K,<H9%P0!
M5?XK_L*_M,?MR>+_`(=6GQKC_9V\-:7\//$=CXBC\6>"CJ=SXGN&M95D,%J+
MF*-;%+DHHE(FEPN4PW##W_\`9+_9$\1?`?\`:\_:5\?ZO?:-=:/\9->TG5-'
M@M'D:XM8K32XK21;@,@4,70D;&8;<9(/%`'G7[1__!2:]\3?\$S/!/Q)^#KV
MT_C_`..!TO0?`UN\:7`M]6OV"/OC;AA:*MQ)(K<?Z,P->`_\%`/^"@WC3X#_
M`/!1&U^$WB#]JSPU^SUX3TWX::;KPUC4/!EEJS^(M5DO+F"<`3<1`I$K[5X'
M.*]:_9-_X)*>)_@!^V_>^(=4\2:#J'P1\%ZQK/B?X:^&X!*;W1M2UD)]M-QN
M01^5#^_$`1B5%R_W<<Z_[1G[)_[0WAK_`(*2ZG\=/@S:?!?7K'7O`%EX,O-.
M\;:KJ-A+;/;WUQ=&:,VMK,&#"55Y(/!H`YG]J7_@HUK?[(W[$_P<;3?B]X&\
M=>+_`(R:DUCIGQ,\2:9'I.@6MB(I;N;5);6!E5O*MU58X593+(R9/)!D_9A_
MX*$Z7X!_93^-'Q6U+]J;PQ^U+HOPYT=]5F@T?PW9:%=Z4\43OY3+;L2RSG8J
MLZ<%3@GD#L_VJ/V,_C)^U3\*O@WXUN7^%/A_X^_!CQ&_B73]/W7>I>$=09DD
M@>UDE>)+E%>%D(E6+='(N0IP#7&67_!*;Q_^U/XS^,_C;X^ZMX"\/^(OBQ\.
M&^&$.C_#^.XGT_3K'S6G%[-<7,<4EU<^:1M!C140;`6SD`''_L`?M\Z_^TM^
MT-X37Q+^V9\';SQ-KJ?;K_X/>'/#EJ]O:AX=WV&#4Y)?M$TT2LK,ZEMSH^%V
M=+6E_M$?M/?MK?#3XM_&;X4?%'PC\//"?PZUS6]'\->#;GPC%JP\3KI$CI))
M?7DD@EA-Q)&ZJ(`NQ"IY;)K3\._\$Y_VB/C3-\$/!_Q>U/X&Z/\`#_X"^(M+
M\1:?JW@JWO?[>\12Z8-MK&8IHDAL(Y``9A$\N1E%P#FIW_8"_:<^`FA_%7X8
M?!OQ+\&H_A+\4]<U76;?5_$2Z@OB#P=_:KL]['#;PQF"[".\C1%Y8L%@&X&:
M`/K;]A[]I(?MA_L?_#;XI#3QI+^//#UIK,ED&+BTDEC#/&">H5MP!]`*]4K@
M/V5OV>=(_9,_9M\#?#/099[C2/`NBVNC6TTY_>SK#&$\QO\`:8@L?<UW]`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'Q/_P5]_:\^)'[
M,>I_#"P\.^(X/A1\.O%-[=Q>,/BG/X:/B*+P?Y42M:Q/;9\N-;B0E#/,"B!<
M<%@:Y?\`:>_:M^*G[,?_``2(U_XDZ+\:O!7Q=\3VNO:9%HOC?1]$M([2_L+G
M5K.V=9((I)+<RJDLZ%HR`/E.`P)/TA^UJO[15KK>B7/P1@^#6L:6UO-!K.E^
M.9]0LG:0E3%-!<VL<W``=6C>+G<"'&,'Y#U/_@BYX_U3]@WXU^#$UGX=:)X[
M^-GC/2?%\VC:'#<67@_PN+2[LI7MK--C2$NELY:7RT\V1@2B#H`?1%A^TQXV
M^%W_``5;O?A3XTU&SN/A_P#$[PFFN?#J06L<,EK?V+;-3T]I!AI69)(KA=W(
M7<!T->:?$;]N3XGZW+^V9XV\(ZA96OP[^`OA2[T3PP)=/BF&I>)[.REN[ZZ,
MA^9HX':&W,9^4LKFO6/^"G/[&OBK]JWX:>$=7^&>KZ'X=^,'PL\26WBGP;JF
ML"3[!'.@,4]O<>6K.8)H))$8!3SL..*S]"_X)Y7?@G_@E'XH^`6EZO97'BGQ
M3X1U?3K_`%NZW^3?:QJ44[7-Y(0"Y1KB=VZ%@@`QQB@#YR_X)0_MI:S^UC\2
M?`OVG]N3PS\4M<O-"36M=^'=CX`T[3YHV:V4S0FYCQ(H@ED`)')V8/4UQGB'
M_@KU=?M#_'#Q/Y?[7?PJ_9C\+Z1XGN_#/AK0KOP[:Z[J_B!;6X^SRWU_)<R*
MEHCS(XBC4(1'\S,<J:^I_P!ACP+^UE\&-/\`A[X)\?\`AO\`9UC\`^$]&MM$
MN]3\/>(=7GUF6.VM1#%(D,UE'$69D0L#(``6P3@9\9U3_@E[^T#\,?AM\7?@
ME\.;[X#7?P6^+^K:MJ,FL^);.];Q%X?BU5F:[B%K%&;>]:,LWDR231D94$80
M"@#6_P""CO\`P5!O?A'^T1H7P>TOXT_#CX'6MOX5@\5>)_B%KVGIJ<A2><PV
MMIIED[^7+)*T<CN[EUCB`P-S*:M>,OV]O%_@W]D/X.Z;\//C1X(^.'CSX[>.
M$\%Z!\0O[$AM=-TY9$EFFN9;*VDV/+;Q0NHCW)N<IO&,@Z?B;_@FC\3_`-F3
MXT?#WXB_L_:C\._$^N>&/AM8?"[5]/\`B,US`FHV-CAK>]BN[6*62*?((=/+
M*.".1M%<Q9_\$:/B!I7P,N->LO&?@FS^/I^+7_"Z;-H-,FC\)6.J&#[,^FI$
M#Y_V1X-RM-CS&=O,V_PT`=]\!?C5\;_V:O\`@HKH'P(^+GQ`TGXP:'\2/"5]
MXE\/>)(_#<&@7^F7-A+$EQ:2PV[&*2)DFC=7P&!R#D8K[<KY`_9U_9!^,GCO
M]M:Q^//Q_O\`X<V6N>$?#=SX7\*^&_!$UY=V%E'=2QR75Y/<W4<3R2R>6B!!
M&%15SN8GCZ_H`****`"F7,CQ6TC1IYDBJ2J9QN..!FGU!J<=Q+IMPMI)%#=M
M$PADD0NB/@[2R@@D`XR,C/J*`/S._83_`&S?C3^U#^T)#;^-?V@?!GPS\?Z?
MXAFBUOX":OX(AM+JWT])Y$"6][-*MU=.]N@F6XBWQEC]W9Q7IOBS]H_X\?%/
MXR_MO^`OAUX@TRT\1?";3?#ES\/(Y=)@F$5S<Z8]W/!+N'[WSY(]@+_<W\8Q
M7.?'K]A/]I_]O@^$/"_QG7]G/P_H/A+Q!9:VOC/P@=4G\4#[)<QS;;&.XB1+
M![@1JLC+<2[5++A\@CZ)_9N_9,\0_!W]NS]HWXGZE?:/<:%\7W\.-H]O;/(;
MNU&G:>]M-YX9`HW.P*[&;(ZX/%`'E_Q@_P""G5YXC_X),^'/C!\-8(9_B+\4
M[6P\/^$M,:-9C%XDO9!;?9W0\,;:83LZG@K;/FNU_:,^$7[0^J>%+*[T7]H_
MPM\+-)\+^'HI=7U9O`MKJ<VI7D<3&ZNKAKB588+;Y0ZK%&I7+Y8@*!Y9\`/^
M"2/B7X0_M\WOB:Z\2:%<_`7P]XEU/Q_X+\+1"4WVF^(-4@2*[:;*B/[/$3<2
M0A6)5K@\#&:L?\%+OV3_`-IO]JOXX:-9>%T^"_B'X#:3;1W%WX-\3:[JNDMX
MEU`'<&U%K2VE\^TC(4K;;A'(PS*'`"T`>8_$'_@HG^T+X\_X(R_!_P"+^CV5
M_P"$?B!XQ\4Z?I^O:AX<\'R>(FBT1[NXAEU>WTUED=DDMXX[E4.>'50V&!KV
MG_@EQ^U%?_'31OB+9/\`'ZY^-WC#PYY6[0]>\`#P'J7AYVC<Q">U,:S>5,<8
ME:,@!3C/(KM+T?M=6WP)T";1](_9QTWQ]I^H2Q:AH3:AJTF@76G>6%@\B[6W
M6:"9&R2IMW1@`H*]:Q/V4/V//BMX>_:/^(7Q]^+&H?#V7XJ>+/#=MX6TK0O"
MWVK^PM(L[9Y)HQ+<S(L]Q)),X+.8UV*-JJ>I`*7[&'QX^-NN?\%`OBM\.?BW
MKO@^_@T/PEHGB&QTSPYIK0V>BRW<MTDD"W$I,]SA84S)($!))$:`[1]B5\"?
M`C]GS]L;PO\`M\ZW\7/%6B?LUQ:9XWTO2O#VN6NE>)-:FN+&SLI9W,UMYEBJ
MR3,+AAM<JOR+SR:^^Z`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`^2
M/VMOVY?BQX!_;?\`"OP.^$7PZ\$^,-=U[P9=^,[F\\3>)Y]&M[>""\CM3&GE
M6LY=RTJGD#C/I6I^RK_P4"\2^._VCM2^"?QD^&TGPL^*UGI+>(-.6TU5=7T'
MQ1IRR^4]Q8W82-LQL5#Q2QI(NX'&*\L_;,N/'OP!_P""N?@/XRZ/\'/B9\5/
M!]M\+-1\)W/_``AMO9W%S:7LVIP7"!UN;B`!/+B;D,3EAP><<[XKT7XB?'_X
MU>+?VFOBGX$G^#'PY^%?PPU[1_#&AZ_J<9UW5&O(]]W>W_V0S+91K'`B+&K2
M2`DOSP*`/?[O_@LO^RM9?$-_"C?'GX;OXA2__LLV46K)*YN?,\OR@5RK-O\`
MEX)YK`_:G_;B^+OA']NG1_@9\(/AQX&\7ZQ>>!G\<7E]XF\4SZ-##`M_]B\I
M!%:W!=MQ5N0."?3G\ROV#OBIXE\#6G[)$WQZ\-^*O"WPD^'VHV,7@74],^'M
MC9PWFI:A;/;6:7EXFI3SR0N)S\T5G&TK;7E"_-C[V_:SU/Q[^SG_`,%?]`^,
M6E?!?XH?%7P=-\(I?"$DG@RVLKB>TOVU@7061;FY@`7RDSD$\LO'7`!ZS^R?
M^W_K_P`1OC_K?P9^+WPZE^%7Q9T72?\`A(+>"#5$U71/$FF>:83>6%X%0LJO
M@/'+&DB;AE?2:+_@LM^RO<?$1?"</QY^&]SXBDU`:4EE!JR3/+=&3RA$I7*L
M2_RC!()KYR^)&@?$#XT^/?BA^U#\6/!,GP<\!>`/A)KGAKPMX?UO4X_[:OH[
MM#-=7VH-:&9;,8ABC2-#(Z_,V3P#\E_L#_$_Q/X(\4?LBR_M`^&_%/A/X>>`
M9K72/A[?Z=\.[#3K:^U/4K$VMK'>W46I7$TD;1LQ!BM8O,?#RA<'`!^A7_!4
M'_@JOK7_``3R^+WPVT+3?AS_`,)SI/B;3=6\0^([J/4C;7.BZ3IIM3=W$,0C
M?SW2*X:382N1$1GGCW#]J']LGPW^S=^RE??%1?\`BH[&>TMF\/V=C(#)XCN[
MPHEC;0'G+3R2QJ"`<!BV,`UX]^UG^S?X@^+7_!5;]G7Q(?"\^M?#[1/"7C+2
M/$MXRHUI;?;K>TCBAF!.2)0DB@`'H<XKP[]BO]@_XOZ5^U#X;^%WQ'TV=OV?
M?V5=3NM8^'.JS7(D/C*:Y).EB5`V?^)5!)-$-P_U@B(^Z#0!])?L8?M\Z]^T
M?^P1XA^+OB7P;8^&/$'A>77K:^T&TU-KR%9M+FGB=%G,:$AF@/.SC/>L'_@D
MA_P5%N/^"D'PROY_$W@^'X>>.-.L]/UMM$CU`WT5UI&HVXN+&^BD*(61QYB,
M-OR/$PR>*P_V&/V>_&_PY_X)E_%CPAKWAK4=,\4:WK7CFXL=.FV>==1WM]?2
M6K+AB,2I(A7)'WAG%?/4/[(_Q^_93_8R_9:^*OP@\#R7WQU\"?#JU^&WBWPI
M=RI#]NL9[8")IR#M)L+T),.3\K2CO0!](VG_``5@N?%/_!3W2/@9X?\`!4&H
M^";B]U'0+WQF^I%,:U8V`O;FS@@$9$BQ))`COO&)'9<97G[-KX&\%?\`!/;6
M_P!FCXZ?L7Z9H.G:CXCTWX>GQ9>^./$I*L9]3U'3T,M[<,QWLUS=M+CAB.`<
M`"OOF@`HHHH`****`"N`_:K^+UW^S]^S+\0/'5A9V^H7W@[P]?:S;VUPS+%<
M26\#RJC%>0I*@''/-=_7B?\`P4H_Y1Z?'#_L1=9_](I:`.9\<_MMZUX4^)WB
MG0HM$TN6#0/'/A+PI%*\L@>6'6!:F:5@.`\?GMM`X.T9KBM(_P""E?B/4?@G
M;^*6\-Z(MS-\&]=^)9@$TOEBZT^6)([;/7RG$A+'[PP,5Q7QC_Y.'^)'_98_
MAA_+3J\C\,?\FB6/_9J7C/\`]*;:@#[)\,_MKZSKOCS3])?1=,CBO/BK+\/V
MD61]RVR>'I-5%P/^FGF((\?=VG/6O.-6_P""H7B73O@WX6\2KX8T)KG7_"VI
M:_+"9Y=D4EKX@TS2EC4]=K1WSR$GG=&HZ$USWP]_Y+/HG_9R=S_Z@UQ7@GB;
M_DU/X<?]DY\0?^IQX>H`_2_X&?&6\^*_B[XGZ==6=M:1^`_%I\.VSQ,Q:ZB_
MLW3[SS'ST;=>.N!QA%[YKT.O"_V./^2G_M$_]E-;_P!1_1*]TH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`*I^(-5_L+0+Z^V>9]CMY)]F<;MJEL9_"KE9GC
M6SEU#P;J]O`C2S3V4T<:#J[%&``^IH`^0/\`@D/_`,%:+K_@I)X<U"'Q3X'@
M^''BQ-+M/$^EZ=%J9OXM8T.Z:2.&]BD,<9RLT,L4BX.U@O/S4_XD_P#!6.XT
M+_@I5X0^!OAKP7!KWAG4-:'ACQ!XLDU(Q+I>L-I\^H"RAB$;"9DMXD:0EUV&
M91C.:^7_`(8_L9?'/]E+_@FU^RW\5/AY\.[N^_:'^"&BW'AW6/!=S-'!+X@T
MB_GE6:SF?=M_<2F"Z3YN/+?N<5ZYH?\`P3S\8_`S4OV-[>WL+_Q;KF@>/]5\
M9_$WQ"C*WF:G?Z5=_:;R8LV2IN)4A3&<(L8Q@4`?HG1110`4444`%%%%`!11
M10!Y]\8_C%>?#7XE?"O0[:SMKF#Q_P"([C1+J61F#VL<>DZA?!TQP6+V:+@\
M8=N^*^=/"W_!33Q)K_P/U/Q5)X:T2.ZL?#WA/65@6:4QL^L:Y?:;,A/7;'':
M(Z]RSL#QBO6_VJ_^3@/V;O\`L?;W_P!1G6Z^#OAO_P`F>^(/^Q&^&?\`ZF.L
MT`?78_;[UT_'WQ#X0_L#2?LFC7WB>TCN/-D\R0:5IND7D1(Z9D;49%;T$:XY
M)JEI_P#P4/\`$%Y/\/T;P]HZCQAHO@'5+@B:3_1W\0WE];W"KZB%;52F>I<[
MNU>)C_D]CQU_V&/B)_Z8/#%9&A_\?OP0_P"Q2^"G_ITUB@#Z?\,?MR:WKWC7
MPKI;Z'I<<7B#7O'&DRNLLFZ)-!NYX('7_:E$0+YX!)Q7L/[,_P`4[KXY_LX?
M#_QM>VL%C>^,?#6G:Y<6T#%HK>2YM8YF12>2JER`3S@5\8?#O_DK?PV_['/X
MP_\`ISO*^I_^">__`"8/\#_^Q`T'_P!-UO0!Z_1110`4444`%<5\0OBA<^#?
MBCX%T&&U@F@\5SWL,\KL0\`@M'G4J!P<E0#GL:[6O(_CE_R<9\&_^OW5_P#T
MV35S8J<HP3CWBOODD_P/:R'#4J^*E"JKI4ZS^<:4Y1?R:3^1R7@K]L[6/%'@
MR+4Y=&TR*22#P=*461RH.M311S#_`+9B0E/7`S4WB_\`;&U?PYI%_<QZ/ILC
M6?B#Q#HZAI'`9--TZZNXW/\`M.UNJMV`8XYKQ7X2?\DFMO\`KT^%7_I5;5:^
M*/\`R*^M_P#8[^.?_3%J5?.+'XCV<7S=/_;VOR/VB7".4?7:E+V"LI-+5[?5
MX3[_`,S;^?8]QU#]JO5+./52-*L#_9]MX4G7,C_.=7O3;R@_]<U&5]3UJ+3O
MVL]5O='TRY;2=/5K[2_%5^RB1\*VD7B6\2CVD5R6]".*\QUS_4>)?^P?\-/_
M`$[-5?0O^14\/_\`8N?$G_TZPUL\;7O\73_W);\M#SH\+Y7[-2]BK\Z6[V^I
M^TMO_/[WKY:'UC\,/%<OCOX:^'M<GBC@GUG3+:^DBC)*1M+$KE1GG`+8K<KC
MOV=_^3?_``+_`-B]8?\`I-'78U]#0DY4XM]D?CF9THTL95IP5DI22]$V%%%%
M:G"%%%%`!1110`4444`%0ZCIUOJ^GSVEW!#=6MU&T,T,R!XYD88964\%2"00
M>"#4U%`'@WPJ_P""77[.?P.^)D7C/PA\$_AKX=\4V\C2PZG9:%!'<0.QR61@
MOR-GNN".U8_[*/\`P4@T7]JS]LGX]?!NP\-:II.I?`:\L+2_U&XN(W@U4W2S
M,K1*OS+M\DYW>HKZ1K\MO^".W_*<G_@HM_V&O#O_`**O:`/U!U72;77M+N;&
M^MK>]LKR)H+BWGC$D4\;`AD93D,I!(((P0:_/_\`X)/>'_V6_C]\=?C'K7PS
M_9P\%_#CQ9\$?&M[X,FU=-*M//NIXI&#W$#(N8@QCXZ,`>O6OT(K\MO^#;G_
M`)+)^W7_`-EXUC_T?/0!^I-?.'[#'_!1S1OVY?BY\=?".E>&M4T&X^!?B^7P
MA?7%W<1RIJDL;S(9H@O*J3"3AN?F%?1]?EY_P;Z?\GH?\%"?^RU7?_H^]H`_
M4.OG#_@F5_P4;T;_`(*9?"'Q;XOT3PUJGA>W\)>+[[PC+;W]Q',]Q+:I"[3*
M4X"L)@`#R-IKZ/K\O/\`@U$_Y,J^,W_9:?$'_HBQH`_4.BBB@`HHHH`****`
M"O$_^"E'_*/3XX?]B+K/_I%+7ME>)_\`!2C_`)1Z?'#_`+$76?\`TBEH`^;_
M`(Q_\G#_`!(_[+'\,/Y:=7D?AC_DT2Q_[-2\9_\`I3;5ZY\8_P#DX?XD?]EC
M^&'\M.KR/PQ_R:)8_P#9J7C/_P!*;:@#V'X>_P#)9]$_[.3N?_4&N*\$\3?\
MFI_#C_LG/B#_`-3CP]7O?P]_Y+/HG_9R=S_Z@UQ7@GB;_DU/X<?]DY\0?^IQ
MX>H`^_OV./\`DI_[1/\`V4UO_4?T2O=*\+_8X_Y*?^T3_P!E-;_U']$KW2@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\&_X*6_MX:3_P`$U/V.?$_Q
MBUO0-1\3:=X9ELX9-.L9DAGG-S=16RD,_P`HVM*&.>P->P_#SQA'\0_`&AZ_
M##);0ZYI]OJ"1.06B66-9`I(X)`;'X5\"_\`!U9_R@]^+'_7[H7_`*>+.OMS
M]FC_`)-P^'__`&+>G?\`I+'0!VU%%%`!1110`4444`%%%%`'AW[5?_)P'[-W
M_8^WO_J,ZW7P=\-_^3/?$'_8C?#/_P!3'6:^\?VJ_P#DX#]F[_L?;W_U&=;K
MX.^&_P#R9[X@_P"Q&^&?_J8ZS0!Z$/\`D]CQU_V&/B)_Z8/#%9&A_P#'[\$/
M^Q2^"G_ITUBM<?\`)['CK_L,?$3_`-,'ABLC0_\`C]^"'_8I?!3_`-.FL4`=
MC\._^2M_#;_L<_C#_P"G.\KZG_X)[_\`)@_P/_[$#0?_`$W6]?+'P[_Y*W\-
MO^QS^,/_`*<[ROJ?_@GO_P`F#_`__L0-!_\`3=;T`>OT444`%%%%`!7D?QR_
MY.,^#?\`U^ZO_P"FR:O7*\C^.7_)QGP;_P"OW5__`$V35R8W^&O\4/\`TI'T
M/#/^^3_Z]5__`$Q4/F[X2?\`))K;_KT^%7_I5;5:^*/_`"*^M_\`8[^.?_3%
MJ55?A)_R2:V_Z]/A5_Z56U6OBC_R*^M_]COXY_\`3%J5?)+^%'T_]O9_0DO^
M1A5_Q/\`]1:9O:Y_J/$O_8/^&G_IV:J^A?\`(J>'_P#L7/B3_P"G6&K&N?ZC
MQ+_V#_AI_P"G9JKZ%_R*GA__`+%SXD_^G6&NB7Q?+_W*>5'^$O\`KXO_`%7G
MTY^SO_R;_P"!?^Q>L/\`TFCKL:X[]G?_`)-_\"_]B]8?^DT==C7U6'_A1]%^
M1^`YQ_O]?_'+_P!*84445L>:%%%%`!1110`4444`%%%%`'SK_P`%3].^.,O[
M&OB'4_V=]<@T?XG^&I8M:L[::QBNUUV&W)>;3]L@(!E7@$<DJ%R-V1^!O[#_
M`/P5,^+W[0_[?W[0.F?L_>&KSPO\8OVJM<T%+>^NX$N(?!%M917!U.YD1P0=
MF_"[UX7.?GV@_P!/E?/?[-W_``3"^$7[*?[5?Q1^,?@[P\EAXR^+$L<FIR<&
M&S`&Z5;9<?NA/+^]D`^\X'0`"@#S[_@K3X@_:)^!/[&^A_$#X):[!K/BKX5W
M5MK?BO1Y=-B?_A-]-ABQ>0J,$Q,1F7$>&PI"G(7/XS?\$>_V_/C!^TI^TC\3
M_AC^SA:W?@WQ!\<OB]=?$;Q!XFO;6&\A\*^&][2RQE7!4S,TBQY_B.U5(+EE
M_I==0ZE6`*D8(/0U\^_L2_\`!,7X1_\`!/WQA\2-<^&_A]-*U#XGZTVL:F[8
M;[,IY6T@P!LMT=I'5.QD/8```Y7_`(+!ZY\?/AS^R2?'?[/>J6X\6?#K48?$
M.JZ%/8QW(\6:7"K?:;(%@2C%3YGR88^654@D5^(__!+/_@HI\7_VG/VL?C/X
M!_9NL;OP9XT_:-^*A\<:GXBO;6*\@\'>'T>>6Y+*P96EW3*@R,'A00S@C^F6
MOGS]C;_@F)\(OV$/BA\3O%_P[\/)I6L_%75O[4U1SM*VJXS]EMP`/+@\TR2;
M!_%(>RJ``>7_`/!9[XR?'C]DKX/>#OC-\(;M-:\/?"_5/M_Q#\*_88I)?$FB
MN$662-R-T;P`.^$(XD+'(CVG\D/^#?/]LGXS?'OQ;:?`WX#"?P?I-W\4=2^)
MWQ"\4WEG%=K:Z%(+1(M.56!423F*1"1ALE2IPKU_1YJ.G6^L:?/:7<$5S:W4
M;0S0RH'25&!#*P/!!!((/7->#_L"?\$U/A3_`,$U_"GBO2/A=HC:7!XQUR?7
M+^25A)+EV/E6RM@$00H=D:'.`6.26)(![]1110`4444`%%%%`!7RI_P59_:!
ML/`O[+OQ8\%ZAIU_%<>(OAKK][I5\Q1;2_D@M)3<6JMG/VA(<S!,?.BMMR5(
MKZKKS#]L3]DOPI^V[^SYK_PY\8K?1Z3KL)5;NQF\B]TZ7!"SP28.R1<D9Z%6
M92"K$$`_-'XM_P#!27X<^(/VL_%6F>'K^#7XO$GQ>^&LMC?17D=O;%8[:VF=
MW,NW8J?9VC<\[))(U;!:O%[?_@IEX&\/_LM&PEMKQKW3_P!GCQAX6DMEN(C,
MUP^I06R,JYP0[1O(BYW/$N\*01G[R\=?\&YG[.7Q`_MV.]L?%8M->U73-4DM
MTUJ4);FT1%EBCSR$NRBO/W9PK`J5&*=E_P`&W7[/%EX'AT,?\)I)%#X0N?"1
MF?6G,CB216AOCV^TVZ*L438VB-54J0HH`\(\,_\`!1CP)X1_:<TK1=;GM=+-
MK^T"FJS79U.WN+1;>X\'/!YR2QEE>*-I5WR<*I^7.<X\&F_X*%^$/%7[-/A^
MUT^TN+H^$_A7KVH7>V[A22=&\9Z5*L4,;E7>X*V;,(L;F66-AD'(^^?A_P#\
M&X?[-WPXM])MK&P\5S6.D>(I==CMKC69'CFBEM#;RZ=(!C=:.S-,R<$NS?-@
MD5A>(_\`@V._9S\3Z!X8M;BY^("WWA2TFM[74TUYQ>22M>17,=R[D<RPK$(4
M8`8CV@@E5(`.W_8;_;=\-^,/B9\3/[!M+K7I/B+\5G@TI;"6.8;(=`T@7T[M
MG"PVK)L>3)#NZ*F[<*^W*\&_8^_X)Q?#/]AWQ?XWUGP)87UM-XVO_MCQ75TU
MQ%I,7EQ(;6T#<Q0EH@Y7)RV,G"J![S0`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`?@3_P`'2G[1_P`<?V>/#_Q7^%_CMQXO^"7QWBTN^\`:E#9QV[>$
MK^PO+6>ZL)64`R!TB=P7))WH5Z/C[7_X(._M._&O]O"3Q!\6-<>3PO\`L]VV
MCV7A3X?^&;FSB%WJ$MI'&ESJCS`;R"Z.@&2IW$#_`%66^N?V]?V$O`'_``4:
M_9PU7X8_$:QGN=#U&6*ZBN+9Q'=Z?<1-N2:%R#M<#<N<'*NP/!KTCX6_##0?
M@K\.-#\(^%M,M=%\.>&[*+3M-L;9-L5K!$H5$4>P'7J>IH`WJ***`"BBB@`H
MHHH`****`/B3]M']N7PMX$^-/PON/$-M>:#+\-_B5=6FIPWLD<;.)_#.L_8I
MXSG!@N2Q5)20JLC*^TBOSX\._P#!1/PAX0_96FLM0M)K>37OAIX`U2UVWL,V
M5M?%NI2-;L(RS+=$3@F#&Y%1V;`'/ZT?M>?\$X/AE^VYX\\$>(/'5A?W-UX(
MN)G2.UNVMXM6MY8)8FM+L+S+"#*7"Y!!W8(#L#\S>"_^#8_]G/P'X2UK3+"X
M^("S:T-/D>_.O.+NVNK2[>X^UQL``LTJOY+L0?W8X`)+$`^;9/\`@I!X*MOV
MC?$GBV:(Q:+K'B[XC:3%/_:%NXB9=#T5?/DVL2L#_89/*?GS3)$J@EP*QO"O
M_!1WPCJ.F>!=2@L)Y;;P+X9^#=O?`:A;+-*\6HZ@[B*)G#OL^T*)>!Y.QB^!
M@G[!A_X-L_V:[;XM:]XMAT[Q3!-X@74(IK&/6)%M(8;J&"-(44<JEN\"S0C/
MR2;3DA$`@F_X-JOV<;KQKX2\031^-)=4\)6>E6D<C:T^+\V3.999^/F>[1_+
MGQ@,HX"DDT`?/WPL_P""EOPG?XI?#6XO_$=AIEI%XQ^+<UW/).9$L[>:XN+J
M&X;:O,<@D"1D??887/2ON7_@F!^T#:^//V;/A7X+M-)U`7GACX:>';C6+O<C
M6MA-+8P^1:,X/S3O"!,5`^1'3=@L!7FFE_\`!O!^SSIE]IDIM?%L\6G3ZU(T
M$FM2E+J'4&9TMI.YBM';?;C.4<;B6)-?4/[(W[*WAC]B_P"`/A_X>>$A>RZ7
MH5ND37E]-YU[J,@14,\\F!OD(51GL%51@*``#TJBBB@`HI&<(,D@#W-)YZ?W
MT_.@!U?*O[2?[5.@^#_BWX&U;5[:\TYO!VKZW97]I,468RC29I(`O."MQ&-T
M;DA2?E.&X'U1YZ?WT_.O(OV@?V+?`7[2_CWP]X@\3P7<MUX?BN+?R[>Z:"*_
MBEC9`DX7EQ&S%TY!5N>Y%>?F5+$5*5L-;FNGKMHT_P`+'U_!6/RG"X]SSE2]
MDX5%>&LKRIRC:S:7O<UKW5G9WLFG\->"?VN_#OA#X<:;;:A$8FN](^&M[&R7
M<4JE;>YB+I\A)\T+&S,F,H,;L=*T?&G[6/AGQ7JFKZ#I<L-Y)-XP\=74=W]L
MBCMWB_L:[C5]S$<.9UV$9#['`.17NG@[_@BQ\&?!.@RV-I-XG)FN-.N_/;56
M\U)K5@SNI``!G`"R<<A5QC`-/\9?\$7O@GXRT:6RNX]=CMFU*]U%%34V"P+<
M1NBVZYZ0PLY>->H8G)(8@_)K*LXY%&T=+=?[S>]OT/Z#EQ[X<O%3J<U?WG+7
MDTUHQII\OM+Z-;<ROK>RLSPR7]N7PKKD5XMO!+YVM6OPZ@BBEN8HF@>/4&E8
M2ECM3:I7?R?+W#=CG%K0?VR/!]D+#3-3NH]+.EZ1\1;*XFEG21%:2^29'&S.
MY'V%4/\`RT/W0>_N&O?\$B?@IXCT[4[6ZFUIX]4@TZ*5O[7)97M6R\RD_P#+
M2X!(E)SNR2`"<TW2?^"0OP2T?1;"PCDUEH+#3]0TX!M78F6.YD#QEO5K8@>2
M1C;M4G<0*M99G'-KR;=_[_-V_4Y)<;^'#I<J^L+WK_"KK_9O97NYVTVLX[ZM
MVU/7OV3OBA%XK^'N@:!!87:3>'/#6E+J5P2I@M[J2UC;[*&!^>58]KMMX42(
M,Y.!ZS7&?!/X:^'/@)\,-(\*:'<+]@TBW6$37%P)+BZ<`!II7ZO(QY)]3Z<5
MU?\`;%I_S]6W_?Q?\:^QPD)PHQC4WM_7_#]3^;\^Q.%KYA6K8)-4W)M7W?FU
M=VN];7=EI=VN[%%5_P"V+3_GZMO^_B_XU-%*LT89&5U;H5.0:Z#R!U%%%`!1
M110`4444`%%%%`!7QK^U?^R;^V)\3?CEJ^L_"O\`:OT'X9^"+I8A8>'KCX<6
M&KR616-1(3<RG>^YPS<]-V.U=?\`\%@_B]XA^"7[`/B_6?#.KW?A[4;F[TO2
M9-6M7:.XTJVO-1MK6>>-QS&ZQ2OM?^$D,.0*\\\7?";3?V._^"DG[-^B_#"/
M4-#T?XA6/B+3/%FF)J$]Q;ZI;65BEQ;74R2NV9XYVQY_WV\YE8G<*`.-_P"&
M#_\`@H1_T?9X7_\`#/Z7_C1_PP?_`,%"/^C[/"__`(9_2_\`&OT0HH`_._\`
MX8/_`."A'_1]GA?_`,,_I?\`C1_PP?\`\%"/^C[/"_\`X9_2_P#&OT0HH`_.
MJX_X)Z_M]ZUA+W]O32[>-/F4V/PFTR)R?<[N14?_``[3_;H_Z/\`KC_PU^F?
M_%UYQ=Z8OQ@_X)0_'?\`:(UG6=:7XTZ)JOBC4=+U^'5;B&Y\-7.EZA/%8V=L
MF\+%"@@C4P[=LGF/N#%S7WU\5/`WBO\`:>_8!UCP]:ZC'X?\:^//`S6:7KM)
M;KI]]<V6/,)C^=`LCY^3D8XYH`^3/^':?[='_1_UQ_X:_3/_`(NC_AVG^W1_
MT?\`7'_AK],_^+KT']EF/3_V-OVGO`'PI\4?"[PMX=\6^/?#-V=*\4>&M>GU
M6'5'T](6NX[I+B&&:%F#)(KXD1B2I8,!G[8H`_.;_AVG^W1_T?\`7'_AK],_
M^+H_X=G_`+<LWR2_M_7@C;AS'\,=,5P.^#OX/O7Z,T4`?G3_`,.H?VO!T_X*
M">/?_"'TW_XJC_AU%^U[_P!)!/'O_A#Z;_\`%5^BU%`'YT_\.HOVO?\`I()X
M]_\`"'TW_P"*H_X=1?M>_P#203Q[_P"$/IO_`,57VK^UK\0=6^$O[+'Q)\5:
M`JOKGAOPOJ6J:>&C\P?:(;622/*_Q#<HX[U\">)_`L'P0_8__90^,'@C5=<N
M?BAXR\6>$8M8U^35KBYN?%T6KE#J,5T'<K/&ZR.X4C]UY2%-H2@#IO\`AU%^
MU[_TD$\>_P#A#Z;_`/%5+%_P2"_:9O(Q)??\%`_C`;IOO_9?#5A#%[84/QQ7
MOG_!3?X;?$/XE_#;P/!X)M-6UOP]8>,+*\\=Z!I.HBPU'Q#H"I*)[6"0O&&)
MD:%FC\V/S$1DW?-@^7?L!>)[OP__`,%%_B[X'\,^'?%?@[X:6W@_1=</AS6I
M%D&BZO-<743F)%FE%N)X(D<Q!AN\L/M&[)`.7_X<\_M'?])`OC9_X(+'_P"+
MH_X<\_M'?])`OC9_X(+'_P"+K]#J*`/SQ_X<\_M'?])`OC9_X(+'_P"+H_X<
M\_M'?])`OC9_X(+'_P"+K]#J*`/SP/\`P1J_:`U`[;_]O[X]R1KRHM-.L[1@
M?=E8Y'M1_P`.5?C9_P!'\_M)?]]6U?H?10!^>'_#E7XV?]'\_M)?]]6U'_#E
M7XV?]'\_M)?]]6U?H?10!^>'_#E7XV?]'\_M)?\`?5M1_P`.4OC1)\LG[?'[
M2IC;A@DMLC$=\'L??M7Z'T4`?G9_PXL^(PZ?MU?M7?\`@\A_^(H_X<6_$?\`
MZ/J_:N_\'D/_`,37Z)T4`?G9_P`.+?B/_P!'U?M7?^#R'_XFC_AQ;\1_^CZO
MVKO_``>0_P#Q-?HG10!^=G_#BWXC_P#1]7[5W_@\A_\`B:AD_P""`'B#49&G
MO_VT_P!KFZO)#F25/%B1*Y[841G'&*_1FB@#\Y/^(?/5?^CS/VO/_"Q3_P"-
M4?\`$/GJO_1YG[7G_A8I_P#&J_1NLKQQX8T_QGX0U'2M5:==,OX&BNC#=R6C
M^41\P\V-E=!C.2K#C/-`'Y\_\0^>J_\`1YG[7G_A8I_\:H_XA\]5_P"CS/VO
M/_"Q3_XU7=?L">'=.\9?MO\`CGQQ\'$OM&_9YL_#T?AM0ES*^D^,-?CNF:74
M+"-V*^5;Q#[.;A`%F=F`W"/=7K?_``5`^$]_\4_V./'1M_&?BWPG9:#X=U;5
M+N'P_>"QFUCRK"=HX)+A1YT<0DVNPB9&?;M+;200#YJ_XAWDU0XUC]KG]K_4
MXDYC1?'7D;#W.5BYH_XAQ?#O_1T/[87_`(<>3_XU7UC_`,$V]0N=6_X)Y_`N
MZO)[BZN[GP#H<LTT\C22S.UA"2S,Q)9B3DDDDYKVJ@#\Y/\`B'%\._\`1T/[
M87_AQY/_`(U1_P`0XOAW_HZ']L+_`,./)_\`&J_1NB@#\Y/^(<7P[_T=#^V%
M_P"''D_^-4Z/_@W$\,&11/\`M.?M@SPD_O(S\2)`)%[C_5=Z_1FB@#\\/^(;
MKX:?]%V_:U_\.9)_\9H_XANOAI_T7;]K7_PYDG_QFOT/KYA_X*7P?"3PW\-Q
MK/Q"T'4/&'B;5X9-`\(>'+&^N?[1UO4)E/EV]C!'(H68G!:=0#&B[V=53-`'
MAW_$-U\-/^B[?M:_^',D_P#C-'_$-U\-/^B[?M:_^',D_P#C-?6_["WPZ\=_
M"3]CWX<^&_B=KTOB;Q_I&AV\&NZC)-Y[SW.W+`RGF0ID)YAY?9N[U^?'@'X[
MZOJ7[-OQ'_:>^+7PVT;XCZ3X5\9ZPEX]UXNFCU/0=-L-4DM(X-/T_P`DVT8A
M1`Y1ITDF<NS'+)0!ZA_Q#=?#3_HNW[6O_AS)/_C-`_X-I_@M-\UU\3/VE+^X
M;EY[CXC7)DD/J2$`_2OT&T;5(=<T>TO;?=Y%Y"D\>Y=K;64,,CL<&K-`'YX?
M\0T7P._Z*#^T7_X<6Z_^)H_XAHO@=_T4']HO_P`.+=?_`!-?H?10!^>'_$-%
M\#O^B@_M%_\`AQ;K_P")H_XAHO@=_P!%!_:+_P##BW7_`,37Z'T4`?GA_P`0
MR_[/MV<:CXJ^/.KJOW%O/B%>,(SW(VXYI?\`B&+_`&:/^?WXQ_\`A?7_`/\`
M%5^AU%`'YX_\0Q?[-'_/[\8__"^O_P#XJC_B&+_9H_Y_?C'_`.%]?_\`Q5?H
M9-$)XF0E@'!4E6*D9]".0?<5^=?Q;\$M^S+^VW\#M:L_"6K_``8\'7'C"?1-
M4\3IK[ZR_C::[AD2TTRZ@65V5+B;$OVB?+1O"JC!<D`%C_B&+_9H_P"?WXQ_
M^%]?_P#Q5'_$,1^S)(=LT_Q>N(CP\4GC[4"D@[J<.#@_6ON?XQ_#^^^*7PZU
M#0-/\3ZYX.GU'RT?5M&,2W]O$)%:187D1UC9T#)OVEDW[EPP!'RS_P`$)3=0
M?L4:W9W.I:QJHTKXC>+-.@N-4OY;ZZ,,.L7,<8>:5F=R%4#)-`'G_P#Q"Z?L
MA_\`0K^.?_"XU7_X]1_Q"Z?LA_\`0K^.O_"XU7_X]7Z&T4`?GE_Q"Z?LA_\`
M0K^.O_"XU7_X]1_Q"Z?LA_\`0K^.O_"XU7_X]7UI^W)XL^(?P^_96\8^)/A9
M'I]UXU\,V1UBSL;VV-Q%JL=N1+-:`!@5>:))$1ADJ[*<'I7S%K'_``5LU+QK
M#\1OB9X`M]/USX/_``D^$\7B[58?)W7FJ:Y>P&\M;%9@V(E@MDS,-I(:=!QM
M-`&1_P`0NG[(?_0K^.O_``N-5_\`CU?:G[-?[.WA?]DWX'^'OAYX,M[RT\,>
M&(&MK"*[O)+R9$+LY#2R$NWS,>23Z5\P?LP_M-_'S6O&_AK4/%^CWT_P^\1>
M&[O5M>UW6?#]GH5AX0N$MQ<6[PO'?2R7-K)EXV#J'41HY<!F`H?"?]O_`,1:
ME^VW\)_"-IXVB^(W@CXP:=K$\=Y_P@]YH5M826D"7,,UA>2@1WMM(I=/E,AQ
ML<.0>0#[GHKX,^`O[1_[3?QE_P"">6H?&+1I/"OB[QCJYNK71O"VG:0MLEO!
M!JKVTEV'EF!GNUMHI'6`O'$[A%R,FOH3]@W]HJ#]HKX4ZE<MXGOO$6L:!JDF
MF:M!JGAN3P[J^C7`1)#:7MFY/ES*LBG*@*R,A&>20#V^BBB@`HHHH`****`,
MCQ]X`T3XJ>"]4\.>)=)T_7=`UJW>TO\`3[Z!9[>[B<89'1@001ZUQ7P<_8]^
M'?P&\2#6?#>A3IK*:>FDPZAJ.JWFK7=K9*VX6T,MW+*\4.[!,<9520"02!CT
MRB@`HHHH`****`/&];_X)^_!_P`1>-M0UZ[\&6TESK&J1ZYJ-FM]=)I6HWZ%
M2MU/8+*+2:;*(Q=XF8LBL22`:Z/Q-^RSX$\8>*O%6MZCHCSZIXUTN#1=8G%_
M<QFYM8&9HD55D"Q,K.Q#QA7S@[N!CT&B@#SCX6_LE>`?@[XVG\3:-HMS+XDN
M+06!U?5M5O-8OXK;=N,$<]W++)'$6PQ1&56(!()`KT>BB@`HHHH`****`&7-
MM'>6\D,T:2Q2J4='4,KJ1@@@]017D/PW_8%^$?PD\4Z1J^@>#X;.X\.RSSZ+
M;R7]W<V&A23%O,:RM)96M[0D,P_<1IA6*C`)%>PT4`>;?\,D>!8M%\0V%K8:
MSIL'BO7'\1ZHVG>(=1L9KJ^=0K2>;#.LB*0!^[1A'QG;FMKX._`3PC\`M)O[
M/PGHL.EC5KIK[4+AI9+F\U*X(`,UQ<2L\T\F`%W2.Q`4#.`!77T4`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`5SOQ<^$^@?'7X9:YX.\56+:G
MX<\26CV&I6@N);?[3`XP\9>)E<`C@[6&02.AKHJ*`/,/@S^QWX#_`&?DM(O"
M=IXATZST^Q_LVUL9O%&J7EC:V^T*(X[:>X>%```!A`5[8JI?_L._#34/@59_
M#0Z-JT'@BQ6X1-,M?$6I6PE2?S/.CEDCN%DFC?S7RDC,OS=.!7K5%`'%_`;]
MGSPI^S/X!M?"W@RRO],T"Q2.&UL[C5;N_2TC1%C2*(W$LACC554!$(48X%=I
M110`4444`%%%%`!7D_Q?_8A^&OQV^+FD>/?$FBZE/XQT"PDTO3M6LM?U'3;B
MRMI&W21QFVGC"ASC<0,L``20`*]8HH`\^F_9=\%7D'@U+K3]3OV\`:BVJZ'-
M>ZU?74]I<E'0R-)),SS?+(PVREU&>!P,<WKW_!/OX/>)O&U_KU[X+MIKG5M5
MCUW4+,7UTFE:C?IM*W<]@LHM)ILHC%Y(F8LBL26`->RT4``&!@<`4444`%%%
M%`!1110`4444`0ZCIT&KZ?/:7423VUU&T,L3C*R(PPRD=P02*\G\&?L(?"WP
M)XHT/6+3P[>7M[X78R:*-6UO4-6@T9RNS?:PW4\D4#A,J&C56520"`2*]>HH
M`\^M_P!EWP58V7C*"TT_4]/'C_4AJ^N2V6M7UK/=W05%\Q)8YE>'B-!MB9%(
M!R.3G/\`V;_V-/AW^R1;ZA!\/]'U'0K759I;FYMGUS4+ZWDFEE,LLPBN)Y$6
M1Y&9F=0&8DY)KU&B@`HHHH`CNC*+63R!&9MI\L.2%+8XR1SC-?.G_!.+]@'3
M?V)_V5[_`,"ZM;^'=7U3Q;K&J:_XH^PV973+ZXOIW=XHXI,GR$A,<(1LC:G3
MG%?1]%`'E/PO_8B^&/P<MS;Z#X<FBT];*738=.O-5O=0T^SM91MD@@M;B:2&
M"-E^4I$BC;\N-O%9OPR_X)[?"#X/^+O"VNZ!X1-OJW@>"6U\.SW.JWUZ=#@D
MB\EX+99YG6&$Q_+Y2`(,#"@@8]HHH`\YTK]DOX?:!\$+3X<:=X?_`+,\':?.
M;JTL;*^N;9[24W#7/F1SQR"9'\YF<,K@@GCCBM;X,?`/PC^SWX?O=-\(Z.FE
M0:I?2ZG?RM/+=76H74F-\\\\S/+-(0%&Z1V.%49P`!V%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
64444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>fig3.jpg
<TEXT>
begin 644 fig3.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0">17AI9@``34T`*@````@`"`$:``4`
M```!````;@$;``4````!````=@$H``,````!``(```$Q``(````0````?@,!
M``4````!````CE$0``$````!`0```%$1``0````!```.PU$2``0````!```.
MPP```````7;R```#Z``!=O(```/H4&%I;G0N3D54('8U+C`P```!AJ```+&.
M_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L`0P$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!_\``$0@!?P+N`P$B``(1`0,1`?_$`!\```$%`0$!`0$!```````````!
M`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$```!?0$"`P`$$042(3%!!A-1
M80<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$
M149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;G
MZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!`0$````````!`@,$!08'"`D*
M"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1!`4A,08205$'87$3(C*!"!1"
MD:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-4
M55976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6F
MIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V
M]_CY^O_:``P#`0`"$0,1`#\`_OXHHHH`****`"OSJ^('[>[?!']L_P`'?LN_
M'?X;:3X&^'_Q>\.?VM\'/VA-&\?ZCXE\-7?B!]<L/#6F^!_B]H6H_#SPK9_"
M7Q#XNUZ\;2?`=Q%XP\;:%XFU-+?2#JVG:UJ-AIL_Z*U^6/QETOX6?'3]N/Q)
M^SM\4?AS\3/%7@/Q_P#L?^(?A1XIU*Z^"/QC;X47&N:GXRT3XEVVE1_&B+P-
M_P`*NL=:L_#FG_VWI6IP^-(VTSQ38VFB6UW#XTAM](`!V7[0/[6/[4?PL^,'
MQ0\`?#S]G#X#^/O!WP]_9]U']HBR\7^,?VI_'WPX\1:]X9T'S-/U[0KGP7HO
M[)7Q-T[1]?CU^PU:UT@1^-M7TW4='AT[5;R_TB]O[G1--^2)O^"K7[31_9F_
MX)Q_M(V7['?P-GLO^"CGQ2^!GPN\#^%+K]L7QY:W7PZO_P!HGP)J_P`0/AYJ
MOBO58OV,[R'4K2STCP]K-MXQATBR:;2-0&FQZ-_PDD%Y=7&G<99>!/VF/V>-
M7_:N\#?';3_B'\9_AI\+?V"-8^$/P`_:#\->#_&OQ.^(OQKT/QSXSUVT\&>#
M/&W@GP!X<\2>)K[XP>`KC4=/\,>+=:TC3KVQ\3Z$EA\2M0BT&UF\0KIGP-XO
MM9?%/_!,/_@@)\$/%7P._:SN=:^`O[0_["NK?M)^#=)_97_:[TSQ3\,O!WP7
M^`OCGP7\6-4UZY\+?"^R\0Z+#X<U_P`3:/IT%_H=\E]JTES+<^%YM1AL;Z>U
M`/W9_:+_`&S_`([?!3]L3]C#]E?PW^S[\)_&^G?MC?\`"U;?2?B'K?[1?B_P
M7>>!M0^!_P`/T^)/Q)BU'P;8_LV>-(=:LSX?D2W\$W=MXML9O$.K[K;7+'PA
M9@:@WW#\5?&EWX#\%:CKFEVUK?:]/=Z3H/AK3[PM]GO_`!)XCU6ST31;::-+
MBTEGB^VWT4TUM#=6\]Q#%)#!/%*Z.OX+_M#?"7X7?!'_`(*L?\$G_&OPH^%/
M[2]_X7\"O^UI=_&/QI8>`?VPOC=X*\%Z=\8/V?V\$_"<ZYXGU;2?'_A?PS<Z
MYXLN+K3-1@M+ZQU#0ALNO&D>E:=%;W"?N'XSTW4?%OQ9^&.@OI]\/"G@J'6O
MBEK>IFVN%TR^\36L)\)^!/#;7$ELUC>E&U[Q/XPN8(;I;[2M2\)^%KIXO(U"
M-R`>0?MR?M#?&/\`97_9Z\1?'3X5_!3P?\=I/``M]8^(7AGQ-\6]8^#J:/X&
MB*)X@\7Z1JVF_"?XO'5%\-))_:^K:5=Z=I(B\/6FIZA!JEQ=V<6G7G2_%[XK
M_'WPG\*_AEXH^$OP?^$OQ2^)7C76/!&E:_X*USX]>)/`7@G2(O$NDO=:WJOA
M/XD:?\!_'NJ>,=-T"_"O:S:E\._!C:SX:2YUZ5-(OH8O#]S](ZWHVE^(]&U;
MP]KEC;ZGHNO:9?Z-K&FW<8EM=0TO5+66QU"QN8F!62WN[2>:":-@5>.1E(P:
M_)/]E+P)\>/"'P5^+GP2^*/PI\3^/-,_8MT#XN?!/]GF'QA<PZ>O[4'@ZY\/
MW\WPPU&#7+BXE;_0_A1=>&O@I>>([EH7G\0WOCR\OUD"6\[`'Z8?#SXU?"'X
ML2>(K3X:?%;X8?$;4?!=['I/C>R^'GC_`,,>-I/!^M-")FTGQ&N@:C>3Z+?!
M-SQVVKV]A=R0@2FV0$@6_"'Q>^$_Q!\/:WXN\!?%#X=^-_"GAK4-9TCQ'XG\
M(>-?#7B7P]X?U7PZSKX@TS6]:T;4[W3=*U#0FCD76;*_N8+G3&1Q>QP%6Q_)
MQXG_`&<OVX/C>?B/K/PA\$_%KX3^+/BW_P`$"-&^#FGVB?#C7/@_X!^'/[1/
MAWX\Z?K5]^S'X*T+5H]%N=!/A/P3_P`)1X"\"ZCKU]J&I3Z#J4_B*T\1ZM9Z
MG)>7/Z2_M*W?CK]IK]B=_C?^S9^RI\=/A+XT\/\`QB_9'\9?%SX)>,_AJWPY
M^*OQF^$_[,OQ=T_Q'\0/@GI/@;4]2M#JVF)X7@US1?#EV\,6D^-M+NHM.THZ
MGI4MN$`/USN_C-X5\6^"?`GQ`^#GQ8^!GB7P=XO\=>$-&L_&UWXXT[6_!/BG
M1=6\0P:-JFD>!/$GA;5I]+UKQUJ<DO\`9/A"RBO;NTN_$,D%C<03,_DGJ-0^
M-/P=TC4K/1M5^+'PTTS5]1\8?\*]T_2M0\=^%K+4K_Q^=.M-8'@>SL;G58[J
MZ\8?V1J%AJG_``C,$3ZU_9U[:7WV+[-<PRO^%'_!1>[T3XM_L_?L2?&;X8_L
ML?M!:%<^(?\`@JY^PK^T9XI\.S?LY?$K5/BWHGA3X>?$CP=J?Q+^)_CKX=^$
MO#GBKQ3\.8M*\#>&4M=6_MVQT:\OH-)BA:UGO;Z&"X^`OB_X&^($'[`G_!>'
MPWX#_9]_:'LOB'\2/^"MNC?%+X&:/X9_9D^.5AXL\:>#I?$?['M_IGQ`^&-M
MIWPZ@U/6O#]G??![XIZB_B?PT)[#29M)%_=7MH?$N@3:P`?UR>+?BE\,O`&J
M>&-#\=_$;P)X*UKQOJ0T;P9H_BWQ=X?\.:IXNU@J7&E>&-/UG4+.[U_4B@+"
MQTJ*[NBH+>5@$UA_'/QIXV^'/P@^(?C_`.'7A'POX\\7^#/#&H>)],\(^,O&
MVJ_#GP[KEOHB+J&LVMYXST7P)\2]1T6=-#M]2N-+:'P3K,5_JT-CIEVVEV=[
M<:SI_P#/_P#M9_#SQ'KW[='[0"?M`?"K]O/XU_LO_MO?L^_`GP)\"5_9:TCQ
MI8>%/"=GX:\/>,;3XD_![X\6.G/INH_#63Q%K_B5O']KXS\<)X7L]/.L-HLM
MU%KFA00Q_M_\=]2L_AS^R5\1C?:5XWU./2?@OJ7A>#1O#7AOQK\7?'5YJ6J>
M&1X3TC3[?1?!&A^)/&/BW4Y=5O[*'4=1L=&NV6,W>O:J]IIMM?WMN`?!_P"S
M[_P5!^(GQ#^$W[!7QR^,_P"S7X4^&GPV_P""A7B#X<^$OA-<_#'XZZ[\:/$_
M@OQ)\5/AUXF^(?A&S^)OAK6?@/\`"!['3YK?PO=Z1JFM>$;_`,8:?H5S-'J6
MKR6>BQ7.H1?J;XH^*?PR\#ZYX7\,^-?B-X$\'^)/'%\^E^"O#WBCQ=X?\/ZY
MXPU*.*2>33O"^DZMJ%I?^(+Y((99GM-)M[NX6**21HPB,1_*U_P3R^"?BW]D
M/X#?\$W_`-L2S^"7[17CKPYX%^`?@3]GC]L']GSQ[\+OV@==^+O[.7Q27P/#
MI<?[07[.7P4^('AJY\4P7-KJ7B*;X=_%VW^$N@P:/K/P]UR]U'0+J\'A'6=&
MN/:_CYX+U?X@?MJ?M'#X[?"?_@H+\8/V;?VZ/AW\`!^S7-^SQX:^)/@WP;X7
MT3P9X"ATWQI\*OC[IMQ;^']>^#>JIX_34OB3:^)/B/9>$3"OB%=.M5DUO1D@
M(!_1N/BM\+CXQ;X=CXD^`3\0$U"TTA_`H\8^'3XQ75;_`,.:SXPL=,;PP-1_
MMM=0O?"7ASQ#XIM+(V(N;GPYH.LZW#$^F:7?74$>D?%SX4Z_X@\7^$]!^)WP
M]UOQ5\/4$OC[PUI'C3PWJ7B#P/&RLXD\7Z-9ZE-J/AI"B.P?6K:R4JC,#A21
M^(WPP^#'[0-[^T'JT/@S7?B)>_#F#Q[^VOJ'P^\$_M'?`G4;/QM^R=\6-=7X
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M'T+PI!X[USXV?"/1O`]UXJE\"6WC+5?B1X-T[PI<^-X-8G\/3>#8/$-WK,.D
M3>*H=?M;K0Y?#T=XVKQZQ;3Z8]F+V&2!?X^?VS?@S\;-<\??M`_$34?@M^TQ
M\4O!7Q4U[_@AAXR\#:O;_LT?$[5)9=<^$?QR\?>,OV@;G1OACX-\!W^O?#N'
MX;?##S-*\16VI^'M-U72]'-CX4U&^U+4M5T^WU3]R/VH++QC\$_^"@G[/?QN
ME^!OQ0^,_P"RAX^_9K^,G[.^O>!O@K\+6\;?\*[^.WQ:^*/PS\3#XJ>.O"6G
M/:W%KH_CSP1H.H^"?$?C6]L!%X>L[:^&O:C!8ZO=`@'O?@3]OC3KC]M']N#]
MFWXPR?"KX2?#K]E7PC^Q]X@\)?%#7_B%!I(\<WO[45C\7[H:=KLOBB+0-"T6
M^TZY^'6EZ;H>E:9=ZI-J5QJ5P_V^XDFM[2V_1U75U5T971U#(ZD,K*PRK*PR
M&5@0002"#D<5_+MX[\":GI7QM_X.`M+TK]GOXU6/AWQQ_P`$QOV7_A/\";:S
M^`/Q=\2Z+XM\2?#[X!?M&>`=8^'/PN\3Z?X*U;2/B!KGACQ%\3/AGHLUGX/U
M;79[HSR:K`]U8>'==O\`2_W-_P""?=UX@NOV$_V-U\7:=XSTCQCI_P"S#\#=
M#\9Z7\1/#_BCPMXYT_QGX=^&WAS0?%MGXJT+QG8:7XHLM:M_$>G:G%>MK%E%
M<7DJF^1[BWN8;F4`FUS]I#Q;XG^*/Q,^#/[.OPV\/_%#QE\&[3PTOQ-U_P`?
M?$+4?A9\,/"_B?Q98VFOZ-\/W\4Z)\/?BIXCU3QK)X/O+;Q7?66D>![W2M'T
MW4=#BUG6+"[UFVA7*_9^_:XF^*-M^U1=_&#X;/\`LTVO[+/QWOO@QX@O_B'X
MZ\.76BZ_I=C\(?A'\5E^)T>OQQ:9HNB>$=6B^*8LM%-]?33SZ9I$&LZDVDWF
MJ3Z!I'SW\'M%O_V)?VCOVU+SQ_X8^*7B7X9?M:_'S0_VD?`7Q*\$>`O'OQ=M
MM'\0Z]\,/AI\)/%'PK\3:'\/="\5>*O"K:%J/PYL_$&@ZG<:&/!\GA[Q#,TV
MMV%SIE[;)X__`,%.8/V@OB!\,OV:_C;X0^&_Q_?X7_`G]JFS^(_QI^$WP-DN
MV_:.\;?!.T\%^*O"NG>-/"'AW2A'K+>)/!GBO7++X@6_P_T==:\3ZUH^C6]O
M8VR^(;I--LP#]8(_CC\%9="TSQ3%\7_A=)X9UKPWJ/C'1O$4?Q`\)OH6K>$-
M(C275O%6F:NNK'3[_P`-Z9%)')J.N6MQ+IEE'(CW-U$K*3X)\:OV^?V6_@+K
M?[,NE^/OB[\/]/TS]J[QGJOA'X7^,9?'G@RR\$3VVD?#[Q1X^E\5W7BK4M=L
M]&F\,78\/6'A;3;_`$Z\O6U#Q3XM\,:9:1RG4"\?X8_L_?"CP1X1_P""I_[%
M?Q5^''[-_P"V3X5^''C'X%?M[^.O&GC;]HCX1_%[Q-X@L/&/Q?UWX(ZWX;_X
M3SQ1<^&-9T?X77WC#4_AK\5M?\/?#/7M>TS5]/U*]O=;GT/2-8^)^G66K^6_
ML:_#OXUV_@W_`()"?$OQ#\%_V@M.T+]FG_@I%_P4XN_BGIGBGX*?%S0?&?@G
MP1\=]-_:CT[X$ZV/`_B7PEIOBP^`==LOBA\.-/T[Q)9:2WA'PU:ZJ+;5]2T>
MW\/Z\ND`']5VJ_%;X7:%XQT#X=:W\2?`.C?$'Q79W.H^%_`NJ^,/#VG^,?$F
MGV:E[R_T#PQ=ZC#K>L6=HBL]S=:=8W,$"J6E=0":=H/Q3^&/BG68_#GACXC>
M`_$?B&;3=4UB'0=!\7^']7UF72-#U^Z\*:WJL>EZ?J%Q?/INC^*;&]\-:I?+
M`;73]?L[K1KN6'4;>6V3^;_7_A#K]Q^U]^US\(?VN_@Y^WY\6=-^.O[4O@K]
MI_\`9_\`&WP5A\81_LTR?#'P=HWPCU#X=>&/B)KWA6>ZTOP!XM^`?B;X>-%J
M6E:K.NL>,X+;[1X;T/7CJE[97?VO_P`$$_AXW@C_`()R_"K2/%GPD\5?"[XC
M>%/BS^V+9ZCHOQ*^$GBSX5^.=(T3QS^US\8OB-X62VTKQYX8\-:^OAWQ!\/_
M`!'X#UJRFTVW?1+B%K6Q:7^T]'OK.P`/VEHHHH`****`"BBB@`HHHH`*_.#]
MFK]LWXV_&[]LW]L?]E3QC\`OA=X!T+]CN?X2VOB'XD^&OV@_%?C_`%7QE/\`
M'+P&?B1\/O[&\!ZG^SK\/K33XHO#,<L7C![[QR[Z)K:QV.C1^*+%VU6/[V\<
M^)+KP;X)\8>+[+PWKOC*\\*^%]?\1VGA#PM!!=>)O%5SHFE7>IP>'/#MM=3V
MMM<:[KDMJNF:1!<7-O!-?W5O'+/%&S2+^$_A[1_VJO#MC_P5X_X*`?LZ?"7Q
MF/B#^U7HW[).H?L[_"7XB^$]8\$_$J&/X-_L[^"_!/Q$U.^\'Z_9PZNOBGP[
MJ?B7QQ9^'/#%_IEI%XE\2>`(;:TU"71O$-EJB`'Z`_LN_MU0_M.Z]//H_P`,
MI?#'PYU#Q7\>/!OA?Q+J7BN2;QE'JG[//Q0U7X3^+[GXB_#^Z\*Z3'X`TSQ-
MX@TN:Z^'LL7BOQ1?:[IJ3RZMI_AV5((;K*_;Z_;,^+_[']Y^R\OPY^!7PW^,
MVF_M+_M,?"_]E>TNO&/QY\2_""\\)>/_`(NRZT/"FM3V6B_`+XPP:SX.MH/#
M^HR:_?Q:CIVLV4K6<6GZ%JZ3S3VWY=?%CX(>"O!?B/7?'-]^RE\:OVH/^"<_
MQ\\9?#;X_P#QC^$UU^S[X@\:_'#P;^U7\.(K:WLO&EE\(?&]EH7Q$U3P;\0Y
M=*TW4?BK;:5X2N+R?QA!JL\$=UX2\?\`BX3?1_[0DGCK]M[Q[^P]\(O"O[-W
MQM^`UO\`LV_MM_LI_M<:OJ?Q&^';:+X#/P6^'G@3XM:__9FCZ_HL]QX3T[Q7
MIFJGPCX`UKX?/JD/B+PUK'B2"2#2=0T;2KF\H`^K?V\?VT_BG^R!\$/C/\;O
M!?P>\`?%R+]F_P"!>H?&_P",/@O7?BOKWPZ+:9:6NJ70TCP7XST[X7?$)[W6
M\:#J7]G6'B#P-H=CKUG.M_+KWAV;3'TS5>'_`&M/V]OV@/V6/V+?A=^UC=?L
MU?"'QIK7BWQ1\&/#'CKX:V_[37C'0]-\)2_M`?%3P+\+_AO=>%?'<O[+NJ7'
MC>.WN?B!H^J^-X]6\$^`FT&.VU&TT%_%QBM[FY\B_P""H>F>*-=_X)8?\%#9
M[7P!\4O%?Q2_:A^'/Q>\#_#GX=^`OA9\1_B1XVO)9_">K>"_A/X='A;P1X2U
MSQ'H5KK7A_PQ%XIU*Z\0Z?8:)H/B7Q=J.GWVJV\U[8QW/PM_P4,_9X^#G_#M
M/X$^(/@M\%_VLO$WQ9U[XG_L::UH_A33_!/[<OCWQ-IUG\(_VD/@MK/QCO/%
MOPDUNQUYO!UOX?\`"_A_Q7JEC_PG'A#1HM5M;!=0\#KJ3#3;@@']&UM\;_`&
MA:S\/_AM\5?B)\&O`7QY\;Z'97<7PAM_BQHFI:SJ6MIIR76OV/@"V\1V/@CQ
MEX[T/2[I+R.RUY/`>A7>H:=;IJ-[H.C222V-M!XN_:7_`&<?`$%[<^._V@/@
MEX)MM-BUZ?4;CQ=\5?`GAN"PA\*W.D6?B>:]EUG7K*.UB\-W?B#0;77I)VC3
M1[G6](@U`V\NI6:S?SV?M^:#\<_VA'_:'B^$G[/OQ;\-P+^TW_P3"^,?PUOO
M!?P@\:Z!K/Q]\"Z?\3_@SXE\??&#X@>(M?T+3M<TK7OA3X;T[7O!-S\*;@^&
M?%G@S3-$N]4\4^%YO[0$]C](?\$I/V??!GQ!_9Z_X*'?#GXG_`SQ3X+\._%3
M_@HA_P`%%-1\.:5\3O@CXR^%6IWOP/\`CW\0=:/@_7_!-A\0O"'AB]3PWXE^
M'^J0"PG\/PBVM;98]-O!:W%N;2,`_8SP]^T7^SYXMG^'MKX4^.WP;\377Q;T
MW6M9^%-MX>^)W@G6I_B=H_AN:6W\1:M\/8=-URYD\::;H$\,T.M7WAM=2M=*
MFBECOI8'C<`T+]HO]GSQ38^-]3\,_';X-^(]-^&=P]I\1]1T+XG>"=7L?A_=
MQQ&>2U\;W>GZY<6_A2X2$&9X=>DL)%B!D90@)K\ZOV)]"_:!U#]DJ^?]H;X.
M:]KOQ;_9O^#OQ0_9-\&^#_&#_P!BW?QTA^&$FH>$-0^(=G=WR+)8Z5^TE9>!
M_`$MEJ]Q<W-M'IZM>V5P;6]N[F__`)R/V[O@9^TM\3O@5\5?%L/[-'Q_U=?B
MA_P0R^&/P9MOA=X-_9M^(D?AWX>_M/:!^UM\/M<M/@#X`^&6B>%M4\2:=#\(
MO"\'BC3?".OZS;:I<OX4M;[Q%'XMOM.UF2_N0#^VB[^,GPCL=#\2^);OXI_#
M>T\/>#==N/"OB[7[OQSX9MM#\*^*;5H([CPWXEU:74Q8Z%KMO+=VL=QI&IS6
MVHPM<P*]L&FC#?#G['7[=GBC]H_]DGXJ?M%^,?`/AGPOXG\`?'+]I7X*Z5X+
M\(^(K[7M(\2:U\%?C%XG^#_@ZUTW7]8L=%N+R_\`B!KFBZ7!:N^FZ9&;S6H(
MH[:%<"N/_:6\-Z_I_P"TM_P3P^/O@SP;XCOOV8?#>K_&74_C+X7\(?"CQ1>^
M*8_''Q0^%_A'PS\`/B=XM\!Z;X=/CV%?!,=MXG\/:TFJ^&6UCPK+XFT^ZUZ#
M28_#]P]GX!_P2K^#_P`3_!/P+@^#WC[X1^.OA?8Q_M^_MP_&Z;3?%7AJ?0+.
MX^'K?M">,_'/PEN[2(Q36?\`9GB&7Q?X4U30[.X>QNYDT6ZO].@EMM'EGH`]
MT^!W_!1_X@^)?V__`(C?\$__`(_?`3PO\,/$GACP_?7OPW^,G@3XLZS\0/`W
MQC\0>&_`WPG^)7C'PO:Z!K_PI^'^I^!?$6@^!/C1X%\1W.C7&M^+XA]MU'3[
M'6M7BTHZM>>A?%/]O/Q5X5_X*'_`+]@?X<_!CP]XXE^*?PW^(7Q1^('Q:\4?
M%?4O`VF?#K1OACJ?PX_X2CPUX?\`"VD_"OQ_-X]\>)X4^)GAWQ39Z)J/B#P#
MI#Q:KH5I>>(K&+5I=1T[\YOV@/#OBOXE?$K]J']H/X!_"GXTZ_\`M#_L@_MY
M_"G]J?X/>']<^"GQA^&]G\;_`(4>'_V7?V7?V?/V@_`/@3Q?X^\$>%_"WBZ3
MQAHGAWXI>'=$L=$UK4)]3UOPUI6M:;;7FD2V.I3]YXRBU;P?_P`%B?V!M7U+
MX??&[5K7P[^SE^UUX7^,'Q'T+X"?&SQ1\,O#OQA_:4\7?L[^(O!.@ZK\5=`^
M'U_\/DL[J#1-7T^775\0CPYX3L?#SP^*-1\/)920P`'V?^W3^VQ\0_V/OV1?
MC_\`M*^'M)^#'Q?U3X2_&CX<>`K/PQH_B_7+.UT;PS\2_B7\*?AM96OCF6QM
M=:N(_B7X>F^)EKXDU3PU$^A:?=Z%+I<L5]9-<QFZ^D?CE^TGX4_9RT?XU?%'
MXK>-OAKI/PD^#'P7?XH^(=*CUH0_%*P;3;K5OM]YJ6FWM_!I<7AK6HX]'T7P
MG,8[>XO_`!/<7%C)<LLML@_E\^+_`()\?S?\$WO^"V_P[\+_`+/7[10\1?%7
M_@LAI/Q/^$O@G1OV8/CG%J_COX:7_P`8OV/_`!.GCKP1X=M/AREWKO@]=)^#
M/Q)U&\U_1[2XTJR&BP+?7,$_B#P^FJ_1G[<GPE^(GQS_`&N/^"OVA_"/X*_%
MG4;O]H#_`((=^$OA-X"\4R_!7XD^&/!?Q$^,RZI\;M;'@JV^(>M>#]+\(ZMX
MZM/!_P`0?AQ9SZ1+KDVMV98^&98(]2\+:SI>D`'[_>&/VQ_V8/$?P3^'7[0D
M_P`>O@UX<^%/Q0L=-E\+>,_$7Q7^'NG^&+W6+Z1;*Y\*V_BE_$9\-WWB?1M<
M%SX;U?2-.U6[NK/Q!97FE2(+NWDB'I'BSXY?!3P%:7=_XZ^,'PM\%V-A:Z)?
M7U[XL^('A/PY:6=EXFN6LO#EW=W.L:O9PV]KX@O$>TT2XF=(M5N5:"P>>52@
M_%CXP2?$CQ]X4_9=\&>&_P!GWXG:9HGB?]@#X[?#G5OC-%\'/%$GQ/TKQ]9?
M"_P`FB_L]/IVO:*]Y\)_#?Q.O].UN\UOQ5XP\/Z,=9U7P'I7A72=8TJYUBQG
MU/Y/_P""-/P1\7>'_P!J1=#^/7[/GQ.T+4X_^".G_!-7X8>-]:^+7P*\>V/A
M'7/C/\);3Q?/\3/"]_\`$'Q5X17P+XJ\;^%+7Q)\/8]3MT\1ZGJRO;+96_FW
M'A368-'`/Z.M$_:;_9N\3:#X#\5>&_V@_@AX@\,?%/Q-+X*^&/B/1/BOX#U7
M0?B-XR@^T";PEX#UBPU^XT_Q?XFA-I=>;H/A^XU#58_LUQOM!Y,FWV^OR3_8
MC^"_C/X1?''XU?LX:MH<4G[/O[,/Q-\7_%7]F+57EM+B&UTO]J,ZGXR@\$P6
M:1*^DO\``J;6OBOX%\+B+:G_``@?C/1;5F>:T)7];*`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@#Q?X\?&[P]\!?`\7BW6M,U3Q)JVM>(M!\$>!?!'A
M]K!?$GCWQ[XKO5TWPUX1T$ZI=V&G1WFHW3-+<7NH7EMI^E:;;7VJZA/%9V4S
MCQK7OCO^TSX(\:?"?P]XO_97TG5_#?Q5^+EA\/Y?&/PF^,.J^/[?X7^%+OPU
MK.MMX]^*NDZQ\'O`UUHL::CI*Z`EAX;F\6:"EYJ%C+J'C+34GC1_/O\`@H7\
M$?B)\2=&_9J^+OPKT/4?&OC3]D;]IWP1^T7#\-=,UB/2+SXD>'=)\.^+_`OC
M/PUIINY[;2;_`,11>%/'.KZWX5TS69[73K[Q'I.FVTE]8221WD/QQ^V1X5O_
M`-LO]J3]@L_!WPM^U-8:7\.?V@B/VNBUK^TO^SKX-B^`!^$?Q<N[#1==U"^G
M^'?@CX@8^*U[X0>3_A!+WQ7J\=PEFEW?KI,4*T`?LU-\4_AE;^/+;X5W'Q&\
M"0?$^]TJ77;/X<3>+_#\7CR[T2!D2;6+;P@^H+XAGTJ%I8UEU"+3GM(VD17F
M!=02Q^*/PUU7QIJ_PUTGXA^!-3^)&@Z?;ZKK7P_L?%^@77C31]-O&GCLM0U?
MPO;7T^O:9I]W+:W,=O>W>G1P3-;SB)I&AD4?SC_`_P""7C1/VH?B!\#OVG_A
M?^WEXO\`C+HW[<?C/]JCX-?&7PC<^*M-_8XO/!NK>,KW7_A=XVU/QGI5Z/">
MDZIX#\(7K_#SQ+\,M3O7\1^)(-(DM9=#&@:_%<IZ3\(/@5^T)XE^#'_!/7X)
M>(=`\=>&/VO/V2?VQ?#?Q(^/GQEU_P"'6MVF@>*/ACIOC/XAWGQD\2>'_B%+
M#'X.U_3_`-HWPK<0:#'X>T+Q9J^O:)'XBL;S7-#B_L2S24`_47]FW]IGXX_%
M;]H']ISX%_&/X%?#?X.2_L_7O@EM`U7PQ\>-?^*&N?$_PI\1-)DUGPC\0++P
MMJGP+^&$&@>#[\:?XE\-S7Q\2:Y=VWC?PAXE\/BRFMK!-7FU?`?[5=]IFH^)
MK?\`:K7]G/\`9KL;_P"*&H_#KX$SS?M-VGB+4OC4NFZI/HYU&RTCQU\,O@V^
MDZI?:BMO9:7X;T*Z\<75_<M<B&\-LFGW6J>/?M@^#_C%X"_:0_9Q_:9^`G@S
MQ#XZUWQ%:ZW^R;\7/#^@PK+;67@+XE2S:]\/?BEXGW3P?9_#/P;^)=B-4U[4
M$$MSI_AGQ9XDDLX9[B86\WP;_P`%1OA3\7/$/AK]J/X`?";X%^-M0@\3?\$G
MOC+X6\`?%[X<?#Z_\3>+_C/\7H9/&4&B_L_:IXJL[*^TSP#INF7EY8_$:'3Y
M'T/4_'6N^)!9Z%JL[:%=Z7<@'[.:C^UW^R?H\GQ,BU;]I_\`9XTN7X+26,/Q
MCBU'XU?#:RD^$TVJ:Y;^&-,B^)B7/B6)O`<FH^)+NU\/6*>*1I37>N7-OI-N
M)+^:.W:7XM?&F^T/]F_QA\?O@+9?#CXXQZ1\/;CXF^#8;CXHR>&/AWX^\+:=
M9+K]]?:7\3_!_@OXL1BWO/"T.H:AX;O],\*:]INMZBFFV$UYI>G:A/KFG_C=
MXBEUW0_"&A_M+>#_`(4?&K4[W]G/X7?L[?"+]M;X$ZQ\`_C@_B']L/2;'0?#
MEC%9>!=%@\"7-[\4/%/P4US6;S4-)\4:#I_C'PQXGCLO$O@'Q=J.B^#KM/%F
ME_J[^T3\2="U']BKXL_$#2_#WQ)N](\7_`GQ)'X=\+Z7\(?B?J?Q+FNO'GA:
MXT+PUHTGPATCPA>_$VQU=M3UO3[35-(NO"4%YX<B^UWFOP:7IVFZA=6H!#^P
M=^T?XW_:^_9+^!O[4'C?X9>%OA%)\>_AUX.^+'A?P-X6^)6J_%5-)\%>//"^
MC>)_#R:_XFU7X9_"HQ>)TAU2:VUC2=/\/ZAI=D]M%)9^(=3%RZ6NK\8/VK/A
MMX,\#_M#2_#?Q]\(?B/\:/@%\*/''Q+USX-1?$_0$\3V`\(>'M5UN*T\8:/H
M+>(?%?A2QU"72Y+$:A=^&Y`DS;%B9E8+^;'_``3?_:ILO@S_`,$[O^">_P``
M[_X(?M27/Q[\.?`3]F#X(^)/AYKG[*'[3W@C3_!_C*#PMX2\'>)[CQM\0/$_
MP<LO`WAOPYX-N$U#4-?U^XUR;3X;+3Y7@DF\R,G\^?%OP3_:B^-/Q(_9!U70
M_P!G/XD?">30!_P6J^$WC_X0Z!X#U3PE\)_A!:?%CX4?$K0O@;;77BR\M8+;
MQ]%\;?$5WX6^(6J_$A]:UGPEKOC[Q#</I;:(VD1Z5IX!_0E^Q!^UIX6_:Y_9
MM_9X^*SZ[\/K'XJ_%/\`9K^`?QV^(WPH\)^+M.UO5?AO>_&CX8^&?'JZ7?Z.
M;V;Q'IND17&NS6FB7NNV=K+J-I;QS!I'9C7T)H7Q6^%WBGQ)?^#?#/Q)\`^(
M_%^E2^(X-4\*Z%XQ\/:OXDTV?P?=>'K'Q;#?Z'I^HW&IV<OA:]\7>%+/Q''<
M6L;Z)=>)_#UOJ8M9=:TU+G\+/V!?V??BI)JW_!'35;7P)XQ^#]U^PO\`\$\O
M%?[._P"UNOC#X=ZOX.N/$OC_`%?X5_L\^#K'X.:7?ZY9:1_PE^G:-\2O`OB3
MXG2^-?";^)_!EU-X>M19ZM<W?B-[BV]<_P"":_PX^+N@?%'PSX@\77'Q`\;_
M``LTW]EQ-(^$5Q^T/\`[_P"$?[2W[*NA^,]:^%'B>/\`9I\:?$0>1HOQ]L?$
M6F:-I>K:KXDCBOO$_A#Q)\)7L_&5^FM>)W6Y`/VUHHHH`****`"BBB@`HHHH
M`****`"BBB@`KYH^(7[(/P`^*?B[5?'7CCPEX@U3Q/K2V"ZC?6/Q0^*_ARUF
M&F:=::39^7H_AGQOH^B6GEV%C;1.;/3K<W$B-<W)ENIIII/I>B@#XT_X8`_9
M4_Z$/Q7_`.'L^.O_`,\NC_A@#]E3_H0_%?\`X>SXZ_\`SRZ^RZ*`/C3_`(8`
M_94_Z$/Q7_X>SXZ__/+H_P"&`/V5/^A#\5_^'L^.O_SRZ^RZ*`/C3_A@#]E3
M_H0_%?\`X>SXZ_\`SRZ/^&`/V5/^A#\5_P#A[/CK_P#/+K[+HH`^-/\`A@#]
ME3_H0_%?_A[/CK_\\NC_`(8`_94_Z$/Q7_X>SXZ__/+K[+HH`^-/^&`/V5/^
MA#\5_P#A[/CK_P#/+H_X8`_94_Z$/Q7_`.'L^.O_`,\NOLNB@#XT_P"&`/V5
M/^A#\5_^'L^.O_SRZ/\`A@#]E3_H0_%?_A[/CK_\\NOLNB@#XT_X8`_94_Z$
M/Q7_`.'L^.O_`,\NC_A@#]E3_H0_%?\`X>SXZ_\`SRZ^RZ*`/C3_`(8`_94_
MZ$/Q7_X>SXZ__/+H_P"&`/V5/^A#\5_^'L^.O_SRZ^RZ*`/C3_A@#]E3_H0_
M%?\`X>SXZ_\`SRZ/^&`/V5/^A#\5_P#A[/CK_P#/+K[+HH`^-/\`A@#]E3_H
M0_%?_A[/CK_\\NC_`(8`_94_Z$/Q7_X>SXZ__/+K[+HH`^-/^&`/V5/^A#\5
M_P#A[/CK_P#/+H_X8`_94_Z$/Q7_`.'L^.O_`,\NOLNB@#XT_P"&`/V5/^A#
M\5_^'L^.O_SRZ/\`A@#]E3_H0_%?_A[/CK_\\NOLNB@#XT_X8`_94_Z$/Q7_
M`.'L^.O_`,\NO2/A;^RU\$/@QXDF\6_#KPQKFCZ]<:5<Z++=ZC\1?B9XK@;3
M;RXL[JXA&F>+_&&O:6DKSV%JRW<=DMY$J/'%<)%-.DGT'10`4444`%%%%`!1
M110`4444`8OB3P_I/BWP]KWA77K>:[T/Q+HVIZ!K-K;WU_ID]SI6L64^G:A!
M#J6E7-EJ>GRS6EQ-''>Z=>6E]:NPGM+F"X2.5?D[_A@#]E3_`*$/Q7_X>SXZ
M_P#SRZ^RZ*`/C3_A@#]E3_H0_%?_`(>SXZ__`#RZ/^&`/V5/^A#\5_\`A[/C
MK_\`/+K[+HH`^-/^&`/V5/\`H0_%?_A[/CK_`//+H_X8`_94_P"A#\5_^'L^
M.O\`\\NOLNB@#XT_X8`_94_Z$/Q7_P"'L^.O_P`\NC_A@#]E3_H0_%?_`(>S
MXZ__`#RZ^RZ*`/C3_A@#]E3_`*$/Q7_X>SXZ_P#SRZ/^&`/V5/\`H0_%?_A[
M/CK_`//+K[+HH`^-/^&`/V5/^A#\5_\`A[/CK_\`/+H_X8`_94_Z$/Q7_P"'
ML^.O_P`\NOLNB@#XT_X8`_94_P"A#\5_^'L^.O\`\\NC_A@#]E3_`*$/Q7_X
M>SXZ_P#SRZ^RZ*`/C3_A@#]E3_H0_%?_`(>SXZ__`#RZ/^&`/V5/^A#\5_\`
MA[/CK_\`/+K[+HH`^-/^&`/V5/\`H0_%?_A[/CK_`//+J*?_`()]?LISP30'
MP-XPB$T4D1D@^.'QWAGC$B%"\,J?$L/%*F=T<BD,C@,O(%?:%%`'P5X/_P""
M:'[(/@K1;;1M.\%^/]2>&*%+S7?$/Q\^/FM^)]=F@B2WBOO$6OWGQ+;4-;U%
M;:.&V%]?RS7'V:""`.(XD4?=]O!%:P06T"E8;>&."%6=Y"L4*+'&IDD9Y'(1
M0"\CL['YG9F))FHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/&OBY\
M`/A5\<QX?'Q-T'5=;'A<ZJ=$_LSQKXZ\'?9CK7]G#4?/_P"$*\2^'3J/G?V3
M8^7_`&E]L^R>5)]C^S_:;KSO&?\`A@#]E3_H0_%?_A[/CK_\\NOLNB@#XT_X
M8`_94_Z$/Q7_`.'L^.O_`,\NC_A@#]E3_H0_%?\`X>SXZ_\`SRZ^RZ*`/C3_
M`(8`_94_Z$/Q7_X>SXZ__/+H_P"&`/V5/^A#\5_^'L^.O_SRZ^RZ*`/C3_A@
M#]E3_H0_%?\`X>SXZ_\`SRZ/^&`/V5/^A#\5_P#A[/CK_P#/+K[+HH`^-/\`
MA@#]E3_H0_%?_A[/CK_\\NC_`(8`_94_Z$/Q7_X>SXZ__/+K[+HH`^-/^&`/
MV5/^A#\5_P#A[/CK_P#/+KNOAQ^R3\!?A-XKLO&W@/PIK^E>)-/@O;:TO;_X
MF_%3Q-;1PZC:R65VKZ1XI\:ZUHT[26\TB))/I\LD#$2V[Q3*DB_2-%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?EQ_P4
M)_X*47'[`OQ`_92\%:E^SWXC^+5G^U_\<?`'[-OPT\1>'OB%X6\,Q:?\9/B+
MK5QI.B:-XFTS7;*6[L?#<47]GWU[XHMI+Q(EOI+=-,>2S=I?7O!W[<OAG7_'
MOQJ^`OB?P'K7P]_:@^"7PIL/C3J?P0\1:[HD[>-?AKK-OJD6C>-OA[XWTTW&
MB>(?"MSXBT/6/".H:C):V-]HGB#3KBWU/2(86@FF_-G_`(+=_L]?M2_M&?%_
M_@EK=_L\?LS?$?XS^'_V4?V^?@/^UK\7O$_AKQ9\#/#>DV7P^\`>)WE\0^'-
M#MOB;\7_``'KVM>/(K+3EU"VTV+1H?#]S;:CI\:>)Q>?;[6P[_Q/^RC\;?'?
M[>OQ@_X*?^)O@YXYTRX\-?L(Z?\`L=?`G]FW0?%?PYN?BWXWFUOQIXR\;^*/
M&/C:27XD:9\'=(>PU'XB3Z1IVDW7Q&U)(-,\.W>LVVH/J%Q9:;>`'<_`[_@M
M+\!OVJ/V&/B)^VK^S-X/U7XE7'P7TK6];^-/P!UGQ9X>\!_%GX:Z9X:T74/$
M&LS:O:ZO'>6=R\FD6<=]X>DM\:;XCAN'2RU)+FRO;>'Z\_:I_;?\$?L5?LX>
M'/VAOVCO#E_X0@U/QE\(_`^O^$=%U2W\577AC5?B=X[\.>#-1NY-9T^SBM=3
MT;P+:ZY=^)=;U*WM(8KO3]'EM+-1?7]C%)^&OQA_X(Y?%GQS\`OAY^TA^R'X
M9UK]C[]M_7_V:_"G[-/[6?P6\9ZMX&D\$_M)_#>S\%6WPQ\=6'C2V\!>+?''
MP\M_'CZ5'>^(?AW\1]-UW^U)A%X?3Q5]CN[=K6P_07]OOX'?M&?MPZ%^T[\#
MK7X::[X!^#EK^S]X\^'FCW/CKX;?"_XG/\>]?\5-<2W=Y\&;_P`._MB_##6/
MAOXELI-"\-'PEK'Q1T+1K$W5RNI7[:)+IQ@F`/UN\8^.-'\'>!]:\?73M?Z-
MI&BOK4?]GD3OJ<+1(]C#8-&'$\NI22V\%GY8?S9+B+8&W`'YJ_:7_;;^$G[*
M/B;]EGPK\63?Z7J'[5/QMT/X&>&I8=LUGX4\1>(?"_B+6-,U3Q-=(CQ0:1/X
MBTG2/!JSAH@=3\26M\7&GZ?J,D/R#_P3ITK]M/Q-^QW^RG\$/VU?@/XR^%/Q
M.^#%WX;T3XR>(/$OBOX0>)-)^)6B_!Q+Z]^&'B#PY=_"WXE^,9X;OQ)K^A_#
MC6O%&G:K86"6S:=XBT5X[VQO8;M_E3_@IO\`LR_MJ?M]_`#]K"T\&_"_Q/\`
M#'5?#MQ\+C^SA\,_&'P^^#7B3XK^+/&_PK\5:9XW\(_$OX=_%O0/VT]%\#?#
MW3I?'332>*-/\?>&IM1A\%:5*MKIGB&]UB;PY0!^]_Q+^)O@SX4>&9/$OC7Q
M3X0\*V]S=V^B>'W\:>+=%\%Z9K_BW5!)%X=\*VNMZ]/!9)JOB"_5+"P@47%Q
M))(6BM9_+*'\D/@G_P`%L_@_\:/^">/Q)_X*"V_PLUOP5X?\!?&'7_@5I_PS
M\=?$[X5^#]0\7_$;2O$/AOPMI.DV'Q&\7Z_X;^&NAP>)]<\36EII>H>)M>TJ
MRC\MY+N>)72O#?VCO@'^WC^V/X&_X)`_'/Q5\#?$?P]^)_[('[5GPX^*7[5O
M[-GBGQG\'KNY\6#3/!]EH>O_`!"\'>*/#'CWQ-X(UJP\.ZK+K1T33+S7=)UJ
M_P!)\2:Y))H\%U86-IJ7S;^Q'_P3@_:+_9J_X)8^-OV8_P!J3_@G[\*/VR]0
MU?\`;5\4?&V7]GN^^+?@":WU;X<^.)H+@^)=(O/%4>E^!D^(G@:6T5=,\/:Q
MXFL--U'[=-<P^([&6VCCE`/Z"?V._P!H?QU^T]\(+;XJ^.O@%K_[/$^IZO>V
MNA^$O$'Q.^$GQ9GUK0[9(#:^*+'Q7\%O%?C/P7+INI2R30VUO%KLU]&;61KF
M"`-&&^JZ^"OV"/V-OAU^QEX/^(WA/X,>$?$WPE^#WQ`\;6WQ#\&_`3Q!KEGK
MMI\'+_5-`TZV\7Z'X<;3]:\2V&D:/K/B"VGUK^P=-\1ZOI&G7UQ=G2YH+2X2
MVB^]:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MKR/X^?&7PS^SS\%?BE\<?&45W<^&OA7X&\2>.-5L=/7?J6IP>']+N-072=-C
MVMYFHZI-#'I]BFUMUS<194KFO7*^#_VHK7]H'XH_$;X;?!'X8>`K_P`->`'N
M;SQOX\^/?CCP+\/OBO\`!2:?3-%U>W\/_#77OAY!^TA\(/B[<RW6JW4/B"37
M=(T.^TS3]<T3PM931ZEI6IZ[/I0!]"?`7X_?#K]HG]G[X5_M*>`M7@;X9?%K
MX9^&?BIH&JW\R6BV7AWQ)H5MKH75WG\E;"[TB*>6TUF*Z$+Z?>6=W!=+#)!(
MJ_!GPR_X*U?!SXJ_MY?&']A[P?X0U3Q:WPN_96'[6VC_`!K^'/BOPQ\2O`GQ
M)\`MXH\#^#X]%\)6'A26ZU2?Q3-KGC&2VALEDN;:3^R)"+H-?0K'^9W[&?['
MO_!03P[_`,$[_P#@H%_P3#\9_"WQW\)-$U&U_:-L?V(OV@_$6L?!:+PO>?#S
MXFZA+J/A_P"'VJ^$O!GQS^+OC?P1J46K>(=:-A;:W-XFT^S\/RZK]M\8M>6N
ME:?J'GO[`7[!_P"WS^QU^U]X*_:]\0_LKP>)M`^''_!%'X!?L,W?PU\.?%[X
M56?Q!\5?'OX,:/\`"674DT`7NN0^#9-"\2:]\*IM/M==U[Q=H<<%AX@LM9NR
M9K2[TH`'[0_LF_\`!2WPO^TI^TY\<_V.O&?P'^,'[-/[1/P/\&>'OBG??#_X
MM2>"=2F\4?"7Q5J,.EZ)X[T76OA]XG\6:!'%)>W>G17^C7.IC4+!M2M4?S)8
M[V.T]^^"O[6WA7]HWQAK]C\%/#M_XT^%OA+Q'XA\(Z[\:EUO0;'PEJ'B#PV+
MFSU"/P-I1N[GQ%XST:W\16MSX9N/$\%AIOA^74K2^DT>_P!:M+.2<_FI^Q]X
M?_:X^*7Q`_:NU[XW_L$?%/\`8Z^,W[3OPHUNQ\7_`+5GC3XV?LU?$:UTBYT/
M09?!?PC^%OPN\(?"'QGXU\0:?IG@&+Q'=^*-/O/%5I]AU:]TSQ#J^N:DVIZK
MH^AQ?!'_``3*_P""8/[>?[)OQ.^#OB^[\+P_"B']G']A#Q[^RQXH@TKQ5X#U
M;PU^T[\:_$WQN\?^*O`OQ:32M%U^>YN?!O@/PGXK\-ZM<ZEXW@\'^.3>>'+C
MPUIVD7.G^6]\`?IO^V%_P6+\.?L6>,_A>?B?^SIX]U'X$_$[Q!KEBOQ_\/\`
MC'PM+H?@KPGX1^*?PO\`@_XQ^(OCGPI?06FLZ-X1T+Q=\6_"S)?17-X-0T?[
M;J<30Q1PK/Z/_P`%!O\`@J?X0_8-^('[+/PR_P"%/>*OC;XK_:L^,?PY^!_A
M*/PGXK\,^&],\,>,/C!K-_H7PPG\3ZCKHF":+XIO]"\3D:A80W36-KX>O+F2
M"59;=7\Y_:Z_9(_X:.^(OA+]E'7?V;_BQK/[+5]^PU^T=^RYKWQPL];^#,GA
MCPGXD^*WB']ECQ5\-_$MMI^O_%*+XG7U_P"#+GX$:K?7^LK\-]1:+Q>F@/'9
MZSIEYJ%_;?D/^T7^PE_P4M\0?!3_`((Y^&O%?[/_`(S_`&B_CM^R;^VY^SK^
MTK^U!\0O`OC7X%:-X<_X5G\`=4F\#:+X;T"7XE?&OPGK7B'QZ/A]X4T#7GM;
M?3HM!U.]\02WMQKUKK=YK-A8@'[I?`3_`(*,>*?BQ^VI\8_V&O'_`.S'XA^"
M'Q3^#/PNT#XN:AJ'B?XG^%-<T7QQX,\5O+::!KWPV.EZ7;S>*M`_M>WN-#U_
M6H_LD?A[6()]/N[:6YMKR.VN?$?_`(*4:)^S[^RAJ'[6/[3_`,'O$/P9\,0?
M%_PA\---\.VWBW1/B#J.L>'?%/C_`,->!)/B?;WOARRCBM_"^E)JVM^*9;2X
MM5U.Y\/^'!(D<5[K6G6E>.?MQ_L;?';XP_M9?L#_`+97[,]K%\/OB+X6F\1_
M`;]IJ3Q)>:+;ZYIG[)GQ?\/W>J>+HKB#3]:O=&UKQW\,O$T)NO!,.G7_`(HT
MNS\8ZU).D6K>'IM2O%@_;:_9_P#CO^USX8^/O[-OAWX5:O\`#/\`9_\`#G[,
MOCWX6:#)XU^&OPQ^*-M\<M0\4:9<Z9+;?!:XT#]L7X7>(/ASXJT;3-&\/VO@
M;7OBCHVC::^IZI<:CJUSH+:1#)<`'[,VEW:W]I:WUC<0W=E>V\-W:75O(LUO
M<VMS&LUO<02H2DL,T3I)%(A*NC*RD@@U8K\Q/^"1=Q^U[HW[$_PD^$_[;GP5
M\9?";XZ_!+PQI?PTU?6O$OB7X3^*-,^)^B^&VO=)\,>,M"O/A;\0O'*6ES<>
M&=.T=O$6FZ_#HUQ9:K=>58-JT(GNH?T[H`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`*:Q8*Q5=S!257.W<P'"[CP,GC)X'6G4C$JK,%9
MR`2%7&YB!D*NYE7<W0;F5<GE@.:`/Q5^"_\`P5Y\5?&7XL_MO?"32OV*_B2F
MM_\`!/C4_#FE_M$)HGQ1^'_B74WG\4:%XM\1Z8OPPT58M*D\>SG2_!6MN]F;
MS0[J2Y%E:6D5S<7:(OW_`.'/VXOV2/$?P`^''[41_:"^%?AGX$?%C1M/UOP-
M\1/'?C/0?`F@ZQ!J,#3)9"Z\57^E)#J]HT5Q;ZAI4C"\LKFUN89HE,+&OPS_
M`&&/@U^W5\"_VR_^"TWQSUO]ACXK:5I/[>?C;X7>+/V;Y_%GQ'_9FBT*"7P'
MX(^+&BW$/Q;?PE\>/%^O>%+2XU?QAH0!\/:!XPFDLOM\@CCD@C2;X0_:>_8C
M^)?_``3%_9C_`."0GPF^$7P5_:2_;`_:,_97U']HOQ@^I?L\>"[_`.-6BZ5=
M_%'PM=Z!\3I/$7P;GU;2]?U+P?-/\1SI_@[Q);:UH%EX0OK"RAF%Q'J\>A78
M!^XO[37_``6D^#7P:\2_LG6GP-\,>%?VQ_A_^V)\?/"/[+7PP^+'P'^/GPQU
MOP9I_P`?/%VH6,%OX.\57MA+K=OINGZ=I>O>%-<U#7+:]OI(K+Q#`/[)_<K)
M<_;OP=_;,\"_$;XQ?$_]F[QOH6I?!O\`:)^$'@_PS\1_%_PR\7:GI&H17_PQ
M\7+=PZ-\2_!?BS2IWT?Q1X*.K:;K'A[4=1"Z=?:1KFD7UEJ>F6@6&6;^3[1_
MV=?C'\7OV>O^"*7P_P#V-OV!OVZ[/P)_P3*_;]^'/Q8_:"T3]II_@Q\,_BKX
M?T[P5XFT#Q_XOT33]*^*OQ,^%.H^+-=N](UNQU_P\/#WA73O`9T[6]/T&R\1
M1ZOI.O:;H_Z]?'#]C?QG\2/VF/VT_P#@I7\<O`'BOP3X+B_X)F^*/V1/AW\!
M=*^(&@:9\5?%GAD1>/OB-X\\0^*==\,:]KOP_P#"OB;4=2\6W'A#P:D&O^)8
MM(;3DUR34(A=M`P!^BWC3_@H_P#LI1:=XST3X(?'K]G7]H3XX^%?#6M>*[#]
MG[P/^T5\+(OB)XETCPK:WVM>+9-.T^+6-8OXGT+PMH?B?7F,FDR0W"^'[NT:
M:V_>7-OY?^P__P`%2_AE^VA\(?C_`/$%?ASXO^"_CC]FGQA?>#_BI\&_'VJ:
M%=^,-'FD\.Z=XG\(ZPEUI$KV$NA^.]-U*)_#>HE5ANO*EE0RP>5+)_,U_P`$
MP[KXA^!?&%QI?Q!_X)T_\%0/#'QTO?\`@G^?V!?V:)?''P*T7X2?"GQ'\.?`
M.E>,O&NBZ%XI\0^./$OA7P7>?$V*#5/$.M:C\1?%/C+P;H.M:)HG]E>&?!5C
MXIO=/TK7_P!@OA%^P_\`M!?#[]KGX=?MB>&OA)XW\&_"_P"+7['_`(%T+]MK
M]FJ\U;X27'Q.\7?M#?LBQ>&-`_9_G\-3:/\`%&;X;MJWC6RT&P-SK$_Q!N-"
MU+P7X7T?1?%5UX6U#5M0MK<`VOA=_P`%V/$'QF_9/^(7[9'P[_8.^*.N_"OX
M;_'9OV==8T0?%_X=0_$?4/B0/%_@[P0MGH?A,6,L-_8OKOCK08EN#K$,S1-=
MO';.UNJ2_57C#_@KK\$-"_X)C>'O^"GGA?P?XG\=_#[Q'\/6\<VGPNTG5="L
MO'=O?Z'I^M:E\1?!5[=W<S:/;>)OAM!X3\:1>)+>241BZ\+7]O"?,E@#?CU_
MP3=_9K_;N_93_8<\1_L\?%+_`()_?'^\\=ZQ_P`%.O"?[6T0\-_$#]C[5O#S
M?"31_P!H'X'?$[4()K^[_:?T^4^*&\.?#K7H(M$-@UI-J$UC;-J:13R30])\
M7O\`@F'^UA\(_P!D?_@J[^S3\%?A7XD^+_PD^/UQ\18?V!/A#X:\1?"K1M5^
M$\G[47A^T\:_&2U\7ZEX[^)/@OPWI'@KP5X^\/6_@_08]/NM5URQL-46;3+;
MQ!::QXBU>U`/Z+?V.OVAM0_:Q_9I^#?[2MQ\.+[X6Z-\<_AYX+^+'@GPMJOB
M;2O%.KKX!^(GA31?&7@_4=8O-%M[>PL-5O=&UNW.H:-&;EM,N8Y(6N[CAZ^F
M:^$?^"8GA'XF_#/_`()]?L<?!SXR?"WQ7\(/B=\#/V:?@7\$/&_A'Q;JG@'6
M[D^)OA3\*/!W@O7=7T;5?AOXU\=^'K_PUJ6KZ3?-H=U)J]KJL]I$)K_1]-9X
MXW^[J`"BBB@`HHHH`****`"BBB@`HHHH`**^:/'?QI\=^#_VF/@5\&XO`7A^
M[^''Q@T#XAW-Q\1I/&%TGB72O%G@;0KOQ`?#EOX$3PW]DDTJXTR.SN6\32^+
M?,>>ZFTY-`B^R"_N?FJ[_P""@H\)>&-9^+_CWP&D/P6U[X:_M`_%#X5/X8U"
M2_\`B+/H?[,VE:CJOCNS\=Z1J*V.@6.H^*[#3+K4O"2:%J][!IC+'H^LS7,D
MQU6$`_2RBOECX9_'KQ"=:^+W@+X\Z1X4\%^._@MX)\%?%GQ9J7@K5M5U_P``
M'X8_$J3XCKX:O;?4=7T[3-=7Q!H%W\)_'FD>*K%](>SGBTG1_$FD79C\32>'
MO#OO?@3QUX1^)W@KPI\1?`&OZ=XJ\$>./#^D^*O"?B7293/INN^']<LH=0TK
M5+*4JC-;WEG/%-&'1)%#;)$2164`'64444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%?G]I7[8/Q!C\#_`!OO
M_&OPI\-^&?B-\/OVJO!7[*G@WPIHWCJ]\5^&=5\3?%+1?@?+\/?$'B7Q=+X7
M\-WEII$NK?&K3I_%":9X9FNM*TS3[BVL(M5O$%Q.`?H#17Y[:=^UQ\3O%GB2
MR^`W@KP!X(NOVF=%U3XO6OCNVU_Q%K>F?!L:3\`[7X"7WC75?"OB*STO4O%L
MUSXSA_:8^#=OX0TC5?#T0\/3:YXQGUW4]7C\`VD7CKWSP[^U3\'-6^!7P(_:
M$U_Q&G@'P%^T1H_P9O\`X>OXR"6-]+JOQYTW1+_X=^%M16RDO[.TU[5)M?T_
M2W07<EA'J+M%]N:+;,P!]&T444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%?+^I?'+QOHO[5VD_`C6?`.A6GP
M[U_X`?%3XR^'OB'9^+[G4O$VKZC\+/%_P-\,:WH%[X+;P[I]EX>LXO\`A<!E
MMK__`(2?7)=7;3XG%OI"++',`?4%%?F5I/\`P4!U>T\*>$/%/C#X;Z<%_:!^
M&OP\^+_[,&F^'->N9)-4\,_%SXJ_!#X*>`_#'QCO-2L43P?XBC\;?M%?"'4_
M$NL^%K;Q=I5CX:UOQ=]@T[4-2\"VD?C?ZE^#/QNU+Q3HWQFL/BE8Z!X9\;?L
MY>.IOA]\6KWPU<ZA>>!9[[_A5'PZ^-MGXC\)W.J11:X=$N/AW\5/"ES?6FJV
MB7^E:_%KFD))JEK86FKZB`?2%%<=\/?B!X,^*_@7PC\3/ASXBT[Q=X#\>>'M
M*\5^$/$^D2--INN^'];LXK_2]3LW=(Y/)NK6:.0)-'%/$28IXHID>->QH`**
M**`"BBB@`HHHH`****`"O-/B5\'/A=\8M-BTCXG>!O#_`(TL(`RP0ZU9B9X$
M>>VN9(H;F-HKJ*&6XLK.::&.98II+6W>5',,97TNB@#$\.^&]!\):1::#X:T
MFRT71[%!'::?80K#;PJ`!PHY9B`-SN6=L#<QJ]J6FZ?K.GWVDZM8VFIZ7J=I
M<6&HZ=?V\5U97UE=Q-!<VEW;3J\-Q;W$+O%-#*C1R1LRLI!(J[10!Y/X`^!7
MP@^%>HZQJWP\^'WAWPGJ7B"\GU#6+W2K1DN+V\N0!/<.\LDIC>8*JR"'RE90
M%*XXKUBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`^:?BE\)/B!XR
M_:!_9F^*/AW7O!VG>#/@W<_%:?QKHNM:9K=UXG\0#Q]X,C\+:4OA;4+&_M]*
MTTZ9,);S4#JUG??:HC'%;"%PSGYNNO\`@GU!XK\-ZU\)/'OCW[7\%=$^&_Q^
M^&'PJL_#6F/IGQ!L-"_:7TO4=+\?W/CC7KZ?4-%U;4/#5AJ=UIW@Z31=%TN&
MY5TU/6XFN(19R?I/10!\"^*O@_XT\*?"G]KSXO?%CQ3X>\4_%CXD?L^7/@/5
M9O!&B7_AOP58^!?A%X:^+5_X(BL='U?4M;U4^(]1U/XG^-==\4:C-JK61DU7
M3="TNPAL_#RZEJ_X"?\`!'+_`()^?\%-OB5^PM^SW\4/''_!67XU?`OP5K_@
M/PI=?`/X/?`[P;\'_%OA'PU^S_-X$\++\.[3Q#+\0?AC!<67CBU=M8MM=L(X
MO$=HL=II^H+XFU+4;Z]EA_J*_:4_Y-V^/'_9'/B7_P"H9K-?('_!&[_E%1_P
M3X_[--^"_P#ZANF4`?,&N?\`!+/]O35[]KR#_@N?^VOIT;11QBVMOA1^SE!$
M#&""_EZ;X*TRVW.3DD6JN?XW<\UY=8>%/VUOV,/^"C?_``3-^#_C?_@HW\=?
MVK/A5^U1J/[6GAGXD>!OBQ\.O@=H%@5^#G[-6O?$;PIJ6GZKX'\"Z3XDAO4\
M4PV%[/)_;(:6.Q%M</<6]U=Q3?T-5^-7[<W_`"E@_P""&W_8\_\`!0S_`-8O
MUZ@#]E:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`*^`8_V2_B)J]I^TPOBCQOX+AU'XE_M:>"/VJ/@Y>>']"US[/X2
MUCX4Z1\&['X?Z)\0[34M4D/B2WEOO@EX=O/%7]@3Z(+N'6-9M=->S,5G,/OZ
MB@#\^M._9$^)/A7Q#9?'/P7\1O!]E^TSK&J?%NZ\>:MKGA75M5^$4VE_'JU^
M`]CXZTGPMX3MM;T_Q-9R^$X/V:_@Y/X)U35/$]X^J3^'O$L?B*RBB\<;O"_Q
M-_P5<^%WA_X'?\$_OV+O@KX2GU&Z\*_!_P#;`_X)F_"[PS=:Q-%<ZO<^'_A_
M\</A=X3T:?5+BW@M8+C49M.TFVDOIH;:WAEN6E>.")&6-?W>K\0?^"_5IXOO
M_P!BOX7V/P_UG1O#GCN\_;G_`&'[;P;X@\1:/<>(-`T3Q1/^T1X*CT+5=:T*
MUU#2;G6=*T_4VMKJ_P!+M]4TZ:_M8I;6*^M7E$Z`'[?45^-7_"C_`/@NM_T?
MY^P-_P"()?$O_P"BBJ.7X)_\%U8HI)?^&^_V!CY<;R8_X83^)8SL4MC/_#41
MQG&,XH`_9FBOS_\`^"5_[3WQ"_;/_P"">O[*?[47Q6M/#UC\1OC-\,;?Q5XO
MMO"EC<:9X=36!K6L:5,VDZ?=WFH7%G:S)IL<RV\M[=&)Y'43,H%?H!0`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7S#XL
M^#?CSQ%^U?\`#CXU1:_X1@^&?@_]GSXS_!S5_#,VFZTWCC4=9^+_`(T^$?BN
MXUS3]8COAH-KI>CQ?!O0;**RN-,GN[A]9U>9KA!;V49^GJ*`/S/TG_@G]J-U
MX5\*>%O&'Q*LYD^`GPW^'_PA_9@U'P[X>FM9O#_A;X3?%+X*?&GP%XB^+=KJ
M.HW47CCQ,/''[/'PBL?$6G^'Y?"6CZAX:\/^(XK.2PU'QK]I\,]YXH^'/C_X
M-?LP_ML_$+4+/3/BI\<_BUX5^*?QH\3>$_!UQ%X+\)^(?'V@_L[>%OA3X0\!
M^"+WQ??77_".Z7>^$_A'X'T1]<\6:K/&=?N=7\1ZA)8:?=+IUC]Z5Y9\<_\`
MDB?Q@_[)=X__`/44U:@#^;O_`()3_MB?\%)O!W_!-_\`8N\+?#;_`((^>./C
M#X"T']G_`,`Z;X2^*-C^V]^R1X(L_'>B6VEJEEXDMO"/B[Q);>)O#L6HQXF7
M2M<MXM1M0=EP@>OT"_X;H_X*N_\`2#/XA_\`BPC]B;_YJZ]3_P""*/\`RB8_
MX)]?]FO_``R_],R5^H5`'XU?\-T?\%7?^D&?Q#_\6$?L3?\`S5T?\-T?\%7?
M^D&?Q#_\6$?L3?\`S5UZI_P3'^'?Q@^'L_\`P42/Q=\-^,?#B^.O^"H/[5'Q
M$^%Q\81WT8U_X0>)-.^&B>#?$GA7[;))O\':G+I^K+HLEGLL6>VO/(C4A\_J
M#0!^-7_#='_!5W_I!G\0_P#Q81^Q-_\`-71_PW1_P5=_Z09_$/\`\6$?L3?_
M`#5U^RM%`'X?>/?^"D'_``4V^&7@7QI\2?&O_!$3XBZ1X-^'OA/Q'XX\6ZLO
M[??[&FHMI?AGPGH]YKVO:BNGZ7XBO-2OFLM*L+NY%GIUG=7UT8O(M+:>X>.)
MOU=_9T^,ND_M&?L^?`G]H30=(O\`P_H7QW^#?PP^,NBZ#JLL%QJFB:3\3_!.
MA^-].TC4I[7_`$:>_P!-L]<AL[R:W_<27$,CP_NV6O.?V[/^3(?VR/\`LU7]
MH;_U4?B^O/O^"7/_`"C,_P""=?\`V8I^R-_ZH#X?4`?==%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>*?M*?\`)NWQ
MX_[(Y\2__4,UFOD#_@C=_P`HJ/\`@GQ_V:;\%_\`U#=,KZ__`&E/^3=OCQ_V
M1SXE_P#J&:S7R!_P1N_Y14?\$^/^S3?@O_ZANF4`?I57XU?MS?\`*6#_`((;
M?]CS_P`%#/\`UB_7J_96OQJ_;F_Y2P?\$-O^QY_X*&?^L7Z]0!^RM%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!7XU?\`!<+_`)->^`G_`&D)_8&_]:8\!5^RM?C5_P`%PO\`DU[X"?\`:0G]
M@;_UICP%0!^RM5[O_CUN?^O>;_T6U6*KW?\`QZW/_7O-_P"BVH`_'K_@WV_Y
M0R_\$^O^R')_ZF'BFOV-K\<O^#?;_E#+_P`$^O\`LAR?^IAXIK]C:`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"O
M+/CG_P`D3^,'_9+O'_\`ZBFK5ZG7EGQS_P"2)_&#_LEWC_\`]135J`/A#_@B
MC_RB8_X)]?\`9K_PR_\`3,E?J%7Y>_\`!%'_`)1,?\$^O^S7_AE_Z9DK]0J`
M/AC]A_\`:O\`$W[54O[8L?B3PKH7A8?LU?MS_'G]E#P^=#N=0N3XD\-?".S\
M$W.E^*M8^WN_V?7=6;Q3<K?VUELL(A:P&W12TF?N>OES]F#2OV6=+?\`:+_X
M9>E\,2R:E^U'\5=5_:-_X1G6-;U@Q_M37=OX9'Q7B\0_VU?7HTKQ.EM%X8_M
M31](^QZ)9*;8V-C`9IB_U'0`4444`?*O[=G_`"9#^V1_V:K^T-_ZJ/Q?7GW_
M``2Y_P"49G_!.O\`[,4_9&_]4!\/J]!_;L_Y,A_;(_[-5_:&_P#51^+Z\^_X
M)<_\HS/^"=?_`&8I^R-_ZH#X?4`?==%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`445_.[J_Q2^)/PD\(_&WXS>%OB'\1+?Q
M-H?[._[=?CWPK\6/%_Q%\>^.OAO^U3XE^&-AK.H^#]3^'WP<\4>)=6\)?!Z'
MX4O90ZCK5I;>&?!\6M/:'3O":^-_"<]YXFMP#]M_VE/^3=OCQ_V1SXE_^H9K
M-?('_!&[_E%1_P`$^/\`LTWX+_\`J&Z963J<.I?#P_M[_L^6'BGQGXF^'O@G
M]D3X>?%;PT?B%XMU[Q]XIT_Q7\8+/]JG0/'R_P#"7^*+[4M?N-#U23X0^'=<
ML-!N;V73/#NK:EX@@\.P:5H%UIVAZ7K?\$;O^45'_!/C_LTWX+_^H;IE`'Z5
M5^-7[<W_`"E@_P""&W_8\_\`!0S_`-8OUZOV5K\:OVYO^4L'_!#;_L>?^"AG
M_K%^O4`?LK1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!117R%^W'=:A;?L_P!^FE^(M=T2]U#XA?"#2(]'\+Z_XA\(
M>)OB8FK_`!1\)Z=/\&?#WC3PI=V'B+P5K7Q>@N9/A]IOB_2KZQG\.76OQZH]
M[96]O-=P@'U[7XU?\%PO^37O@)_VD)_8&_\`6F/`59/P5C\1?$7XG^"OV9?$
M/Q!^,7A#P'>1_MK?$K5_AG!\7?'US\8/@KXG^!?B_P#8J\(_"SX7>+/CLWB?
M5O&'CR'3].^/7B?XU:M;Q>+?$W@?5]6\<>%?"]IK_P`1/AGX0TZ]\5^#?M]_
M$?Q3\8O^"47_``3<^+GCBZM[[QK\4_CU_P`$E?B-XPO;2UCL;6\\4^-_B7\&
M_$WB"ZMK*']S9V]QJVIW<L-K%^ZMXW6&/Y$%`']$E5[O_CUN?^O>;_T6U6*K
MW?\`QZW/_7O-_P"BVH`_'K_@WV_Y0R_\$^O^R')_ZF'BFOV-K\<O^#?;_E#+
M_P`$^O\`LAR?^IAXIK]C:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`***IZ@Q73[YA="R*V=RPO2GF"TQ"Y^U%"1O%O\`
MZW9D;MF,\T`7*\L^.?\`R1/XP?\`9+O'_P#ZBFK5^%?P\\??$CP1X,\*7VC_
M`!'^*OAG4/BMX!_99\+W'BGQA\4O'WQ,D_:KTOXZ?MC_`+.GP/\`'/[7OP;T
M[QWXA\3:7^S[8Z-X!^(=[?>'/!FC6/A[5+#Q!^T!I%QJ7@>P\-_#GX=^(/'/
MZ(>`+S4]*^&O_!1'X1-KGB+7/"'P$\=^)/AS\-9/%_B/7?&?B?3?!OB']B_]
MG[XU3:/K'C/Q3J&K^*?%+:?XR^+7BY-,U/Q)JVJ:Q#HC:9I=SJ%VNG1S,`<I
M_P`$4?\`E$Q_P3Z_[-?^&7_IF2OU"K\O?^"*/_*)C_@GU_V:_P##+_TS)7ZA
M4`?`_P"P;^RKX]_99E_;4D\=ZYX1UL?M(_M\?M!?M5>"QX2N]9NSH_@+XLV7
M@6V\/Z'XH_MC0]$%KXNL'\+WQUBSTHZQHT*S6ALM<OR\RP??%?F!_P`$R/C?
M\5?C7/\`\%$%^*7C+4/&*_"'_@I_^U/\$?AN-0M].M_^$4^%7@73_AI-X3\&
MV/\`9UE9>?I^BR:UJCV]Q?\`VO4I#>2?:;V<+&$_3^@`HHHH`^5?V[/^3(?V
MR/\`LU7]H;_U4?B^O/O^"7/_`"C,_P""=?\`V8I^R-_ZH#X?5Z#^W9_R9#^V
M1_V:K^T-_P"JC\7UY]_P2Y_Y1F?\$Z_^S%/V1O\`U0'P^H`^ZZ***`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KY]\(?LL?`;P
M+XPUCQUX;\!I;Z[K5OKUH]MJ7B3Q?XB\*Z+:>*9O/\36O@SP%XB\0:KX%\`6
MWB%RR:W;^!O#GAZ'58));6^2>VEDB;Z`5U=0R,KJ<X92&4X)!P1D<$$'T((Z
MTZ@#Y)^('P>^&WP3_95_:"\+?"_PK:>%=$O_`(9?%/7+^""ZU+4KJ_U.;P%>
M:9%/?:KK5[J6K7D>EZ'I6C>&/#]I<WTMGX:\(:!X=\(>'[?3/#'A[1=)L/"_
M^"-W_**C_@GQ_P!FF_!?_P!0W3*^O_VE/^3=OCQ_V1SXE_\`J&:S7R!_P1N_
MY14?\$^/^S3?@O\`^H;IE`'Z55^-7[<W_*6#_@AM_P!CS_P4,_\`6+]>K]E:
M_&K]N;_E+!_P0V_['G_@H9_ZQ?KU`'[*T444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`5P_Q%^''@OXL>$M1\#^/M%&N
M>&]2EL+J6VCU#5=&O[/4-)O[;5='UC1=>T&^TO7_``[KVBZI9VFIZ+K^@:II
MNM:/J-K;WVFW]K=0QRKW%%`'S?/^R+^SO>?#JQ^%6H_#BWU?P;8>*)?&HBUO
MQ'XPUOQ)J'BJZL;G1M1US7O'NK>(;SQYXEOM:\,7M[X(\0OXA\2ZHGB+X=WM
MY\.M<34/`UU/X?D_/7_@MW!#:_LK_L_6UM#%;VUO_P`%!/V`H+>W@C2*"""+
M]I7P#'%##%&%CBBBC54CC151$4*H``%?LU7XU?\`!<+_`)->^`G_`&D)_8&_
M]:8\!4`?LK5>[_X];G_KWF_]%M5BJ]W_`,>MS_U[S?\`HMJ`/QZ_X-]O^4,O
M_!/K_LAR?^IAXIK]C:_'+_@WV_Y0R_\`!/K_`+(<G_J8>*:_8V@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"FNB2H\4J+
M)'(K))&ZAT='!5T=&!5E92596!#`D$$&G44`?-W@K]D3]G7X?VOBW3_#WPUL
MY]*\;>%=0\!:UHGBO7_%OC[P_:_#[5T\K5OAUX5T#QYK_B31O`GPZU2".SM=
M1\`^!['P[X/OK/2/#]G=:++:^'="ATZ7Q;\-O!7PF_9H^*?@KP!HO]B>'K'X
M:_$V\$,VHZMK>I7^I:IX?UN_U76-=\0^(+_5?$7B/7M5OIYKS5=>\0:KJ>LZ
MG=2/<7U]<2G?7T97EGQS_P"2)_&#_LEWC_\`]135J`/A#_@BC_RB8_X)]?\`
M9K_PR_\`3,E?J%7Y>_\`!%'_`)1,?\$^O^S7_AE_Z9DK]0J`/ES]F#]JGP/^
MU))^T7'X)\.>)_#I_9O_`&H_BK^RMXP/B:#2(1KOCCX3V_AFYUWQ'X>_LC5-
M3\WPQJ2>*+)=+GU3^SM7D:WN?MFEVH$1D^HZ^7/V8/V6/`G[+K_M%R>!?$?B
M?Q$?VCOVH_BK^U/XS'B:YT:Y&@^//BO;^&;;7_#GA[^Q]*THV_AC34\,6+:7
M;:J=2UF)KBY-[JMV&A$7U'0`4444`?*O[=G_`"9#^V1_V:K^T-_ZJ/Q?7GW_
M``2Y_P"49G_!.O\`[,4_9&_]4!\/J]D_:[\(^(_B!^R?^T]X#\':5/KOB[QM
M^SQ\:O"/A70[5X([G6?$?B3X;>)=&T/2K:2YE@MDGU'4[VUM(7N)X8%DF4RR
MQQAG'XH_L0_\%7?AO\`_V+OV0_@5\1/V.O\`@J!:?$#X+?LO_`'X2^.K32O^
M"=7[3FL:7;>,?AS\*?"?@[Q/;Z;JUIX):TU2PAUO1KZ.SU&U8V][;K'<P$QR
MJ:`/Z-:*_&K_`(?;_`;_`*-"_P""I_\`XK9_:D_^8BC_`(?;_`;_`*-"_P""
MI_\`XK9_:D_^8B@#]E:*_&K_`(?;_`;_`*-"_P""I_\`XK9_:D_^8BC_`(?;
M_`;_`*-"_P""I_\`XK9_:D_^8B@#]E:*_&K_`(?;_`;_`*-"_P""I_\`XK9_
M:D_^8BC_`(?;_`;_`*-"_P""I_\`XK9_:D_^8B@#]E:*_&K_`(?;_`;_`*-"
M_P""I_\`XK9_:D_^8BC_`(?;_`;_`*-"_P""I_\`XK9_:D_^8B@#]E:*_&K_
M`(?;_`;_`*-"_P""I_\`XK9_:D_^8BC_`(?;_`;_`*-"_P""I_\`XK9_:D_^
M8B@#]E:*_&K_`(?;_`;_`*-"_P""I_\`XK9_:D_^8BC_`(?;_`;_`*-"_P""
MI_\`XK9_:D_^8B@#]E:*_&K_`(?;_`;_`*-"_P""I_\`XK9_:D_^8BC_`(?;
M_`;_`*-"_P""I_\`XK9_:D_^8B@#]E:*_&K_`(?;_`;_`*-"_P""I_\`XK9_
M:D_^8BC_`(?;_`;_`*-"_P""I_\`XK9_:D_^8B@#]E:*^`?V0_\`@I%\!/VS
M_'OQ&^%GP\\*?M`_#CXD_"SPWX:\8>+/`G[1'P&^(7P&\61^%O%U[J6G:!X@
MT[0?B%I>E:EJ&DW]]I&H6L5]#;^0\UK,D;N8Y-GW]0`4444`%?RK?\%>?V6O
M!_P1^,/PN^,.D?$OXW?$GQU^U[\==3^'%I\#_%/_``4R_:?_`&1]+U+XA_$&
M]\)Z5\---^#T?PCT[QEX4T;PWX=O!<>';[PY<_#[3X;R[\5Z-J^K>.[*6QEM
M=:_JIK^=;_@L+XG\`^,?CO\``CX8^._@O_P56LI/!OA/Q/\`$;1?CS_P3M^#
MNL?$O5+RY\/?%'X&>,-'^&NLQ:%\._BI;OX3U#QAX+\->.-:U.\MO">O^&O$
MWP]\%KI3WL/B![BT`/UV_83^%J_!7]D+X!?#!;K3[N3PKX"LK>[ETOQ-XC\:
M6J:AJ%Y>ZQJ5HWC#Q?>ZAXI\5WMAJ&HW-CJ?B/7[A-5UO4K>[U*]LM-FN6TZ
MU^LZ^;OV/]+T?1_V8_@I9:!\/_'/PLTMO`NEZA#X"^)PU`?$;P_/J[3:M?Q^
M.UU98]63Q=?ZA?76J^(8]5@MM3CU6^NH]0L[.\6:UA^D:`/%/VE/^3=OCQ_V
M1SXE_P#J&:S7R!_P1N_Y14?\$^/^S3?@O_ZANF5]?_M*?\F[?'C_`+(Y\2__
M`%#-9KY`_P""-W_**C_@GQ_V:;\%_P#U#=,H`_2JOQJ_;F_Y2P?\$-O^QY_X
M*&?^L7Z]7[*U^-7[<W_*6#_@AM_V//\`P4,_]8OUZ@#]E:***`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OQJ_X
M+A?\FO?`3_M(3^P-_P"M,>`J_96OQJ_X+A?\FO?`3_M(3^P-_P"M,>`J`/V5
MJ&Y`:WN%+!08906.<*#&P+'`)P.IP"<=!4U13(9898@0#)%(@)Z`NA4$^PS0
M!_+9_P`$K/BG_P`%1_@M_P`$^/V7_A5^SG^P[^RQ^U;\#?`O@.]T#X8_M&Z9
M^WQ?_#+3_C#X6M?%GB)K+QK9_#_Q-^R]?>(/"5OJ;22B/1M9NI=0M5BQ<[)&
M:-/T#_X:C_X+8_\`2)O]F;_Q9E8__0IU]7_\$T?V5/%7[#_["/[-'[)WC?Q-
MX?\`&7BOX'_#U?!VN>)_"L6HP^'M9O!K>L:J;O2HM7MK34DMO*U*.+%W;0R^
M9&YV;2I/W-0!^-7_``U'_P`%L?\`I$W^S-_XLRL?_H4ZR/$'[7W_``6B\-:#
MK?B/5/\`@D[^S6NF>'](U+6]1:'_`(*764TRV.E6<U_=M%$/V4P991;P2&.,
M$%WPH()K]K*\V^,O_)(/BM_V3;QS_P"HOJE`'DW[$O[2D?[8W[(_[.O[4\/A
M*3P''\?/A-X/^*"^#)-87Q`_AC_A*M+AU%M%.N+I^DKJOV%I3"+\:9I_VE5$
MIM("QC7ZBK\L_P#@B'_RB(_X)T?]FF_"'_U&K6OU,H`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"O+/CG_R1/XP?]DN\?\`_J*:
MM7J=>6?'/_DB?Q@_[)=X_P#_`%%-6H`^$/\`@BC_`,HF/^"?7_9K_P`,O_3,
ME?J%7Y>_\$4?^43'_!/K_LU_X9?^F9*_4*@#\P?^"97P/^*OP2G_`."A[?%/
MP;?^#U^,'_!3[]J;XX?#8WUUIEU_PE7PJ\=Z?\-8?"7C&R_LR^OOLUAK4FBZ
MHEO:ZC]CU2(V;_:K&`-$7_3ZO@7]@S]JKQ_^U++^VK'X]T3P?HH_9N_;Z_:"
M_95\%'PC9:U9'5_`/PFLO`ESX?UOQ3_;.O:Z+OQA?/XHOQK-[I(T719TAM!9
M:#8%)FG^^J`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@#\:O@]_RG8_;4_[,`_9(_P#5H_&>OV5K\:O@]_RG8_;4_P"S`/V2/_5H
M_&>OV5H`****`"OQT_X*D?'CXL_`7XA?LBZE\`_B-X?T3XN_$;QQ>_!C2O`W
MC_X'_%KXY_"U]!^+WCGX2?#N?XN>/--^#_Q'^&.K>!++X?\`B[Q)X*\(V'Q`
M\6:YJ'@NPO?BBNAW>C3:WKVAWEG^Q=?S+?\`!2H?&?XB?'&'X4?M-?\`!,;X
MF?MA_!WPKXL\4_%'X`?'/X'?M0^`_P!E"Q\,Z%9:G\+)?#WPV\1>)==^-OPU
MO]=UR'7-/D\4^)-'\3:SIL7B+5]'\/:KX.\)ZW8>"M9UO0`#]\OV8IYKCX!_
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MD?LY_M+7/P3_`&G_`-G#PT/BYKOC?XM_"']L[3OCU/\`&+[79?"&_P#BA\8E
M\8WWP(U/X$>*Y-#T;PAJ3^(/^$GG_P"$SU'P#)K*V^DM)+\=_)^+4>GSN`?I
MMX^^,WPV^-G[+?[0WB#X;>(GURQTOX7_`!.TG5+>^T3Q#X6US2[MO`FHZCI[
MZEX9\7:3H7B2PT_Q#H=[IGBKPAJ]WI,.D^,_!>M^'_&WA.]UGPEX@T36;_Q#
M_@C=_P`HJ/\`@GQ_V:;\%_\`U#=,K-U1=<\>Q?MY_M##P9XY\$>!?'?[(_@'
MX3^&M.^)WA+6?`'C>]\2_!JR_:CU[QY>R^#/$-M:ZU9^&K.[^,&C>'-$\07<
M$-CXNU'0?$6N>$VUKP%-X2\8^*M+_@C=_P`HJ/\`@GQ_V:;\%_\`U#=,H`_2
MJOQJ_;F_Y2P?\$-O^QY_X*&?^L7Z]7[*U^-7[<W_`"E@_P""&W_8\_\`!0S_
M`-8OUZ@#]E:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`*R]<US1?#.CZIXB\1ZOIF@:!H=A=:KK6N:U?VNEZ1I&F6,
M+W%[J.IZE?2P6=C8VEO')/<W=U-%!!"CR2R*BDC4KXS_`&]_AGXK^+?[..K>
M#/"\_C2.TE^(/P<U[Q];?#C[(_CW5OA+X3^*W@_Q1\5M$\(6=YIFKKJOB#5O
M`>DZ[9:;I%K83:MJES*EGH1BUN;3I4`.XNOVN/@7IOP_TSXFZ[K?C?PKX6UK
MQ%=>&-&C\:?!;XV>"O%NKWFGVCZIJNJZ7\._%GP\T;XA:AX,T30(+[Q;K_Q"
MM/"\W@/0/!&D:]XYUGQ)8^$/#^M:W8?GI_P6UOK+4_V4?V>=2TV[M=0T[4/V
M_P#_`()_7UA?V4\5U97ME=_M)^`)[6[M+J!Y(+FUN8)(YK>XA=XIHG22-V1@
M3VG@VY^,'@;XD?!S]HKQMX(^-WC[X/>"O`G[5_P0^%T#>!O&'B[]IJ7P!\:O
M%O['GC+X%ZM\7O`EQ80>/+>YO]1^!GQ"\)ZAXD\=:9I?COP?X?U;X4:Y^TI'
MH?B1_C+XZ\/?)7_!0+X:^)_@Q_P2I_X)P_![QM'90^,_A/\`'[_@DS\-/%T6
MFW0O].B\3^!/B;\'/"^OQV%\$B%Y9)JNE7:VMV(HQ<0".8(F_:`#^B"H;EF6
MWG920RPRE2.H8(Q!'N#TJ:F2R>5%)*02(T=R!U(12Q`]SB@#\Q_^",/Q-^+?
MQE_X)<_L8?$_X[^)_%/C/XO>,OA*FK>//%/C4S-XJUK6CXF\0VQN];:XA@G-
MY]DM[:+,D,;>5''\N,$_IW7RG^P]^U;X<_;B_9.^!W[67A'PKK?@CPW\<?!P
M\8Z1X3\1W=C?:YH=J=5U+2OL>I7>F$V$]QYFFR2[[8F/9(@^\#7U90`5YM\9
M?^20?%;_`+)MXY_]1?5*])KS;XR_\D@^*W_9-O'/_J+ZI0!^?G_!$/\`Y1$?
M\$Z/^S3?A#_ZC5K7ZF5^6?\`P1#_`.41'_!.C_LTWX0_^HU:U^IE`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!115/48[F73[Z*S?RKR
M6SN8[63<4\NY>%U@?>`2FR4JVX`E<9P<4`>+Q_M*?!F35OB/IK^*K^TT_P"$
MFDZAK'Q`\>:CX,\=:7\']"@T>1(==L(_C?J7AFU^#VM>(_#MP[6WB;PGH'CC
M5/%'ANZM[VUUW1]/N+"]CM\+Q3\3O!7Q<_9K^+/C#P)J=YJ&D2?#GXEZ;=VV
MKZ!XB\(>)M!UG3O#.K0ZGX>\7>"O&6DZ!XR\%^)]+E*QZKX8\6Z#HOB#3'>-
M;[3;<R)N_)GX0_`C]I#0/V=?"OP:T?2OC?XQM?A1'^R_\3?VA;'XU6\EGJ_B
M3]J3X%_M4_`;XY?$ZU_9?U'5M,\):%XJ\+^/_`_@[XGZG<WGAQE^"OB#QC>_
M"9/#&O\`A_XB:M^T/<M]R^!--UF^^&7_``4*^+MWX=\3^&/"_P"T#XV\2_$O
MX<Z=XX\+^(/`OC6;P9X>_8U^`?P2;5/$W@/Q=INC>+?!=WJOBSX1>*;_`$S0
M/%6D:3XBC\/3Z-?:QI.DWM]+IMH`<?\`\$4?^43'_!/K_LU_X9?^F9*_4*OR
M]_X(H_\`*)C_`()]?]FO_#+_`-,R5^H5`'X\O_P1W\.:+\8_C!\7/A-^W]_P
M4@^`%C\<OCMXE_:+\??!_P"#7QF^#>A?!^]^)7C.;29O%MY:Z#XB_9Y\5>)8
M]/\`$(T2PMM0M;GQ=>7`LXA:VMY;0QP+#]I?M4_LL:U^T[X6\(>&='_:O_:S
M_9:F\)ZI<:E/XH_97\>>`O`WBGQ<EQ8QV0TSQ??>.?A?\2['4-,MVC^W6\.G
MZ;I4Z7TDDKW,D3"%?K2B@#\P/A[XGTW]@;XL?LF?L4>+?C-^UA^UKXL_;0\9
M_M!7OA'XQ_M(^.?A[XR\3>!!\$_A)!\2]9T/5+_PCX#^&D$GAO4-.L&M/#UG
M8^'KR]MM7O+N>_OFM)(UB_3^OEOXM_LV?"GXI?M(_LD?M!^,/$WB+2OB9^RU
MJ'QOO_@_X=TS7/#^GZ#XJN?C)\,9/ASX[C\3:-J6B7^N>($T7PM(VI:0GAS6
M-!?3-0`OM6?4K`&RKZDH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`_&KX/?\IV/VU/\`LP#]DC_U:/QGK]E:_&KX/?\`*=C]M3_LP#]D
MC_U:/QGK]E:`"BBB@`K^7#_@O)\5O@AXB^(?[-W@WQOXH_8R?0_#]O\`M%:5
MKWAS]LW]CC]L[]JW2;GQIX=N/V>KI'\#>"_V==.L]-L&T?2O%\3ZMXZ\07-U
M;[]5T[0O"UW,UQXJA@_J/K\0/^"LNC?M4?$7Q7\`O#/[*OPV_;:^)%C#HGQG
MN/B-XA_87_:9_9Q_96\1^%;_`$;6?A-::)X>\<?%[X\Z;>6\\&KSW^KSVOPY
M\,ZIIVHZM-H-[K>K65Y;>&(FM`#ZJ_X)*:O:Z]_P3E_92U2PMO`MIIUS\/;M
M--@^&/@*Z^%OP\33+7Q;XCM--/@OX=:A:6.J^"_#DEC!;R:5X=URV3Q!IMJ\
M=OX@:76EOYI/T5KXD_X)P^$O%/@3]B3]GWPEXW\#?$SX;>,-&\*:G!XE\%?&
M7Q7IGCOXJZ)K4WBSQ#=Z@GC[QMHFE:)HGBWQ-?7-Q)J>I^)-%TRWT?6IKTZA
MI;W-A<6]W/\`;=`'BG[2G_)NWQX_[(Y\2_\`U#-9KY`_X(W?\HJ/^"?'_9IO
MP7_]0W3*^O\`]I3_`)-V^/'_`&1SXE_^H9K-?('_``1N_P"45'_!/C_LTWX+
M_P#J&Z90!^E5?C5^W-_RE@_X(;?]CS_P4,_]8OUZOV5K\:OVYO\`E+!_P0V_
M['G_`(*&?^L7Z]0!^RM%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!7XU?\%PO^37O@)_VD)_8&_\`6F/`5?LK
M7XU?\%PO^37O@)_VD)_8&_\`6F/`5`'[*TR5%DCDC<D*Z.C$'!"LI4D$Y`(!
M/)&!3ZAN%:2WG1!EGAE11P,LR,`,D@#)(Y)`]30!\R_L6_LZ?";]DG]EGX+?
MLX?`KQ)KGC#X1?"3PB/"_@3Q-XDU_0O%&NZQHPU/4=1%UJ7B#PSI.A:#JEQ]
MKOKF/[3IFD6%OLC2/R?,1W;Z@K\U/^"._P``?BW^RU_P3*_8[_9]^/'A(^!/
MB]\+/A4GAOQYX1.N>&O$IT+6AXDU^_-D==\'ZSX@\,ZG_HE[;2_:-'UG4+7]
M[L\_S$D1/TKH`*\V^,O_`"2#XK?]DV\<_P#J+ZI7I->;?&7_`))!\5O^R;>.
M?_47U2@#\_/^"(?_`"B(_P""='_9IOPA_P#4:M:_4RORS_X(A_\`*(C_`()T
M?]FF_"'_`-1JUK]3*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`KRSXY_\`)$_C!_V2[Q__`.HIJU>IUY9\<_\`DB?Q@_[)=X__
M`/44U:@#X0_X(H_\HF/^"?7_`&:_\,O_`$S)7ZA5^7O_``11_P"43'_!/K_L
MU_X9?^F9*_4*@`HHHH`_,S]JOX!?%SXC?\%$/^"5'QO\&>$)-:^%W[.>O_MH
MWOQF\4KK/AVQ3P7;?%7]FV?P'X!EDTC4]7LM>US_`(2#Q8ZZ2J>&=+UI].8_
M;-773]/!NQ^F=?GU^TC^U'\1_A)^W/\`\$V_V;_#%EX5G\`_M;:W^UEI_P`3
M[S6-,U&Z\36$'P0^`<WQ.\'GPAJ-MK%E8:5)<^(HUAUUM3TK6UO=+S;6BZ?<
M?Z6/T%H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_&KX
M/?\`*=C]M3_LP#]DC_U:/QGK]E:_#SP5\0/`?@+_`(+I_MDS^.?&WA'P9!J'
M[`G[)D5A-XL\2:-X=BOI8?B?\9GEBM)-8O;-+F2)&5I$A+LBD,P`(-?J_P#\
M-%_L^_\`1=?@W_X<[P3_`/+R@#V2BO([3]H#X#W]U;V-C\;/A'>WMY/%;6EG
M:?$CP;<W5U<SNL<-O;V\.LO+//-(RQQ11(TDCLJ(I8@5ZY0`5_.;\4?"GQ5B
M^./[03^&O^#?9/VC]'U'XU>-[^V^/U_^T_\`LV^`W^+!O)[5I?&<?A;XZ>-;
M#QWI-K>2;K>&.UL;?PS(EIYWA>+^S9(B?Z,J_#S_`(*;_ME_MD?L7_%KX=>-
MO"'Q-_X)S>`/V;O$O@;QKX=:V_;+^.OC#X&W>L?$N36_`UYI5]8WWA[X<_$'
M5]:O_#VAVFOV^G6VBG3O#[6GB75)/%-O+J5GX5D8`_3/]D/P'X^^&7[-GPC\
M#?$]/LWCG0O#3IKFDC77\3IX9-_JNHZKIW@R+Q$\UP-:@\$:1?6'A&WU*&:2
MTNX-$CFLV^R-"!](5\R?L9?%^X^/G[+/P/\`C#>>./!7Q*OO'O@73]9U'QW\
M-X=8B\`>)M3$US9:EJ7@Y]>T?P]JM]X=>^M+B/2M6N="T==:M(HM7MM.L[2]
M@@3Z;H`\4_:4_P"3=OCQ_P!D<^)?_J&:S7R!_P`$;O\`E%1_P3X_[--^"_\`
MZANF5]?_`+2G_)NWQX_[(Y\2_P#U#-9KY`_X(W?\HJ/^"?'_`&:;\%__`%#=
M,H`_2JOQJ_;F_P"4L'_!#;_L>?\`@H9_ZQ?KU?LK7XU?MS?\I8/^"&W_`&//
M_!0S_P!8OUZ@#]E:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"OQJ_P""X7_)KWP$_P"TA/[`W_K3'@*OV5K\
M:O\`@N%_R:]\!/\`M(3^P-_ZTQX"H`_96HIW:.":1<;HXI'7(R,JA89''&1S
M4M,E*+'(9`#&$<R`C<-@4E\K@Y&W.1@YZ8H`_/\`_P""5G[3WQ'_`&S_`/@G
MI^RK^U'\7+7PQ9?$GXT?#5?%OBZU\&:9>Z-X7AU0Z_K>F%-%TO4=5UN^L[3[
M/I\!\JYU6^D\TR-YVU@J_H'7R_\`L6>-OV8?B-^RS\%O&_[&&F^&=(_9<\1^
M$1?_``7TWP;X%O\`X9^&+/PE_:>HPB+1O`>IZ'X:O_#-I_:<.H-_9]UH6FR>
M:TD_V?;,'?Z@H`*\V^,N3\(/BJ`,D_#;QR`!W_XIC5*])J*>&&YAFMKB*.>W
MN(I()X)D62*:&5#'+%+&X*O'(C,CHP*LI*D$$B@#\!/^".?[>G[$_P`/O^"6
M/[`_@CQU^U=^S_X0\8^%OV8/A9HOB3PQXB^*O@W2-=T+5['P];0WFF:MIE[J
MT-W87UK*ICN+6YBCFB<%70$8K]*/^'DO_!/S_H]']F7_`,/-X#_^7=;TO[`'
M[#,\LDTW['O[-$LTTCRRRR?!/X=L\DDC%WD=CX>)9W8EF8DDDDGFH_\`AWW^
MPK_T9U^S+_X9'X=?_,]0!Z=\(/VF/V>?V@9=:@^!OQM^%WQ<G\-QVDOB"'X=
M^-_#_BV;18K]I4LI=3BT6_O'LH[MX)DMY)U1)6BD5"2C`>X5^%/[*WPF^%WP
M8_X+@?MM^$/A%\._!7PQ\*R_\$]OV--9E\-^`O#.C^%-#DU>]^,O[2MO=ZF^
MEZ):65DU_=065I#<79A,\L5M`CNRQ(%_=:@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`KRSXY_\`)$_C!_V2[Q__`.HIJU>IUY9\<_\`
MDB?Q@_[)=X__`/44U:@#X0_X(H_\HF/^"?7_`&:_\,O_`$S)7ZA5^7O_``11
M_P"43'_!/K_LU_X9?^F9*_4*@`HHHH`^6_BWXQ_9;T3]I']DCPI\6['PQ<?M
M(^-]1^-\7[)%YJW@?5M?\16&H^'OAC)J_P`<#X4\8V>@ZCI?@&2Y^&(D@UJ;
M6=:\/+XFTW.B6#ZI='["?J2OB3X]?LF:M\9/VPOV"_VGK/QGI^A:9^QOJW[2
MNI:QX1N='N;V_P#'2_'KX+R_"JPBTW58KZWM]$;PY=2?VS=M=6=^-0MQ]DA%
MM(?/K[;H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`^'O
MC?\`\$T_V!?VE_BGJ/QK_:(_9(^!_P`<OBAJGA7PQX)G\6?%CP3IOC^ZMO"_
M@Z\\17^@:7I%AXG74](T%8+KQ7K4E]=Z'I^GWVMK+80ZY=:C#HFB1Z=Y?_PY
MC_X)+_\`2.']C+_Q'SX;?_*"OTQHH`_F'_X+-_\`!,S_`()Y_L[_`/!.[XM_
M&3X$?L5_LT?"#XL>"_B=^R1/X1^(WPZ^#_@KPEXS\-3:S^V+\`O#NJRZ)XAT
M;2+34]-DU'0=7U31[Q[6XB:?3M0O+20M#/(K?T\5^-7_``7_`/\`E%+^T#_V
M4G]C;_UM[]G&OV5H`*_G/_X+E^+_`(A>$/C!^PD?`WQYU7X$V'BKQ!XN^'OC
MOQ%8^$?V4M2L]$\'_$CXM_LU?#^Y^(FJ^(OVJ?!WC33+JP^'>H>)]/U.]^&O
MP^TV/Q9XKTV]O_%=W=67A_X>ZIJ-E_1A7YC?\%%K:S>X^"]]\0/^"?UU_P`%
M!?@OI5_XJO=9\`^%?@Y\$/C;\0_!?Q29O#-M\,/%NC^&_CKXQ\#^']!\,VUM
M-XP?Q+XPT+5;[Q!I-U;:#;KI+Z7>ZAJ.G`'M/_!/A)M/_8L^`ZZI\5=2^,LU
MGX0U$WOQ;U_2;7PY=^-?)\2:\TWB*73+1+?2;*PE4$:=)HUO9>'9]*AM+S0+
M*PT.:PM(/G3QQ^WWX[\->._C[XQTOP7HFK?LY_"W]CWX\?'[X87;27EIXD^-
MVJ_`YOAO<ZMXPTS6)OW.A_#C6M3\8>(?`/A>&30+BYUJ7P9>?$?3M7U;PAXL
M\**OW[\$V\5ZU\%_`8^)OP\TKX=>)=1\)6D'B+X9VDFD:AIOA>&6%X(?#4ZZ
M.)=`\RVTDVMMJFG:3)>:-97AN].T^\U"PMX;RX^68_\`@F!^Q1IGC37?%'@W
M]GWX1?#/2O%?[//Q-_9L\4>%?A7\,?!'PVL]9\#?%6\\-OXAF?5?!>C:+K%G
MJ,>D>'GT"RDL[J$0:=JMZJ%6$>`"AXA^(?Q+?P1^VC\`_BWJ_ASQEXO^&?[-
M&F_%&'Q_X5\/S>#]+U;P_P#&S0_CMH]EX7F\+7&JZ\]M?^#-9^#OB&*/6X]7
M=-=\/ZQX>-UI]IK%AJUUJ61_P1N_Y14?\$^/^S3?@O\`^H;IE>C^,?@C)\-/
M@;^U3XU\5>.M;^*GQ2\>?`_Q%X>\2?$+7]-T;0+NY\$_#WPEX_D^'GA*WT#P
MS;6&@6MMX=E\9>+]7O=4CLSJNO>)/%OB'4+NYAT@^'_#WAWSC_@C=_RBH_X)
M\?\`9IOP7_\`4-TR@#]*J_$/_@JSH'[57A/]IO\`X)G_`+6O[,G[*?BK]KW_
M`(9:\;_M3S^/_AEX.\<>%?`.M?8/C5\!)?A9X>OTUKQ2MU;QV]KJ&IWFH3F#
M3+_<NF_8Y/LKWUO<#]O**`/Q`\/?\%/?V_KK2+F?Q3_P0^_:WT/74><6FF:'
M\:/@'XDTNX18@;9KC6KW6/#%S:M--F.9(]$NQ;Q@2H]RQ\D;7[)'_!5+X^?&
MW]LC1OV-?VE/^"<WQ6_8S\7>+/@=XZ^.7@WQ'XQ^+O@GXDZ?KNA>`O%/A/PM
MJ=I+8>%]`TIM.26[\4QA+]]0N'CNX+>T;3WCOQ>6W[2U^'_Q7\0SVO\`P<*?
MLAZ`MO$T&H?\$S?VFB\[%Q+'YOQO^&EX=@!V'#:#`@R/NSRD\JF`#]P****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KRSXQ_
M%/3/A#X'O_%%S8S>(-?NI#H?@'P/83-%KOQ'\?WUG>3^&O`?AY4MKV4ZIKUQ
M9RB2[%G<6NB:5;ZGXCU80:)H^I7=OZG7EWQ9^!_P8^/6@:9X5^./PE^&OQC\
M,:+KT'BK1O#OQ1\#^&?'VAZ3XGM=+U?0[;Q%INE>*=,U6QL=<M]%U_7=(AU6
MV@BOHM,UK5;%)UM=0NXI0#X`^$G[2W[3'QCTCX4_"XW_`,-O`/QS\9^(_P#@
MH3K?BCQFOA/4/$O@;2/#7[$7[8NG?LY6?@;2?"3>)K6^GO?&*^/?`PO_`!7/
MXHG-AI7AWQ7=VFG7&KZ[I%QH_P`L?\%.OBRGQ\_X)O?L(_'6+17\-Q?&G]J?
M_@ES\68_#LEX-1DT&/XC?&/X3^,$T5]06"U6^?2UUD6+7BVUNMR8#.((0_EK
M]\>!O^"?'PV^#'A#P_H?[/.O/\!?$OA7QY^TMXC\/^+_`(>^"?`]FFF^"OVJ
M_C$/BW\3/AE%X-FTA_!IT:RFT;X<:)X,UIM(.N^&8?A'\/\`[/<S:';^(/#/
MB#XW_P""OO@#PI\)_P!AS]DGX6>`],_L3P/\-?VU_P#@F_X`\&:-]IN[W^R/
M"G@WX^_#7P[X=TS[;?SW-]=_8-(TZSM?M5[<W%W<>5YMS/+,[R,`?N/4<R>;
M#+%G;YD;QYQG&]2N<<9QG.*DJ&Y+"WG*;@XAE*E<[@VQMNW'.[.,8YSTH`^,
M?^"=/[)^H_L,?L2?LZ?LDZOXULOB+J7P+\!KX-N_&^G:)/X<L?$<HUG5M5^W
MVVB7.HZO/IT>W4EA^SRZE=MNB+^;APJ_:E?F)_P1AUWXT^)O^"7/[&&O?M%:
MM\3M=^-NI_"5+CXBZO\`&:]\4ZC\4;_7O^$F\0QF;QG>^-I)?%5QJWV)+1#)
MK<CWGV9;=<^4(Z_3N@`HHHH`****`/QJ^$/_`"GB_;7_`.T<G[%?_JZOVGZ_
M96OQJ^$/_*>+]M?_`+1R?L5_^KJ_:?K]E:`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`*S]7U?2]`TK4]=UW4K'1M$T73[W5M8U?5+N"PTS2M*
MTVVEO-0U+4;ZZ>*VLK&QM(9KJ[N[B6."WMXI)IG2-&8:%87BCPQX:\;^&O$7
M@OQGX?T3Q;X/\7:%JWA?Q7X5\2Z78ZYX<\3>&M?L+C2M=\/Z_HFIP7.FZQHF
MLZ7=W6G:KI>H6UQ8ZA8W,]I=P2P321L`?EZW[<OQA/C?]I!7\"Z#I'@G2_#_
M`.PG;_LUV^MV6L6>M:B_[8?[4_QQ_9<TSXJ?$.&XFM-2F\,W&I>#_!_Q'TWP
M5!IOAG6QX0AGT>348M4UE-:MO=M$^(_C;Q;\'/VT_AU\1;_2_$7C+]GB_P#&
M/PDU?QQHVC_\(UI_CU-:_9H^&/QSTGQ(GA87NJ)X;NX-$^,VF^&M3TZ#5=0M
M9]4\/7NK6<MM::E#I]GDZ=_P31_9-\,>,OBWXP^'/PJ\"?""?XJ_#SX$>#1:
M_"+X?^!_AX?!OB+]GOXK^//C5X%^)/AZ;P[H5I%<^*4^(?B;P;KVH6FO6>J^
M'-7F^$O@2TU_1]:TFUNM,F]&NO@_'\)?@#^TC<ZEXFOO'7C_`.)V@>/_`(A_
M%/Q[?Z?9:)+XP\91_"71_A]8W\'AW2C_`&/X=T[2/`?@'P5X3TO2=,78FG>'
M;:[U"XU+6KO5-5O@#YV_X(H_\HF/^"?7_9K_`,,O_3,E?J%7Y>_\$4?^43'_
M``3Z_P"S7_AE_P"F9*_4*@`HHHH`_+W]K/Q+\:=+_P""CO\`P28\/^!-9^)5
MC\(O%/B']MN/X[:3X6N_$L/P]URTT;]F:XU'X;I\4[72W'A^]@T[QD$O/!@\
M4J\=OXC"RZ-MU'!K]0J^/_C7^UK8_!O]JK]BG]E^X\#W>OWO[96I_M!:;I_C
M&'7H=.M?`)^`GPDE^*UU->:(^E7DOB(>)H(_[$@2#4]'.E2G[=(U^@^RU]@4
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'XU?\`
M!?\`_P"44O[0/_92?V-O_6WOV<:_96OQJ_X+_P#_`"BE_:!_[*3^QM_ZV]^S
MC7[*T`%?A%_P5R^,'[2_PE_:`_89'[,_Q,T7X<>(?'FJ>-?ACKNJ3?LX1_M)
M:IH%M\5?BM^S=\*O#WCS7M#UGXS_``0\.>#/A/X<\6>.=%TGQ[XQM]?\2^-8
M=1\3^$M+\,^"]7LM0UZ>R_=VOYF/VROCU^S7^U!^UEX;^#G[<_A7_@G?XG_9
M`^%_[16M_!S2M%^*'[0>M^$_VP?`GQ:T3PY?Z@_Q/U[P=%XA\*^#=&^!VKZI
MH4=@5U;6[NYU6SN-`O;[29#<01P`'[>?L0Z_\1O$_P"RM\'M;^+OQ/\`#GQG
M^)EWHFK)XU^)WA'1QX>\.>*]>LO%&NV%Y=:7H*PQQZ+#9&U72I-*AEU"WL+B
MPFM;;6M>@BCUJ_\`JNO*O@=KGP=\1?"3P'JG[/M[X-U#X+'08+#X;W7P\%B/
M`[^&=&EFT:TC\+'3$33GT:V>PEMK.6P!LYHX1+;22PNDK^JT`>*?M*?\F[?'
MC_LCGQ+_`/4,UFOD#_@C=_RBH_X)\?\`9IOP7_\`4-TROK_]I3_DW;X\?]D<
M^)?_`*AFLU\@?\$;O^45'_!/C_LTWX+_`/J&Z90!^E5%%%`!7XE_%./0#_P<
M#_LDR71@_MU?^"9O[3GV`-)*)\#XZ?"D1>7&K"-O]$DUW&Y3E1,3\T<17]M*
M_#SXL>'[NZ_X.%OV0=>26W6UL/\`@F;^TR)8G:47#^5\;OAO9MY:B)HSF37K
M5ANE7Y(K@G#+&LH!^X=%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%?C5_P7"_Y->^`G_:0G]@;_P!:8\!5^RM?C5_P
M7"_Y->^`G_:0G]@;_P!:8\!4`?LK4<LGE12RXW>7&\FW.,[%+8S@XSC&<''I
M4E,E57CD60X1D=7.<80J0QSVP">>W6@#Y$_8%_:RM?VZ?V.O@%^UO8^!KCX:
M6GQU\$KXS@\"77B&/Q7<>&D.KZII7]GR^(H=&\/QZLV=-,_VE-%T\8F$?D93
M>_U]7R_^Q;\'?@'^S]^RS\%O@U^RYXAM?%?[/_P_\(KH?PM\167C.P^(=KJW
MAP:GJ-X+J#QIIDL]AXA0W]U>Q_;K65X\H8<[HB!]04`%%%%`!1110!\%_M3_
M`/!,']@S]M7QCI'Q$_:7_9Q\)_$;Q_HFB1>&K/QQ!K/C7P+XNG\.VUS<WECH
M.L>(_ASXG\(ZQXAT;2[N^O[K1],U^\U.RT:XU'49M+AM)-0O6G^7O^(??_@D
M+_T:%;?^'P_:3_\`GQ5^RM%`'\J7_!43_@DS_P`$_P#]C?\`9M\%?'_]FGX#
M3_"OXO\`A3]KW]AW3/#_`(TTOXN?'+6;S3K#Q=^UM\'O"GB2U73O%/Q+UW1+
MB+5O#VL:EI=P+O3)RL%W(T)BF"2K_5;7XU?\%WO^3#-+_P"SR_\`@GU_ZVM\
M#*_96@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"O+/CG_`,D3
M^,'_`&2[Q_\`^HIJU>IUY9\<_P#DB?Q@_P"R7>/_`/U%-6H`^$/^"*/_`"B8
M_P""?7_9K_PR_P#3,E?J%7Y>_P#!%'_E$Q_P3Z_[-?\`AE_Z9DK]0J`"BBB@
M#Y;^+?P5^`OCO]I']DCXO?$3Q%%IGQL^!.H?&^[_`&=]!?QCIVB2>)KSXD?#
M&3P9\4TB\*71%_XW_LCP*[Z@\6F`MX>4?VO>8MQFOJ2OS?\`VH/V<?BK\3_V
M_P#_`()>_'[PAH]A>_#3]F'7?VQ+[XOZK<ZUIEA?:);?&']G:?X=^!6T[2+J
MXCU'76U#Q2ZVETFE07+:;!_IEZ(K8>97Z04`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`'XU?\%__P#E%+^T#_V4G]C;_P!;>_9Q
MK]E:_&K_`(+_`/\`RBE_:!_[*3^QM_ZV]^SC7[*T`%?&_B/_`()V_L#>-?%7
MBOQWX[_8L_98^(?CCQSXAU#Q7XO\:?$;X#?#+X@^+O$.OZH8S>7^I^)?&?AK
M7-:GRL445O:&^%E8V\<=M8VUM;HL8^R**`."^&'PO^'OP6\!>&_A=\*/"&B>
M`?AWX.LY=.\*>#?#=HNGZ!X=TV:\N;\Z;HVGH3#I^G17-W<&TL+81VEE"RVM
MG#!:Q0PQ][130Z,6565F0X<!@2I/0,`<J3@]<4`>+?M*?\F[?'C_`+(Y\2__
M`%#-9KY`_P""-W_**C_@GQ_V:;\%_P#U#=,KZ^_:296_9U^/!4AA_P`*=^)@
MRI!&1X-UH$9'<$$'T(Q7R#_P1N_Y14?\$^/^S3?@O_ZANF4`?I51110`5_.3
M^WA:_MC'_@MO^R/??L57?[.\GQ0B_P"">7[1*ZAI/[3TWQ(LOAI-X07XV_#-
M-<EBO/A58ZCXJ;Q*^I7?AF33(&@BTL6^GW[75QYC01/_`$;5^-7Q*_Y3U_LK
M_P#:,[]J'_U?_P`#*`/O'X,O^VLWP"\1-^T+;?LMQ?M1BW\9_P#")P?!F]^+
M-Q\`FNQI\G_"O?\`A(KKQO86WQ$2W?5?*'C,Z;9O)'I_F'1!+<[17S#\'_&W
M_!4OP#XLN?&O[>NJ?\$R/!/[,/A?PWXCUKQ_XK^"/B?]I&T\;Z";+3)I=)U'
M[9\6])TSP/9Z!;Z@(7\076IWL4L.FB5[3,X45^H5?&__``4+^"/C;]I3]A[]
MJ;X!_#A=,?QY\6_@OXU\#>$UUJ_32]).MZ[I<EK8C4-1D1TL[7S6'G7#(RQK
MEB#0!]=Z;J6GZSIVGZOI-[;:EI6JV5KJ6F:C931W-G?Z??01W5G>VEQ$S13V
MUU;2QSP31LT<L4B.C%6!J[7F'P6\.7W@GX0?"CP/K,MFVN>#OAKX%\+:NEG<
MI<VXU3P]X7TO2=0%O,F/.@%W:3>5,%`DCVO@`XKTIIX4.UYHD8=5:1%(STX)
M!YH`EHI`00"""",@CD$'H01U!I:`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`***1F"@LQ"J.2S$``>I)X'XT`+7XU?\%PO^37O@)_VD)_8&_]
M:8\!5^R9=`H<NH1MNUBPVG=C;ALX.[(VX/.1BOQL_P""X7_)KWP$_P"TA/[`
MW_K3'@*@#]E:AN$:2">-?O/#(BYX^9D91SVY/6IJ:^\HXC(#E6V$C(#X.TD>
M@.,^U`'YT_\`!)#]G+XI?LC?\$WOV1_V;?C9I>FZ+\5?A%\+U\+^-M+TC6;'
MQ#IMEJX\1:[J)AL]:TR2:PU"+[+?VS>?:R/'N9DSN1A7Z,5^8/[#FM_\%9K7
M4-&\%?M\>`?V5[_0-%\,:I#JWQN^#7C_`,0OXJ\:^*X+XG2;M_AA/X-T;P]X
M;TR^LI"MS%9:M,UJUO$PC>2:7;H?'KXC?\%8-#^+'B#2_P!G']F?]D'Q[\&8
M)-.'AGQ9\3?C_P"//!GC?4(Y+*V?5&U3PUH_P^UK3;)K>_:ZAM%AU.<3V\<4
MKE&=E4`_2ZBOG'PW^TOX$U#]H4?LC:W-<67[16D_LX^#?VE_%?AS3]/O[KPG
M8>!/%OC?Q'\,HIM,\5S10VU_<)XY\(>(K&/3WCBO_P"S;>UU*:*..[11]'4`
M%%%%`!1110!^-7_!=[_DPS2_^SR_^"?7_K:WP,K]E:_&K_@N]_R89I?_`&>7
M_P`$^O\`UM;X&5^RM`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%>6?'/_`)(G\8/^R7>/_P#U%-6KU%71\[&5MI*MM8-M8=0<$X([@\BO+?CB
MP;X)?%]E(93\+O'Y#*001_PBFK<@C@_A0!\(_P#!%'_E$Q_P3Z_[-?\`AE_Z
M9DK]0J_+W_@BC_RB8_X)]?\`9K_PR_\`3,E?J%0`4444`?%_[8>B?M]WMO\`
M"[7?V"_&W[,ND:[X?\1^(%^*?@#]J7P_X^F\#_$#PIJ_AV>UT2YTOQG\,4O_
M`!CX6UWP=XCBMM1BTVST=['Q/;ZA,NHZSID6C)IVO=%^R>_[<;^&?%1_;EMO
MV4;;QB-=MO\`A"%_9/OOB]?>&6\,_P!GQ_;#XJ?XOZ?I^J)KHU3S1;+I"2:>
M=/\`+,KBXW"OJZB@#\OOA7-_P6D;XM^%5^-VG?\`!+Z/X$'Q+CQO+\*]9_:N
MG^+:^#]T_P`WA6#Q=H-OX.?Q+L^S?)J]Q'I>[S_GP(\_J#7Y_P#_``54^%?Q
M#^-__!.;]L?X1_"7PQJ'C3XE?$'X%^,?#/@KPII,EK%J6OZ_J%M&EEIME)?7
M-G:)/.X(1KBZ@B!'S2+7UQ\(K&ZT/X5?#'0=6C%GK.C_``^\%Z3J=A)+"T]I
MJ6G>&]-L[ZTD\N1T:6WN8987V,ZED.UF&"0#TBBHWFBC($DL:$C(#NJDCID!
MB#C(/-/!!`(((/((Y!'J".#0`M%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110!^-7_``7_`/\`E%+^T#_V4G]C;_UM[]G&OV5K\:O^"_\`_P`HI?V@
M?^RD_L;?^MO?LXU^RM`!1110`5^%WQ9\.^#/!W@K]I?Q_P#L6W-I\/=:T']G
M#]KN(^./#%_:7/Q7_;"^.%KX+UK5;'4=$MK;/BWXLS?`WQ/'-<:?\5M577KY
M=9U%O"?@W[9X?&JZH/W1KQ/P;^S5^SE\.?&FH?$CX>_`#X)^!/B)JPU0:IX]
M\&_"KP+X7\::D-<N5O-;&H>*=$T&QUR\&L7BK=:H+B^D_M"Y59[OSI0&H`^!
M=,TGP/X1@_X*">!O@5#H5E^SKI/[)7PL\2>&=+\!3VU_\-;'XN^-_"G[1^L_
M$VZT>]TV6[TB+QCXJ\`1_`GQSXUL[6[%]J]OXJ\+_$G6K:?4OB-+XB\1]Y_P
M1N_Y14?\$^/^S3?@O_ZANF5]-_&CP;X0\!_LO?';P[X&\*^&_!GA]/A7\8M5
M30O"FAZ9X=T==4U_0?$NN:[J2Z9H]K9V2W^M:UJ%_K&K7@@%QJ6J7UWJ%Y)-
M=W,TS_,G_!&[_E%1_P`$^/\`LTWX+_\`J&Z90!^E5%%%`!7XU?$K_E/7^RO_
M`-HSOVH?_5__``,K]E:_&KXE?\IZ_P!E?_M&=^U#_P"K_P#@90!^RM<SXU\'
M>&/B+X.\6_#[QMHUIXB\&>.O#.O>#?%WA^_\W[#KOACQ/I=UHFOZ->>3)#-]
MDU/2KZ[LKCRI8I?)G?RY$?##IJ*`/SI_9O\`^"2?_!.#]D/XHZ?\:OV:_P!D
MGX8_"'XIZ5I>L:)IWC7PN/$0U>TTKQ!:&PUFRB_M+7;^U\G4+-C!/NMF?8?D
M9#S4/[27_!)+_@FY^UI\3M8^./[2G[(_PQ^+OQ3U?2M(TS5_&WB=?$1UB^TS
MPWIT>FZ-9R_V=KUA:^7I^G016MOMMT;RT7>S-EJ_1RHYH_-BEB)($L;QD@9(
M#J5)'N,YH`^4_P!B3XW_``<^/W[-_@3QE\`?#NJ>$OA)X=DU[X3^#?#6KV:V
M%QH>F?!S7;_X9)I=O;+>7Y73;)O"YM]+>2[EFEL([>28B1F`^L*_![X-:/\`
M\%`/^"?>@7G[+G[.O[!^E_M*?!7PUX_\=^)_#/QO\7?M7^!/AGK_`(FM_B7X
MTU?QYJ\UUX!A^'6N-HT6C:EXAO=,LK:75I[JZL[&"XN&BFG:-/TW_:?^*7[3
M_P`,O`?AC7?V:_V8]'_:1\<:GJ\%IXD\$:O\9=(^$-OX;TI].EN)M4A\2:KX
M7\2V^KO#J"QZ>+**QMGD60W0E"H8R`?55%?(G[,WQS^.7CGPT#^UO\#?!O[)
MWQ+USQGJ/ASX=_#>'XZ^&_BQ=^/])TWPY::_<ZOHNI66@^$GFU&W`UO[9X?L
MM-U"[L]-T676)YEM)6$'UW0`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%?//[4FG?!75/@YK-M^T%:+K'PP37?!EUJGA.2*348?'^KV?B[1KGPK\.[C
MPPHDB\=V_CKQ-%I7AB;X?WEM>Z=XU34CX>U*RN;&_N(S]#5QWCWX=_#_`.*G
MA>_\$?$_P+X.^)'@O59+*75/"'CWPQHOC#POJ4NG7L&HZ?)?Z!XALM1TF\DL
M-0M;6_LGN+21K6]MH+J`I/#&Z@'X_>'_``%X`'Q'^$WPS^.EU\.K3]EF]\-?
MME^/(O@9J7B;0+GX._LU_$;PHW[(&N?!3X+WWB"TOK3PMI?Q$^&7PAU#]H7X
MS^$/!NG3:?IWPLL]1\9ZM\++:[\)_!;PK\1+/PC]O35O'NO?\$G/^":VN?%6
M37YOBAK/QU_X)(ZM\2)?%=I<6'BF7Q[J/Q(^#-YXPD\26-W!:W=EK[^(9M1;
M6+2ZMK>XMM1-S#-!#(C1K^Y6B?L^?`/PUX(B^&?ASX'_``@T#X;P>(;'Q=#\
M/]$^&G@S2O!$/BO3-2L=9TWQ/%X4L=%@T&/Q#I^L:7INJV.M)8#4K34M.L;Z
M"YCNK2WEC_,G_@N%_P`FO?`3_M(3^P-_ZTQX"H`_96BBB@`HHHH`^-[+]DB.
MS_X*"^)OV[_^$^>27Q%^QOX'_9(/PN_X1<)'9Q^#/C9\0OC&/'W_``FG_"0,
MUP^I-X]/AT^%_P#A%85M%TH:K_PD%R;TZ;:?9%?E[I5A\;1_P6D\>:I/9?%,
M?LXO_P`$O?A)8:5J,UMXM'P2?XVQ_M7?&NXU^RT^[=/^$$;XIQ^!)?#<^L6U
MM(?%J>$I-#EO4&CO8,?U"H`****`"BBB@#\:O^"[W_)AFE_]GE_\$^O_`%M;
MX&5^RM?C5_P7>_Y,,TO_`+/+_P""?7_K:WP,K]E:`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`J"Z6)[6Y6XD,,#03+-,)3`8HC&PDE$X93"8T)<2AE
M,>-^X8S4]-=$D1HY$5XW5D='4,CHP*LK*P*LK*2&4@@@D$8H`_!C7O#GPP\#
M_#_5O$7[+]_H_P`(/V?]3T_]G_PEXKTOP[K=KI7B?]IOX52?M8?LXZ#^T-^V
M/XX;3;C3]9L_!WA/X$:CXY\/^,OVEM7GG\5_$7PG\2=>^(/C;Q1X:\->#OAQ
MXD\2?7?PGTS2?#/PN_X*.>!O`VGZ=HGP8\`_$_QMX7^"7AWPS:6UEX`\,>$E
M_8Y^`6L^-/#GP[MM.C31;+PYH_QQUGXM6>H:/H>-+\->,H_%7AB*VTV?1;C2
M;#[!^&W[-'[.'P:O]5U7X0?L_?!+X4ZIKNF'1=<U+X;?"GP)X&O]9T=IH[EM
M)U6\\,:#I=QJ.F-<113FPNY)K4S1QRF+>BL(?B1X2\*^!/V</B1X/\#^&?#_
M`(-\(^'OA#X[TW0/"WA31=.\.^'-#TZ'PIJYAL-'T32+:STS3+*(LQCM;*U@
M@3<=L8R:`/C#_@BC_P`HF/\`@GU_V:_\,O\`TS)7ZA5^7O\`P11_Y1,?\$^O
M^S7_`(9?^F9*_4*@`HHHH`****`"OS#^$G_!&'_@ES\"/BOX3^.7PA_8P^$W
M@/XM>!=>;Q/X2\<Z*OB?^V="U]X[F)M3L_M?B&ZM/M!CN[E#YMM+'B9ODZ8_
M3RB@#\_?VQ_^":?_``3Z_;0U:V^)_P"V-^SO\._BKKO@;P)?>&+#QSXRNM;L
M;OPGX'L[G5O$-W#!?:=K6F6UE9Z?>:GJVL&[GC=K:6:69I?+0*OTA^S-X?\`
M@YX3_9^^#WAC]GK7++Q+\#?#_@#P[H_PIUW3?%$OC73]3\#:?81VWA^XL?%<
M]W?RZ[9_8(XDMM0:\N/-A1-LA51CK_B[X8U+QO\`"?XG^#-&\@:OXN^'GC7P
MQI1NI/)MAJ6O^&]3TJQ-Q-M;RH/M5W%YTFUMD>YMIQBOGG_@GG\"O&O[,7[#
M_P"RW^SY\1VTI_'?P?\`@SX-\">*VT*\.HZ.VMZ%IR6MZ=-OC%`;JT,JGRIC
M#&77G8*`/LFBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_&K_@O_
M`/\`**7]H'_LI/[&W_K;W[.-?LK7XU?\%_\`_E%+^T#_`-E)_8V_];>_9QK]
ME:`"BBB@`HHHH`\4_:4_Y-V^/'_9'/B7_P"H9K-?('_!&[_E%1_P3X_[--^"
M_P#ZANF5]?\`[2G_`";M\>/^R.?$O_U#-9KY`_X(W?\`**C_`()\?]FF_!?_
M`-0W3*`/TJHHHH`*_&KXE?\`*>O]E?\`[1G?M0_^K_\`@97[*U^*GQCU_0_#
MO_!>#]E:_P#$&M:3H5BW_!-3]IZW6]UG4;/3+1KB3X^_!!XX%N+V:"$S.D<C
MI$'WLL;L%(1B`#]JZ*X'_A:WPN_Z*3X!_P#"Q\/?_+&G)\4_AC(ZQQ_$;P&\
MCLJ(B>+_``^SN[$*JJJZ@2S,Q`50"22`!F@#O****`"BBB@#\V?VQ?V>?BG\
M6OVQ_P#@EI\6_!&B6VI>!_V:/CY\=_'/Q=U*;4[.SFT'PYXV_99^*7PS\/7=
MK97$B7.JR7?B_P`3:1826]BDLMO%.]W*JP1.P_2:OSN_:W_:9^)OP9_:Y_X)
MF?!CP7)H*>"_VK/CG\;_`(?_`!735-)^WZI+X?\``/[,OQ,^*V@+X>O_`+3#
M_8UZOBSPKI+7ESY-U]ITX7%GY<?G>:GZ(T`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`5^-7_!<+_DU[X"?]I"?V!O_6F/`5?LK7XU?\%PO^37
MO@)_VD)_8&_]:8\!4`?LK1110`4444`?F%^TM_P42\:_LO\`[6>B?`[7_P!B
M']L/XQ_!7Q/\#?"OC_1OVAOV9/@)\4?CWH]A\5=;^)7C+PAK'PH\8:7X)\(W
M.C>$H_#WA/P]H?CBX\0:CXM-W):^)[2W?P]!:QQZE<?0O[7O[8?AC]C?P?X?
M\;>+/@K^U'\9M*U[4]2T^>U_9?\`@!XW^/NL>%K?2M+DU:[UWQKIO@FVN)O"
MWAL6T3QIKFJ&&Q>Z4V_F!@<?7%87BG5-*T/PQXCUK78?M.B:/H6KZIK-O]G2
M[\_2M/T^XN]0A^R2D177FVD,R?9Y"(YMWEN=K&@#SG]GKX[_``]_:?\`@=\*
MOVAOA/>:AJ'PU^,O@C0?B#X(O=6TZ72-3N?#GB.RCO\`39+_`$R=GEL+LP2J
M)[5W=HI`R[F`R?8Z^>?V3/BY\(/CW^S1\#OC1^S_`*&?#/P3^)OPW\,^,?A?
MX?/AG3_!IT?P9K5A'=:)8'PKI3/IN@&WM'1/[+LG:VM,>7$2H%?0U`!1110!
M\%?\%*OV2_''[:G[*'B3X)_#/QMX5^'_`,1K?XA_!3XL^!/$/CO1-7\0>"3X
MM^!OQ>\%_%[0='\6Z=X?U'2M=/AS7]1\&P:/J]SHUVNIVEE>S7%E')/&BU\O
M_P!D?\'"/_10?^"-7_AG?VV__GYU^RM%`'XU?V1_P<(_]%!_X(U?^&=_;;_^
M?G7Z@_!*+XVP_"OP;%^T=>_"O4OC<FFS#XA7WP2TOQ;HOPKN-7_M"\-N_@W2
M_'>L:_XML]-&E'3TFCUO6+ZZ.H+>2)*MN\,:>J44`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!7EGQS_P"2)_&#_LEWC_\`]135J]3KRSXY_P#)$_C!
M_P!DN\?_`/J*:M0!\(?\$4?^43'_``3Z_P"S7_AE_P"F9*_4*OR]_P""*/\`
MRB8_X)]?]FO_``R_],R5^H5`!1110`4444`%%%%`!7P7^U98_P#!3^Z\;^'W
M_8>\3_L%Z'\.%\*PKXIMOVK/`G[0GBGQO+XW_M?5C<3^'[WX1?$;P=H-OX5.
M@G0XX;74=/N=775X]6E>\:SELX8?O2B@#Y;N[;]M8_LLI;6&M?LMK^VS_P`(
MS8K)K=WX7^++_LL_\)D-;MVU*9/"\/B]/BT/#+>&_M45C;'Q>=536S;SSW<E
M@LENWG'[*%E_P4SM?%7B=OVY/$W["FN>"&\/Q+X,@_90\#?'_P`*^*H?%7]H
MVYGE\3W7Q?\`B'XRTBY\/G2/M:16^E6=IJ(U$V\CW)MEDB;[KHH`_+[XF:;_
M`,%I)/B]XGE^#GC3_@E]9_`1O%;-X,L/B9\,?VKM2^+T/@;[1%M@\3ZOX6^+
M>D^#+GQ7]D\\-=:5HEII'V@Q,+,1AU;ZK\*?M2>`_%_[5/Q<_9'T[3M?B^(?
MP;^&'PU^*WB74[FVMU\.W7A_XH7_`(BT[0K;3+E;AKF74+>;PU?-?Q2VT4<:
M20&.20LP7Z6KXKT?X$?"+X5_MF?&C]K75?BO:Z=X\^-WP?\`A1\+-7\"^(=9
M\,Z5I&D:%\+=4\57^CZYI8N9;?6);K5Y_$=]#>&Y>2S`LXQ:A7$N0#[4HK&F
M\1^'K;1AXCN-=T:#P\T,%PNO3:I8Q:,UO=21PVLXU1YUL3#<RS0Q02B?9-)+
M&D;,SJ"S1/$_AKQ+'/+X<\0Z'X@BMG6.YDT35K#58[=W!9$G>PN)UB=U!95D
M*E@"0"*`-RBBB@`HHHH`****`"BBB@`HHHH`_&K_`(+_`/\`RBE_:!_[*3^Q
MM_ZV]^SC7[*U^-7_``7_`/\`E%+^T#_V4G]C;_UM[]G&OV5H`****`"BBN(^
M)GQ$\*?"'X<^/?BMX[OY=+\$_#3P;XE\>^+M2@L[K49[#PUX1T:\U[7+R&PL
M8I[V]EMM-L+F6.TM(9;BX=%BAC:1U!`.+_:4_P"3=OCQ_P!D<^)?_J&:S7R!
M_P`$;O\`E%1_P3X_[--^"_\`ZANF5Z)XP^-MY\1O@C^U7X#\:>`M3^%7Q8\`
M_`S7_$WB3X?ZEK>D>*Q#X%^(_A/XA1?#KQ99^*?#33:!=KKMQX(\9Z#J^BK/
M'JWAWQ5X.\0VKP:CX5N/!WC/QCXK_P`$=_&W@VS_`."5_P#P3^M;OQ;X9M;J
MW_91^#4-Q;7.O:5!<02IX.TU7BFAENUDBD1@0R.JLI&"`:`/U0HKDO\`A/\`
MP)_T.OA+_P`*/1__`),H_P"$_P#`G_0Z^$O_``H]'_\`DR@#K:^4?VF/V%_V
M//VRG\)R?M4?LX?"7X\S>!5U1/!\_P`2?".G>(KCP['K9LVU6'3+BZ3S[>&^
M;3[-YX1(8B\"NJ*Y=F^@?^$_\"?]#KX2_P#"CT?_`.3*/^$_\"?]#KX2_P#"
MCT?_`.3*`/S5_P"'&W_!(+_I'7^RQ_X;'2/\*_+K_@M5_P`$EO\`@FG\`?\`
M@EA^VG\9?@K^Q/\`L_?#'XJ_#SX3#Q!X'\?^#?`FGZ-XH\*ZY#XJ\-P0ZKHF
MJVNVXL+Z**>9([B%ED02-M()S7]-_P#PG_@3_H=?"7_A1Z/_`/)E?GU_P56^
M$5[^V;_P3Q_:K_9>^$/COX6V_P`2OC-\-6\)^$)O&'C>QT7PS'JAU_1-3#:Q
MJEE%J]U96OV;3YQYT.FWC^88U\K#%E`/TJM#_HMM_P!>\/\`Z+6K%<;!X[\#
M1P0QMXU\([HXHT;'B31R,J@4X/VSID<5+_PG_@3_`*'7PE_X4>C_`/R90!UM
M%<E_PG_@3_H=?"7_`(4>C_\`R91_PG_@3_H=?"7_`(4>C_\`R90!X1\;OB7^
MSKX-^-_[(_@SXNZ3I]]\7OBI\1?B%X?_`&8[^[\+/K=WH_CK0?A'XM\5>.+G
M3=<6"5?",]S\,=*\36<^HO+;C4+::72`[F[$;?4E?`G[17P,\$_'?]HO]A?X
M\)\9?!WAY/V-_BO\4_B7-X>?4-)O7\;K\2/@7XY^#:Z5'>C581I+:6_C$:V;
MAH;H7"V)M!&AF\U/L[_A/_`G_0Z^$O\`PH]'_P#DR@#K:*Y+_A/_``)_T.OA
M+_PH]'_^3*/^$_\``G_0Z^$O_"CT?_Y,H`ZVBN2_X3_P)_T.OA+_`,*/1_\`
MY,H_X3_P)_T.OA+_`,*/1_\`Y,H`ZVBN2_X3_P`"?]#KX2_\*/1__DRC_A/_
M``)_T.OA+_PH]'_^3*`.MHKDO^$_\"?]#KX2_P#"CT?_`.3*/^$_\"?]#KX2
M_P#"CT?_`.3*`.MHKDO^$_\``G_0Z^$O_"CT?_Y,H_X3_P`"?]#KX2_\*/1_
M_DR@#K:*Y+_A/_`G_0Z^$O\`PH]'_P#DRC_A/_`G_0Z^$O\`PH]'_P#DR@#K
M:*Y+_A/_``)_T.OA+_PH]'_^3*/^$_\``G_0Z^$O_"CT?_Y,H`ZVBLK2]=T3
M6UE?1=9TK5T@95G;2]0M+]86<$JLK6DTHC9@"5#D$@$C-:M`!7XU?\%PO^37
MO@)_VD)_8&_]:8\!5^C'QB^-U[\.O$'@SX?^"?A_JOQ9^+'CO1_&7C/0_A]I
M.MZ+X4D?X<_#&]\%V'Q)\8S>)_%,EIX;A?0M3^(WP^\-:+X>DODU;Q)XJ\<^
M'H533/"-EXV\:^#?RM_X*_\`Q)\&_%/]A/\`9+^+W@K5UU+X??$?]M#_`()O
M_$CPCKUU;7>DK?\`@[QA\>OAKXFT#5KBSU6&SOM-%WHNHVEY+:ZE;VMW9^8T
M5Y!!-')&H!^Y]%<E_P`)_P"!/^AU\)?^%'H__P`F4?\`"?\`@3_H=?"7_A1Z
M/_\`)E`'6T5R7_"?^!/^AU\)?^%'H_\`\F4?\)_X$_Z'7PE_X4>C_P#R90!U
MM<[XO\/IXM\)^*/"LMT]E'XF\.ZWX?DO4B$[VB:SIMSIKW20L\:S/;K<F58F
MDC$A0(74'<*G_"?^!/\`H=?"7_A1Z/\`_)E<IX\\4>%]?\#>,]"T7QWX0MM9
MUKPIXBTG2;A_%6EVJ6^IZEH]Y9V$SW,-T\UNL5U-$[3Q(TD(4R(K,H!`///V
M,/V;+#]CK]E#]GW]EG2_%EWX[T[X!_"SPG\,+/QE?Z3#H-[XEM_"VG1:='K%
MSHUO?:G!IDUXL?FO9Q:A>)"3L6XD`W5]-U\&?\$]O#&N?L[?L0?LL_`SXZ?%
M+P1XG^,7PI^"O@?P1\2?$-C\1(O%EIK'B_0M)AM-9U"W\2ZT]GJVMQ7%TCNF
MHZA:V]U<@^9+$C$BOL;_`(3_`,"?]#KX2_\`"CT?_P"3*`.MHKDO^$_\"?\`
M0Z^$O_"CT?\`^3*/^$_\"?\`0Z^$O_"CT?\`^3*`.MHKDO\`A/\`P)_T.OA+
M_P`*/1__`),H_P"$_P#`G_0Z^$O_``H]'_\`DR@#K:*Y+_A/_`G_`$.OA+_P
MH]'_`/DRC_A/_`G_`$.OA+_PH]'_`/DR@#K:*Y+_`(3_`,"?]#KX2_\`"CT?
M_P"3*/\`A/\`P)_T.OA+_P`*/1__`),H`ZVBN2_X3_P)_P!#KX2_\*/1_P#Y
M,H_X3_P)_P!#KX2_\*/1_P#Y,H`ZVBN2_P"$_P#`G_0Z^$O_``H]'_\`DRC_
M`(3_`,"?]#KX2_\`"CT?_P"3*`.MHKDO^$_\"?\`0Z^$O_"CT?\`^3*/^$_\
M"?\`0Z^$O_"CT?\`^3*`.MHKDO\`A/\`P)_T.OA+_P`*/1__`),H_P"$_P#`
MG_0Z^$O_``H]'_\`DR@#K:*Y+_A/_`G_`$.OA+_PH]'_`/DRC_A/_`G_`$.O
MA+_PH]'_`/DR@#K:*Y+_`(3_`,"?]#KX2_\`"CT?_P"3*Z.ROK+4;:*]T^[M
M;^SG!:&[LKB*ZMIE!*EHIX'>*0!@02C$`@CJ*`+5>6?'/_DB?Q@_[)=X_P#_
M`%%-6JU\7/BCX?\`@WX#U/Q[XD@U&^MK;4_"GAK1]%T>"*;6/%'C;X@^+M"^
M'OP[\&:2;N>STNUU3QKX^\4^&O">G:EKVI:/X9TF\UF'4_%&NZ%X>M-3UBQ\
M,N/C`WQ7^`?[2MCK/AB?P-\1?A7H?C[X<_%;P-)JUOXCM_"GC*;X1:)\1].M
M=,\56-K9:;XHTC6OA_\`$+P1XMTO5K*VM94LO$4.F:UIVC>(].UG1-.`/GG_
M`((H_P#*)C_@GU_V:_\`#+_TS)7ZA5^2_P#P1;\:^#K+_@E!^P!:7GBWPS:7
M5O\`LQ_#2*>VN=>TJ"X@E71T#1S0RW221R*>&1U5@>HK]._^$_\``G_0Z^$O
M_"CT?_Y,H`ZVBN2_X3_P)_T.OA+_`,*/1_\`Y,H_X3_P)_T.OA+_`,*/1_\`
MY,H`ZVBN2_X3_P`"?]#KX2_\*/1__DRC_A/_``)_T.OA+_PH]'_^3*`.MHKD
MO^$_\"?]#KX2_P#"CT?_`.3*/^$_\"?]#KX2_P#"CT?_`.3*`.MHKDO^$_\`
M`G_0Z^$O_"CT?_Y,H_X3_P`"?]#KX2_\*/1__DR@#K:*Y+_A/_`G_0Z^$O\`
MPH]'_P#DRC_A/_`G_0Z^$O\`PH]'_P#DR@#K:^(_VB_^";7[!7[7/CNR^)_[
M37[)OP3^-_Q"T[PUI_@VQ\8?$/P7I^OZ[;>%M*U#5M5T[0HKZY'FC3K+4==U
MB\MX"2(YM1N6'^LP/J__`(3_`,"?]#KX2_\`"CT?_P"3*/\`A/\`P)_T.OA+
M_P`*/1__`),H`\A\1_LC?LR^+_V<K?\`9#\3_`_X=ZY^S':>'O"WA2V^!VH^
M'[:X^'4'AOP1J^D:_P"$=%C\/M_HJZ?X>UK0-%U+2X`-MK=Z9:2I\T2UX-^R
M'^RW_P`$]?V3?BQ\=OAW^QMX#^%OPC^)=QIWP\U;XX_"[X::G=62:)9W>FWL
MG@#6-7\!IJ,VD^')-;TU[VXMM1LM-LI]:C#S7,MR4##[7_X3_P`"?]#KX2_\
M*/1__DROS^^"_P`&I/A[_P`%!?VU/VI]9^(OPPG^'_[0_@']G'POX+T^Q\7V
M,OB*RO\`X2^%M5T7Q')KEG)Y5I:V]S=7L3Z8]M>W;30AVF2!@%(!^EU%<E_P
MG_@3_H=?"7_A1Z/_`/)E'_"?^!/^AU\)?^%'H_\`\F4`=;17)?\`"?\`@3_H
M=?"7_A1Z/_\`)E'_``G_`($_Z'7PE_X4>C__`"90!UM%<E_PG_@3_H=?"7_A
M1Z/_`/)E'_"?^!/^AU\)?^%'H_\`\F4`=;17)?\`"?\`@3_H=?"7_A1Z/_\`
M)E'_``G_`($_Z'7PE_X4>C__`"90!UM%<E_PG_@3_H=?"7_A1Z/_`/)E'_"?
M^!/^AU\)?^%'H_\`\F4`?DO_`,%__P#E%+^T#_V4G]C;_P!;>_9QK]E:_$;_
M`(+Z>,O"&H?\$K/C]:6'BKPW>W4GQ'_8Z:.VM-<TNYN'6']MK]G2>9DAANGD
M98H8Y)I"JD)%&\C816(_:32]>T/6Q*VBZSI6KK`5$[:7J-G?B$N"4$IM)I1&
M7`)4/C<`<9P:`-6BBB@`KQW]H?X31_'KX!_&OX'RZP_AV+XP_"CX@_#&37X[
M5;Z31$\=>%-5\,MJJ632PK=MIXU/[4+9IHA,8O+,B;MP]BHH`^2/A-\(/'.K
M^./C5\6_CQHG@W2M?^,WP\^&/P;U/X;>$]:O_&'A:W\$?"6]^+MY#K%WXCU3
M1?#=W>ZAX[OOC-XHEN]$71HK;P_H-CH.G-J.K:FVJ7K?!?A;_@CQ_P`$5_$O
MB;Q;\/?!7[.OPGU+Q1\.);.R\7^#?#7Q.^)!O?!KWT7G6=G?Z)IOQ"5=(CV9
MC2V2WBBM74VC)#+&85_:NOR!_9)\/:_%\0/V3?!;Z)J]GXV_9I^$/[1/@_\`
M:8MKO3;VPD\*>,OB%XE^'NH^$+/7-9NH8-/\57'C2YT7Q+XOT#4-#U#7[;7=
M&G7QO975QHFN6&L7X!J_\.+O^"5'_1HWAK_POOB]_P#/`H_X<7?\$J/^C1O#
M7_A??%[_`.>!7ZTT4`?DM_PXN_X)4?\`1HWAK_POOB]_\\"O+M8_X)-_\$2O
M#_Q'T'X0:Y\#_A1I7Q0\46OV[P]X#O\`XN?$ZV\3:O:[;ADEL]+D^(ZW$GG+
M:7)MTVB2Y\EQ;I(17[=5^57[6OQC_9W7XMW_`.SMXIU?1OACJ?BS4/@UXP^,
M?CM?#&M77C_QF^F^*-//PD\#?"ZPT'1=0UGQ7XJFU'3H%UKQL8;O0?AMX8+6
M,$6KZQJU^OA$`R_^'%W_``2H_P"C1O#7_A??%[_YX%'_``XN_P""5'_1HWAK
M_P`+[XO?_/`K]::*`/R6_P"'%W_!*C_HT;PU_P"%]\7O_G@4C?\`!##_`()3
M*I9OV2/#*JH+,S>/_BZ%50,DDGX@X``Y)/`')K]:J^1OVR/"/QW^(?PVLOAW
M\&O"_@SQ9X<\=:E?>&/CEH_B;XGZQ\(]:U7X0ZKH.J6OB#PYX,\:Z/\`#[XB
MW6AZIXNEEMO#.L:S9:7IGB+1/#&IZQJG@SQ#X>\86^B:YIH!\4>#?^",?_!'
MCXB^&M,\9>`OV;?A[XR\):TMT^C^)?#/Q2^*6M:%JB65[<Z;=R:?JFG_`!&G
ML[R."_L[JTDDMYI$6>WECW;D-=/_`,.+O^"5'_1HWAK_`,+[XO?_`#P*]\_X
M)K6/C#2_V._ASIGCCP+I?PWUS3_$_P`9K8>#]&U:XUG3M)TT?&SXAR:9%:75
MSX8\(2):FRDB-G`NA6L*V0MI("8945/NV@#\EO\`AQ=_P2H_Z-&\-?\`A??%
M[_YX%'_#B[_@E1_T:-X:_P#"^^+W_P`\"OUIHH`_%"#_`()&_P#!%>Z^)M[\
M&+7X!_#*Y^*^FZ"GBC4?A_;_`!4^*DWBG3_#\AM`FJWVE1_$1KBTM7&H6$B-
M<+&S0WUG.JF&Y@D?T;_AQ=_P2H_Z-&\-?^%]\7O_`)X%5/\`@G_/\;O!?BP?
M#7QEXJ\1^/?$&MK\8OB-^UAH?B/P/H/A.W^`_P`=?$7Q`M=<\.:?X<U[2M#T
MVZ\6VGQ9T_7O$NNHMSXF\>Z%)H>@:#XD^$[>!?@QJG@GP;I_ZZ4`?DM_PXN_
MX)4?]&C>&O\`POOB]_\`/`H_X<7?\$J/^C1O#7_A??%[_P">!7ZTT4`?CWXD
M_P""*?\`P2'\':!J_BKQ7^S!X'\.^&]`L+C5-:US6?B5\5]/TO2]/M(S)<7E
M[>7/Q#CA@@B0$L[N,G"KEF4'D/A=_P`$D?\`@BI\;-`G\4_"3X#?##XB>'K6
M_ETJZU;PI\5?BGJUI:ZE!''++97+VWQ$9K>Y6*:*413*C-%(DB!D8,?T2_;2
MMK:[_9>^,,=UX7U7Q<L?AZSN[?3=%NKBSU#3M0L-?TB^TOQ@L]M9:DWV7X?Z
ME;VGCS4H)M,U.QNM-\-W=KJ.F:AI\US9S^-_L(:\GC"[_:&\93>*;/XMZIK_
M`,1?"POOV@O#VC3^%_!/Q8@TOX<>&M/TZT\*>$_,N;'08_AW!"_A'6%M-1UB
M;4-7@N-0OM3>6=+&P`/&_P#AQ=_P2H_Z-&\-?^%]\7O_`)X%'_#B[_@E1_T:
M-X:_\+[XO?\`SP*_6FB@#\BM0_X(??\`!)C2-/OM6U;]E3P=IFEZ99W.H:EJ
M6H?$?XKV6GZ?I]E"]S>7U]>7/Q$BM[2SM+>*2XN;FXDCA@AC>65T1&8>7WW_
M``2J_P""'>F_#.U^,U[\'/@[!\)[YXX[#XBGXR_$B3P?J$DNIRZ-$FGZ[%\2
MGL+YI-4@GLD%I-,6F@G`RL,C+^V^J6>FZAIFHV&LVEG?Z/?6-W9ZK8:C;0WF
MGWNFW-O)#?6E_:7"2V]U9W-J\L-U;3QR0SP.\4J.C,I_$C]GSQ%X0T/X&?L&
M_&:<);_`3X5^._VK=/\`&FN6>AZA<:#X.;Q9K7Q'\._#^;4/#UCI\M_9:;=7
MMU%HNEZE'H_]FZ?-J^G6+7-J=:L([L`]4M/^"'/_``2=O[6VOK']D_PE>V5[
M;PW=G>6GQ$^+-S:W=K<QK-;W-M<0_$-X9[>>%TEAFB=XY8W5T9E8$V/^'%W_
M``2H_P"C1O#7_A??%[_YX%?8W[%?A+Q5X&_9?^$OACQIH^H>'_$%AI&L3S:)
MJR&#4M*T[5?%.O:QH%C>V3L9M+N+?P_?Z7')HMTEO>Z(1_9-]9V-Y93V<'U'
M0!^2W_#B[_@E1_T:-X:_\+[XO?\`SP*X:+_@CY_P1AF\8^(/AY#\`?A9+X[\
M)Z!;>*O%/@^+XO\`Q(D\2>&O#=[M^QZ[K^CK\2S?:-I=VK+);7NHPVT$\3+-
M$[1,'/[15^;WBB_^$ND?\%`_B7;>)-+T1SK7[!-WK'Q)M(?"L^J7GBGPSI/Q
M*O[2_CUR#3-*NKKQ7+#X7C.GV^CE=2U.?3/*T^RLI(GB@8`Z[]A/X%_L$_!S
MPUX\F_80TOP#8^&M>\06EMX]F\!^-]?\:6LOB#1K5X[.&_EU[Q'X@EL9X+2Z
M?R5@:VBN(W,B^=MW+]YU^:/[&7Q>^#?Q]^+OCCXG>!O$6E6GB!?A%X&\)Z#\
M)?"NF:D=/^'?P:T?Q#X@D\%_\+#\0VNGGP=/\5=4O9M0DO?!^@:Q<Q^`-"2T
M\.02^(+>"3Q/J7Z74`?*_P`;OAO\3Y?BO\*_C]\';#PEXG\;?#OX>?&3X.S>
M"?'.NZCX3\/:AX7^.?B3X(>*-3\6IXCTK1?$=['J_@K7/@1X6EBT`Z0;?Q)H
M6L^([-=4TC5(=*NCYYXG_8[_`&9S^PI\._V4/VJ=-\+?%#X"?!#X0_"/PCXC
MU'Q_)+X<T:]3X&^&O#VE:+XUOKBPU2RGT&]BO/#EMK4#6>JH]G=NL,,\N%W_
M`'77R%^VAI>I77PZ^'NO06%Y?^'?A[^T%\#?B5\1/L5M-J#:?\-_!/CS3=:\
M8ZU=:3:)/?:OIVB:;`=5U&RL;*_N5LK2:]%H\-I-)$`?&7A/_@BU_P`$@?'?
MAO1?&/@S]F7P+XH\+>(K"#5-#\0:'\2_BMJ.E:I87`S%<V=Y;?$.2&:,D,C`
M-NBE22&54EC=%Z'_`(<7?\$J/^C1O#7_`(7WQ>_^>!7U1^QO97LGAWXV>,XK
M.[MO!?Q3_:,^(WQ+^%MU<VT^GQ:[\//$.G>%;?3?$^FZ3=I;WVG:/XDUK3=>
MUK2I+RQL3KME>P^*K*.[TK7]/U2_^P:`/R6_X<7?\$J/^C1O#7_A??%[_P">
M!37_`."&/_!*6-&DD_9)\,(B*SN[^/\`XN*B(H+,S,WQ!`55`)9B0``23BOU
MKJCJ;62:;J#:E&LVG+8W;:A$UN]TLMD+>0W4;6L<<LERKP"13!'%(\P/EK&[
M,%(!^*OPR_X),?\`!$SXSVVO7GPG^!OPJ^(=MX7U9M"\0S>$OBU\3]:31]5$
M?FK:7QL_B-(86EC#O;RL/(NA%-]FEE\B;9Z?_P`.+O\`@E1_T:-X:_\`"^^+
MW_SP*Z']C3XQ?`/X^?&2+QS\,M;TC09O"WP"_P"%=_"CX,>$/#^KV%OX*^`.
MF>*?"DNEZE\5+V/2(O#>A^-[S4;?0XO`_P`+!>V&I?#CPK)XBT\VFK:K>^+C
MX>_4B@#\EO\`AQ=_P2H_Z-&\-?\`A??%[_YX%'_#B[_@E1_T:-X:_P#"^^+W
M_P`\"OUIK@OBG/\`$FV^&_CF?X.:?X4U7XK1>%]9?X>:;XZU/4=&\&WOB\6,
MW]A0>)]5TG3=8U.PT5]0\D:A<V.EW]S%;[S%:RMA2`?E5I7_``1E_P"".VN^
M)O%?@O1?V;_AYJWBWP(N@MXU\-:=\4_BC>:WX3'BBRN-2\.#Q#IL'Q&DNM(;
M7-.M9[_2DOHH'O;*,W5NKP%9#U/_``XN_P""5'_1HWAK_P`+[XO?_/`H_P""
M?OP\^+WPU_:/_:ZTCXG?"W1/!=SK?@_X`^+=:\8:7\4M1^)US\1_B-XJ\1_M
M`^*_'OBF_P!3N/A1\,=-@O-7U[Q)?7SZ%H=E'H/@?2WT+P=X:TK2_"NGZ%IN
MF_K30!^2W_#B[_@E1_T:-X:_\+[XO?\`SP*/^'%W_!*C_HT;PU_X7WQ>_P#G
M@5^M-%`'XH>/_P#@D;_P17^%=QX3L_B-\`_AEX+O/'>OP>%_!EGX@^*GQ4T^
M[\3^(+EX8H=*T6VF^(@GO[HRW-K$RP1NL4EU:QRLCW,"R>C?\.+O^"5'_1HW
MAK_POOB]_P#/`JI\4Y_C;X%_;D\<_$'1_%7B2;Q/XHTWX`?#O]GOX,+X'T'4
M/!_Q=^$EOJ;WGQW?4_'4FAZC?^&Y_ASK'B+Q7XWNIM*\3>`=9TF:S\.W?Q(?
MQWX)U7X6:-H/ZZ4`?DM_PXN_X)4?]&C>&O\`POOB]_\`/`H_X<7?\$J/^C1O
M#7_A??%[_P">!7ZTT4`?DM_PXN_X)4?]&C>&O_"^^+W_`,\"O&O!W_!+7_@A
MG\0?'7B#X9>!_@_\'O%7Q`\*_;/^$A\(:'\8?B9J&NZ7_9URMGJ'VBQ@^([2
MG[#=.MO>&(2?9I6"S;#7[G5^+7[(NJV=_P#M%_#SPH&N=3L/AW!^TLOAKX,)
M87]GXC_8[77?&,+FW^)OB-[:.Z\=O\0-/,NE^%FUW["V@0W8MS_PEE^8O$=L
M`=Y_PXN_X)4?]&C>&O\`POOB]_\`/`H_X<7?\$J/^C1O#7_A??%[_P">!7ZT
MT4`?DM_PXN_X)4?]&C>&O_"^^+W_`,\"N%T;_@C[_P`$8/$6K>-M!T#X!_"O
M6M9^&LEM#\0]-TOXP?$B_O/`\]W'?S6\'BR&V^)<C>'[B2+2]2D\C5/LLJ)8
MW32(HA<C]HZ_&3XK^&[;QA\0_P#@JQ\,_A#H4%YX^UCX0_LS:AJ'AKPMI<>F
MZCK^O367Q%USQ'(3#!9P:[X@U'1M1L)+^..>\U75#J-C9.MS=7MO;R@$?P^_
MX([_`/!&GXL>&H/&/PT_9W^''CKPM<W=[8PZ]X8^*7Q3U?3'O=-N&M;ZT-S:
M?$61$N;6="LL+[9`K1R;3%+$[]M_PXN_X)4?]&C>&O\`POOB]_\`/`KZ+_9?
MOK'QO\9/VFOC'X(@N)_@[\0S\%]+\">(?[+OM!TOQ'KG@/PCK>B>.I])TG5+
M73=0DCT:ZN=%\-ZAK/\`9J6,^J:1>>'H;VXU#POJMEIGV]0!^2W_``XN_P""
M5'_1HWAK_P`+[XO?_/`JK??\$//^"3>F65YJ6I?LI>$-/T[3[6XOK^_OOB-\
M6+2RL;*TB>>ZO+RZG^(<<%M:VT$<DUQ<32)%#$CR2.J*2/USJM>V5GJ5G=Z=
MJ-I;7^GW]M/97UC>V\5U9WMG=1/!=6EW:SI)!<VUS!(\,\$R/%-$[QR(R,00
M#\+];_X)B_\`!"7PY\.M-^+FM?"SX)V'PPUK5KS0M&\>O\:?B/+X6UC6-/U/
M4M&O]-TG6(/B5+9ZE=V>J:-JUE<Q64DYAGTV]63:+:4K^P'P,^$_PG^"'PI\
M&?#/X&Z%IOAOX4^'-*4>"M)T?5;_`%S2X=(U&635(IM/U?4]1U:\U"TO&O'N
MX+J34;I98YU>*4Q%*_*7X,_M#_!#X,_L8_!_QO%IG@BYU>;]I?\`:L\)?`G7
M/$^D76B^`_AYK'B;XV?'_4$\3:MK<6D^;X.\*0_">_O;F*'2H;?4O%^CZE8>
M$?#:O-XBMY8/T>_9`LOA[8?LY_#:W^%?BS4O'7@9K?Q)=Z1XMU+0=4\+_P!N
MW6H>,O$5_K]YI/AS5[*PO=#\*_\`"17.K0^#-*$4]E9>$HM$M]+U+5]+2SU6
M]`.B_:.^%&I?&?X57?@W0]4L](\0Z9XY^#_Q0\,W.IQ32Z1=>*O@=\8/`GQK
M\+Z+KGV8_;+?0?$7B#X?:=X?UV^L4FU#3M(U.]O["VNKRV@MY>2^`OPD\4:+
M;?'[Q7\6]+\/67B;]IGXHI\2O%_P_P!"U:?Q3X;\(6=I\$/A%\!;3PC!XGN]
M)\/S^*5N_#'P?TW6]7U1]`T:)M5\0:E86EB+*SMYY_J"N7\;V&HZIX+\7Z9I
M"-)JVH^%]?L-,1)DMG?4;S2KNWLD2XEDBB@9KF2(+-)+%'$2'>1%4L`#\?/`
M7_!'C_@BOX_;Q-IOPS_9T^$WB,>`]>G\*^*-+\&?$SXCSV_A/7+=?-DT2[T[
M2/B$MOI+Q`LL-M'!#;#RIH;<9MIDB]"_X<7?\$J/^C1O#7_A??%[_P">!6E^
MQ7IM]J7Q!^!]UI&C:K:6OP/_`&&/#_[//QRFN]&U#08O#_Q[TOQ#\.+Z7P#J
MAU.UL!XA\3Z%'H/CG5M0?2?[7AT*RU^PU:]N[.T^(7AVY\0?JO0!^2W_``XN
M_P""5'_1HWAK_P`+[XO?_/`H_P"'%W_!*C_HT;PU_P"%]\7O_G@5^M-%`'XK
M?$O_`()"?\$7O@UX8D\:?%7]G[X:_#_PI'?6FF-KWBGXI?%32=.;4;]G%G81
M37/Q$3S[RX$4TD=M"))C#!<3[!#!-(G7Z1_P1%_X))^(-*TS7=#_`&6/!NL:
M+K5A9ZKI&K:9\1_BQ>Z=J>F:A;QW=CJ%A>6_Q#DM[NSO+66*XMKF"1XIH9$D
MC=D8$_9'[7WQH^&_P$\%^`OB'XYT/P]JWB:W^)MMH?P9U'Q7;20>'/"/Q1\1
M^`OB!H\GBW7/%BV-ZG@+1--^&=U\2+;7?$(\K4M5T2_U'P%X8@UOQ?XS\/>&
M=<O_`+&4?P^7]GGPK/\`##QE<?$#PIJ?BSXPZZ_B]M`U?PMI6K^+?$/QG^(.
MN_$0^#?#NMV=E>:-\-K'XA:CXHTWX6V$/]HZ1!\.+/PLOA_7_$N@_P!F^(=3
M`/CG_AQ=_P`$J/\`HT;PU_X7WQ>_^>!1_P`.+O\`@E1_T:-X:_\`"^^+W_SP
M*_6FB@#\C+[_`((>?\$FM+LKS4]3_92\(:=IVG6MQ?:AJ%]\1OBQ:65C96D+
MW%W>7EW<?$.."VM;:".2>XN)Y$AAA1Y)'5%9AE^%?^"*_P#P2$\<^%_#?C;P
M;^S'X&\3^$/&&@Z/XI\*^)=#^)7Q7U+1?$/AOQ!I]OJVAZYH^HVOQ#DMK_2]
M6TR[M;_3[VWD>"ZM+B&>)VCD5C]:?MA>#/V@/B)'\-O!WPP^'OPY^)/PEN=6
MU#7_`(W^%_&/Q:U?X2:UXBF\*:KX0USX9>%=,U?3OA9\3X[KP=J^M6VN:E\0
MX%AT74[RT\/Z%X:@N+O1/%'B1+<_X)O6_B>R_P"">_[#MAXR\/CPMXETW]DK
M]GK2]4T`W=U>3:;)IGPH\*V$$5Z][I6BW=MJ4EI;V\^IZ9<:=%)H^HRW6DM+
M>?8OMMP`?-/_``XN_P""5'_1HWAK_P`+[XO?_/`H_P"'%W_!*C_HT;PU_P"%
M]\7O_G@5^M-%`'Y+?\.+O^"5'_1HWAK_`,+[XO?_`#P*\Y\/_P#!(W_@BOXL
M\=>+?AEX9^`?PRU[X@>`X;:?QGX2TGXJ?%2^UOPS'>&-;<ZS9V_Q$=[)G>5(
MS'*5DCE)BE1)%9!^Q_BW^WCX5\3#PMQXG/A_6?\`A'#_`*'QKW]G7/\`9!_X
MF'^@?\A#[/\`\?W^A_\`/S^YWU^9?_!-BX^)_A?PUHGPCU?Q3XD^)GAOPK\+
M-)U3XM^(O%O@?3/`NH?"7]J74M5@G^(OP6TK^S]#T!_$^GSW-YKOB^^75I_&
M_BOPK=O;WVO>/-2\/_$'P'I]@`97_#B[_@E1_P!&C>&O_"^^+W_SP*/^'%W_
M``2H_P"C1O#7_A??%[_YX%?K310!^2W_``XN_P""5'_1HWAK_P`+[XO?_/`K
MQKQE_P`$MO\`@AG\//''A[X:>.?@_P#![PIX_P#%?V/_`(1[PCKOQA^)NGZY
MJO\`:-TUEIYM[*?XCI(!?7:M;VAE\L7$JE82Y!K]SJ_%K]L#5;.P_:'^(OA5
MC<Z98?$;2OV;H?$WP;:PO[OQ'^V1%H?C6_D_LGX8>(X[:6Z\!W'@/36_LGQ1
M+H0OI=>@E2V'_"*:@H\3.`=Y_P`.+O\`@E1_T:-X:_\`"^^+W_SP*/\`AQ=_
MP2H_Z-&\-?\`A??%[_YX%?K310!^2W_#B[_@E1_T:-X:_P#"^^+W_P`\"N,U
M3_@CI_P1IT3QCX:^'>K_`+/?PQTSQ]XSAU"Y\)^"KWXM_$NW\5>([72K&_U/
M4KO1M`E^)*ZIJ%I86&E:E=75U;6LEO##8W322#R)`O[.5\"?M+77@K2/VPO^
M">=YJ-OI-MXSUCXD?&_2]/U4Z4LFMS^'K;]G;XE6DVGOK$5I)<6^C)XE\3^'
MX1:7-W#8OK&L6/EQM=3J:`/E31/^"0'_``1@\2^-?%7PX\/_`+/_`,,M9\>^
M!H+"Z\7^$--^*_Q/N_$/ARWU12UC-JVEP_$=KJT2;Y06DC'DO)"D_EO/"LG>
M_P##B[_@E1_T:-X:_P#"^^+W_P`\"LK]GSP]K_\`PM']F[P`-$U>'XB?`'XO
M?ME>,/C]%-IM[:GPOX-^,&K?%6Y^&EYK7B6>&+1]>M_B$WB/P)JGA?3]*U;5
M[G7+31KO5K2UFM/`>OW.@_K]0!^2W_#B[_@E1_T:-X:_\+[XO?\`SP*/^'%W
M_!*C_HT;PU_X7WQ>_P#G@5^M-%`'XBW7_!'[_@B'K,OQ$\/WGP!^#&KR?"NP
MT[6?BII$_P`7/'^HCP#87$FL7>EWOC:S?XDS)X>1IO"FMW-JVL);.DFA7DR!
M6LV9/M#]A?\`9T_85^"O@SQ)XH_85\.>"M,\$_$'4X8O$FL^!O&/B/QCINKZ
MMX8^T6D=M<7'B#Q%K[6-WIHNY0]K$;1VBN(9Y(Y(I;>1O%]4\3?`/P9^U%_P
M4EG\>^'-'U3P%HW[)7[-/BCXS>%M.\$/KH\56FDWG[5GB'QS#J.@6.F/'XRU
MVZ\+>*?![ZI9E;Z^NK77]"BOB(KJ#'JG[%OQ'^'OQI\8_';XQ:!XRTC7?B#X
MVB^%J>//"?@R+5KWP'\.M#T2P\86GP\\.CQC-IEOX?\`'OQ,.FS:R_Q)\1>'
MM0N((5A\*:'%IMEH&D>&]4\0`'W]1110`4444`%%%%`!1110`4444`%%?)'[
M<_C[XM?#']F#XB>-/@9XA\->%OBII]YX#TOPCK7C'PT_B[PS9ZAXM^(GA3P<
MTFLZ#%J6DSWMFD'B"65Q;W\$Z&,/$68;3^4?AS_@K_XM^&6F?M?_`!<_:=\*
M^*)?#W["G[//P&NOVH/V?/A#X'\'7/C[P-\=/&GQ0^,/@#Q]XI\*^)_B%\2?
M`=CXQ^%-[I/PO\/^.OA]`MW;ZMJOA+X@)<I%>ZGI?]G*`?T)T5^1M]_P6+^"
M5C\6Y/@L?@!^U'=^,H_VP?&/[$#?8=$^!-SIA^-?AGX)Z?\`M!:(T<Z_'\7D
MO@_XB?#6]N-0\':Y'8/=6.HZ5J&E?$'2O`MT^F#4?D/]K;_@N-X-U/\`8E^.
MWQI_8NO=>\._%KP%^S[\,_VM?A))\9?AMI>I>$/C)^S[XR^-FC?!2Z\::!I^
MD>-Y[_3M-3QE<Z]X2O--\8GP7XYTO7=#-[_PBMQX>O=/UB_`/Z+J*_*GQY_P
M6'_9+^'/A;6=8\36WQ(LO%^@_M,^+_V1=2^%-[8_#_0/&5O\<?`_@2V^*?B'
MP[/XB\5_$?P_\'[/3X/AE>V/C:TU[4?BE9Z7J&GWMIH]G<3>+9T\.'>_8V_X
M*L_`/]N[QSXS\'?L_P#P\^.^K:7X'L?@]KNJ?$77/"W@;3/`EQX2^.WP_P#$
M/Q'^&_C"UEM/B1J?BRUT75M'\.7&G7=IKGA+1_$FE:]?:=8:AH,$,EU=V8!^
MG%%?G5\3?^"GO[./PK_:1N?V8=;T[XEZIXQTKXD?`KX+>)_%>@^'=!F\`>$O
MC1^T[HU]K_[/OPLUS4]5\6:1XA?Q)\4]+TZZGT?5-%\+ZQX*T(B"+QMXK\+2
MWEFL_P`Q_L;?\%%?C#\4OV'OVG?^"B_Q\\*GPE\*_AO+^TU=^$O@KI7AC1;S
MQ;H^D?LN^//BAX2U^YM_%7@[QSXYD\9?\)'!X)M=+NK2]T/0-4TSQSI'B]-!
MMO$/@>Y\'^)-;`/VQHK\P]2\8_MS:A^SGX0^/^@_$_X(V$'B#X8^+OC)\0-!
MNOAUJL\G@7PW=_LU>/?$O@/0?AS<+KMU%XTU'3?C--\-K[Q+-XOET*+4/!MM
MXJ@T^[M;S[!97?B7[$7_``5ELOCA^S1\(]4^('PS^)OC/]J.Y_9,_93_`&A_
MB-X"^&'A?P-IFG^+;/\`:3T34HM*\5>`+CQ5\4-(\+^&_"#>+_"_BS2)W^)G
MBWP2-*>PM09KNUU71;S4P#]J:*_GR_:1_P""I_CSQ-=_L)?$7]C3QQH%O\$_
MVN?A%_P46UJ^7X@_"\ZAXIT/QQ^QW\!OB!XXTG]W+XBL%LY]+^)_@K4/"7BW
M1LZCINHVNE7,ND:NT-U!?OT7PH_X+H_`'PY\$/V-H_VBYM?U/]H7XV?LE_L;
M?&WXHV?PYT?P9I7AG0/&?[6OA71;?X>Z7INC^-?B+X<U_48OB%\29]2\/:+:
M^"['QK8>!8&M-6^)^L^#?"I_X20@'[UT5^/_`,)?^"W'[&_Q2^&6H?%C4-,^
M,OPI\,6'[+?Q`_;#\CXE>$?"[:U??!7X7?&'5/@3XZU+3].^'7COXA"XUG0O
MB/IUMI+Z69XTO+?6]&O;"\NH9KW[#!?_`/!:?]GOPWH_C?4/B'\%OVB?A;JG
MA']H#P=^R]I7AGQ[-^S/8W_C_P"-WC/X<:A\7;/PAX5\0:/^TKKGP^T>#2_A
MQ8Q^)]8\3_$OQI\/O"<<-_::9I^N:EKD6HZ98`'[#T5^7/P4_P""MO[-O[2'
MQ$^"O@'X#>#_`(V?$ZU^-_P^\*_%'1?'FE^%O!OAWPCX;\%^+-0\6Z-#K.OV
M/COX@^$_B!K=KX=UOP7J^C^.;GX9^!?B%9^!K^YT(>*;K2[?Q#HUQ>_J-0`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%?DI^W+^UM^T7^S%^T9\--
M5\)6_AWQ'^RSX>^"OBWXG_M0>'H/!UYK7Q2\*^#=+\>>%O`MS\6O`%]9ZI%_
M;-M\.F\;:=XL\8^"IM+FN-3\(>']=N-&N9-56"QG`/UKHK\'?"__``64\*?!
M7X`_#'Q'^T3X2^+OQN\:>)_V*/B_^WC=_$3X%^#/@SI'@/Q7\&OA!XZTS3/'
M=IX7TCQ5\=O#>I6_BGP7X1\6^%_$QL=0MK32O%GA^.ZF\+Z]K/BMO^$5/L<'
M_!:']G:7QOXO^'4_P:_:8LO%WAGXI?`GX*Z/IUQX:^$$L'Q`^*7[3_P5/Q[_
M`&?/!_@_5+#XVWNE6U[\5/`K01Z/>>.+WP7I.@^(+F'2/&^H>%F\Z>(`_7^B
MOYZ/$G_!:SPUI/[0WPL^)^BWFM^)?V!?&?[!?[1?[2?CJ"Q^'&FP?%GX8^*_
MV</VG?`?P#^(?B#6;G4/&FG"^\,>!)]7\;Q>-?#^@6WB'5KB3PK]M\#IXJ:Y
ML[2_^D_C?_P7`_8J^!GQ3\4_!_5C\2O&7B_PDWA72+Z#P5IWP]Q?>/?'OP?E
M^/'@+X;Z5IGC3XE>#/$]UK_B[X7PMKUCXHE\/V_PITB\EL?#?BOXC>'O$VJ:
M5H]Z`?L)17R5\"OVQ_AU\=OV9M*_:WL_"?Q+^&_P8UOX+>$_C_I6L?$W0M!T
M_4;[X9>*_AEI_P`55UFWT_PEXH\9+)/H6@WTFG:]9"Y\V/6].O8=+_M73)-.
MU74/RO\`VBO^"Y'A1/V<-6\??LL_"7XI>(/B?=>*?V)H]%\/^/-$^'&D31_!
M;]N_QE'H/P*_:#TRTO/BO:Z+JOA[Q]I4-X?!GA+6?$&A>-M/\2WV@VGQ4\*_
M#WP__P`)'KF@@']`M%?G3\7_`(__`!E^%WBG]B']E`^)O"]_^T?^U0_Q)L-<
M^+DGP_OK?P-H&E_`[X:+XW^)/BO3_!D/B"^TZW\0ZK>:CX<TSPKX/U#QA/:R
M'4=7OXKO4[+P_=HWSO\`M5_M)_MO?LJ_';]C#0M4U[X8?$?X;_M%_MJ:?\`8
MO"_@[P%]F^(7BKX:WG[,OB[X@SW4][XE\5Z#X:\(?$*+XI?#/Q!%I[0:U=^$
M[GPKXEM/[4O-(FTQW0`_9ZBORYT#_@KC^S#XD\$_LR_%?3/#OQD_X4O^U9>_
M"C0_AW\8KOPEX:LO!>F>,/C;XHF\$?#CP9XEL;CQNGCF;6M6\902>%]4U#P5
MX-\9^$_">L&V@\6^)=#CO]/FNOSY\,?\%+OVN+?]L[1_@UXF\5_#;4OAG:_\
M%>OCQ^PWKL,'PS;3M;OO@MX7_8FT#]IOP=J<6KP^)[G[%XP\.>)GU31K_4XK
M&>U\0:+>1>;IUE=VB22@'])E%?A3X>_X.%?V%_&>O_#+PYX"\.?'7Q[??%_X
MA_`WP/X";PIHOPBOTU+1/VBOB???!OX6?$[4+>X^-%GJ7AWP;JWQ'TV\\/ZE
MX=\16&E_&+0819Z_J_PKM?#>KZ+K&H^S>-O^"SO[+'A+X+:+\9]*\'?&_P"(
M46J^%_VGO&U]\.O!6@?#=/B!X9\)_L:ZU?\`AW]H_6M=?QI\5/!WP_=?AUK>
MGR:;)IF@^/M<USQ)/-`WA+2]=A\Z6$`_7"BOR/N?^"TW['NC_&GP+\`?%]I\
M3O!7Q)\977P+T#4-&US3_AU?S>!?'_[2W@]/'?P2^&_B6P\)?$SQ-KNM^)/&
MOAR:VN#K7PRT?XA?#KPS=WVF:;XP\<^'[_5=-M[OZG_8W_;6\#_MM>%O$_CC
MX;_#;XN>"_!N@WUA8:7XC^)NG_#ZPLO&,MW+K%O>Q:';>"/B-X\U71=7\-W.
MCM;>+O"'Q"T_P/XZ\,7&HZ3#K/A>T>]`0`^R:***`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBOSE_X**?&;]JKX+Z3^S5>_LFV/@SQ1XP\<_'G7?"7BSX
M<^,=$EOV^(?@CPG^SC\?/CYK/AKPGK4.J:<_AGQKJ\?P1_X1_P`-ZC<1WVG-
M?:^HOX$BB650#]&J*_#OX'_\%:=$U+1?"_CWQ3IGQ'^-G@;]J?\`;=U7]F#]
MEY_ACX"^&WA"]\":U?\`P,T;XU>%_A;\8+7Q_P#%OP?JUMXOC>+X@^"-1UQ-
M-FM=$\3>!;O3/'">$[BYM9;QOA7_`(+]?L>>(O"VA>/M6^&7[37@7X>:U^RU
MJG[8EQXZ\5^#?A9=:+X=^"?A_P"/MO\`LW^)]5\0V'@KXS>,/%%MJ_AOXBW"
MMJ6EV/A[41<Z`K:GHUUJLICLI`#]QJ*_!OXY_P#!6'Q1+\2?V2-._9]\&>-;
M>]U']N_6/V-OVL/V;_'7@KP!/\8[36[K]FKQ=^T#X>T/PAXGL_BPWPML/%,N
ME^'_``U<Z5J5I\1-7\):C8>-3;ZUK&BW^DSQVWI7CS_@O/\`\$]?`/A#X+>/
M[WQKXQU?P9\;/@KIO[1>EZ[I_A[1]*'A'X*ZK\0G^%-KXX\5:/XS\3^%/$6I
M$?$*&Z\.3^$?ASH_C_Q]`+#4M>?PH/"^F:AKEL`?LU17Q5^QO^W!X-_;7\,Z
MUXN\`_"3XW?#_0_#OB[XI_#W6[SXJZ/\.[*WL/B!\&_B5K'PM\=^#3>>`/B9
M\1-/NM5L-?T2ZOK&[L+RZT'5=#DCN[#6)KN&_L++XH^,G_!;/X#^&/AG^TEK
MOPE\!_$_QSXV^$_P2_;'^*'PE&KZ1X4T#P+\<-0_8B,VB?M!0^&=7O/',6NZ
M9HWP?\6R64'C:3QCH'A'6=?T6+4;OX2Z5\2+^.ST^\`/VLHK\AX/VT?CI\,?
MV"OV:_CC\5H=!\0?'?\`:^^)_P"S1\,OA=ILG@M/#OA?P'X@_:[\5^$=!\#Q
M>/[/P;XR\=6-WHGPYLO$>H:QJ>LV/BFQ'BJVTS3-+E;P]K6KNEMQW_!2OX[?
MMZ?L0_LM_$3]HKPC\4?@MXPT+X;6GP0LRVK_``JOX/%7B/QI\2_VG?AI\+=<
MTRXT"V\1#0K+PI;?#_QY>7&D:G9ZXNMQ>)]+M/MEC=V-[-);`'[4T5^8/B?_
M`(*P?L_^%?AA\6?BY>?#SX[WO@[]GSXH?&7X5?M#W.F^&/`<LWP1U;X!C2[O
MXFZOXP:Z^)=GI^N:7H^@:UIGBRSTGX:W_CSQSK7AFXDU'2O!UV]AJ5O9_F_^
MWG_P5%_:I^!?QE_:>L_@GXQ^&U]\+OAQ\%_^"8OQY^&-KXB^&,FHZC>:'^V'
M^UE'^S3\0?#VKZK_`,)+IUQ=6TVA3P>/?#6IFPL]0T75G_L:YM[VP!8`']+U
M%?B/\=O^"^_[#7P%\6?&_P`%:MIWQB\=:_\``G5/C7X=U^P^'VD_"Z[O?$WB
MS]FW1H/%'Q^\,>%-'\6_%OP?K\=]\+O"#7_BB_U;QEI/@_PGXPLM#US2/ACX
MC\=>+-.D\.M]"R_\%6/V=%TKQ>(/"WQ>O/'_`(4^/GPA_9H@^#T.A^!H/B#X
MI^+GQX^&ND_%_P"$^A:!>:A\1++X<65GXM^'.KQ>)4U?QA\0?"FGZ-%:W^G>
M(IM(UBW&GN`?IG17XA:C_P`%]_V)_#7PQ^$_Q4^(/AOXV_#31_BY\-_%GQNT
MS1?&FG?!R'Q)X<^!7@KQW8_#/7_BWK]KH7QJU[3-1TB'QQJ$.B6G@3P'J_C7
MXTZBD&H:U9?"^?P]I>I:M:_;WP`_;P^''[2/QX^+WP*^'GPW^,4+?!6Y\3Z7
MXM^*/B/1_`>E_#F3Q%X8U7PKIC>'+.R@^(E_\5M/OO$D'BG^W?`VI^*_A?X:
M\+^./#WAOQ7JOA?Q!J<6C,LX!]OT444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110!XO^T!\$=$_:(^%VM?"CQ'XI\:^#='US4O#&J7.N_#Z_T3
M3/$]O<>$O$VD^+-*6SO/$/A[Q/ID<+:QHFGO=I+I$[301O"KQB1FKR_XP_L-
M?LT?';3/VC-,^(_P\L]67]J[X4>"?@U\=;RVF;3[[QOX-^'-WXSO_!1O)K5$
MCCUSP_=^/-?FL-:2'[9'_P`2Z(L8=,M(X_KBB@#\GH/^"/7[/$'QKT_X\K\5
MOVDW\8V/[3.E_M>R6$_COP1/X<U+X]Z=\,;7X,W/C#4+&7X9-J#0:U\,;>3P
MCJF@VFJVFAK97MU=Z58:7JJVE_:\3X3_`."%'[#WACP=HGPYO)_C5XP^'VC?
MLQ1?L?R^#_%?Q#LI-+UOX$V7QHOOC]HGAC6;O0/"_A_7'O?#WQ+O?[5TK7-.
MU?3=4:TM;73=3N-1M5F6?]EZ*`/SJC_X)?\`[,D?@F3PX1X]N?&MS\?;O]J.
M^^..H:]HNJ?&#4?C[J7A>Q\!ZQ\2;_4]3\,W?@ZXU36O`.G6G@?4]+;P2/#E
MQX;B6U718[E5O%].^`?[$7PL_9S^.?Q^^/\`X%\4?$W4/%_[2-C\.-/^(VC^
M*_$6C:OX4$'PDT2X\-?#YO#^GV_AG3M4TN3P[X?O;_2(3)K5XEW:WLSZA'=7
M:6US;_8]%`'P9\1?^";_`.S'\3OVA&_:5\1:+XH@\?WGC;X1_%/7]-TKQ&UI
MX.\5_%W]GW2KW1/@-\5_$>@365T;SQM\(=,U&[M?!\]O>V>BLKP/X@T779+&
MP>U[G]EG]BSX1_LF_`#5OV:/!U_XR\??"O6O$_Q0\47^E_%O4-!\5W4\OQD\
M1:MXO^(FCS2Z9X:\.V=UH'B#Q7XC\3Z_+IU]8730W7B34[.">/1TTW3=/^NJ
M*`/C[3/V,?!6B^`/$OPJTSXH?'&W^&VI^`]5^'/@WP=/XUTG4]-^$?AO5_"M
MYX-N(_AY>:MX6O\`6Y[NVT+4+VUTJ?XA:KX]71TN&@TN&TLDAM(_E7X8_P#!
M&+]DWX4ZK\.-8\/^*/C[>W?PK^$OP)^#7A%=3^)MK!%#X4_9D\?^(?B%\!KG
M4AX>\,:#+JVL?#B]\3ZMH>FR7TLNEZOH+6G_``E&DZ[KUA9Z[#^M=%`'Y':I
M_P`$8OV6[CPA\!_`OASQY^T)X"\-?LV0_M.6WPFL?"?CSPJ[Z':?M?7/C%OC
MG:WEWXH^'WB:ZUB/Q)I?CSQ+X=L7U"6:XT71[U#I\T6JV\.J+ZE\,?\`@EU^
MSM\'[/X21>`-?^*NBZK\'_@7X3_9QTCQ3_PD'A6Y\3>)_A1\-4U*+X0:)XQU
M&X\$/%?WWP@CU*6'P/K>D6NAZK);1K:>+KKQ59W&H07OZ/T4`?BI8?\`!%/X
M,_"7X=+I'[.7Q4^,GA7X@^%_V9/C#^RO\.]<\=>)?!/BSP_9_##XT?$W_A<G
MBC0/%&C:E\*=7TW7;2/XE$^)[":^T34&614TC5+76O#DEUHEQ3_97_X)9_$3
M1OV?D^"O[8GQ0\/^-8O!_P`2/"7Q6^!-S\)-"^$.@ZG\#/'?A6#7=.'B3PGK
M7@K]F']G[P/J3ZCHNJQ:6=)\0?!'4;>WL)=9TZ^O-;LM1C2U_;>B@#XYG_8:
M^"E_\5/A9\7M8O/B'KWB7X+>)7\7?#/3]:\;7]_X<\(Z]/X$F^']_/HFER0B
M32=.U?2[W4]6UOPYI5W8^&=9\3ZB^NZEH]U=:=H?]E?8U%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`5X1KG[/WA7Q%\=+;X[ZOX@\7WNI0?!S7O@
MA/\`#Z>Y\/3_``RU+PCXG\16GB77;O4]$N/#<NN76N:C>:;I5K-<'Q,FF?V?
MIEM;+I(:6]EN_=Z*`/S<^+'_``2E_9!^+7PV\)?"J]\-^*?!?A7P3^SM\6?V
M4?#W_"O_`!&FA:I9_`+XUV&F6/COX>+J%[INKNFE7C:'HE[9-`D%Q976DVD:
MRO8O=V5SY+I/_!%K]FC3/$<WC&?XJ_M+ZUXME^-7[,?[0*^(=7\=^`VO;?XF
M_L@^`)OA9\"]6@@T[X6Z=I@M/#?P]>W\+7VF2V$MIK=GI]G>:DDVKBYU&Y_7
MVB@#\@]/_P""(W[%%CX$T3X<R_\`"X-2\,Z)H7QL\`"WO_B'&)]6^"_[1GQ/
ME^,OQI^!.MR6.@6,6H_#'QY\2YG\4:BC0Q^-K*?;I^D>--.T=1IX^AO&W_!.
M3]GKQ?XH^*WBO3)?''P[O?C7\-M-^&OQ'M/A[J^@Z59:_;:!X13P!X7\5,^K
M^&->U*U\7^&O`Z+X4T^\MM1BT:]T:.V@\0:%K4ECI\UK][44`?.GP;_9?^&?
MP6_9<\$_L?Z6WB'QE\&?`?PE@^!FDV/C[4;/5M;OOA98Z#+X2TSPIK6J:1IF
M@Q7]MIOA!K?PM;W8LH-0FTJRMI-0N[W5#=:C<_"NI_\`!%3]CZ]^'5S\-]/U
MCXV>'+*76?V;9[7Q'HWCS1Y/%NE^"_V.[Z]U3]E[X2:=J6N>#]:LXOAI\%-4
MNH-0\+:;/IEQXAU"?3;)/%GB;Q';2:C;ZA^NM%`'BOQ@^`G@3XV67@[_`(2M
MM<TWQ3\-]?/BWX:_$7PMJ:Z'X^^'_BQ]&U#P_/X@\-:REK<6L<]_HVJZCI>L
M:5J>FZGX;U[3KR?3M=T34M/D:UKP3XF_L$_#KXO:[^S-XI\=?%+XZ:MXI_99
M^+\7QU\%>(?^$L\*1ZAXJ^)4'AJ?P7;:SX^B/@1]-U"TMO!^I>)/#<&B^&;#
MPGH\=AXJUN<67]J+I&H:3]RT4`?D/\-_^")O[&/PN^&7P_\`A1X?OOCA>>&_
MAEKGP&\0>$IM<^*5Q?WUC??LR_%+7OB_\$4>"/1[70GMO!7B_P`5>)FCB318
MFUNQUV]C\12:M>1V-]9[=I_P1_\`V>+3X[P?M!CXI?M&3^+8?VKM<_;/;0;G
MQIX#D\&S_'+Q+X#@^$_B#5+C2A\,$U)]!U;X46\7PYN-`764M8_#X-Y:/;^)
MV/B&OU=HH`_++6O^"0_[,6H^"?AW\.=&\3_&?P/X+^#_`,>O!'[0_P`)_#_@
MOQ3X1TNQ^'OC+X:>*E\=>`-&T-+SP#J37O@_PEXU4^(](TKQ(VO7Z3G^R+C5
M[CPU'#H<?R-^T;_P1K\?KX5^$O@G]C'XTGP7X6\#_&SXW_&G4=)^,R_!KQE+
MH?B7X^^,;+QOXOO?`FH?$;]D+]H>.P@TSQ#<>+=7TC3;?3/#NO22^+=4TF7Q
M_;Z&+&RL/Z!J*`/A#P?^PIX.MO'-M\</&_BOQ'=?'WQ-\-O`_@KXT>,?`4NE
M^"=%^*OB'X>:9>:9X+\?ZCIUCHIU;1?%?A"VU"[M=!O?"VL>';.6Q-M8:YI>
MK:=I^FV-EZS^SU^RC\*OV9[_`.*>M?#UO%=_XB^-'B/PSXK^)'B3QCXCG\0Z
MSXEU[PEX(T+X?Z1J=Y.T-I`VHR:!X>L9-:U9K9M8\2ZU-J'B#Q%J&J:Q?W-X
M_P!+44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7BOQ/\`@?HOQ5\<
M?`CQYJWBSQQH-_\`L^_$/5OB=X2TGPO?Z%9Z%KOB;6/`/BSX7W7_``F-OJGA
MW6+_`%+3T\#>/?&^A6]II>HZ(T<?B>_O&FDU"VTFZTWVJB@#XP\4?L"_LU>)
M-/TRRM/!]QX/FT+]J5OVSO#VJ>#+R'2-0\/?M$W.E7NAZMX^T7S[._L;&[U_
M2M6URTUNWCL3#?'7]:N2([R_DN!\$Z;_`,$`?V+=/\#ZG\-)?'W[3.J>`]2_
M9L\9?LD)X:U+XD>$'M=-^!'CKXH1_&K7/"&GWEI\-+/5EE'Q3AB\8V6MWFHW
MFLV]Z@L&O9=$+:6W[BT4`?ENW_!)#]FU_$GC#QS+XV^/+_$'Q5\<O!7[35EX
M]C\>Z%9^)/!/[0?@SX-3?`3_`(6QX-_L_P`%V>CVGB#Q/\-I1I7B?2M;TC7O
M"$]U%'J&C^&M%N?-:3T3P_\`\$Q_V3/`R?`"'X9>$=8^&%O^SC\,M3^"?@>'
MP;K$2OJOP>UC7+;Q5?\`PY\6W_B'3_$&J:GHK^+[6/Q9;:GIU_H_BO3=>EO[
MG3/$5G!JNJ6U[^@E%`'RI^R#^R'\/OV+?AQXF^%_PT\4_$;Q5X?\5_%/XB?&
M+4KOXEZUH6NZS'XT^*VOS>+?'<UG=Z#X9\+6T.GZWXMOM7\2&QDLIELM1UF_
M@L)+;2EL--LOEGQ+_P`$=?V-_$=E\7-,2R^)/A_3?BSX(_:$^'::?H'C."*T
M^&?A3]K;5H=:_:DL/A9#J>AZJ/#\OQYOX3)XXO-7_P"$ANK,33?\(;+X48HR
M?JC10!\VK^RI\)KW]F[PE^RSXMMM=\>?#3P3X4\$>%-`OO$^JK%XULA\-6TJ
M?X?^)[+Q5X8M/#=UHOC?P;?Z%H>K^&O%OAV'1M8T;6M(T_5["X@U"W%P?'/C
MQ_P3Z^'G[3'P%\5?L]?&GXQ?M">,_"?C+Q!X0UK7/$-SXR\(6?C*2R\!^-=,
M^(GA3PQ:WMA\/K;0K30M,\9:%X>UJ6:#PZOB/5I=`TRVUKQ!J5DES;77WK10
M!^4=W_P1O_9'U6/]H.'Q#JOQN\0P?M-ZQ\>-;^*EK?\`Q-DLK*^O?VF/"_A_
MPI\;/[,L-`T71;&RC\:V/A'PG<S>=;WDVE7GAZS70YM-T^[UC3]3POC1_P`$
M7_V:/CKXB\5>(/%_Q2_:4T\>-/AC^SA\(/$.B^&_'7@73]%O?`O[*'BW2OB+
M\%-,6.\^%^I:C!/X=^)>E#XA7M]#J27.L^(;^_M=1>;PR]KX?M?UYHH`_-'X
MJ?\`!*?]FCXL^&/VE?!FK:O\5/#?AC]K--0NOC/I'@KQ'X9T.'6_$OB;2=+\
M/?$/QI83R>"[Z\TWQ)\4/#VDPZ1XX"7,N@W)N+S7-"T/0?%4_P#;R?,/[3/_
M``1[NM=^%WQ@TW]EWXP^)M'^)WQQ^(/[/OCSXG3_`!LO/A1XL\%^,;W]G?X,
MK\&?"]U-IOC#]F7XV>%='UK6-&T3P5J6NWLOPL\0Z>FN>'8]<\/:3X>U(0RK
M^YE%`'Y>_!W_`()UE?"7P`US]I/Q_/XV_:#^!?A'7OAI8?$[X>:=X(\)-K7P
M;\27?AO5M0^#7B2#0OAAX,\+:KX577?"VAZO%K'A#X<?"[6[2^TBRN/#H\,+
M-JEOJ'TS\,OV/?A-\+/CEXQ_:,TF\\=^(?BQXU\*:WX$U/Q'XU\87WB22V\%
M:U\3M>^*Z>%K%;B**5M'\/Z]KW]B^$(=3GU*3PGX)T;0/!V@36.B::+:7ZIH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHK+T_6++4[O7+*U6_$_AW5(='U(W>DZKIUNU[/
MHNC^((VTN\U&RM;37K#^SM<L%DU;0I]2TJ'4UU'0IKV/7-%UG3K``U***:DB
M2`M&ZNH=T)1@P#Q.T<B$J2`\<BLCKU1U96`8$4`.HK@+_P"*?PZTSXF>&_@U
M?^,-#M_BIXO\(>*/B!X<\!M=JWB35/!/@O5/#>B>)_%$6GQAY(M&TG5_%_AS
M39;VY,,4U[J<=O:&XDANE@[^@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MK+36+*36KCP^JW_]HVNEV>L2LVDZJFF&RO[N_LK=8==>R70[F_$^FW1N=)MM
M1EU6RMS:7E[96]IJ%A/<@&I1135D1]VQU?8Y1]K!MC@`E&P3M<`@E3@@$$CD
M4`.HK@/&_P`4_AU\-]0\!:3XZ\8:'X7U3XI>-+/X=?#K3=5NUAO_`!EXWO\`
M3-4UJV\-^'[-0]QJ&I'1]$U?59DAC,=KIVFWE[=20VT$D@[^@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`K.UB+4IM)U2'1KF"SUB;3KV+2KRYC\
MZVM-2DMI4L;FXBV2>;!!=&*66/RWWQJR[&S@Z-%`'\UFI?LN_P#!T#+J.H2Z
M7_P4W_80M=,DO;J33K:?]FV"2>WL7GD:T@FD_P"%0/YDL5N8XY'WON=2VYLY
M-+_AEG_@Z/\`^DGW[!?_`(C5!_\`.>K^F"B@#^9__AEG_@Z/_P"DGW[!?_B-
M4'_SGJ/^&6?^#H__`*2??L%_^(U0?_.>K^F"B@#\,_V1O@%_P7O\&?'SP1XB
M_;(_;Q_9'^,/[/-A)J1\=_#[X:_`Z'PEXRUV.73+J+2UTG7E^&N@FR:UU1[2
MZN"-4MO-MXI(OGW;#^YE%%`'Y5?M8?#7]H[5_P!IWP'I'PT\;?M$V?PQ_:!T
MWX=:+XG\0?#SQQK>A^$OV<+WX*?$K2_%WC[5ETZQ9[::;]I3X7:S=>!);FZN
M_#</@ZZ^'EUJFC7/B/Q%XY71X/FKX^_&_P#;4\+?M,?&KPQ\&/!_[0L]_KWP
MN_:ATCX>G5/"?Q@\=^!'\?\`AOX'Z[XA_9YO-&6R^`-E^ROX`\/Z]\0]-TJW
MT'79_CIK/C;6IY[?P]\4-/T_5M6OK2']ZJ*`/Q^\2^)-4A\&_"\>%_&W_!0>
MY_9UN_BA\0H?&?B^_P#AG\=Q^T+97-M\/?#UQX`T[1M&'POB_:-E^&MU\0Y/
M$*3ZIX^\'2:9)K']IV-_JT?PTMO!F/&O$/Q#_:'\0?$R\^'FJ?%3]OOP_P"$
MKC_@HMX6\*ZKK^B_LT>+--U&Y_9J\4?\$_\`P?)JFCGQKX,_9SN_"6B_#_2?
MVH['Q5X;O/B-\.]3T^WT#Q1J5]XB7QS%./#?BJV_>:B@#^>;XW?M)_M>Q_LE
M_LY?%'P7X/\`VKKOXIVGPP\;ZS>0I\*_VD/#6HW?Q-\%>)!H^C:5XZ^"7@+]
MF?QY\1_%GB?5;/36OM-T#XRVGPS^"_C+2'GO7\375WK%I>CSVR\.?M*^%?!-
MWX7^$GQ`_;`^"?A35?VO?V[_`!7\0?'/BW]G/]I[XXW<^K^)/VD_B+XS_9TT
M_P"'OPX\'^+OA/\`$BW\+^._!/BRZ\;^)O&LL\GP.U#6K^RM?B'<7NOM);:%
M_2W10!^'_P"S_<?M`:A^WG\'M9^,.C_M1>*/$NG^&/V_/!?Q#USQ!\,'\/?L
M[^`='OOC'\*[_P#9IUG0-=.GQ>%=*U'XC_L^^`?"%SK&C_#/Q=XRTF7QI?7L
M'BFVM_'UEXXET?\`<"BB@`HHHH`_+C_@H7\)O^"L'Q)U[X;7'_!-_P#:K_9\
M_9S\/Z7I&NP_$_3_`(U_"^/X@WGB;6;B\LGT"\T*=_!?BO\`LVVL+)+Z"\A$
MMGY\L\3^7)LW+YS^PC\$_P#@M9\/OC/<ZY_P4`_;0_9@^/GP0;PCJ]G:^"?A
M!\'HO`OBF+QC-/8MHVL2:RGP_P##);3;."._2YM/[1/G//"WD2;,K^QM%`'Y
MU_\`!0OX:?\`!2KXD^&_AM:_\$W_`-I'X(?LY^)]+US79_B?J?QK^':?$&P\
M3:#<6%E'H%CH5L_A/Q7_`&;=V&H1WUQ>3B&S\^&>*/S)=FU?E/\`8Z^`O_!>
M+P3\?/"7B+]M3]NK]DOXS_L\V=OK*^,/A]\,/@C%X/\`&6KW,^F3Q:))INO+
M\-]`:T2RU1K>ZNE&J0>=!&\>)-VP_N!10!\._M[>`?V\_B'\)=&T;_@GO\=O
MA)^S]\88/%UE>ZWXO^,?@=/'GAN]\')9WB7VCVNDOX;\3B'4I[U[*>*[^P1E
M(H94\]=^UO6OV4O#7[2?A#X!_#[P[^UW\1_!'Q;_`&AM-T^\C^(WQ!^'/AX>
M%?!OB+47U.\ELKC1=!72=#73X8=+>RM98QI=KON(99-K;][?1%%`%>[MQ>6M
MS:-+<6ZW5O-;F>TF>VNH1/&T1EMKB,B2"XC#;X9D(>*15=3N45_.3XO^+7[9
MNA?"#XE>'-/F_;ZT3XC>!OV#)/#>L?$;0?@KXS^(`7]J'P9\:](T[2[/P-IN
MJ_#SQJ?B)XZ\7>%O$":;XA\=>`O!'BWPUJ_@VXO?$NG>+K23PA?>(?#G]'U%
M`'X@:_KW[0TW@[XP:U\/M3_;'^(=G^R/^V+X.'@[P9K6A?%KX4>-?VF?@!\0
M_@/\(]-\?VLWC#Q!X!\/7_C[1/AM\?/B#\5_BEIFH>$O#OBK;I7P>A^$.A66
MF>%?$6B7MGRG[3?B#]KK]F+X)_LSZ1X9O_VIOBU\2/!OPQT;7O%GC:PM_C1\
M1O\`A)_B5<^)M-U#QCIWB;P=\!_@A\<=5\>>(;*SOM1BL/"_Q<\3>!/A&GAR
MWT_3?"^MW>JPZDMI^]5%`'XXQ^,OV@+OPO\`M6ZMHFI_M:-^T!;WW[036_A.
M^^'7C.S^#&E?"VT_:(O-/_9[UCX37/B7P3:>';_XD7O[+@T/6K72?@MKVN:W
M=:S>>*7^+&BV_P`4K+0M.M/FOXF_%WXY:'!^TOH7P4^*_P#P4R_X0RW^"'[.
M_B/X,>(O%/[)7Q7\4>+]"\0Q_M&ZSHGQ9LO`EWXL_9>UCQ5XLU+5?"FM:'/K
MVD?%&P\2_$BQ\,PWVIZ-9Z9\/]"M[RS_`*(J*`/Q#\8?%'XW6OP0^*/A+1;7
M]KSQ)8_#;]LK7?AEHOBS4?#?[2'P\\::E\(K'X;Q:]8>)]=\9>"_V<_B9\>_
MB-\/[GXFOJN@Z3XS^"/P_P#$MO?ZM)X5T_6?$=E\*+7Q!=#\^?V<;_\`;%UK
M]FQ?%4_B/]M'X&>/OBY^T?X2\=?M;>-/B!^R]^USXO\`["_M_P#9FU36M9MO
MA7\#?`U[\%_C;!:7/[0UII'AKQ-K?PFC@\)Z9HC>%=-U2YU+PQH^IV&F_P!8
M5%`'X._$B?\`:6O?CK^S3:_$>S_:K^).K>$_CE^Q_J=M#X.^#<6C_"?6OAT_
MP=TZV^+7Q5^*ECI46N_#3X>>)]&^/6K>*K[6=&T;XCR^/?"VF6]OI%HNN_#&
M&WN]3_>*BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
:HHHH`****`"BBB@`HHHH`****`"BBB@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>fig4.jpg
<TEXT>
begin 644 fig4.jpg
M_]C_X``02D9)1@`!`0$`7P!?``#_X0">17AI9@``34T`*@````@`"`$:``4`
M```!````;@$;``4````!````=@$H``,````!``(```$Q``(````0````?@,!
M``4````!````CE$0``$````!`0```%$1``0````!```.PU$2``0````!```.
MPP````````!?`````0```%\````!4&%I;G0N3D54('8U+C`P```!AJ```+&/
M_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L`0P$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!_\``$0@!*@*\`P$B``(1`0,1`?_$`!\```$%`0$!`0$!```````````!
M`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$```!?0$"`P`$$042(3%!!A-1
M80<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$
M149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;G
MZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!`0$````````!`@,$!08'"`D*
M"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1!`4A,08205$'87$3(C*!"!1"
MD:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-4
M55976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6F
MIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V
M]_CY^O_:``P#`0`"$0,1`#\`^XOV[OC7\5/#W[77QTT71O&NK:?I>G^,%@LK
M*`6GDV\1T;2GV1[[9VV[G9OF9B,GG%?)7_#0GQH_Z*#K?Y6/_P`B5[)_P4'_
M`.3SOV@?^QU3_P!,>D5\;5_H-POEV`EPWD$Y8+#.4LGRV4I.A3;E)X.BW)MQ
MNVWJW_F?QAGN.QL<ZS:,<7B$EF.,22K5$DEB*EDES*R5M%T/9?\`AH3XT?\`
M10=;_*Q_^1*/^&A/C1_T4'6_RL?_`)$KQJEP>N#CZ5[G]FY<M\%A/G0I>7]W
MR7],\GZ]CGMB\3_X.J?_`"1[)_PT)\:/^B@ZW^5C_P#(E'_#0GQH_P"B@ZW^
M5C_\B5XU0>.O'UH66Y=TP.$_\$4MM/[OI_3#Z_CO^@S$_P#@^I_\D>R_\-"?
M&C_HH.M_E8__`")1_P`-"?&C_HH.M_E8_P#R)7C>">U)1_9N7?\`0#A.G_+B
MEY6O[OD@^O8[_H+Q/_@ZI_\`)'LO_#0GQH_Z*#K?Y6/_`,B5K^'_`-H'XRRZ
M]HL<GC_6WCDU;3D=2++#*UY"&!_T3H0<'VKP.MKPYG_A(="_[#&F?^EL.:RK
MY;E_L*W^Q85?NJFOL*7\C_N^7]7-:&.QOMJ/^UXG^+3_`.7U3^=?WCZ/^+7Q
M[^,%G\2O&EK:^/=9AM[?7[^*&)!9E8XUE(55)M"2`.F237G?_#0GQH_Z*#K?
MY6/_`,B5B_&/_DJ/CG_L8]1_]''I7FE1A<MR[ZMAV\%A/X-/5T*76,?[O<K$
MX[&K$5DL7B=*LTDJU3^9V7Q'LO\`PT)\:/\`HH.M_E8__(E'_#0GQH_Z*#K?
MY6/_`,B5XUST[_Y_S]>**Z/[-RY_\P.$?_<"ETM_=]/Z9A]>QW_07B?_``=4
M_P#DCV7_`(:$^-'_`$4'6_RL?_D2C_AH3XT?]%!UO\K'_P"1*\:H.1VH_LW+
MO^@'":_].*6O_DNNB_K4/K^._P"@S$_^#ZG_`,D?3?PV^/OQBNO'_@ZWN/'N
MM2P3^(M*BFC;[%M>-[J-64XM!PPX."/7-9WC+X__`!D@\6>(X8O'^M)%%K6H
MQQH!981$NI`JC_1#P!P*\P^%_P#R47P5_P!C+I/_`*615F^-_P#D</$__8=U
M/_TKEKC678#^T)+ZEA++"0T^KTO^?LO[N_X6N=?U[&_4O][Q/^\RU]M4O_#I
M]>8[S_AH3XT?]%!UO\K'_P"1*/\`AH3XT?\`10=;_*Q_^1*\:HYZ?A79_9N7
M+3ZEA-.GL*6VG]WR7],Y/KV._P"@O$_^#JG_`,D>R_\`#0GQH_Z*#K?Y6/\`
M\B4?\-"?&C_HH.M_E8__`")7C7/H?RY_*EP>F.:/[-RW_H"PG?\`@4NEM?A\
MEK_F'U['?]!>)_\`!U3_`.2/9/\`AH3XT?\`10=;_*Q_^1*Z[P#\?OC'<>-O
M"D$_C_6GAFU_2XY4/V,!XWNXE93BT!P5)!P:^;<$=01^%=E\.O\`D??!_P#V
M,>D?^EL-88K+LO6&KM8+"_P:FJH4OY'UY?Z^\VP^.QWUBA?%XG^-2NG6J?SQ
MT:YCU_Q[\?OC';^,_$T$/C[6HXHM:U!(T466U56YD"@9M"<`#C-<E_PT)\:/
M^B@ZW^5C_P#(E<9\0_\`D>?%?MKNH]/^OF2N-'/3_/\`C3P^6Y=["@W@<)_!
MI_\`+BGUA'O$,1CL;[>K_M>)_B2_Y?5.[_O'LO\`PT)\:/\`HH.M_E8__(E'
M_#0GQH_Z*#K?Y6/_`,B5XUS_`$_R**V_LW+G_P`P6$?7^!2Z6_N]+?UJ8_7L
M=_T%XG_P=4_^2/9?^&A/C1_T4'6_RL?_`)$H_P"&A/C1_P!%!UO\K'_Y$KQJ
MCGKCBC^S<N_Z`<)_X(I?_(^7]:A]>QW_`$%XG_P=4_\`DCZ+\&?'_P",<_BW
MPU#-X^UJ2*77-,CDC866UT>\B5E.+0'!!(.*O?$;X^_&*V\=>*X+?Q]K,4,6
MNZC'%&HL]J(EPZJHW6A.```,DFO#_`__`".7A;_L/Z5_Z6PUH_$W_DH'C#_L
M8-3_`/2J2N+^S<O_`+0M]2PMOJNWL*?_`#\_PG4L=C?J;_VO$7^L/7VU2]N2
M.GQ;'5_\-"?&C_HH.M_E8_\`R)1_PT)\:/\`HH.M_E8__(E>-4N#Z?Y_Q]J[
M?[-RY?\`,%A%_P!P*6VG]WR7],Y?KV._Z"\3_P"#JG_R1[)_PT)\:/\`HH.M
M_E8__(E'_#0GQH_Z*#K?Y6/_`,B5XU1STQS1_9N7?]`.$[_P*72VOP^2_IA]
M>QW_`$%XG_P=4_\`DCV7_AH3XT?]%!UO\K'_`.1*W_"O[0'QEF\3>'XI/'^M
M/'+K.FQR(1989'O(593BT!Y4D<&OGS!'4$?A70^$/^1J\-_]AS2__2V&L<3E
MV7_5Z[6"PO\`"GJJ%+3W?\._]=3:ACL=[>BGB\3_`!J::=:IUG'=<Q[_`/%#
MX^?&&T^(7B^VMO'NLPP0Z[?QQ1*++:B+,P55S:DX`]S]:X/_`(:$^-'_`$4'
M6_RL?_D2N=^+/_)2?&O_`&,.H_\`H]J\\Y/%+"Y;E_U;#MX+"7]C3U="E_+'
M^[Y(,1CL;[>JEB\3_$DDE6J=_P#$>R_\-"?&C_HH.M_E8_\`R)1_PT)\:/\`
MHH.M_E8__(E>-<],<TN#Z'\JW_LW+G_S`X1_]P*72W]WT_IF/U['?]!>)_\`
M!U3_`.2/9/\`AH3XT?\`10=;_*Q_^1*/^&A/C1_T4'6_RL?_`)$KQKFBC^S<
MNZ8+"=_X%+R_N^G],/KV._Z"\3_X.J?_`"1[YH'[0/QEEUW18Y/'^M/')JVF
MHZD66&5KR$,#_HG0@G/MZ5UGQ9^/GQ@L_B3XTM;7Q[K,-O!K]_'#$HL]L<:R
MD*JYM2<`>I)]Z^<?#G_(PZ%_V&=,_P#2V"NQ^,?_`"5'QU_V,>H_^CC7&\MR
M_P#M""^I86WU63M["E:ZJQ_N_P!?-G6L=C?J,G];Q-_K*5_;5+V]G>WQ&U_P
MT)\:/^B@ZW^5C_\`(E'_``T)\:/^B@ZW^5C_`/(E>-45V?V;EVWU'">GL*6V
MG]WR7]-G)]>QW_07B?\`P=4_^2/9?^&A/C1_T4'6_P`K'_Y$H_X:$^-'_10=
M;_*Q_P#D2O&J.>F.:/[-R[_H!PG?^!2Z6U^'R6O^8?7L=_T%XGM_&J?_`"1[
M+_PT)\:/^B@ZW^5C_P#(E:>B?M`_&:36=)C;X@:T5?4K%&!%ERIN8@P/^B<Y
M''7\:\'K6T'_`)#FC_\`84L/_2J*HJY;EWLJML#A/X<W?ZO2O\+MKRFE''8Y
MUJ2^MXG^)3T=>IUDM_>_I'TM\7?CU\8++XD>+K6U\>:S#;PZO.L42"RVH@Q@
M#-H3CZDUYQ_PT)\:/^B@ZW^5C_\`(E97QH_Y*AXR_P"PQ/\`R6O+ZRPN6Y=]
M5P[>"PK_`'-/5T*76,>O+ULO(TQ6.QOUFLEB\3;VDK6K5._3WCV7_AH3XT?]
M%!UO\K'_`.1*/^&A/C1_T4'6_P`K'_Y$KQO!SC'-)71_9N7/_F"PCV?\"ETM
M;[/DOZ9S_7\=_P!!>)_\'5/_`)(]E_X:$^-'_10=;_*Q_P#D2C_AH3XT?]%!
MUO\`*Q_^1*\:H]J/[-R[_H!PG?\`@4O+7X?)?TP^OX[?ZWB;;?QJG_R1[II?
M[0?QF?4].5OB!K95K^T5@19<@W$8(_X].XKO?C#\>OC!9?$;Q-:VOCS68;>*
M]58XD%GM1?)C.!NM">N>YKY>TG_D*Z9_V$++_P!*8Z]$^-?_`"4[Q5_U_+_Z
M)CKCGEN7_7Z"^HX6WU:M_P`N*?2=*WV?7^F=<<=C?J51_6\3?ZQ!7]O4O;D>
MGQ;&C_PT)\:/^B@ZW^5C_P#(E'_#0GQH_P"B@ZW^5C_\B5XT.>G^?\:7!]/P
M[_E79_9N7+3ZEA%_W`I>7]WT_IG)]?QW_07B?_!]3_Y(]D_X:$^-'_10=;_*
MQ_\`D2C_`(:$^-'_`$4'6_RL?_D2O&J/_P!5']FY=_T`X3O_``*72VOP^2_I
MA]?QW_09B?\`P?4_^2/9?^&A/C1_T4'6_P`K+_Y$JU8_M!_&=KVT4_$'6R&N
MK<$8LN09D!!_T3TKQ"K=A_Q_67_7W;?^CDI3RW+N27^PX3X7_P`N*7;_``^7
MY]W>H8_'<\?]LQ/Q1_Y?U.Z_O'U7\9?CU\7[+XB^(+:T\>:S!;QM9>7$@L]J
MAK&V8XW6I/+$L>>I->7?\-"?&C_HH.M_E8__`")5/XX?\E-\1_[]C_Z;[:O)
MJYL#EN7_`%/"MX'"_P`"F[NA3_E3?V?(WQ>.QOUFLEB\3\>B5:IV7]X]E_X:
M$^-'_10=;_*Q_P#D2C_AH3XT?]%!UO\`*Q_^1*\:YZ4'C&>,].*ZO[-R[_H"
MPG2W[BETM;[/E_6IS?7\=_T%XG_P?4_^2/9?^&A/C1_T4'6_RL?_`)$H_P"&
MA/C1_P!%!UO\K'_Y$KQJCIUXH_LW+O\`H!PG?^!2UVU^'79?TP^OX[?ZWB?7
MVU3_`.2/:[?]H/XSM/"#\0=;(,L8/%CTW#/_`"Z5Z?\`&GX\_%ZQ^(>L6UGX
M[UF"".WTG9$HL\*7TJS=S\UJQ^9V8GGJ>@KY+M_^/B#_`*[1?^AK7K'QT_Y*
M7K?_`%[Z/_Z:+*N2>6Y?]>P_^Q83_=\3_P`N*?2>'M]GIK]_F=D,=C?J6(?U
MO$W5:C;]]4[3_O$__#0GQH_Z*#K?Y6/_`,B4?\-"?&C_`**#K?Y6/_R)7C7)
MXHYZ8YKK_LW+EI]2PB_[@4O+^[Z?TSC^O8[_`*"\3_X.J?\`R1[+_P`-"?&C
M_HH.M_E8_P#R)1_PT)\:/^B@ZW^5C_\`(E>-44?V;EW_`$`X3O\`P*72VOP^
M2_IA]>QW_07B?_!U3_Y(]E_X:$^-'_10=;_*Q_\`D2M?P_\`M`_&677M%CD\
M?ZV\<FK:<CJ19896O(0P/^B="#@^U>!UM>',_P#"0Z%_V&-,_P#2V'-95LMR
M[V%6V"PO\*IJJ%+I%_W?+\^YK1QV.]M13Q>)_BT]ZU3^=+^8^D/BW\>_C!9_
M$KQI:VOCW68;>WU^^BAB46>V-$E("KNM"<#H,DUYU_PT)\:/^B@ZW^5C_P#(
ME8OQC_Y*EXZ_[&/4?_1QKS2HPF6Y?]5P[>"PK_<T]70IW^&-[OE\M2L1CL:L
M162Q>)TJS27MJG\SM]H]E_X:$^-'_10=;_*Q_P#D2C_AH3XT?]%!UO\`*Q_^
M1*\:HKH_LW+G_P`P.$?_`'`I=+?W?3^F8?7L=_T%XG_P=4_^2/9?^&A/C1_T
M4'6_RL?_`)$H_P"&A/C1_P!%!UO\K'_Y$KQJBC^S<N_Z`<)_X(I>7]WR7],/
MK^._Z#,3_P"#ZG_R1[OHO[07QFDUC24;X@:VROJ5BK*198*FZB#`_P"B#@C(
M_EVK^X?X=SRW/@/P=<3R-+-/X:T:661OO2226$#.YQ@99B2<`=:_@5T/_D-:
M/_V%-/\`_2N&O[YOAK_R3WP3_P!BOHG_`*;[>OYS\?\`"X;#4>'/J^'HT>:K
MCN;V5.,.:T*-K\J5[7?WG[CX-XBO6GG2K5JM6T<-;VE24^75[<S=K_H?QG?\
M%!_^3SOV@?\`L=4_],>D5\;5]D_\%!_^3SOV@?\`L=4_],>D5\;5^^<+?\DS
MP_\`]B7+/_4*B?C.??\`([S?_L98W_U(J%JQN4L[VTNI(([J.VN89WMIL^5<
M)%(KM#)CG9*%*-[$U^I7PIUKPOXT_9._:G^+5]\,OAW;^)?A_P")/AQ:>#WC
M\-VTD6D6.M'4UU"V*O\`\?/GBTBS)/EPP)4@DY_*NOKGX8_M+^'?A[^S[\4?
M@3<?#*;74^*]YI-_K_B?_A,)=/FM[G0/M7]CFQTQ="NHHXX/M3F='NG-P>=\
M>0!S<4Y?BL=@\,L#1K5<3#,LMG+V.(]@UA*6/P];&7<JM*,E+#TYQ<;N4D^1
M)IV.G(,;0PF)K_6JM*G0G@\9&+J4?:WQ,\-4IX:R5.HTXU91E?2,;<U]#UKX
MH_LS^$KCP%X*^/>M_$7PKX%TSXG^&;K6=(\):?H-Y!C4=&$5M=Z?:0JYB#W;
MAY(G#K%YGR<`@UW'Q^_90TW5_P!H/2/`NF:GX,\":;;_``$\#>-W.AV%ZBZK
M]HMK^-FM=,G8SWFOZA]G$US'&X1B!M)*G/RW\5OVCM/^)_PJ^#7PN?P))HUM
M\(K>ZLHM53Q,][-KEI?7*W-VDENVD0)8S.P98I4DN!$I&8W*Y/O^J_\`!0:V
MU+XOVWQ<;X+Z4^H6WPBTWX3PZ=>^*KB\2V@T=;F/3]>L[O\`L."2WOTCNI5F
MC6-EDRI66+!!^7EA.-*7U:M256K4I4\[IQHNKA8QHPE6PRRM)NM:IST(5'*<
M^>4'I+E;=_=CB>&)NM2J>SA3J3RN<ZBAB'*JXTZKQ[LJ7[OEJ2CRQBHJ:U7-
MT]J^"G[(>C?"[XI?%+P/\0;;0?B!I>H?LT^*OB-X8O+[2WAN;&Y_X1^[O-.N
M?L\^);'4+.3&]-S?.@ST&/QOK]/#_P`%&Q=>-[KQQJ?P>@N+Z]^#]Y\'KJVM
MO&UU;6[:3?64MA<:I$9/#]U+'>F"4E$9I$60;B6!*U^8K%2S%%*H6)52=Q52
M?E4MA=Q`P"VT9ZX'2O9X5PW$-/&9GBL^A*$L3A<KC37M:<Z3KT(8F.)=.E2J
MSC3;YJ7-)1CSNV]M/,XAKY-.A@J&3R4H4:^.<OW<X5/9594'0YYSA%SVJ<JO
M+EU6@VMKPW_R,.A?]AC3?_2R&L6MKPW_`,C#H7_88TW_`-+(:^QK_P`"M_UZ
MJ?\`I#/FZ'\>C_U]I_\`I:.Q^,7/Q1\<_P#8QZC_`.CCZ?X5[?\`LE>)O#.G
M^.]"\,7OPBT/XG:UXI\2Z7I\C>(_-FT[3=!>1%U"2&WB*B.=(VDG:[E)CB1.
M0.37A_QB_P"2H^.?^QBU'_T<:]R_96_:6\'_`+.-[XBU;6O@SI?Q0U?7+1M.
MM[S5?$EQHR:5I\R;+F"UAM]*O7\VX!8/<"=&VG:JCK7@YO3Q%;AZI2PN$K8W
M$5,+3C2P]#$1PLY3E&,5+VTJM%14+\[7M$WRV/7R^I1I9U"IB,13PM&&(G*I
M6JT98B*BI-N/LXPJ-N?PWY7RIMGVG_PJOX`W_P`;?VU?'/@3PUI&K^"?@UX.
MTS5/!?A^X#W'A\>(IM-TC3]?>*,MBYL+3Q&-8^Q9)C:(1D94`5W6I?LR?";2
M-2\9?%J+PII4J:;^RU8?%RR\)3*S^'X?%>HV"HTOV0D;K:*;=.EL?W:DA<%1
MBOB%_P!M&SM/B#XYUOPW\'?#GA?X;>/O`MIX"UKX8Z5J]RD#Z=`7NYK\Z^UA
M]HDU.XU6XNKW[3+8N4C>*V82"$2,J_MT>+)/%^KZE>^$M/N_`NL?#:/X3W/@
M1M4N%5?"$%F+2VBCUO[(TO\`:$)`G%VUDRM+G,&T[1\#+A_C&48^RJXNE&.$
MP$%&MCH3K.E0PV$IXC"U94ZKB\54J4J\YUHMPE*II6MJ?7QSCAI*2J0P\Y/%
M8J=Z>$FJ<:E2M6G2Q$%*"DJ$(SIPC3^)*'\-;'I?Q_\`V:="UCQ7\#?$/@[1
MXO#>C?$3X.>&_B7X^M])MYI-/T4-;02:O/86L0D=&N]S):VR@`W$BJN%S7#?
M\%"?A7X%^$_Q'^'FA_#W06T/0;WX4^$]5Q)$T=Q?7EW;-)<7EXS??O)"1Y_.
M5;Y3BO/_`!3^V=\5;_Q/H6M>![M_`.F>%_!>D?#_`$#1K&Y&I^1X9T=(DAM;
MR]O+9#>S3-$'GG-M#N8G;&HXK'_:G_:D\1?M2>)/"GB+7]%AT-_"WA/3?#,5
MM#?&_6ZELTQ<ZFTAL[,Q27TI,SVX1TB8[4<BO>RC+>*L/F.0RQM15,OPN%S&
MGB5]9<JD9UJBGA57@[JM.G3Y:49*<U'ED[W:D_(S+'</UL#FL<)!QQN(Q&"G
M1DZ'+"4*4>6LZ4O^749RO4E%QBVVM.AXI\+_`/DHO@K_`+&72?\`TLBK-\<?
M\CCXH_[#NI_^E<M:7PO_`.2B^"O^QETG_P!+(JS?''_(X^)_^P[J?_I7+7VR
M_P"1A/\`[!(?^G9'RW_,#_W,R_\`3=,^A/V5?$_AO2O&VD>'[WX2Z+\4-<\3
M^(-+TZ)/$7FSZ9I^D2RHE_(EI%MVW`0O)]ID;9"B9/>ONFZ^%'P!U/X]_M@>
M,/`?AG2-2\&_!KX<6FN^&O#<@:X\.CQ:-*TZUUP0Q[BMS8V>M_;Q;KN,9(_N
M@5\/?LK_`+2/A']G+5M=U[6O@[IGQ0U?5K-M.L[C5?$=QHT6DV<R%+E+:*WT
MN]<SS@D-.)HV5/E4=37=7'[:EE;_`!$\6^(/"_P;\->%/AWXV\"_\(%XA^&V
MEZM<B*\T^8RW-Y?MX@>Q%P^ISZC/-=+<2V,@C0QP%9!'O;X+/,LS[&9QCZF6
MX7'8>C++XT(XK^T*4<+BY/%86M6BL,Z_M*57V-*="C/V5-)3JN<]4G]?E.89
M1A\MPE/&XC"U:D<6ZLJ#P4Y5L/'V%6G"3K>RY:D/:3C5J1YYZQ@E%V;7VZ_[
M,OPDAUF^^+@\):2\-O\`LE_\+IC\'LI/A_\`X2]M*<^9]DS_`,>?VA?/%KGR
MP3@#`%<:/@=\!8/BM^S+\0/&<W@OP-X:^(OPGTWQKXAT36VF@\+7_B=8A`EM
M]GA5WBM;ZX97GA0HJIOVE17RE#^W3XMC\:/JK^$M/F\!R?##_A4#^`9-4N"C
M^"OL)LA;MK?V7SO[0&3.;S[$5,I/[C'`Q]0_:S\/^)O$7A^3QS\&=%\7^`?!
M_@&W^'_A+P5?>(KZ&;1+"WC")J::_%8F:;52V9&G^PQ)O("QJ!7DT^'^,(U)
M>WQ.+E2>&JPOA\52=:-&>&J4H8:"K553EB*=:4*OM)OEDE_$TL>A/.>&[1]E
M1PO/&O3FHUL+45.56%>E4==RIP<O92IJ<.1:J_P=3T/_`(*)^$K+POXV\%/X
M?\$_"_PUX0U30KFZ\.:U\++N:[T?Q1;"[*R7EVTRJ\=W;L%A:(@[`/O'-?#7
MPZ_Y'WP?_P!C'I'_`*6PUT?Q(^)-OXUM=`T/1M"F\.>%O"PU%="TBZUJ[U^Y
MM5U2Y%U<H^HW4-MO02`"*..VA1%'W2Q9CSGPZ_Y'WP?_`-C'I'_I;#7WN48+
M$9=P]#!XJ3G6H8>M%SDVYSC[[A*I>K6_>.+7/:I)<U^6RLE\AF6*H8W.I8G#
MQ4*57$4)*,4E"+]Q2C"U.E[BDGRWA&5K75P^(G_(\^*_^P[J7_I3)7MO[,'B
MGP[HGC33M(N_A/H_Q1\0>)-;TG3+*U\0^;-I=EITUPJ7["TA()N2C%A<R'9`
MBEB,*37B/Q#_`.1Y\5]?^0[J/7_KYDKWW]EC]HOPE^SGX@UGQ-K?PAT[XH:M
MJ%BVGZ=)JGB*?1H='@F5DNFMX[?2[UWN)E.T3B6(QKPHS\U:9O3KU<AJT\-A
M:V-Q$\)35+#4:ZPTYS=.,5^^E4HJ$8M\S_>1ND]2<OG1IYQ3GB*]/#488B4J
ME:I1=>,8J3;_`':A4<G+9>Z[7N?>&H?"/]G[5_VD/VI/$/@;PSI%[X0^$7PL
MM?$6F>&LF?PXOC:/2+./6X($RPN;"SU1YE55;RS(C#C&*ZZT_9E^$D^OV/Q;
MD\):2;>/]D75?C?)X-"LOA^?Q?8:3<M%NM`P(LS<0B=K8'9DG^'%?$EY^VO9
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MZ5HX:"RN)/#7FK=_8XD#&S34!#NG$0^3<QC&<5\<?MG_``YU+P3J7@;5+3PO
MX$T'P!XITBYU+P%>>"O/D.IZ0L_EAM8N;H+<7&H1843-(HPS$+Q6EHW[=_B_
MPYXO\&ZCHOA+3H?`W@OX?S_#.Q\"WFJ3W@N_"][%)'J"7FMFTBE>^NWE>8W*
MV*QQO@+`5&#X[\?/VB=1^-UIX&T&'P[;^%/"/PZTB;2/#.AQ:A+JTT$=U.;F
MZFN=1FM[1KB264_*!;QK&@"J.N?8R/*^+<+F^!J8^I[;+Z<*\91JXA3]A2G/
M$SIQ48SYIXF*EAJ;DU4A[-22DG%-^;FV8<.8C+,53P<?9XV<J4DX47#VU2$:
M,9R;<>6-&7+5G9.$N>2?*[L\8\#_`/(Y>%O^P_I7_I;#6C\3?^2@>,/^Q@U/
M_P!*I*SO`_\`R.7A;_L/Z5_Z6PUH_$W_`)*!XP_[&#4__2J2OO?^9C_W*_\`
MN0^.7^YO_L(?_IN!ZS^S5XLT#P]XOM+"Z^%.D?%/Q'XAU?1]*TFPU_S9]*M+
M2>Z1+XFRA(9[F5#A;AR8[=`7(XK]%M4^#W[/NO\`[4O[06H^"?#&CW'A3X4?
M!^V\3#PQ$6F\-+X^MM'A.L6L"[F%Q8V=[(B.BML^T1S@=#C\_OV5_P!H;PI^
MSGXHU7Q=KGPDT[XHZK=6#6&E?VIX@FT:WT6.962ZF@C@TR^>2ZF1B@G$D+0K
M]P$DFO3K[]MNTMOB;?\`C#P5\&?#'@KP;KG@V_\`!GB/P!IVK7,\>MVNKRRW
M&J7]UKTEC'<F_GGEWPR-:2>0$"_O`>/A<^RS/,9G.+JY;A<;0IO+)4(8U8^E
M##8BK.MAZDHO#.O[2G4ITZ,J5&?LH6]I4<IK2_UN48_*<-EF&IXW$86K46.5
M:6'>#E*K0IQIU(1E[?V24U*=13J1YYZ4X)1>I]L:)^S/\(]8U_PM\6[CPAI*
M6S?LK>*?C1>^#(PT?AZ\\5:!H][-;(]LI!%E+<P))+;J=A!(P!Q7A_C:'X*_
M!O2OV:/V@_$/PGT;Q5+\3?A7J%[JW@6)1:^&[[Q5I][-ID.I36P;_1X9UC%Q
M/%"K+YA^1:\1L?V[/%NE^.=#UNP\(:8O@31?AS?_``H_X5]<ZG<SPWO@K5+*
M:QU"RN-;^RQS_;)XYG<7:60"2'(A(XKQ?XJ_'ZY^)O\`PJ[1?^$;CT;P+\)-
M$M-`\,>&/[4EU"X>SCO&OKV2_P!7>TMC-=:A</(TDL=E$D2N%2+"BO.P'#G%
M,LPI?VEB<1/+G1Y*D(8YQE'#>PQ\)8.].IS^V=6KA)>VC=\L+^UO"QW8O/,A
M6&J/`TJ$<6JG-!RPB<77]MA)?6&I4VG25*%9<CMJ_@]YGK7[8'Q!\#>+[#X:
M6_A?X1>#_A3K#Z+)KGB"P\+PR#?_`&DV=.@N)I@)':.V`D9<*H,@X/6OC_PA
M_P`C5X;_`.PYI?\`Z6PUH^/O&5WX]\4:CXEN[=;,WAB2WLHY#+'96EO&L-O:
MQR%8RZQ1J%W%%W$9VC)%9WA#_D:O#?\`V'-+_P#2V&OO\#@5EN3K"+VGN4:L
MFJE6I7E&4^:;C[2I.<I*-[*\FDE9:'R&+QCQV:K$ODM.O12<*<:46H.$4^2$
M813=KNT5OJ=#\6/^2D^-/^QAU'_T>U>A_L[^+M"\,>+;:VN?A7I?Q3\1Z]J>
ME:5HFE:[YT^E01SW<<=WOLH-KRW$R/MCF9MD"@R,/EKSSXL_\E)\:_\`8PZC
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M\6Z+XV\):UHOA#3;7P1X3\#:C\.(/`5SJEQ>0WWA+5[::UU.SN]9^RPSFYN$
MF8K<I:`1MC$35^<SX?XSGAZ4<-6Q="4,KI8>"Q&.ISK1E3P\J52C5G3JRC*O
M6J<M15DY*/\`S]T;?VRSGAF-6HZM/#U5+,*E9NEA)QARSJPG"K&,H*2ITXWB
MX.S;3]RS1]K?#?X'_`KQ)X@_91^(_C#PCI=@GQ>^&7C"YUS2K.SD/A>'Q3H$
MUU9:;KFHV<9V6NG#RUN-0^9(%VEN!7R_^W?\%]-^$7A[X5"32_"S^(O$,GB2
M_G\4>!+46_A36-"^UI_8MO`4<QR7]K`2;ED4?*R`L2#7GT'[:^K6&I>"[+3?
M`ME;_#WP/\/]>^'6E>#IM<N;B\;2/$PG.LWC^(18PRQZG/)<-)#<1Z>$@VJ@
MB9:\Y^.G[25U\8?!OPS^'MCX87PQX2^%UE?6VBV]QK4_B#5+J7475[B>]U.>
MSL2X&U5CB2V1(P.,UZ63Y'Q3A<[R[%8FM6E@8RQ*Q%&IB54A2P[GC*F%BDJK
MDZM-5:%*<>6I&:2?.G3UX\RS7A^OE.,P]"%)8MQI>QJ0P\HRJ55'"JM)WII*
M$G3JRC+F@TVUR6DVOGOPW_R,.A?]AC3/_2V&NP^,?_)4?'/_`&,6H]?^NQKC
M_#?_`",.A?\`88TS_P!+8:['XQY_X6CXZS_T,>H_^CC7Z*_^1A#_`+!)_P#I
MV)\4O]PE_P!A2_\`39V?[/WB[0O"WBN);OX7Z7\4?$&L7NG:9H.DZYYLVE0F
MXN42Y:6RAP\\TB-MC<L$A&78$"OTZUGX,_L]>+?VQO'MKX2\*Z/'X=^'/P%7
MQGXC\(V+&3PTGQ)T[17N]2TV##,)K2T%QI\=W$C;!>Q743#(85^<'[+_`,>?
M"W[/7C6?QOKOPKT_XGZ@MH]MI-MJFNS:/:Z2\H*RW<:PZ;?M-<LIVQONB\H<
MKD\U[)JO[<=M!\6+'X@^`/@OX6\`Z`_A;7O"_B;P;8:M=WP\4Q>*)Y9=;OM0
MUN6QANEN9E:!+;-M-]F,+,"XE*+\+Q!EV>XS.<14RS"XZA3_`++K4(8V./I4
M\+7K5949\DL,Z_M(RIQHNG1FJ4+2K3DZEE8^JR;'Y5ALMH0QU?#59_7Z566&
M>#G.O1I4^>*DJ_LN62G*HISCSR]VFH\KOI]I>!_V8_A'X_\`$/P2^)VH^$M+
MM+?Q#\$_&GQ$U[PE8J8-"U'6_"EI<26:M:J04MYY5C::*/"LJD=,FLKX?_L_
M_!#XAWW[+'Q(\5Z'X?\`#DGQ,\%^-[K4]!B==.\-ZMXI\-?;(]"CE@9E2..\
MGCA6XA5E67!7J2*^--._;K\6^'_&G@+6?#/A'3M-\%^`?"FI>";#P-<ZI<:A
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MU^=&@_\`(<T?_L*6'_I5%7L'QU^/_C#X\:SI%[X@BM-+T7PUIR:/X6\-:89C
MINAZ9&<K#`T[M+-,_6>YF)DF?YFQTKQ_0?\`D.:-_P!A33__`$KBK[_A_`X_
M+LBAALRK.MBU]:J3;J2J^SA5G4J4Z/M).3E[&$E"_,]K)V/D<WQ>#QN<^WP-
M)4L.YX:$4H*'/*G&G"=3DBDH\\TY;+?9'=?&?_DJ'C/_`+#,_P#):]=_95\3
M^&]*\;:1X?O?A+HOQ0USQ/X@TO3HD\1>;/IFGZ1+*B7\B6D6W;<!"\GVF1MD
M*)D]Z\B^-&?^%H>,O^PQ/_):]E_97_:1\(_LY:MKNO:U\'=,^*&KZM9MIUG<
M:KXCN-&BTFSF0I<I;16^EWKF><$AIQ-&RI\JCJ:>:TZ];AZI3PN$K8W$3PE.
M-+#T,1'#5)S<8I/V\JE)14+\[_>1<K61.7U*-+.H5,17IX:C&LY5*U6B\1",
M4TVO9J%1R<K<J?*[7N?<-U\*/@#J7Q\_;`\8>`_#.CZEX-^#7PXM-=\-^')-
MUQX='BT:5IUKK@BCW%;FQL]:-^+=03'E<=`!7+>+O@U\(])_:4_9.%YX$T^\
M\,_'SPMX`U'Q#X7M[N>QTRRU7Q)+:VMY=V:PG>D*.S3):[A&2=N5'->`S_MJ
M65M\1/%WB#PO\'/#?A/X>>-_`O\`P@7B#X;:7J]T(KO3Y3+<W>H-K[6(N'U.
M?4;B:Z2XDLG\I#'`1((]YYV3]KJ34/C9\+_BMKG@2/4-%^#MAX?T[P+X)@\1
MSV<=G;^&/+;2?MVLG3+B:\82QB6ZQ9P>>QP/+'%?$4,CXKBI2<L:J:R7ZO3I
MU,?3GB/:QRN-"G1J3C6Y/K/UU>WJ5U+DNW:I);_4U<UX?DDE]5<WF4:TY0P<
MX4N1XWVLZL4Z?,J/U9NE&FU?1?NT?2O@[X&_#C4?VN?VLK.Y\-:?+X8^#NF_
M$+Q'X9\+.I&D^?HD#G3;66'.9+:%\,8LX;&&X->'?ME_#CPCX>\+?L]?$GPQ
MHECX<NOBQ\.SKNOZ3I2&+38M3L[Q[1YK6WR5A6=55F1?EW#(`S6*?VQ)['X]
M_$'XT^'_``#!IMA\4[+6K#QOX*N_$4^H6NHV_B"%X=46TU7^S+::R\S<)(,V
MD_DN/XU^6O)OCG\>-0^,W_"%::FA0^&/"OP\\.Q^&O">@Q7\NJ/96"R-/,]Q
MJ$T%JUS//,Q=G^SQ`#"A<"O3RS*>):>;Y-B<34K0PM#`86GC8SQ,9IRAEWL*
MU"4(U)J=26-Y:_M%=246^>[L>?C\PR2>69AAZ$:<L14Q>(GAW"A*+M/%JI2J
M1E*$7"$:%Z?(VFF_A=KGB.D_\A73/^PA9?\`I3'7HGQK_P"2G>*O^OY?_1,=
M>=Z3_P`A73/^PA9?^E,=>B?&O_DIWBK_`*_E_P#1,=?<S_W^A_V#5O\`TY2/
MEH_[C4_["(?^D'IG[,'BGP[HGC33M(N_A/H_Q1\0>)-;TG3+*U\0^;-I=EIT
MUPJ7["TA()N2C%A<R'9`BEB,*37Z`:A\(_V?M7_:0_:C\0^!O#6D7O@_X1?"
MRU\1:9X:R9_#@\;1Z/9QZU!"FXBXL++5'F"@,8S(CC`P17P=^RQ^T7X2_9S\
M0:SXFUOX0Z=\4-6U"Q;3].DU3Q%/HT.CP3*R736\=OI=Z[W$RG:)Q+$8UX49
M^:O0[O\`;7L[?XD:]XH\(?!KPSX.\">*?!%QX&\0_#O3-7NGCU.ROGEN+_4)
MM?>R6X;4)[R9YXY7LI/)4)$?,`W'X3/<LSW&9QC:F6X7'8>E++?80Q:Q]*&&
MQ526(P]:<?J[K^TIU(TZ4J5&:I4TO:5G*IJD?691C\HPV686GC:^%JU5CO:R
MH/!SE6H4U2JP@_;>RY9Q<YQJ5(\\V^2*4=&>W>/?A#\)M(^/7[']]=>!;"[\
M._'_`,.^`;CQ1X3M+J;3M,M-3\2ZG8Z3=WMF("7C1#,]PEJ"J%OER!FL+3OA
MO\+(O^"E'B;X2:MX#T[5/`5S\3)?#NG>'UN)[*QTNW%O:O"T<<!+3+&VXF%V
M"/DANM>!W_[69UGXP?";XD:WX$2[\.?!6T\.V?@;P/;^(IK1+:+PO<07>E?;
MM<.F7$UW_I4"S76VQA\\_*/+7@ZW_#6WAS_AJJ?]J+_A4S_VE/J__"1OX4_X
M36X^P_\`"0^6D?VS^T?[!\\6I6-3]C^SG#9;SL?+7/3RCB>FJD:JQE;FX9QV
M#BX8VG%1S&IC55PD8WKQ<:U/#)4Y8A:.UG49M/,<BE.G*G+#4XQSS"XB2EA9
MWE@H894\0WRTFG3E5<I*D[/JHG@/Q^T72_#OQH^)>AZ+9Q:?I6E>,-:L;&R@
M&(;6VM[V2.*&,9)"(@4#)KRNP_X_K+_K[MO_`$<E>A_&/Q[I?Q/^(WB?Q[I7
MAM_"L?B?4[C5KC1GU9]:6WO+MS+<F*]>SL7,3RLQ1&@!12%W-UKSRP_X_K+_
M`*^[;_T<E?H.`C7AEN$AB8RCB(8.E"M&<E*2JQI)34I1<HR?,G=J33WN?'8N
M5*>/Q$Z#C*C/$SE2<8N,7"51N/+&23BK-632MM8].^.'_)3?$?\`OV/_`*;[
M:NZ_9J\6:!X>\7VEA=?"G2/BGXC\0ZOH^E:38:_YL^E6EI/=(E\390D,]S*A
MPMPY,=N@+D<5POQP_P"2F^(_]^Q_]-]M7I_[*_[0WA3]G/Q1JOB[7/A)IWQ1
MU6ZL&L-*_M3Q!-HUOHL<RLEU-!'!IE\\EU,C%!.)(6A7[@))->9CX5ZG#LZ>
M&PM7&UYX.$:6&HUUAIU9.*LO;2J4E!)^\_WD;VLF=V$G2IYU3G7Q$,+1C74J
ME>I1=>,(JU_W2A4YVUHO=:3UZ'Z`ZI\'OV?=>_:E_:"U'P3X9T>X\*?"CX/V
M_B8>&(BTWAM?'UMH\)UBU@7<PN+&RO98XW16V?:(YAV./*OB-\*/A5IOQ8_8
M[U^Y\"Z?-H?Q[TWP1%XK\)V-U-IVF0WWB/7M/T*YO;/R,R0B);IKE(`45W4#
M(4DUY#??MMVEM\3;_P`8>"O@SX9\%>#=<\&W_@SQ'X`T[5KJ>/6[75Y99]4O
M[K7I+&.Y-]/-+OAD:TD$`0+^\!XXK5_VK1K_`,4OA#XWUCP(DWA3X)IX?7P7
MX'MO$4]OY?\`PC-[!J6F&^UUM,FFN,WMM'-<[+"+S@"B^6.:^)PN2<4P]E*<
ML;&E3R?ZLJ53'4YXCVD<OJ4%2G.%;D=>6*]G6=52<;+^+IK]57S;A^4:D8K"
MNI+,57YX8.4::@\7"JZD4Z;E[)4.>FZ=E)_R:GIGQI_X5_\`!?\`;4^,OAW1
MOA1H_BZQTWQ9::'X+\'7:S'0;&6XT_2.);&+]Y=`F>4I&'QYLA9LYK#_`&^M
M*^%&D_$;PG!\-?#FE>$]1E\%:1=>.M`T,LVEZ7XEN8A+<6EOEF"M$K`2H#E'
M^4U:'[97@:?]IS7_`-I;5_@)9:UJFO.+]_"NH>-KF72K371;PV@U:"X_X1_S
M21;V\0CMC$%CE'F+*?NCR;]IG]H3PW\>]9TK4_#7PB\/?"F&Q^VSW\.CZI<Z
MS=:U?WTHDEO+Z^NK.SE)4`+'%L=4Y(;G`];*<#G-/,^'Y8O`X^"P>24L/F&,
MEF%*>'JXSZO3A4A6PZQ,Y57"=-RC5C2ES3FWSV1YN/Q>62R_.*=#%X2<\3F<
MZV#H1P=2-6&&]M*<94ZSI04.>,TG"4K1C!+E;/F.W_X^(/\`KM%_Z&M>K_'3
M_DI6M]_]&T?G_N$65>46_P#Q\0?]=HO_`$-:]8^.G_)2]<_Z]]'_`/3395]M
M4_W[#?\`8/BO_2\,?,4_]RQ'_7ZA^4SJ/V=_%VA>&/%MM;7/PKTOXI^(]>U/
M2M*T32M=\Z?2H(Y[N..[WV4&UY;B9'VQS,VR!09&'RU^EFM?!O\`9Y\2?M<_
M&,^"_#&C-X7^&'P3@\5ZCX5MF:;PVOQ&L=&\[5K&VP[+/96<L]G'.B/L^V17
M2$9#"OSN_9;_`&@/"W[.WC"]\::W\*-.^*&J/9/9:1'JFO3:-;:/YRLEQ<PI
M!IE^TMU(C%4EW1&$<ISS7K&H?MO6MM\4AXX\"?!GPQX%\*WWA'6/"/B3P-I^
MKW=VOB*#Q!/-/K%_>Z[+917/VRX9X_(9K27[,8R0T@<J/A<^RW/<7G.)JY9A
ML=0I_P!EU*$,:L?3AAJ]:I4H3<7AG7]I"=.%%TJ,U1@E*K4DYI6O]7D^/RG#
MY9AX8ZOAJM19A3K/#2P<Y5J-*$*D.;VWL^6:G*HIU(N<O=A%1AN>H?%#X7_"
MW3O&?['_`(SG\"Z;)I?QQLO#<'BWPG87,VF:7]KU;7+31I;RV\@%X-J7)G$2
M85W0#(!KRO\`:7T;P+\'_P!M[XB>'-#\$>'KGPKH/BC2].T3PSJDD]MX<LFN
M-(TDQ37ZQ$R36<4\SW%S$6429<LW:N%\0?M31^)O'_PA\1:IX$7_`(0SX++I
M`\(^![;Q'/$W_$DOXM3LS>Z\VF22R[KR&-Y]EA'O1?+78,DZ7Q#_`&G_``'\
M3/C_`.)OC?XJ^!MAJ=KXQL)X=>\&7GC"\FM3JDEC%80ZOINJIH\,]C/;Q01/
M%&UM<*)5W!ADBEE^6Y_AJ^&>+HXS$T%D>98:M"&,I_[S6QU"K@J=IXB-ZU/#
M1JQ=:UE\+J6=QXO'9/B*598>IAJ%1YK@J].4L-.[HT\+.&)GS*B_W<Z[C)4]
M[+FY+Z'KO_!17X6>'_!&J_"7Q-X3\":#X4TCQ?X'M+B]U3PE,LWA77=<1$EO
M)-(`=WC2$2`,'"ELY&>:_._PW_R,.A?]AC3?_2R&O<_C=^T1JGQ?\/>`/!-M
MH@\->"/AK8W5EX8T5]5GUR[B^VR;[B:ZU2YM[62=V`5$401I&B!5%>&>&_\`
MD8="_P"PQIO_`*60U]%P_A,?@>'Z>%S*[Q5*&*3<JCJS=+GJ.A[2;G4O4]DX
M*:4Y135HMJQXN<8C!XO.GB,"DJ%2>&=HPY(^T4:<:O)'EA[G.GRMQBVM6KG8
M_&/_`)*EXZ_[&/4?_1QKL_V?O%VA>%O%<2W?POTOXH^(-8O=.TS0=)USS9M*
MA-Q<HERTME#AYYI$;;&Y8)",NP(%<9\8_P#DJ7CK_L8]1_\`1QKT[]E_X\^%
MOV>O&L_C?7?A7I_Q/U!;1[;2;;5-=FT>UTEY05ENXUATV_::Y93MC?=%Y0Y7
M)YKHS"-:>0U(8?"U<;7E@XJEAJ-98>=6?+'EC[:52E&"OJVZD;I63,,).G#.
M(RK5Z>&I+$R=2O4I.M&G#F=VZ2A4<GT2Y7J[GZ/ZS\&?V>O%O[8WCVU\)>%=
M'C\._#GX"KXS\1>$;%VD\-I\2M.T5[O4M-@PS"6TLQ<:='=Q(^P7L5W$PR&%
M>#?%KX<?#'3KW]D7XDR^!M,:S^,MKIUOXO\`"6GSS:7I4]S<:U!I374'V<-)
M;D).)=D8"NR@9`R:\^U3]N.V@^+%C\0?`'P7\+>`=`?PMKWA?Q-X-L-7N[X>
M*8?%$\LNN7VH:Y+8PW2W,RM"EMFVF%L8F8%Q*47S;Q5^U!!XN\6?"2\U#P((
M?`/P;6Q7POX&M?$<R2O]AODU*,WFOMI;2.9+N.,R[-/3,2^6NW[U?"9?DG%-
M*I@I57CHX>EEL:,Z5;'TZN(YH86O1E2G.%=PE6J5Y4:L:J<E%1LZJ<;GUF+S
M;(9PQ"A]6=6IF'MHRIX24*7+*O0FJD8RI75.%)5(.'*N9W:@KZ>C?M8_`K3O
M^&TO'_PD^&.AV^AZ!IMYIP@L[..5K32-*M]$L;G4+UU422%(H_-GD."TDAP`
M6:MK]N3X0?#WX5^"OV:9/A]H<UA!XE^'5SJ6LZK=VTEO?:UJG]H%9+J\#C*N
M5_U4)PT<)3(Z&O*_C#^UWXC\>?'?6/C_`/#[1KCX5>+O$%I]FUA++7/[?AG8
MVT=E(T#76EV7D136T4:20,DH+`L&`.*J?M)?M<^,/VE/#7PI\/\`BC3(K%_A
MGH,VE2WZ7HNY/$-_<.AFU>>$65JMC+(B)&;:)YHP%R'Y(KUL#@.*57X.>(;C
MA,OP?L\WA+%)UGB/J#I2E7493CB?WZBZ<HU)ZMS:5KGGXS&9"Z7$BH6>(Q>)
MY\OE'#M4O8?68S4:3DE*@U2<E*+C'163:T/EW0_^0UH__84T_P#]*X:_OF^&
MO_)/?!/_`&*^A_\`INM_K_,U_`SH?_(:T?\`["FG_P#I7#7]\WPU_P"2?>"O
M^Q7T3_TWV]?EWTAOX'#7_7W'_P#I%`_0O!;^)G?^##_FS^,[_@H/_P`GG?M`
M_P#8ZI_Z8](KXVK^M7XU?L2?L4_$+XI>,_&GQ`T3QI<^,O$&K?;?$$VG^*-0
ML[.2]%I;0;H+:&,QQ)Y,40VJ2-P)[UY=_P`.\O\`@GS_`-"[\0/_``L=4_\`
MC=>[D?C!P[@<ERG!5LOSR57!Y=@L-4E3PE"5.4Z&&I4Y2@WBHMP<HMQ;2;CK
M;H>1FGAAGN+S+'XJGBLL5/$8S$UH*>(J*:A5K2G%22HM*24E=)M7TN[W/Y>Z
M*_J$_P"'>7_!/G_H7?B!_P"%CJG_`,;H_P"'>7_!/G_H7?B!_P"%CJG_`,;K
MU?\`B-7#/_0MS_\`\(L/Y?\`47Y_@<'_`!"CB#_H+RK_`,**G6W_`$Y\_P`N
M^G\O=%?U"?\`#O+_`()\_P#0N_$#_P`+'5/_`(W1_P`.\O\`@GS_`-"[\0/_
M``L=4_\`C='_`!&KAG_H6Y_T_P"8+#^7_47Y_@P_XA1Q!_T%Y5_X4U/+_ISY
M_EWT_E[HK^H3_AWE_P`$^?\`H7?B!_X6.J?_`!NC_AWE_P`$^?\`H7?B!_X6
M.J?_`!NC_B-7#/\`T+<__P#"+#^7_47Y_@P_XA1Q!_T%Y5_X45/+_ISY_EWT
M_E[K:\-_\C#H7_88TW_TLAK^FK_AWE_P3Y_Z%WX@?^%CJG_QNK5C_P`$^/\`
M@G_;7MG<6WA[Q\+BWNK>:`MXPU-E$T4J/$64QX*AU7(/!'!J*GC1PU.E4BLN
MSY.4)Q5\'A[7<;*_^U^>NFEGV+I^%6?PJ4YO%Y4U&<).V)J;*47I^Y^[Y=]/
MYO/C'_R5'QU_V,>H_P#HXUYI7]47BC]@3]@S6/$&K:IK/A_QV^J7U[/<7S0^
M+=2BB-Q(Y:0QQK'M5<G@#@=.U8/_``[R_P""?/\`T+OQ`_\`"QU3_P"-U&'\
M:.&Z="E"66Y]>%.,7;!X>S<5%77^UK1^FR'6\*\_J5:DUBLK2G4E))XBI>S=
MU_RYWU^^W?3^7NBOZA/^'>7_``3Y_P"A=^('_A8ZI_\`&Z/^'>7_``3Y_P"A
M=^('_A8ZI_\`&ZV_XC5PS_T+<_\`_"+#^7_47_5F9_\`$*.(/^@O*O\`PIJ>
M7_3GS_+OI_+W17]0G_#O+_@GS_T+OQ`_\+'5/_C='_#O+_@GS_T+OQ`_\+'5
M/_C='_$:N&?^A;G_`/X18?R_ZBWW_!]@_P"(4<0?]!>5?^%%3R_Z<^?Y=]/Y
MMOA?_P`E%\$_]C+I'_I9'6;XX_Y''Q/_`-AW4_\`TKEK^G/P_P#L`?L#Z7KF
ME:CIGA_QZFHV5_;7-DTOB[4I(UN8I5>$NC1X90X&0>HXJOJW_!/S]@*^U/4+
MR]\/>/FO+F\N)[HIXOU-%,\LK-(501X5=Y.`.![US+QFX;^MNM_9V>\KP\:=
MOJF'OS>T<F[?6MDGWW3-_P#B%N??5O9?6LKYO;N=_K%2W*X0C_SYWNM/+\/Y
M:Z*_J$_X=Y?\$^?^A=^('_A8ZI_\;H_X=Y?\$^?^A=^('_A8ZI_\;KI_XC5P
MS_T+<_Z?\P6'\O\`J+\_P9A_Q"CB#_H+RK_PIJ>7_3GS_+OI_+W17]0G_#O+
M_@GS_P!"[\0/_"QU3_XW1_P[R_X)\_\`0N_$#_PL=4_^-T?\1JX9_P"A;G__
M`(1X?R_ZB_-_<'_$*.(/^@O*O_"BIY?].?/\N^G\O==G\.O^1]\'_P#8QZ1_
MZ6PU_2C_`,.\O^"?/_0N_$#_`,+'5/\`XW6KH?\`P3^_8%T[6-,O].T#QXM_
M9WMM<V;2>+]3=%N(I5>(NAC`8!P"5)`(XSS6-?QHX:J4*L%EV?*4Z<XJ^#H6
MO*-E=K%Z+77Y[FE'PKS^%6E-XO*VHU*<G;$5+V4HMV_<[VV^7?3^9CXA_P#(
M\^*_7^W=1S_X$O\`Y[5QM?U,:W_P3^_8%U#5]1OM0\/^/6OKN\GGNC'XOU-(
MS/)(SR%$$9"@NQ(`Z=.@%9?_``[R_P""?/\`T+OQ`_\`"QU3_P"-U5'QHX:A
M2I0>6Y]>%.$7;!X>UXQBO^@O:]_DMN@5?"O/YU:DUB\K2E.35\14O9M-?\N=
M]?OLNI_+W17]0G_#O+_@GS_T+OQ`_P#"QU3_`.-T?\.\O^"?/_0N_$#_`,+'
M5/\`XW6G_$:N&?\`H6Y__P"$6'\O^HO^K,S_`.(4<0?]!>5?^%-3R_Z<^?Y=
M]/Y>Z*_J$_X=Y?\`!/G_`*%WX@?^%CJG_P`;H_X=Y?\`!/G_`*%WX@?^%CJG
M_P`;H_XC5PS_`-"W/_\`PBP_E_U%^?X/L'_$*.(/^@O*O_"BIY?].?/\N^G\
MTG@?_D<O"W_8?TK_`-+8:T?B;_R4#QA_V,&I_P#I5)7]+>D?\$_/V`['5-/O
M+'P_X^6\M;RWN+5G\7ZDZ+/%*KQ%D:/#`.`2IX/2IM?_`&`?V"-4UK4]0U3P
M_P"/&U"[O)Y[QHO%VI1QM<2.6E*1K%A%+<A1P,X%<W_$9>&_K?MO[.S[E]@J
M=OJ=#FOSIWM];M:W6^Z:\WO_`,0LS_ZO[/ZUE=_;<]_K%2UG&*M?V.]UMVLS
M^62BOZA/^'>7_!/G_H7?B!_X6.J?_&Z/^'>7_!/G_H7?B!_X6.J?_&ZZ?^(U
M<,_]"W/^G_,%A_+_`*B_/\&8?\0HX@_Z"\J_\*:GE_TY\_R[Z?R]T5_4)_P[
MR_X)\_\`0N_$#_PL=4_^-T?\.\O^"?/_`$+OQ`_\+'5/_C='_$:N&?\`H6Y_
M_P"$6'\O^HOS_!A_Q"CB#_H+RK_PHJ>7_3GS_+OI_+W71>$/^1J\-_\`8<TO
M_P!+8:_IB_X=Y?\`!/G_`*%WX@?^%CJG_P`;J]IG_!/K]@&TU&QNK/P_X^6Z
MM[NWGMF;Q?J;J)XI4>(LICPP#JN1W''>LJWC1PU4I5(++L_3E"44W@L/9<RL
MK_[7YZ]K/?KI2\*\_A5IS>+RIJ%2$VEB:FJC*+=OW/W?+OI_-A\6?^2D^-?^
MQAU'_P!'M7GE?U/>(_V`OV"=6UW5=2U70/'CZE>WLUQ>M#XNU.*,W$C$R%(Q
M'M12V2%'`[5B_P##O+_@GS_T+OQ`_P#"QU3_`.-TJ'C/PW3HTJ;R[/FX4X1;
M6#H6NHQ6E\6M+WUMLKA5\*\_G5J36+RM*4Y-7Q%2]FTU_P`N=]?OLNI_+W17
M]0G_``[R_P""?/\`T+OQ`_\`"QU3_P"-T?\`#O+_`()\_P#0N_$#_P`+'5/_
M`(W6W_$:N&?^A;G_`/X18?R_ZB_ZLS/_`(A1Q!_T%Y5_X4U/+_ISY_EWT_E[
MHK^H3_AWE_P3Y_Z%WX@?^%CJG_QNC_AWE_P3Y_Z%WX@?^%CJG_QNC_B-7#/_
M`$+<_P#_``CP_E_U%^?X/L'_`!"CB#_H+RK_`,**GE_TY\_R[Z?S*>'/^1AT
M+_L,Z9_Z6P5V7QC_`.2I>.O^QCU'_P!'&OZ0['_@GQ_P3_MKVSN+;P]X^%Q;
MW5O-`6\8:FRB:*5'B+*8\%0ZKD'@C@UJ>*/V!/V#-9\0:MJFLZ!X[?5;Z]GN
M;YH?%NI11-<2.6D*1K'M523P!P.G:N9^,W#?UN%99=GO*J#IM?4Z',FYJ5[?
M6K6MOKOH;KPMS_ZLZ/UK*^9UXU+_`%BI:W)RV_@[W>GEV/Y7:*_J$_X=Y?\`
M!/G_`*%WX@?^%CJG_P`;H_X=Y?\`!/G_`*%WX@?^%CJG_P`;KI_XC5PS_P!"
MW/\`I_S!8?R_ZB_/\&8?\0HX@_Z"\J_\*:GE_P!.?/\`+OI_+W17]0G_``[R
M_P""?/\`T+OQ`_\`"QU3_P"-T?\`#O+_`()\_P#0N_$#_P`+'5/_`(W1_P`1
MJX9_Z%N?_P#A%A_+_J+\_P`&'_$*.(/^@O*O_"BIY?\`3GS_`"[Z?R]UJZ#_
M`,AS1O\`L*Z?_P"E<5?TW_\`#O+_`()\_P#0N_$#_P`+'5/_`(W5FS_X)[_\
M$_H+NUG@\/>/Q/#<0RPEO&&ILHECD5XRP,>"`X!(]*BIXT\-RA.*RW/KRA)*
M^#PZU:LO^8I]_P`'O;6Z?A5G\*E.;Q>5-1G"3MB:FRE%Z?N?N^7?3^<+XT?\
ME0\9?]AB?^2_US7E]?U1^*?V!?V#-9\0:IJFLZ!X[?5+VZ>:]:#Q;J441G;&
MXI&L>%'3@$XK`_X=Y?\`!/G_`*%WX@?^%CJG_P`;J,/XS\-TZ%&G++L^;A3A
M!M8/#V;C&*NO]K6CW]$56\*\_J5JDUBLK2E-M7Q%2]FU;_EPNC_)>G\O=%?U
M"?\`#O+_`()\_P#0N_$#_P`+'5/_`(W1_P`.\O\`@GS_`-"[\0/_``L=4_\`
MC=;?\1JX9_Z%N?\`_A%A_+_J+_JS,O\`B%'$'_07E7_A34\O^G/G^7?3^7NB
MOZA/^'>7_!/G_H7?B!_X6.J?_&Z/^'>7_!/G_H7?B!_X6.J?_&Z/^(U<,_\`
M0MS_`/\`"/#^7_47Y_@^P?\`$*.(/^@O*O\`PHJ>7_3GS_+OI_,7I/\`R%=,
M_P"PA9?^E,=>B?&O_DIWBK_K^7_T3'7]&]M_P3V_X)^17$$L7A[Q^)8IHI(B
M?&&J$"1)%9"1Y?(#`9'<?G6UXK_8'_8.UO7]1U36]`\=OJEW*'NV@\6ZG%$7
M"*HVQK&0HV@<`]>:YI>,W#;Q=*JLNS[EC1G!IX.AS7G*#O;ZW:R2UUWT.B/A
M;GRPTZ/UK*^:5:$T_K%2UN6S7\'?56Z6WL?RM45_4)_P[R_X)\_]"[\0/_"Q
MU3_XW1_P[R_X)\_]"[\0/_"QU3_XW73_`,1JX9_Z%N?]/^8+#^7_`%%^?X,Y
M_P#B%'$'_07E7_A34\O^G/G^7?3^7NBOZA/^'>7_``3Y_P"A=^('_A8ZI_\`
M&Z/^'>7_``3Y_P"A=^('_A8ZI_\`&Z/^(U<,_P#0MS__`,(\/Y?]1?F_N#_B
M%'$'_07E7_A14\O^G/G^7?3^7NK=A_Q_67_7W;?^CDK^GG_AWE_P3X_Z%WX@
M?^%CJG_QNI(?^">G_!/M)8GC\/?$`2)(CH3XQU3`=6#*3^[Z;@,CN*F7C5PT
MXR2RW/[M-*^#P_735_6_/7Y_-Q\*>($XOZWE6C3_`-YJ=U_TY\_R[Z?SH?'#
M_DIOB/\`W['_`--]M7DU?U4>+?V"/V#]<U^^U/7-`\=R:G<F$W+P>+-2AC)2
M&.--L:Q[5_=JH..IY[US?_#O+_@GS_T+OQ`_\+'5/_C=8X7QFX;I8>C2EEV?
M.5.G"#:P="S<5%75\6G;Y;+8UK^%F?U:U2I'%Y6E*5U?$5+]/^G.^OY=S^7N
MBOZA/^'>7_!/G_H7?B!_X6.J?_&Z/^'>7_!/G_H7?B!_X6.J?_&ZZ/\`B-7#
M/_0MS_\`\(L/Y?\`47_5F8_\0HX@_P"@O*O_``IJ>7_3GS_+OI_+W17]0G_#
MO+_@GS_T+OQ`_P#"QU3_`.-T?\.\O^"?/_0N_$#_`,+'5/\`XW2_XC5PU_T+
M<_\`_"/#]E_U%]W^#]`_XA1Q!_T%Y5_X45/+_ISY_EWT_F!M_P#CX@_Z[1?^
MAK7K'QT.?B7K9_Z=]'_]-%E7]%,?_!//_@GT'1E\._$#<K*5_P"*QU3[P88_
MY9^N*Z/Q?^P3^PAKFO76I:[H'CJ34YH[5)F@\6ZG#&4AMHH80(UC(!$*("1U
M.2>37/+QFX<>*HU5EN?<D*5:#O@Z'->I*BTTOK=K+D=]=/F;P\+<_CAZM)XK
M*^:=2E)-8BHU:/,G?]S>_O*W?R/Y5:*_J$_X=Y?\$^?^A=^('_A8ZI_\;H_X
M=Y?\$^?^A=^('_A8ZI_\;KI_XC5PS_T+<_Z?\P6'\O\`J+\_P9A_Q"CB#_H+
MRK_PIJ>7_3GS_+OI_+W17]0G_#O+_@GS_P!"[\0/_"QU3_XW1_P[R_X)\_\`
M0N_$#_PL=4_^-T?\1JX9_P"A;G__`(1X?R_ZB_-_<'_$*.(/^@O*O_"BIY?]
M.?/\N^G\O=;7AO\`Y&'0O^PQIO\`Z60U_35_P[R_X)\_]"[\0/\`PL=4_P#C
M=6K'_@GQ_P`$_P"VO;.XMO#WCX7$%U;S0%O&&ILHFBE1XBP,>"H=5)!ZCBHJ
M>-'#4Z52*R[/DY0G%7P>'M=QLK_[7YZZ:6?8NEX59_"I3F\7E5HSA)VQ-392
MBW;]S]WR[Z?S>?&/_DJ7CK_L8]1_]'&O-*_JB\4?L"?L&:SX@U;5-:T#QY)J
MM_>SW-\T/B[4HXC<2.3(8XUCVHN>BC@=.U8/_#O+_@GS_P!"[\0/_"QU3_XW
M44/&?ANG1I4WEN?7A3C%M8/#V;BHJ_\`O>S_`"0ZWA7G]2K4FL5E:4ZDI)/$
M5+V;NO\`ESOK]]N^G\O=%?U"?\.\O^"?/_0N_$#_`,+'5/\`XW1_P[R_X)\_
M]"[\0/\`PL=4_P#C=;?\1JX9_P"A;G__`(18?R_ZB_ZLS/\`XA1Q!_T%Y5_X
M4U/+_ISY_EWT_E[HK^H3_AWE_P`$^?\`H7?B!_X6.J?_`!NC_AWE_P`$^?\`
MH7?B!_X6.J?_`!NC_B-7#/\`T+<__P#"/#^7_47W?X/T#_B%'$'_`$%Y5_X4
M5/+_`*<^?Y=]/YC]#_Y#6C_]A33_`/TKAK^^;X:_\D^\%?\`8KZ)_P"F^WK\
MDK/_`()[_P#!/V"[M9H/#WC\30W$$L);QAJA42QR*\9(\OD!P,CH<>E?L9H-
ME8Z9HFDZ=INY=/L=/M+6Q65M\@M8(4C@#N>781JH9CRQ!)YK\;\6^-\KXOIY
M-'+L-F&'>"GBI5?KU"G14E5C24?9\E:K=KE=[V\KGZ=X<\)YAPS/,GCJV$J_
M6HT53^K5)5+<C;?-S0A;I:U[^1\)?$__`)'[Q/\`]A`?^D\%<'7=?%%TC\=^
M*'D941;_`"SNP55'V>`DEF(``]2<"O._MUEL\S[7:[-VW?Y\6S=C.W=OQNQS
MC.<5\KA?]VP__7BCO_@CW?=GU]7^+/\`Q/\`,M457CN[68E8;FWE8#<1'-&Y
M`'4D*Q(`]3Q3#?V(&3>6@!)`)N(0"5QN'W^HR,CMD9K?Y_/\OOZ$??\`<6Z*
MJK?V3L%2\M79CA56XA9B?0`.23]!4CW$$3*DLT,;O]Q'D1&?M\JLP+<\<`T"
M)J*:SJBEG944=68A5'U)P!064+N+*%QG<2`N,9SGIC'.?2C^OZV`=5BT_P"/
MJV_Z^(?_`$8M4WFAB0222QQQG&'=U1#GIAF(7GMSS5NS(-S:D$$&>`@@Y!'F
M+R#TQ2E\+]'I_7]?@-;KU1HZ_P#\AC4?^OJ7U_O'UK'K7U[_`)#&H?\`7S+_
M`.A'\/RK(H6R]%^02W?JPHHHIB"BBB@#2T?_`)"NG?\`7Y!_Z,6HM1_X_P"\
M_P"OF;_T,U)HS`ZKIV"#_ID'0Y_Y:+Z52UNZMK&;4;N]N(;6UMI;B6XN;F1(
M8(8T9B\DLLA5(T49+.Q``R216?\`R]_[A_\`MW7KIWV'T7J_RB1T5RVC>.?!
MGB*0P:!XK\.ZU,O6/2M8T^_<8)!W+:SRL#GUY%:5OX@T*Z;4DMM8TRX?1W:+
M5EAOK:1M-D1-[I?!)";5E3YRLVPA>>E6G?:S7=:BU[&O16+HGB/P_P")()+K
MP]K>EZY;0R&&6XTJ^MK^&.4=8GEM9)460=T8AAZ5>L=1L-3@^TZ;>VM_;^9+
M"9[.>*YA$T#F*:(R1,ZB2*1621,[D<%6`((IW`N5H:3_`,A.Q_Z^H?\`T,5G
MUH:3_P`A.Q_Z^H?_`$,4I;/T?Y#CNO5?F)JG_(1O?^OF7_T,U0JA<>*?#FH^
M+_$OA:PUO3+SQ'H`L[[6]%M[R&74M)M-6EO$TRXO[1',UM%?M8W@M7E11-]E
MFV$[&JU//#:PRW-S+'!;P1M+--,ZQQ11H"SR2.Q"HBJ"69B``,DXHB[Q5M59
M?\'[@L^S^XEHKDM+\>^"-;,PT?Q?X;U4VRN]P-/UK3[PP+$#YAE%O<2&/RPI
MW[L;,$-C%:7A_P`2Z!XKTR/6?#6L:?KNE3R3PQ:CI=U%>6<LMM*T,\:7$+/&
M[Q3(\<@#':ZD'!%%U>UUUM9I[6O_`$K_`(B-NBBBF!=TW_C_`+/_`*^8?_0Q
M4NK_`/(4OO\`KYES_P!]&L^"_L;&_P!.-[>6UH)[ZWAA^TSQ0>;*\BA(X_,9
M=[L>`JY8]A5W6I$CU#4))'5(TGF9W<A55022S,3@`#DG.`*F_O\`_;NOWCUY
M5ZO\H^10HJM9WMKJ%O'=V5Q%=6TN[RYX'$D3A6*DHZDA@&!&0:LU0@HK+;6]
M'34TT9]4T]=7DB,\>F->0+?R0C@RI:&03,@/5E0@=S4G]JZ8+R33SJ%G]NBC
M\^2S^TP_:DBQ_K&@W^:%P/O%`,4?U_7_``WW`:%6[#_C]M/^OF'_`-&+6397
MUGJ-NMU87,%W;.659K>198RR$JR[D)`9&!5EZ@C!%:UA_P`?UI_U\P_^C%I2
MV?71Z_(:W7JOS+&M?\A6_P#^OF3^=9E:FM?\A;4/^OJ7^=9=$=EZ+\A!1113
M`****`+%I_Q]6W_7Q#_Z,6K^O_\`(8U'_KZE_P#0C5"T_P"/JV_Z^(?_`$8M
M7]>_Y#&H?]?,OX_,:G[?_;OZE?8_[>_0R****HD****`"IK?_CX@_P"NT7_H
M:U#4UO\`\?$'_7:+_P!#6@:W7JC3\0?\AF__`.N[?R%8U;/B#_D,7_\`UW;^
M0K&J8?!'_#'\D(****H`HHHH`E@_U\/_`%UC_P#0Q6IX@_Y"][_UU'_H"UEP
M?Z^'_KK'_P"ABM/7_P#D+WO_`%T'_H"U+^./^&7YP+7P/U_R,>BBBJ("BBB@
M`I\?^LC_`-]?_0A3*?'_`*R/_?7_`-"%`UNO5?F;/B/_`)#%U_VR_P#125AU
MN>(_^0Q=?]LO_125AU%/X(^@/=^K_,****L04444`.3[Z_[P_G6YXE_Y"\__
M`%SM_P#T1'6&GWU_WE_F*W/$O_(7G_ZYV_\`Z(CJ7\<?\,OS@/I\U^I@T445
M0@HHHH`*L6G_`!]6W_7Q#_Z,6J]6+3_CZMO^OB'_`-&+2>S]'^0UNO5?F:&O
M_P#(8U#_`*^I?_0C6/6OKW_(8U#_`*^9?_0C611'X5Z+\@>[]7^84444Q!11
M10!-;_\`'Q!_UVB_]#6OTJTG_D&:?C_GSM__`$4M?FK;_P#'Q!_UVB_]#6OT
MJTK_`)!EA_UYV_\`Z*6OG>(/APW^*I^43T\NWJ>B/S4_:9TJQUQ/BYI6HQO+
M9W>CZY',D<LL#X&B,X*S0LDD;JRAE=&4@@$'I7\G?B#Q%XRA_P""1OBF_B^&
M7Q*@N[+XA>%;BV^-8\?:?LLGN_V@O!WAFXN?*&O'Q(8+W1;J?0#`ML2([TLT
M8B#N/ZVOCUX<@\7:U\0?#-W>ZAI]KKGVG3;B\TJX-IJ,$%W8Q0S-:7(5C#*8
MW8*^TE<FOSMN?^"=?P0N_P!GZX_9EGUKXC/\)[O7K7Q!=:,?%D_GW%S9:Y9>
M);2WDN_(\TV<'B#3[35TAR`+N%6R5RI]*-*=3#8?DZX2,=TE>5.-N_:]TDSE
M<XQJ5.97?M+_`"3^?3^NAYA:>#?!'[)OQ]T+Q0\-_:?#GXY?#L^$$NM0UK5K
MS3]!\>:7:IJ5O8(+VZFM[0^*;!;B*(C8\M[;HD9+OM,'QB_9-^'NC_`'Q_\`
M$F5O$UOKNA_"CXF:EI5@GB;6X[*PU7Q&8=>75A$+P,=2T]=-M;2S=BRP0-*L
M84.2?O?5_@WX*\3>"O#?@7Q?:3^+M)\+WNBZGIMQX@F^VZC_`&GH$HETW4)K
MK:A>[A;K*%4LI*G@D5H?%+X9:'\6OA]XA^&VOWFL:=X?\3:=)I.IR:!?'3=0
M;3YD\J>UBND1VCCGAS#*`N3&Q`(KJ]E>,DTFK>ZM;IM*]WZK3UL9<_O*6SZ^
M:5OTW/Q+TG]F?2-8_8K_`&=/C)X2\8^,_"/Q:US0OA/I4/BFU\3:Q<1KK&N>
M(K-I=<O+*XO'@O+J3>;>X$JE);8M&1WKVO0_B0OQ7^.7P)^%?QTT>Y\)_M(?
M"/QQJFB^+M#34[NRTSQWX270[W4?#'Q(\*)#<10Z[X6\0QQ6=S<?)-)HVMPW
MVDWPCEM_G^U(_P!C3X=6_P`&_!?P,LO$_P`1+'P5X"U'3]2\/&U\421ZM`^D
MRQSZ5;2WYMR\MIIT\22VL3+\C#DL.*]2USX`?#/Q)\1OAO\`%K6=$6]^(GPK
MT^_TOPMXIDD(U1+#4[06E]:WTR!3>17"CS624%5G)D0*Q-9QHS2C;2T::FKZ
M2:2YGUU36CZ[=1J:=^9.6K::6JNNOET:U\CY\_:G\7^)%^-'[*_PBMX-0B\#
M?$_Q=XH3QM?VDTEM#);^'M`DO].T>ZN8V21$OK@[@B.K2>5CD9K\Z/B!^UYK
M:?L#?M'>']<^)NE>`OB)X,\2_M'^$?!^KZ]XLTC1O%6N>"_AYX^UWP]X3U'0
M(;Z^@OM3GOK2VBTV"XLXYY'^QRR;BX-?N!\1?AEX8^)NGZ=9^(([J"ZT;48M
M6T+6M,G-GK.AZC&"GVO3+Y07MY9(6:&7`*R1.R,I!K@_$W[,/P6\6?"35?@K
MJ_@K29?!.LZ'J6@WL0L[4ZHUKK$TMUJDZ:I)#)>)?7]Y<3WMU=K)YLMW-).[
M%V)-SIU).;4TN9-*ZO:Z@K/5/>+E=/K8(S@N6\;VDF_D]]NMUIY6/SV^.G@K
MXI?M!_L@_L]>+OA;XFT/QYX2\(^$?"_C?Q]X9L?%>HV&J?$"32-&L)9;73/%
MWAN^S#J%E*MY=/;3O)'=7D2VUPHW,!^J_P`)]5LM=\#>`-7TZRO=.L=2T#P_
M=VMAJ7FC4+.":TMF6VO//_?FYA!$<K2_O&=2S<FN(T_X%^$-'A\$:?HEWKNB
M:#X$\/KX8T_PUI>I-9Z!J.E);):QQZSIT2+%>RQI&K+.=DI?)9F#$'VS3H8K
M>6Q@@18H89;:..-%"HB(Z*J*HX"J```,<=JJ,.7F;>LH)2W:O&*5T]TM].NY
M+E=Q712;7?5]>_3HC\X/VFM._P""H<_QG\82?L^ZQ\`;7X6&[C_X1Z#QG%JI
M\0(/)077VTV\$D1)N/,,>UN$VYYS7@7]D_\`!:[_`*&#]E?_`+\ZY_\`(M?M
M?KW_`"&-0_Z^I>/3YC61793Q#C3A'V5%VBE=PU>BWUWW_K?FG0O.3]K65Y-V
M4VDM5HON_'R/QG_LG_@M=_T,'[*__?G7/_D6C^R?^"UW_0P?LK_]^=;_`/D6
MOV8HJ_K+_P"?-'_P#_@^O]+6?J__`$^K_P#@Q^7^3^_R/QG_`+)_X+7?]#!^
MRO\`]^=<_P#D6FR:3_P6M"/_`,5!^RP?E/"PZX6Z?PC[+UK]FJ*/K3_Y\T?_
M``#T\_7^EJ?5_P#I]7_\&/R_R?W^2/YV_P!@=?\`@L4O[4?BA/BC:Z0OP<3Q
MS,NN7_C&&[M=#N?]+C%P_P`/89UCU2:SQN^SR%!;=PQ`K^@GQ_:V-[X>\66N
MMQ6D]C/I>K1ZA%=!39R1-;3><LOFX4Q'G.\_=ZUUNC_\A73O^ORW_P#1BUD^
M)])TS7H]:T;6;"UU/2M2^U6=_I]["L]K=VLY=)K>XBD!62*1"5=&7#`D&L,1
M6]O6TITX?NK>Y%J^MN[_``\BZ%+V$%'VDZGON5YN]MM%V^_5G\Y7P$TW0]!_
M8#/B;X7)I-M\<U_:)\9V?@1M(N1_;^JW"?$^6VBTV2*TD>^NM,72//#QF-X(
MK5=QVQC-?5'CO0/'WA']J+XJ?$_X310:WK6@?!KX,ZE\6?@W8W$,EM\0;/6+
MSX@1^,9X=*5R&\5VUK86;6\K1B6Y2&&VF^65*_33P-\`?@E\,KEKSX??"OP+
MX.NG9G:?P]X<T[37\QV+,X-O"FV1F)9I%"NQ)R36UI?PD^&6B^--7^(VD^!/
M#&G>/-?5TUOQ;::3:PZ]JJ2`!TOM11!<7*$`?+([*.<`9.>)4)*,5=*UMFTE
M:^JTU=VM'962.OVJ;NX]U:U]+QT^Z/R;/S\_9G^(7ASPO^Q[!XI^&/A=+/Q+
M\3?%_CL>"O!VVT\.>(=5U;5/%&JQVUDUMJTMEY%[I5J'$JW)1+86NPE1C/*_
ML2>*_&/PEN/VF?@/<>"M5M/%OA/7]3^)OPJ^&WBKQ?X?N-?US1_%MLVHMIR:
MI:7]Y:013>(5ND:9Y&2U%R&DVIBOTJU3X0_"_6[OP_?ZMX!\*ZA>>%-0EU;P
MU<W.CV<DNAZG//\`:9K[3&,?^B74MP3-)-#M=Y"68DDTD?P@^%L/CR;XH0^`
M/"L?Q$N(1;S^-$T>S7Q)+`$\H0R:J(A=/&(P$"&3;CC%7[*=X/G^#332\6M7
M:SUOJE=KO<3FK27+\33UZ--;/TT[ZGP-XL_:'_:"U[QC\'_AGXY\%7?[-.I^
M/_AE\8?'6IZDNNZ+XGAM?%'PYOO#3>&_!=MKT(_LF:[UO2[[4]9NK-";F73K
M66.%08I&7XDU;]OO]IB)O%M]JNK6O@F]\)_LMS_&&UT*:QM(+N;Q1H?CN+0H
M99OM&9/L&NZ:OVQ+?:&$4X9.,-7[Y>+/`_@_QW8P:;XR\-:+XFL;6[@O[6UU
MK3[>_AM[RVD2:"YA6='\J:.2-&5TP<J,D@8KDM1_9U^!'C/Q(=8\5?"/P!X@
MU35+*U\/ZC?:MX9TR]N;[0XI49-(NI9K=FFT]616%H^800"$R!45*55\UJNE
MMG==(W3MUW=U:]_F.$XIKW+>C>]]]7^#[(_$'P;XA^*OQ5_:I_;T\<?";Q@?
M"WQ2U7]D7]A+XAVCZ+]CNDU75(K+XV:EK6D_9IA-'MOQ,EM.Z)YD3RVY8@LF
M[]4?V9_'5Y\=_"]S\5;_`%S5+OP)K_AO3?#H\*Z[:PV]I;:UI5L;;QC/=)-!
M#-YHU0W%A<K*?()MW:/*\UWWC']FSP=I">)[OX&:+X.^"_Q"UFUT_P`/3>//
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MUYI5Y9LI-QYDL5U,DL1SYD4:B-,J37[M>"?@E\(OAMI^N:5X`^&_@[P=IOB5
MI6\06'AW0['2[36'G\SSWU""UBCCNGF\Z4RO*K-(9'+DEB:P]`_9L^`'A;4]
M`UKPW\'?AWH>K>%9;^?PWJ.F>%M*M+O0YM4:1]2DTN:&W5[-K]II6NS"5^T&
M1S+NW&H6&E'V;4[.-E/5ZZQ^&R[)JSM?N6ZL6I)Q=GMMVMKY]5_P#\8?A-^W
MI\:?$VO_`!!TK2_&5EXY\.ZEX#\*^./`&NZJVG^$KWQ!)KGC#4M`GT_PRMXJ
MP:7+?06871;#666Y\Y4-T8_-`';_`!&_;.^-^@R_!7P-;>([+P*_Q93XL:E/
MX_\`C'>:9\-M*\+^(_!4^DMX=^'6I^(+^.?1)]3NEN+J;RX9,:[91LMA*9'4
M-^P=O\$OA!:6QL[7X9^"+>U8$&WA\.:7'%@W4M]C8EL``+R::Y`'"SR/(,,Q
M-7M;^$GPO\2Z#IGA;Q#X`\(ZYX;T:]M=2TG1-6T'3K_3=.U"QG2ZL[RSM+JW
MEBM[FVN(HYHI8E5UD16#9`JO8U>5I5M>FFE[Q?=VO9^:NGJ+GI\R?(K75]%]
M^VZ>NVY^9/[<VO:Y)\`OV/\`Q3XMUK1H/'MQ\?\`X!C6]3\,:O-'HM]->ZDJ
MZW-I,S-;/>:->L#,CRQF)K=T;[A!/UC_`,%`?B#XH\`_`35-8\&P75[=ZWXT
M\`>%[VZTUMSV.@^)_%&EZ3K&J>8F=L%M87,LDL@(VQDMD=:^B/%GP7^$OQ3G
M\.6?Q&^'7A#QK::#>V\NBVWB/0['5(-+D1D5)+"*YB=+9T55"-$%*!0%(P*V
MO'_P\\*^*_#NM>`+_2[9/#5Q%]@@L(842&RBM71K(VL>TK$;.2**2WVCY&C7
M'2ATY>TJ/GMS4XQBWO=66NG7=]63S1Y87B])R;]';;_+3U/PQ^,7[8GQ@^$O
MC;]ICP[X;\8:3:^&?@)XZ_9>T;P?HL=M91176B?$RYLK+Q-8ZC(S-)/A+B28
M3*4DCD4%CU%?:OB'Q9^VI-XEU27PSX5\3W7AB;4Y7T6YM;3X9O:SZ3)+OM9K
M=[SQ+#?-!);LK1M<P1W!7!>-7RH^E8?V5?@1>VEY_P`)=\*_A_XOUK6?[-?Q
M+KVL>$])N-0\27&C\:5>:S));L;VZL5"^1-,6:)P6CVU]!VUM!96\%I:PQV]
MK:PQV]O!$H2*&"%!'%%&HX5(T4*JC`"@`=*<*517<JDDF]%%M]KK5.V]KKUN
M$IQ:5H*ZW;6^B[/O?^GI^2O[5+>)-,^*O[(/Q<\,QZ7XKG\+_&+PKX1^(_A?
MP=>P7GQ(DU/QS$_AV^?4DT>\N;?_`(1SPDUU-K?B#3YQY-M;6<D^\")2?'?"
MNL_%Z?Q/X<U6>"X7XR7?[?\`X_\`#?B:Q+W372?!&TUB2#0A-`1Y@T&7P:MC
M?0R/&MBT\TI5R0:_9C3?A?\`#K1_$^I>--+\%>&[#Q9K$GG:IXAM=)M(=6OI
M<$>;<WBQB667!(\PG?@D9K47P9X6BUZZ\66_A[1X/%-W:BTF\0)I]N-4DA12
M(DENQ'YSI&3D`MG'&:'1<I.3EJVM%>R225UYNRTVU?<%425G%/2U_2SMWMYW
MU^1\>?L]^+->C_:A_:I^%8L;I/!'A*[\%^(/#UZ3G3X]1\3Z5)/K&FVG\*-#
M-&L\L2GY6F!VC-?>MA_Q_6G_`%\P_P#HQ:\P\"?#G2?!%QXDU2!OMFO^+M5?
M5_$.KR(J3W]P%$5O&V!D0VD"K#`F2%1?4FO3[#_C^M/^OF'_`-&+6L4XP:;N
M_>?HG>R^2(O>2TM\*^Y)7^=KEG6O^0MJ'_7U)_.LNM36_P#D+:A_U]2_^A5E
MTX_#'_"OR)"BBBJ`****`+%I_P`?5M_U\0_^C%K0U_\`Y#&H?]?4O_H1K/M/
M^/JV_P"OB'_T8M:&O\:SJ/\`U]2_^A&I^W_V[^I7V/\`M[]#'HHHJB0HHHH`
M*FM_^/B#_KM%_P"AK4-36_\`Q\0?]=HO_0UH&MUZK\S3\0?\AB__`.NY_D*Q
MJV?$'_(9O_\`KNW\A6-4P^"/^&/Y(044450!1110!+!_KX?^NL?_`*&*T]?_
M`.0O>_\`70?^@+69!_KX?^NL?_H8K4\0?\A>]_ZZC_T!:E_''_#+\X%KX'Z_
MY&-1115$!1110`4^/_61_P"^O_H0IE/C_P!9'_OK_P"A"@:W7JOS-GQ'_P`A
MBZ_[9?\`HI*PZW/$?_(8NO\`ME_Z*2L.HI_!'T![OU?YA1115B"BBB@!R??7
M_>7^8K<\2_\`(7G_`.N=O_Z(CK#3[Z_[R_S%;GB7_D+S_P#7.W_]$1U+^./^
M&7YP#^OS,&BBBJ`****`"K%I_P`?5M_U\0_^C%JO5BT_X^K;_KXA_P#1BTGL
M_1_D-;KU7YFAK_\`R&-0_P"OJ7_T(UCUL:__`,AG4?\`KZE_]#-8]"V7HOR!
M[OU?YA1113$%%%%`$UO_`,?$'_7:+_T-:_2O2O\`D&6'_7I;_P#HI:_-2W_X
M^(/^NT7_`*&M?I7I7_(-L/\`KTM__1:U\YQ!\.&]:GY1/3R[>IZ+\T?!7Q._
MY'WQ/_V$/_;>"N#KV[X@>!/$&H^,O$%];0VY@N+W?$6N$5BOD0KDJ3D<@]1_
M+GCO^%;^)O\`GA;?^!,?^->OAL116'H)U87C1I)IM:-0BG?T?R..I3FZDVH2
M^)]#@J*[W_A6_B;_`)X6W_@3'_C1_P`*W\3_`//"V_\``J/^>:V^L4.E6'_@
M2\OU:_I$>RJ?R2^[^NZ."HKO?^%;^)O^>%M_X$Q_XT?\*W\3?\\+;_P)C_QH
M^LT/^?T/_`DNW_`_I![*I_)+[OG_`,$X*BN]_P"%;^)O^>%M_P"!,?\`C1_P
MK?Q-_P`\+;_P)C_QH^L4/^?L/_`EY?YH/95/Y)?=_7=?><%5BT_X^K;_`*^(
M?_1BUVO_``K?Q-_SPMO_``)C_P`:GMOASXF2X@8P6V%FB8_Z5'T#J3WZX']*
M3Q%!I_O8;=_+R]?S\P5.=U[KW7YG):]_R&-0_P"OF7_T(UD5ZAK'P]\23ZG>
MRQP6^R2XD9<W,8."QQD9X/\`^NLS_A6_B;_GA;?^!,?^-"Q%"RO5@M%]KR7^
M:!TZEW[KW?\`7XG!45WO_"M_$W_/"V_\"8_\:/\`A6_B;_GA;?\`@3'_`(T_
MK%#_`)^P_P#`E_77^K,/95/Y)?=\OS."HKO?^%;^)O\`GA;?^!,?^-'_``K?
MQ-_SPMO_``)C_P`:/K%#_G[#_P`"7E_G_5F+V53^1_=\_P`CE-'_`.0KIW_7
MY;_^C%J+4?\`C_O/^OF;_P!#-=]IGP\\20ZC92O#;!([F%VQ<QYPK@G'OQQ4
M=[\.O$LEY<NL%MAYY&&;F,<,Y(STQQ^59^WH^UO[6%N1*_,M^:Z^?Y%>SJ67
MN/=].Z7](\XHKO?^%;^)O^>%M_X$Q_XT?\*W\3?\\+;_`,"8_P#&M/K%#_G]
M#_P)?UU_JS%[*I_)+[ON_`X*BN]_X5OXF_YX6W_@3'_C1_PK?Q-_SPMO_`F/
M_&CZQ0_Y^P_\"7E_F@]E4_DE]W]=U]YP5:&E<ZE8?]?4'Z2*:ZW_`(5OXF_Y
MX6W_`($Q_P"-7=.^'?B6*_LY&@MMJ7$3-BYC)VA@3CGDX[>O%2\10L_WL-G]
MI=O^&_I`J52Z]Q[KIYG":I_R$;W_`*^9?_0S5"O2M0^'?B26^NY$AMBKSR,I
M-S&."Q/?I5+_`(5OXF_YX6W_`($Q_P"--8BA9?O8;+[7DO\`->GWA[*I_)+[
MOZ[HX*BN]_X5OXF_YX6W_@3'_C1_PK?Q-_SPMO\`P)C_`,:?UBA_S]A_X$OZ
MZ_U8/95/Y)?=\OS."HKO?^%;^)O^>%M_X$Q_XT?\*W\3?\\+;_P)C_QH^L4/
M^?L/_`EY?Y_U9A[.I_++^M?^"<?IW_'_`&?_`%\P_P#HQ:EUC_D*7W'/VF7/
MUW&NVL?AUXECO+5V@MMJ3Q,?]*CZ!P3^E2:G\._$DNH7DB0VQ62XD8'[3&."
MW?.,'U]*GZQ0<_XL+<O=6O=?CM_PY7LJG*GR/XFMM=H_U^!YG17>_P#"M_$W
M_/"V_P#`F/\`QH_X5OXF_P">%M_X$Q_XU7UBA_S^A_X$OZZ_U9D^RJ?R2^XX
M*BN]_P"%;^)O^>%M_P"!,?\`C1_PK?Q-_P`\+;_P)C_QH^L4/^?L/O7E_FOZ
MN'LZG\C^[T_X'W^9P56[#_C^M/\`KYA_]&+79?\`"M_$W_/"V_\``F/_`!JS
M9_#KQ+'=VSM!;86>)C_I4?0.I/Z=O6D\10:?[Z&W\R[?\'^K,%2J77N/==/,
MXW6O^0MJ'_7U+_.LNO3=5^'?B6;4KV1(+;;)<2,I-S&."W'7I6?_`,*W\3?\
M\+;_`,"8_P#&E'$4%&*]K!:)?$NR].Z#V51?89P5%=[_`,*W\3?\\+;_`,"8
M_P#&C_A6_B;_`)X6W_@3'_C5?6*'_/V'_@2_KK_5F'LJG\DON^7YG!45WO\`
MPK?Q-_SPMO\`P)C_`,:/^%;^)O\`GA;?^!,?^-'UBA_S]A_X$NMO\_ZLQ>RJ
M?R/[OG^1Q5I_Q]6W_7Q#_P"C%K0U_P#Y#.H_]?4O_H9KK+;X<^)DN(&,%MA9
MHF/^E1]`ZD]^N!_2KFL?#WQ)<:I>S1P6^R2XD9<W,8."Q(R,\?C]:7MZ/-_%
MA\/?S7^?YE>SJ<OPOXOT/+Z*[W_A6_B;_GA;?^!,?^-'_"M_$W_/"V_\"8_\
M:?UBA_S^A_X$OZZ_U9B]E4_DE]QP5%=[_P`*W\3?\\+;_P`"8_\`&C_A6_B;
M_GA;?^!,?^-'UBA_S]A_X$O+_-![*I_)+[OZ[K[S@JFM_P#CX@_Z[1?^AK7;
M_P#"M_$W_/"V_P#`F/\`QJ6#X<>)EGA)@ML"6,G_`$F/H'4^M'UBA_S]A_X$
MO+_/^K`J<[KW7NOS.6\0?\AF_P#^N[?TK&KU'6?A[XDN-4O)HX+;9),Q7-S'
MG'3G.,'V[5E_\*W\3?\`/"V_\"8_\:F.(H*,;U8+1+65NB_S#V53^27W?UW1
MP5%=[_PK?Q-_SPMO_`F/_&C_`(5OXF_YX6W_`($Q_P"-5]8H?\_8?^!+^NO]
M68>RJ?R2^[Y?F<%17>_\*W\3?\\+;_P)C_QH_P"%;^)O^>%M_P"!,?\`C1]8
MH?\`/V'_`($O+_/^K"]E4_D?W?/\CAX/]?#_`-=8_P#T,5IZ_P#\A>]_ZZ#_
M`-`6NIA^''B82Q$P6V%D0G_28^@8$]ZT-:^'GB2?4[N6.&V*/("I^TQC^$#U
MXJ7B*'.OWL/AEU[N%B_9S46N25V^WH>745WO_"M_$W_/"V_\"8_\:/\`A6_B
M;_GA;?\`@3'_`(U7UBA_S^A_X$OZZ_U9D^RJ?R2^XX*BN]_X5OXF_P">%M_X
M$Q_XT?\`"M_$W_/"V_\``F/_`!H^L4/^?L/_``)>7^:#V53^27W?UW7WG!4^
M/_61_P"^O_H0KNO^%;^)O^>%M_X$Q_XT]/AQXF#IF"V^^I_X^H_4>]'UBAO[
M6%O\7]=_ZLP5.=T^5VNM?F<WXC_Y#%U_VR_]%)6'7J>N?#[Q'<:G<2QP6^QC
M'M)N8QTC13UZ<@_SK)_X5OXF_P">%M_X$Q_XU$*]%0BG5@M.LE_75`Z=2[]R
M6[Z?UW1P5%=[_P`*W\3?\\+;_P`"8_\`&C_A6_B;_GA;?^!,?^-7]8H?\_8?
M^!+^NO\`5F'LJG\DON^7YG!45WO_``K?Q-_SPMO_``)C_P`:/^%;^)O^>%M_
MX$Q_XT?6*'_/V'_@2\O\_P"K,7LJG\C^[Y_D<(GWU_WE_F*W/$O_`"%Y_P#K
MG;_^B(ZZ%?AOXF#+^XMOO+_R\Q^H]ZUM>^'WB.YU.:6.&W*LD(!-S&/NPHIZ
M^X//2I^L4'.-JL-I=>[C8?LJG\DNG3^MSRJBN]_X5OXF_P">%M_X$Q_XT?\`
M"M_$W_/"V_\``F/_`!JOK%#_`)_0_P#`E_77^K,/95/Y)?<<%17>_P#"M_$W
M_/"V_P#`F/\`QH_X5OXF_P">%M_X$Q_XT?6*'_/V'_@2\O\`-![*I_)+[OZ[
MK[S@JL6G_'U;?]?$/_HQ:[7_`(5OXF_YX6W_`($Q_P"-3VWPY\3+<0,8+;"S
M1,?]*CZ!U)_3MU[=:3Q%!I_O8;/KY?\`!_JP*G.Z]U[K\SD]?_Y#.H_]?4O_
M`*&:QZ]0UGX>^))]4O9HX;8I)<2,N;F,'!8GD$\5F?\`"M_$W_/"V_\``F/_
M`!H6(H67[V&RW=NB[^J!TYW?NO=_F<%17>_\*W\3?\\+;_P)C_QH_P"%;^)O
M^>%M_P"!,?\`C3^L4/\`G[#_`,"7]=?ZLP]E4_DE]WR_,X*BN]_X5OXF_P">
M%M_X$Q_XT?\`"M_$W_/"V_\``F/_`!H^L4/^?L/_``)>7^?]68O95/Y']WS_
M`".(M_\`CX@_Z[1?^AK7Z5Z5_P`@RP_Z]+?W_P"62]^]?"$'PX\3+/"3!;8$
ML9/^DQ]`X/KZ5]X:<K16%E&RG<EK`K;>0"L:@C/?!%?/Y[5IU(X?DG&=G.]G
M>VD;'I9?"474YHM:+<\8\1_\AO4O^OCW_P">:5B5M>(O^0WJ/_7P?_0$K%K*
MG_#I_P""/_I*(G\3^7Y!1115DW84444`%%%%`7?]?UY(*?'_`*R/_?7_`-"%
M,I\?^LC_`-]?_0A0-;KU7YDUX?\`2KC_`*ZO_.JU6;S_`(^KC_KJ_P#.JU);
M+T7Y`]WZL****8KA1110!8M21<P8_P">J?\`H0IMP<S2_P#71OYTMM_Q\0?]
M=4_]"%-G_P!=+_OM_.@J[Y(_XI?E$BHHHH)"BBB@+O\`K^O)!4]M_P`?$'_7
M5/\`T(5!56VUC2L2WHU*Q>TL)RE]<1W4,L5H\)!FCN'C=A#)$.9(WVNO=10-
M;KU7YFC<DF>;/_/1_P"=051CUO1M1OKFUL-5TZ\NHXX[J2UM[RWENHK:XR8)
MYK6-S/%#,!F*21%5^=I.*;/J^E6MY;:=<ZGI]OJ%[N-G8SWEM#>780$N;:UD
MD6:<*`2WE1MM`R<`&@5S0HHHH"X4444`36_^OA_ZZ)_Z$*==_P#'S/\`]=&_
MG3;?/GP_]=$_]"&:==_\?,__`%T;^=+[7R?YK^OO+N_9K7[;_)%>BBBF0%%%
M%`7?]?UY(*DA_P!;%_UT3_T(5'4D/^MB_P"NB?\`H0H&MUZK\R6[.;J<^LK?
MSJM5F[_X^I_^NK?SJM26R]%^02>K]6%%%%,5PHHHH`?'_K(_]]?_`$(5->'_
M`$JX_P"NK_SJ&/\`UD?^^O\`Z$*FO/\`CZN/^NK_`,Z75>C_`#17V?\`M[]"
MM1113)"BBN-UGXB_#[PYJ`TGQ#XZ\&Z%JK+&RZ9K/B?1-,U`K*=L3"ROKZ"Y
M*R-Q&?+(<\+GI0%W_7]>2.RI\?\`K(_]]?\`T(5AW7B/P]8QZ=+?:[HUG%J\
M\=II,MUJEC;IJEW,I>&VTYYIT2]GE56:.&V\R5U!9`0#4%WXQ\):7K5AH.I^
M*?#FG:Y?O']AT6_UO3+/5KW<V%^R:=<74=Y<[B"!Y,+YYQTH&MUZK\SJK[_C
M[N/^NC55INIZA8V^K16$][:07NHO=-I]G-<PQW=\+-$ENS9VSNLUR+6)TDN#
M`KB!'5Y=JLIKG_$7C#PKX1AM[GQ5XDT/PW;74IAM[G7=4L]*MI90-WEK<7TT
M$&['.TN">V:2>B]%^0:ON_ZM_P``Z*BLF;7]"MM(_P"$@N-:TF#0?LZW?]MS
M:C9Q:1]D<!DNO[2>86?V=E(99_.\IE((8]3@Z?\`$GX=ZM?6>EZ5X]\%ZGJ>
MHIYNGZ=I_BG0[R^OHMK-YEG:6U])<72;59M\$;KM5CG`-,5SM**P;#Q5X8U6
M]U+3M,\1Z#J6HZ*S)K%A8:OIUY>:2ZYW+J5K;W$D]BRX.X74<1&#G&*U;.^L
M]1MH[NPN[6^M9@3%=6<\5U;2@$@F.>%GC<!A@E6.""#0!;3[Z_[R_P`Q5F^/
M^ES_`.__`$%5D^^O^\O\Q5F^S]KG_P!_GZ[12ZKT?YHM?`_7_(J45RY\;^#E
MUO4_#3>)]"77]%TY-8U?1WU2T6_TO2I2XCU#4;=I5DL[-RC[;B<1QG8Q#8!Q
M?T?Q'X>\1:>=6\/Z]HVNZ4'FC.IZ/J=CJ>GB2W)6=#>V4\]L'@((F7S-T9!#
MA2*9!LT5Y_)\6?A7""9OB7\/X@+E[,F7QEX<C'VN,@26N7U$8N8R0'A_UJ$C
M<@)%=)+XG\-0:U#X;G\1:'#XAN8C/;Z#+JUA'K4\(S^^ATM[@7TL7!S)'`R#
M!YZT#N_/^K?\#\#<IR??7_>7^8JE;:A8WDES%9WMI=RV4QM[R.VN89Y+2<`-
MY-RD3NT$VT@F.4(X!!VX-74^^O\`O+_,4`MUZHMZ@<W<O_`?_015*KNH9^UR
M\=QG_OD=/_UUR&F>+O"^M:SK7A[2/$&D:GKOAPVRZ_I-C?V]S?Z,UXC26JZE
M:PN\MF]PBEXEG5&=!N`(YI+9>B_('>[]7_E_D=%15:\O;+3;6>^U"[MK"RM8
MFFN;R\N(K6UMHD&7EGN+ATBBC4#<[R.J@<DBN:T?X@^`O$*7<F@>-O".N1V$
M,EQ?OHWB31M46RMXD,DL]T;&]G%O%&BL[R2E$5068@`FF*YUU%8?AKQ/X>\9
M:'8>)O"FM:9XB\/:M%)-IFM:/=PW^F7\,4\MM)+9W=LSP3QI<030EXV9=\;K
MG(-;E`"CJ/J/YU<U#_CZD^D?3_<6J8ZCZC^=.UB^L[.[07EW:VC7+Q0P"YGB
M@,\S(F(H1*ZF60D@!$W,<CCFI^TO\,OSB5=\O_;WZ#**9++'!')--(D4,*-)
M++(RI''&@+.[NQ"JBJ"S,Q``!).*@LKVUU&TMKZQN(KNSNX4N+6Y@820SPR*
M&CEC=>&1U(96'!!R*HDM44566^LFNVL5O+4WJQ^<UF)X3=+#D#S3;;S,L>2!
MO*[<D#=F@+O^OZ\D6:?'_K(_]]?_`$(5E6VLZ/>7MUIMGJNFW6HV(4WMA;7U
MK/>V8?[ANK2*5I[</_#YR)N[4J:YHHFO%_M;36?2L2ZG$E[;R2Z?&OSE[R))
M&DME"`MF95XYYH&MUZK\S:O#_I5Q_P!=7_G5:E:ZMKYFN[.XANK6X)E@N+>1
M989HGY62.1"R.C`Y#*2"*2DMEZ+\@>[]6%%%%,5PHHHH`?'_`*R/_?7_`-"%
M?0UM_P`>\'_7)/\`T$5\\Q_ZR/\`WU_]"%?0UM_Q[P?]<D_]!%<&.VI^LOR1
MV87[1\N_&B?Q#9^'_B!>^%-2LM(\1V.BZM?Z/J6I::VKV-K?6>G274$EUIJW
M=BUY#OB"O"+N`LI($@K^=_6/^"G'Q\T__@G)KG[2\'QK^`4O[0&C^.-!TF/X
M?MX(F^RWNEZQ\6_#7PSETX:,/&_]HI?V=GK5UXA-VL[!A:?9FMECS,/Z(_C)
M8>(=5T/Q[I?A5=-;Q#J>D:IIVDC5WGCTT7=]I[VL37CVZM,L*F7<_E`M@<5^
M$VK?\$R/CAJ7_!/+6?V0A!\!X?B%K/C+1-8;XDC1[KS[72M%^*7A[XG*T5T+
M`:F=1N;C0SHTA-P$^QW3MN)RE=*YO9PY;_PUUZVC;UZ_CY&2Y+OFM>\=^W7Y
M^G0^V_A7\3OVC_#O[0FK_"KX[_$KX>ZQX>\0_"9/''PNO]!^&]WX4FU+5+5X
M$U^"[N[CQ;J\%Q+HBW$-P=.@C1[BVD,AGCV$'B?B%XK_`&\_#/PP\5?%/3_B
MG\'(O#7A/X?_`!+\:R3W7PEU"6_U2_T>\M9?!FBQV(\<Q+;6DFC6^J7.IZEY
M\KS7$UJD-M&D9+_1/Q=_9RUSXU^"_A!+K&MVO@WXG_#;6M'U8Z_X;::6W^RB
MT?3?$^A6TTZI<2:9KFG2-#(DP^^L;E=R`CO_`-H3X;^+?'/[/?C[X5_#A]"M
M?$'BCP7?^$--G\0M<1Z5:Q:E8/ITUS/]C1IBT,,C2(J#YG`#$#-79Z[];:ZZ
MI=4^Z)<HW6D=U>RLNE_OUZGY9Q?M(?\`!12P_9P^#O[45AXA^"WQ#T'QQX<\
M!ZMJOPXL_ASJ/AO7-0UOQ7K=O93>'=%UE_&>HPVX^P3-)9WUQ:2;KL+%)%M;
M</J>R_:H\8_&S5OV;_$?P*\=^%=!\(>/?%VO>!_BKX-\3^"YM8\8>&/%/ABW
MO)=>\.W4X\0:5)X?U?3;O3I].FMKO3KG<DL-_"7B>,/CZ)^S-^TCX<_8Y^!W
MP!T^\^&-UXU^%NK>"'U+5+FXUM-#U#3/`VHVNHV36P2$W*7=\\!BG5QY<2D,
MA)S78:C^Q$\'[7'PZ_:@\&>(+?P?;D7&I?&CX>Z;&Z>'?&OBX>'#HFF^+[:W
M4)'!K]K$?L=W?F)9M2LXX?M;/)&IJ4I^;TC>[^^WXII7].H_<OT6]K=K;/;S
MMI?\CUS]HCX^ZE\./'7P-^#OA.72[;Q]\=O$>L:/HNHZO:O?V.CZ;X=TI]5U
MC5&TV*XM7OGCC6.&*W-U""TN\R`+7RG;?\%*-.U+X9^&_P"S[#1%^+NK_%3X
MK?"#5K*YGN3X;\/ZE\%_$NI>'_'7BV_^SK+??V+9VVGKJL=K&&F(NX;4R9S)
M7U_^T#\![OXE^)OA)\3_``K+I=M\2/@KXBO];\*2:S'(VFW=MK5@=+UG3;N6
M!3<01W%JWF))#EA+&F<C)KY2T[_@GBO@`?#GQO\`#W4=!N_BKX4U_P"-'B'Q
M)=:_;S)X?\2WWQ_U:_U?Q]))!;!I(FANK\?V<Y1W,5I#'*2"QJFYO;;S](][
M>:_X:PE[.RNK[7WU?6_E;?\`X<QOVM_VNOC-\(O@S\(O$OPM\2>%?$'_``G&
MOP7'B[X\Q_#/7_%_PJ\&^$UN(EEFU71_#NMC4++[=)/'I]OJ<EZT-HXDN[N!
M4C=1^H_@S49=7\,^&=5FU+3]9FU'2-+O9=6TJ-HM-U*2YMH9GO;")Y)GCM+A
MG,ENC2R,L;*K.S`FOC[X7_LU>+?A#\*O"OP#T"X\,:]\,+K1?$]EX\F\0?;9
M]6^V>([BYNYAHMOA[-]/$EW+`MM<;1%$$*8*A:^P/!GA?3/!7AKPYX1T6(PZ
M1X;TS3]&TZ$DMY=G811P0)DDD[40`9.<52YMWU2376ZMV>WR6NPGR^[:U^9.
M_=>>EE;LOGJ=3>?\?5Q_UU?^=5JLWG_'U<?]=7_G5:A;+T7Y$/=^K_,****8
M@HHHH`GMO^/B#_KJG_H0IL_^NE_WV_G3K;_CX@_ZZI_Z$*2X_P!?+_UT;^=!
M3^"/^*7Y0(:***"0HHHH`\7^//C_`%#X=>`+C5=*\/\`BG7[_5+ZWT"$>$]#
MO/$.HZ2-0AN9)M<GT^Q5YS:6%O;2GS0A47<MK$V/-R/QX_X)L^-=;\5?LV?&
M?PUIS^+;K7/$7[7WQ1T&TG\;1ZK#J\MA_:POIDFENF:[CDABM_*DC7;':,XM
MRJ)@5^]Q`(((R"""#T((P0?4$<'VKEO"OP]\#>%+A1X:\)Z#H0GUN\UZ8:7I
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M?+A6((+@`.6P,4-%^'/@/PYKNK>)]!\(Z#I/B'79/-U?6+#3;>WOK^3`!>XG
MC0,S,`-[#!<\ODU*@U9\STM^%O+K:S&YJ[T]-;_+K^NQYC^TP?VCA\+M3/[+
M'_"`#XL_:+;^RO\`A9,5[-X8^S>9_I?VJ.QN+:<R>7GRMLJ_-C(.*_+;S/\`
M@OMZ_L1?^"[Q9_\`+JOW+HKMHXGV,>7V%"IK>]2'-+IHW?;0Y:E'VDD_:U8;
M*T)66CNW:V[ZGX:>9_P7V]?V(O\`P7>+/_EU1O\`^"^WK^Q%Z?\`(.\6?_+J
MOW+HK;Z]_P!0N$_\%>5N_P`_7Y&2PNW^T8CI_P`O/\/=>7R^1^'$3_\`!?CS
M8]I_8@W;UVYT[Q9C).!DC6Q_/-.N)/\`@OR9I-Y_8@W[SNVZ=XLQNS@X_P")
MV>_Z5^Y=O_KX?^NB?^A"G77_`!\S_P#71OYU/U[WO]UPGPK_`)<^:_O>7XLK
MZK[M_K&(^)*WM.R3O:WE9>OD?A9O_P""^WK^Q%Z?\@[Q9_\`+JCS/^"^WK^Q
M%_X+O%G_`,NJ_<NBJ^O?]0N%_P#!7_!_K[B?JO\`U$8CI_R\[6_N^7Y=M?PT
M\S_@OMZ_L1?^"[Q9_P#+JCS/^"^WK^Q%_P""[Q9_\NJ_<NBCZ]_U"X3_`,%>
MGGY?BP^J_P#3_$?^#/\`#Y?W?Q/PUW_\%]O7]B+KC_D'>+/_`)=__6I\<G_!
M?<2Q[3^Q"3O7&=.\68SGC.-;]?0YK]QZDA_UL7_71/\`T(4GCGM]5PG_`()7
M^?X#6%U7^T8CHOXGFO+R]=NQ^&]R_P#P7Y$\WF']B#?O.[;IOBP#.><?\3L\
M9Z#M4&__`(+[>O[$7I_R#O%G_P`NJ_=2\_X^I_\`KJW\ZK4+':+_`&7";+_E
MUY)?S>7X]]0>%U?^T8C?_GYYKR_N_CY'X:>9_P`%]O7]B+_P7>+/_EU1YG_!
M?;U_8B_\%WBS_P"75?N713^O?]0N$_\`!7_!%]5_ZB,1T_Y>+I;^[Y?EVU_#
M3S/^"^WK^Q%_X+O%G_RZI=__``7V]?V(NN/^0=XL_P#EW_\`6K]RJ*/KW_4+
MA/\`P5Y6ZM^O](/JO_41B/\`P9Z+^7R_JQ^&Z/\`\%]]Z;3^Q#G<NW.G>+`,
MYXS_`,3OCFI;E_\`@OSY\OF']A_?O;?MT[Q7MW9YP3K9/7U/TK]QH_\`61_[
MZ_\`H0J:\_X^KC_KJ_\`.E]>=_\`=<)JK7]CMJO/J4L+[J;KXAVDO^7G9;[:
M_,_D[_:]U/\`X."K#QO\$V\/77PTA\02:U=K:Q?`BRU,Z+<6^Z+[1'\0;?7[
MO4-*GT@KP@N(T9<L8V#8-?T=_LPS_M#W'P9\(S?M1VW@JU^,CVF?$\7@,W)T
M+?G]RP6XR(KMX\&ZBMWDMDDXB<CA??\``)!P,COCG\#VI:6(QBKTZ=-8>A2Y
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M@NE3Z;<D01F>*+;"&2O5OASJOB"7]LKX(_"GX_\`AC3?$?CKX9^'/'FI^%OC
M)>:/8W%GX\\!VMM81Z%KLVM?9Q!'KNGJRIJ(613YVZ[3`F8U^L7BGX,_"GQM
MX6M/!'BSX?>%->\(6%W#?6?AO4-'M9='@O+<,(+I+$(L'GQ;V*2%2P8[L[@"
M.A_X0+P7+#IEE+X9T:2VTO39="TZ)[&%OL6CW42VUSIMO(RF6*TG@`BEB1PK
MH,-FI47W[/KTZ6NBN?;3??\`X'](_%_]M'XJ^)A\<?@_^U?X:\.^(Y_`G[//
MQKTGPW9?$/3]=T'_`(0.7X5>,;2Z\(?%^WOK:346N9Y]9U&_TJXGE2T$Z#P9
MH/V>:)4N5G^G_P!L2'P5\8?AA\:+G7O^$?UWX?\`AWX.7"V-Q>S0SZ?/K'B8
M+*MS:S2$V37$>GF/[-<12"Y@=R8W7.:^TM4_9Y^!USX-OOA;<?"SP7-\.KC5
M&U2?P7+HMM)X>FU$W`NC>2::ZF!YS<_OR[*<R?,>:L7?P2^$=_X,D^'5[\//
M"MSX&E6!)?"LVE0/HLB6J[;=)+,CRW2%0%C1LJH``&`*(Q=G=_$D]]GY]]+=
MONW'-:635M+K333;L]'M;>^Y_.)\;/$&M>'_`/@FA^TE^R-X@\073/\`L[^&
MWO\`P[XJDU&11XK^#7B:.T\6_"22WU?SQ]OFAL]4D\*WOE3.[W7AJ\B=-H85
M^B/C;X?>!OA%\)OV5/VQ/`/@[PFC_!WP)X!'Q&O=#\/:7=7=W\+=9\+Z7;^*
M;^UEL[=I?MOA^24ZUY]NWVGRX;R,EO,*U^BVL_L[?`OQ%X4B\#:[\*/`^K>$
M(K'3M,3P]?Z!97.EG3M):Y?3+&2WDC99;2P:[NFM;>7?%"9Y=BC<:[K1/`G@
MWPWX3@\":'X9T;3/!EK8/I<'ABVL85T6+39$*/8K8,K0?960E#`4,>T[=NWB
MA0L]^B5_1Z;_`/#OJ#J*R5M.9MK35.UUIYK;I]Y\':CK7AS0_AGKWC'PGX,T
MZZ^(W[3FH3W.FZ'X=31M&\6Z]X4U9#'!<1S3R6,LT[Z"QO7FGF8^=<AP^2*\
MW_X)E>-[_P`+^`?C)^SIXM74/#GBOX"^._$D.C>'?%6I:7J7B6R\`ZUOU[PS
M=7::;<S?:8+:VN3;LX>1P8!')(7P3^DFI?"CX:ZQKWAGQ/J?@GP[>^(/!D*6
MWA35IM.A-YX>@B18XX=)D4+]CCC151$B`54`4#``JCH_P4^$OA[QQK?Q+T3X
M>^%=,\?^)+>:TU_Q=9Z5!#KVL6MQY9F@U&_51-=Q/Y:`I,6`"`*`.KL[IM[:
M6[Z*]_G_`,#J+F7+):ZI>>JM_EOOOW/Y]KS_`(*1_M(:=JG[3Z^'?BEI'BGP
M_P"$_@7XF^*GP]\5:YX)\/V&GZ7K_A[X@)X5DT?3=.M+73[FYTP6Y>(CQ!=Z
MA?R7,37*N(F6.O:?#W_!0WX\:-K/[;=CJ.K67Q0G^#W[+W[)_P`=_`=K::/H
MEO>Z?KWQKTOQQ!XUL$M]$M;0W^@Z'>>&M.U2);TWEY:K<S0SW31/$M?L5=_L
MZ?`?4K#4](O_`(1^`+K3-=BGM=9L9?#.F&WU.UN[T7]U;7D8MP)[>YO?]*FA
M?,<D_P"\92W-6M&_9V^!?@O7]=UOPK\)_`N@ZOKV@6OA+6M1TWP]8076K>&+
M)$6ST'4)5BS=Z5:*H%M9S;X(1D1(FYLQRSYH^^]+OKJM-/E^-M;%\T7%^[I=
M::7=N7R\G?U/R'_9?E_M3_@IC\7+KQ=X[M?B5!XN_8O^$NLZAK.H6'A^ST^]
M&I:YKUSJ%C);Z)8V&D36ME',;<>=;O<K:!$O9IF!D/E/[(VIM\#;;XC_``Q\
M,:@B?#7]J"3XS>,_"+V-T)='\&^/O#OQ/\?>&O'&GVTD<IMM(M=1\-6&CZW;
MVBM;QK+YTD(`9:_=[1?@U\*/#B7B:!\//"6CC4-+?1+U].T6SM9KC1Y&D9],
MDGBC68V+-+*WV42"$%VVH,UD:'^SY\$?#6@77A;0/A;X+TCP[>S:A/<Z/8Z)
M:0V4DVJQF+4Y?*5/DDOXR5NVC*&XW,9-Q8DOE>FNNKOYNW]7$JD;_#=>ZK-)
M;=;]-?EWWT_#K]AW]F7P?\<?^"7.D6_A+1_!>I_&3P=XX^)'C+X?^*M8TG2M
M?ND^(/A+Q]K=YX>'B"6ZCN);^QU=+.+2=4AO7<W&EW3A2K+%(GZ"_#3XU?#C
MXKZ#J'[7%]X6TG1M5T'PNGA#14UVQL+#Q'9>/(XVA\1>%H[Z^2*<W6G>(`^B
M*$F".R.Z_(RM7VY\-OA#\,/@]I5SH7PM\"^&O`.C7ET][=:9X7TR#2K&:[D_
MUER]O;*L?G.22[A0S$DMDG-'B+X0_"_Q;HR>'O$G@/PQJ^AQZNVOII-WI-JU
M@NM--]I;5/LR(D9OFN/WS7!4R-+\[,6YJHQ:MY147V;5K.W^9+G>^^^COK9V
MNN[VWO\`F?D/^RMX^\:?"#]L+XU^"?%_A'Q+X9?]H3X=0_&CX?\`AOQCXAT!
MG\4_$'PZK:;XJTKP[+!J%RUN-2232IH8IY,!9?,CC"HU>N>,/VJ?VE-5N?@G
MX-\9_#O6/V3-8^*&I>.HM9UZYU'P?XVF\/+X5T8:CH-JE_=V>J^'$D\1W.Z(
M1W%I).(894B,4K*Z_H;K7P.^$'B+Q7X8\<Z[\.?"FJ^,?!<<$7A/Q+>Z5;SZ
MQX=BMF5X(])OG'G6:(R(=L+*'VJ'#`5UWBKP/X/\>6,6D^,_#>C^)M.BN8KF
M*SUFQAO88KB)@8YHEF1C'*O.'0J>V<<$2:5KZ7OIZIV[]^O4?,FT^57=EZ-6
ML_\`.ZU/YZ_$O_!0[]K"Y\::)X<U7Q=H_P`/5N/V(?VAOC?<0#PMX=.L7WCK
MX1_$;0O"_AG6A+K$%];)I/B71I[B]_LV.PA0QSRO$25B>'QK]FWXI?'GXM^+
M_P!N#XY?!CXBOX2^*K?#G]E'XK:_IOA/1_!^MP>++=/`;:CXS\/1:?XAT76[
M6SEU&W6[CAGL(+>Z@O/*7S!PH_H_\9_LV_`/Q?XA.N^*/A%X"UW68?#<G@Z+
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MP/\`1!H7PY\)Z'\/]-^&<>D65QX1T[0XM`_LB6WC%E<6"Q>7/'-;H%C*W+-)
M),H`#O(Y/)-8?@GX&?![X;^'M<\)>`OAOX2\(>&?$L=Y%K^AZ!I%MIVF:LFH
MP26U^MY:VZI'+]K@EECN"5!E61MQ))-7*-W&[VWWUNX]5TT]/D2II)JSU:MV
M2ZZ=][=GJ?S:?\$G_P!JCX@_#3]G#_@GK\)F^(&G/X"\:?L1_%;QYJ=KJVG:
M7>S>%?$?@/Q)XAN[34H);:"/7+YY8Y7:^L+R\N$F6-!;Q0L26]Q^$W_!0C]H
M_P`1W7QQ\,CQH/'L&C:W\&I_A[K[:1X)\)^+M<TCXB:?K^IZUI?@JWGT8>&9
M=6M;717O=$L?$EI?7,UA:W]M<W+WKP2+^V?AO]E?]G#P?<Z%=^%O@G\.-`N?
M#&G7^C^'9=+\+Z;:-HNE:J7.I:=I@BA5;.ROC)(;JVA"0S%V+H<FNB@^`GP5
MMH!;6_PM\#00":UN!'#X=TV,">QM[RTLILI`&\RTM=1OH+9\[H([N=8BH=LR
MH244N9NUOFK)6_-_G97&ZD'?W-TNWKKW_#L?BK\2?V[/VE=+U?X)_#OPSXRT
MK0=1^)WASXA^,K?XA_$?3_"O@*R&M>'O$-G8:+\,M575]%O]*DO;>TN9?[1C
MTB*#4M2C@-QIU_&,Y]O_`."E&O74.D_\$\/%/B75-*TGQW??M7_!:SUF\T?6
M)+6UGL=3TZ^E\0VUHXGMQ=Z'<7D-LTGG1/$P6#=C(!_4O7/@O\)?%&G^'-(\
M2_#?P9K^F>$KR"_\,66L>'M-U&#0KVW_`-3=:6EW;R_9)X^TL15R>22:/BA\
M"O@[\5M1T&Y^)'PV\(>-9_"3++X8?Q#HUKJ']@RG[/)YNEK.A%G*'MX626$+
M(GEKM8`4<KYK.5[Q=K]$G#_@_@'/%<LE&UIZKOI^'IT/E/\`X*"_$3Q3X+^%
MOPTT_P`*Q7DUE\2OCI\+OA[XJU#3BI^Q>#_$>N*-8DEE^;;:7D,*64SHP+1W
M)4,-U?FA\3?V]/V@/AK\9?VO/!VC_$+PQ#X/_9Q_:Y_93^#/@+PO9>'/#=O;
M7GP_^,'PD\%^+O$FE:Q<W$-WJ-Q=Z5JWB>YL8[ZSO+&:.7350^0IEMQ^\?Q!
M^&7ACXB^"I_`VM6:)I0^PS:8T**)='O])ECN=(O[#<"(;C3KF&*6W8="FT\'
M%>7V_P"R5^S[=QWM[XI^$7PZ\2^)_$&HZ7XA\8^([WPKIIOO%7BS2D06OB75
MF,1-SJL#H&MKJ4O+;`!(75%4"I1E>Z=MORV_&Y,9QBM5?7;?JM==-E8^2?$?
MC_\`;Y77M7_X1W2[R30?[0NCH\D?P>\+7T<FFF5C9NE[)\8+*2Z5H"A6=[2V
M:48=H8R2HXCPOJ6G6'_!8WQ/I$.K06K:M^QMIVHZQI,>J%(;CQ+_`,)S!#-<
MR:<;N2*+4ULT5"(D\Y+<`!C&`Q_7N&&*WABMX$6*&"*.&&-!A8XHD"1HH[*B
M*%`[`"O*%^`GP83XAS?%I?AGX/'Q,G&V;QT-'MAXEE3RQ%Y;ZKM^TF+RU5?*
M+^7@9VYYIJ/=MZIZZ[=M=PYH]5IRM:>=O^#]_0_/W7O$GP9U[]LFSUSX8?%3
MPGIOC[X=?#?XF^#Y?`N@^++4ZU\2_'GB32?M%I#XDT6TNWNM83PC!ITMY;W&
MH6\PT^ZE$D3QM'Q\\?LN:M\4+_XA_L5RM')/XI\;:7\;O^&I+66>>XDF6"]8
M:8GB&-]WFR6VH^5;Z:MZ%*6S%(!Y9Q7ZV>&OV6_V<O!WQ!?XK^%O@G\-M`^)
MDLE_+)XZTOPII5IXI>75(I(-1D?68[<7K/>PR/%<L9298W96.#BO1K+P!X7T
M:]UO5_"^@:)X?\1Z^K_;=<L=-MX[R>Y<82>X=%5IBKX<J6`=@"V3S2<6];VW
M>B;[:][Z6T*4ULEV2O9_U^/9GQY^PSXX\2^(+_\`:R\!:O:WJ>'/@O\`M4_$
M'X=?#Z]NB&AO/"$>GZ%X@MH+!P,O9:/?:U>Z-%N+%#8M'NP@`^]JX+X>?#30
M?A9H]]H6B*9)=1US5O$6NZE(BK=:UXAUJZ:[U75;QE'SW%U.Q)8Y(0*@X4"N
M]IP5HQ7DC.;3G)I65_\`A_O>H44451(4444`/C_UD?\`OK_Z$*^AK;_CW@_Z
MY)_Z"*^>8_\`61_[Z_\`H0KZ&MO^/>#_`*Y)_P"@BN#';4_67Y([,+]K^NQX
MCXC_`.0WJ/\`UW_]II6)6WXC_P"0YJ/?]_\`^TTK$KLI_P`.G_@C_P"DHY9_
M$_E^2"BBBK)"BBB@`HHHH`*?'_K(_P#?7_T(4RGQ_P"LC_WU_P#0A0-;KU7Y
MDUY_Q]7'_75_YU6JS>?\?5Q_UU?^=5J2V7HOR![OU?YA1113$%%%%`$]M_Q\
M0?\`75/_`$(4V?\`UTO^^W\Z=;?\?$'_`%U3_P!"%-G_`-=+_OM_.@I_`O\`
M%+\H$5%%%!(4444`%3VW_'Q!_P!=4_\`0A4%3VW_`!\0?]=4_P#0A0-;KU7Y
MB7'^OF_ZZ/\`S-0U-<?Z^;_KHW\S4-`@HHHH`****`)K?_7P_P#75/\`T(4Z
M[_X^9_\`KHW\Z9`?W\/_`%U3]6`I]U_Q\S_]=7_G2^U\G^:+_P"7?_;[_P#2
M5_P"O1113("BBB@`J2'_`%L7_71/_0A4=21?ZV+_`*Z)_P"A"@:W7JOS);S_
M`(^I_P#KJ_\`.JU6;S_CZG_ZZO\`SJM26R]%^0/=^K_,****8@HHHH`?'_K(
M_P#?7_T(5->?\?5Q_P!=7_G4,?\`K(_]]?\`T(5->?\`'U<?]=7_`)T6=UH]
MGT\T5]C_`+>_0K4444$A1110`4^/_61_[Z_^A"F4^/\`UD?^^O\`Z$*!K=>J
M_,GO?^/N?_KH:JU:O?\`C[G_`.NAJK26R]$(****8!1110`Y/OK_`+R_S%6;
M[_C[G_W_`/V4563[Z?[R_P`ZLWW_`!]S_P"__P"RBEU7H_T+7P/U_P`BI111
M3("BBB@`IR??7_>7^8IM.3[R_P"\/YB@:W7JOS+>H?\`'W+CID?^@BJ57-0_
MX^Y<<_=_]!%4Z2V7HOR![OU?YA1113$%%%%`"CJ/J/YU<U#_`(^I/I'_`.@+
M5,=1]1_.KFH?\?4GTC_]`6I=^:.GV9?G`K[/_;WZ%*BBBJ)"BBB@`I\?^LC_
M`-]?_0A3*?'_`*R/_?7_`-"%`UNO5?F37G_'U<?]=7_G5:K-Y_Q]7'_75_YU
M6I+9>B_('N_5_F%%%%,04444`/C_`-9'_OK_`.A"OH:V_P"/>#_KDG_H(KYY
MC_UB?[Z_S%?0UM_Q[P?]<D_]!%<&.VI^LOR1V87[7]=CX=^(WB/6+7QOXBMX
M+R2.&*^VQH`,*/(A..1GJ37%?\)5KW_00E_)?\*VOB?_`,C]XG_["`_])X*X
M.OKL+"'U;#OECK1I-WCUY(ZZKN>15E)5)I2EI)Z7?1]/T9T7_"5Z]_S_`,GY
M+_A1_P`)7KW_`#_R?DO^%<[16WLX?R1_\!7E_DB.>?\`-+_P)_YG1?\`"5Z]
M_P`_\GY+^?3_`#Z4?\)7KW_/_)^2_P"%<[13]G!?8CT^RO+NO+\.H<\_YI?>
MSHO^$KU[_G_D_)?\*/\`A*]>_P"?^3\E_P`*YVBE[.'\D?\`P%>7^2#GG_-+
M[W_F=%_PE>O?]!"7ZX7\^E3VWBK7FN;<'4)?FGA!X7.#(H]*Y:K%I_Q]6W_7
MQ#_Z,6DZ=-I^Y#9KX5^?0:E*Z]Z6ZZOR.OUSQ/KD>K7Z+?2A5N90!A>`&(`Z
M=JRO^$KU[_G_`)/R7\^G^?2JNO\`_(9U'_KZE_\`0S6/1&G327N1V7V5V7^2
M!SG=^]+=]6=%_P`)7KW_`#_R?DO^%'_"5Z]_S_R?DO\`A7.T57LX?R1^45I:
MWEY+[A<\_P":7WLZ+_A*]>_Y_P"3\E_PH_X2O7O^?^3\E_/I_GTKG:*2IPZ0
MC_X"O+R\D'//^:7WO_,[+2?%.NOJ=@C7\A5KN!6&%Y4R*"#QT/>HK_Q3KJWM
MTHOY`%N)0!A>!O;CI_G%8FC?\A73O^OR#_T8M1:C_P`?]YQC_29>/^!FH]G#
MVG\.'P+7E6_-I_7WCYYV7O2W?VGVCYFK_P`)7KW_`#_R?DOY]/\`/I1_PE>O
M?\_\GY+_`(5SM%7R0_DC_P"`KR\O)?<+GG_-+[V=%_PE>O?\_P#)^2_X4?\`
M"5Z]_P`_\GY+_A7.T4>SA_)'[EY?Y+^KASS_`)I>MW_GTZG1?\)7KW_/_)^2
M_P"%7M,\4ZX^H62-?R;6N80PP.1O&1^-<?6AI/\`R$['_KZA_P#0Q2E3I\LK
MPCL_LK^O^&0U.=U[TMUU?D;^I>*=<34+Q5OY`%N)0!@=`Q`'2J7_``E>O?\`
M/_)^2_GT_P`^E9FJ?\A&]_Z^9?\`T,U0HC3A9>Y'9?979?Y('.=_B?R;L=%_
MPE>O?\_\GY+_`(4?\)7KW_/_`"?DO^%<[15>SA_)'_P%>7EY+\!*4_YI?>_Z
M7Y'1?\)7KW_/_)^2_P"%'_"5Z]_S_P`GY+_A7.T4>S@OL1\O=7EY>2#GG_-+
M[V==I_BG76OK13?R8:XB!&!R"XR.G>I-5\4ZXFHWJ+?R!5N)`H^4X`8X'3M[
M5S6F_P#'_9_]?,/_`*&*EUC_`)"E_P#]?4O_`*$:CV=/G^"/P_RKH]/G\O)E
M<\^5>]+=]?*)H?\`"5Z]_P`_\GY+^?3_`#Z4?\)7KW_/_)^2_P"%<[15^SA_
M)'_P%=+>7I]Q///^:7WLZ+_A*]>_Y_Y/R7_"C_A*]>_Y_P"3\E_PKG:*7LX?
MR1_\!7E_D@YY_P`TOO?^9T7_``E>O?\`/_)^2_X5:LO%.NM>6JF_DPUQ"IX7
MH9%!'2N3JW8?\?MI_P!?,/\`Z,6E*G"S7)';^57V6WX?A;H-3E=>]+==7Y'4
MZQXHUQ-4OD6_E"K<R!1\IXSTZ?RK-_X2O7O^?^3\E_/I_GTJCK?_`"%M0_Z^
MI?\`T*LNB-.%E[D-E]E6Z>7DA<\_YI?>U^1T7_"5Z]_S_P`GY+_A1_PE>O?\
M_P#)^2_X5SM%5[.'\D?3E5U:WEY?<M=`YY_S2^]_YG1?\)7KW_/_`"?DO^%'
M_"5Z]_T$)?KA?SZ5SM%+V<-N2/\`X"GV7;R0<\OYI/RN_P#ACJ;;Q5KS7-N#
MJ$OS3P@\+G!D4>E7M;\4:Y'JU^B7\@5;F0*,+P,\#I_*N0M/^/JV_P"OB'_T
M8M7]?/\`Q.=1_P"OJ7_T+_/<_6I]G3Y_@C\/\J[K_(I2ER?%+?N]%9?UT+?_
M``E>O?\`/_)^2_GT_P`^E'_"5Z]_S_R?DO\`A7.T57)#^2/_`("O\O)?<3SS
M_FE][.B_X2O7O^?^3\E_PH_X2O7O^?\`D_)?\*YVBCV</Y(_^`KR_P`D'//^
M:7WO_,Z+_A*]>_Y_Y/R7_"IK?Q5KIGA'V^3!FBSP/[X]JY>IK?\`X^(/^NT7
M_H:T>SIO3DA;;X5_D-3E=>]+==7Y'9:[XGUR/5KU$OI`JSL`,+P/3O\`S_3B
MLG_A*]>_Y_Y/R7\^G^?2JWB#_D,7_P#UW;^0K&J84X<L?<C\*?PKJE_DA<\_
MYI?>SHO^$KU[_G_D_)?\*/\`A*]>_P"?^3\E_P`*YVBJY(?R1_\``5Y>7DON
M#GG_`#2^]G1?\)7KW_/_`"?DO^%'_"5Z]_S_`,GY+^?3_/I7.T4>S@OL1_\`
M`5Y?Y(.>?\TOO9TT/BK73-$/M\G,L8Z+_?'M6EKGBC7$U6[1+^0*L@`&%Z;%
M]OZ_G7&0?Z^'_KK'_P"ABM3Q!_R%[W_KJ/\`T!:ETZ?/'W(_#+[*Z.%BU.7(
M_>EOW?D6?^$KU[_G_D_)?SZ?Y]*/^$KU[_G_`)/R7_"N=HJN2'\D?_`5_EY+
M[B.>?\TOO9T7_"5Z]_S_`,GY+_A1_P`)7KW_`#_R?DO^%<[11[.'\D?_``%>
M7^2#GG_-+[W_`)G1?\)7KW_/_)^2_GT_SZ4]/%6NET'V^3[Z]E_O#VKFJ?'_
M`*R/_?7_`-"%/V</Y(_^`KR\O+\$.,YW7O2W75]T=QK_`(GUR+5;E$OY`J^7
M@87O$A/;U)Z8K&_X2O7O^?\`D_)?SZ?Y]*A\1_\`(8NO^V7_`**2L.LZ=.')
M'W([?RKR_P`D#G.[]Z6[ZLZ+_A*]>_Y_Y/R7_"C_`(2O7O\`G_D_)?\`"N=H
MK3V</Y(_^`KR\O)"YY_S2^]G1?\`"5Z]_P`_\GY+_A1_PE>O?\_\GY+^?3_/
MI7.T4O9P7V(_^`KR_P`D'//^:7WLZ1?%>O;E'V^3&X=AZCVK8\0^)M;BU69$
MOI0@2`A?EQEH(R>WKS7"I]]?]Y?YBMSQ+_R%Y_\`KG;_`/HB.I]G3YX^Y#X9
M?971P\A\\K?%*]^[V]?Z_,D_X2O7O^?^3\E_/I_GTH_X2O7O^?\`D_)?\*YV
MBJY(?R1_\!7^7DON%SS_`)I?>SHO^$KU[_G_`)/R7_"C_A*]>_Y_Y/R7_"N=
MHH]G#^2/_@*\O\D'//\`FE][_P`SHO\`A*]>_P"@A+]<+^?2I[;Q5KS7-N#J
M$OS3P@\+G!D4>E<M5BT_X^K;_KXA_P#1BTI4Z?++W([/[*&I2NO>ENNK\CK]
M<\4:Y'JU^B7\@5;F0*/EX`8@#IT^E97_``E>O?\`/_)^2_GT_P`^E5=?_P"0
MQJ/_`%]2_P#H1K'HC3II+W([+[*[+_)`YSN_>EN^K.B_X2O7O^?^3\E_PH_X
M2O7O^?\`D_)?\*YVBGR0_DC_`.`KR\O)?<+GG_-+[V=%_P`)7KW_`#_R?DO^
M%'_"5Z]_S_R?DOY]/\^E<[11[."^Q'_P%>7^2#GE_-+[W_F=/!XJUTSP@W\F
M#-&#PO0NH(Z5^A6F$OIUB[?,S6D#$D#))B4DFOS4M_\`CX@_Z[1?^AK7Z5:5
M_P`@RP_Z\[?_`-%+7SV?QC&.'M&*;<]E;1*/9'I9?*3=2[;T6[;['YS_`!^\
M02>%=6^(GB2/2KW6VT-+S5#I6GF(7MZEE81W$D%OY[)$)62-MOF.%/&3@U^9
M-W_P4?\``]E^R[>?M:3_``M^(@^&EAX@LM!O$6/2_P"UH/[1\4:;X-L[\V_V
MO8;:7Q'JMGIW#%U,AD("#-?I)^TMJ4>E+\6K^6WO;I8-)UO%MIUI-?7T[OHS
M1I%;6ENKS7$SNP5(XU+,2,"OY6]=^"'C*X_X)6^)/#D'_#3\WQ,O_B!X8^Q_
M!UI->;PO<?8?CMX2\7WAF\(_V0%.F6WANQO=6A<W2QB\M8B':1`A]2%2<,-A
M^37_`&.,ME\4:<+=[[M6ZG(XQE4GSO\`Y>I?)R^7W_CU/WQ^%?[4/_"R_B%X
MK^&UU\+/&_@O7O"GA6R\6W!\1G2T@U#3]1.VQ&GM;7<C3-,^4:3:(HG&R1P2
M*\]\0_MO-X<L+_4KKX#_`!5FL]*T'QIXHU2ZAM]*-I8Z%X)O[+3[Z\ENVNQ`
M7O9KMGT^V5S/-#:W$NT*F3!\7O"_CB^NO@K^T!\%-'O)O%<%A:>!O&.BWMO+
MIMUJGP^\46\45Q+J%K<JDL5UX9U2"VU2W$RB9%6=%P'(/H_[26F?\(S^R?\`
M%'1K#2=3UG4[CX;:]H=G8Z)IL^IZK?ZKJVFS0)'!:VD3SR&>]F#2%5V@G>W`
MS70W4Y9>\URKF4N56DFHM+SMJM-S*T'**M=-I6NU9W2=^OGN?/[?\%+_``5I
MWA;P?\0/$WP?^*GAOX<>,='T3Q!:^.;O3["XT6PT;7M133+*\U![2YEEBQ<2
MJTL(4RQPYE9=BY'U)XP_:(TOP[XC^$NC:)X4UWQMI?QA=5\.^*?#DVGSZ)`&
MMOMJR74LEPCF-K$/<AX5<%8V7AN*_/W0+W['_P`$\_V</"WB/X?>-+K5--O/
MAAHGB7PM+X+U6\U6UA\.:O9W'B"/4-,^R/,+&.U63+R)Y,X!5"QXK<\)_!7X
MM?!/]ICX->!_!ECK'BG]D_5/$WB7XD>"Y=4DEN-3^!^J:QH5Y-K'@#S[@?:Y
M/!E_JM[<:GX9M+MWE\/M=7&C02"QBM(8HC5K>[?WE*--MI:Q<K=+6:=VF_L_
M-VKE@VU\+BY7N[J5O/OMIZZ*Q^@WQQ^--I\$O"B>)9O!OC/QU<RSK%!X>\#:
M0^L:S+&,-/<>0K(J16\>YW9GY"[5!8UP.D?M?_"?Q/\`#;X6?$OPC<:AXFTW
MXQZ5+K7@?3-/M]NK:A86=K+=ZK,]M,4,/]E16]P+T.1LDB9`2<9N_M4?&P_!
M/X>/JMMX/\?^+-1UR231+3_A7GA6X\6:UHPNX7CFUA;&%67=9HWFVXG_`'+S
MK&)%=-ZGX3TCP+;;_P!DKXW?#3X7_$#P1\*/A9X`^)/PNL/A=JND3V_B+2].
M\0:0-%T#6M2T$^==QW4U[:YDFF+3+'=R7,Y_>,:TJ3E&5HM/W;N-M5JM4^N[
MNO2W4F,4TKZ7=D^CT^'LM=GZWMH?8_Q3_;0^&GPW\!_#[QKIUAK/CZ?XGZO!
MI'@_PMX4^Q2>(M4DRW]HSPVE[<VVZ'2%5VOPK%T"$*K-@5]<^'KYM4MM%U)[
M2XL&OXK"[:QNU"W5HUP(I3;W"J6"S1%MD@#$!E(!K\D_"?[*7@)OV=/`'P"^
M-?@G7?$WQ%N[?QCXG\$>+HK*_DU/X?Z]JNL76NV0TWQ9II@F\/7NGR/:^4OV
MB))T@^SR"5"R-^I_PWTC6=`\*>"]$\0ZDVLZ[I.D:+I^JZLZA)-0OK2""&XN
MW4<"2=T+OZN2>].$JCYN9))Q3271VN^;S=[KR^]GNII1;=I?)K2S7]>9WOB`
MXUC4>,_Z5-TZ_>/3_/XU\#_\-L:4_P`:/B1\$[?X3_$.\U[X5Z5I^O\`BK4K
M6#3IK"'0M52>2PU*U1;HW-TLZ6TK"&.,S#;@KS7WOK__`"&-1X_Y>9>/^!'C
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M"^6\HM]==FKLIQA9V=WKRM];22TMU:;WTZGUOX>_:'\">)/CEXN^`5DU]'XS
M\'^'K#Q)=/<0"/3[^RO)3!*FG3L<W,MC)L6\55Q$TB`G)(KS/]I/]L7PQ^S-
M`^M>*O!OBK7_``G8ZWX.\.Z[K_AN&"[70M5\;ZS::-HZ7EH\B320&>]@>>2#
M>88Q(SJ`N3\>7_PC^.WPP^-/[.W[06ER_$WXK76J'7=(^)'@[_A#_A_HDGA7
MP]XUVZCJ/V_4-'L].U349M%U9XS;1WU]?,(87"MG&?9OVC/`OBCQ#\.-`TJ7
MX8>)O&EYX]_:!^'OC;QAIND0P7/]E>#_``OXQTB_O5U%;N\6.)TT*U98(+<E
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M]$?VFOA3\0_$OC+X7_&CX.6D%A\1-";5_A_XPL]2D6U.K_"3XA3:7-XCT^_`
M+)+J'A;5M'TOQ%HA)WVMW;W]O#(L6I7:RY*=5UF[62C#W&M;-KG2?5IZZ+96
M&XP4(V:NW/6^FEFOO6GJ[G3:[^U'H'@_X)>(OCCXV\'^*?#.@^'KB[CDTBXA
MMKO6;VVM+A8'O[2&TEDC>U/[R7>S@K%"[L`HKW?0_&_AKQ!X:\,>*K/5+5-(
M\86&F:AH,\T\48OH]7M8[NRBA+-MDFEBD&U$))((`/;XU^*OP[\:?%C6/^%+
M:;)XX^''@'PKX*O+>?QA8^%?!OB72?%]UJ>G2V%YIL4'BRSU:-9EMW<I.MK%
M-]HE++*"H:O-OV7O$GQ+^%/[-/@?P#\7O@QXZ\1:]\(_&*>`M(U;5;'0X[_7
M?"L'B34+3PGX[@MK:;[/%/:>'VT]]2M;:.*6"176",K6RG/FM)/EY?B:M>2<
M;[=/>TT6UKD<JY;W]ZZT\FE;MU^Z^I])>/OVM/!OPU_:"^'?[/\`XL\.^(].
MU/XHPW!\)>+C%`_A>ZO;=-QTZ>X$IFMKN60^1`LD8$TN%0LQQ65XS_;$\*>&
MOVA(/V:M&\&^+/&/Q"?P5>>.K@:)'9KIMII%F_E/'+<W,\6;IY2B+$@)!D4M
M@5\\_MB_"GQS\:OBI8:7X7\"^*;>^\/_``[N]2\!_$R&"V&B^'?B=HVL6/BK
MPI)).9UG\A[S2UL;X>08WBN'@<%'-</X$\!_&BT_;Z^'?Q<\4_";Q'!INH?`
MZ]\.>/O%ED+.XT'3_'/B.\L=7GL;:=KE;J?2M($;Z<ER8<CR1P0V:ESJ*7+9
MV=6*4E%:1O:2:MT[WU[EJ,&KW^R[W?VM+?GJKGVAX2_:IL?%_P`&_%WQ<L/A
MSXP@?P?KL^@ZAX*NFTV/Q.]W::M:Z5>8A%T;>(P-<M<^5-(DLD,+;%+,@;LO
M$_[2_@SX9>(/@EI?C;3]8T74_C!XCT[0=,M)88I!H6I7L)N((==GCD,-MO=/
MLR,K,'N"$6O&9O@=XYT#]I&^O/#L%HWP"^(DMK\3?B'8"4+?0_$?P6H&C:78
M0?*?L'B;4QHFNZEM;RY'\/3V4Z-!J4P;YY_:%^%7QN^/_AKQW\0-(_X6;X0U
M_P`'>*M`O/A[\+E\'^`+V?Q+=>$=5BOM-O[36]4LKO6K"'4Y4=+EK/4[3$#K
MD=J)RJ*G/1N:325E9V^*731IV7Y=6HQCS1U5KKOU:26G6Z?HM]3]>-38-J%X
MP(P;B4@^H+$@Y_7//%<!'\0O`TUYJ^GQ^+O#S7N@1&?6K8:K9B;2X0I9I;Y#
M*#;QJH)9Y-JKT8@U\QR_#?XP?&F?X8?%B\^+/QG^`^I^'_"-UIGBGX&62>$!
MX1\5>()5N<W_`(Q6[T;5-7>:WFE6*`Z/K-A$;:"'<A?<S?G3XL_96_:!U3X4
M+H#^'];;QS\/?AO\;/#'BS6+3[#O^->H^-HM0/A1H;A9E:?[-/=PW,CS^2UC
M+$$C(5<4_:SC%-4I2]V+WT?NQ\GZ=-@4(MM.5K/7^GT\[]4?IU\?OVMOAO\`
M`SX>:EX_^U6OC6'2=2\)V.H:5X<U.QN;ZTMO&-]:V6DZG,@E.+&;[7'/'-RL
ML7,985ZMIWQL^%.HZ/J>N0>/_"IL-"EL[3Q#.-9LVCT'4+[REAT_5'$I%I=M
M-,L*PS;7:0A5&2*_FN^*'[,G[5NK:9\-M(T7X$>/;FWB_9*_9[^'/B>&&33A
M;GXA^`_'-MK.NOJ"M?!;B:TTFV>-+UP[L&6%7VFOU7\*_!^!?VGKO2_"4'AN
M[^%WQ(\/>&?''QJ\*`V-U=^'/B7X)CM(;*UO[2%9HX9=9E^S7-_;S,CK=Z7Y
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M;?VHOV3/B-IWCO\`:[T7X)?!#7[GP9XD_8)M?@O\([S2'M3"_P`1H?$=W/90
MVES=78NX;JSGUJUU@ZE(5=#I]U<+)YL*!U*I7BYR24H*HXVMKRJ-_DK_`&G?
M6VEAJ$&HK:3C=N^S;7XV>VVA^]B^//!6E>*=`\.:EXJT&QU_6)H9-*TBZU.T
MAU#4$+*5>UMGE$DRL#E2JX;^'/:?7O''@ZV\4:EHEQXGT.#5X[UXGTV74;:.
M[64P7%YL\AY%?=]DMI[@J!E887D("J37XC?%+]GO]I[XG>+?V>[S1OAR^@?\
M(19_LU:KK/B=;V&+Q/JE[X5FMK?QUI7B&_FGDGC33DCDFAM;%DCU`RO)<O+A
M0.N^.W[,/[2OQ#USXQ6_@F35=#_MJX^(&K^%;?Q<FF7MSX.\0W5K=Z38:]\/
M/'-@MIK%LWB.S>XL[OPUX@&IV&G6]_\`:K"2W>'8Y[:I[1_N9<J2MO>5[/LK
M;V]05./)%N:5V[ZJRV7]7MW/UTM_'/AS5=%O]:\-:E9^*+>PEDMG30KJ"_=[
MV,X^Q9A=ECG+87$FW;G)XYKSGX8?M!^!_B5:?$616NO"VH_"7Q.?"'Q$TOQ)
MY5E)X:UHZ-IWB"*&YNMYM)(I]&U:PODFBF=1'.%;:P(KXN_9/\$?$#X!?`GX
ME>/G^#7Q8?XI:I;:<]UX"\6?$6U\::EXJ\0>']*BTN.^T-!]ETG0M/OG0,J*
M4FGC`EN,N,G!\$_\+L\<?LY?'-6_95U+P7\1O%/B-?$NIZ5\2M4TJ[O/B/XH
MU>2U34M9:'1;J2V2QT72;.PTG1[2>Y`%IIEI;2(561GU5234&XOF<')QLWLM
M%>VFOD]/DW'(KR6ZYHJ]UU:3TO\`UOW/U'T#Q3X;\4Z4FN^&]=TO7=&D$A74
M]+O8+RR/E9\S%Q"[QCR]I+@D%<'.!7FGA'X]?#KQ5X>@\6?\)'HVD>'M5AN-
M3\-W^J:I9VIU_P`.P.47Q)9PR2K(=(NL>;:W6#'-;M'.&V2*:^$/V2_V<_CG
MX)_9N_:L^&WB6]U#P=XN^)VM?&"7X9ZPUQ;3R^'$\:^&[VQ\-ZI96UJ5M;+^
MQM4NH[N&RA6.*)K<(`!R?B8?!OXM>)O#O[*UUX6^$_B+7+7P-_P3UU;X(^,V
ML?L872/BQ#\.='\,1Z%?P37,3KJ5CXATR]#3/'^Z=Q,'(?<T.M448/V;O*-W
M%]'=+HNVOHT-0BY6YU:]D_*U_P`=O5']!S^,?"420O+XH\/1)<0QW,!FUG3H
M?.MY5#Q31B2Y4M%(A#*Z_*P(()KS/XF_M!>$OA!IVF>+M:L]1U;P>FJ:7;ZQ
MXFT+R+_3=$34;^&PM;BY>&1FGC>[FBA86OF-&S991@&O@OX*?L6^+O&GP0^#
M]Q\1_%%]X#\:Z-X`T+P_XA\.ZY\+?A-XSU&UU#2[?[/*T^N>*O#FM:I/O(RJ
MM?/&@QY:J.*WOC5%\4OA5I?PO^!7A/\`9[\;_M%>!(]4L]:\4Z]X9L/`?@G2
MY[JSU6.\TK2[_2M.32-,MK**Z*7=]_9^G[I8[9`06<DU*I/V<I<CCI=/XMTG
MJEKUU[?(F,5S1M+F]Y76W5+1NRU]3ZS^)?[6_P`-/"/CCQ/HCKJ.JVGA!/#.
MH_$+7-/2)M.\"6'C@7<GA:YU[S)%EC&J)8W3JD:,\447F2A5()Q-;_;!^%6C
M>)I]&\Z\O]"TO6M!\-^(_&=H8'\.^'=?\3I;R:#IFI3F02++J"W=ML949%:>
M-68;A7SY\8/V6+KXN_$3XJOHFB^+OAO_`,+Q\/>`-!^/%M++I%QX+\06?A2&
MXFT63299[:?5H=>T"TOM0T22?2)M/@N$F3[8L@AA8<[XF_8@T7Q=XF\4^"?"
MMMXT\(_#3Q/XJ^'WB#XEV6J2:8^@>)M2^'3:9/I6I^')WBFUZ"[O5TK3[6^\
MF^M[1E@=VB,AR9C*NTG:.RVV\EKK:V[Z.Z70MQI]WW=O^W=_6[M;?NF?H7X:
M^)6C^(/&/BOP#(C:=XH\+1VFI/I\TBL=3\-ZH6_LKQ!I[*<RV=PRM;S8&;>Z
MC>)^JEN.^+_[0O@CX*>(OA5X:\7PZL+OXO\`CFP^'WA6YL[-IK+_`(2#48+F
MXMX;R?($*M%:2MNYZ=*\'L?!WB'4_P#@H$OC?0;^XC\#>!?V<6\#>*;>)0UE
M?>)]8\46FI:':3S<[KW3=,LY[DQY+1QW"[\;U!\]_P""A'A7XD>+?%7[)%YX
M!^&GBGQW:?#']H3P[\3_`!=/H$5HZ6/AW2--U2RN%7[3<P&6]>6\C:*!!\R[
MCN&*N52:A*2C=QFHZ)M-<T4]+WV;6G5=B$H\T5T:O:^S:T5WYV?S/MKXJ_%_
MPS\(]/L]5\3R>3ITPNIKJXW[?LMI90&:68C!WN[^7!#'QYDLJ(#7F5Q^US\+
MM,\+^*/$.NRWVA7OA6_\*Z5?>&]12%-;FU'QU?6>G>#K2V@$FV677[R_M8;,
M!ADR$/MVL!YY^UA^SWXC_:+\)^/M%M7N=)N(/#?A^/P?*MU-:O=:C9ZW9>)-
M0M91'*8O+NCIMMI\C/'N`>1-WEN:^=]>_92G^)5Q\:/B1\2O"'CFV;XB-\"]
M.\*>&?#-Y;)XE\,^(?A)JMKJNA^-+:&>273(7T[7X(KV5[A)XI].B:.>!T<I
M1*=53M&-U;3[KWVNK/3Y_<TH<J<FT[ZV[76EN[3>VUM3]&?@[\9?#GQ7N-9M
M=.M[W1_$?@_6K;2?%7A?51&FK:%>RB.XMX[M(G="MQ`RRPR(Q5U/'2O;M>_Y
M#&H?]?,O_H1KX_\`V7?@'J'PMU_XA_$7Q9JEUK'Q`^+VOZ)J?B6[N?L<;K;Z
M)9Q:;I<,UOIL%KIT=WY"-+=FSMHHC-(0N55:YG]L_P#8E'[4_CG1=>/[1/Q\
M^"W_``BUGJ>E?V7\'_%5MX>TW63?7D5S]MU>&>RNS<7EMY/DV\BL@2&1UP<Y
MK2BE*<55DZ=XV;Y7*SOIL^JWU:3T(JMQ@W3CSOG5E?EO=*^K[:[GV?17XS_\
M.?%_Z/S_`&W/_#EZ?_\`*>C_`(<^+_T?G^VY_P"'+T__`.4]=?LL/_T$_P#E
M.7EY_P!?)G+[7$?]`S_\&P\O\W_2U_9BBOQG_P"'/B_]'Y_MN?\`AR]/_P#E
M/1_PY\7_`*/S_;<_\.7I_P#\IZ/98?\`Z"?_`"G+R\_Z^3#VN(_Z!G_X-AY?
MYO\`I:_LQ4UO_P`?$'_7:+_T-:_&'_ASXO\`T?G^VY_X<O3_`/Y3U+#_`,$>
ME::)?^&]/VW5W2(,CXF:>",N!D?\2?J,Y%'LL/\`]!'_`)2EY>?]?)@JN(NO
M]F>Z_P"7D/[O^;_I:_M9X@_Y#%_[3M_(5C5^/.K_`/!'5;?4KN$_M[_MP3>7
M*5\R7XF:>9'P!RQ_L?K6;_PY\7_H_/\`;<_\.7I__P`IZF%+#\D?]I^S'_EU
M)=%Y_P!?)A[7$7_W9[_\_8>7^;_I:_LQ17XS_P##GQ?^C\_VW/\`PY>G_P#R
MGH_X<^+_`-'Y_MN?^'+T_P#^4]5[+#_]!/\`Y3EY>?\`7R8>UQ'_`$#/_P`&
MP\O\W_2U_9BBOQG_`.'/B_\`1^?[;G_AR]/_`/E/1_PY\7_H_/\`;<_\.7I_
M_P`IZ/98?_H)_P#*<O+S_KY,/:XC_H&?_@V'E_F_Z6O[.P?Z^'_KK'_Z&*T]
M?_Y"][_UT'_H"U^*<7_!'M3+$O\`PWG^VZ-TB#(^)>GY&6`R#_8_!J]J_P#P
M1U6WU&ZA_P"&]_VX)MDF/,E^)NGM(WR@Y8G1^O:I]EA^:/\`M/1_\NI=7&_7
M_ANI2JXCD?\`LW5?\O(];?UY'[#45^,__#GQ?^C\_P!MS_PY>G__`"GH_P"'
M/B_]'Y_MN?\`AR]/_P#E/5>RP_\`T$_^4Y>7G_7R9/M<1_T#/_P;#R_S?]+7
M]F**_&?_`(<^+_T?G^VY_P"'+T__`.4]'_#GQ?\`H_/]MS_PY>G_`/RGH]EA
M_P#H)_\`*<O+S_KY,/:XC_H&?_@V'E_F_P"EK^S%/C_UD?\`OK_Z$*_&3_AS
MXO\`T?G^VY_X<O3_`/Y3TY/^"/:EU'_#>?[;HRRC(^)FGYZC_J#T>RP__03_
M`.4Y>7G_`%\F.-7$77^S=5_R]A_=_P`W_2U_;+Q'_P`ABZ_[9?\`HI*PZ_'O
M6?\`@CJMMJ-Q"?V]_P!N";84_>2_$W3V<Y13R3H_/7CVK+_X<^+_`-'Y_MN?
M^'+T_P#^4]3"EA^6-L3=6_Y]R\O/^ODP=7$<S_V9[_\`/R'E_F_Z6O[,5S7B
MSQCX7\":-)XA\8Z[IGAO0X;BUM9]6U>ZCL["":\E6"V2:YF98X_.E98U+L!N
M(K\C/^'/B_\`1^?[;G_AR]/_`/E/7A/[2'_!%/QCXS^%&M^'/`/[9'[3'C/Q
M+J-WI<=KH?Q5\?P:AX)D@6\C:ZNM5L[33(;B<V<(,UND4BOYJC'-:1HX9RBG
MB6M5JJ<EV_/^MF2ZN(46UAFY6T7M(6V7SZ[>NNA_0+9WEIJ%M#>V%U;WMG<Q
MK+;W5K-'<6\T3*&62*:)FC=&'(96(YJS7P/^P1^Q=KW[&OPUC\'>(?CG\0_B
M_J%Q%"9XO$VHF3PUHDBK\\'AO395EN;6`$E=\]Y*74`A(\X'WQ7--14I*$N>
M*>DK-<VW1G13<I0C*</9R:UC=2L_5;_UV')]]?\`>7^8K<\2_P#(7G_ZYV__
M`*(CK#3[Z_[R_P`Q6YXE_P"0O/\`]<[?_P!$1UF_CC_AE^<"^C]5^I@T4450
M@HHHH`*L6G_'U;?]?$/_`*,6J]6+3_CZMO\`KXA_]&+2>S]'^0UNO5?F7]?_
M`.0QJ'_7S+_Z$:R*V-?_`.0QJ'_7U+_Z$:QZ%LO1?D#W?J_S"BBBF(****`)
MK?\`X^(/^NT7_H:U^E6E?\@RP_Z\[?\`]%+7YJV__'Q!_P!=HO\`T-:_2K2N
M-,L!Z6=O_P"BEKYSB#X<-ZU/RB>GEV]3T7YH^"OB=@^/?$_&?^)AWP?^6$/Z
M>U<%L3IM7'IM&/RQVKOOB=_R/OB?_L(?^V\'^17!U[F%TPV'_P"O-)_^219P
M5?XD_P#$PZ#`&!Z8I"`>"`1Z$9I:*W,QNU<8V+CL-HX^G'^<"EP/3IT]OIZ?
MA2T4`(0&^\`1Z$9_G1M&`,#`Z#`Q^5+10`F,X)`R.^.?P]*LVG_'U;?]?$/_
M`*,6J]6+3_CZMO\`KXA_]&+2>S]'^0UNO5&AK_\`R&-1_P"OJ7_T(_Y[UCUL
M:_QK.H_]?4O;_:-8]"^%>B_0'N_5A1113$%%%%`&EH__`"%=._Z_(/\`T8M1
M:CQ?W@]+F;_T,U+H_P#R%=._Z_+?_P!&+46H_P#'_>?]?,W_`*&:S_Y>_P#<
M/_VX?1>K_)%*HY(HI=OFQ1R[&#H)$5]KCHR[@0&'8C!'K4E%:""BBB@`K0TG
M_D)V/_7U#_Z&*SZT-*_Y"5C_`-?4/_H8I/9^C_(:W7JOS$U3_D(WO_7S+_Z&
M:H5?U3_D(WO_`%\R_P#H9JA0MEZ+\A!7(>'/`/@OPAJ7B'6/#/AG1]$U7Q7J
M+ZMXDU#3[.*"[UG4G`5KR_G4>9/,0`,LV..!77T4P"BBB@"[IO\`Q_V?_7S#
M_P"ABI=8_P"0I?\`?_2I?_0C46F_\?\`9_\`7S#_`.ABI=8_Y"E__P!?4O3_
M`'C4W?/_`-N_J/HO5_DC-HHHJA!6?8Z5INF->/IUC;63:A<M>7OV:)8A<W3*
M%>XE"`!IG"C?(1N?&6)-:%%'R_/]0"K=A_Q_6G_7S#_Z,6JE6[#_`(_K3_KY
MA_\`1BTGL_1_D-;KU7YEG6_^0MJ'_7U+_P"A5EUJ:W_R%M0_Z^I?_0JRZ(Z1
MCY)?E]PBA8Z5INF&\;3[*WM'U"[FO[YX8D22[O;ABTUS<.`'EE<G&YV;:H55
MPJ@"_113`****`+%I_Q]6W_7Q#_Z,6K^O_\`(9U'VNI?_0O:J%I_Q]6W_7Q#
M_P"C%K0U_C6=1_Z^I3_X\?85/VO^W?U*^Q_V]^ACT4451(4444`%36__`!\0
M?]=HO_0UJ&IK?_CX@_Z[1?\`H:T#6Z]5^9I^(/\`D,7_`/UW;^0K&K9\0?\`
M(9O_`/KNW]*QJF'P1_PQ_)""BBBJ`****`)8/]?#_P!=8_\`T,5J>(/^0Q>_
M]=1_Z"M9<'^OA_ZZQ_\`H8K4\0?\A>]_ZZCI_N+4OXX_X9?G`M?`_7_(QJ**
M*H@****`"GQ_ZR/_`'U_]"%,I\?^L3_?7_T(4#6Z]5^9L^(_^0Q=?]LO_125
MAUN>(_\`D,7?_;+_`-$I6'44_@CZ`]WZO\PHHHJQ!1110`Y/OK_O+_,5N>)?
M^0O/_P!<[?\`]$1UAI]]?]Y?YBMSQ+_R%Y_^N=O_`.B(ZE_''_#+\X#Z?-?K
M\_Z]#!HHHJA!1110`58M/^/JV_Z^(?\`T8M5ZL6G_'U;?]?$/_HQ:3V?H_R&
MMUZK\S0U_P#Y#.H_]?4O_H9K'K8U_P#Y#.H?]?,OK_>/TK'H6R]%^0/=^K_,
M****8@HHHH`FM_\`CX@_Z[1?^AK7Z5Z5_P`@VP_Z]+?_`-%+7YJ6_P#Q\0?]
M=HO_`$-:_2G2_P#D&V'4?Z';\`9'^J7O@U\YQ!\.&]:GY1/3R[>IZ+\T?/7B
MWPEX<O?$>K75W8RR7,]UOE=;ET#-Y<8SM'`X`''I[USO_"$>%/\`H'3?^!<M
M>A^(_P#D.:C_`-=__::5B5-*O65*FE4FDH0LD]M%_DOR%-0YY/D@[N^L5ULS
ME_\`A"/"G_0.F_\``N6C_A"/"G_0.F_\"Y:ZBBK^L5_^?L__``+T_P`D1RP_
MY]P_\!7E_E^?<Y?_`(0CPI_T#IO_``+EH_X0CPI_T#IO_`N6NHHH^L5_^?L_
M_`O3_)#Y8?\`/N'_`(#_`%V_J[.7_P"$(\*?]`Z;_P`"Y:/^$(\*?]`Z;_P+
MEKJ**/K%?_G[/_P+T_R0N6'_`#[A_P"`KR_R_/N<O_PA'A3_`*!TW_@7+4D/
M@GPJLL3#3ILB1&'^ER=0P(__`%=*Z2GQ_P"LC_WU_P#0A0Z]9JWM9VV^)^7^
M2&HPNO<ANOLKNO\`+\^Y@ZCX-\+S7UU+)I\S.\SLQ^U2#))YX'3VJE_PA'A3
M_H'3?^!<M=C>?\?5Q_UU?^=5J4:]9)?O9[+[3\O\D#4;OW(/7K%=/^&_,Y?_
M`(0CPI_T#IO_``+EH_X0CPI_T#IO_`N6NHHI_6*__/V?_@7I_D@Y8?\`/N'_
M`(#_`%V_J[.7_P"$(\*?]`Z;_P`"Y:/^$(\*?]`Z;_P+EKJ**/K%?_G[/_P)
M^7^2%RP_DA_X"OZZ?U=F%9>#/"T=Y;2)ITH=)XW4_:I.&5@0<<9Y[4RZ\%>%
M7N)G;3I2S2R,Q%W(`2S$D\?7\ZZ>V_X^(/\`KJG_`*$*;/\`ZZ7_`'V_G2]O
M6O?VL[VM\3V5K?D4XPY4^2'Q-;=E"VAR7_"$>%/^@=-_X%RT?\(1X4_Z!TW_
M`(%RUU%%/ZQ7_P"?L_\`P+T_R0N6'_/N'_@/]=OZNSE_^$(\*?\`0.F_\"Y:
M/^$(\*?]`Z;_`,"Y:ZBBCZQ7_P"?L_\`P+T_R0N6'_/N'_@*\O\`+\^YR_\`
MPA'A3_H'3?\`@7+5JS\%^%DNK9TTZ4.D\;*?M,AP0P(.._TK>J>V_P"/B#_K
MJG_H0I>WK/3VL]5;XGMI_DAJ,+KW(;I?#YK_`".9N_!?A:2YG=M/F9FED+'[
M5(,DGD\>_3TJM_PA'A3_`*!TW_@7+777'^OF_P"NC_S-0TUB*VEJL^EO>?2U
MOR06B]7"'_@*\O\`+\SE_P#A"/"G_0.F_P#`N6C_`(0CPI_T#IO_``+EKJ**
M/K%?_G[/_P`"]/\`)!RP_P"?</\`P'^NW]79R_\`PA'A3_H'3?\`@7+1_P`(
M1X4_Z!TW_@7+7444?6*__/V?_@3\O\D+EA_)#_P%?UT_J[.?M?!?A5+F!UTZ
M4,LT;*?M4APP8$'&.<'UXI]]X+\+27=Q(^GRL[3.S'[5(,DGG@?Y%=';_P"O
MA_ZZ)_Z$*==?\?,__71OYU/MZW/?VL[\O\SZ-6T\K?,OECR7Y(_%;9;)1Z6\
ME^)Q_P#PA'A3_H'3?^!<M'_"$>%/^@=-_P"!<M=115?6*_\`S]G_`.!>G^2)
MY8?\^X?^`_UV_J[.7_X0CPI_T#IO_`N6C_A"/"G_`$#IO_`N6NHHH^L5_P#G
M[/\`\"]/\D+EA_S[A_X"O+_+\^YR_P#PA'A3_H'3?^!<M36_@KPJD\+KITP9
M98V4_:Y>"&&#CV/;I715)#_K8O\`KHG_`*$*'7K-6]K.VWQ/R_R0U&%U[D-U
M]E=U_E^?<YZ_\%^%I;RYDDT^5G>9V9A=2#)).3Q^GYU4_P"$(\*?]`Z;_P`"
MY:[&\_X^I_\`KJ_\ZK4HXBO9?O9[+[3\O\D#4;OW(/7K%=/^&_,Y?_A"/"G_
M`$#IO_`N6C_A"/"G_0.F_P#`N6NHHI_6*_\`S]G_`.!>G^2#EA_S[A_X#_7;
M^KLY?_A"/"G_`$#IO_`N6C_A"/"G_0.F_P#`N6NHHH^L5_\`G[/_`,"]/\D+
MEA_S[A_X"OZZ?U=G-P^"?"JRQ,-.FR)$8?Z7)U#`C_\`5TJSJ/@WPO-?74LF
MGRL[S.S'[5(,L3R<#]*WH_\`61_[Z_\`H0J:\_X^KC_KJ_\`.I]O6YD_:SO;
M^9]+6*Y8\OP0^)?971+_`"U.._X0CPI_T#IO_`N6C_A"/"G_`$#IO_`N6NHH
MJOK%?_G[/_P+T_R0N6'_`#[A_P"`_P!=OZNSE_\`A"/"G_0.F_\``N6C_A"/
M"G_0.F_\"Y:ZBBCZQ7_Y^S_\"]/\D+EA_P`^X?\`@*\O\OS[G,?\(1X4_P"@
M=-_X%R4^+P3X5$L9&G3`B1"#]KDX(8$<?TZ5TE/C_P!9'_OK_P"A"CV];_G[
M/_P)^7^2&HPNER0W7V?3_)&%J/@SPO+?7,DEA,[M*Q9OM4@R3Z`?IZ51_P"$
M(\*?]`Z;_P`"Y:[*]_X^Y_\`KH:JTHUZR2_>SV7VGY?Y(+1>KA#_`,!7E_E^
M9R__``A'A3_H'3?^!<M'_"$>%/\`H'3?^!<M=113^L5_^?L__`O3_)!RP_Y]
MP_\``?Z[?U=G+_\`"$>%/^@=-_X%RT?\(1X4_P"@=-_X%RUU%%'UBO\`\_9_
M^!>G^2%RP_Y]P_\``5_73^KLYJ/P3X5#H1ITP(=2#]KDX(((X_ITJYJ7@WPO
M->SR2:?*SLWS$74@!.T<@`>G2MM/OK_O+_,59OO^/N?C'S]/^`BI]O6YD_:S
MND_M/IR_Y%J,>1^Y'=?97E_3.,_X0CPI_P!`Z;_P+EH_X0CPI_T#IO\`P+EK
MJ**KZQ7_`.?L_P#P+T_R1/+#_GW#_P`!_KM_5V<O_P`(1X4_Z!TW_@7+1_PA
M'A3_`*!TW_@7+7444?6*_P#S]G_X%Z?Y(7+#_GW#_P`!7E_E^?<Y?_A"/"G_
M`$#IO_`N6GIX)\*;UQITN=R_\O4GJ/:NEIR??7_>7^8H]O6_Y^S[?$_+_)#4
M8W7N06R^%=U_D8NJ>#?"\U]-))I\K.2NXBZD`/R*.@]L?SK/_P"$(\*?]`Z;
M_P`"Y:[74/\`C[E^H]_X15*E&O645:K/9?:]/\D#C"[]R#UZQ73_`(;\^YR_
M_"$>%/\`H'3?^!<M'_"$>%/^@=-_X%RUU%%/ZQ7_`.?L_P#P+T_R0<L/^?</
M_`?Z[?U=G+_\(1X4_P"@=-_X%RTO_"$>%/\`H'3?^!<E=/11]8K_`//V?_@7
MI_D@M#_GW#_P%>7^7]79S*^"/"FX'^SIOO`_\?<G4'_/M5_5/!OAB:]DDEL)
M6<K&"PNI!G$:@<#VK8'4?4?SJYJ'_'U)](_?^!:GZQ6YX_O9_"_M/HX6'RPY
M;\D-TOA717_X<XK_`(0CPI_T#IO_``+EH_X0CPI_T#IO_`N6NHHJOK%?_G[/
M_P`"]/\`)"Y8?\^X?^`_UV_J[.7_`.$(\*?]`Z;_`,"Y:/\`A"/"G_0.F_\`
M`N6NHHH^L5_^?L__``+T_P`D+EA_S[A_X"O+_+\^YR__``A'A3_H'3?^!<M2
M0^"?"JRQ,-.FR)$8?Z7)U#`C_P#5TKI*?'_K(_\`?7_T(4.O6:M[6=MOB?E_
MDAJ,+KW(;K[*[K_+\^Y@ZCX-\+S7UU+)I\S.\SLQ^U2#))YX'3VJE_PA'A3_
M`*!TW_@7+78WG_'U<?\`75_YU6I1KUDE^]GLOM/R_P`D#4;OW(/7K%=/^&_,
MY?\`X0CPI_T#IO\`P+EH_P"$(\*?]`Z;_P`"Y:ZBBG]8K_\`/V?_`(%Z?Y(.
M6'_/N'_@/]=OZNSE_P#A"/"G_0.F_P#`N6C_`(0CPI_T#IO_``+EKJ**/K%?
M_G[/_P`"]/\`)"Y8?\^X?^`K^NG]79SD7@GPHLL973ILB1",W,G!#`CU[]NE
M?55DBQVEM&@PB01*HZX54``SWXKY[C_UD?\`OK_Z$*^AK;_CW@_ZY)_Z"*\W
M,:E2HJ7/)RLY)7Z;'9A$ES627HDNW8^?_'>L:7H%SKVLZWJ%II6E:=ONK[4;
M^>.VL[2WBB1I)KB>5ECBC102SNP51R3BO$F_:&^!:^'?^$O;XN?#U?"WVX:;
M_P`)"WBS11HQU`XQ9?VB;O[+]IRRCR?-\S+*,9(%>D?&ZUT^\\+_`!+M=6@M
M+K3YO#/B%;J"_CAEM)(SHMQ\L\<X,+)G'$@(S7\@?BBS\?#_`((?^-(SX"^#
M`^&L?Q&\$2CQ&FJR?\)M$S?M3^`;47%MIG]FBS^W31.MC<`78;^R9;@,QC&P
M[*3C3A9?\ND_N4;?F9\G.Y-[W6FR=TOZW/ZS/"WQF^$WC>^O=,\'_$;P;XFU
M'3;-M1U"RT3Q!INHW5E8K]Z[N8+6XDDA@&1^]D4)[UAW7[1GP&LD26\^,'P[
MMHY&OTC>;Q9HT2LVEM#'J(!>[&?L,ES;I=?\\'EC60J77/P?XZT7P=^R7\:?
M`7QV\+>#-!M?`/QO\%V/PE\=#P_H5A$MEXK^RQWW@K5C)86WS6NJS)<:->J<
M1.T]NSEB*Z;X_?LT_!;PW^RW\6?'>H?#SP='XRL?@A\3(8-5GT;38QIY\60C
MQ!JJ6T<D(MX;JXU&RL2;I$6ZQ;1QB3:,5I>33^'3LM-EV\F_G8GEA=*[=VDO
MP37R9]DZ;^T=\`]8O;'3=*^,7PXU"_U-HDTZTM/%VB3W%^TS!(1:11WC/.97
M(6/RPVYN!SQ7:>(/B1X!\*:OH^@>)?&/AS0M;\0?\@/2M4U>RLK_`%8[Q'C3
M[6XECFNSO(7]PC\FOP=TW]FOX"^.?^";O[+'BB]\.>'M!\9:WH/P2\'KX]T$
M6.C^)=.MM1\46$UQ<V.JVHBECU&WN&\\7.YIP%V2,8RP/IGAGQKXH@_:?_9N
M_9@_:9\/Z5XB^+GPU\9>(=0^''Q7?2(;FP^+_P`)4\.7\^A>(X[B>"7^S?%.
MC)+;:9XKTM+B2,ZI9#5+5O*NT6.%4?5+7EM:_P!JVC^_0;IQO9-W5[IKLMUY
M?\,?MOJVMZ/H-C)J>MZG8Z3I\6/,O;^YBM;9-WW=TLS(@)[#.3Z5F:MXT\(Z
M%I5OKNM>)M#TO1KOROLNJ7VIVEM8W/GX\GR+F658I?,R-NQCG-?"'[8=SXHD
M_:%_8LT*XB@D^$>K_$#Q:?'XO&8:=-J5KX8FD\+VNHQMBVEMGNS,4CNOW;3(
MF`6`K\[?AGX:^,&H?#CPS\8O&<^D>(OA#\+?C9^V%X8TWX>>(M42WC\0?"_5
MO'7B32OAIXCTM=02==2N]!MT\K1+%87\RT-J+)T(C-4Y.[7*].O_`(#?SLN;
MSV9*@FDV][;>MK>O^9_0??\`B/0-+T:7Q'J6LZ98Z!#`EU+K-W>V\&F1V\K(
ML4SWLDBVZQR-(BHY<*S.H!R16Q;2QS?9YHG62.412QR(0R/&^UD=&!*LK*0R
MD$@@Y&1S7\M_[7OC[Q_X*_X)->,_AI\6)/']IXFL/#/A?Q/!=VOAS7C;R6NI
M_&+PK<^'-"O]<MHWMK>#2M!D$=Q#/.AN9O)MGCPVT_TI?"'7K/Q/\-?A]KFG
MI>1VE_X5\/2PIJ%I/8WBJ--M4(GM;E(YXF+*2%=0<<XYS1&5VUY1>W5WNO.U
MK_-#<.7E=[^_;:W;S/2+S_CZN/\`KJ_\ZK59O/\`CZN/^NK_`,ZK52V7HOR,
MWN_5_F%%%%,04444`3VW_'Q!_P!=4_\`0A39_P#72_[[?SIUM_Q\0?\`75/_
M`$(4D_\`KI?^NC?SH*?P1_Q2_*!#11102%%%%`!4]M_Q\0?]=4_]"%05/;?\
M?$'_`%U3_P!"%`UNO5?F)<?Z^;_KH_\`,U#4UQ_KYO\`KH_\S4-`@HHHH`**
M**`)K?\`U\/_`%T3_P!"%.NO^/F?_KHW\Z;;_P"OA_ZZ)_Z$*==_\?,__71O
MYU/VO^W?U7]?>5]C_M[]%_7WE>BBBJ)"BBJUY=PV%G=7URP2WL[:>[G<]$AM
MXFFE8^RHC'\*`+-20_ZV+_KHG_H0K\V;[]L/Q%K'PA\5_M+Z!K_PY\)_!?PV
M_BK3-)'C);_[3XFU+1VO+*QNKC6[>1;30[&?4+.4$S6\ZB)=SRQ]:\>\+_M_
M?%&']HK]G_0/$=O\/M:^`OQK^'7AS5KWQ5X<34H]2\&^/M?:"SL-,GOIY'L-
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M[X9\?^'-`\%>&KS3_&'A*TU4&?Q/J/B,6'B*74/#@>ZO8=+T'1I$U-8;:6>6
MZ2.3,D9&T_/'[07[=OQW^'W[(G[2G[3'PTOO@YXTTSX&?#[3/'&@ZG%'J=QI
M_BZ4);IKNA:EID=XFH^'+ZTNKE8U%R'>,1D-&6-)R26M]-6NJ_K[N^ZN*$K)
MJS3=EYW_`.'\GHS]G:*_.#]F?]J'QM\0?$/C/5/&WQ+^$.O_``F\$Z!HR>)?
M%^CZ7J7@M=!\9:W9V6J66F2S:_J,UO=V!TZXF$USFW\NYC1`&#5]3?&#]HGP
M#\'?`6F?$34_[3\4:#K5W%::.W@VV37#J`DMI[Y[J*XAE%G'8P6-M<74EY-<
MQP>7%M5VD=%:HM-7OI\]K(3BT[6OZ;:J^Y[Y'_K(_P#?7_T(5->?\?5Q_P!=
M7_G7Q1K'[:WPMU'X9>$/&GPWU"\\6:I\4/!>N^+_`(>:9I6G_;[V;3M&L9IK
MK6-0L?.A:/3-+NDCBOV,@.3LCW,0*^$/V8/^"J^C^*_A)!\1_C?K5W<^,M#_
M`&;X_CIX_P#`7A'PC*@T_P`/7'Q/U+P7!XLTZ_GN5%U!(\"Z?)IB;FA>SNIV
ME+#92<HIK6VCM?MIN^_7H4HR<-G\5MNY^WM%?G'K?_!3?X&:,GCMD\-?$G5)
M/AYX:^'OC#7H=-\.QS/_`,(W\2XDE\.:K;YNU#VI,BI>R2%!:MG?\HS7OGB'
M]JGP?X:M_%%[J/A7QR]AX7\)^#?%5Q?66BK?6]\/&\+3:3HVGFVN)6DU>%5)
MOH76.*V0K(TIC=6+NFKIJQ/)+^5_=Z?YH^H**_.O1_\`@IY^S/XA@C70;SQ3
MJVL-X1\?>,IO#]GH<DFI6VF_#*62'QI;S'S!:_;]&>&836ZW#;O+;8QR,\_\
M)/\`@I!X(^+?QT^('@W1-&OA\'O!_P`"?!/QOA^*CQ1II#Z!XPTV\URWN[V5
MYU:WM&TNW!A_=NYG617*@`E<\=KJ]UIUU\A^SG_*]/\`@?Y_F?II3X_]9'_O
MK_Z$*^$?#O\`P41_9P\5Z9KEWH?B*ZO=1TO6/"6A:;H-O#!=:QXEU'QY<-:^
M#X?#]M;W$BWSZW)'(8(_,CDC2&5YUB6-B/A^?_@H%^T2_P"S[^W/\8=(M?!F
MGZU^S#\4YM&\/:1XJT*_B@N?"UO::=+)8ZQ#:7HE@U6.2_!DNDEDA`A8!"&W
M`<DM7MKMY#C"5]MFM_5;?>?NK>_\?<__`%T-5:_!/XO?\%,?CMX-^%_Q0U#1
MH/A[XP\0>#?@9\$/CE;?$SPE8WMQX&6?XE_$G5?!6M_#34K62[N/L_BG3[#3
MH]8T]X[V4RV<TTES;P>5$)?T>\.?MM?"S5_"?CO53!XENO$/PKO_``[X?\;^
M&;/1I)M;CUSQ#I=GJ&G"TM(Y&5K74$NA);SR21QK'DRL@6E&2:2OK:]NMOR$
MZ<ETOKY>7GYKYGV=17QQX2_;E^!OCGX7>#?BMX6U'4M4T7QQKGBWPUI&F1V\
M$>MC7?`FK:EH?B_3);2:X1&O=#U/2;^VN;>&661W@(A63(K$TK_@H1^SGJOC
M7P9X"C\0W=IX@\:7^B:-:6M];Q6\VE>(/$5LUWHV@ZU:23B\LM2O85RL36Y1
M69$D=6<"GS)6NU=[>?H)0D_LO[MK;]C[BHKXCG_:9\9V'[=&D?LL7OAO1/\`
MA$];^$&J_$NP\2P7=RVL";3=3M]--C<6C1"W1':9G#I(QP!QSQWGQE^/MOX)
M^*/PS^"VCRQ)XM\>>'O'?Q&U6\>(W9\/_#7X7P:7-XFU6.P0B2[OM1U#6=)T
M+3(_EC6:]FN&+&V$;NZU\G9[[Z?YH.5Z:;Z_+^NY]1)]]?\`>7^8JQ??\?4W
M^\/_`$$5\&?#S_@HA^SQ\2+SPM!X?U#Q$8?&?ACQ3XM\*W-QH=PJZ[IO@O5?
M[)\116%NI:ZEO+"Z'SVYA5BOW<GBO5?#W[7'PC\:^++/PQHQ\7IJ6JW/V>V;
M4?!^N:=9*ZQEB9[RZM8X($`1LO(RCISR*5U=:K9_H7RR4&FFFVK?@?2E%?G1
MIG[9WC7Q!^U;\=/@%X?^'MIJ&D?"_P"`NE_%3PI>R7[6VI^--;U+4=:L8]-7
M>@@L=.DETM(8;AR[,7:3&P`US'[-_P"U?\<_CMHOCF\G\/\`A/3W\/\`@6S\
M5^=:"ZAN/#?C%;S48]9^&6M:9>.;B]ETV'3AM\26WE65X+E'@B('+NKV]?PW
M7XD\DMVK*Z3\K[,_3ZBO'_@-\7]$^.WPI\)?$[0-JV?B.Q9YX%=9/L>HV<TE
MEJ=FS+P3;7T$\78X49`/%>P&G^NQ&JT"G)]]?]Y?YBO@K_@H?^UUKG['?[.O
MBCXL^#?"]GXR\3Z'XA^%&DMIFH7$EMI>FZ=\1OC!X"^%KZKJ,D*M*QMI/&B3
MVEHFU[F6'ED16:O7?C/\5_%G@]_$?_"$V^EW][X)^&_B3X@:M8ZFTL=M<?V=
M;,^G64T\2-)`MS+'*=\>Y@4`*X;(+K5=5:ZMWVU^\N,6^5VW?Y6^[RVZJY]1
M7_\`Q]2?\!_]!%4Z^/OV??CW\0/VCOV4?AY\<M.TSP[X5\8^/?"YURXMKMKF
M_P!`T26/[1YA*@P7-W`OD!0-T;G?N)P*W/V>OCWK'C_X%W/Q8^+FCV'PZ;1-
M5\6V.LW,ET5T:;2/"VIW%BOBF"6X5'MM,U2"W-[$DI8PQG!D8#<5'[*LVW:R
M2;OMIIZH4E;F;V3>O;9Z^5G_`)GU+17Q(W_!2']A=25;]J'X1!E)4@^+-/R"
M#@@_O.H/%)_P\B_85_Z.B^$/_A6:?_\`'*Z/JV(_Y\5?_!<O\C'VU+_G[3_\
M#C_F?;E%?$?_``\B_85_Z.B^$/\`X5FG_P#QRC_AY%^PK_T=%\(?_"LT_P#^
M.4?5L1_SXJ_^"Y?Y![:C_P`_:?\`X''_`#\T?;HZCZC^=6[_`/X^G_W8_P#T
M6M?#`_X*1?L*Y'_&47PAZC_F;-/_`/CE6KW_`(*2?L*/<NR_M1_"!@0G(\6Z
M>?X%S_'ZU/U7$<R?L*OPR^Q+JX^7D/VU'EM[6G?F_GCV]3[1HKXC_P"'D7["
MO_1T7PA_\*S3_P#XY1_P\B_85_Z.A^$/_A6:?_\`'*KZMB/^?%7_`,%R_P`B
M?;T?^?M/_P`#C_GYK[T?;E%?!FO_`/!3?]A?0]!UO6U_:4^%>I-H^D:EJBZ=
M8^*M/DO=0;3[.:[%E9Q^9\]U=&'R+=/XII$'>K'[(G_!1O\`94_;6TJ"Y^"_
MQ%T^\\0-")+SP7JKII_BBQ8??233I6WS*A!!E@\Q",'(S3>%Q*A*HZ-50BTI
M2<))*^JNVNOX`J]%S4%5@YRO:*DFW;>UNUS[KI\?^LC_`-]?_0A3*?'_`*R/
M_?7_`-"%<YLMUZK\R:\_X^KC_KJ_\ZK59O/^/JX_ZZO_`#JM26R]%^0/=^K_
M`#"BBBF(****`'Q_ZR/_`'U_]"%?0UM_Q[P?]<D_]!%?/,?^LC_WU_\`0A7T
M-;?\>\'_`%R3_P!!%<&.VI^LOR1V87[7]=CYU^)'AK0_&"^)?#/B73H-7T'6
MHIM/U73;H,;>]L[F%8YK>8*RDQR1LR,`>0:^5)/V'OV3IOAT?A'+\"_`DGPT
M;5UUYO!+Z7GP\VKI-%<)?-IQD\AITN8(;E6*G;<1),`)%#5]C^(_^0WJ/_7?
M_P!II6)793_AP_P1_P#24<TFU)V;Z?DCC;?X>^"K;PSI'@Z/PYI;>&=`^Q'1
M]&GMEN;/3VTU@]@]LD_F;'M'`:%\EHR`5.>B>/OAYX+^*'A34_`WC_P[IWBC
MPEK,(M]4T'4XS+I]]`IXAN(590\1Q@QD[67@@@UV=%60?.4G[(_[.$OP_P!"
M^%;_``D\)_\`"O/#%^-4\/\`A);-TT;2;]2K)<V5JLH6&2-HT:,K@1E5*`'-
M>K7?PW\"7^L>$O$-[X6T>ZUWP)%+!X0U>>SBEU'P_#/:_8IXM.NW!G@2:U`A
MD57PZ##9KMZ*+>7X=MON'=]V<MXO\$^%/'VD/H/C+0=.\0Z3)+'.;+48!+$L
M\+!XIHCD/%*C#*O&RL.F<5A77PD^&MZ/#R77@O09H?"D1@\/6KV,1M-*BWI)
MMM;7'D*?,C1\F,G>-V=V2?1J*!7.,\=_#OP1\3?"6J^!/'WAC1_%?@_7(K2#
M5_#NLV4-YI>H0V%[:ZC9Q7-M(I1TMKZQM+F)2,++!&PP5%=?8VUO9Q6EI:PI
M;VUJD%O;P1+LCA@A58XHD0<*D:*JJ`!A0!])*?'_`*R/_?7_`-"%`UNO5?F3
M7G_'U<?]=7_G5:K-Y_Q]7'_75_YU6I+9>B_('N_5_F%%%%,04444`3VW_'Q!
M_P!=4_\`0A23_P"NE_ZZ-_.EMO\`CX@_ZZI_Z$*2?_72_P#71OYT%/X(_P"*
M7Y0(:***"0HHHH`*GMO^/B#_`*ZI_P"A"H*GMO\`CX@_ZZI_Z$*!K=>J_,2X
M_P!?-_UT?^9J&IKC_7S?]='_`)FH:!!1110`4444`36_^OA_ZZ)_Z$*==?\`
M'S/_`-=&_G3;?_7P_P#71/\`T(4Z[_X^9_\`KHW\ZG[7_;OZE_8_[?\`T_K[
MNO2O1115$!4%S;PWEM<6EP@DM[J"6WGC;I)#/&T4J'V9&93[&IZ*`NS\R?&?
M[!_C.X^#'Q:_9@\`_$3PGIWP`^,VG^--+U:R\5>%[W4O&OP]M/&]M=IJ0\`7
MVFWUGHMPUO=7DUU8#Q#I]P;9F*[W`!K*UK]@#QQXAOK+P?/XZ\"6?PIT7X,^
M!_A/X8N]/\/:Y;?$W1]3\!7VFZIH?C:/4!J+>&DU4ZG8E[B&+3!"8)G13O)8
M_J74D/\`K8O^NB?^A"IY(VM;6VN]ON_2[-%4E=;:M7=M7M_D?F/X%_8=^)GA
M+]L/Q[\>/$GC+X9>*_AMX[_9^\)?LXZ[X(N?#?B5?$M[X6\':_K_`(DBUZ[U
M9M6.D3Z[K>H>(;N'5X?[/73_`+*J_9HXY69CZYJ7[$?PQ\)W/PY\1_L^Z#X7
M^$/BWX2W?B.Z\'16>C-/X5N(?%<<8U_2];TRVFM[QK/4IH()I)K&[@NHI8PZ
M,V2M?<-W_P`?4_\`UU;^?X_S-5J48KEM;LUY.RU^_43G*[UMTT[:+]$?*?BW
MX6?M!^//#&F1ZI\7O#/A'Q7;Z]X;U.\@\&^%[Z?P;+IVCW<D^K:6;/7-1FUB
M]C\0PF.VN3>WWE6L:L(H7+!A\*?'[_@F3\0OC)\+OVJ_"&A_$3X:^`=?_:J\
M(0?#[Q%;:+X8\30_#_P[H%O<I<'Q'IWAR+64GNO&]\T40OKZYG&GL-RI;@!3
M7[+T532>ZOT[/[U8%.4=N]]O3_);?,^;-&_9R\$^(?A+=_#WXS^`_AIXHG\7
M:;I%I\2['P[H5W9^$?%=UH4"V6FW+Z?J<]Q?N(;*&`8O+B619!($;R]JCSO]
MHG]D4_%3X9_"OX4_##Q7;_";P5\.O%UAJ>H>$[+2_M/AOQ1X0M=#U?1F\(7U
MK#+!<PVEM-J-MK%B(+B.(W^F6R7:36IDB;[7HHLMGJM/+3U_JQ/,T[K1W;_I
M'Y2_#K_@FWJOPAT/]G]?`'Q1L)?%WP9^&7C/X-:AJ/B70+FYT3Q+X&\<W#W5
M_+'IMA?VTFFZ]I]R();&Y626W<(\5Q&T;<?!O[/'_!.#6I/C%\</A"_B?Q#J
M'PJTG]@O3OV5F^)NJ>%G\-7-WX\NOVA?'_CV[@TS3)3)'?V>D:5);227T;LE
MS!>6C*0TAV_TGQ_ZR/\`WU_F*DNE5;NY*HJEIG+%5`W'/5L`9/N<GWK-TX\T
M=++5M>EK==.GW=-6:^TERR;LVVM=OPMK]_GZ_EY\)O\`@G:?"?B+XIZYX^^(
M-GXJL?BO\!_!7P.UKP_I7A_^S[.RL_!.DW>D6&O6-]=W5U=B^DCGCNC'(K)'
M<PJZ8``'?WG['WC^X_9/T_X")\;+V/XB"70)/$7Q672!')XFM_#UU9VMGIE_
MIRR&6.Q?PMIFG>'9_L]Q',Z02W:R)-<2$_?M%6HQ6EOZ_K[NA#J2O>]MNBZ+
MT/P:\'_\$B/B=\-/&-WKW@GXT?#ZXTBY\$?M#>%H].\0>#/$`N+:Y^/CW<MU
M<1RZ7K4$)L_#KW(6UA*>;<1I^]DW'=7IO[-W_!*;4/A%X#\4^`/'7Q5TWQ1I
M/C_]E+P9^S#XS/A[0K_29IK+P+H6H>'=)\1Z-->7\\EC/<V%Y'<7MM*9PUY&
MRQ.EN^P?LQ125.-[VZ^?6W^7YH?M)^2VV2Z?\,ON1^/'@S_@F)XUT#X:?#GP
M_K?QC\#ZG\0?@/\`%/X??$GX*>+=!^$MEX1T^(?#;[;9Z-I7Q,M--U::_P#&
MDFIZ'J>HZ;JE\MW8B":XCO\`3[6&Y@5SH^*O^"<GQ0U/X*?M;?#/0?BWX'.N
M_M=>-4\5>)K[7O!^KOH/A%+FWL8M0M-#MM.UB+4+\O)8Q_9SJ<S(L3R"4.V*
M_7:GQ_ZR/_?7_P!"%/DC:UM/5_Y@JDFUKU73SV].MC\S_C5^PKXM^(_[$TG[
M+>@ZS\)?`7CG4;7P3IOB7QEH7@[6(?"U_;^$=4L;Y[BWT>+48M7-W>1V6(S>
M7\T<,]Q,Y4JV*\NT'_@G?\;K/5/VA=5N_CGX2T>?XX>+OA3XHQX2\,ZY;"RM
M_AWINGZ5J'A_5&U+5+I[O2_$=K9,LYM&MKF+S`OFE0V?V(O?^/N?_KH:JTE!
M-1=MHI?+^OZOJ+GEKYMM_.W^2/R$\$_\$O[OP-\`?"'P$A\?>%_%'A[PW\4O
MCA\3[K_A(/#%_://?_%_QSX@\<6<6CZEHFI6FL^'[KPE>^(;F*ROK&]5[M((
MA=1NI=3T/PK_`.";>L?"#]HB[^*_AKXLZ)K/@3Q1<>&O$/CKPQXW^'.E>*_'
M=[XS\,:9;:9::IX9^(-Y=Q2>'K.[2UB>]B72KFY)4M!-!)(\E?JU134(JUEM
MMN[?>P]I+57W=]CX`UK]F#XS:C^W;X=_:MMO&OPSB\$Z!\.[WX9KX,GT#Q2_
MBBXT74[V'4KS46UB/5UTI=4CNHMELOV$VGD']ZC2<U=_:&^!6IWO[2'PB_:7
M\.0FYO\`P_\`"/XO?L]^(D:&ZO4T[1/BO<>&=6T#Q'+86TT<EQ8Z-XI\-6\6
ML+;XNOL&I&9'"6SU]Y4<'@@$>AZ4[+7?XE)[[JUOR7D'.]/[JM\C\3?V??\`
M@EM\3?A=XN_9RO\`QS\3?AAXS\*?!7PY\6O#&O:%8>$_%-A<^++'XJZ\^N71
MAGN=<FALCILCF"-9(Y!+'\QPW-?I%+^QW^SC87MS/I7PSTK1KYHI[>/4]'O-
M4T[4[5;F!H99;*^MKU+BUN-DKB.>!TEC)W(P8`U]))]]?]Y?YBK-]_Q]S_[_
M`/[*/K_,U*BHM671^=OAV?\`6I3E*46WO=;:=C\N?"7_``35\+^"OVBOB[\9
MM`^(WC:TT#XG_`.R^"MOH=WXL\6:[XA\.R0W&JR7&OVFO:]K&H!]L>HQ_P!G
MVIBVV4T+2QD&5\Z'P?\`V1->_9PE\2?$'4_&EQXXURR^">B?!#PSH7AW3KW3
M[/7=*\/27[:5XJ\76MS=W7]I>.]1>_6'5M4MV@L_*BW11+O;'Z5TA`/49'H1
MGG\?_K4^5:6TU;Z[Z?G^A'/+OVW\NA\Q?L>?`H?LY?L_>"/A<9/,O=.75-8U
M8^8\B)K'B35;O7=3BC9RQ$<-U?R1(N2%"8''%?3U%%5LK+;33\A-MNY^<'[>
MG_!.WPC^V?\`"SQWX2M/&?BOP+XT\9ZW\)]3;7_^$K\87'A:"V^&_P`5?`_Q
M`GMKCP59:U::+<S:CI_A2ZTRRN#:A]/U*]M=70FXLHV'T=XW^"_B?5/`WQ9T
M/PAKVAP^*/B%X67P;HVI^+;?6-4TS1M'&DR:0GV];2]BU2^N0L\US)*EVIN+
MD))-N.\M](TY/OK_`+R_S%3RK5I6;5F_+7_-E*3]U7V>GWK_`"/S2\#_`+*/
M[5?PD_8DT#]F'X>_&3X.:-\3?"D,6@:7\2;_`,`>+=9\,2^%1*T\RWOA=O%%
MAJ#ZS<^;)!))#JT-FL)RD8;FOH3X`_!OXHZ'\$[SX:?M1>,?A[\8M8U7[=IV
MI_\`"$>`IO`O@,^&;B%+>#1+7PO?ZMKUVJ&(2M>R76J737,LK,"B_)7UGJ'_
M`!]2_P#`?_015.G'11:NFDK.[TM;;7?3<)2;YHM*S?;T7Z;;>1\)-_P3&_8"
M=F=OV3_@RS,2S$^#].R2>23^[ZFF_P##L3]@#_HT[X,?^$?IW_Q%?=]%='UG
M$?\`/^K_`.!R_P`SG]C1_P"?5/\`\`CTMY>2/A#_`(=B?L`?]&G?!C_PC]._
M^(H_X=B?L`?]&G?!C_PC]._^(K[OHH^M8G_G_5_\&2_S#V%'_GU3_P#`(^7E
MY(^$1_P3$_8`R/\`C$[X,=<?\B?IW?@_P5:O?^"8/_!/Y+AU7]DWX,*`$X'@
M[3P,E%S_``=^OUK[E'4?4?SJW?\`_'T_^['_`.BUJ?K6)YH_OZOPR?QRZ./F
M5["BH_PJ?Q?R1[+R\D?`G_#L3]@#_HT[X,?^$?IW_P`11_P[$_8`_P"C3O@Q
M_P"$?IW_`,17W?15?6<1_P`_ZO\`X'+_`#)]A1_Y]4__``"/EY>2/SW\1_\`
M!*[]@;7O#VO:';_LP_"319]:T75-)@UC3O"&F+J&DS:C8SV<>IV+/&4%Y8/,
MMW:E@5$\*%@1Q5;]BS_@EU^R-^PE8PR?!GP/-=>,6@\K4?B)XLNEU?Q;J#,/
MWI6Y2&VM-/@<D[;:QM8412%+2$;C^B-%4\7B73E2=>HZ<OBBYMJ5MKJ_3H)8
M>BIQJ*E!3C?EDHJ\=KM:73T6OEY!3X_]9'_OK_Z$*93X_P#61_[Z_P#H0KF-
MUNO5?F37G_'U<?\`75_YU6JS>?\`'U<?]=7_`)U6I+9>B_('N_5_F%%%%,04
M444`/C_UD?\`OK_Z$*^AK;_CW@_ZY)_Z"*^>8_\`61_[Z_\`H0KZ&MO^/>#_
M`*Y)_P"@BN#';4_67Y([,+]K^NQ\X>+?%&BV?B/5K6XNU2:&ZV2(1]UO+C./
MR/Y5SO\`PF/A_P#Y_E_+_P"O7F7Q._Y'[Q/[Z@/_`$G@_P`^]<)7T6'P%*5"
MA)RG>5*G)ZKK!/L>94K252:LM)/[DU^B_$^B/^$Q\/\`_/\`+^7_`->C_A,?
M#_\`S_+^7_UZ^=Z*V_L^C_-/[U_D1[:79?U;_)_?Y'T1_P`)CX?_`.?Y?R_^
MO1_PF/A__G^7\O\`Z]?.]%']GT?YI_>O\@]M+LOZM_D_O\CZ(_X3'P__`,_R
M_E_]>C_A,?#_`/S_`"_E_P#7KYWHH_L^C_-/[U_D'MI=E_5O\G]_D?1'_"8^
M'_\`G^7\O_KU)#XP\/M+$HOERTB`9!ZE@!ZU\YU8M/\`CZMO^OB'_P!&+2>7
MT;/WI[/JO\AJM*ZT6Z_3_)_?Y'T9J'BW08KZZC>]4.DSAA@\'/2J?_"8^'_^
M?Y?R_P#KUX?K^?[9U'_KZE_]"-8]"R^C9>]/9=5V]`=>5WHMW^:_R?W^1]$?
M\)CX?_Y_E_+_`.O1_P`)CX?_`.?Y?R_^O7SO13_L^C_-/[U_D+VTNR_JW^3^
M_P`CZ(_X3'P__P`_R_E_]>C_`(3'P_\`\_R_E_\`7KYWHH_L^C_-/[U_D'MI
M=E_5O\G]_D?25EXNT&2[MHTO5+/-&JC!Y)88'U/04RY\8:`MQ.K7R[EE<'@]
M0Q!]._M7@6C_`/(5T[_K\M__`$8M1:E_Q_WG_7S-_P"AFH^H4N?EYIVY.;=;
MWMV*]O+E2LOB?Y1O]]CWO_A,?#__`#_+^7_UZ/\`A,?#_P#S_+^7_P!>OG>B
MK_L^C_-/[U_D3[:79?U;_)_?Y'T1_P`)CX?_`.?Y?R_^O1_PF/A__G^7\O\`
MZ]?.]%']GT?YI_>O\@]M+LOZM_D_O\CZ(_X3'P__`,_R_E_]>K-GXOT![NV1
M;U2S31J!@\DL`!7S=6AI/_(3L?\`KZA_]#%)Y?12;YIZ+NO\AQK2NMMU^GYZ
M_?Y(^@+OQ?H$=U<(UZH9974C!X(8Y[U7_P"$Q\/_`//\OY?_`%Z\&U3_`)"-
M[_U\R_\`H9JA0LOI67O3V75=O07MY=E_5O\`)_?Y'T1_PF/A_P#Y_E_+_P"O
M1_PF/A__`)_E_+_Z]?.]%/\`L^C_`#3^]?Y![:79?U;_`"?W^1]$?\)CX?\`
M^?Y?R_\`KT?\)CX?_P"?Y?R_^O7SO11_9]'^:?WK_(/;2[+^K?Y/[_(^D+7Q
M?H#W,"K>J6:5%`P>26`'3/\`*G7OB_04N[E'OE#+,ZD8Z$,1CK7SUIO_`!_V
M?_7S#_Z&*DU?_D*7_P#U\R_^A'M4_P!GTN?XI_#W7?T*]O/E2LOBO]RC^>OW
M^1[O_P`)CX?_`.?Y?R_^O1_PF/A__G^7\O\`Z]?.]%5_9]'^:?WK_(GVTNR_
MJW^3^_R/HC_A,?#_`/S_`"_E_P#7H_X3'P__`,_R_E_]>OG>BC^SZ/\`-/[U
M_D'MI=E_5O\`)_?Y'T1_PF/A_P#Y_E_+_P"O4L'C#0&GA47RDM+&`,'DEP`/
MQ/%?.56[#_C^M/\`KYA_]&+2>7T4F^:>B[K_`"&JTKK;=?I_D_O\CZ(O_%V@
MQWERCWJAUF<,,$X(/O53_A,?#_\`S_+^7_UZ\+UO_D+:A_U]2_\`H59=$<OH
M\J]Z>RZKMZ`Z\FV]'K?UV_/7[_(^B/\`A,?#_P#S_+^7_P!>C_A,?#__`#_+
M^7_UZ^=Z*?\`9]'^:?WK_(7MI=E_5O\`)_?Y'T1_PF/A_P#Y_E_+_P"O1_PF
M/A__`)_E_+_Z]?.]%']GT?YI_>O\@]M+LOZM_D_O\CZ,A\8>'VEB47RY:1`,
M@]2P`]:L:AXMT&*^NHWO5#I,X88/!STKYSM/^/JV_P"OB'_T8M7]?_Y#.H_]
M?4O_`*%W]ZG^SZ7-\4_A[KOZ%>VGR;+XE^2_/]3W'_A,?#__`#_+^7_UZ/\`
MA,?#_P#S_+^7_P!>OG>BJ_L^C_-/[U_D3[:79?U;_)_?Y'T1_P`)CX?_`.?Y
M?R_^O1_PF/A__G^7\O\`Z]?.]%']GT?YI_>O\@]M+LOZM_D_O\CZ(_X3'P__
M`,_R_E_]>I(O&/A\RQ@7RY,B`9!ZE@`._6OG.IK?_CX@_P"NT7_H:T?V?2_F
MG]Z_R&JTKK1;K]/\G]_D?1^H^+M!BOKF-[U0RRL&&T\&J7_"8^'_`/G^7\O_
M`*]>(>(!C6+\#_GNW]*QJF.7T7&+YIZQ75=O07MY=E_5O\G]_D?1'_"8^'_^
M?Y?R_P#KT?\`"8^'_P#G^7\O_KU\[T57]GT?YI_>O\@]M+LOZM_D_O\`(^B/
M^$Q\/_\`/\OY?_7H_P"$Q\/_`//\OY?_`%Z^=Z*/[/H_S3^]?Y![:79?U;_)
M_?Y'T7'XQ\/F1!]N7)=0.#U)``Z]SQ5O4O%NA17MQ&]ZJLK@$8/'RC_/]37S
M=#S-#_UUC_\`0UK4\0?\AB][_O1_Z`M3_9]+F2YI_#+JNCCY>9:K3Y'MNNG:
MWYGM_P#PF/A__G^7\O\`Z]'_``F/A_\`Y_E_+_Z]?.]%5_9]'^:?WK_(CVTN
MR_JW^3^_R/HC_A,?#_\`S_+^7_UZ/^$Q\/\`_/\`+^7_`->OG>BC^SZ/\T_O
M7^0>VEV7]6_R?W^1]$?\)CX?_P"?Y?R_^O3D\8^']Z_Z<OWAV/J*^=:?'_K(
M_P#?7_T(4?V?1_FG]Z_R&JTKK;=?I_D_O\CZ5U3Q=H45],DEZH92N1@GJBD=
M?K6?_P`)CX?_`.?Y?R_^O7B?B/\`Y#%W_P!LO_1*5AU,,!1<8OFGLNJ_R!UI
M7>BW_5?Y/[_(^B/^$Q\/_P#/\OY?_7H_X3'P_P#\_P`OY?\`UZ^=Z*K^SZ/\
MT_O7^0O;2[+^K?Y/[_(^B/\`A,?#_P#S_+^7_P!>C_A,?#__`#_+^7_UZ^=Z
M*/[/H_S3^]?Y![:79?U;_)_?Y'T2/&/A_(Q?+G(QP>N?K5_5/%NA0WLL<EXJ
MN%CR,$]8U([_`.??K7S2GWU_WE_F*W/$O_(7G_ZYV_\`Z(CJ7E]+GC[T_AEU
M7>/D/V\K6TW3_#7\OQ\CVK_A,?#_`/S_`"_E_P#7H_X3'P__`,_R_E_]>OG>
MBJ_L^C_-/[U_D+VTNR_JW^3^_P`CZ(_X3'P__P`_R_E_]>C_`(3'P_\`\_R_
ME_\`7KYWHH_L^C_-/[U_D'MI=E_5O\G]_D?1'_"8^'_^?Y?R_P#KU)#XP\/M
M+$HOERTB`9!ZE@!ZU\YU8M/^/JV_Z^(?_1BTGE]&S]Z>SZK_`"&JTKK1;K]/
M\G]_D?1FH>+=!BOKJ-[U0Z3.&&#P<]*I_P#"8^'_`/G^7\O_`*]>':__`,AG
M4?\`KZE^OWCU]ZR*%E]&R]Z>RZKMZ`Z\KO1;O\U_D_O\CZ(_X3'P_P#\_P`O
MY?\`UZ/^$Q\/_P#/\OY?_7KYWHI_V?1_FG]Z_P`A>VEV7]6_R?W^1]$?\)CX
M?_Y_E_+_`.O1_P`)CX?_`.?Y?R_^O7SO11_9]'^:?WK_`"#VTNR_JW^3^_R/
MHR+QCX?,L0%\O,B#H>I8`?F<"OJNS</:6SKRKP1,I]0R`C]*_,ZW_P"/B#_K
MM%_Z&M?I7I7_`"#;#K_QYV_7K_JEKP\YP\,.J'(Y/F<[\SOLHGH8"I*;FG;1
M+]$?!7Q._P"1]\3_`/80_P#;>"N#KO/B=_R/OB?_`+"'_MO!7XJ?M4?%O7_A
M;_P4"_99\-:E\2OB3HOPI^('P[^+'B7Q7X2\(Z1KOB>._P!<\#+HLGAY1HOA
MC1=9UG[#*UU<+J3QVWD%&7SY8@1GZ&C-4\)AI/;V5".]OBC"-_Q//G%RJS2[
MR?W'ZWT=>E?@;\-_$/QD_:!\5?MVR?#OX[_&.&U^#7C+PL_PPTF\AU'PQ='3
M[SP^/$.L:+<Z1XDT33]4B^UNDUK9-=V<;1J8S&67!/W];OJO[1'A[X-7_P`-
M/BSXR\*RQ>!-6U+Q%=:?>0L3<2V]MI=HOB2V:(^?JEOKL-THCW1N/L]R679D
MK<*W.KJ.][*Z]ZTN5V>WGZ6[DNG9I-]+RT?NZ)J_K=+UTW/O3KQ1_GU_S_DU
M^++^"OC3<?MG:U^S1%^TM\5H=+C_`&7++QU::U_:5LTL'CV^U_5-&_M@P?9L
M-8QFW@E_L_=Y9"%-W)-;7P^^.GQ3^!?Q+^-_PA^.OC77_%OP;'Q2T_X3_#_X
MT2J?^$@\&>,KOX&?"+Q_=V'BR[AB\FUTK6M:\>W_`/8&INGE6+PQVER^&5@_
M;)?%%Q7,X7NFKI7UL]%TOZ?(=-]'=\JE:SV>GWWZ'[&?Y]**^6_V/FUR[^"V
MD:QXA\8Z]XVU'5M5UV9M7U^[CO+@V]OJUW:6D4#Q1QIY"V\,97`(.<YYKY&\
M>V'[4/P\^)?QA<?&'5?&WP[U3X#?%#QKK\-Q8V6G1_#'Q59:;<R^#K/PC<6D
M0G*2,LNZ.\+RF*U\]FW-@TZEHQDXMJ6]NFE]NJ_IV)4;OEND_P"K_=^A^KN<
M].?IS5BT_P"/JV_Z^(?_`$8M?ES^PG^UC<>)O`'[,WPK^*=CXBA^(WQ6^#]Y
MXU\)^+]6O-/O[+Q]_P`(Q%'-XH56MIVO++5-/MYH[QX+V%1/;!Y8W^0K7ZC6
MG_'U;?\`7Q#_`.C%IJ<9Q;B[JVOD[7L_.S0W%QDD^^C[Z_UZ&AK_`/R&=1_Z
M^I?_`$,UCUL:_P#\AC4/^OJ7_P!"-8]4MEZ+\B7N_5_F%%%%,04444`:6C_\
MA73O^ORW_P#1BU%J/_'_`'G_`%\S?^AFI='_`.0KIW_7Y;_^C%J+4?\`C_O/
M^OF;_P!#-9_\O?\`N'_[</HO5_DBE1116@@HHHH`*T-)_P"0G8_]?4/_`*&*
MSZT-)_Y"=C_U]0_^ABD]GZ/\AK=>J_,35/\`D(WO_7S+_P"AFJ%7]4_Y"-[_
M`-?,O_H9JA0MEZ+\A!1113`****`+NF_\?\`9_\`7S#_`.ABI=8_Y"E__P!?
M4O\`Z$:BTW_C_L_^OF'_`-#%2ZQ_R%+_`/Z^I?\`T(U/V_\`MW]1]%ZO\D9M
M%%%4(****`"K=A_Q_6G_`%\P_P#HQ:J?7I7B/CWXT#PO\0/!WPF\':?8^(_B
MSXRL=1U_1=#U*]DT[2;#0-$D@CU#7M=OH8KBXM]/BNKFUM42VMYKB>:8+&AV
ML1,VE%M]G^0UNO5?F?06M_\`(6U#_KZE_P#0JRZ_/;XS?MF?$WP+8?'VXTSX
M<_#_`,2^+O@IIO@;7KG2;'Q]-)IWC.#Q*_B5/$=GX<GM].EOH;_PW-H^G0M;
MZE:0;FU2(W+0AHB^'\:?^"@MG\./V1O!W[2WA?P,GBK5_&&I^$]#3P3=:L=/
M31M6\0:[8>'=1CU34(X)Y4AT/4;Y4N3';M+(JY1.:SC6IJ/Q/W87=XRV7N]K
M-W5M/R+]G.Z25[M+?JTFO31GZ2T5YS'X[A\/?#Z#Q=\1[K0M!O\`3O"</B/Q
M9;Z9?2W>G:<T=@+S4?[/DNXK:^NK*%A(MM--;12S(H9HT)('SW=_M!?&&_\`
M`-C\7/`OP<L/&?@+7[CPL_AO3K/Q'/#XWN]!\0^(=.TN;Q-<Z6=/>P%A9:5>
MR:V;.WO);XVT#;T0!RMN<5W>E[)-O[EK_7<GE?;K;7J^R[L^RJ*^`M*_;-UW
MQ7XM\?\`A_P9\/=/U9O`/Q9@^%FH^';S7Y-/\?HB:E:6.H>.)O#4EH6/A)8[
MIKRPNK:2::\M86N-J1D&O%;3]OCXS:C\3?C!\,++X>_!=/$OPP^)6C_#31?#
M]Y\0_$4'B+XCZYKVF'6M,M/#%G_PCQ@ANI].2<&34YK:PBN866:[BC*N9=:F
MK7;U=D[.U[7L4J<W?1*R3U:6C_X=>A^M]I_Q]6W_`%\0_P#HQ:T-?_Y#.H_]
M?4OX_,:^>_'O[1OPE^##>$C\6_%=IX*O_$7V"6*SN;34]06T>26UAN'OKC2[
M*]AT^PM;RYCM)=3U![:P65XU:X!=0?./VS?VO?"7[/G@CXB>)=$OM*\2^.M`
M\*R>-M,\+&/5KJ";2)GE^Q7VL7FCV-[#HECJ7V>Z33+O59;*"^GMIH;:21HW
M"CG!3=Y+W8^\MVM=+I:_AJP492BDD]9::.VR_P`U]Z[GUG17P;\./V[_`(-Z
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MD0-3]I!.SG&_JA<LM^5_<_ZZGU)4UO\`\?$'_7:+_P!#6OA?X7?MZ_!?XAM\
M:[B]U"]\,:3\&_B1-\.;S4]4T/Q$D&MZBK06]LND2'2O*U74+R^E>WM](TB2
M_P!095CE:W5)4)Z7XI?ME_";P9\)-=^)'@[Q7H_BO5;?PAXD\4^%M%@MM:NF
MU*3PW:SW%Q'JEOI^G7%_HEK%<6_V2[N=3M[2.VG80S/'(0I7M:=N;F35KZ-;
M=7^)2A)22<6M4MGO=:7V/M;Q!_R&;_\`Z[M_2L:OD?P+^V7\.]=^$7P!^)_Q
M:U_1/`'B3]HG2+*Z\)^&\WMW)K&OS:3%J]]H^A0V]O<75[+9VDGGLIC!$(W'
MV[JZ_:B^!%CXZTCX;7WQ!T^T\9:Y#!-IFE7-AK,$=PUS:-?6]HVI2:<NEP:C
M-9JURFF3WD5^T0+_`&?`-$)PY(^\MH+?JTK;^HG&5[6?7H];;_=U['OU%?,6
ME_ME_LTZW_91T;XIZ/JJ:[/XTL]$FTZQUJ\M]8U#X=ZC=Z5XTTW3+BWTR2&^
MU/0;_3[R"[TZV>2\8022P0S1+YE4[;]MK]EV^A:;3?BYH6K&/PM%XUN+?2+/
M6]4O;/PK+=-9'6[ZQL-,N+NRL8+E)([R6ZAB^P^5*UV(5BD9:]I#?GC;_$@Y
M9?RR^YGU317EGB_XK^"M!^&6K?$N/QMX5L?#5OX4D\56?BK4;X3>'DTE[/[9
M:ZS<2V?FS2Z6T+),TMNCLT1RF37DS_ME_L[Z)I5Y-XE^+7A;[?X=\&>$?'/B
MQ])M]9OK;2/"_C.\33-"\3W4=MI]Q<6/A^_OFP-0NU2"SMP;F^>WMT>54ZD%
M:\DK[:K^G\M>NPN635U%O6SLGIMO]_K^!]8P?Z^'_KK'_P"ABM3Q!_R&+W_K
MJ/\`T%:^"_VO/VH?&_[.VD?"'Q+X&\)>"_&VC_$[XC>%OA^MUXA\2:EHD=A=
M>+-[Z1JT,EAIM_'<Z;LCWSDLDFQT:)6!X\6^(G_!1O5="^(_P[\'7?@73+*_
MU+]JNV_9L^*5Y!?:CJVDZ=<7GP]U'Q_:>(?`][;V*MK]G)8Z7/;7$3Q+=6MT
M\<#0M*'49RKTXU.64K-1[/7F<+6[]WV^\UC3E*FVK:RMOVL?J)17S;JO[7?[
M.VB^`-)^)]_\2M-3P3K=[J.G:?K%OIVN7K/>:/))%K$$^G66F7&J6;:3)#*-
M4-Y9P)8"-GNFB0%AT=U^T?\`!>TFT2%_'%E,OB&VT"\TFYL;+5M0L+F#Q2EO
M+X?+ZC8V%Q8VLFK075O<6<-U/#++;RK<!/)RXUYX_P`T?O77;[S/EEOROKT?
M2U_S1[?17C?AK]H#X0>,/&U]\.O#?C;3-5\8V$-[.^D01WB&YCTV46^H'3KV
M>VBT_4S87#""]73[NY:TE(CN!&QQ7E.H?M%>+M$^)_BCX7:W\/H[>_@^&GB#
MXE^%=:L-0DO=+^PZ)!(RZ5XM)AC;2M4N9E41I9?;;=DWA92R\CE&U[JVUUK^
M5_\`@BL]K6VWTW:7ZGUU3X_]9'_OK_Z$*^&?V0OVT?"/[1?@?X>3>(KK3O"W
MQ1\=Z/KFMV?@M(=4BAOK+0;Z:VU&30=2O[."RU@V$21S7T5E<SW%HDBR3Q(A
MS7M7CO\`:=^"/PSU^3PSXN\;VMCXA@C$KZ3;:=K&J7`F,+W-O8,VE:?>1)J=
M[%%(UCIKR+>W@1OLT$NUL)5(.//S+E?6_P"'KY;_`"*4)*:CRN]ULF]+[^GF
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MLM'O+J\M;BT@LM7N+&[DN8)H%A,L;J$^)/[6_P``?A++KT7CGQR^G_\`",6U
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M%Y_^N=O_`.B(Z^8;']JK]GN[T8>(O^%I^&K+25U_5?#$EQJTUSH\L/B#0I!'
MJNDSVFJ6UI>07MDQ4RPRP(Q1E=-R.K'UG1_BW\-/BA?:Q>?#[QMX?\6VNE2:
M?:ZC/HU_#=1VEQ=VK/;0S,IPLDZ03-&O5A&^/NFES1<XV:?NRZ^<!6=FVGH[
M/R]3IZ*\Y^*OQ(TKX5?#_P`7^/=2M[C4HO"GA[6-<&D:?MDU'5)-)TVYU+[!
M:H6"B:>.V8!Y"J1J3([!5Y^.?!7[=]I\0/AA^SYXN\.^"T_X3#XX_`Z'X_3>
M$+W53$GAGP5#I%EJFJ^;?QPR-=7<#7L=E:*(5CGN`=SQKS1*I"+LW9VO:S[I
M?>[[#49/5)O6WSWL?H917P/JG[>'@^^T`^(?AWHI\6VFB?!^^^.OC."2\%G=
M:1X#TJWN[K48K&-%F6\UX0Z??M;6<C0P2M;;&G5I%J]XG_;E\$V@U;6?!MC#
MXK\&^#?AKX/^+OCW75O?LTFE^"/',:W.@7.EVX21;V^GL"^HR0S26\2VT9Q(
M78`+VM/^9?UU7]:#Y);6MZM+M_G\^A]U58M/^/JV_P"OB'_T8M?/?AWXY:3J
MGQ-T;X=WAMXV\=>"6^(?PXU"!G*:_P"'K46?]JQ2(PQ%>Z>+^UG9`Q$EO-O7
M[CX^A+3_`(^[;_KXA_\`1BU5TXRLT[73MWM?\K/YKN2KIKU3-#7_`/D,ZC_U
M]2_^AFL>O,OBY^T1\"_A;XQO?#WQ'^+/@+P3KLH-]'I/B7Q+I>DW[V<TCI'=
M+;7=Q%(89'CD5'"[248`G%/^'GQC^%7Q9BOI_AE\0?"?CN'3'2/49/"^MV.L
M)9/(,HEPUE-*(F<<J'QGM5J$^2,G&7*TO>Y7;9=27./.X\T>:[]VZO?MZKKZ
M/L>E45XKXZ_:.^`OPQUY_"_Q"^+WP_\`!GB*.UM[V31?$?B;2])U)+2[!:VN
M6M+NXCF$,ZJQBD*[9`"5)KIOA]\7/AA\6+6\OOAIX]\*^.K/3Y5@OKGPQK-E
MK$-I*XRL=P]E+*L;L.0K')%/DGR\W)+EWO9VZ=?FA<\6^523EVNK^>GD>B45
MX?XT_:6_9_\`ASKL_ACQY\8_AYX1\0VT<<MQHVO^*-*TS488YANB>2UNKB.5
M%D7YE)4;@<C(KL?A_P#%7X;?%;3[K5OAKXX\,^.=,LI_LMW?>&-7L]7M;:Y*
MAQ!--9RR)'*5(8(S`XYZ4.,E'F<6H_S--+IU^8U*+?*I1<NUU=>JZ'HMO_Q\
M0?\`7:+_`-#6OTKTK_D&6'_7I;_^BEK^>SXZ_P#!1K]D_P#9F^)_A#X9?%WX
MD6/A_6_$UUY!N(%_M*S\/W"O&8D\3"R:6ZT>.X#`PW$]N8>"79!S7[Q_#3Q_
MX*^)'@?P[XQ\">*-%\6>%]9TZVN-,UW0[^WU#3;V(Q(=T-S;N\;$9`9<AE/#
M*#Q7SW$-*I&GA9RA)0DZEI.+2=U'9_(]'+*D)3K0C.+E%+FBFFUMNMSXZ^)_
M_(_>)_\`L(?^V\%?GS\1?V5]?\<_M5?"/]IRT^*5SH=S\(O#GBKPGI'@]/#E
MG>V-]HOC<6*>)8KJ_ENDN!/<I80K;3+'FV)8A7)X_0;XG?\`(^^)_P#L(?\`
MMO!7!UZV'BIX7#*2NE1H27K&$6G]YR5&U5G;^9_=U7S1\;?`;]E?6_@Q\9?C
MO\6;[XGW'C"/X\:QI^MZ]X<N/#MGIMMIM[I%B-+TS['=PW,TKQ0Z</(ECD3]
M\Y,A*_=/L/P@^!OA#X+3>.I/"?VL1>.O%5UXHNK:YD,D&F/=-),VF:8F2+;3
MDN[F]NX[=,*LMY*<=*]HHK>,(Q226S;5];-N[^;9#DWN^B7R6Q\:Q?LL:]'^
MUY<_M5GXI7#27/@.W^'+^!_^$<LQ8CPW:7]SJD$?]I_:?M)NA?7,DC7'E\IM
M3;U-3:/^R@+_`$W]H30/BGXT'Q%\/?'_`,6-XQU+39?#UGH[>']7'@GP?X!@
METRZ@N)Y";70?`^@^0Y"2)>137`;,FT?8E%)4X+IO)RUN_>DK-Z]T'-+TT2O
MULG=:_(\;^`'P=TWX!?"7P?\)='U;4==TSP=8R:?9ZIJS^9J-U`UQ+,C7<F3
MYDJK($,A)+[<GFOF/P[^Q[\6%\>>-==^(?[4OC+QWX"\;V_BBTU#X;'PQH6B
MZ9':^([*YT^*V&J6>[4)8-*M;DI:1RNRY56?G-?H!13<(M133M'1*[2VMT>N
MBMJ)2:ZZM6;:3_/8^+O@A^QAX5^#NO?#?7)?$FH>*S\&O"&O>!OA7!J%G;VY
M\+>'_$AA755,T19[R^N;:!+1[M_+)M]R;,,:^V;3_CZMO^OB'_T8M5ZL6G_'
MU;?]?$/_`*,6CE48M15E9[>EOR2&FW)7UU7YFAK_`/R&=1_Z^I?_`$,UCUL:
M_P#\AC4?^OJ7_P!"-8]-;+T7Y">[]7^84444Q!1110!I:/\`\A73O^ORW_\`
M1BU%J/\`Q_WG_7S-_P"AFI='_P"0KIW_`%^6_P#Z,6H=1_X_[S_KXE_]#-9_
M\O?^X?\`[</HO5_DBG1116@@HHHH`*T-)_Y"=C_U]0_^ABL^M#2?^0G8_P#7
MU#_Z&*3V?H_R&MUZK\Q-4_Y"-[_U\R_^AFJ%7]4_Y"-[_P!?,O\`Z&:H4+9>
MB_(04444P"BBB@"[IO\`Q_V?_7S#_P"ABI=7S_:E_GK]JES_`-]&HM-_X_[/
M_KYA_P#0Q4NL?\A2_P#^OJ7_`-"-3]O_`+=_4?1>K_)&;1115""BBB@`KY6^
M*7P)\2:I\<OAO^T7\,;C2!\1?!.@:SX(O]%\0//#I/BGPCK]U:7T^EM>P)+)
MIUU#J-E:SP70AE7&])$*FOJFK=A_Q_6G_7S#_P"C%J9Q4HM->:\FBHMJ2]5?
MS5]F?D/JG[$OQ<TGQ5^V)\4])\*_"T?$#]IOQ!\+O[/\)C5;FVTKP#I'@G3=
M2L_$OE:^-+9[R7Q+=W5O>3P6UE;I+)"'N"[A37#_`!L_8,^/'B?X(^/?AOX#
MF\#2R^-O'_@KQKHVA:UK-]::1X$71]>T+Q3XEL;*\AT^=[Y=5U;2Y4MBL$"P
MI-O;H5/[<ZW_`,A;4/\`KZE_]"K+K".'IN"7O)2CKKK[VLM;=6RG5FW=VW3V
M[6LOP];-GQOXB_9!\!?%>[A^(7Q+T_6+#XF:Q\*+;X<^(;+1_&&M7/A*TMI-
M,N[:ZAMM(\ZWTJ^:&;4+KR]1EL$N)T$3/C8H&_\`"/P;\;/AGX8\(_">.T\&
MS>#O!6G:5H6F>,EU&\;5;C0=**PP6TN@-:B..\-A''`9OMAB$F7V\`5]4T5L
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M(;]/$<VNZ+J6E:DMW:0237%A##8W,,MBTB1F66.8JY0`<5\=_P!B?XIW.I?M
M/-X?\3>%[K0OVB?@-\*?AKXGNO$=QJ._X?ZS\&M,\66%MJ.AV\-O-]MT77H?
M$\]S>VBF&:*^M!<$2>:-OZOVG_'U;?\`7Q#_`.C%J]XA17U?4T=5=&N9E96&
M5922""IR"".".14/#TY5'/WN:4;-WZ7M^3:U[]2E4FJ:2:LI/2RZ\LM_6)_-
MM^S[^QW\0?B?X4^,EEH5_I"CPU^T3\$?''A+Q!<07VG^'O&T7PM\+Z+IVK"R
MDFMQ=007,UM/&D[0MB5<,#UK[:\+?L)?$72/AK^U7HMYXF\+Q^-?C!^UKXV_
M:D^&.J645V8O!VK^(%\,KIUAJ$\B"222`>&HO.EMEP4NY4^8*,_JA:65I81>
M196MO:0!BPAMH8X(@S<L0D2JN6/).,DU9HAAJ<4KW;2LM;=EKU=EU]+[`ZTV
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MX&UF+]CSXFQ^,_B3JLUW>6)U2RTOP!JW@JPLO#-J]I<-.]ZWB.[OKK[3)`D7
M]E6Z8<W`,:?&;]B_XU?$[]IKPM\8!XJ\(GP?X"^)7AOQSX7T5DN;*]_L_3-!
MO-.U+2+Q+>`PW%S=7D\<L=],TI6#,>T!<'];_$'_`"&;_P#Z[M_(5C41H0<4
MW?7DEOUC&*7RT%[27_I5M-N9W?S/P5^&/_!/_P#:H\"6O[/UM<6OPMG7X0_'
MG]J?XJ:H;?Q+J2C4=(^/&O\`BW7=#L+16TD8NM(/BM[:]$F(V^PJ\9(E`7YW
M_9E^`OQG^#'[4$G[.VKVG@#4?'T_[)WB_P`+ZG>PZGJ$N@16?C+XA:_J27:7
MDFFJUS>Z;INLK,^FNJF58@%D56R/Z<JS?[&TC^TCK(TNP&K&(0'4Q:0"_,(X
M$1N_+\\QX_@\S;[5+PL+P<7)<K5[N]TE;[[=2_;RLTTG>_3K=6O>^BML?F'X
MS_X)N^%K#]G(^!?`%YJNL?%?0?V<6^`_A?5_$OC#7[7PI<QGP^^BC4M6T6.:
MYL&??++<"9K.6X`$:AQMR/DGQ'_P3M_:KUKPO\>]$@@^%<%U\5_V'?AE^S!I
M5PWB74@MCXH\&ZNYU'7+PC2-_P#9LFFZMJ-Q;!-T[7&GV\#(JW)>+^@2BJEA
MJ4K:-)*UD[7TMK\F_P`"%5FE:_6^J3ZI_HC\N_VLOV6OC9\=_@G^S-\*]$T'
MP)?S?#7Q;\+_`!-X_CUOQ-J.G65V/`NGQV%WIFDW%KI\EQ.+]@SQ7+^0T8`)
M&2#72_M5?L?^+_$NO_LE?\*,\)>`?#>F_!+X_0_&GX@:9?ZK=V9OI+3P3K'A
M=;/3KF.SNI=4OKJ7Q'=32WM\Z,D6GPKEO/\`D_22#_7P_P#76/\`]#%:GB#_
M`)#%]_UU'_H*T2H0E-MW]Z"3=];0Y$M=_4:G)0NG\,F_6^CO]Y^$>D?L!?M.
M3?LV3?!#4?$7P]T9M6^(WQZ\0Z^+.\O;V.[T'XI_VC<Z"MMJ#6,-U:SZ3>7R
M_;[6()'<QQ\2$':?7OAA^PM\3_!VJ_#0ZCXAT2TB\"^!OA1X(N]6T+4K_P`O
M7[#P)X&TS0M4;7O#U];R6&HW$FKVUR=$OT:"]L;+[/ND)0)7ZRT4UAZ=[OF;
MLE>_;^F+VDMM$M=E;>W^7IOW/RV_8^_8?\:_L[_$SQ/K'BF'X<^)M"TS6/&N
MI?#[QU"^O3_$FXM?&NKSZM<Z9K?VR3^RK.&V,JP2/9!C<".-BJ[:Z_X8^`?V
MT]8^*?Q(O_C/HGP/T7P'XPTOQ'HMAK?A/6M>UKQE#I%U;75EH.FR6]_IUI96
MT,"3"XO3#,WF3;L*1M-?HU15*C%)*\N5-NU][_S/=_@)SDVV[-M)7MM:VJ^[
MTN?ES^SW^PUXS^'FM_LQ#QMK6B2:1^R9?_%;4?!M_H$]U]N\:7GQ.\.:EX5D
M;7+>2*%;.RTS2]5NIELO,N5FOUM[GY6A0CG?%G["_P`24_:D^)/QCT.S^&?C
M[PA\1+G1_%,-GX]O/$$7B/PEXN\.Z8VG:=;^'Q:>9I26-R6\TW$\9DM6+E4?
M?7ZT4^/_`%D?^^O_`*$*7L(6Y==)*2=];J*C?[DEV'&I+F3OO9;>=^GG?[^Q
M^!MC^PA^VIX;^'/[/WPTF\/?!J>X^!W[3^K_`+0-WJ*^-M66'7;/5)_%%S#X
M>@A;0MUO-$/$N'N9"T;&VX7YLUW?P[_82_:=\&_"SP;<V.K?#C1_B_\`#3]I
M3XE?&KPWI#ZIJNH^!M;T3XC3R&YT?6IX;*WNHKRP@N9U@ECMY4$D888$AQ^Z
M'B/_`)#%U_VR_P#125AUE3PT.6+O/X4E[VUDDFO-6]/(<JLKO2*U?V?O^_K_
M`,,?D)\<_P!ASX_?&GXD^#O$FH^+?A[IOAGPU?\`PJ\4PZ3H]C=:6EEXE\*^
M)[_7?%T4<=O`&U"UU*.[CCTZ>[D#121S2O$KW#&O3_#/P6\>?L\^/?CKXT\;
M^(OA[JG[,/B?7M>^+OB.Z\0Z=JFK^,]!N;ZQEBUO3([5;>YM9-)C@9Q'-#YE
MPMNSP)"58U^EE07-K;7MO-:7MO#=6MS&\-Q;7$2303Q.,-'+%(&21&7AD=2I
M'!&*U]A"[>MVT[MWU2MJMM>I/M)6MI9*VBMV_'0^(_V&?A1>?#GX8W4#:Y=Z
M_P"#TU34]*^#$VHVMS:7^E_!N.Y>Z\'Z5/%>`70%C;W3V5HTZ1RG3;.R#H"*
M^(?'G['7Q;UWP]%\'_`ZZ'<ZOX1_;G\`_M7O?>,=0OK2VU+P7X:\5?\`"42Z
M?I=[%978EOKN9WT[RFV+;;$+DJ0#^WT<<<,:111I%%&H2..-0B(BC"HBCA54
M```<`"C8F_S-B^9MV;]HW[,YV[NNW/.,XS0Z,'&,=;15EJ]G:Z7;96ZJP*<D
MV^MT_FOZ_P""?F/^SE^Q+XGT>V^--K\<9X;1?&WQ\\9?%3PD/`/BO4HFBTGQ
M6EK&++5V^RVW^E6XM%.U`\>9"0<CG[%_X9<\`>%]2>VTW5O&;V:W<>I26U]X
MEOKI9;]=.^R6=P9&*RJ;$2RS0(K^697W2(^U<>\)]]?]Y?YBMSQ+_P`A>?\`
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MPTK5K+4[2?Q+IL$<<HNKJ`:O>F.Q<Q*[%-TH`-7=>_8`31[3Q=X.^&\^E6G@
M;XI_!;X<_`WQK_:4LR7ND>'/AM8?V1I5_I4$<;I>37&DE[.2"22$1OMEWMC%
M?J!11["ETC;T[=O1]?PL'M)_S=;^NW^1\%-\$FU+]K/]GCQ1H+WEOX4_9C^$
M?COPE/*#+#;:GJ?C;2=*\/:?ISK@)="QT^SGOG&6$$Q@(^;I]^VG_'U;?]?$
M/_HQ:J+'&A9D1%9SN<JH!8XQEB!DG``R:MVG_'U;?]?$/_HQ:I14%*W6[?KR
MJ/W6BA<S;C?I9+[SYK_:"_8O_9H^/WQ`NO&GQ<^%7ASQGXF@MUTB+5=5@>2Y
M33[:::6&V!5U'EQO/*RC'5CFM7X)_LS_``0_9UM]7M?@WX`T;P-!KTL4VK)I
M$31K>R0#;&\H9FR47`'3WKZ/U_\`Y#.H_P#7U+_Z&:QZU52?)&#E+DLO=OIT
M(<(*;DH14KM\W*N;[[7/E/XO_L2?LP?'CQA+X^^*_P`)?#7C'Q;-I]EI<FLZ
MI`[W36&G(\=G;EED4>7`CL$&.,]:[WX*_LY?!C]GC3M3TGX.^!=(\$:?K%PE
MUJ5MI,;1I=7$:[%DD#,WS*IP/05[?13=2;CR\\N791OI9;*Q*IP4N90BI;\R
MBK_?;R/DKXJ_L,?LL?&SQ?=^//B=\(?#/BSQ7?0P6]UK&I02/=30VR;(4=A(
M`1&O"\=*]/\`@Q^SY\(/V>]%U#P[\'_!.D^"-&U2]_M"_L=)C=(KB\"",32!
MV;YPBA<C'`QC@8]FHH=2HX\CG+E_EOI]P*G!2YE"*E_,HJ_WV/S<_:+_`."5
MO[+7[4WQA\,?%CXE>&Y9-5TNY676;/3I/LL?BN3=&MNNLS@F22"!%VK%&$W`
MD%J_H+^#?PC^'?P9^&_A?X=_#/PGI'A+P=H.G0Q:9HFF6RPVMOOC1I7"@'=)
M*PWR2,2SMR37P[;_`/'Q!_UVB_\`0UK]*]*_Y!MA_P!>EO\`^BEKYWB*M5G3
MPE.4Y2A%SM%M\JLHK1>G>[\STLLHTHU*TXTXJ<[.4E%7>O5GPM\2M-U&7QUX
MEDBL+Z6-]0RDD=I.Z,/(A&598RI'&,@\XKA_[)U7_H&:A_X!7/\`\;K]+3%&
M3DQH2>I**3^9&:3R8?\`GE'_`-^U_P`*PI9U.G2IP6'B^2G"%_:/7EBE>W)U
ML:2P:E)R]HU=W:Y5_F?FG_9.J_\`0,U#_P``KG_XU1_9.J_]`S4/_`*Y_P#C
M5?I9Y,7_`#RC_P"_:_X4>3%_SRC_`._:_P"%:?V[/_H&C_X,?_R`OJ,?^?DO
M_`5_GZ_TM?S3_LG5?^@9J'_@%<__`!JC^R=5_P"@9J'_`(!7/_QJOTL\F'_G
ME'Z?ZM?\*/)B_P">4?\`W[7_``H_MV?_`$#1_P#!C_\`D`^HQ_Y^2_\``5_G
MZ_TM?S3_`+)U7_H&:A_X!7/_`,:H_LG5?^@9J'_@%<__`!JOTL\F+_GE'_W[
M7_"CR8O^>4?_`'[7_"C^W9_]`T?_``8__D`^HQ_Y^2_\!7^?K_2U_-/^R=5_
MZ!FH?^`5S_\`&JGM=*U075L3IM^`+B$DFSN`!^\7J?+K])?)A_YY1^G^K7_"
MCR8O^>4?_?M?\*'GDVFOJ\=?^GC_`/D`6!BK/VCT_NKR\_7^EK^=.NZ7JC:Q
MJ#+IU\RFZEPRV=P0?F/((C(_4UD_V3JO_0,U#_P"N?\`XU7Z6>5%_P`\H_\`
MOA?\*/)A_P">4?I_JU_PH6>322^KQT_Z>/\`^0&\#&_\26NOPKK9]_7^M_S3
M_LG5?^@9J'_@%<__`!JC^R=5_P"@9J'_`(!7/_QJOTL\F+_GE'_W[7_"CR8O
M^>4?_?M?\*/[=G_T#1_\&/\`^0%]1C_S\E_X"O\`/U_I:_FG_9.J_P#0,U#_
M`,`KG_XU1_9.J_\`0,U#_P``KG_XU7Z6>3%_SRC_`._:_P"%'DP_\\H_3_5K
M_A1_;L_^@:/_`(,?_P`@+ZC'_GX__`5_GZ_UO^<FD:5JBZII[-IM^JB[@)9K
M.X``$BDDDQX`]SQ46HZ5JAO[PC3;\@W,Q!%G<$$;SR"(^:_2#RHO^>4?_?"_
MX4>3%_SRC]?N+_A4_P!MRY^;ZO'X4OXCZMO^3R']1C;^(]-?A77E7<_-/^R=
M5_Z!FH?^`5S_`/&J/[)U7_H&:A_X!7/_`,:K]+/)A_YY1^G^K7_"CR8O^>4?
M_?M?\*K^W9_]`T?_``8__D`^HQ_Y^2_\!7^?K_2U_-/^R=5_Z!FH?^`5S_\`
M&J/[)U7_`*!FH?\`@%<__&J_2SR8O^>4?_?M?\*/)B_YY1_]^U_PH_MV?_0-
M'_P8_P#Y`/J,?^?DO_`5_GZ_TM?S3_LG5?\`H&:A_P"`5S_\:J_I>E:HNHV+
M-IM^H%U"239W``&\<DF/`K]'?)A_YY1^G^K7_"CRHO\`GE'_`-\+_A2EGL[/
M_9X[/_EX^W^`%@4G?VCTM]E?YGYPZGI6J'4+TC3;\@W,I!%G<$$;CR"(^:H_
MV3JO_0,U#_P"N?\`XU7Z6>3%_P`\H_7[B_X4>3#_`,\H_3_5K_A0L\FDE]7C
MHK?Q'_\`(!]1C_S\E_X"O\_7^M_S3_LG5?\`H&:A_P"`5S_\:H_LG5?^@9J'
M_@%<_P#QJOTL\F+_`)Y1_P#?M?\`"CR8O^>4?_?M?\*?]NS_`.@:/_@Q_P#R
M`?48_P#/R7_@*_S]?Z6OYI_V3JO_`$#-0_\``*Y_^-4?V3JO_0,U#_P"N?\`
MXU7Z6>3%_P`\H_\`OVO^%'DP_P#/*/T_U:_X4?V[/_H&C_X,?_R`?48_\_)?
M^`K_`#]?Z6OYOZ?I6J+?V9;3;\`7,))-G<`#YQU)CXJ75]*U1M3OF73K]@;F
M4@K9W!!^8\@^61^1-?HWY,7_`#RC]?N+_A1Y47_/*/\`[X7_``I?VY.]_J\=
MK?Q'WO\`R#^HQM_$EIK\*ZV3Z_UYGYI_V3JO_0,U#_P"N?\`XU1_9.J_]`S4
M/_`*Y_\`C5?I9Y,/_/*/T_U:_P"%'DQ?\\H_^_:_X4_[=G_T#1_\&/\`^0%]
M1C_S\E_X"O\`/U_I:_FG_9.J_P#0,U#_`,`KG_XU1_9.J_\`0,U#_P``KG_X
MU7Z6>3%_SRC_`._:_P"%'DQ?\\H_^_:_X4?V[/\`Z!H_^#'_`/(!]1C_`,_)
M?^`K_/U_I:_FG_9.J_\`0,U#_P``KG_XU5JQTK5!>VA.FWX`N822;.X`'[Q>
MI\NOTB\F'_GE'Z?ZM?\`"CR8O^>4?_?M?\*'GDVFOJ\=?^GC_P#D`6!BK/VC
MT_NKR\_7^EK^<VLZ5JC:K?LNG7[*;J4@K9W!!^;L1'@_A69_9.J_]`S4/_`*
MY_\`C5?I9Y47_/*/_OA?\*/)A_YY1^G^K7_"DL\FDE]7CHDOXCZ?]N`\#%?\
MO)=/LKJD^_K_`%O^:?\`9.J_]`S4/_`*Y_\`C5']DZK_`-`S4/\`P"N?_C5?
MI9Y,7_/*/_OVO^%'DQ?\\H_^_:_X4_[=G_T#1_\`!C_^0#ZC'_GY+_P%?Y^O
M]+7\T_[)U7_H&:A_X!7/_P`:H_LG5?\`H&:A_P"`5S_\:K]+/)B_YY1_]^U_
MPH\F'_GE'Z?ZM?\`"C^W9_\`0-'_`,&/_P"0#ZC'_GY+_P`!7^?K_2U_-JUT
MK5!=6Q.FWX`N(22;.X`'[Q>I\NK^NZ7JC:OJ#+IU^P-S*05L[@K]X]"(R"/Q
M-?HMY,7_`#RC_P"_:_X4>5%_SRC_`.^%_P`*7]N3O?ZO':W\1][_`,@U@8V:
M]H]-?A7DN_F?FG_9.J_]`S4/_`*Y_P#C5']DZK_T#-0_\`KG_P"-5^EGDP_\
M\H_3_5K_`(4>3%_SRC_[]K_A3_MV?_0-'_P8_P#Y`7U&/_/R7_@*_P`_7^EK
M^:?]DZK_`-`S4/\`P"N?_C5']DZK_P!`S4/_``"N?_C5?I9Y,7_/*/\`[]K_
M`(4>3%_SRC_[]K_A1_;L_P#H&C_X,?\`\@'U&/\`S\E_X"O\_7^EK^:?]DZK
M_P!`S4/_``"N?_C536^DZK]H@_XEFH?ZZ+_ERN?[Z_\`3.OTF\F'_GE'Z?ZM
M?\*/)B_YY1_]^U_PH_MV?_0-'_P8_P#Y`%@8JS]H]/[J\O/U_I:_G5KVEZF^
MKW[+IU^RF=L%;.X(/T(C(-9']DZK_P!`S4/_``"N?_C5?I6(HB`3%&3@'[B^
MGTI?)A_YY1^G^K7_``I+/)I)?5XZ)+^(^G_;@/`QO_$ET?PKJD^_K_6_YI_V
M3JO_`$#-0_\``*Y_^-4?V3JO_0,U#_P"N?\`XU7Z6>3%_P`\H_\`OVO^%'DQ
M?\\H_P#OVO\`A3_MV?\`T#1_\&/_`.0#ZC'_`)^2_P#`5_GZ_P!+7\T_[)U7
M_H&:A_X!7/\`\:H_LG5?^@9J'_@%<_\`QJOTL\F+_GE'_P!^U_PH\F'_`)Y1
M^G^K7_"C^W9_]`T?_!C_`/D`^HQ_Y^2_\!7^?K_2U_-B'2M5$T1.F:@`)8R2
M;.XX^<?],ZTM>TO4WU:]9=.OV4R`AEL[@@_*O((C/\Z_17R8O^>4?_?M?\*/
M*B_YY1_]\+_A4K/)OEE]7CL_^7CZV?\`)Y#6"7*U[1]'\*[KS/S3_LG5?^@9
MJ'_@%<__`!JC^R=5_P"@9J'_`(!7/_QJOTL\F'_GE'Z?ZM?\*/)B_P">4?\`
MW[7_``JO[=G_`-`T?_!C_P#D!?48_P#/R7_@*_S]?Z6OYI_V3JO_`$#-0_\`
M`*Y_^-4?V3JO_0,U#_P"N?\`XU7Z6>3%_P`\H_\`OVO^%'DQ?\\H_P#OVO\`
MA1_;L_\`H&C_`.#'_P#(!]1C_P`_)?\`@*_S]?Z6OYI_V3JO_0,U#_P"N?\`
MXU3X])U7S$_XEFH??7_ERN?[P_Z9U^E/DP_\\H_3_5K_`(4>3%_SRC_[]K_A
M1_;L_P#H'C_X,?\`\@"P*33]H]'_`"K_`#/SM\0Z7J;ZM=,NG7[*?*P5M+A@
M?W2="(R*Q?[)U7_H&:A_X!7/_P`:K]*Q%$0"8HR<#DHOI]*7R8?^>4?I_JU_
MPI1SN44E]7CI_P!/'_\`(#>!C?\`B2UU^%=;/OZ_UO\`FG_9.J_]`S4/_`*Y
M_P#C5']DZK_T#-0_\`KG_P"-5^EGDQ?\\H_^_:_X4>3%_P`\H_\`OVO^%/\`
MMV?_`$#1_P#!C_\`D!?48_\`/R7_`("O\_7^EK^:?]DZK_T#-0_\`KG_`.-4
M?V3JO_0,U#_P"N?_`(U7Z6>3%_SRC_[]K_A1Y,/_`#RC]/\`5K_A1_;L_P#H
M&C_X,?\`\@'U&/\`S\E_X"O\_7^EK^:J:3JNY?\`B6:A]X?\N5SZC_IG6WXC
MTO4VU:<KIU\P\NWY6TG8<0H.JQD=0:_0XPQ?\\H^H_@7U'M2^5$>3%'GUV+_
M`(4O[;G=/ZO'1-?Q'K>W]S2U@6!C9_O'T?PKO:V_G^1^:?\`9.J_]`S4/_`*
MY_\`C5']DZK_`-`S4/\`P"N?_C5?I9Y,/_/*/T_U:_X4>3%_SRC_`._:_P"%
M/^W9_P#0-'_P8_\`Y`/J,?\`GY+_`,!7^?K_`$M?S3_LG5?^@9J'_@%<_P#Q
MJC^R=5_Z!FH?^`5S_P#&J_2SR8O^>4?_`'[7_"CR8O\`GE'_`-^U_P`*/[=G
M_P!`T?\`P8__`)`/J,?^?DO_``%?Y^O]+7\T_P"R=5_Z!FH?^`5S_P#&JGM=
M*U075L3IM^`+B$DFSN`!^\7J?+K])?)A_P">4?I_JU_PH\F+_GE'_P!^U_PH
M>>3::^KQU_Z>/_Y`%@8JS]H]/[J\O/U_I:_G3KNEZHVKZ@RZ=?L#<RD%;.X*
M_>/0B,@C\363_9.J_P#0,U#_`,`KG_XU7Z6>5%_SRC_[X7_"CR8?^>4?I_JU
M_P`*%GDTDOJ\=/\`IX__`)`;P,;_`,26NOPKK9]_7^M_S3_LG5?^@9J'_@%<
M_P#QJC^R=5_Z!FH?^`5S_P#&J_2SR8O^>4?_`'[7_"CR8O\`GE'_`-^U_P`*
M/[=G_P!`T?\`P8__`)`7U&/_`#\E_P"`K_/U_I:_FG_9.J_]`S4/_`*Y_P#C
M5']DZK_T#-0_\`KG_P"-5^EGDQ?\\H_^_:_X4>3#_P`\H_3_`%:_X4?V[/\`
MZ!H_^#'_`/(!]1C_`,_)?^`K_/U_I:_FS;Z5JGGP'^S=0QYT7/V.XQ]]?^F=
M?HWI>1IM@&!!%I;Y!!!!\I<@@\BK?DQ?\\H_^_:_X4UOO'\/Y"O-S''RQBI)
<TU3Y')Z2<KWM_=5MCJPM!47-J3E>VZM_6Q__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Government Grants<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_GovernmentGrantsTextBlock', window );">Government Grants [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Government

        Grants</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NIH

        Grant</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        September 2007, the NIH awarded us an Integrated

        Preclinical/Clinical AIDS Vaccine Development (IPCAVD)

        grant to support our HIV/AIDS vaccine

        program.&#160;&#160;The project period for the grant covers

        a five-year period which commenced October 2007, with an

        aggregate award of $20.4 million.&#160;&#160;As of December

        31, 2011, there is approximately $3.9 million of unused

        grant funds remaining and available for use through August

        31, 2012 (the end of the original project

        period).&#160;&#160;We are utilizing this funding to

        further our HIV/AIDS vaccine development, optimization and

        production.&#160;&#160;We record revenue associated with

        the grant as the related costs and expenses are incurred

        and such revenue is reported as a separate line item in our

        statements of operations.&#160;&#160;During 2011, 2010, and

        2009, we recorded $4,899,885, $4,940,778, and $3,668,195,

        respectively, of revenue associated with this grant.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">QTDP

        Grant</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        November 2010, we were awarded a one-time grant of $244,479

        pursuant to the Qualifying Therapeutic Discovery Project

        (QTDP) program enacted as part of the Patient Protection

        and Affordable Care Act of 2010.&#160;&#160;The QTDP

        program was intended to provide incentive to smaller

        companies who are focusing on innovative therapeutic

        discoveries.&#160;&#160;We received the full amount of the

        grant during 2010, which is recorded as revenue for 2010 in

        the accompanying Consolidated Statement of

        Operations.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_GovernmentGrantsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_GovernmentGrantsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>18
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B
M,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3-E
M86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?;V9?4W1O/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A
M=&5D7U-T871E;65N='-?;V9?0V%S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\Q7TYA='5R95]O9E]"=7-I;F5S<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?,E]3=6UM
M87)Y7V]F7U-I9VYI9FEC86YT7SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?,U]';W9E<FYM96YT7T=R86YT<SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-%]#;VUM:71M
M96YT<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970Q,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO
M=&5?-5\R,#`V7TUE<F=E<E]A;F1?4F5C87!I=#PO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-E]3=&]C:VAO;&1E<G-?17%U
M:71Y/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T
M95\W7U)E=&ER96UE;G1?4&QA;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?.%]);F-O;65?5&%X97,\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7SE?4F5L871E9%]087)T
M>5]4<F%N<V%C=&D\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y.;W1E7S$P7U-E;&5C=&5D7U%U87)T97)L>5]&:6X\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S$Q7U-U8G-E<75E
M;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^4V-H961U;&5?24E?5F%L=6%T:6]N7V%N9%]1=6%L/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#$X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@/"]X.D5X
M8V5L5V]R:W-H965T<SX-"B`@/'@Z4W1Y;&5S:&5E="!(4F5F/3-$(E=O<FMS
M:&5E=',O<F5P;W)T+F-S<R(O/@T*("`\>#I!8W1I=F53:&5E=#XP/"]X.D%C
M=&EV95-H965T/@T*("`\>#I0<F]T96-T4W1R=6-T=7)E/D9A;'-E/"]X.E!R
M;W1E8W13=')U8W1U<F4^#0H@(#QX.E!R;W1E8W17:6YD;W=S/D9A;'-E/"]X
M.E!R;W1E8W17:6YD;W=S/@T*(#PO>#I%>&-E;%=O<FMB;V]K/@T*/"]X;6P^
M/"%;96YD:69=+2T^#0H\+VAE860^#0H@(#QB;V1Y/@T*("`@/'`^5&AI<R!P
M86=E('-H;W5L9"!B92!O<&5N960@=VET:"!-:6-R;W-O9G0@17AC96P@6%`@
M;W(@;F5W97(N/"]P/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDS96%A83@W7S`X9F1?
M-#4S95\Y-&%E7V(P,S<Q-#@X83$V,B]7;W)K<VAE971S+U-H965T,#$N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$564D%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D1O8W5M
M96YT($%N9"!%;G1I='D@26YF;W)M871I;VX@*%531"`D*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3X\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,P+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3$\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&]C=6UE;G0@
M86YD($5N=&ET>2!);F9O<FUA=&EO;B!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!296=I<W1R
M86YT($YA;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D=E;U9A
M>"!,86)S+"!);F,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4>7!E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XQ,"U+/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#=7)R96YT($9I<V-A;"!996%R($5N9"!$
M871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XM+3$R+3,Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#@U,"PV,3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!0
M=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M."PW-#$L.#<P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!;65N9&UE;G0@1FQA9SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X($ME>3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,#`P,#@S,C0X.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT
M:71Y($-U<G)E;G0@4F5P;W)T:6YG(%-T871U<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@5F]L=6YT87)Y($9I;&5R<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3F\\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE
M<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^4VUA
M;&QE<B!297!O<G1I;F<@0V]M<&%N>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A
M<V]N960@27-S=65R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y.
M;SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#Y$96,@,S$L#0H)"3(P,3$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A
M;"!996%R($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR
M,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$;V-U;65N="!&:7-C86P@4&5R:6]D($9O8W5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#Y&63QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S
M-S$T.#AA,38R#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDS96%A
M83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,B]7;W)K<VAE971S+U-H
M965T,#(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5.,T%%/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R
M;VYG/D-O;G-O;&ED871E9"!"86QA;F-E(%-H965T<R`H55-$("0I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#=7)R96YT(&%S<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#$V-RPY.#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$L,#<Y+#`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1W)A;G0@9G5N9',@<F5C96EV86)L93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3@S+#4Q-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W-"PR-S4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97!A:60@
M97AP96YS97,@86YD(&]T:&5R(&-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV-BPU,#@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT."PX,S`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C=7)R
M96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT
M,3@L,#`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PV,#(L,3DR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@97%U:7!M96YT+"!N970@
M;V8@86-C=6UU;&%T960@9&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W-BPR,#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-#@L-#0Q
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D]T:&5R(&%S<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&EC96YS97,L(&YE="!O9B!A8V-U;75L
M871E9"!A;6]R=&EZ871I;VX@;V8@)#(P."PY,S,@86YD("0Q.#0L,#0W(&%T
M($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"`R,#$P(')E<W!E8W1I=F5L>3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDL.3(S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C0L.#`Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E
M<G)E9"!O9F9E<FEN9R!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#,P+#0P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5P;W-I=',@86YD(&]T:&5R(&%S<V5T<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L,#$P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L.3DP/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@;W1H97(@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,"PY,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU,#<L,C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&]T86P@87-S971S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#8T-2PQ-#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,U-RPX,S0\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0W5R<F5N="!L:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3,X+#,S.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDV+#@Y,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!E
M>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(U+#@V
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(T,2PW,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%M;W5N=',@<&%Y86)L92!T;R!%;6]R>2!5;FEV97)S:71Y
M("AA(')E;&%T960@<&%R='DI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV-S<L,S(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3@R+#DX,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-U<G)E;G0@;&EA8FEL:71I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDT,2PU,S4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,C$L
M-C`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#;VUM:71M96YT<R`H3F]T92`T*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-T;V-K:&]L9&5R<^*`F2!E<75I='DZ/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@)"XP,#$@<&%R
M('9A;'5E+"`T,"PP,#`L,#`P('-H87)E<R!A=71H;W)I>F5D.R`Q-BPT-#(L
M-C$Q(&%N9"`Q-2PV-30L.#0V('-H87)E<R!I<W-U960@86YD(&]U='-T86YD
M:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"`R,#$P+"!R97-P96-T:79E
M;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#0T,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#8U
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^061D:71I;VYA;"!P86ED+6EN(&-A<&ET86P\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(S+#,Q.2PQ-C8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPQ,#4L-S0W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969I8VET
M(&%C8W5M=6QA=&5D(&1U<FEN9R!T:&4@9&5V96QO<&UE;G0@<W1A9V4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(R+#8S,BPP,#(I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C`L,C@U
M+#$W-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!S=&]C:VAO;&1E<G/B@)D@97%U:71Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,#,L-C`W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PX,S8L,C(V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@;&EA8FEL:71I97,@86YD('-T;V-K:&]L9&5R<^*`F2!E<75I='D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PV-#4L,30R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#,U
M-RPX,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7SDS96%A83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,@T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y,V5A86$X-U\P.&9D7S0U,V5?.31A
M95]B,#,W,30X.&$Q-C(O5V]R:W-H965T<R]3:&5E=#`S+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%5T=!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYS;VQI9&%T960@
M0F%L86YC92!3:&5E=',@*%!A<F5N=&AE=&EC86QS*2`H55-$("0I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&EC96YS97,L(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B`H:6X@1&]L;&%R
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C`X+#DS,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,3@T+#`T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P87(@=F%L=64@*&EN($1O;&QA<G,@
M<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,"PP
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#0T,BPV,3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PV-30L.#0V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M;VUM;VX@<W1O8VLL('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,38L-#0R+#8Q,3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#8S,BPU-C0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDS96%A83@W7S`X
M9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,@T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q
M-C(O5V]R:W-H965T<R]3:&5E=#`T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,45!1SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VYS;VQI9&%T960@4W1A=&5M96YT<R!O
M9B!/<&5R871I;VYS("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(V
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P.3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N="!R979E
M;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L.#DY+#@X
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-2PQ.#4L,C4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`S+#8V."PQ.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(P+#,Q,2PV.3(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M3W!E<F%T:6YG(&5X<&5N<V5S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y297-E87)C:"!A;F0@9&5V96QO<&UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,C<V+#,W-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-SDS+#DU
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0L,#8X+#8X,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(U+#8S,"PV-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=E;F5R86P@86YD(&%D;6EN:7-T<F%T
M:79E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DW,BPU-34\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#$V,BPQ,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#DQ-"PX-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-RPV-#<L-C4Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^#0H@("`@("`@(#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPR-#@L.3,P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPY-38L,#DP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-BPY.#,L-3(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#,L,C<X+#,S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@9G)O;2!O<&5R871I;VYS/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#,T.2PP-#4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPW-S`L
M.#,S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,L,S$U+#,S,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R,BPY-C8L-C0S*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/=&AE<B!I;F-O
M;64@*&5X<&5N<V4I.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);G1E<F5S="!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C,L-3`U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L,#@P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0P+#,Q,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E
M<W0@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PV
M-CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^#0H@("`@("`@(#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPR,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,RPU,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS,2PP.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,S0L-C0Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPS-#8L.#(V*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPW-#<L
M,S(X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H,RPR.#0L,C4R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,C(L-C,R+#`P,BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0F%S:6,@
M86YD(&1I;'5T960Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DQO<W,@<&5R(&-O;6UO;B!S:&%R92`H:6X@1&]L;&%R<R!P
M97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N
M,34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@P+C$X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H,"XR,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#(N,3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E('-H
M87)E<R!O=71S=&%N9&EN9R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,34L-S,U+#4T,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#8U,2PS,#@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PQ.3$L,C<X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`L-S`T+#@P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDS96%A83@W7S`X9F1?-#4S
M95\Y-&%E7V(P,S<Q-#@X83$V,B]7;W)K<VAE971S+U-H965T,#4N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$502$A+/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-O;G-O;&ED
M871E9"!3=&%T96UE;G1S(&]F(%-T;V-K:&]L9&5R<R<@17%U:71Y("A$969I
M8VEE;F-Y*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D-O;6UO;B!3=&]C:R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!9&1I=&EO;F%L(%!A:60M:6X@0V%P
M:71A;"!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y3=&]C:R!3=6)S8W)I<'1I;VX@4F5C96EV86)L92!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y2971A:6YE9"!%87)N:6YG
M<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y4
M;W1A;#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L
M86YC92!A="!*=6XN(#(V+"`R,#`Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<&ET86P@8V]N=')I8G5T:6]N(&%T(&EN8V5P=&EO;B`H
M2G5N92`R-RP@,C`P,2D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3<P+#4Y,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q-S`L-3DR*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R
M,#`Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W,"PU.3(I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3<P+#4X,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N('-T;V-K(&9O<B!C87-H/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<Y,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,S(P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V%L
M92!O9B!C;VUM;VX@<W1O8VL@9F]R(&-A<V@@*&EN(%-H87)E<RD\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S@Y+#DU-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@
M;V8@8V]M;6]N('-T;V-K(&9O<B!T96-H;F]L;V=Y(&QI8V5N<V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<P-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T."PQ-3$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#@L.#4V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R('1E8VAN;VQO9WD@;&EC96YS
M92`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-S`T+#4S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#8Q."PQ,S<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-C$X+#$S-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#DT+#0X.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC
M92!A="!$96,N(#,Q+"`R,#`R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#0Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$T-2PX-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@W.#@L-S(Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8S.2PS.3,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y386QE(&]F(&-O
M;6UO;B!S=&]C:R!F;W(@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PR,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#0U."PS.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#0U.2PV,#D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N
M('-T;V-K(&9O<B!C87-H("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#(R.2PR-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Y-#<L.#`T*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DT-RPX,#0I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E
M("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#<R,RPW-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@,C`P,SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-"PW,C0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#8P-"PR,C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#<S-BPU,S,I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#<R+#0Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4V%L92!O9B!C;VUM;VX@<W1O8VL@9F]R(&-A<V@@86YD('-T
M;V-K('-U8G-C<FEP=&EO;B!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#0X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L.3@X+#0S-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L-S4P+#`P,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SDL.3$Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y386QE(&]F(&-O;6UO;B!S=&]C:R!F;W(@8V%S:"!A;F0@<W1O8VL@<W5B
M<V-R:7!T:6]N(')E8V5I=F%B;&4@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L-#@R+#8P-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!P87EM96YT<R!R
M96-E:79E9"!O;B!S=&]C:R!S=6)S8W)I<'1I;VX@<F5C96EV86)L93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<U,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!F;W(@=&5C:&YO;&]G>2!L:6-E;G-E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDY+#DU,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!F;W(@=&5C:&YO;&]G>2!L
M:6-E;G-E("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT.2PT,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@R+#,U,2PX,C@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPS-3$L.#(X*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92`H:6X@4VAA
M<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPR-34L-SDQ
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P,#0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8L,C4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-2PV.3(L-C`X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPP,#`L,#`P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,#@X+#,V
M,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@S.#DL-#DW*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%S:"!P87EM96YT<R!R96-E:79E9"!O;B!S=&]C:R!S
M=6)S8W)I<'1I;VX@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PV,3$L,#@V*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-C$Q+#`X-BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D)A;&%N8V4@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8L,C4U+#<Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`U/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#(U-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-CDR+#8P.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4P
M,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-2PV.3DL-#0W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#4P,"PU.#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H('!A>6UE;G1S(')E8V5I
M=F5D(&]N('-T;V-K('-U8G-C<FEP=&EO;B!R96-E:79A8FQE/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R
M<VEO;B!O9B!P<F5F97)R960@<W1O8VL@=&\@8V]M;6]N('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4U,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#<Q+#4V-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#<U
M+#$Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]N=F5R<VEO;B!O9B!P<F5F97)R960@<W1O8VL@=&\@8V]M;6]N
M('-T;V-K("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#4U,"PX-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!I<W-U960@:6X@8V]N;F5C
M=&EO;B!W:71H(&UE<F=E<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PS-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#<P."PT.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#<Q,BPX-#D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!I<W-U
M960@:6X@8V]N;F5C=&EO;B!W:71H(&UE<F=E<B`H:6X@4VAA<F5S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PS-3DL.#DQ/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC
M92!O9B!C;VUM;VX@<W1O8VL@9F]R(&-A<VAL97-S('=A<G)A;G0@97AE<F-I
M<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3<I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U
M86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R(&-A<VAL97-S('=A<G)A;G0@97AE
M<F-I<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4V+#@R-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4X-"PQ
M-C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-3@T+#$V-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$T+#(R,RPS-3@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C
M+B`S,2P@,C`P-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L
M,C(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^."PT-S(L-C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-BPR.#,L-C$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C`S+#(Q-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V%L92!O9B!C;VUM
M;VX@<W1O8VL@9F]R(&-A<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0P-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,L,38R+#4T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,38R+#DU,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V%L92!O9B!C;VUM;VX@<W1O
M8VL@9F]R(&-A<V@@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0P-BPW,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U
M<&]N('-T;V-K(&]P=&EO;B!E>&5R8VES93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L.3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S
M=&]C:R!U<&]N('-T;V-K(&]P=&EO;B!E>&5R8VES92`H:6X@4VAA<F5S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT-S$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A
M<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#4Q."PT.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4Q."PT.38\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#(T,2PW.38I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PR-#$L-SDV
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC92`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,30L-C,R+#4U.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`W
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PV,S,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPQ-3@L
M-C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3`L-3(U+#0P.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#8T-RPX-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N('-T;V-K
M(&9O<B!C87-H/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S8\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#,V-"PX,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#,V-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N('-T;V-K(&9O<B!C
M87-H("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-S8L,3(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y4<F%N<V%C=&EO;G,@<F5L871E9"!T;R!C;VUM;VX@<W1O
M8VL@<'5R8VAA<V4@86=R965M96YT('=I=&@@1G5S:6]N($-A<&ET86P\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P-2PY-C$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#8L,#DQ
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y4<F%N<V%C=&EO;G,@<F5L871E9"!T;R!C;VUM;VX@<W1O8VL@<'5R8VAA
M<V4@86=R965M96YT('=I=&@@1G5S:6]N($-A<&ET86P@*&EN(%-H87)E<RD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S,"PR.3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K
M+6)A<V5D(&-O;7!E;G-A=&EO;B`M(%-T;V-K(&]P=&EO;G,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-SDX+#$V.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-SDX+#$V.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O
M8VLM8F%S960@8V]M<&5N<V%T:6]N("T@0V]N<W5L=&%N="!W87)R86YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30V+#@X,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T-BPX.#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B`M($ES<W5A;F-E(&]F(&-O;6UO
M;B!S=&]C:R!F;W(@<V5R=FEC97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-S,L.3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S0L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C;VUP96YS871I
M;VX@+2!)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R('-E<G9I8V5S("AI
M;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S
M+#<R."PQ.#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,RPW,C@L,3@W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92`H:6X@4VAA<F5S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L.30X+#DW-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC
M92!A="!$96,N(#,Q+"`R,#`X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-"PY-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-BPY-#@L-#8V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,30L,C4S+#4Y-BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<P.2PX,3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1R
M86YS86-T:6]N<R!R96QA=&5D('1O(&-O;6UO;B!S=&]C:R!P=7)C:&%S92!A
M9W)E96UE;G0@=VET:"!&=7-I;VX@0V%P:71A;#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PU,3DL-S@T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,C`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4<F%N<V%C
M=&EO;G,@<F5L871E9"!T;R!C;VUM;VX@<W1O8VL@<'5R8VAA<V4@86=R965M
M96YT('=I=&@@1G5S:6]N($-A<&ET86P@*&EN(%-H87)E<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q-BPR-C$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N
M('-T;V-K(&9O<B!C87-H('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@<'5R8VAA
M<V4@=V%R<F%N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PT.3DL-3,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y386QE(&]F(&-O;6UO;B!S=&]C:R!F;W(@
M8V%S:"!U<&]N(&5X97)C:7-E(&]F('-T;V-K('!U<F-H87-E('=A<G)A;G0@
M*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0V
M,BPX,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B`M(%-T;V-K(&]P=&EO
M;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C(Q+#<V-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,C(Q+#<V-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N("T@0V]N<W5L=&%N
M="!W87)R86YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4L
M-#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#4L-#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C;VUP96YS871I;VX@+2!)<W-U86YC
M92!O9B!C;VUM;VX@<W1O8VL@9F]R('-E<G9I8V5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S$L-#DU/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L-3`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C
M;VUP96YS871I;VX@+2!)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R('-E
M<G9I8V5S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%S:"!P87EM96YT<R!R96-E:79E9"!O;B!S=&]C:R!S
M=6)S8W)I<'1I;VX@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,RPP,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,RPR.#0L,C4R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L,C@T+#(U,BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@
M*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U
M+#8S,BPU-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@,C`P.3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-C,S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L,C8V+#0T-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W+#4S-RPX
M-#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPW-#0L,C,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@:6X@;&EE
M=2!O9B!C87-H('!A>6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.#DL.3@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@
M:6X@;&EE=2!O9B!C87-H('!A>6UE;G0@*&EN(%-H87)E<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@8V]M
M<&5N<V%T:6]N("T@4W1O8VL@;W!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-3<U+#8V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4W-2PV-C(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E
M;G-A=&EO;B`M($-O;G-U;'1A;G0@=V%R<F%N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$R,2PP-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C$L,#4W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C
M;VUP96YS871I;VX@+2!)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R('-E
M<G9I8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S+#@P
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4S+#@Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N("T@27-S=6%N8V4@
M;V8@8V]M;6]N('-T;V-K(&9O<B!S97)V:6-E<R`H:6X@4VAA<F5S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-3`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&<F%C=&EO;F%L
M('-H87)E('!A>6]U="!U<&]N(')E=F5R<V4@<W!L:70\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$L,C$P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,C$P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1G)A8W1I;VYA;"!S
M:&%R92!P87EO=70@=7!O;B!R979E<G-E('-P;&ET("AI;B!3:&%R97,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,3@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPW-#<L,S(X*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L-S0W
M+#,R."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$U+#8U-"PX-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@
M,C`Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-C4U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(L
M,3`U+#<T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(P+#(X-2PQ-S8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PX,S8L,C(V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y386QE(&]F(&-O;6UO;B!S
M=&]C:R!F;W(@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-C4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#0P+#4U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0T,2PR,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]M;6]N('-T;V-K(&9O<B!C
M87-H("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV-3@L-3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C;VUP96YS871I;VX@+2!3=&]C:R!O
M<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-C,L-S4R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#8S+#<U,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N("T@0V]N<W5L=&%N
M="!W87)R86YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34Y
M+#(T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$U.2PR-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B`M($ES<W5A
M;F-E(&]F(&-O;6UO;B!S=&]C:R!F;W(@<V5R=FEC97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$T.2PX-S$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB
M87-E9"!C;VUP96YS871I;VX@+2!)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@
M9F]R('-E<G9I8V5S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,CDL,C0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H('!A>6UE;G1S(')E8V5I=F5D(&]N
M('-T;V-K('-U8G-C<FEP=&EO;B!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT,#0L-#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,BPS-#8L.#(V*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,S0V+#@R-BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A
M;&%N8V4@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$V+#0T,BPV,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@,C`Q,3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-BPT-#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(S+#,Q.2PQ
M-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#(R+#8S,BPP,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`W,#,L-C`W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B
M,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3-E
M86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R+U=O<FMS:&5E=',O
M4VAE970P-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P15A$0D<^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@0V%S:"!&;&]W<R`H
M55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0V/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$R-B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CY$96,N(#,Q+"`R
M,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/D1E8RX@,S$L(#(P,#D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H(&9L;W=S(&9R
M;VT@;W!E<F%T:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#(L,S0V+#@R-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#(L-S0W+#,R."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#,L
M,C@T+#(U,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(R+#8S
M,BPP,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D%D:G5S=&UE;G1S('1O(')E8V]N8VEL92!N970@;&]S<R!T;R!N970@8V%S
M:"!U<V5D(&EN(&]P97)A=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`Y+#`Q-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q.2PW-S,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XX.2PW-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU-C4L-C,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8V-R971I;VX@;V8@<')E9F5R<F5D('-T;V-K(')E9&5M<'1I;VX@=F%L=64\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,T-BPV-S,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A
M=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M-S(L.3DW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4P+#4S,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,CDX+#8V-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8L,S4Y+#<S.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5W)I=&4M;V9F(&]F(&1E9F5R<F5D(&]F9F5R
M:6YG(&-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S`L
M-#`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#,P+#0P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY#:&%N9V5S(&EN(&%S<V5T<R!A;F0@;&EA8FEL:71I97,Z/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT(&9U;F1S(')E8V5I=F%B;&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y,"PW-C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-3,L.34T*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#@L.34S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$X,RPU,34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O=&AE<B!C=7)R96YT(&%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL,3(R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-"PR,34I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C4T+#8W,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#(Y+#<P."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E
M<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,2PP,3`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3$L,#$P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C
M;W5N=',@<&%Y86)L92!A;F0@86-C<G5E9"!E>'!E;G-E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#$Y+#DR-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,Y+#`S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(R-"PY-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`S
M,"PS,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A
M9&IU<W1M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPP
M-#,L,C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S0P+#$U.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#4Y+#$P,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@L-3`X+#4T,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('5S960@:6X@;W!E<F%T:6YG
M(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,P
M,RPV,C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPP,#<L,38Y
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-#(U+#$U,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-"PQ,C,L-#4Y*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H(&9L;W=S(&9R
M;VT@:6YV97-T:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!U<F-H87-E(&]F('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Q+#@Y-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T+#<P-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R-S`L,C0V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#4S."PT.3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]C965D<R!F<F]M('-A;&4@;V8@<')O<&5R='D@86YD(&5Q=6EP;65N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PU.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#4X,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('!R;W9I9&5D
M("AU<V5D*2!B>2!I;G9E<W1I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3$L.#DV*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(W
M,"PR-#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3,R+#DQ,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F
M;&]W<R!F<F]M(&9I;F%N8VEN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('-A;&4@;V8@8V]M;6]N('-T
M;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#0L-#$P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPP,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,34L-3(V+#,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')O8V5E9',@9G)O;2!S86QE(&]F('!R969E<G)E9"!S=&]C:SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S(X+#0T,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@;V9F97)I;F<@8V]S=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0S,"PT,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#,P+#0P
M,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!P
M<F]V:61E9"!B>2!F:6YA;F-I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#`T+#0Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#0S,"PT,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPP,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L
M.#(T+#,T.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!I
M;F-R96%S92`H9&5C<F5A<V4I(&EN(&-A<V@@86YD(&-A<V@@97%U:79A;&5N
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@X+#@Y,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ
M73PO<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPT,S8L
M-CDW*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PS,C0L-C`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#$V-RPY.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<R!A="!B96=I;FYI;F<@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#`W.2PP.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#4Q-2PW.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#$Y,2PQ.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A
M;&5N=',@870@96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PQ-C<L.3@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PP-SDL,#@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPU
M,34L-S@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ-C<L.3@P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L
M96UE;G1A;"!D:7-C;&]S=7)E(&]F(&-A<V@@9FQO=R!I;F9O<FUA=&EO;CPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S="!P86ED/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L-C8Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS1#D^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE<D9O;W1N
M;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^#0H@("`@
M("`@(#QT9"!C;VQS<&%N/3-$."!V86QI9VX],T1T;W`^4W5P<&QE;65N=&%L
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M;R!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&%S(&]F(%-E<'1E;6)E<B`R."P@
M,C`P-BX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?.3-E86%A.#=?,#AF
M9%\T-3-E7SDT865?8C`S-S$T.#AA,38R#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+SDS96%A83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V
M,B]7;W)K<VAE971S+U-H965T,#<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$@+2!.871U<F4@;V8@0G5S:6YE<W,\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYA='5R
M92!O9B!/<&5R871I;VYS(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU<W1I9GD^
M#0H@("`@(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/C$N)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[3F%T=7)E#0H@("`@#0H@("`@("`@(&]F($)U<VEN97-S/"]F;VYT/@T*
M("`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L
M969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^1V5O5F%X#0H@("`-"B`@("`@("`@3&%B<RP@26YC+B`H)B,X,C(P
M.T=E;U9A>"8C.#(R,3L@;W(@=&AE#0H@#0H@("`@("`@("8C.#(R,#M#;VUP
M86YY)B,X,C(Q.RDL(&ES(&$@8FEO=&5C:&YO;&]G>2!C;VUP86YY#0H@(`T*
M("`@("`@("!D979E;&]P:6YG('9A8V-I;F5S('1H870@<')E=F5N="!A;F0@
M9FEG:'0@2'5M86X-"B`@#0H@("`@("`@($EM;75N;V1E9FEC:65N8WD@5FER
M=7,@*"8C.#(R,#M(258F(S@R,C$[*0T*("`@(`T*("`@("`@("!I;F9E8W1I
M;VYS+B8C,38P.R8C,38P.TA)5B!I;F9E8W1I;VYS(')E<W5L="!I;B!!8W%U
M:7)E9`T*("`@#0H@("`@("`@($EM;75N;V1E9FEC:65N8WD@4WEN9')O;64-
M"B`@("`-"B`@("`@("`@*"8C.#(R,#M!2413)B,X,C(Q.RDN)B,Q-C`[)B,Q
M-C`[5V4@:&%V92!E>&-L=7-I=F5L>0T*("`-"B`@("`@("`@;&EC96YS960@
M9G)O;2!%;6]R>2!5;FEV97)S:71Y("@F(S@R,C`[16UO<GDF(S@R,C$[*0T*
M("`@(`T*("`@("`@("!V86-C:6YE('1E8VAN;VQO9WD@=VAI8V@@=V%S(&1E
M=F5L;W!E9"!I;B!C;VQL86)O<F%T:6]N#0H@("`@#0H@("`@("`@('=I=&@@
M=&AE($YA=&EO;F%L($EN<W1I='5T97,@;V8@2&5A;'1H("@F(S@R,C`[3DE(
M)B,X,C(Q.RD-"B`@("`@#0H@("`@("`@(&%N9"!T:&4@0V5N=&5R<R!F;W(@
M1&ES96%S92!#;VYT<F]L(&%N9"!0<F5V96YT:6]N#0H@("`@#0H@("`@("`@
M("@F(S@R,C`[0T1#)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[1V5O5F%X(&ES(&EN
M8V]R<&]R871E9`T*("`@(`T*("`@("`@("!U;F1E<B!T:&4@;&%W<R!O9B!T
M:&4@4W1A=&4@;V8@1&5L87=A<F4@86YD(&]U<B!P<FEN8VEP86P-"B`-"B`@
M("`@("`@;V9F:6-E<R!A<F4@;&]C871E9"!I;B!3;7ER;F$L($=E;W)G:6$@
M*&UE=')O<&]L:71A;@T*(`T*("`@("`@("!!=&QA;G1A(&%R96$I+CPO9F]N
M=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY/=7(-"B`@("`@#0H@("`@("`@(&-U<G)E;G0@=F%C8VEN97,@
M=6YD97(@9&5V96QO<&UE;G0@861D<F5S<R!T:&4@8VQA9&4@0@T*("`@#0H@
M("`@("`@('-U8G1Y<&4@;V8@=&AE($A)5B!V:7)U<R!T:&%T(&ES(&UO<W0@
M<')E=F%L96YT(&EN('1H90T*("`@#0H@("`@("`@(%5N:71E9"!3=&%T97,@
M86YD('1H92!D979E;&]P960@=V]R;&0N)B,Q-C`[)B,Q-C`[3W5R#0H@("`@
M(`T*("`@("`@("!V86-C:6YE<R!A<F4@8F5I;F<@979A;'5A=&5D('1O(&1E
M=&5R;6EN92!T:&5I<B!P;W1E;G1I86P-"B`-"B`@("`@("`@=&\@*&$I('!R
M979E;G0@2$E6(&EN9F5C=&EO;B!A;F0@*&(I('1O('-E<G9E(&%S(&$@=&AE
M<F%P>0T*("`-"B`@("`@("`@9F]R(&EN9&EV:61U86QS('=H;R!A<F4@86QR
M96%D>2!I;F9E8W1E9"!W:71H#0H@("`@#0H@("`@("`@($A)5BXF(S$V,#LF
M(S$V,#M4:&5S92!V86-C:6YE<R!A<F4@8W5R<F5N=&QY(&)E:6YG#0H@(`T*
M("`@("`@("!E=F%L=6%T960@:6X@:'5M86YS("TM(&)O=&@@:6X@=&AO<V4@
M:6YF96-T960@=VET:"!(258@86YD#0H@(`T*("`@("`@("!T:&]S92!W:&\@
M87)E(&YO="X\+V9O;G0^#0H@("`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%S#0H@("`@#0H@("`@("`@(&1I
M<V-U<W-E9"!I;B!.;W1E(#(L('1H92!#;VUP86YY(&ES(&$@9&5V96QO<&UE
M;G0M<W1A9V4-"B`@("`-"B`@("`@("`@96YT97)P<FES92!A;F0@=V4@87)E
M(&1E=F]T:6YG('-U8G-T86YT:6%L;'D@86QL(&]F(&]U<@T*("`@(`T*("`@
M("`@("!P<F5S96YT(&5F9F]R=',@=&\@<F5S96%R8V@@86YD(&1E=F5L;W!M
M96YT+B8C,38P.R8C,38P.U=E#0H@("`@(`T*("`@("`@("!H879E(&9U;F1E
M9"!O=7(@86-T:79I=&EE<R!T;R!D871E(&%L;6]S="!E>&-L=7-I=F5L>2!F
M<F]M#0H@(`T*("`@("`@("!E<75I='D@9FEN86YC:6YG<R!A;F0@9V]V97)N
M;65N="!G<F%N=',L(&%N9"!W92!W:6QL#0H@#0H@("`@("`@(&-O;G1I;G5E
M('1O(')E<75I<F4@<W5B<W1A;G1I86P@9G5N9',@=&\@8V]N=&EN=64@=&AE
M<V4-"B`@("`-"B`@("`@("`@86-T:79I=&EE<RXF(S$V,#LF(S$V,#M792!A
M;G1I8VEP871E('1H870@;W5R(&5X:7-T:6YG(&-A<V@-"B`-"B`@("`@("`@
M<F5S;W5R8V5S+"!C;VUB:6YE9"!W:71H('1H92!P<F]C965D<R!F<F]M('1H
M92!.24@@9W)A;G0-"B`@("`@#0H@("`@("`@(&1I<V-U<W-E9"!I;B!.;W1E
M(#,@86YD('1H92!F:6YA;F-I;F<@979E;G1S(&1I<V-U<W-E9"!I;@T*(`T*
M("`@("`@("!.;W1E(#$Q+"!S:&]U;&0@8F4@<W5F9FEC:65N="!T;R!F=6YD
M(&]U<B!P;&%N;F5D#0H@("`-"B`@("`@("`@86-T:79I=&EE<R!I;G1O('1H
M92!F:7)S="!Q=6%R=&5R(&]F(#(P,3,N)B,Q-C`[)B,Q-C`[26X-"B`@(`T*
M("`@("`@("!O<F1E<B!T;R!M965T(&]U<B!O<&5R871I;F<@8V%S:"!F;&]W
M(')E<75I<F5M96YT<RP@=V4@;6%Y#0H@(`T*("`@("`@("!P;&%N(&%D9&ET
M:6]N86P@;V9F97)I;F=S(&]F(&]U<B!E<75I='D@<V5C=7)I=&EE<RP@9&5B
M="!O<@T*("`@#0H@("`@("`@(&-O;G9E<G1I8FQE(&1E8G0@:6YS=')U;65N
M=',N(%=E(&%R92!A;'-O('-E96MI;F<-"B`@(`T*("`@("`@("!A9&1I=&EO
M;F%L(&9U;F1I;F<@9F]R(&]U<B!R97-E87)C:"!P<F]G<F%M<R!T:')O=6=H
M#0H@#0H@("`@("`@(&=O=F5R;FUE;G0@9W)A;G0@9G5N9&EN9R!M96-H86YI
M<VUS+CPO9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDS96%A83@W7S`X9F1?
M-#4S95\Y-&%E7V(P,S<Q-#@X83$V,@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q-C(O
M5V]R:W-H965T<R]3:&5E=#`X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`R("T@4W5M;6%R>2!O9B!3:6=N:69I8V%N
M="!!8V-O=6YT:6YG(%!O;&EC:65S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC
M:65S(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@(`T*("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0G/C(N)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[4W5M;6%R>0T*("`@("`-
M"B`@("`@("`@;V8@4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<SPO
M9F]N=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U19
M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D)A<VES#0H@(`T*("`@
M("`@("!O9B!0<F5S96YT871I;VX@86YD(%!R:6YC:7!L97,@;V8@0V]N<V]L
M:61A=&EO;CPO9F]N=#X-"B`@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=7(-"B`@("`@#0H@("`@("`@('!R
M:6UA<GD@8G5S:6YE<W,@:7,@8V]N9'5C=&5D(&)Y(&]U<B!W:&]L;'DM;W=N
M960-"B`@(`T*("`@("`@("!S=6)S:61I87)Y+"!'96]687@L($EN8RX@5&AE
M(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960-"B`@(`T*("`@("`@("!F:6YA
M;F-I86P@<W1A=&5M96YT<R!I;F-L=61E('1H92!A8V-O=6YT<R!O9B!'96]6
M87@L($EN8RX-"B`-"B`@("`@("`@9G)O;2!I;F-E<'1I;VX@=&]G971H97(@
M=VET:"!T:&]S92!O9B!'96]687@@3&%B<RP@26YC+@T*("`@(`T*("`@("`@
M("!F<F]M(%-E<'1E;6)E<B`R."P@,C`P-B`H<V5E($YO=&4@-2DN)B,Q-C`[
M)B,Q-C`[06QL#0H@("`@#0H@("`@("`@(&EN=&5R8V]M<&%N>2!T<F%N<V%C
M=&EO;G,@:&%V92!B965N(&5L:6UI;F%T960@:6X-"B`@(`T*("`@("`@("!C
M;VYS;VQI9&%T:6]N+CPO9F]N=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D1E=F5L;W!M96YT+5-T86=E#0H@("`@#0H@("`@("`@($5N=&5R<')I<V4\
M+V9O;G0^#0H@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/E=E#0H@("`@#0H@("`@("`@(&%R92!D979O=&EN9R!A
M;&P@;V8@;W5R('!R97-E;G0@969F;W)T<R!T;R!R97-E87)C:"!A;F0-"B`@
M("`-"B`@("`@("`@9&5V96QO<&UE;G0@86YD($=E;U9A>"!I<R!A(&1E=F5L
M;W!M96YT('-T86=E(&5N=&5R<')I<V4@87,-"B`@(`T*("`@("`@("!D969I
M;F5D(&)Y($9I;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD87)D<R!";V%R9`T*
M(`T*("`@("`@("`H)B,X,C(P.T9!4T(F(S@R,C$[*2!!8V-O=6YT:6YG(%-T
M86YD87)D<R!#;V1I9FEC871I;VX-"B`-"B`@("`@("`@*"8C.#(R,#M!4T,F
M(S@R,C$[*2!4;W!I8R`Y,34L(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z
M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY$979E;&]P;65N=`T*("`@("`-
M"B`@("`@("`@4W1A9V4@16YT:71I97,\+V9O;G0^+B8C,38P.R8C,38P.T%L
M;"!L;W-S97,@86-C=6UU;&%T960-"B`@("`-"B`@("`@("`@<VEN8V4@:6YC
M97!T:6]N("A*=6YE(#(W+"`R,#`Q*2!H879E(&)E96X@8V]N<VED97)E9"!A
M<PT*("`@(`T*("`@("`@("!P87)T(&]F(&]U<B!D979E;&]P;65N="!S=&%G
M92!A8W1I=FET:65S+CPO9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M="<^57-E#0H@("`@(`T*("`@("`@("!O9B!%<W1I;6%T97,\+V9O;G0^#0H@
M("`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L
M969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^5&AE#0H@("`@(`T*("`@("`@("!P<F5P87)A=&EO;B!O9B!F:6YA
M;F-I86P@<W1A=&5M96YT<R!I;B!C;VYF;W)M:71Y('=I=&@-"B`@(`T*("`@
M("`@("!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D
M(&EN('1H92!5;FET960-"B`@(`T*("`@("`@("!3=&%T97,@;V8@06UE<FEC
M82`H)B,X,C(P.T=!05`F(S@R,C$[*2!R97%U:7)E<R!U<R!T;R!M86ME#0H@
M("`@(`T*("`@("`@("!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS('1H870@
M869F96-T('1H92!R97!O<G1E9"!A;6]U;G1S#0H@(`T*("`@("`@("!O9B!A
M<W-E=',@86YD(&QI86)I;&ET:65S(&%N9"!D:7-C;&]S=7)E(&]F(&-O;G1I
M;F=E;G0-"B`@(`T*("`@("`@("!A<W-E=',@86YD(&QI86)I;&ET:65S(&%T
M('1H92!D871E(&]F('1H92!F:6YA;F-I86P-"B`@("`@#0H@("`@("`@('-T
M871E;65N=',@86YD('1H92!R97!O<G1E9"!A;6]U;G1S(&]F(')E=F5N=65S
M(&%N9`T*("`@("`-"B`@("`@("`@97AP96YS97,@9'5R:6YG('1H92!R97!O
M<G1I;F<@<&5R:6]D+B8C,38P.R8C,38P.T%C='5A;`T*("`-"B`@("`@("`@
M<F5S=6QT<R!M87D@9&EF9F5R(&9R;VT@=&AO<V4@97-T:6UA=&5S+CPO9F]N
M=#X-"B`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%
M.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87-H#0H@#0H@("`@("`@
M(&%N9"!#87-H($5Q=6EV86QE;G1S/"]F;VYT/@T*("`-"B`@("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*("`@(`T*
M("`@("`@("!C;VYS:61E<B!A;&P@:&EG:&QY(&QI<75I9"!I;G9E<W1M96YT
M<R!W:71H(&$@;6%T=7)I='D@;V8-"B`-"B`@("`@("`@=&AR964@;6]N=&AS
M(&]R(&QE<W,@=VAE;B!P=7)C:&%S960@=&\@8F4@8V%S:`T*("`@("`-"B`@
M("`@("`@97%U:79A;&5N=',N)B,Q-C`[)B,Q-C`[3W5R(&-A<V@@86YD(&-A
M<V@@97%U:79A;&5N=',-"B`@("`@#0H@("`@("`@(&-O;G-I<W0@<')I;6%R
M:6QY(&]F(&)A;FL@9&5P;W-I=',@86YD(&UO;F5Y(&UA<FME=`T*("`@("`-
M"B`@("`@("`@86-C;W5N=',N)B,Q-C`[)B,Q-C`[5&AE(')E8V]R9&5D('9A
M;'5E<R!A<'!R;WAI;6%T92!F86ER#0H@("`@#0H@("`@("`@(&UA<FME="!V
M86QU97,@9'5E('1O('1H92!S:&]R="!M871U<FET:65S+CPO9F]N=#X-"B`@
M("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET
M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9A:7(-"B`-"B`@("`@("`@5F%L
M=64@;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S(&%N9"!#;VYC96YT<F%T:6]N
M(&]F($-R961I=`T*("`-"B`@("`@("`@4FES:SPO9F]N=#X-"B`-"B`@("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:6YA
M;F-I86P-"B`-"B`@("`@("`@:6YS=')U;65N=',@=&AA="!S=6)J96-T('5S
M('1O(&-O;F-E;G1R871I;VX@;V8@8W)E9&ET(')I<VL-"B`@(`T*("`@("`@
M("!C;VYS:7-T('!R:6UA<FEL>2!O9B!C87-H(&%N9"!C87-H(&5Q=6EV86QE
M;G1S+"!W:&EC:"!A<F4-"B`-"B`@("`@("`@;6%I;G1A:6YE9"!B>2!A(&AI
M9V@@8W)E9&ET('%U86QI='D@9FEN86YC:6%L(&EN<W1I='5T:6]N+@T*("`-
M"B`@("`@("`@5&AE(&-A<G)Y:6YG('9A;'5E<R!R97!O<G1E9"!I;B!T:&4@
M8F%L86YC92!S:&5E=',@9F]R(&-A<V@-"B`@(`T*("`@("`@("!A;F0@8V%S
M:"!E<75I=F%L96YT<R!A<'!R;WAI;6%T92!F86ER('9A;'5E<RX\+V9O;G0^
M#0H@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@
M:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4')O<&5R='D-"B`@("`@#0H@
M("`@("`@(&%N9"!%<75I<&UE;G0\+V9O;G0^#0H@("`@(`T*("`@("`@/"]D
M:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E!R;W!E<G1Y
M#0H@("`@(`T*("`@("`@("!A;F0@97%U:7!M96YT(&%R92!S=&%T960@870@
M8V]S="P@;&5S<R!A8V-U;75L871E9`T*("`@(`T*("`@("`@("!D97!R96-I
M871I;VX@86YD(&%M;W)T:7IA=&EO;BXF(S$V,#LF(S$V,#M4:&4@8V]M<&]N
M96YT<R!O9@T*(`T*("`@("`@("!P<F]P97)T>2!A;F0@97%U:7!M96YT(&%S
M(&]F($1E8V5M8F5R(#,Q+"`R,#$Q(&%N9"`R,#$P(&%R90T*("`@#0H@("`@
M("`@(&%S(&9O;&QO=W,Z/"]F;VYT/@T*("`@#0H@("`@("`\+V1I=CX\8G(O
M/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H
M/3-$,3`P)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@("`@#0H@("`@("`@("`@/'1R/@T*
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^,C`Q,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/@T*("`@(`T*
M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3&%B;W)A=&]R>0T*("`@("`-"B`@("`@("`@("`@("`@("!E<75I
M<&UE;G0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXS.#@L,#`P/"]F;VYT/@T*("`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXS.#@L,#`P/"]F;VYT/@T*("`@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@
M("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^#0H@("`@#0H@("`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,96%S
M96AO;&0-"B`@("`-"B`@("`@("`@("`@("`@("!I;7!R;W9E;65N=',\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C$Q-2PV,#4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXQ,34L-C`U/"]F;VYT/@T*("`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@
M("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-
M"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S8E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D]T:&5R#0H@("`@(`T*("`@("`@("`@("`@("`@(&9U
M<FYI='5R92P@9FEX='5R97,@)F%M<#L@97%U:7!M96YT/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR."PV.#4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,38L-S@Y/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*
M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W-B4^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;`T*("`@("`-"B`@
M("`@("`@("`@("`@("!P<F]P97)T>2!A;F0@97%U:7!M96YT/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXU,S(L,CDP/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^-3(P+#,Y-#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT
M<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#<V)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*
M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY!8V-U;75L871E9`T*(`T*("`@("`@("`@("`@("`@(&1E<')E
M8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH
M,S4V+#`X-#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*#(W,2PY-3,\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W-B4@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^4')O<&5R='D-"B`@(`T*("`@("`@("`@("`@("`@(&%N9"!E<75I<&UE
M;G0L(&YE=#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
M+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-S8L,C`V/"]F;VYT/@T*("`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-
M"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXR-#@L-#0Q/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^
M#0H@(`T*("`@("`@("`\+W1A8FQE/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&QE9G0^#0H@("`@(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P="<^17AP96YD:71U<F5S#0H@("`@#0H@("`@("`@(&9O
M<B!M86EN=&5N86YC92!A;F0@<F5P86ER<R!A<F4@8VAA<F=E9"!T;R!O<&5R
M871I;VYS(&%S#0H@("`@(`T*("`@("`@("!I;F-U<G)E9"P@=VAI;&4@861D
M:71I;VYS(&%N9"!I;7!R;W9E;65N=',@87)E#0H@("`@(`T*("`@("`@("!C
M87!I=&%L:7IE9"XF(S$V,#LF(S$V,#M$97!R96-I871I;VX@:7,@8V]M<'5T
M960@=7-I;F<@=&AE#0H@("`@(`T*("`@("`@("!S=')A:6=H="UL:6YE(&UE
M=&AO9"!O=F5R('1H92!E<W1I;6%T960@=7-E9G5L(&QI=F5S(&]F('1H90T*
M("`@#0H@("`@("`@(&%S<V5T<R!W:&EC:"!R86YG92!F<F]M('1H<F5E('1O
M(&9I=F4-"B`-"B`@("`@("`@>65A<G,N)B,Q-C`[)B,Q-C`[06UO<G1I>F%T
M:6]N(&]F(&QE87-E:&]L9"!I;7!R;W9E;65N=',@:7,-"B`-"B`@("`@("`@
M8V]M<'5T960@=7-I;F<@=&AE('-T<F%I9VAT+6QI;F4@;65T:&]D(&]V97(@
M=&AE(')E;6%I;FEN9PT*("`-"B`@("`@("`@=&5R;2!O9B!T:&4@<F5L871E
M9"!L96%S92XF(S$V,#LF(S$V,#M$97!R96-I871I;VX@86YD#0H@#0H@("`@
M("`@(&%M;W)T:7IA=&EO;B!E>'!E;G-E('=A<R`D.#0L,3,Q+"`D.30L.#@W
M+"!A;F0@)#8T+#@Y,0T*("`@#0H@("`@("`@(&1U<FEN9R!T:&4@>65A<G,@
M96YD960@1&5C96UB97(@,S$L(#(P,3$L(#(P,3`@86YD(#(P,#DL#0H@("`@
M(`T*("`@("`@("!R97-P96-T:79E;'DN/"]F;VYT/@T*("`@("`-"B`@("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D]T:&5R#0H@(`T*("`@("`@("!!<W-E=',\+V9O
M;G0^#0H@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY/=&AE<@T*("`-"B`@("`@("`@87-S971S(&-O;G-I<W0@
M<')I;F-I<&%L;'D@;V8@;&EC96YS92!A9W)E96UE;G1S(&9O<B!T:&4-"B`@
M("`@#0H@("`@("`@('5S92!O9B!T96-H;F]L;V=Y(&]B=&%I;F5D('1H<F]U
M9V@@=&AE(&ES<W5A;F-E(&]F('1H90T*("`@#0H@("`@("`@($-O;7!A;GDF
M(S@R,3<[<R!C;VUM;VX@<W1O8VLN)B,Q-C`[)B,Q-C`[5&AE<V4@;&EC96YS
M90T*("`@("`-"B`@("`@("`@86=R965M96YT<R!A<F4@86UO<G1I>F5D(&]N
M(&$@<W1R86EG:'0@;&EN92!B87-I<R!O=F5R('1E;@T*("`-"B`@("`@("`@
M>65A<G,N)B,Q-C`[)B,Q-C`[06UO<G1I>F%T:6]N(&5X<&5N<V4@<F5L871E
M9"!T;R!T:&5S90T*("`-"B`@("`@("`@86=R965M96YT<R!W87,@)#(T+#@X
M-B!D=7)I;F<@96%C:"!O9B!T:&4@>65A<G,@96YD960-"B`@#0H@("`@("`@
M($1E8V5M8F5R(#,Q+"`R,#$Q+"`R,#$P(&%N9"`R,#`Y(&%N9"!I<R!E>'!E
M8W1E9"!T;R!B90T*("`@#0H@("`@("`@("0Q.2PY,C,L("0Q,"PP,#`L("0Q
M,"PP,#`L("0M,"TL(&%N9"`D+3`M(&9O<B!E86-H(&]F('1H90T*(`T*("`@
M("`@("!N97AT(&9I=F4@>65A<G,L(')E<W!E8W1I=F5L>2X\+V9O;G0^#0H@
M(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F
M=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A
M;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P="<^26UP86ER;65N=`T*("`-"B`@("`@
M("`@;V8@3&]N9RU,:79E9"!!<W-E=',\+V9O;G0^#0H@(`T*("`@("`@/"]D
M:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E#0H@("`@
M#0H@("`@("`@(')E=FEE=R!L;VYG+6QI=F5D(&%S<V5T<R!F;W(@:6UP86ER
M;65N="!W:&5N979E<B!E=F5N=',@;W(-"B`@#0H@("`@("`@(&-H86YG97,@
M:6X@8VER8W5M<W1A;F-E<R!I;F1I8V%T92!T:&%T('1H92!C87)R>6EN9R!A
M;6]U;G0-"B`@#0H@("`@("`@(&]F(&%N(&%S<V5T(&UA>2!N;W0@8F4-"B`-
M"B`@("`@("`@<F5C;W9E<F%B;&4N)B,Q-C`[)B,Q-C`[4F5C;W9E<F%B:6QI
M='D@;V8@87-S971S('1O(&)E(&AE;&0-"B`-"B`@("`@("`@86YD('5S960@
M:7,@;65A<W5R960@8GD@82!C;VUP87)I<V]N(&]F('1H92!C87)R>6EN9R!A
M;6]U;G0-"B`@(`T*("`@("`@("!O9B!T:&4@87-S971S('1O('1H92!F=71U
M<F4@;F5T(&-A<V@@9FQO=W,@97AP96-T960@=&\@8F4-"B`-"B`@("`@("`@
M9V5N97)A=&5D(&)Y('-U8V@@87-S971S+B8C,38P.R8C,38P.TEF('=E(&-O
M;G-I9&5R('-U8V@-"B`@(`T*("`@("`@("!A<W-E=',@=&\@8F4@:6UP86ER
M960L('1H92!I;7!A:7)M96YT('1O(&)E/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/G)E
M8V]G;FEZ960-"B`@("`@#0H@("`@("`@(&ES(&UE87-U<F5D(&)Y('1H92!A
M;6]U;G0@8GD@=VAI8V@@=&AE(&-A<G)Y:6YG(&%M;W5N="!O9@T*(`T*("`@
M("`@("!T:&4@87-S971S(&5X8V5E9',@=&AE(&5X<&5C=&5D(&9U='5R92!N
M970@8V%S:"!F;&]W<R!F<F]M#0H@(`T*("`@("`@("!T:&4@87-S971S+CPO
M9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M5%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^06-C<G5E9`T*("`@
M(`T*("`@("`@("!,:6%B:6QI=&EE<SPO9F]N=#X-"B`@(`T*("`@("`@/"]D
M:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%S#0H@("`@
M#0H@("`@("`@('!A<G0@;V8@=&AE('!R;V-E<W,@;V8@<')E<&%R:6YG(&]U
M<B!F:6YA;F-I86P@<W1A=&5M96YT<RP-"B`@#0H@("`@("`@('=E(&5S=&EM
M871E(&5X<&5N<V5S('1H870@=V4@8F5L:65V92!W92!H879E(&EN8W5R<F5D
M+"!B=70-"B`@#0H@("`@("`@(&AA=F4@;F]T('EE="!B965N(&)I;&QE9"!B
M>2!O=7(@=&AI<F0@<&%R='D@=F5N9&]R<RX@5&AI<PT*(`T*("`@("`@("!P
M<F]C97-S(&EN=F]L=F5S(&ED96YT:69Y:6YG('-E<G9I8V5S(&%N9"!A8W1I
M=FET:65S('1H870-"B`-"B`@("`@("`@:&%V92!B965N('!E<F9O<FUE9"!B
M>2!S=6-H('9E;F1O<G,@;VX@;W5R(&)E:&%L9B!A;F0-"B`@#0H@("`@("`@
M(&5S=&EM871I;F<@=&AE(&QE=F5L('1O('=H:6-H('1H97D@:&%V92!B965N
M('!E<F9O<FUE9"!A;F0-"B`@#0H@("`@("`@('1H92!A<W-O8VEA=&5D(&-O
M<W0@:6YC=7)R960@9F]R('-U8V@@<V5R=FEC92!A<R!O9B!E86-H#0H@("`@
M(`T*("`@("`@("!B86QA;F-E('-H965T(&1A=&4@:6X@;W5R(&9I;F%N8VEA
M;"!S=&%T96UE;G1S+B!%>&%M<&QE<R!O9@T*("`@#0H@("`@("`@(&5X<&5N
M<V5S(&9O<B!W:&EC:"!W92!A8V-R=64@:6YC;'5D92!F965S(&9O<B!P<F]F
M97-S:6]N86P-"B`@#0H@("`@("`@('-E<G9I8V5S(&%N9"!F965S(&]W960@
M=&\@8V]N=')A8W0@;6%N=69A8W1U<F5R<R!I;@T*("`@("`-"B`@("`@("`@
M8V]N:G5N8W1I;VX@=VET:"!T:&4@;6%N=69A8W1U<F4@;V8@=F%C8VEN97,@
M9F]R(&]U<@T*(`T*("`@("`@("!C;&EN:6-A;"!T<FEA;',N(%=E(&UA:V4@
M=&AE<V4@97-T:6UA=&5S(&)A<V5D('5P;VX-"B`@("`@#0H@("`@("`@('!R
M;V=R97-S(&]F(&%C=&EV:71I97,@<F5L871E9"!T;R!C;VYT<F%C='5A;"!O
M8FQI9V%T:6]N<PT*(`T*("`@("`@("!A;F0@:6YF;W)M871I;VX@<F5C96EV
M960@9G)O;2!V96YD;W)S+CPO9F]N=#X-"B`@("`@#0H@("`@("`\+V1I=CX\
M8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\
M9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY.970-"B`@("`@#0H@("`@("`@($QO<W,@4&5R(%-H87)E/"]F
M;VYT/@T*(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D)A<VEC#0H@(`T*("`@("`@("!A;F0@9&EL=71E9"!L;W-S
M('!E<B!C;VUM;VX@<VAA<F4@87)E(&-O;7!U=&5D(&)A<V5D(&]N('1H90T*
M("`@#0H@("`@("`@('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO
M;B!S:&%R97,@;W5T<W1A;F1I;F<N($%L;`T*(`T*("`@("`@("!C;VUM;VX@
M<VAA<F4@97%U:79A;&5N=',@*'=H:6-H(&-O;G-I<W0@;V8@;W!T:6]N<R!A
M;F0-"B`@(`T*("`@("`@("!W87)R86YT<RD@87)E(&5X8VQU9&5D(&9R;VT@
M=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@;&]S<PT*("`@#0H@("`@("`@
M('!E<B!S:&%R92!S:6YC92!T:&4@969F96-T('=O=6QD(&)E(&%N=&DM9&EL
M=71I=F4N($-O;6UO;@T*(`T*("`@("`@("!S:&%R92!E<75I=F%L96YT<R!W
M:&EC:"!C;W5L9"!P;W1E;G1I86QL>2!D:6QU=&4@8F%S:6,-"B`@(`T*("`@
M("`@("!E87)N:6YG<R!P97(@<VAA<F4@:6X@=&AE(&9U='5R92P@86YD('=H
M:6-H('=E<F4@97AC;'5D960-"B`-"B`@("`@("`@9G)O;2!T:&4@8V]M<'5T
M871I;VX@;V8@9&EL=71E9"!L;W-S('!E<B!S:&%R92P@=&]T86QE9`T*("`@
M(`T*("`@("`@("`R+#<Y."PX,#$L(#(L,#$S+#4R,BP@86YD(#$L.#8V+#4U
M,"!A="!$96-E;6)E<B`S,2P@,C`Q,2P-"B`-"B`@("`@("`@,C`Q,"!A;F0@
M,C`P.2P@<F5S<&5C=&EV96QY+CPO9F]N=#X-"B`@("`@#0H@("`@("`\+V1I
M=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@
M("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY2979E;G5E#0H@("`@#0H@("`@("`@(%)E8V]G;FET:6]N
M/"]F;VYT/@T*("`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P="<^5V4-"B`@("`-"B`@("`@("`@<F5C;V=N:7IE(')E
M=F5N=64@:6X@86-C;W)D86YC92!W:71H('1H92!314,F(S@R,3<[<R!3=&%F
M9@T*(`T*("`@("`@("!!8V-O=6YT:6YG($)U;&QE=&EN($YO+B`Q,#$L(#QF
M;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL
M:6YE)SY2979E;G5E#0H@#0H@("`@("`@(%)E8V]G;FET:6]N(&EN($9I;F%N
M8VEA;"!3=&%T96UE;G1S+#PO9F]N=#X@87,@86UE;F1E9"!B>0T*("`-"B`@
M("`@("`@4W1A9F8@06-C;W5N=&EN9R!"=6QL971I;B!.;RX@,3`T+"`\9F]N
M="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN
M92<^4F5V96YU90T*("`-"B`@("`@("`@4F5C;V=N:71I;VXL/"]F;VYT/B`H
M)B,X,C(P.U-!0B`Q,#0F(S@R,C$[*2X@4T%"(#$P-`T*("`@("`-"B`@("`@
M("`@<')O=FED97,@9W5I9&%N8V4@:6X@87!P;'EI;F<@1T%!4"!T;R!R979E
M;G5E(')E8V]G;FET:6]N#0H@#0H@("`@("`@(&ES<W5E<RP@86YD('-P96-I
M9FEC86QL>2!A9&1R97-S97,@<F5V96YU92!R96-O9VYI=&EO;B!F;W(-"B`@
M#0H@("`@("`@('5P9G)O;G0L(&YO;G)E9G5N9&%B;&4@9F5E<R!R96-E:79E
M9"!I;B!C;VYN96-T:6]N('=I=&@-"B`@("`-"B`@("`@("`@<F5S96%R8V@@
M8V]L;&%B;W)A=&EO;B!A9W)E96UE;G1S+B8C,38P.R8C,38P.T1U<FEN9R`R
M,#$Q+`T*("`@("`-"B`@("`@("`@,C`Q,"!A;F0@,C`P.2P@;W5R(')E=F5N
M=64@8V]N<VES=&5D(&]F(&=R86YT(&9U;F1I;F<-"B`@#0H@("`@("`@(')E
M8V5I=F5D('!R:6UA<FEL>2!F<F]M('1H92!.24@@*'-E92!.;W1E#0H@("`@
M(`T*("`@("`@("`S*2XF(S$V,#LF(S$V,#M2979E;G5E(&9R;VT@=&AI<R!A
M<G)A;F=E;65N="!I<PT*("`@(`T*("`@("`@("!A<'!R;WAI;6%T96QY(&5Q
M=6%L('1O('1H92!C;W-T<R!I;F-U<G)E9"!A;F0@:7,@<F5C;W)D960-"B`-
M"B`@("`@("`@87,@:6YC;VUE(&%S('1H92!R96QA=&5D(&-O<W1S(&%R92!I
M;F-U<G)E9"X\+V9O;G0^#0H@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY297-E
M87)C:`T*("`@("`-"B`@("`@("`@86YD($1E=F5L;W!M96YT($5X<&5N<V4\
M+V9O;G0^#0H@("`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E)E<V5A<F-H#0H@("`@(`T*("`@("`@("!A;F0@
M9&5V96QO<&UE;G0@97AP96YS92!P<FEM87)I;'D@8V]N<VES=',@;V8@8V]S
M=',-"B`@("`@#0H@("`@("`@(&EN8W5R<F5D(&EN('1H92!D:7-C;W9E<GDL
M(&1E=F5L;W!M96YT+"!T97-T:6YG(&%N9`T*("`@("`-"B`@("`@("`@;6%N
M=69A8W1U<FEN9R!O9B!O=7(@<')O9'5C="!C86YD:61A=&5S+B!4:&5S92!E
M>'!E;G-E<PT*("`@(`T*("`@("`@("!C;VYS:7-T('!R:6UA<FEL>2!O9B`H
M:2D@9F5E<R!P86ED('1O('1H:7)D+7!A<G1Y('-E<G9I8V4-"B`-"B`@("`@
M("`@<')O=FED97)S('1O('!E<F9O<FTL(&UO;FET;W(@86YD(&%C8W5M=6QA
M=&4@9&%T82!R96QA=&5D#0H@#0H@("`@("`@('1O(&]U<B!P<F5C;&EN:6-A
M;"!S='5D:65S(&%N9"!C;&EN:6-A;"!T<FEA;',L("AI:2D@8V]S=',-"B`@
M#0H@("`@("`@(')E;&%T960@=&\@<W!O;G-O<F5D(')E<V5A<F-H(&%G<F5E
M;65N=',L("AI:6DI('1H92!C;W-T<PT*(`T*("`@("`@("!T;R!P<F]C=7)E
M(&%N9"!M86YU9F%C='5R92!M871E<FEA;',@=7-E9"!I;B!C;&EN:6-A;`T*
M("`-"B`@("`@("`@=')I86QS+"`H:78I(&QA8F]R871O<GD@<W5P<&QI97,@
M86YD(&9A8VEL:71Y+7)E;&%T960-"B`@#0H@("`@("`@(&5X<&5N<V5S('1O
M(&-O;F1U8W0@9&5V96QO<&UE;G0L(&%N9"`H=BD@<V%L87)I97,L#0H@("`@
M#0H@("`@("`@(&)E;F5F:71S+"!A;F0@<VAA<F4M8F%S960@8V]M<&5N<V%T
M:6]N(&9O<@T*(`T*("`@("`@("!P97)S;VYN96PN)B,Q-C`[)B,Q-C`[5&AE
M<V4@8V]S=',@87)E(&-H87)G960@=&\@97AP96YS92!A<PT*(`T*("`@("`@
M("!I;F-U<G)E9"X\+V9O;G0^#0H@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0
M871E;G0-"B`@(`T*("`@("`@("!#;W-T<SPO9F]N=#X-"B`@#0H@("`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^3W5R#0H@
M("`@(`T*("`@("`@("!E>'!E;F1I='5R97,@<F5L871I;F<@=&\@;V)T86EN
M:6YG(&%N9"!P<F]T96-T:6YG('!A=&5N=',-"B`-"B`@("`@("`@87)E(&-H
M87)G960@=&\@97AP96YS92!W:&5N(&EN8W5R<F5D+"!A;F0@87)E(&EN8VQU
M9&5D(&EN#0H@#0H@("`@("`@(&=E;F5R86P@86YD(&%D;6EN:7-T<F%T:79E
M(&5X<&5N<V4N/"]F;VYT/@T*("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E!E
M<FEO9`T*("`@#0H@("`@("`@('1O(%!E<FEO9"!#;VUP87)I<V]N<SPO9F]N
M=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D]U<@T*("`@("`-"B`@("`@("`@;W!E<F%T:6YG(')E<W5L
M=',@87)E(&5X<&5C=&5D('1O(&9L=6-T=6%T92!F;W(@=&AE#0H@("`@(`T*
M("`@("`@("!F;W)E<V5E86)L92!F=71U<F4N(%1H97)E9F]R92P@<&5R:6]D
M+71O+7!E<FEO9"!C;VUP87)I<V]N<PT*("`@#0H@("`@("`@('-H;W5L9"!N
M;W0@8F4@<F5L:65D('5P;VX@87,@<')E9&EC=&EV92!O9B!T:&4@<F5S=6QT
M<R!F;W(-"B`@#0H@("`@("`@(&9U='5R92!P97)I;V1S+B8C,38P.R8C,38P
M.T-E<G1A:6X@<')I;W(@>65A<B!A;6]U;G1S(&AA=F4-"B`@("`@#0H@("`@
M("`@(&)E96X@<F5C;&%S<VEF:65D('1O(&-O;F9O<FT@=&\@=&AE(&-U<G)E
M;G0@>65A<B!F:6YA;F-I86P-"B`@#0H@("`@("`@('-T871E;65N="!P<F5S
M96YT871I;VXN/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/DEN8V]M90T*("`@#0H@("`@("`@(%1A>&5S/"]F;VYT/@T*("`-"B`@("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*
M("`@(`T*("`@("`@("!A8V-O=6YT(&9O<B!I;F-O;64@=&%X97,@=7-I;F<@
M=&AE(&QI86)I;&ET>2!M971H;V0N(%5N9&5R#0H@(`T*("`@("`@("!T:&ES
M(&UE=&AO9"P@9&5F97)R960@=&%X(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@
M87)E#0H@#0H@("`@("`@(')E8V]G;FEZ960@9F]R('1H92!E<W1I;6%T960@
M9G5T=7)E('1A>"!C;VYS97%U96YC97,-"B`-"B`@("`@("`@871T<FEB=71A
M8FQE('1O(&1I9F9E<F5N8V5S(&)E='=E96X@=&AE(&9I;F%N8VEA;"!S=&%T
M96UE;G0-"B`@(`T*("`@("`@("!C87)R>6EN9R!A;6]U;G1S(&]F(&5X:7-T
M:6YG(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@86YD#0H@("`@#0H@("`@("`@
M('1H96ER(')E<W!E8W1I=F4@=&%X(&)A<V5S+B8C,38P.R8C,38P.T1E9F5R
M<F5D('1A>"!A<W-E=',-"B`@("`@#0H@("`@("`@(&%N9"!L:6%B:6QI=&EE
M<R!A<F4@;65A<W5R960@=7-I;F<@96YA8W1E9"!R871E<R!I;B!E9F9E8W0-
M"B`@#0H@("`@("`@(&9O<B!T:&4@>65A<B!I;B!W:&EC:"!T96UP;W)A<GD@
M9&EF9F5R96YC97,@87)E(&5X<&5C=&5D('1O#0H@("`-"B`@("`@("`@8F4@
M<F5C;W9E<F5D(&]R('-E='1L960N)B,Q-C`[)B,Q-C`[1&5F97)R960@=&%X
M(&%S<V5T<R!A<F4-"B`-"B`@("`@("`@<F5D=6-E9"!B>2!A('9A;'5A=&EO
M;B!A;&QO=V%N8V4@=6YL97-S+"!I;B!T:&4@;W!I;FEO;B!O9@T*("`-"B`@
M("`@("`@;6%N86=E;65N="P@:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@
M=&AA="!S;VUE('!O<G1I;VX@;W(-"B`@(`T*("`@("`@("!A;&P@;V8@=&AE
M(&1E9F5R<F5D('1A>"!A<W-E=',@=VEL;"!B92!R96%L:7IE9"X\+V9O;G0^
M#0H@("`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,
M13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4W1O8VLM0F%S960-"B`@
M(`T*("`@("`@("!#;VUP96YS871I;VX\+V9O;G0^#0H@("`@#0H@("`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^5V4-"B`@
M("`-"B`@("`@("`@86-C;W5N="!F;W(@<W1O8VLM8F%S960@=')A;G-A8W1I
M;VYS(&EN('=H:6-H('1H92!#;VUP86YY#0H@#0H@("`@("`@(')E8V5I=F5S
M('-E<G9I8V5S(&9R;VT@96UP;&]Y965S+"!D:7)E8W1O<G,@;W(@;W1H97)S
M(&EN#0H@("`@(`T*("`@("`@("!E>&-H86YG92!F;W(@97%U:71Y(&EN<W1R
M=6UE;G1S(&)A<V5D(&]N('1H92!F86ER('9A;'5E(&]F#0H@(`T*("`@("`@
M("!T:&4@87=A<F0@870@=&AE(&=R86YT(&1A=&4N)B,Q-C`[)B,Q-C`[0V]M
M<&5N<V%T:6]N(&-O<W0-"B`@("`-"B`@("`@("`@9F]R(&%W87)D<R!O9B!C
M;VUM;VX@<W1O8VL@:7,@97-T:6UA=&5D(&)A<V5D(&]N('1H92!P<FEC90T*
M("`-"B`@("`@("`@;V8@=&AE('5N9&5R;'EI;F<@8V]M;6]N('-T;V-K(&]N
M('1H92!D871E(&]F#0H@("`@#0H@("`@("`@(&ES<W5A;F-E+B8C,38P.R8C
M,38P.T-O;7!E;G-A=&EO;B!C;W-T(&9O<B!S=&]C:R!O<'1I;VYS(&]R#0H@
M#0H@("`@("`@('=A<G)A;G1S(&ES(&5S=&EM871E9"!A="!T:&4@9W)A;G0@
M9&%T92!B87-E9"!O;B!E86-H#0H@(`T*("`@("`@("!I;G-T<G5M96YT)B,X
M,C$W.W,@9F%I<BUV86QU92!A<R!C86QC=6QA=&5D(&)Y('1H90T*("`@#0H@
M("`@("`@($)L86-K+5-C:&]L97,@;W!T:6]N('!R:6-I;F<@;6]D96PN)B,Q
M-C`[)B,Q-C`[5V4@<F5C;V=N:7IE#0H@#0H@("`@("`@('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;B!C;W-T(&%S(&5X<&5N<V4@<F%T86)L>2!O;B!A#0H@
M(`T*("`@("`@("!S=')A:6=H="UL:6YE(&)A<VES(&]V97(@=&AE(')E<75I
M<VET92!S97)V:6-E('!E<FEO9"!F;W(-"B`-"B`@("`@("`@=&AE(&%W87)D
M+B8C,38P.R8C,38P.U-E92!.;W1E(#8@9F]R(&%D9&ET:6]N86P@<W1O8VLM
M8F%S960-"B`-"B`@("`@("`@8V]M<&5N<V%T:6]N(&EN9F]R;6%T:6]N+CPO
M9F]N=#X-"B`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-4
M64Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY296-E;G0-"B`@(`T*
M("`@("`@("!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]F;VYT/@T*("`-
M"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^
M#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY4:&5R90T*("`-"B`@("`@("`@:&%V92!B965N(&YO(')E8V5N="!A8V-O
M=6YT:6YG('!R;VYO=6YC96UE;G1S(&]R(&-H86YG97,@:6X-"B`@(`T*("`@
M("`@("!A8V-O=6YT:6YG('!R;VYO=6YC96UE;G1S('=H:6-H('=E(&5X<&5C
M="!T;R!H879E(&$-"B`@("`@#0H@("`@("`@(&UA=&5R:6%L(&EM<&%C="!O
M;B!O=7(@9FEN86YC:6%L('-T871E;65N=',L(&YO<B!D;R!W90T*("`@#0H@
M("`@("`@(&)E;&EE=F4@=&AA="!A;GD@<F5C96YT;'D@:7-S=65D+"!B=70@
M;F]T('EE="!E9F9E8W1I=F4L#0H@("`@(`T*("`@("`@("!A8V-O=6YT:6YG
M('-T86YD87)D<R!I9B!C=7)R96YT;'D@861O<'1E9"!W;W5L9"!H879E(&$-
M"B`@(`T*("`@("`@("!M871E<FEA;"!E9F9E8W0@;VX@;W5R(&9I;F%N8VEA
M;"!S=&%T96UE;G1S+CPO9F]N=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X
M-U\P.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T
M.#AA,38R+U=O<FMS:&5E=',O4VAE970P.2YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,R`M($=O=F5R;FUE;G0@1W)A
M;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M;W9E<FYM96YT($=R86YT<R!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*
M(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0G/C,N)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1V]V
M97)N;65N=`T*("`@#0H@("`@("`@($=R86YT<SPO9F]N=#X-"B`@(`T*("`@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-
M"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P="<^3DE(#0H@("`@(`T*("`@("`@("!'<F%N=#PO
M9F]N=#X-"B`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^26X-"B`@("`-"B`@("`@("`@4V5P=&5M8F5R(#(P,#<L
M('1H92!.24@@87=A<F1E9"!U<R!A;B!);G1E9W)A=&5D#0H@(`T*("`@("`@
M("!0<F5C;&EN:6-A;"]#;&EN:6-A;"!!2413(%9A8V-I;F4@1&5V96QO<&UE
M;G0@*$E00T%61"D-"B`@(`T*("`@("`@("!G<F%N="!T;R!S=7!P;W)T(&]U
M<B!(258O04E$4R!V86-C:6YE#0H@#0H@("`@("`@('!R;V=R86TN)B,Q-C`[
M)B,Q-C`[5&AE('!R;VIE8W0@<&5R:6]D(&9O<B!T:&4@9W)A;G0@8V]V97)S
M#0H@#0H@("`@("`@(&$@9FEV92UY96%R('!E<FEO9"!W:&EC:"!C;VUM96YC
M960@3V-T;V)E<B`R,#`W+"!W:71H(&%N#0H@("`@(`T*("`@("`@("!A9V=R
M96=A=&4@87=A<F0@;V8@)#(P+C0@;6EL;&EO;BXF(S$V,#LF(S$V,#M!<R!O
M9B!$96-E;6)E<@T*(`T*("`@("`@("`S,2P@,C`Q,2P@=&AE<F4@:7,@87!P
M<F]X:6UA=&5L>2`D,RXY(&UI;&QI;VX@;V8@=6YU<V5D#0H@("`@#0H@("`@
M("`@(&=R86YT(&9U;F1S(')E;6%I;FEN9R!A;F0@879A:6QA8FQE(&9O<B!U
M<V4@=&AR;W5G:"!!=6=U<W0-"B`@#0H@("`@("`@(#,Q+"`R,#$R("AT:&4@
M96YD(&]F('1H92!O<FEG:6YA;"!P<F]J96-T#0H@("`@(`T*("`@("`@("!P
M97)I;V0I+B8C,38P.R8C,38P.U=E(&%R92!U=&EL:7II;F<@=&AI<R!F=6YD
M:6YG('1O#0H@("`@#0H@("`@("`@(&9U<G1H97(@;W5R($A)5B]!2413('9A
M8V-I;F4@9&5V96QO<&UE;G0L(&]P=&EM:7IA=&EO;B!A;F0-"B`@#0H@("`@
M("`@('!R;V1U8W1I;VXN)B,Q-C`[)B,Q-C`[5V4@<F5C;W)D(')E=F5N=64@
M87-S;V-I871E9"!W:71H#0H@("`-"B`@("`@("`@=&AE(&=R86YT(&%S('1H
M92!R96QA=&5D(&-O<W1S(&%N9"!E>'!E;G-E<R!A<F4@:6YC=7)R960-"B`@
M("`@#0H@("`@("`@(&%N9"!S=6-H(')E=F5N=64@:7,@<F5P;W)T960@87,@
M82!S97!A<F%T92!L:6YE(&ET96T@:6X@;W5R#0H@("`-"B`@("`@("`@<W1A
M=&5M96YT<R!O9B!O<&5R871I;VYS+B8C,38P.R8C,38P.T1U<FEN9R`R,#$Q
M+"`R,#$P+"!A;F0-"B`-"B`@("`@("`@,C`P.2P@=V4@<F5C;W)D960@)#0L
M.#DY+#@X-2P@)#0L.30P+#<W."P@86YD("0S+#8V."PQ.34L#0H@#0H@("`@
M("`@(')E<W!E8W1I=F5L>2P@;V8@<F5V96YU92!A<W-O8VEA=&5D('=I=&@@
M=&AI<R!G<F%N="X\+V9O;G0^#0H@("`@#0H@("`@("`\+V1I=CX\8G(O/CQD
M:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY15$10#0H@#0H@("`@("`@($=R86YT/"]F;VYT/@T*("`-"B`@("`@(#PO
M9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);@T*("`@
M(`T*("`@("`@("!.;W9E;6)E<B`R,#$P+"!W92!W97)E(&%W87)D960@82!O
M;F4M=&EM92!G<F%N="!O9B`D,C0T+#0W.0T*("`@#0H@("`@("`@('!U<G-U
M86YT('1O('1H92!1=6%L:69Y:6YG(%1H97)A<&5U=&EC($1I<V-O=F5R>2!0
M<F]J96-T#0H@("`@(`T*("`@("`@("`H451$4"D@<')O9W)A;2!E;F%C=&5D
M(&%S('!A<G0@;V8@=&AE(%!A=&EE;G0@4')O=&5C=&EO;@T*("`@("`-"B`@
M("`@("`@86YD($%F9F]R9&%B;&4@0V%R92!!8W0@;V8@,C`Q,"XF(S$V,#LF
M(S$V,#M4:&4@451$4`T*("`@(`T*("`@("`@("!P<F]G<F%M('=A<R!I;G1E
M;F1E9"!T;R!P<F]V:61E(&EN8V5N=&EV92!T;R!S;6%L;&5R#0H@#0H@("`@
M("`@(&-O;7!A;FEE<R!W:&\@87)E(&9O8W5S:6YG(&]N(&EN;F]V871I=F4@
M=&AE<F%P975T:6,-"B`-"B`@("`@("`@9&ES8V]V97)I97,N)B,Q-C`[)B,Q
M-C`[5V4@<F5C96EV960@=&AE(&9U;&P@86UO=6YT(&]F('1H90T*("`@("`-
M"B`@("`@("`@9W)A;G0@9'5R:6YG(#(P,3`L('=H:6-H(&ES(')E8V]R9&5D
M(&%S(')E=F5N=64@9F]R(#(P,3`@:6X-"B`@(`T*("`@("`@("!T:&4@86-C
M;VUP86YY:6YG($-O;G-O;&ED871E9"!3=&%T96UE;G0@;V8-"B`-"B`@("`@
M("`@3W!E<F%T:6]N<RX\+V9O;G0^#0H@("`-"B`@("`@(#PO9&EV/CQB<B\^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A
M86$X-U\P.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S
M-S$T.#AA,38R+U=O<FMS:&5E=',O4VAE970Q,"YH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-"`M($-O;6UI=&UE;G1S
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M:71M96YT<R!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^
M#0H@("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^-"XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#M#;VUM:71M96YT<SPO9F]N=#X-"B`@#0H@("`@("`\+V1I=CX\8G(O/CQD
M:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S
M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY,96%S90T*("`-"B`@("`@("`@06=R965M96YT<SPO9F]N=#X-"B`@#0H@
M("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*
M(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^
M5V4-"B`@("`-"B`@("`@("`@;&5A<V4@87!P<F]X:6UA=&5L>2`X+#0P,"!S
M<75A<F4@9F5E="!O9B!O9F9I8V4@86YD#0H@("`@(`T*("`@("`@("!L86)O
M<F%T;W)Y('-P86-E(&QO8V%T960@:6X@4VUY<FYA+"!'96]R9VEA("AM971R
M;W!O;&ET86X-"B`-"B`@("`@("`@071L86YT82DN(%)E;G0@97AP96YS92!F
M;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+`T*("`@(`T*("`@("`@
M("`R,#$Q+"`R,#$P(&%N9"`R,#`Y('=A<R`D,3$Y+#(U-2P@)#$Q."PY.#@L
M(&%N9"`D-C,L,S4P+`T*("`@("`-"B`@("`@("`@<F5S<&5C=&EV96QY+B8C
M,38P.R8C,38P.T9U='5R92!M:6YI;75M(&QE87-E('!A>6UE;G1S#0H@#0H@
M("`@("`@('!U<G-U86YT('1O('1H92`V,B!M;VYT:"!L96%S92!T;W1A;"`D
M,3(Q+#4V,"!I;B`R,#$R+`T*("`@#0H@("`@("`@("0Q,C4L,3@P(&EN(#(P
M,3,@86YD("0Q,C@L.3(P(&EN(#(P,30N/"]F;VYT/@T*("`@("`-"B`@("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D]T:&5R#0H@(`T*("`@("`@("!#;VUM:71M96YT
M<SPO9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/DEN#0H@("`@#0H@("`@("`@('1H92!N;W)M86P@
M8V]U<G-E(&]F(&)U<VEN97-S+"!W92!M87D@96YT97(@:6YT;R!V87)I;W5S
M#0H@("`@(`T*("`@("`@("!F:7)M('!U<F-H87-E(&-O;6UI=&UE;G1S(')E
M;&%T960@=&\@<')O9'5C=&EO;B!A;F0@=&5S=&EN9PT*("`@#0H@("`@("`@
M(&]F(&]U<B!V86-C:6YE(&UA=&5R:6%L+"!C;VYD=6-T(&]F(&-L:6YI8V%L
M('1R:6%L<RP@86YD#0H@("`@(`T*("`@("`@("!O=&AE<B!R97-E87)C:"UR
M96QA=&5D(&%C=&EV:71I97,N($%S(&]F($1E8V5M8F5R(#,Q+"`R,#$Q+`T*
M("`@#0H@("`@("`@('=E(&AA9"!A<'!R;WAI;6%T96QY("0T-S@L,#`P(&]F
M('5N<F5C;W)D960@;W5T<W1A;F1I;F<-"B`@("`-"B`@("`@("`@<'5R8VAA
M<V4@8V]M;6ET;65N=',@=&\@;W5R('9E;F1O<G,@86YD('-U8F-O;G1R86-T
M;W)S+"!O9@T*("`-"B`@("`@("`@=VAI8V@@=V4@97AP96-T(&%P<')O>&EM
M871E;'D@)#0T-2PP,#`@:6X@,C`Q,B!A;F0@)#,S+#`P,`T*("`-"B`@("`@
M("`@:6X@,C`Q,RX\+V9O;G0^#0H@("`@(`T*("`@("`@/"]D:78^/&)R+SX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDS96%A
M83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,@T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B,#,W
M,30X.&$Q-C(O5V]R:W-H965T<R]3:&5E=#$Q+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`U("T@,C`P-B!-97)G97(@
M86YD(%)E8V%P:71A;&EZ871I;VX\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DUE<F=E<G,L($%C<75I<VET:6]N<R!A;F0@1&ES
M<&]S:71I;VYS($1I<V-L;W-U<F5S(%M497AT($)L;V-K73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@("`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SXU+B8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.S(P,#8-"B`@#0H@("`@("`@($UE<F=E<B!A;F0@4F5C87!I=&%L:7IA
M=&EO;CPO9F]N=#X-"B`@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@("`@#0H@("`@("`@($-O;7!A
M;GD@=V%S(&]R:6=I;F%L;'D@:6YC;W)P;W)A=&5D(&EN($IU;F4@,3DX."!U
M;F1E<B!T:&4-"B`@#0H@("`@("`@(&QA=W,@;V8@26QL:6YO:7,@87,@1&%U
M<&AI;B!496-H;F]L;V=Y+"!);F,N#0H@("`-"B`@("`@("`@*"8C.#(R,#M$
M875P:&EN)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[1&%U<&AI;B!W87,-"B`@#0H@
M("`@("`@('5N<W5C8V5S<V9U;"!A;F0@:71S(&]P97)A=&EO;G,@=V5R92!T
M97)M:6YA=&5D(&EN($1E8V5M8F5R#0H@("`-"B`@("`@("`@,C`P,RXF(S$V
M,#LF(S$V,#M);B!397!T96UB97(@,C`P-BP@1&%U<&AI;B!C;VUP;&5T960@
M80T*("`-"B`@("`@("`@;65R9V5R("AT:&4@)B,X,C(P.TUE<F=E<B8C.#(R
M,3LI('=I=&@@1V5O5F%X+"!);F,N('=H:6-H#0H@("`@#0H@("`@("`@('=A
M<R!I;F-O<G!O<F%T960@=6YD97(@=&AE(&QA=W,@;V8@1V5O<F=I82!I;B!*
M=6YE#0H@("`@#0H@("`@("`@(#(P,#$N)B,Q-C`[)B,Q-C`[07,@82!R97-U
M;'0@;V8@=&AE($UE<F=E<BP@=&AE#0H@("`@#0H@("`@("`@('-H87)E:&]L
M9&5R<R!O9B!'96]687@L($EN8RX@97AC:&%N9V5D('1H96ER('-H87)E<R!O
M9@T*("`@#0H@("`@("`@(&-O;6UO;B!S=&]C:R!F;W(@1&%U<&AI;B!C;VUM
M;VX@<W1O8VL@86YD($=E;U9A>"P@26YC+@T*("`@#0H@("`@("`@(&)E8V%M
M92!A('=H;VQL>2UO=VYE9"!S=6)S:61I87)Y(&]F#0H@("`@#0H@("`@("`@
M($1A=7!H:6XN)B,Q-C`[)B,Q-C`[1&%U<&AI;B!T:&5N(&-H86YG960@:71S
M(&YA;64@=&\@1V5O5F%X#0H@#0H@("`@("`@($QA8G,L($EN8RX@86YD(')E
M<&QA8V5D(&ET<R!O9F9I8V5R<R!A;F0@9&ER96-T;W)S('=I=&@-"B`@("`-
M"B`@("`@("`@=&AO<V4@;V8@1V5O5F%X+"!);F,N)B,Q-C`[)B,Q-C`[4W5B
M<V5Q=65N="!T;R!T:&4@365R9V5R+`T*("`@("`-"B`@("`@("`@=&AE($-O
M;7!A;GD@:&%S(&YO="!C;VYD=6-T960@86YY(&)U<VEN97-S(&]T:&5R('1H
M86X-"B`@#0H@("`@("`@($=E;U9A>"P@26YC+B8C.#(Q-SMS(&)U<VEN97-S
M(&]F(&1E=F5L;W!I;F<@:'5M86X-"B`@#0H@("`@("`@('9A8V-I;F5S+B8C
M,38P.R8C,38P.U1H92!-97)G97(@=V%S(&%C8V]U;G1E9"!F;W(@=6YD97(@
M=&AE#0H@#0H@("`@("`@('!U<F-H87-E(&UE=&AO9"!O9B!A8V-O=6YT:6YG
M(&%S(&$@<F5V97)S92!A8W%U:7-I=&EO;B!I;@T*(`T*("`@("`@("!A8V-O
M<F1A;F-E('=I=&@@1T%!4"X@56YD97(@=&AI<R!M971H;V0@;V8@86-C;W5N
M=&EN9RP-"B`@(`T*("`@("`@("!$875P:&EN('=A<R!T<F5A=&5D(&%S('1H
M92!A8W%U:7)E9"!C;VUP86YY(&%N9"P-"B`@#0H@("`@("`@(&%C8V]R9&EN
M9VQY+"!A;&P@9FEN86YC:6%L(&EN9F]R;6%T:6]N('!R:6]R('1O('1H92!D
M871E(&]F#0H@("`-"B`@("`@("`@365R9V5R('!R97-E;G1E9"!I;B!T:&4@
M86-C;VUP86YY:6YG(&-O;G-O;&ED871E9"!F:6YA;F-I86P-"B`@(`T*("`@
M("`@("!S=&%T96UE;G1S+"!O<B!I;B!T:&4@;F]T97,@:&5R96EN+"!A<R!W
M96QL(&%S(&%N>0T*("`@(`T*("`@("`@("!R969E<F5N8V5S('1O('!R:6]R
M(&]P97)A=&EO;G,L(&%R92!T:&]S92!O9B!'96]687@L#0H@#0H@("`@("`@
M($EN8RXF(S$V,#LF(S$V,#M);B!*=6YE(#(P,#@L('1H92!#;VUP86YY('=A
M<PT*("`-"B`@("`@("`@<F5I;F-O<G!O<F%T960@=6YD97(@=&AE(&QA=W,@
M;V8@=&AE(%-T871E(&]F#0H@("`@#0H@("`@("`@($1E;&%W87)E+CPO9F]N
M=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P.&9D7S0U,V5?.31A95]B
M,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3-E
M86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R+U=O<FMS:&5E=',O
M4VAE970Q,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/DYO=&4@-B`M(%-T;V-K:&]L9&5R<R<@17%U:71Y/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:VAO;&1E<G,G($5Q
M=6ET>2!.;W1E($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F
M=#X-"B`@("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^-BXF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#M3=&]C:VAO;&1E<G,F(S@R,3<[#0H@#0H@("`@("`@($5Q=6ET>3PO
M9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M5%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^0V]M;6]N#0H@("`-
M"B`@("`@("`@4W1O8VL@5')A;G-A8W1I;VYS/"]F;VYT/@T*("`@("`-"B`@
M("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@
M#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)
M;@T*("`@(`T*("`@("`@("!&96)R=6%R>2`R,#$P+"!W92!I<W-U960@,3(L
M,#`P('-H87)E<R!O9B!O=7(@8V]M;6]N('-T;V-K#0H@(`T*("`@("`@("!I
M;B!S971T;&5M96YT(&]F(&%N(&]B;&EG871I;VX@86-C<G5E9"!A="!$96-E
M;6)E<B`S,2P@,C`P.0T*("`@#0H@("`@("`@(&EN('1H92!A;6]U;G0@;V8@
M)#DP+#`P,"X\+V9O;G0^#0H@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D1U<FEN9PT*("`@#0H@("`@("`@($1E
M8V5M8F5R(#(P,3$L('=E('-O;&0@86X@86=G<F5G871E(&]F(#8U."PU,C`@
M<VAA<F5S(&]F#0H@("`@(`T*("`@("`@("!O=7(@8V]M;6]N('-T;V-K('1O
M(&9I9G1E96X@:6YD:79I9'5A;"!A8V-R961I=&5D(&EN=F5S=&]R<PT*("`@
M#0H@("`@("`@("AI;F-L=61I;F<@;65M8F5R<R!O9B!O=7(@8F]A<F0@;V8@
M9&ER96-T;W)S(&%N9"!M86YA9V5M96YT#0H@("`-"B`@("`@("`@+2US964@
M3F]T92`Y*2!F;W(@86X@86=G<F5G871E('!U<F-H87-E('!R:6-E(&]F("0T
M-#$L,C$P+`T*("`-"B`@("`@("`@)#,V+#@P,"!O9B!W:&EC:"!W87,@<F5C
M96EV960@:6X@2F%N=6%R>2`R,#$R(&%N9"!I<PT*(`T*("`@("`@("!T:&5R
M969O<F4@<F5F;&5C=&5D(&%S(&$@<F5C96EV86)L92`H3W1H97(@0W5R<F5N
M="!!<W-E="D-"B`-"B`@("`@("`@:6X@=&AE(&%C8V]M<&%N>6EN9R!#;VYS
M;VQI9&%T960@0F%L86YC92!3:&5E="!A<R!O9@T*(`T*("`@("`@("!$96-E
M;6)E<B`S,2P@,C`Q,2XF(S$V,#LF(S$V,#M792!A;'-O(&ES<W5E9"!T;R!T
M:&4-"B`@(`T*("`@("`@("!I;G9E<W1O<G,@=V%R<F%N=',@=&\@<'5R8VAA
M<V4@86X@86=G<F5G871E(&]F(#DX-RPW.#,-"B`@(`T*("`@("`@("!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K(&%T(&$@<')I8V4@;V8@)#$N,#`@<&5R('-H
M87)E+"!W:&EC:`T*("`@#0H@("`@("`@(&5X<&ER92!I;B!$96-E;6)E<B`R
M,#$V+CPO9F]N=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY&<F]M#0H@#0H@("`@("`@('1I;64@=&\@=&EM
M92P@=V4@:7-S=64@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@=&\-"B`-
M"B`@("`@("`@8V]N<W5L=&%N=',@;W(@;W1H97)S(&EN(&5X8VAA;F=E(&9O
M<@T*(`T*("`@("`@("!S97)V:6-E<RXF(S$V,#LF(S$V,#M$=7)I;F<@,C`Q
M,2P@,C`Q,"!A;F0@,C`P.2!W92!I<W-U960-"B`@("`-"B`@("`@("`@,3(Y
M+#(T-2P@,3`L-3`P+"!A;F0@-"PU,#`L(')E<W!E8W1I=F5L>2P@9F]R('-U
M8V@-"B`@("`-"B`@("`@("`@<V5R=FEC97,[(&%N9"!W92!R96-O<F1E9"!G
M96YE<F%L(&%N9"!A9&UI;FES=')A=&EV90T*(`T*("`@("`@("!E>'!E;G-E
M(&]F("0Q-3`L,#`P+"`D-3,L.#$S+"!A;F0@)#,Q+#4P,"!D=7)I;F<@96%C
M:`T*("`-"B`@("`@("`@<F5S<&5C=&EV92!P97)I;V0@<F5L871E9"!T;R!T
M:&5S92!I<W-U86YC97,N/"]F;VYT/@T*("`-"B`@("`@(#PO9&EV/CQB<B\^
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/E-T;V-K#0H@(`T*("`@("`@("!/<'1I;VYS/"]F;VYT/@T*("`@(`T*
M("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-
M"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/DEN#0H@("`@#0H@("`@("`@(#(P,#8L('=E(&%D;W!T960@=&AE($=E;U9A
M>"!,86)S+"!);F,N(#(P,#8@17%U:71Y#0H@("`@#0H@("`@("`@($EN8V5N
M=&EV92!0;&%N("AT:&4@)B,X,C(P.U-T;V-K($]P=&EO;B!0;&%N)B,X,C(Q
M.RD@9F]R#0H@("`-"B`@("`@("`@=&AE(&=R86YT:6YG(&]F('%U86QI9FEE
M9"!I;F-E;G1I=F4@<W1O8VL@;W!T:6]N<PT*("`@#0H@("`@("`@("@F(S@R
M,C`[25-/)B,X,C$W.W,F(S@R,C$[*2P@;F]N<75A;&EF:65D('-T;V-K(&]P
M=&EO;G,L#0H@(`T*("`@("`@("!R97-T<FEC=&5D('-T;V-K(&%W87)D<R!O
M<B!R97-T<FEC=&5D('-T;V-K(&)O;G5S97,@=&\-"B`@(`T*("`@("`@("!E
M;7!L;WEE97,L(&]F9FEC97)S+"!D:7)E8W1O<G,L(&-O;G-U;'1A;G1S(&%N
M9"!A9'9I<V]R<R!O9@T*("`@#0H@("`@("`@('1H92!#;VUP86YY+B8C,38P
M.R8C,38P.U1H92!E>&5R8VES92!P<FEC92!F;W(@86YY(&]P=&EO;@T*("`@
M(`T*("`@("`@("!G<F%N=&5D(&UA>2!N;W0@8F4@;&5S<R!T:&%N(&9A:7(@
M=F%L=64@*#$Q,"4@;V8@9F%I<B!V86QU90T*("`@#0H@("`@("`@(&9O<B!)
M4T\F(S@R,3<[<R!G<F%N=&5D('1O(&-E<G1A:6X-"B`@#0H@("`@("`@(&5M
M<&QO>65E<RDN)B,Q-C`[)B,Q-C`[3W!T:6]N<R!G<F%N=&5D('5N9&5R('1H
M92!3=&]C:PT*(`T*("`@("`@("!/<'1I;VX@4&QA;B!H879E(&$@;6%X:6UU
M;2!T96XM>65A<B!T97)M(&%N9"!G96YE<F%L;'D@=F5S=`T*("`@#0H@("`@
M("`@(&]V97(@=&AR964@>65A<G,N)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@
M:&%S(')E<V5R=F5D#0H@("`@(`T*("`@("`@("`Q+#(P,"PP,#`@<VAA<F5S
M(&]F(&ET<R!C;VUM;VX@<W1O8VL@9F]R(&ES<W5A;F-E('5N9&5R('1H90T*
M("`@#0H@("`@("`@(%-T;V-K($]P=&EO;B!0;&%N+CPO9F]N=#X-"B`@("`@
M#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T
M/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M="<^00T*("`@#0H@("`@("`@('-U;6UA<GD@;V8@86-T:79I='D@=6YD97(@
M=&AE(%-T;V-K($]P=&EO;B!0;&%N(&%S(&]F#0H@(`T*("`@("`@("!$96-E
M;6)E<B`S,2P@,C`Q,2P@86YD(&-H86YG97,@9'5R:6YG('1H92!Y96%R('1H
M96X@96YD960-"B`-"B`@("`@("`@:7,@<')E<V5N=&5D(&)E;&]W.CPO9F]N
M=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Q,#`E('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-
M"B`@("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:R<^#0H@#0H@("`@("`@("`@("`@("`@
M)B,Q-C`[#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX-"B`-"B`@("`@("`@("`@
M("`@("`F(S$V,#L-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@
M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@
M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY.=6UB97(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO
M9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SYO9@T*("`-"B`@("`@("`@("`@("`@("!3
M:&%R97,\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D+3PO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!=F5R
M86=E/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*
M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*
M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D5X97)C:7-E/"]F;VYT/@T*(`T*("`@("`@("`@("`@("`\
M+V1I=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^4')I8V4\+V9O;G0^#0H@("`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^5V5I9VAT960M/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D
M:78^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/D%V97)A9V4\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4F5M86EN:6YG/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D-O;G1R86-T=6%L/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I
M=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C
M96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^5&5R;0T*("`@(`T*("`@("`@("`@("`@("`@
M("AY<G,I/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K)SX-"B`-"B`@("`@("`@("`@("`@("`F(S$V,#L-"B`@
M#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9V=R96=A
M=&4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^26YT<FEN<VEC/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D
M:78^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/E9A;'5E/"]F;VYT/@T*("`@#0H@("`@("`@
M("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R
M('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*
M("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^
M#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D]U='-T86YD:6YG#0H@#0H@("`@("`@("`@("`@("`@870@
M2F%N=6%R>2`Q+"`R,#$Q/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@(#PO
M9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXQ+#$S-RPS-38\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C4N,S,\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@
M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D=R86YT960\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@("`\+V1I
M=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,C,P+#`P,#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,CDQ('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`S-G!T)SX\+V9O;G0^,"XY,3PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE
M/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@
M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@
M("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D5X97)C:7-E9#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM
M/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M/&9O;G0@:60],T1404(Q+3(Y,B!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P
M="<^/"]F;VYT/BT\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M(#PO='(^#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9O<F9E:71E9`T*("`@
M(`T*("`@("`@("`@("`@("`@(&]R(&5X<&ER960\+V9O;G0^#0H@("`@(`T*
M("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B@T,SDL,3$T/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF
M;VYT(&ED/3-$5$%",2TR.3,@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#,V<'0G
M/CPO9F]N=#XR+C@Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ
M(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT
M<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4R)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*
M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY/=71S=&%N9&EN9PT*(`T*("`@("`@("`@("`@("`@(&%T($1E
M8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@
M/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CDR."PR
M-#(\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C4N-#,\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/CQF;VYT(&ED/3-$5$%",2TR.30@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#,V
M<'0G/CPO9F]N=#XV+C4\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM,"T\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X
M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<CX-
M"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-3(E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D5X97)C:7-A8FQE#0H@#0H@("`@("`@("`@("`@("`@
M870@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M-3<X+#(S,3PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^-RXU.3PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^/&9O;G0@:60],T1404(Q+3(Y-2!S='EL93TS1"=-05)'24XM3$5&
M5#H@,S9P="<^/"]F;VYT/C0N.#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BTP+3PO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@(#PO
M=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@("`@
M#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!
M9&1I=&EO;F%L#0H@(`T*("`@("`@("!I;F9O<FUA=&EO;B!C;VYC97)N:6YG
M(&]U<B!S=&]C:R!O<'1I;VYS(&9O<B!T:&4@>65A<G,-"B`@(`T*("`@("`@
M("!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2P@,C`Q,"!A;F0@,C`P.2!I<R!A
M<PT*("`@#0H@("`@("`@(&9O;&QO=W,Z/"]F;VYT/@T*("`@("`-"B`@("`@
M(#PO9&EV/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN
M9STS1#`@=VED=&@],T0Q,#`E('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@("`-"B`@("`@
M("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3$\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*("`@
M("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E
M<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@
M/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`P
M.3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T
M<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/@T*("`@(`T*("`@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M5V5I9VAT960-"B`@(`T*("`@("`@("`@("`@("`@(&%V97)A9V4@9F%I<B!V
M86QU92!O9B!O<'1I;VYS(&=R86YT960@9'5R:6YG('1H90T*("`@("`-"B`@
M("`@("`@("`@("`@("!P97)I;V0\+V9O;G0^#0H@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C<Y/"]F;VYT/@T*
M("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(N.34\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^-BXQ-3PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@
M#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^#0H@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);G1R:6YS:6,-"B`@("`-"B`@("`@("`@("`@("`@("!V86QU92!O9B!O
M<'1I;VYS(&5X97)C:7-E9"!D=7)I;F<@=&AE('!E<FEO9#PO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXM/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXM/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`\+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^#0H@("`@#0H@
M("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*
M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY4;W1A;`T*("`@("`-"B`@("`@("`@("`@("`@("!F86ER('9A;'5E
M(&]F(&]P=&EO;G,@=F5S=&5D(&1U<FEN9R!T:&4-"B`-"B`@("`@("`@("`@
M("`@("!P97)I;V0\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-30P+#,S.3PO9F]N=#X-"B`@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C0Y.2PU-3<\+V9O;G0^#0H@
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$T,RPS,C8\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M(#PO='(^#0H@(`T*("`@("`@("`\+W1A8FQE/CQB<B\^/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&QE9G0^#0H@("`@(`T*("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^5V4-"B`@("`-"B`@("`@("`@=7-E('1H
M92!";&%C:RU38VAO;&5S(&UO9&5L(&9O<B!D971E<FUI;FEN9R!T:&4@9W)A
M;G0@9&%T90T*("`-"B`@("`@("`@9F%I<B!V86QU92!O9B!O=7(@<W1O8VL@
M;W!T:6]N(&=R86YT<RXF(S$V,#LF(S$V,#M4:&ES#0H@#0H@("`@("`@(&UO
M9&5L('5T:6QI>F5S(&-E<G1A:6X@:6YF;W)M871I;VXL('-U8V@@87,@=&AE
M(&EN=&5R97-T#0H@("`@(`T*("`@("`@("!R871E(&]N(&$@<FES:RUF<F5E
M('-E8W5R:71Y('=I=&@@82!T97)M(&=E;F5R86QL>0T*("`@(`T*("`@("`@
M("!E<75I=F%L96YT('1O('1H92!E>'!E8W1E9"!L:69E(&]F('1H92!O<'1I
M;VX@8F5I;F<@=F%L=65D#0H@(`T*("`@("`@("!A;F0@<F5Q=6ER97,@8V5R
M=&%I;B!O=&AE<B!A<W-U;7!T:6]N<RP@<W5C:"!A<R!T:&4-"B`@("`@#0H@
M("`@("`@(&5X<&5C=&5D(&%M;W5N="!O9B!T:6UE(&%N(&]P=&EO;B!W:6QL
M(&)E(&]U='-T86YD:6YG('5N=&EL#0H@("`-"B`@("`@("`@:70@:7,@97AE
M<F-I<V5D(&]R(&5X<&ER960L('1O(&-A;&-U;&%T92!T:&4@9F%I<B!V86QU
M92!O9@T*("`-"B`@("`@("`@<W1O8VL@;W!T:6]N<R!G<F%N=&5D+B8C,38P
M.R8C,38P.U1H92!S:6=N:69I8V%N=`T*(`T*("`@("`@("!A<W-U;7!T:6]N
M<R!W92!U<V5D(&EN(&]U<B!F86ER('9A;'5E(&-A;&-U;&%T:6]N<R!W97)E
M(&%S#0H@(`T*("`@("`@("!F;VQL;W=S.CPO9F]N=#X-"B`@("`@#0H@("`@
M("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@("`@#0H@("`@
M("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT
M97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P
M,#D\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO
M='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X-"B`@("`-"B`@("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/E=E:6=H=&5D#0H@("`-"B`@("`@("`@("`@("`@("!A=F5R86=E(')I<VLM
M9G)E92!I;G1E<F5S="!R871E<SPO9F]N=#X-"B`@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,2XT/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,BXV/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,BXX/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@
M("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^#0H@("`@#0H@("`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E
M8W1E9`T*("`@#0H@("`@("`@("`@("`@("`@9&EV:61E;F0@>6EE;&0\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^,"XP/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^,"XP/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^,"XP/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A
M8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D5X
M<&5C=&5D#0H@("`-"B`@("`@("`@("`@("`@("!L:69E(&]F(&]P=&EO;CPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L
M<W!A;CTS1#,@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-PT*(`T*("`@("`@("`@("`@
M("`@('ER<SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@(`T*("`@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+C<-"B`@(`T*
M("`@("`@("`@("`@("`@('ER<SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@
M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@(`T*("`@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXW#0H@#0H@("`@("`@("`@("`@("`@>7)S/"]F;VYT/@T*("`@#0H@("`@
M("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@
M("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0V-"4^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E9`T*("`@#0H@("`@("`@
M("`@("`@("`@=F]L871I;&ET>3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@
M("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3$Q+C(\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3(N.3PO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO9F]N=#X-"B`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$Q,BXS/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@
M("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-
M"B`@("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY3=&]C:RUB87-E9`T*("`@#0H@("`@("`@(&-O;7!E;G-A=&EO;B!E
M>'!E;G-E(')E;&%T960@=&\@=&AE(%-T;V-K($]P=&EO;B!0;&%N('=A<PT*
M(`T*("`@("`@("`D-#8S+#<U,BP@)#4W-2PV-C(L(&%N9"`D,2PR,C$L-S8T
M(&1U<FEN9R!T:&4@>65A<G,@96YD960-"B`-"B`@("`@("`@1&5C96UB97(@
M,S$L(#(P,3$L(#(P,3`@86YD(#(P,#DL#0H@(`T*("`@("`@("!R97-P96-T
M:79E;'DN)B,Q-C`[)B,Q-C`[4W1O8VL@;W!T:6]N(&5X<&5N<V4@:7,@86QL
M;V-A=&5D#0H@("`@(`T*("`@("`@("!T;R!R97-E87)C:"!A;F0@9&5V96QO
M<&UE;G0@97AP96YS92!O<B!T;R!G96YE<F%L(&%N9`T*("`-"B`@("`@("`@
M861M:6YI<W1R871I=F4@97AP96YS92!B87-E9"!O;B!T:&4@<F5L871E9"!E
M;7!L;WEE90T*(`T*("`@("`@("!C;&%S<VEF:6-A=&EO;G,@86YD(&-O<G)E
M<W!O;F1S('1O('1H92!A;&QO8V%T:6]N(&]F#0H@#0H@("`@("`@(&5M<&QO
M>65E('-A;&%R:65S+B8C,38P.R8C,38P.T9O<B!T:&4@=&AR964@>65A<G,@
M96YD960-"B`@#0H@("`@("`@($1E8V5M8F5R(#,Q+"`R,#$Q+"!S=&]C:R!O
M<'1I;VX@97AP96YS92!W87,@86QL;V-A=&5D(&%S#0H@("`@(`T*("`@("`@
M("!F;VQL;W=S.CPO9F]N=#X-"B`@("`@#0H@("`@("`\+V1I=CX\8G(O/CQT
M86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$
M,3`P)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<^#0H@("`@#0H@("`@("`@("`@/'1R/@T*(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E
M;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,C`Q,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,#D\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#8T)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D=E;F5R86P-"B`@#0H@
M("`@("`@("`@("`@("`@86YD(&%D;6EN:7-T<F%T:79E(&5X<&5N<V4\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR.#0L,S4R/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXS-CDL,38Q/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXY,3<L,3$P/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0V-"4@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-
M"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^4F5S96%R8V@-"B`@(`T*("`@("`@("`@("`@("`@(&%N9"!D
M979E;&]P;65N="!E>'!E;G-E/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$W.2PT,#`\
M+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R
M:6=H="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C(P-BPU,#$\+V9O;G0^#0H@("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C,P-"PV
M-30\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@
M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[
M)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-C0E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E1O=&%L#0H@("`@(`T*("`@("`@("`@("`@("`@
M('-T;V-K(&]P=&EO;B!E>'!E;G-E/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-#8S
M+#<U,CPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^-3<U+#8V,CPO9F]N=#X-"B`@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,2PR,C$L-S8T/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-
M"B`@#0H@("`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$;&5F=#X-"B`@("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY!<PT*("`@(`T*("`@("`@("!O9B!$96-E;6)E<B`S
M,2P@,C`Q,2P@=&AE<F4@=V%S("0U,34L-CDW(&]F('5N<F5C;V=N:7IE9`T*
M("`@("`-"B`@("`@("`@8V]M<&5N<V%T:6]N(&5X<&5N<V4@<F5L871E9"!T
M;R!S=&]C:RUB87-E9"!C;VUP96YS871I;VX-"B`@("`@#0H@("`@("`@(&%R
M<F%N9V5M96YT<RXF(S$V,#LF(S$V,#M4:&4@=6YR96-O9VYI>F5D(&-O;7!E
M;G-A=&EO;@T*(`T*("`@("`@("!E>'!E;G-E(&ES(&5X<&5C=&5D('1O(&)E
M(')E8V]G;FEZ960@;W9E<B!A('=E:6=H=&5D#0H@#0H@("`@("`@(&%V97)A
M9V4@<F5M86EN:6YG('!E<FEO9"!O9B`R+C`@>65A<G,N/"]F;VYT/@T*("`@
M("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET
M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D-O;7!E;G-A=&]R>0T*("`@(`T*
M("`@("`@("!787)R86YT<SPO9F]N=#X-"B`@("`@#0H@("`@("`\+V1I=CX\
M8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^1G)O;0T*(`T*("`@
M("`@("!T:6UE('1O('1I;64L('=E(&ES<W5E('-T;V-K('!U<F-H87-E('=A
M<G)A;G1S('1O#0H@("`-"B`@("`@("`@8V]N<W5L=&%N=',@;W(@;W1H97)S
M(&EN(&5X8VAA;F=E(&9O<B!S97)V:6-E<RX@02!S=6UM87)Y#0H@#0H@("`@
M("`@(&]F(&]U<B!C;VUP96YS871O<GD@=V%R<F%N="!A8W1I=FET>2!A<R!O
M9B!$96-E;6)E<B`S,2P-"B`@("`-"B`@("`@("`@,C`Q,2P@86YD(&-H86YG
M97,@9'5R:6YG('1H92!Y96%R('1H96X@96YD960@:7,@<')E<V5N=&5D#0H@
M#0H@("`@("`@(&)E;&]W.CPO9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R
M+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T
M:#TS1#$P,"4@<W1Y;&4],T0G1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*("`@(`T*("`@("`@("`@(#QT<CX-
M"B`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M)SX-"B`-"B`@("`@("`@("`@("`@("`F(S$V,#L-"B`@#0H@("`@("`@("`@
M("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VLG/@T*(`T*("`@("`@("`@("`@("`@("8C,38P.PT*("`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DYU;6)E<CPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/F]F
M#0H@(`T*("`@("`@("`@("`@("`@(%-H87)E<SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^5V5I9VAT960M/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D
M:78^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/D%V97)A9V4\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AE<F-I<V4\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0
M<FEC93PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9"T\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^079E
M<F%G93PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-
M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-
M"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY296UA:6YI;F<\+V9O;G0^#0H@(`T*("`@("`@("`@("`@
M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^0V]N=')A8W1U86P\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY497)M
M#0H@("`@#0H@("`@("`@("`@("`@("`@*'ER<RD\+V9O;G0^#0H@("`@(`T*
M("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VLG/@T*(`T*("`@
M("`@("`@("`@("`@("8C,38P.PT*("`-"B`@("`@("`@("`@("`@/"]D:78^
M#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N
M=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D%G9W)E9V%T93PO9F]N=#X-"B`@#0H@("`@("`@
M("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);G1R:6YS:6,\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5F%L
M=64\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\
M+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*("`@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^3W5T<W1A;F1I;F<-
M"B`-"B`@("`@("`@("`@("`@("!A="!*86YU87)Y(#$L(#(P,3$\+V9O;G0^
M#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C4Y+#0P,#PO9F]N=#X-"B`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-RXP,#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@
M/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^1W)A;G1E9#PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXW+#0P,#PO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+3(Y-B!S='EL
M93TS1"=-05)'24XM3$5&5#H@,S9P="<^/"]F;VYT/C$N-#`\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY%>&5R8VES960\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^+3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TR.3<@<W1Y;&4],T0G34%2
M1TE.+4Q%1E0Z(#,V<'0G/CPO9F]N=#XM/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&
M;W)F96ET960-"B`@("`-"B`@("`@("`@("`@("`@("!O<B!E>'!I<F5D/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BPT,#`\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TR.3@@<W1Y;&4],T0G34%21TE.+4Q%
M1E0Z(#,V<'0G/CPO9F]N=#XW+C`P/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@
M("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&
M.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN9PT*(`T*("`@("`@("`@("`@
M("`@(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/C8T+#0P,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
M+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+C`P/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,CDY('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`S-G!T)SX\+V9O;G0^,"XV/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3`M/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#1P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@
M("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY%>&5R8VES86)L90T*(`T*("`@("`@("`@
M("`@("`@(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT/@T*("`@("`-"B`@
M("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C4X+#@U,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^
M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+C`P/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,S`P('-T>6QE/3-$)TU!4D=)
M3BU,1494.B`S-G!T)SX\+V9O;G0^,"XW/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3`M
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#1P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@
M("`@/"]T86)L93X\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*
M("`@("`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D%D9&ET:6]N86P-"B`@#0H@("`@("`@(&EN9F]R;6%T:6]N(&-O;F-E
M<FYI;F<@;W5R(&-O;7!E;G-A=&]R>2!W87)R86YT<R!F;W(@=&AE#0H@("`@
M(`T*("`@("`@("!Y96%R<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2P@,C`Q
M,"!A;F0@,C`P.2!I<R!A<PT*("`@(`T*("`@("`@("!F;VQL;W=S.CPO9F]N
M=#X-"B`@("`@#0H@("`@("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D9&EN
M9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<^#0H@("`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*("`@("`-"B`@("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-"B`@
M#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R
M/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C(P,#D\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\
M+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T
M)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D#0H@("`-"B`@("`@("`@("`@("`@
M("!A=F5R86=E(&9A:7(@=F%L=64@;V8@=V%R<F%N=',@9W)A;G1E9"!D=7)I
M;F<@=&AE#0H@#0H@("`@("`@("`@("`@("`@<&5R:6]D/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,"XY-CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C0N-S4\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO
M='(^#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/@T*("`@
M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-
M"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^26YT<FEN<VEC#0H@("`@#0H@("`@("`@("`@("`@("`@=F%L
M=64@;V8@=V%R<F%N=',@97AE<F-I<V5D(&1U<FEN9R!T:&4-"B`@("`@#0H@
M("`@("`@("`@("`@("`@<&5R:6]D/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-
M"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@
M("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&
M.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#8T)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1O=&%L#0H@("`@
M(`T*("`@("`@("`@("`@("`@(&9A:7(@=F%L=64@;V8@=V%R<F%N=',@=F5S
M=&5D(&1U<FEN9R!T:&4-"B`@#0H@("`@("`@("`@("`@("`@<&5R:6]D/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C$L-S@P/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C$Y+#(S.#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^-BPT,3,\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@(#PO=&%B;&4^
M/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@("`@#0H@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*("`@
M(`T*("`@("`@("!U<V4@=&AE($)L86-K+5-C:&]L97,@;6]D96P@9F]R(&1E
M=&5R;6EN:6YG('1H92!G<F%N="!D871E#0H@(`T*("`@("`@("!F86ER('9A
M;'5E(&]F(&]U<B!C;VUP96YS871O<GD@=V%R<F%N=',N)B,Q-C`[)B,Q-C`[
M5&AE#0H@(`T*("`@("`@("!S:6=N:69I8V%N="!A<W-U;7!T:6]N<R!W92!U
M<V5D(&EN(&]U<B!F86ER('9A;'5E#0H@("`-"B`@("`@("`@8V%L8W5L871I
M;VYS('=E<F4@87,@9F]L;&]W<SH\+V9O;G0^#0H@#0H@("`@("`\+V1I=CX\
M8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I
M9'1H/3-$,3`P)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@("`@#0H@("`@("`@("`@/'1R
M/@T*(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,C`Q,#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,#D\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*
M("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&
M1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#8T)3X-"B`@("`-"B`@("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D
M#0H@("`-"B`@("`@("`@("`@("`@("!A=F5R86=E(')I<VLM9G)E92!I;G1E
M<F5S="!R871E<SPO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,"XY.#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXQ+C4T/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)3PO9F]N=#X-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@
M(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-C0E/@T*("`@(`T*("`@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AP96-T960-
M"B`@(`T*("`@("`@("`@("`@("`@(&1I=FED96YD('EI96QD/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C`N,#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/BT\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C`N
M,#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O
M=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E
M9`T*("`@#0H@("`@("`@("`@("`@("`@;&EF92!O9B!W87)R86YT/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#,@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,RXP#0H@("`-"B`@("`@("`@("`@
M("`@("!Y<G,\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&-O;'-P86X],T0S('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@#0H@("`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C,N,`T*("`@
M#0H@("`@("`@("`@("`@("`@>7)S/"]F;VYT/@T*("`@#0H@("`@("`@("`@
M("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@
M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V
M-"4^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E9`T*("`@#0H@("`@("`@("`@("`@
M("`@=F]L871I;&ET>3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`@(#PO
M9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3$U+C0V/"]F;VYT
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$Q,BXQ/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@
M(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@
M("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY%>'!E;G-E#0H@("`@#0H@("`@("`@(&%S<V]C:6%T960@=VET:"!C;VUP
M96YS871O<GD@=V%R<F%N=',@=V%S("0W+#$Q.2P@)#$R,2PP-3<L#0H@("`-
M"B`@("`@("`@86YD("0T-2PT,#$@9'5R:6YG('1H92!Y96%R<R!E;F1E9"!$
M96-E;6)E<B`S,2P@,C`Q,2P@,C`Q,`T*("`-"B`@("`@("`@86YD(#(P,#DL
M(')E<W!E8W1I=F5L>2XF(S$V,#LF(S$V,#M!;&P@<W5C:"!E>'!E;G-E('=A
M<PT*("`-"B`@("`@("`@86QL;V-A=&5D('1O(&=E;F5R86P@86YD(&%D;6EN
M:7-T<F%T:79E#0H@("`-"B`@("`@("`@97AP96YS92XF(S$V,#LF(S$V,#M!
M<R!O9B!$96-E;6)E<B`S,2P@,C`Q,2P@=&AE<F4@=V%S(&YO#0H@("`@#0H@
M("`@("`@('5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX@97AP96YS92!R96QA
M=&5D('1O(&-O;7!E;G-A=&]R>0T*(`T*("`@("`@("!W87)R86YT(&%R<F%N
M9V5M96YT<RX\+V9O;G0^#0H@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN
M=F5S=&UE;G0-"B`@#0H@("`@("`@(%=A<G)A;G1S/"]F;VYT/@T*("`@("`-
M"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^
M#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);@T*("`@(`T*("`@("`@("!A9&1I=&EO;B!T;R!O=71S=&%N9&EN9R!S
M=&]C:R!O<'1I;VYS(&%N9"!C;VUP96YS871O<GD-"B`@(`T*("`@("`@("!W
M87)R86YT<RP@87,@;V8@1&5C96UB97(@,S$L(#(P,3$@=V4@:&%V92!A('1O
M=&%L(&]F#0H@#0H@("`@("`@(#$L.#`V+#$U.2!O=71S=&%N9&EN9R!S=&]C
M:R!P=7)C:&%S92!W87)R86YT<R!I<W-U960@=&\-"B`@("`-"B`@("`@("`@
M:6YV97-T;W)S(&EN(&-O;FYE8W1I;VX@=VET:"!F:6YA;F-I;F<-"B`@#0H@
M("`@("`@('1R86YS86-T:6]N<RXF(S$V,#LF(S$V,#M787)R86YT<R!A<R!T
M;R`Y.#<L-S@S(&AA=F4@86X-"B`@#0H@("`@("`@(&5X97)C:7-E('!R:6-E
M(&]F("0Q+C`P('!E<B!S:&%R92!A;F0@97AP:7)E(&EN($1E8V5M8F5R#0H@
M("`@(`T*("`@("`@("`R,#$V.R!W87)R86YT<R!A<R!T;R`X,3@L,S<V(&AA
M=F4@86X@97AE<F-I<V4@<')I8V4@;V8-"B`@(`T*("`@("`@("`D,38N-3`@
M86YD(&5X<&ER92!I;B!$96-E;6)E<B`R,#$T+B8C,38P.R8C,38P.T1U<FEN
M9R!T:&4-"B`@("`-"B`@("`@("`@9F]U<G1H('%U87)T97(@;V8@,C`Q,2P@
M=V4@<F5C;W)D960@9V5N97)A;"!A;F0-"B`-"B`@("`@("`@861M:6YI<W1R
M871I=F4@97AP96YS92!O9B`D,34R+#$R-B!A<W-O8VEA=&5D('=I=&@@=&AE
M#0H@("`-"B`@("`@("`@97AT96YS:6]N(&]F('=A<G)A;G1S('=H:6-H('=E
M<F4@9'5E('1O(&5X<&ER92!I;B`R,#$Q('1O#0H@#0H@("`@("`@(#(P,3,N
M/"]F;VYT/@T*("`-"B`@("`@(#PO9&EV/CQB<B\^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P.&9D7S0U,V5?
M.31A95]B,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R+U=O<FMS
M:&5E=',O4VAE970Q,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/DYO=&4@-R`M(%)E=&ER96UE;G0@4&QA;CQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5N<VEO;B!A;F0@3W1H
M97(@4&]S=')E=&ER96UE;G0@0F5N969I=',@1&ES8VQO<W5R92!;5&5X="!"
M;&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/@T*("`@("`-"B`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SXW
M+B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.U)E=&ER96UE;G0-"B`@(`T*("`@("`@
M("!0;&%N/"]F;VYT/@T*(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/E=E#0H@("`@#0H@("`@("`@('!A<G1I8VEP
M871E(&EN(&$@;75L=&DM96UP;&]Y97(@9&5F:6YE9"!C;VYT<FEB=71I;VX-
M"B`-"B`@("`@("`@<F5T:7)E;65N="!P;&%N("AT:&4@)B,X,C(P.S0P,6L@
M4&QA;B8C.#(R,3LI(&%D;6EN:7-T97)E9`T*("`@("`-"B`@("`@("`@8GD@
M82!T:&ER9"!P87)T>2!S97)V:6-E('!R;W9I9&5R.R!A;F0@=&AE($-O;7!A
M;GD-"B`@("`-"B`@("`@("`@8V]N=')I8G5T97,@=&\@=&AE(#0P,6L@4&QA
M;B!O;B!B96AA;&8@;V8@:71S(&5M<&QO>65E<PT*("`@(`T*("`@("`@("!B
M87-E9"!U<&]N(&$@;6%T8VAI;F<@9F]R;75L82XF(S$V,#LF(S$V,#M$=7)I
M;F<@=&AE('EE87)S#0H@("`@(`T*("`@("`@("!E;F1E9"!$96-E;6)E<B`S
M,2P@,C`Q,2P@,C`Q,"!A;F0@,C`P.2!O=7(@8V]N=')I8G5T:6]N<R!T;PT*
M("`@#0H@("`@("`@('1H92`T,#%K(%!L86X@=V5R92`D-38L.3(X+"`D-3(L
M-C,R+"!A;F0@)#(U+#`U-RP-"B`@(`T*("`@("`@("!R97-P96-T:79E;'DN
M/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV/CQB<B\^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P.&9D7S0U
M,V5?.31A95]B,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R+U=O
M<FMS:&5E=',O4VAE970Q-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/DYO=&4@."`M($EN8V]M92!487AE<SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE(%1A>"!$:7-C
M;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@(`T*("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'
M2%0Z(&)O;&0G/C@N)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[26YC;VUE#0H@("`@
M#0H@("`@("`@(%1A>&5S/"]F;VYT/@T*("`-"B`@("`@(#PO9&EV/CQB<B\^
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!=`T*("`@(`T*("`@("`@
M("!$96-E;6)E<B`S,2P@,C`Q,2P@=V4@:&%V92!A(&-O;G-O;&ED871E9"!F
M961E<F%L(&YE=`T*("`-"B`@("`@("`@;W!E<F%T:6YG(&QO<W,@*"8C.#(R
M,#M.3TPF(S@R,C$[*2!C87)R>69O<G=A<F0@;V8-"B`@#0H@("`@("`@(&%P
M<')O>&EM871E;'D@)#<Q+C,@;6EL;&EO;BP@879A:6QA8FQE('1O(&]F9G-E
M="!A9V%I;G-T#0H@("`@(`T*("`@("`@("!F=71U<F4@=&%X86)L92!I;F-O
M;64@=VAI8V@@97AP:7)E<R!I;B!V87)Y:6YG(&%M;W5N=',@:6X-"B`-"B`@
M("`@("`@,C`Q,B!T:')O=6=H(#(P,S$N)B,Q-C`[)B,Q-C`[061D:71I;VYA
M;&QY+"!W92!H879E#0H@("`-"B`@("`@("`@87!P<F]X:6UA=&5L>2`D-S8T
M+#`P,"!I;B!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0-"B`@("`-"B`@("`@
M("`@*"8C.#(R,#M2)F%M<#M$)B,X,C(Q.RD@=&%X(&-R961I=',@=&AA="!E
M>'!I<F4@:6X@,C`R,@T*(`T*("`@("`@("!T:')O=6=H(#(P,S$@=6YL97-S
M('5T:6QI>F5D(&5A<FQI97(N)B,Q-C`[)B,Q-C`[3F\@:6YC;VUE#0H@("`@
M(`T*("`@("`@("!T87AE<R!H879E(&)E96X@<&%I9"!T;R!D871E+CPO9F]N
M=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY!<PT*("`@(`T*("`@("`@("!A(')E<W5L="!O9B!T:&4@365R
M9V5R(&1I<V-U<W-E9"!I;B!.;W1E(#4L(&]U<B!.3TP-"B`@("`@#0H@("`@
M("`@(&-A<G)Y9F]R=V%R9"!I;F-R96%S960@<W5B<W1A;G1I86QL>2!D=64@
M=&\@=&AE(&%D9&ET:6]N(&]F#0H@("`-"B`@("`@("`@:&ES=&]R:6-A;"!.
M3TP@8V%R<GEF;W)W87)D<R!F;W(@1&%U<&AI;B!496-H;F]L;V=Y+`T*(`T*
M("`@("`@("!);F,N)B,Q-C`[)B,Q-C`[2&]W979E<BP@4V5C=&EO;B`S.#(@
M;V8@=&AE($EN=&5R;F%L#0H@("`@#0H@("`@("`@(%)E=F5N=64@0V]D92!C
M;VYT86EN<R!P<F]V:7-I;VYS('1H870@;6%Y(&QI;6ET(&]U<@T*("`@("`-
M"B`@("`@("`@=71I;&EZ871I;VX@;V8@3D],(&%N9"!2)F%M<#M$('1A>"!C
M<F5D:70@8V%R<GEF;W)W87)D<R!I;@T*(`T*("`@("`@("!A;GD@9VEV96X@
M>65A<B!A<R!A(')E<W5L="!O9B!S:6=N:69I8V%N="!C:&%N9V5S(&EN#0H@
M#0H@("`@("`@(&]W;F5R<VAI<"!I;G1E<F5S=',@=&AA="!H879E(&]C8W5R
M<F5D(&EN('!A<W0@<&5R:6]D<R!O<@T*(`T*("`@("`@("!M87D@;V-C=7(@
M:6X@9G5T=7)E('!E<FEO9',N/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$969E<G)E9`T*
M("`@("`-"B`@("`@("`@:6YC;VUE('1A>&5S(')E9FQE8W0@=&AE(&YE="!E
M9F9E8W0@;V8@=&5M<&]R87)Y#0H@(`T*("`@("`@("!D:69F97)E;F-E<R!B
M971W965N('1H92!C87)R>6EN9R!A;6]U;G1S(&]F(&%S<V5T<R!A;F0-"B`@
M(`T*("`@("`@("!L:6%B:6QI=&EE<R!F;W(@9FEN86YC:6%L(')E<&]R=&EN
M9R!P=7)P;W-E<R!A;F0@=&AE#0H@#0H@("`@("`@(&%M;W5N=',@=7-E9"!F
M;W(@:6YC;VUE('1A>`T*(`T*("`@("`@("!P=7)P;W-E<RXF(S$V,#LF(S$V
M,#M3:6=N:69I8V%N="!C;VUP;VYE;G1S(&]F(&]U<B!D969E<G)E9`T*(`T*
M("`@("`@("!T87@@87-S971S(&%N9"!L:6%B:6QI=&EE<R!I;F-L=61E9"!T
M:&4@9F]L;&]W:6YG(&%T#0H@#0H@("`@("`@($1E8V5M8F5R(#,Q+"`R,#$Q
M(&%N9"`R,#$P.CPO9F]N=#X-"B`@("`-"B`@("`@(#PO9&EV/CQB<B\^/'1A
M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Q
M,#`E('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)SX-"B`@("`-"B`@("`@("`@("`\='(^#0H@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@
M("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N
M=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C(P,3$\+V9O;G0^#0H@(`T*("`@("`@("`@("`@
M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR
M,#$P/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\
M+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^#0H@(`T*("`@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5F97)R960-"B`@
M(`T*("`@("`@("`@("`@("`@('1A>"!A<W-E=',Z/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D<M3$5&
M5#H@-"4[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-
M"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^3F5T#0H@("`-"B`@("`@("`@("`@("`@("!O
M<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F0\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C0L.#<U
M+#$Q.3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(U+#$Q-BPY
M-3@\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG
M<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E('-T>6QE
M/3-$)U!!1$1)3D<M3$5&5#H@-"4G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@-
M"B`@(`T*("`@("`@("`@("`@("`@(&%N9"!D979E;&]P;65N="!T87@@8W)E
M9&ET(&-A<G)Y9F]R=V%R9#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@("`@
M/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW-C,L-CDP/"]F
M;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-S,Q+#(Y,#PO
M9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%!!1$1)3D<M3$5&5#H@
M-"4G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/E-T;V-K+6)A<V5D#0H@#0H@("`@("`@("`@
M("`@("`@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXQ+#DY,2PW-CD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,2PW-SDL.34P/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@
M/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-
M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-S8E('-T>6QE/3-$)U!!1$1)3D<M3$5&5#H@-"4G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-
M"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^5&]T86P-"B`@("`@#0H@("`@("`@("`@("`@("`@9&5F97)R
M960@=&%X(&%S<V5T<SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`@("`@/"]D
M:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-RPV,S`L-3<X/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(W+#8R."PQ.3@\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)3X-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT
M<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#<V)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D1E9F5R<F5D#0H@("`-"B`@("`@
M("`@("`@("`@("!T87@@;&EA8FEL:71I97,\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@
M("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)2!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X.R!0041$24Y'+4Q%1E0Z(#0E)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY$97!R96-I871I;VX\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@("`\
M+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L
M969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S@L-3@W/"]F
M;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^
M#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B@U,2PY-#4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R
M/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO
M<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@4$%$1$E.1RU,1494.B`T)2<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^5&]T86P-"B`@("`@#0H@("`@("`@("`@("`@("`@9&5F97)R960@=&%X
M(&QI86)I;&ET:65S/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I
M=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S@L-3@W/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B@U,2PY-#4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*
M("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-S8E/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E
M/@T*("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^3F5T#0H@("`-"B`@("`@("`@("`@("`@("!D969E
M<G)E9"!T87@@87-S971S/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\
M+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(W+#4Y,2PY.3$\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C<L-3<V+#(U
M,SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V
M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY6
M86QU871I;VX-"B`@("`-"B`@("`@("`@("`@("`@("!A;&QO=V%N8V4\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R
M:6=H="<^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B@R-RPU.3$L.3DQ/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#(W+#4W
M-BPR-3,\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-S8E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3PO
M9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H
M="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T
M<CX-"B`@#0H@("`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`@("`@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY790T*("`@(`T*("`@("`@("!H879E(&5S=&%B
M;&ES:&5D(&$@9G5L;"!V86QU871I;VX@86QL;W=A;F-E(&5Q=6%L('1O('1H
M90T*("`@("`-"B`@("`@("`@86UO=6YT(&]F(&]U<B!N970@9&5F97)R960@
M=&%X(&%S<V5T<R!D=64@=&\@=6YC97)T86EN=&EE<PT*("`-"B`@("`@("`@
M=VET:"!R97-P96-T('1O(&]U<B!A8FEL:71Y('1O(&=E;F5R871E('-U9F9I
M8VEE;G0@=&%X86)L90T*("`-"B`@("`@("`@:6YC;VUE('1O(')E86QI>F4@
M=&AE<V4@87-S971S(&EN('1H92!F=71U<F4N(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N
M=#Y!#0H@("`@#0H@("`@("`@(')E8V]N8VEL:6%T:6]N(&]F('1H92!I;F-O
M;64@=&%X(&)E;F5F:70@;VX@;&]S<V5S(&%T('1H90T*(`T*("`@("`@("!5
M+E,N(&9E9&5R86P@<W1A='5T;W)Y(')A=&4@=&\@=&AE(')E<&]R=&5D(&EN
M8V]M92!T87@-"B`@(`T*("`@("`@("!E>'!E;G-E(&ES(&%S(&9O;&QO=W,Z
M/"]F;VYT/@T*("`@(`T*("`@("`@/"]D:78^/&)R+SX\=&%B;&4@8V5L;'!A
M9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4]
M,T0G1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86XG/@T*("`@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,C`Q,3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3`\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E
M;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR,#`Y/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y
M;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0V-"4^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY5+E,N#0H@("`@#0H@("`@("`@("`@("`@
M("`@9F5D97)A;"!S=&%T=71O<GD@<F%T92!A<'!L:65D('1O('!R971A>`T*
M("`-"B`@("`@("`@("`@("`@("!L;W-S/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#<Y-RPY
M,C$\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Y,S0L,#DR/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PQ,38L-C0V/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-
M"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^#0H@("`@#0H@
M("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*
M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY097)M86YE;G0-"B`@("`-"B`@("`@("`@("`@("`@("!D:69F97)E
M;F-E<SPO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,S`Q('-T>6QE
M/3-$)TU!4D=)3BU,1494.B`S,BXQ-7!T)SX\+V9O;G0^,RPU,S8\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#<W+#(P,#PO9F]N
M=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q
M+3,P,B!S='EL93TS1"=-05)'24XM3$5&5#H@,C$N.'!T)SX\+V9O;G0^,38Y
M+#0V.3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@
M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E
M/@T*("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$
M;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^4F5S96%R8V@-"B`@(`T*("`@("`@("`@("`@("`@
M(&%N9"!D979E;&]P;65N="!C<F5D:71S/"]F;VYT/@T*("`@#0H@("`@("`@
M("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O
M;G0@:60],T1404(Q+3,P,R!S='EL93TS1"=-05)'24XM3$5&5#H@,C4N-#5P
M="<^/"]F;VYT/C,R+#0P,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^-3DL.34Y/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,S`T('-T>6QE/3-$)TU!4D=)
M3BU,1494.B`R,2XX<'0G/CPO9F]N=#XQ-CDL-C8W/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*
M("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)2!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#:&%N9V4-"B`-"B`@
M("`@("`@("`@("`@("!I;B!V86QU871I;VX@86QL;W=A;F-E/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-
M"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^/&9O;G0@:60],T1404(Q+3,P-2!S='EL93TS1"=-05)'24XM
M3$5&5#H@,3@N.'!T)SX\+V9O;G0^-S8Q+#DX-3PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXY-3$L,S,S/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M,S`V
M('-T>6QE/3-$)TU!4D=)3BU,1494.B`R,2XX<'0G/CPO9F]N=#XW-S<L-3$P
M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@
M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[
M)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-C0E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E)E<&]R=&5D#0H@("`-"B`@("`@("`@("`@("`@
M("!I;F-O;64@=&%X(&5X<&5N<V4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@
M("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3PO9F]N
M=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXM/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@/"]T86)L93X\8G(O/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?.3-E86%A
M.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T.#AA,38R#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+SDS96%A83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q
M-#@X83$V,B]7;W)K<VAE971S+U-H965T,34N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#D@+2!296QA=&5D(%!A<G1Y
M(%1R86YS86-T:6]N<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4F5L871E9"!087)T>2!4<F%N<V%C=&EO;G,@1&ES8VQO<W5R
M92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD)SXY+B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U)E;&%T960-"B`@("`@#0H@
M("`@("`@(%!A<G1Y(%1R86YS86-T:6]N<SPO9F]N=#X-"B`@("`@#0H@("`@
M("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^5V4-
M"B`@("`-"B`@("`@("`@87)E(&]B;&EG871E9"!T;R!R96EM8G5R<V4@16UO
M<GD@56YI=F5R<VET>2`H82!S:6=N:69I8V%N=`T*("`-"B`@("`@("`@<W1O
M8VMH;VQD97(@;V8@=&AE($-O;7!A;GDI(&9O<B!O;F=O:6YG(&-O<W1S(&EN
M(&-O;FYE8W1I;VX-"B`@(`T*("`@("`@("!W:71H('1H92!F:6QI;F<L('!R
M;W-E8W5T:6]N(&%N9"!M86EN=&5N86YC92!O9B!P871E;G0-"B`@(`T*("`@
M("`@("!A<'!L:6-A=&EO;G,@<W5B:F5C="!T;R!A(&QI8V5N<V4@86=R965M
M96YT(&9O<B!T96-H;F]L;V=Y#0H@(`T*("`@("`@("!A<W-O8VEA=&5D('=I
M=&@@=&AE('9A8V-I;F5S('=E(&%R90T*("`@(`T*("`@("`@("!D979E;&]P
M:6YG+B8C,38P.R8C,38P.U1H92!E>'!E;G-E(&%S<V]C:6%T960@=VET:"!T
M:&5S90T*("`@#0H@("`@("`@(&]N9V]I;F<@<&%T96YT(&-O<W0@<F5I;6)U
M<G-E;65N=',@=&\@16UO<GD@86UO=6YT960@=&\-"B`@("`-"B`@("`@("`@
M)#(T.2PY,#<L("0Q.3,L-C<T+"!A;F0@)#@U+#8W,R!F;W(@=&AE('EE87)S
M(&5N9&5D#0H@("`@(`T*("`@("`@("!$96-E;6)E<B`S,2P@,C`Q,2P@,C`Q
M,"P@86YD(#(P,#DL(')E<W!E8W1I=F5L>2X\+V9O;G0^#0H@("`@(`T*("`@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-
M"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E
M#0H@("`@#0H@("`@("`@(&AA=F4@96YT97)E9"!I;G1O('1W;R!S=6)C;VYT
M<F%C=',@=VET:"!%;6]R>2!F;W(@=&AE#0H@(`T*("`@("`@("!P=7)P;W-E
M(&]F(&-O;F1U8W1I;F<@<F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&%C=&EV
M:71I97,-"B`-"B`@("`@("`@87-S;V-I871E9"!W:71H(&]U<B!G<F%N="!F
M<F]M('1H92!.24@@*'-E92!.;W1E#0H@(`T*("`@("`@("`S*2XF(S$V,#LF
M(S$V,#M$=7)I;F<@,C`Q,2P@,C`Q,"P@86YD(#(P,#DL('=E(')E8V]R9&5D
M#0H@(`T*("`@("`@("`D,2PQ-S(L-S4X+"`D,2PS.3$L,C`S+"!A;F0@)#@Q
M-BPV-3$L(')E<W!E8W1I=F5L>2P@;V8-"B`@(`T*("`@("`@("!E>'!E;G-E
M(&%S<V]C:6%T960@=VET:"!T:&5S92!S=6)C;VYT<F%C=',N)B,Q-C`[)B,Q
M-C`[06QL#0H@("`@(`T*("`@("`@("!A;6]U;G1S('!A:60@=&\@16UO<GD@
M=6YD97(@=&AE<V4@<W5B8V]N=')A8W1S(&%R90T*("`@(`T*("`@("`@("!R
M96EM8G5R<V%B;&4@=&\@=7,@<'5R<W5A;G0@=&\@=&AE($Y)2"!G<F%N="X\
M+V9O;G0^#0H@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L
M:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/E1H<F]U9V@-"B`@("`-"B`@("`@("`@3F]V96UB97(@
M,C`P.2P@=V4@;&5A<V5D(&]F9FEC92!A;F0@;&%B;W)A=&]R>2!S<&%C92!O
M;B!A#0H@#0H@("`@("`@(&UO;G1H+71O+6UO;G1H(&)A<VES(&9R;VT@16UT
M96-H($)I;W1E8VAN;VQO9WD@1&5V96QO<&UE;G0L#0H@("`-"B`@("`@("`@
M26YC+BP@82!R96QA=&5D('!A<G1Y(&%S<V]C:6%T960@=VET:`T*(`T*("`@
M("`@("!%;6]R>2XF(S$V,#LF(S$V,#M296YT(&5X<&5N<V4@87-S;V-I871E
M9"!W:71H('1H:7,@;&5A<V4-"B`@("`-"B`@("`@("`@=&]T86QE9"`D-#,L
M,3$R(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B`S,2P-"B`-"B`@("`@
M("`@,C`P.2X\+V9O;G0^#0H@(`T*("`@("`@/"]D:78^/&)R+SX\9&EV('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN#0H@("`@#0H@("`@("`@($UA<F-H
M(#(P,#@L('=E(&5N=&5R960@:6YT;R!A(&-O;G-U;'1I;F<@86=R965M96YT
M('=I=&@-"B`@("`-"B`@("`@("`@1&]N86QD($AI;&1E8G)A;F0L(&$@9F]R
M;65R(&UE;6)E<B!O9B!O=7(@0F]A<F0@;V8-"B`@("`-"B`@("`@("`@1&ER
M96-T;W)S(&%N9"!O=7(@9F]R;65R(%!R97-I9&5N="`F86UP.R!#:&EE9B!%
M>&5C=71I=F4-"B`@("`-"B`@("`@("`@3V9F:6-E<BP@<'5R<W5A;G0@=&\@
M=VAI8V@@37(N($AI;&1E8G)A;F0@<')O=FED97,@8G5S:6YE<W,-"B`@(`T*
M("`@("`@("!A;F0@=&5C:&YI8V%L(&%D=FES;W)Y('-E<G9I8V5S('1O('1H
M90T*("`-"B`@("`@("`@0V]M<&%N>2XF(S$V,#LF(S$V,#M4:&4@=&5R;2!O
M9B!T:&4@8V]N<W5L=&EN9R!A9W)E96UE;G0L#0H@("`@#0H@("`@("`@(&%S
M(&%M96YD960L(&)E9V%N(&]N($%P<FEL(#$L(#(P,#@@86YD(&5N9',@;VX@
M1&5C96UB97(@,S$L#0H@("`-"B`@("`@("`@,C`Q,BXF(S$V,#LF(S$V,#M$
M=7)I;F<@,C`Q,2P@,C`Q,"P@86YD(#(P,#DL('=E(')E8V]R9&5D#0H@("`@
M#0H@("`@("`@("0R-"PP,#`L("0U-RPV,#`L(&%N9"`D-3<L-C`P+"!R97-P
M96-T:79E;'DL(&]F(&5X<&5N<V4-"B`@("`-"B`@("`@("`@87-S;V-I871E
M9"!W:71H('1H92!C;VYS=6QT:6YG(&%G<F5E;65N="X\+V9O;G0^#0H@("`-
M"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^
M#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);@T*("`@(`T*("`@("`@("!$96-E;6)E<B`R,#$Q+"!M96UB97)S(&]F
M(&]U<B!M86YA9V5M96YT(&%N9"!";V%R9"!O9@T*("`-"B`@("`@("`@1&ER
M96-T;W)S('!A<G1I8VEP871E9"!I;B!T:&4@<')I=F%T92!P;&%C96UE;G0@
M;V9F97)I;F<@;V8-"B`@(`T*("`@("`@("!O=7(@8V]M;6]N('-T;V-K(&%N
M9"!W87)R86YT<R!D97-C<FEB960@:6X@3F]T92`V+"!W:&5R96)Y#0H@(`T*
M("`@("`@("!T:&5Y('!U<F-H87-E9"!A;B!A9V=R96=A=&4@;V8@,S,U+#DU
M-"!S:&%R97,@;V8@;W5R(&-O;6UO;@T*("`@#0H@("`@("`@('-T;V-K(&9O
M<B!A('1O=&%L('!U<F-H87-E('!R:6-E(&]F("0R,C4L,#@Y(&%N9"!R96-E
M:79E9`T*(`T*("`@("`@("!F:79E+7EE87(@=V%R<F%N=',@=&\@<'5R8VAA
M<V4@86X@861D:71I;VYA;"`U,#,L.3,R('-H87)E<PT*("`@#0H@("`@("`@
M(&]F(&]U<B!C;VUM;VX@<W1O8VL@97AE<F-I<V%B;&4@870@)#$N,#`@<&5R
M('-H87)E+CPO9F]N=#X-"B`@(`T*("`@("`@/"]D:78^/&)R+SX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7SDS96%A83@W7S`X
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3F]T92`Q,"`M(%-E;&5C=&5D(%%U87)T97)L
M>2!&:6YA;F-I86P@1&%T82`H=6YA=61I=&5D*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^475A<G1E<FQY($9I;F%N8VEA;"!)
M;F9O<FUA=&EO;B!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD)SXQ,"XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M396QE8W1E
M9`T*("`-"B`@("`@("`@475A<G1E<FQY($9I;F%N8VEA;"!$871A("AU;F%U
M9&ET960I/"]F;VYT/@T*("`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^00T*("`@#0H@("`@("`@('-U;6UA<GD@
M;V8@<V5L96-T960@<75A<G1E<FQY(&9I;F%N8VEA;"!D871A(&9O<B`R,#$Q
M(&%N9`T*(`T*("`@("`@("`R,#$P(&ES(&%S(&9O;&QO=W,Z/"]F;VYT/@T*
M(`T*("`@("`@/"]D:78^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E
M;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T0G1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*("`@
M(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,30@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@#0H@("`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,0T*("`@
M(`T*("`@("`@("`@("`@("`@(%%U87)T97(@16YD960\+V9O;G0^#0H@("`-
M"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@
M("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DUA<F-H#0H@("`@(`T*
M("`@("`@("`@("`@("`@(#,Q/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@
M/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^2G5N
M90T*("`@(`T*("`@("`@("`@("`@("`@(#,P/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^4V5P=&5M8F5R#0H@("`@#0H@("`@("`@("`@("`@("`@,S`\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E<@T*("`@#0H@("`@("`@("`@
M("`@("`@,S$\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O
M=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X-"B`@("`-
M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@
M#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/E)E=F5N=64-"B`@#0H@("`@("`@("`@("`@("`@9G)O;2!G<F%N
M=',\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXX.3,L,#`R/"]F;VYT/@T*("`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ+#<U,RPP,S,\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,2PR.3<L,#`V/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/CDU-BPX-#0\+V9O;G0^#0H@("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@
M("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#4R)3X-"B`@("`-"B`@("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DYE=`T*("`@
M#0H@("`@("`@("`@("`@("`@;&]S<SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-C`V
M+#(X,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@R,3$L
M,S0T/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#,W-2PX
M-3(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PQ-3,L
M,S0X/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI
M/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/@T*("`@(`T*
M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3F5T#0H@("`-"B`@("`@("`@("`@("`@("!L;W-S('!E<B!S:&%R
M93PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-#PO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B@P+C`Q/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*#`N,#(\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH
M,"XP.#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@(#PO='(^#0H@(`T*("`@("`@("`\+W1A8FQE/CQB<B\^/'1A8FQE(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Q,#`E('-T
M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N)SX-"B`@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,30@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,C`Q,`T*("`@(`T*("`@("`@("`@("`@("`@(%%U87)T97(@16YD
M960\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\
M+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/DUA<F-H#0H@("`@(`T*("`@("`@("`@("`@("`@(#,Q/"]F;VYT/@T*("`-
M"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@
M#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^
M#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^2G5N90T*("`@(`T*("`@("`@("`@("`@("`@(#,P/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^4V5P=&5M8F5R#0H@("`@#0H@("`@("`@
M("`@("`@("`@,S`\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-
M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E<@T*
M("`@#0H@("`@("`@("`@("`@("`@,S$\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P
M>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@
M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#4R)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A
M;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E=F5N=64-"B`@#0H@("`@("`@("`@
M("`@("`@9G)O;2!G<F%N=',\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO
M9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#,S."PU-C`\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,2PW,S<L,38Y/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$L,38S+#(X.#PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY-#8L,C0P/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^#0H@
M("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T
M/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY.970-"B`@(`T*("`@("`@("`@("`@("`@(&QO<W,\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^*#8Y,"PW.#D\+V9O;G0^#0H@("`@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH.3,S+#`X.3PO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B@V-#0L-C8V/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^*#0W."PW.#0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\
M='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0U,B4^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-"B`@(`T*("`@("`@("`@
M("`@("`@(&QO<W,@<&5R('-H87)E/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@P+C`T
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#`N,#8\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-#PO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B@P+C`S/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@(#PO
M=&%B;&4^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7SDS96%A83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,@T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Y,V5A86$X-U\P.&9D7S0U
M,V5?.31A95]B,#,W,30X.&$Q-C(O5V]R:W-H965T<R]3:&5E=#$W+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`Q,2`M
M(%-U8G-E<75E;G0@179E;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=6)S97%U96YT($5V96YT<R!;5&5X="!";&]C:UT\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1L969T/@T*("`@(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/C$Q+B8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.U-U8G-E<75E;G0-"B`@("`-"B`@("`@("`@179E
M;G1S/"]F;VYT/@T*("`@#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=&
M3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0<FEV871E
M#0H@("`@#0H@("`@("`@(%!L86-E;65N="!O9B!#;VUM;VX@4W1O8VL@86YD
M(%=A<G)A;G1S/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$=7)I;F<-"B`@(`T*("`@("`@
M("!*86YU87)Y(#(P,3(L('=E('-O;&0@86X@86=G<F5G871E(&]F(#0P-RPY
M.3D@<VAA<F5S(&]F(&]U<@T*("`@#0H@("`@("`@(&-O;6UO;B!S=&]C:R!T
M;R!T=V5L=F4@:6YD:79I9'5A;"!A8V-R961I=&5D(&EN=F5S=&]R<PT*("`@
M#0H@("`@("`@("AI;F-L=61I;F<@-#4L,#`P('-H87)E<R!S;VQD('1O(&UE
M;6)E<G,@;V8@;W5R(&)O87)D(&]F#0H@("`@(`T*("`@("`@("!D:7)E8W1O
M<G,@86YD(&UA;F%G96UE;G0I(&9O<B!A;B!A9V=R96=A=&4@<'5R8VAA<V4@
M<')I8V4-"B`-"B`@("`@("`@;V8@)#(W,RPS-C`N)B,Q-C`[)B,Q-C`[5V4@
M86QS;R!I<W-U960@=&\@=&AE(&EN=F5S=&]R<PT*("`-"B`@("`@("`@=V%R
M<F%N=',@=&\@<'5R8VAA<V4@86X@86=G<F5G871E(&]F(#8Q,BPP,#$@<VAA
M<F5S(&]F#0H@("`-"B`@("`@("`@8V]M;6]N('-T;V-K(&%T(&$@<')I8V4@
M;V8@)#$N,#`@<&5R('-H87)E+"!W:&EC:"!E>'!I<F4@:6X-"B`@(`T*("`@
M("`@("!*86YU87)Y(#(P,3<N/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/DES<W5A;F-E#0H@("`@(`T*("`@("`@("!O9B!#;VYV97)T
M:6)L92!0<F5F97)R960@4W1O8VL@86YD(%=A<G)A;G1S/"]F;VYT/@T*("`@
M("`-"B`@("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE
M9G0^#0H@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY/;@T*("`@(`T*("`@("`@("!-87)C:"`R,2P@,C`Q,BP@=V4@<V]L
M9"!S:&%R97,@;V8@;W5R(%-E<FEE<R!!(&-O;G9E<G1I8FQE#0H@(`T*("`@
M("`@("!P<F5F97)R960@<W1O8VL@=&\@8V5R=&%I;B!I;G-T:71U=&EO;F%L
M(&EN=F5S=&]R<R!F;W(@86X-"B`-"B`@("`@("`@86=G<F5G871E('!U<F-H
M87-E('!R:6-E(&]F("0R+C(@;6EL;&EO;BXF(S$V,#LF(S$V,#M4:&4-"B`@
M(`T*("`@("`@("!P<F5F97)R960@<W1O8VL@:7,@8V]N=F5R=&EB;&4@870@
M86YY('1I;64@:6YT;R!S:&%R97,@;V8-"B`-"B`@("`@("`@;W5R(&-O;6UO
M;B!S=&]C:R!A="`D,"XW-2!P97(@<VAA<F4@*#(L.3,S+#,S,R!S:&%R97,@
M:6X-"B`@("`@#0H@("`@("`@('1H92!A9V=R96=A=&4I+"!S=6)J96-T('1O
M('!O<W-I8FQE(&%D:G5S=&UE;G0@87,@<')O=FED960-"B`@#0H@("`@("`@
M(&EN('1H92!C97)T:69I8V%T92!O9B!D97-I9VYA=&EO;BX\+V9O;G0^#0H@
M#0H@("`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T
M/@T*(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M="<^4'5R<W5A;G0-"B`@("`@#0H@("`@("`@('1O('1H92!T97)M<R!O9B!T
M:&4@<V5C=7)I=&EE<R!P=7)C:&%S92!A9W)E96UE;G0L('1H90T*("`@#0H@
M("`@("`@(&EN=F5S=&]R<R!A;'-O(')E8V5I=F5D(&9I=F4M>65A<B!397)I
M97,@02!W87)R86YT<R!T;PT*("`@#0H@("`@("`@('!U<F-H87-E(&%N(&%G
M9W)E9V%T92!O9B`R+#DS,RPS,S,@<VAA<F5S(&]F(&]U<B!C;VUM;VX-"B`@
M("`-"B`@("`@("`@<W1O8VL@870@)#$N,#`@<&5R('-H87)E+B8C,38P.R8C
M,38P.U1H92!397)I97,@02!W87)R86YT<PT*("`@("`-"B`@("`@("`@87)E
M(&EM;65D:6%T96QY(&5X97)C:7-A8FQE+B8C,38P.R!792!A;'-O(&=R86YT
M960@=&\@=&AE#0H@("`@(`T*("`@("`@("!I;G9E<W1O<G,@82!O;F4M>65A
M<B!A9&1I=&EO;F%L('!U<F-H87-E(')I9VAT+"!E=FED96YC960-"B`-"B`@
M("`@("`@:6X@=&AE(&9O<FT@;V8@4V5R:65S($(@=V%R<F%N=',L('1O('!U
M<F-H87-E('5P('1O#0H@("`@(`T*("`@("`@("`R+#DS,RPS,S,@;V8@;W5R
M(&-O;6UO;B!S=&]C:R!F;W(@;VYE('EE87(@=VET:"!A;B!E>&5R8VES90T*
M("`@#0H@("`@("`@('!R:6-E(&]F("0P+C<U('!E<B!S:&%R92P@86YD(&9I
M=F4M>65A<B!397)I97,@0R!W87)R86YT<PT*(`T*("`@("`@("!T;R!P=7)C
M:&%S92!U<"!T;R`R+#DS,RPS,S,@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O
M8VL@870-"B`-"B`@("`@("`@)#$N,#`@<&5R('-H87)E+B8C,38P.R8C,38P
M.U1H92!397)I97,@0B!W87)R86YT<R!A<F4-"B`@("`@#0H@("`@("`@(&EM
M;65D:6%T96QY(&5X97)C:7-A8FQE+B8C,38P.R8C,38P.U1H92!397)I97,@
M0R!W87)R86YT<PT*("`@(`T*("`@("`@("!O;FQY('9E<W0@86YD(&)E8V]M
M92!E>&5R8VES86)L92!A="!T:&4@=&EM92P@86YD('1O('1H90T*("`@("`-
M"B`@("`@("`@97AT96YT+"!T:&%T('1H92!397)I97,@0B!W87)R86YT<R!A
M<F4@97AE<F-I<V5D+CPO9F]N=#X-"B`-"B`@("`@(#PO9&EV/CQB<B\^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X
M-U\P.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q-C(-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO.3-E86%A.#=?,#AF9%\T-3-E7SDT865?8C`S-S$T
M.#AA,38R+U=O<FMS:&5E=',O4VAE970Q."YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-C:&5D=6QE($E)("T@5F%L=6%T:6]N
M(&%N9"!1=6%L:69Y:6YG($%C8V]U;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!686QU871I;VX@86YD
M(%%U86QI9GEI;F<@06-C;W5N=',@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1C96YT97(^#0H@("`@(`T*("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/E-#2$5$
M54Q%#0H@("`@#0H@("`@("`@($E)("8C.#(Q,3L@5D%,54%424].($%.1"!1
M54%,249924Y'($%#0T]53E13/"]F;VYT/@T*("`@("`-"B`@("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0G/D9O<@T*("`@(`T*("`@("`@("!T:&4@665A<G,@16YD
M960@1&5C96UB97(@,S$L(#(P,3$L(#(P,3`@86YD(#(P,#D\+V9O;G0^#0H@
M("`@(`T*("`@("`@/"]D:78^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P
M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*
M("`@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0V('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A
M;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&1I=&EO;G,\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*
M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\
M+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G/@T*(`T*("`@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:R<^#0H@#0H@("`@("`@("`@("`@("`@)B,Q
M-C`[#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX-"B`-"B`@("`@("`@("`@("`@
M("`F(S$V,#L-"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D1E<V-R:7!T:6]N/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I
M=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60G/@T*("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A
M;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E#0H@(`T*("`@("`@
M("`@("`@("`@(&%T/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^
M#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N
M=&5R/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D)E9VEN;FEN9SPO9F]N=#X-"B`@#0H@("`@("`@
M("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/9@T*("`-"B`@("`@("`@
M("`@("`@("!097)I;V0\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D-H87)G960-
M"B`@#0H@("`@("`@("`@("`@("`@=&\\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^0V]S=',-"B`@("`@#0H@("`@
M("`@("`@("`@("`@86YD/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@(#PO
M9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E;G-E<SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^0VAA<F=E9`T*("`-"B`@("`@("`@("`@("`@("!T;SPO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE
M<CPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-
M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^06-C;W5N=',\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<^#0H@("`@(`T*("`@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Q*3PO9F]N
M=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@#0H@("`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D1E
M9'5C=&EO;G,\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^0F%L86YC90T*("`-
M"B`@("`@("`@("`@("`@("!A=#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG
M;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%;F0\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&-E;G1E<CX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/9@T*("`-"B`@("`@("`@
M("`@("`@("!097)I;V0\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A
M8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*("`-"B`@("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z("TY<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`-"B`@("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M4F5S97)V90T*("`-"B`@("`@("`@("`@("`@("!$961U8W1E9"!I;B!T:&4@
M0F%L86YC92!3:&5E=#PO9F]N=#X@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D9R;VT-"B`@#0H@("`@("`@("`@("`@("`@=&AE($%S<V5T
M('1O(%=H:6-H(&ET($%P<&QI97,Z/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@
M("`@("`@("`@/'1R/@T*(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;3X-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^#0H@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O
M=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-"B`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;&QO=V%N
M8V4-"B`@("`-"B`@("`@("`@("`@("`@("!F;W(@1&5F97)R960@5&%X($%S
M<V5T<SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;3X-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#0P)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TS,#<@
M<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#EP="<^/"]F;VYT/EEE87(-"B`@(`T*
M("`@("`@("`@("`@("`@(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR-RPU-S8L,C4S/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^.#@Y+#,R,CPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^+3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#<S+#4X
M-#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C<L-3DQ+#DY,3PO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`\+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T,"4^#0H@("`@#0H@
M("`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*
M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SX\9F]N="!I9#TS1%1!0C$M,S`X('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`Y<'0G/CPO9F]N=#Y996%R#0H@("`-"B`@("`@("`@("`@("`@("!E;F1E
M9"!$96-E;6)E<B`S,2P@,C`Q,#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@
M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@
M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C<L,#DQ+#,S.#PO
M9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$L,38P+#0P-3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/@T*("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@
M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N
M=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@V-S4L-#DP/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR-RPU-S8L,C4S/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@
M("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#`E/@T*("`@(`T*("`@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O
M;G0@:60],T1404(Q+3,P.2!S='EL93TS1"=-05)'24XM3$5&5#H@.7!T)SX\
M+V9O;G0^665A<@T*("`@#0H@("`@("`@("`@("`@("`@96YD960@1&5C96UB
M97(@,S$L(#(P,#D\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO
M9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(U+#8W-"PX.#(\+V9O;G0^#0H@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#0Q-BPT-38\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3PO9F]N=#X-"B`@#0H@("`@("`@
M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@
M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/C(W+#`Y,2PS,S@\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@(#PO=&%B;&4^
M/&)R+SX\=&%B;&4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,"!C96QL<&%D
M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P(&ED/3-$:&%N9VEN9VEN9&5N="TQ
M,3<@=VED=&@],T0Q,#`E('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@#0H@("`@("`@("`@
M/'1R('9A;&EG;CTS1'1O<"!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3LG
M/@T*(`T*("`@("`@("`@("`@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX-
M"B`@(`T*("`@("`@("`@("`@("`\9&EV/@T*(`T*("`@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!S='EL93TS1"=72414
M2#H@,3AP="<^#0H@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*#$I/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@
M("`@("`@("`@/'1D/@T*("`@#0H@("`@("`@("`@("`@(#QD:78@86QI9VX]
M,T1L969T/@T*("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY$961U8W1I;VYS#0H@("`@(`T*("`@("`@
M("`@("`@("`@(')E<')E<V5N="!T:&4@969F96-T(&]F(&5X<&ER:6YG($Y/
M3"!C87)R>69O<G=A<F1S#0H@(`T*("`@("`@("`@("`@("`@(&9R;VT@<')I
M;W(@>65A<G,N/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*
M("`-"B`@("`@("`@/"]T86)L93X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?.3-E86%A.#=?,#AF9%\T-3-E7SDT865?
M8C`S-S$T.#AA,38R#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+SDS
M96%A83@W7S`X9F1?-#4S95\Y-&%E7V(P,S<Q-#@X83$V,B]7;W)K<VAE971S
M+V9I;&5L:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M
M;6EC<F]S;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-"B`\;SI-86EN1FEL92!(
M4F5F/3-$(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970P,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#(N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970P-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`V+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-RYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,"YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3$N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,30N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$U+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970Q-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$X
M+FAT;6PB+SX-"CPO>&UL/@T*+2TM+2TM/5].97AT4&%R=%\Y,V5A86$X-U\P
>.&9D7S0U,V5?.31A95]B,#,W,30X.&$Q-C(M+0T*
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary

        of Significant Accounting Policies</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basis

        of Presentation and Principles of Consolidation</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

        primary business is conducted by our wholly-owned

        subsidiary, GeoVax, Inc. The accompanying consolidated

        financial statements include the accounts of GeoVax, Inc.

        from inception together with those of GeoVax Labs, Inc.

        from September 28, 2006 (see Note 5).&#160;&#160;All

        intercompany transactions have been eliminated in

        consolidation.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Development-Stage

        Enterprise</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        are devoting all of our present efforts to research and

        development and GeoVax is a development stage enterprise as

        defined by Financial Accounting Standards Board

        (&#8220;FASB&#8221;) Accounting Standards Codification

        (&#8220;ASC&#8221;) Topic 915, <font style="FONT-STYLE: italic; DISPLAY: inline">Development

        Stage Entities</font>.&#160;&#160;All losses accumulated

        since inception (June 27, 2001) have been considered as

        part of our development stage activities.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use

        of Estimates</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

        preparation of financial statements in conformity with

        accounting principles generally accepted in the United

        States of America (&#8220;GAAP&#8221;) requires us to make

        estimates and assumptions that affect the reported amounts

        of assets and liabilities and disclosure of contingent

        assets and liabilities at the date of the financial

        statements and the reported amounts of revenues and

        expenses during the reporting period.&#160;&#160;Actual

        results may differ from those estimates.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash

        and Cash Equivalents</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        consider all highly liquid investments with a maturity of

        three months or less when purchased to be cash

        equivalents.&#160;&#160;Our cash and cash equivalents

        consist primarily of bank deposits and money market

        accounts.&#160;&#160;The recorded values approximate fair

        market values due to the short maturities.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair

        Value of Financial Instruments and Concentration of Credit

        Risk</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial

        instruments that subject us to concentration of credit risk

        consist primarily of cash and cash equivalents, which are

        maintained by a high credit quality financial institution.

        The carrying values reported in the balance sheets for cash

        and cash equivalents approximate fair values.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

        and Equipment</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

        and equipment are stated at cost, less accumulated

        depreciation and amortization.&#160;&#160;The components of

        property and equipment as of December 31, 2011 and 2010 are

        as follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory

                equipment</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold

                improvements</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other

                furniture, fixtures &amp; equipment</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,789</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                property and equipment</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">520,394</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated

                depreciation and amortization</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(271,953</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property

                and equipment, net</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">248,441</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expenditures

        for maintenance and repairs are charged to operations as

        incurred, while additions and improvements are

        capitalized.&#160;&#160;Depreciation is computed using the

        straight-line method over the estimated useful lives of the

        assets which range from three to five

        years.&#160;&#160;Amortization of leasehold improvements is

        computed using the straight-line method over the remaining

        term of the related lease.&#160;&#160;Depreciation and

        amortization expense was $84,131, $94,887, and $64,891

        during the years ended December 31, 2011, 2010 and 2009,

        respectively.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

        Assets</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

        assets consist principally of license agreements for the

        use of technology obtained through the issuance of the

        Company&#8217;s common stock.&#160;&#160;These license

        agreements are amortized on a straight line basis over ten

        years.&#160;&#160;Amortization expense related to these

        agreements was $24,886 during each of the years ended

        December 31, 2011, 2010 and 2009 and is expected to be

        $19,923, $10,000, $10,000, $-0-, and $-0- for each of the

        next five years, respectively.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment

        of Long-Lived Assets</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        review long-lived assets for impairment whenever events or

        changes in circumstances indicate that the carrying amount

        of an asset may not be

        recoverable.&#160;&#160;Recoverability of assets to be held

        and used is measured by a comparison of the carrying amount

        of the assets to the future net cash flows expected to be

        generated by such assets.&#160;&#160;If we consider such

        assets to be impaired, the impairment to be<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>recognized

        is measured by the amount by which the carrying amount of

        the assets exceeds the expected future net cash flows from

        the assets.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued

        Liabilities</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

        part of the process of preparing our financial statements,

        we estimate expenses that we believe we have incurred, but

        have not yet been billed by our third party vendors. This

        process involves identifying services and activities that

        have been performed by such vendors on our behalf and

        estimating the level to which they have been performed and

        the associated cost incurred for such service as of each

        balance sheet date in our financial statements. Examples of

        expenses for which we accrue include fees for professional

        services and fees owed to contract manufacturers in

        conjunction with the manufacture of vaccines for our

        clinical trials. We make these estimates based upon

        progress of activities related to contractual obligations

        and information received from vendors.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net

        Loss Per Share</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic

        and diluted loss per common share are computed based on the

        weighted average number of common shares outstanding. All

        common share equivalents (which consist of options and

        warrants) are excluded from the computation of diluted loss

        per share since the effect would be anti-dilutive. Common

        share equivalents which could potentially dilute basic

        earnings per share in the future, and which were excluded

        from the computation of diluted loss per share, totaled

        2,798,801, 2,013,522, and 1,866,550 at December 31, 2011,

        2010 and 2009, respectively.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue

        Recognition</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        recognize revenue in accordance with the SEC&#8217;s Staff

        Accounting Bulletin No. 101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

        Recognition in Financial Statements,</font> as amended by

        Staff Accounting Bulletin No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

        Recognition,</font> (&#8220;SAB 104&#8221;). SAB 104

        provides guidance in applying GAAP to revenue recognition

        issues, and specifically addresses revenue recognition for

        upfront, nonrefundable fees received in connection with

        research collaboration agreements.&#160;&#160;During 2011,

        2010 and 2009, our revenue consisted of grant funding

        received primarily from the NIH (see Note

        3).&#160;&#160;Revenue from this arrangement is

        approximately equal to the costs incurred and is recorded

        as income as the related costs are incurred.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

        and Development Expense</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

        and development expense primarily consists of costs

        incurred in the discovery, development, testing and

        manufacturing of our product candidates. These expenses

        consist primarily of (i) fees paid to third-party service

        providers to perform, monitor and accumulate data related

        to our preclinical studies and clinical trials, (ii) costs

        related to sponsored research agreements, (iii) the costs

        to procure and manufacture materials used in clinical

        trials, (iv) laboratory supplies and facility-related

        expenses to conduct development, and (v) salaries,

        benefits, and share-based compensation for

        personnel.&#160;&#160;These costs are charged to expense as

        incurred.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patent

        Costs</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

        expenditures relating to obtaining and protecting patents

        are charged to expense when incurred, and are included in

        general and administrative expense.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Period

        to Period Comparisons</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

        operating results are expected to fluctuate for the

        foreseeable future. Therefore, period-to-period comparisons

        should not be relied upon as predictive of the results for

        future periods.&#160;&#160;Certain prior year amounts have

        been reclassified to conform to the current year financial

        statement presentation.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income

        Taxes</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        account for income taxes using the liability method. Under

        this method, deferred tax assets and liabilities are

        recognized for the estimated future tax consequences

        attributable to differences between the financial statement

        carrying amounts of existing assets and liabilities and

        their respective tax bases.&#160;&#160;Deferred tax assets

        and liabilities are measured using enacted rates in effect

        for the year in which temporary differences are expected to

        be recovered or settled.&#160;&#160;Deferred tax assets are

        reduced by a valuation allowance unless, in the opinion of

        management, it is more likely than not that some portion or

        all of the deferred tax assets will be realized.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based

        Compensation</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        account for stock-based transactions in which the Company

        receives services from employees, directors or others in

        exchange for equity instruments based on the fair value of

        the award at the grant date.&#160;&#160;Compensation cost

        for awards of common stock is estimated based on the price

        of the underlying common stock on the date of

        issuance.&#160;&#160;Compensation cost for stock options or

        warrants is estimated at the grant date based on each

        instrument&#8217;s fair-value as calculated by the

        Black-Scholes option pricing model.&#160;&#160;We recognize

        stock-based compensation cost as expense ratably on a

        straight-line basis over the requisite service period for

        the award.&#160;&#160;See Note 6 for additional stock-based

        compensation information.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent

        Accounting Pronouncements</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There

        have been no recent accounting pronouncements or changes in

        accounting pronouncements which we expect to have a

        material impact on our financial statements, nor do we

        believe that any recently issued, but not yet effective,

        accounting standards if currently adopted would have a

        material effect on our financial statements.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EN3AE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 1,167,980<span></span></td>
        <td class="nump">$ 1,079,087<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grant funds receivable</a></td>
        <td class="nump">183,515<span></span></td>
        <td class="nump">474,275<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">66,508<span></span></td>
        <td class="nump">48,830<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">1,418,003<span></span></td>
        <td class="nump">1,602,192<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation and amortization</a></td>
        <td class="nump">176,206<span></span></td>
        <td class="nump">248,441<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Licenses, net of accumulated amortization of $208,933 and $184,047 at December 31, 2011 and 2010 respectively</a></td>
        <td class="nump">39,923<span></span></td>
        <td class="nump">64,809<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred offering costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">430,402<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
        <td class="nump">11,010<span></span></td>
        <td class="nump">11,990<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
        <td class="nump">50,933<span></span></td>
        <td class="nump">507,201<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">1,645,142<span></span></td>
        <td class="nump">2,357,834<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">138,339<span></span></td>
        <td class="nump">96,892<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump">125,869<span></span></td>
        <td class="nump">241,736<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amounts payable to Emory University (a related party)</a></td>
        <td class="nump">677,327<span></span></td>
        <td class="nump">182,980<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">941,535<span></span></td>
        <td class="nump">521,608<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments (Note 4)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 40,000,000 shares authorized; 16,442,611 and 15,654,846 shares issued and outstanding at December 31, 2011 and 2010, respectively</a></td>
        <td class="nump">16,443<span></span></td>
        <td class="nump">15,655<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
        <td class="nump">23,319,166<span></span></td>
        <td class="nump">22,105,747<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Deficit accumulated during the development stage</a></td>
        <td class="num">(22,632,002)<span></span></td>
        <td class="num">(20,285,176)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">703,607<span></span></td>
        <td class="nump">1,836,226<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#x2019; equity</a></td>
        <td class="nump">$ 1,645,142<span></span></td>
        <td class="nump">$ 2,357,834<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CurrentAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CurrentAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CurrentLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CurrentLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br> -Section S99<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Publisher FASB<br><br><br><br> -Paragraph 1<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 25<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Section 45<br><br><br><br> -SubTopic 10<br><br><br><br> -Topic 210<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Paragraph 1<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7<br><br><br><br> -Footnote 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 5<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net amount of long-term deferred finance costs capitalized at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 21<br><br><br><br> -Paragraph 16<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28555-108399<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredFinanceCostsNoncurrentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepositsAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 7<br><br><br><br> -Paragraph 11<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 4<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 57<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DueToRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrantsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Section 45<br><br><br><br> -SubTopic 10<br><br><br><br> -Topic 210<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Paragraph 1<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 7<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph b, c<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A3<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EXDBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="6">12 Months Ended</th>
        <th class="th" colspan="2">126 Months Ended</th>
      </tr>
      <tr>
        <th class="th" colspan="2">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,346,826)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (2,747,328)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (3,284,252)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (22,632,002)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">109,017<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">119,773<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">89,776<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">565,637<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Accretion of preferred stock redemption value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">346,673<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
        <td class="nump">772,997<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">750,532<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,298,665<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">6,359,739<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Write-off of deferred offering costs</a></td>
        <td class="nump">430,402<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">430,402<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ChangesInAssetsAndLiabilitiesAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Grant funds receivable</a></td>
        <td class="nump">290,760<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(153,954)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(8,953)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(183,515)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">19,122<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(4,215)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">254,671<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(29,708)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits</a></td>
        <td class="nump">980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,010)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,010)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
        <td class="nump">419,927<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">39,033<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">224,943<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,030,325<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total adjustments</a></td>
        <td class="nump">2,043,205<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">740,159<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,859,102<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">8,508,543<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(303,621)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(2,007,169)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(1,425,150)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(14,123,459)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(11,896)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(4,706)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(270,246)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(538,490)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">5,580<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">5,580<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided (used) by investing activities</a></td>
        <td class="num">(11,896)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">874<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(270,246)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(532,910)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
        <td class="nump">404,410<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3,020,000<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">15,526,308<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from sale of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">728,443<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Deferred offering costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(430,402)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(430,402)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">404,410<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(430,402)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3,020,000<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">15,824,349<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
        <td class="nump">88,893<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="num">(2,436,697)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">1,324,604<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">1,167,980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
        <td class="nump">1,079,087<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3,515,784<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">2,191,180<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
        <td class="nump">1,167,980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,079,087<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3,515,784<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,167,980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_SupplementalDisclosureOfCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 5,669<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr>
        <td colspan="9"></td>
      </tr>
      <tr>
        <td colspan="9">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">Supplemental disclosure of non-cash investing and financing activities: In connection with the Merger discussed in Note 5, all of the outstanding shares of the Company's mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ChangesInAssetsAndLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ChangesInAssetsAndLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_SupplementalDisclosureOfCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_SupplementalDisclosureOfCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of amortization of deferred charges applied against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDeferredCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDepositOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or  income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18, 19, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of accretion of the preferred stock redemption discount during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockAccretionOfRedemptionDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001437749-12-003067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-12-003067-xbrl.zip
M4$L#!!0````(`(M:?D"#..^'UW4``.K8!P`1`!P`9V]V>"TR,#$Q,3(S,2YX
M;6Q55`D``S;/=4\VSW5/=7@+``$$)0X```0Y`0``[%U;;]O&GG]?8+^#U@LL
M=H'C>.Z<\28&?)+V(-TV">)VSWDK:&IL<RN3.B3E./WT.T-:%CD2Q2$Y%&6#
MZ4,3B>+\_O?+W-[^V^GI[&\RDHF?R?GL^OLL?/^?V?U_S4YG[^/[Y540SCY&
MF?HVR,('J3Z+'F2B_JV^O\NRY?G9V;=OW]X$ZM$T"!.9QJLDD*G^8'9Z>C'3
M?_[U7][J0=XG4@]Q/OOU;C7[Q4]F2,P`."?DG(+9;[^^GR$`4?$C]8O'ZV0Q
M>[Q?1.F[D])`^N,W<7)[A@#`9V&49GX4R)/BR7/];=CR^?GF!^6'V5GQY?K1
MV_CA\?G!6QD_^(^:2/4HA!!AN'YNE9YFWY=R@_K&3Z_SEZZ_R7]R"N#IYD>+
M,/IC#VS]];6?;F`O]CS\CY_5TR4TM[Z_W`E&?[$#2YC&!$%O'Q>+)]8_F$N#
M@ZD,WBAVG:DO=KS_<8O8;SA_-Q1"G.7?/C^:[GI.88!G__CEYZO@3M[[I\\R
M72O;;/96O^0\S;__*F]F^4O/-?/?G:3A_7*A.9E_=I?(FW<G6K:G:T&^>4SG
M)V<7Q8N"6.G^8S8+Y^].`O#[9?KY!L,/,M`/%P/JQ]2#,LK"[/O%\P?JHW"N
M/[P)E:WD4&2%F#63WG_\GY,+H/YPC`@7;\\V/RN__VPSP/JCI4S">%X=,N=%
M=I%S'2+%];=GZ\^>W[3Y74'CV1.1ZS=5B885HL%Q$PT<$8U^_S&)[^%/?J0Y
M^6M\S#)7A";9!^59+]:V!A0#-I_.9N6G933?//O$K/5G'9F%R\P"&V8=HZY4
MF`5:,`LX8A8I,0N(9V8!<>3,`L*>6>I9-\RB.;.0]]-*<VO;#H^878I7[!1Y
M!S5$5L,NH'SX?!YF81SYBR]^./\8O?>78>8O?I'WUS(Y*#,UH^3MO=PXY_RS
M(MDZEX_+11B$60%L-@_5@ZG"_>[D*6$YO\H4A_3/?_CG2N'4.6H<J7^FEX]A
M>G*Q?FPOP6_/=@Y7H?GL&>5AM`"XT@*O5@M>D]$X8Q>O-YJO,O/#2,Y_\),H
MC&[3DK6\*EO936>MD;Q\$Q'EG-;..[XJ@8_F'#>I.G!6GP!#F)/5#F.U0\@.
M5F5WC`%J"+++Y25`FY"#?E?"OH^CJRP._GBM>KM%XH$"#6I1P"!'@0;B6DE/
M&?DH&?DH6D#JM.`8'=[X[**U1C/%]M?J*%DE$Y@"X6"Y&W*5Q'B&Q*:`-D(5
MY4R:W)#FY&E?CB56VQE'F50,0#8"Y30!;]($/`6/X9(#W"(YP(Z2`P1K)3T%
MG5&JJ%&T`-5IP3$ZO/'9A6N-9HKMK]51DDHF,`7"P7(W["J)H8;$IH`V0A7E
M3)K,D.;D:5^.)5;[&4>95`Q!-B^G"623)I`I>`R7')`6R0%QE1R(6DE/06>4
M*FH,+<"@5@MR,[A:7:=!$BXU=[[*0(8/_O5"OKJ5,'K%_WDCP7LTX36H`JQ3
MA6.,?>.S"]5:SI3FO=*8B7$E*9QRHL'2>.(HG\7$D-B4VXQ04#N3)C6D.>4H
M!\U1AA`I,T0Z!<^7XURK/9*CS!.'(+O2(Z&;S(]._FC$FHFV2`BIJX10U*G"
M,=K"Z.PBH-9R)K=_@)II%)E7-W70J68:*JQ31_&-($-B4\TT0LWD3)K8D.:4
MHXQ5,SD3*3%$.@7/E^-<JRV,H\P3AR";E3,_MLG\V.2/1JR96(N$D+E*"+TZ
M53A&6QB?7;S6<J9,>K!*:11)BUI)3QGX*"LRQM`""FJU8$KS7JGETVJ/9/+L
M@Z7QS%$^2Y$AL<E#C]`C<29-;$AS\K0OQQ*KS9"C+"*&(+MR*H:W21.\*7@,
MEQQX+9(#SU5RP&HE/06=4<J"4;3`J]."8W1XX[.+UQK-%-M?JZ.L'GPQ!<+!
M<C?/41+#@"&Q*:"-4$4YDR8TI#EYVI=CB=5^QE$F%4.073D5@V_2!#X%C^&2
M`]XB.>"N+D,@M9*>@LXH5=0H6D#KM.`8'=[X[&*U1C/%]M?J**N;.J9`.%CN
MQETE,=R0V!301JBBG$E3&-*</.V+L42OVL\XRJ1B"+(K)T>4;[&;@L=PR<$8
M-_!YJ%;24]`9I8H:10MPK19,P>JU6GYUF<7DV0=+1H2KJ$P-B4T>>H2RP)DT
MF2'-R=.^'$NLME3$D9<%SL@NK\&HW`0^!8_!DH-1;C'W1*VDIZ`S1EDPBA9P
M4*L%4[!ZI9;/*VL^)L\^6#*RD5C/J,R1(;')0Q^^+'`G36Q(<_*T+\<2RTM2
M(-S$2SAYT>&B)&P1):&K*$EK)3UYWU'RXU&T@-5JP>2U7ZOE5UH_DV<?+BI#
M5U&9&Q*;//0(^;$S:0I#FI.G?3&6*)Y6TX!?_$2]]L@O,E8T`WR*07^RGUHJ
MX*=5GB<<.=DJI+*.9*^BL*!YE<[+%G@O_725R(LPC0F"WOEO5Q_>GJT_G&W>
MIW]?^G?Y=5]D<G7G)_+D&<X\?%`45ZC0/_BTNI>)G\7)Q:QLCHT0-@9COJ7Z
M_@\RBN_#:/W=KC&T28;GJ8:;[J!S,XKYKF=.;VAKX$PQR(8I#1!VOFP11G^<
MW\1Q%L69_%G]8_:8?Y1]7RK-4_)5*9.<GSQ]FL2+JC[JH=[$R>T9`@"?Z:_/
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M+[G?^!@%B=)#J0)W_O_3`-653^O7WBE2WYW\N[/7GEWL5,G+I$J<GP1K!.JO
M#3KY],39C=*54U,W;Q00]VS)XHVZQ\E<)N].<MH.(#)<-R/43V3UKWT9(FMD
MRX@B(W5K^_J)K/ZU+T-DC6P9461%=Q%Y><((W'G&/>_=(NQ(Q=;,FGJY/:4_
M6_G.)G]=-SQV0KK,WOM)\EU%\/_U%RLYTVG45RT&G>W.GG+A_(,`5(O4D]E<
M!N&]OTC?G8"3"PB9)[C*L%N-=^$:I#'3:X($G@#<ZPGR;XFJ(-+-><@]F,8Q
MA70#QWSS1L!=QM[/"^(1Y+4:^TLBEWXX_^%QJ<I]J=CV6:5ZR:5*$+/T_4IE
M;U'6G16,4<`W:"S&NG"*KH%9G&/0!YTC+D$"N?)!&R3&F*;(')$/&4!0(.MA
MOR2QJJNS[U]4T9(I]FC;6NIJY9/L0[S'$&!E*=2/LN7^ND+:SQA$."&P(Z0?
M0S6L<M8/4L4$54?=ZE*HX&PO/F$A4$E%]@]SX0K3?D8QPH%PC^DR"%;WJX6O
MBL3+^U@5DW_Z>27;F7<(<('MF%<SMADMW*)OL%-.`/%<HO_P5)?_F+</Y/LX
M51**HZ"P_%XJ03`@H.13&H?:,J`/<AFGH:*E4)SG9_MD,0IG&=+N`;8]7A<H
M#;*$0G2"4HI%+EA"0<4@=KY]2S*M,>SG!04>`M`"Q*[HUT,;&*&0;(6]<L_2
M>J2&.(*IQS&Q&2D(XI6N)?SO.DOKGU%@CG'),^]^OYG-M`:QGWS!>"6[J,&P
MBQG)2LY_#OWK<)&W-/OS`U'.JOS8/83I*3MA:<HNH(=9!RP?5O+7^*O,O?L7
M/W'"&.9Y&)5B2_T8.[QC)SQ-L0Y5ZLTV>%PJC""0XE(=M5,Z?89O<(U()>>\
MU?!ZZ4.8W>>5KJI]U5BJTI51H'[2B@V/Z7D4+MZ=9$HIR\V(GN-LT6LSSM-2
MCKY-#$9(*=:9+][)2=N1&[29,DJ[C:R4_7.23[C/\V?7LXH5,,]3C=;LP"<7
MX`TH1UV+,?<*IP_0/=QS#S1_(KU<97=Q$OXIYQN`3U.3UDS\^.E'E>B"XL].
M@.98^R3=$M<>G@V!ZV.:KGKS2EL@8G"W,,OC[,@&NB%JXI*V3%7E,R>(/I=F
M3`=G5&DPM]@L6(819:0SMIK%7:6W]*CP,88"LG):U3C:5J[7"U]#TH<@H%ZY
MBF^/[X-\D(LX;SPIWW<K?U"C)\LDU),.-WI%5:GZ_[!*E!#,7_3@+U+"!]7"
MOB^:BT.2UR`>@#B%'AN0O%RD=_%B+I.T6#_771H>P`R4=&G[W5N.O=WP34DZ
M9DHAFL:O38]5WNB2&UL%?=-0IF'U@=:R`]`6VE>E5-%*ZIG$8BIG'Y8]RS&,
M>0\A."\EIENC](*Q9XE!M<B!G"+J#05CS[1YM;'.&(=B,&[LFP8V?!"&D)4[
M)KN`;$%)I9\$>KJSY'^>IK"<Z`KR&/8JW-DSXH4C=+8J1#R!!64'1F>K600P
MSC@Z,#I[A5,)'6">/??,66L9R<1?J(<OY_=A%*99XF?A@W2H?4AXB)9+Z(8Q
M=V2=/5#::B&&#,&RES\H2EMM1`*JBF<L7EIKI<K"B,>H:(.S.DNQU.NA54+V
M]+V3D.GIA>OEQ0);H_2"8:MIGG)V0`P&PU:5F."8EMO&;F%8ZPK!2*57Y3[M
M+B!U4#Y&07PO?XY3)QIRBC`1@.S"LAFHEBUV6&S5Y!1Y'N"5"3[G6&QUY515
MYA1C-"06:X4Y14@PQD@C9PP\'_-5]SH8%D]]U-6@^L1)C$.PY.SJ1MJ*OET@
MV>J/*EL`M</4'Y1UG@Y!>69H6%#6&H6)2MNM8!F8BH]=1D[*6$61*B,8XW^*
MH[BJ^"ZSMHI&UPZU(\'H!*NC5N_!U1]31Z4>%).]3F/"RNO?]DJPBDMF[J.J
M*J%*-4IEB%TJ9`NA13`E'D9\``CV,11Q@B@:`$*;T&FV@$T0%03KW;_KN;F_
M^FD8Z,(R7*RR\OQ-_?2@E9(@!0V\*:^W;ACYPCE.*TUZPLE'Q&FE;@5.A$;$
M::>3&BAZ4YXK:P1:1?IW&=[>Z962#\JWW<I/*[W3\//-UE16_IJ&R3,K57V:
M1O,PI67WV@K'=GKCD@PK37Z>0(6XO$;EB,BP4O0G,J"`JH@\2C+L[*"@`WB`
M\/(>@O9T%(3<Q@^/YY?S_UL566SZ:UPW4[F>L(RR)+Q>Z2<N=3R0RZ;ESJR&
M+M!TXHFY[^?MF2.TAZ7?JZ7_(!2VSA%XO;QJSC0Q4@?H`2KV92_=<%GSL1E`
MK]G2ZK5)[96XS31JR]E)8$#K)B_W\\O5^WIWRHLW`M@%H5BU4\S(%SLS"X_W
M27[+OTH;?"ZL7#.#-CJ%=IR?97IA%4B$H,3`W0AI-S.W?Y:O==M!R`[^=J1"
M5\F>,%6R"<D`^'$M_C;&I:I'U)X8QZ20.E*VYC*[\+V%"7Q9)<&=G\K/-^;&
M!O>6H+(1BFT-P0360@3U-#DU"J_<.&J#9RA2W-@')%PEP,=%F:VY*.R<FFN0
MNF&W3C@@K66[76!ED$/L.4^$K)G6#,!T*"V6W%:OB;'Q$I@(HL18$F)EY6V?
M!*,5F+R/+TP3M\HW[!%Y!J)VADHY,0W5;:;(#7AV"NUQ[B$Q9*983:ZW%1H+
M]=\8F2(JWSD!\,;HL(7F0X1$I>TP5J;8E0I0T#!ZIHA@+?XV!H:4@6$^?N*+
M4!TYVX`%`[WY;S]A@VOY;.<I!/$X(,Y#GS7#F@%T#WVH>D.AC0,@'L)>>;^"
ML]#7#DQ>>"`S4W<;^A`U$+6R3`8(0LVQKQ=`9@"T;9-@1G%S\.F#K)HUF$JM
M@B^!S7V236-S;YAY.C>IV-"SNDZ#),Q[A[L.)MIM!^5KUP#9&".Q"8F$*UG3
MIXYG3Z`7%D3GKK$-S3O$TY'@HG[!^VFUQ'<H4D4MJ:W,67!.]/;WET,Y!K64
M[WEC34/*H\7FS!=$/JPC?VM]C1!ZX8\3TLQCG@(IYZG&H=^I3Y+Y?&.Y,<^A
M^-;"L\:UZ\"J'I382J(3SN$ZB;W"`A'$HH=;UTBTI:MUGZJ'YR>66?LAJ7'C
MW(40W=N)@Q%G;3;0V#A_B)8B1K6<MTM"$::0[U^=UA&9+=L:(70MJW#EACDK
M;\$0I9Z``Y15[<"`'$KS%ME>B(B!J(VI4B90Y8B9(0!2`V#[=,D\RV((E,Q`
M:6=W!'".V:`]65PM_K;L#G-!1.,V<*<92"7JT8U/H*UE"RGHG:3THT74T>(&
M:=<UP:"6Q99="08AX'M73'<,"+8,:X30-2"0ZK(1.FI`:`?F$`&!(`/1L04$
M@@V`K0.":8KNG2XA!D8[JU/L$X0T.^,^R*KA=,OJ%&\H;SL5ULN%DO*UDH!M
M/`)K+=E./M8A)5X=)2YPMBBMW^?7X^A[U_1;GN_2N9*!>C0+&V<E":\5B<5\
M/*6`6U1PEE!;+!%I0?8.X76D&>046Q:LQT.MJ*6VW<)33Z_A?VG$V]JI(H]"
M:+D^R!%Y3Z?K!<K7IKD<!C56@JG@PM98RZBL75+.G-WT.+5"@IEEV^4`9#@R
M+P_P_*[#(Z'*VFX\B+AMAW(W;KOYNX5,T[_[B3[7Z(='F01APX;:[MI%&4?6
MTXH[8%W8$/8\L7%`NCS+N9:#T^3&A$[[$=AQ/RRHQ6Y9"'!2.8?2T3H7:P-N
M!M!]G0NMEKPV40H2A#"FM6L\^Q1$[>"``DS#4I<^<)`!IXVR<^(5JQ\&++\I
M-@!:+EI&NM$YZ#(76BVZ39U&"&"TE<P=9)4GK2SY]C9VY]FD:(!MKXZU6>3I
M=E%A5QKR(^S,EH;%$D/'Z%DM^C8&I@]IH\34XL.O\*1>'3D[``LZU)+40N?R
M+S_G_9ET'3D;@T`?BT#$LZU8=F)KEQTWD.?44LQ5>&T@#4V5&PLB0C0O6!^/
M2%N[HM9S_)9DV&S.SE7ZVE>_UY=HRRCUBYYH43_)*YD\A($LQOXJ@_@VRM_2
M>/^$(]%""E715SD]?5B:S*N'QF2AK>*,S23[&H;7*H7EW+:^HT@,,(5HS>M&
M")U+F.I^(IN8!8F^^&"@$J85'%"`:4C%>\!AP(#3RHE@2#DC#<O1^Z"#!CK+
M"7%`5>:WM5?&;6W%JL6?J<^($8^S42H85MFYPS<VQVUTWV/P""J8KC04YPF/
M7<$P4HN^G7TQPK?Z%X>O8!BM(V<;L'VRU;&"R2^-'-0",$`6)V*4T+1+=`T"
MW.H^MF3^(+C=:#T!5&PMLSLD&;;:3@`#%M-Q^X!:)Y1_-1/*<JG2F%P>PE=Y
M@L/*C9N'(6WGM5/C,]7:8[XLMCW-N9B)]W!:11@O;])NC;%#V6E/H[60'5.Q
MOXNV4SD&#9A6FRCVH6N3@#71YS:>VC:.QB#+C8EY6-B>_S4*E;9&YA'[-I\5
M'=8]#L9J!6%7KV(/<<CW'M+3$9DM\QHA=.V^L.J.!BMW0@3APO.&Z+ZT@P,*
M,`U]A#YPN`&G56QD0E]HVM!BZ(-.&.@LNR\$44S%L"O?O6K?RM1GY`&55W5J
M`/6I.[W*#KKR.<0V,V60(8NZ9[BZLRMZD&,?KV#S4"WNEE,BPN.6W98-'0X)
ML;T=`%)DOV_5X'CSHK@?XT0OL?IM&4?K.;#/-_DOUEM@GW+3(8V!,)1?`N$0
MKGGD\SZF=>"!4WLBS.:HD",FW9%)$B$HMED4V((5!V2#O4$#RT-"NHC\B/HB
MKO0"(7UKX$OIF@S,5&LM&Y-KP[5A'.D4H03`7CV:8<FTOH/6!1T#MYOZI0:T
M=[=IP'Y%CZ!ON35K#*+<F!B&VV?N'E&KR?X*-QL-M)>5_?47N%8,EHVFYEO%
MNC9ZO.J";AM#AE0OLRD')'>-GG9P0`%FN&4V'C7@M#I!#R+&&K>:]T''#'2V
MIV&JW)R384\0\*H=NRU;]`A!V/;BD.9J\F/T<RA7GV]TDOW%_Z[C9I/BE]?>
M5:[0LCH5NC'MK\75IJC;2]8.IG>D*4\R+:J8`U,C:JEIM6%'"'UR_9$19WNI
MI;`L,.O0'UO1XTBHU*.,H1=2$@W,4EM5&I%G`U:1;O0)(@BHYVZJWRF-M@)V
M0,0ABLA>@1?TKR('K;AZ1.`CGLUWY;5QY>;+8Z/2VI%BOK7+=H"BO]#BKU*?
M>%)L<;I:+L+&0WQ[V=<I@K9WG6P#Z^3I-[\_@`*>:A?9,@(^X^L8_*WHL[[C
MO"\!W3H8'-2RW_+PV^:KV;MV,'AELXE=%*&,ZC480W0PVL$I.ABTX3B!/G"0
M`:=5!R-/*`;L8'!LH+/4)H`XW=XO<I!=.KS<;JS<(&YSR"7EU/J0].'VN72E
M09^-23M<9>08/:U%WVKBB`#K,^6&(\;J/OH<;=7S6Z(]MEK5E>P8]NA4_K?3
MH/%X-EQI[$B?(!6(T",M_VT%[("(`Y3_O>(G1%42N]7_0]:0/4*KS?[=_;7Q
MH(0YLC0BN,7),N/1:6]M]FLY'6]<X*Q6%+97D1"6+],<H!JKS/O9&34C!#%8
M>_1[KP*C%1Q0@!EN/IES`TZK:@QC*."`&P>X,-!9:A-B&`%@.YF[?NB#7";J
M/;DIJ+\OI/[+932_O(^3+/S3G:$"`6"IA+49=]L$^J*U[N%#X7EX;+2V2VKT
M?A_6'JQ3K$5<0MY/*PUVCR)01AGNH@CF\?7R1B:)+*[%NPR")/_AYYNO<B[O
M\ZSX0Y@&\6K_!+`U;.6K65DC6HQ?X\D'B8>>AX0P-W\U=KX'Z]%[%-#*^I)A
MX-BOX16<50YQMYO?:`W(6JT8IL+#XO_9N_+FMHTE_U6F]N6EY"K2X2F1UCY7
M49?-C2*[+"79[#];(#`DYQG$,#@D<3_]=O?@&`!#$J)(60==E9@F@9F>/GY]
M##!=@:)":J-9QY?Q6:R+IW#S9$N5CG:CHSN3E1.:GM[=E,#*K'L@A3GJ(,SR
M.3`91J:_AUJ_C:VPK][J-X[T4]I7SK@MZBJ[MVZ[W^U4)JXDW(T)K.[1NNT'
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M.]V-^5XL&:L7<G`;'ANQ^1R&@1O#Q5?7\D+PE;A),E_WRE#E#8]F3S_%J?KD
M.Z.\<E9]U-B<\!W073GF.VJT.AM2O@.RJ^^(M'L=_1#!!W&\L"F2==>]MES^
M9;Q31>EV>TM:^ZZ9O,CO[9!=G>&;TUT)$(?>+0]VX#\+D%)]]FIN_X%D5]62
MWE%G,YIWPNSJM;@"FCR(\AT07MUM=MNM?G.]QZ_"\T<U":]<3VET.LTE!FF<
M=,N]S*L>7-%H/;J7^:,(K5XHZ'9;AVV]\EJ!U`IT%O:\/4=]P>''[1%_U.KE
MGOW9C)0E'CT^[2L9YU0&6]J(*.Q%KIJOK+T;$K?Q3NDZZBK!UX7PX*:M.[DB
M&%2?O9J3>R#9E5/$(H\?0O<N"-\8U7XTX0]`N5ZKT^ZLSP[-I!>(QQL!1O`O
M#/=N(1#$.BH]/5JLLS+A_.L__O<A=]17Z?\6K*;7Z_4US'P(:44I[IH1*RQJ
M*Z6:3OOP4'\"ZH&\>&J]6&&GVZBFMB&&;70>P8TG9<8JV]_.QN/A46Y+]V'L
MJ,"+`2"0[R\`;-8V4EQW-E.WV<T=J%QIPE)P\7@RUYP5WNQ#6KJ6I>O(',*,
M/J0C^/SUEAXSU>NU^O":D3M<?#CW0A$NOO&)"$)\">?*FO&J(/SQ$Y=_6/?L
MTAH%-08*\_X_?UDVYD=]TC-I1QB"W2SFU2=K-NJ_JO'UVS_F5G,:05#LA1<B
ML"WW+V[YYYYS9H75)ZG7FZUZNZGF63;:QR+[M$PB/F$]"H/0\AP0^)I7%?JQ
M?C5^LWP@H65X,:'7;1QB3%AM/J-\OT8C5]@7KK16EI#Z\6OC#=*OLIL]ZC1[
M1SE*M($+$P]`0@Y*Z<*U)I7Y/X:YN)H@-\#'TI).X1??<H>>P^]_Y8O*,V"X
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M\/KKY>"O#VSD`A(>L]\&WSX-K^J7YQ?)%?$WW]0X\)4:G5FNF'CQ5+B]+,8+
M]8^?)_#?/^Z=X]0^U!^D<0SKR1&9SB\\5WC\F%U\N;JI7PQ^&U["ES=B!JG>
M%;]CW^3,\N)?KX?_<PXK(NKHBS_C18ZDZV0T--__;,WFQ_]H'C:.G^*3$E^Z
M\FSA<LQ.H@!6%P3(@U^0"3J3DBOI1Y`B_0:?1_XOR<<?*%N7C\.B8'<JU&PR
M%1L5V<2T8(D=*/[W6JU&<GGR1?.829^%4UZB.;LEAEGMGG<U)@)FL9&0(;>G
MGG3E!(%<7:=(R89R^"UWY1P1^]:R;90QS`@1PMR'7X`M$%"PL9A,0_8Y@L66
M!AC.9I$G'3X6MN">O6!_"!]`35_6Y^$?.GT&!1/>F-L$&$:5AP&T2QC$.I$;
MPC<LWAQTRAPND76]\!P`'Y-ZZ[0.AF?7.K%&>O[D;&K=<L;O;1?L`CA89BQ$
M1/@<+S`/9F7G,_2FOWL"3ZK"EQ_U.>G'-1R*A<,TD=Y-A3UE=U:0"!$F`Y[8
MTG6MD50`;!CI3H135"IV9:GW/4$/`?S"*`31@Z5_YI8+5^@$7@T_&\G31D4U
MP4$QAL(`90R:>R8"RH)/P;Q\Z=(U7Y5:F4G3YSP].UTKASCU`'47GBW].2XZ
M4P9MX`A".K(DYEIWM$K\C/$6QW^<<?@:0FBB4$8^*#\,*.:66[0\.0:%`C[A
MQ8!).!WR_'JV\#VKQH`@?R(L=C#CL.*Y=$68F$PVQB#$/54+Q[!@765`W</I
M$CC]$ODFW;-5')T!F!)W;!6T96XY#J!&0&*W7<OA[*2,&4$T"C$9C=4#4>>6
MP(P`$;1L)@,%C)30H^!3<-;'`3-'O2#U"E++R(ST3OJN8U3H)0M,%X9J-^((
MUDA#1.H72A@:;&Y&\##E`M07D!]LK*R^<.V!]2[%]ARN$J$'HW=X4<!]@#<+
MW0@^?V[-R_B&!BX@V;P53@3Y&J"1)/(L%]3:6<3CXFH!;PPF"7,;67`SY0`9
MN17'\G47:NTE4C)>@$2FZ*4"5J]#,`4P1C*26(K3Z:&5PWI+0ZEKD[5X,C39
MI[Z0O8T6;'00&(3M0*H2!8&2T!5H)VO5E+M088F*6#2#K0>A-3'Y:G(O`,^!
M`NL[3H*".R5EG6#"6`-!W0=U@?^A,4O-JK*1P`@"-`(^!E4.`U1[_,;RP:GB
MT!HU2X(`DZE27#!&`%*>Q,HV?-!0T>%8+N&(%CQ0C%!6:W5,PCC9NE%0,I$0
M0G@$:A.LJT$<&3/B3K@E@\?T2W@15ZNC8$GG$5%*E&47HOT9V)4M9%E(A$.B
MTPRY`DQ</K\7]'P%LZU@6B0.V`W7@#NM87@ZPO,=LNAD'N]YJ_B)XI7A9[5D
M$]_+&M9.D3?E("/8"W(7%XFB>YO-&@NF,G(=@!Q@V%B%D2%R"EFF@@1PXYXI
M]M1D+CRX0]'@@\S_CBP?]!>5$M+>MI&30Z\\HO0I?I%LQKEBK$P>]R3.LK$K
M[Q(!T[YV#35B9I5Q&ZE&=Q@?]H$1#?=)NY2E)&H7<(!=6D0-3&$$L_IEND!K
M0!M#,7*YNDA`*.E3I2!XS_[DL4<(T*/P[QEVZ\S*2$'.XHK0M2`EJ3F"+H#@
M9^B(?1E-2HI4M(ETI!E$RY8G@EE@QO$U**YMJY8J&X83#0!_!2@*/C"GWD'!
MLW<@!@35"6[X?7B"D/Y2*B(F%_(#:R&M)ZZ%7$>SF>4O3%`#=J*)FF6R9HFP
MWT),KX1W\]<E2`\/"A*V1LPC8X@3*Q!!2>6`[U^5S[;2>/6K2M1<E;I"HAF`
M"!R5^AH#MU<GAQWG5A!JH1VP45S_PT@-$,R)*)8>+0BH(5Z&<*LN[XSN$.,-
MX0@8A1)DR-CCTA>$^N`KX\H4N;)4?J9Q8C<.CB+`S(J<#";^;N10V$)CX9M_
MJ`KZ1$4^4D0!-W(ZH@;<ZH138]TX]L`,(!U!*]49@B(:Z1K&H>.H6*M7`[_>
M.&0'X.Y4)-$U5RX&2:B6&TY@<!OS@^&N:6#%)2\**T><>XR[`C*].-LQ>N3,
M!-Y$<6&70'2F92372S*2\S0C,2'.JV/WMEC[IS')T'.Y+'M;EZN9,DZ]^`..
M(BL5YO),1GEF+JL,RD:%961/P=U%"D*:W[_&;7?+AV3E1,)?13[J9<V+P?6)
M7M<T#W,J'0HOLCKIDFKU=:Y(RF[D7-BLW^S6-K85H_*;/`/9`Z.MUF+(LPSR
MF"LAZPH0J*-9Y"XIU@8(S1H^'_Q7Y''6.B)L;;[3L!#!3D!F!**Q3&6'.61;
MB0J5A:YGM&]B5VN72/E[8"R'`///@Q!"B-`8%;]&+F^+HS=3(T?G>%R,RD&1
MNTN"(C0-@,H99O)Z`58O4J2X,\^"Z`GW(,&EVIF-]J?J*1A<J:)V>9RXR@VD
M#&;<!\S*[V@.!E]S"!77*`(6$8K/K._&5?)$:0B\K2"(U'F"<2W>&F,QE^CR
MZ8D31(`9!7^FM,%2Y[;@4*YV(`55^41@`RI!<H\7JBK81$,\C6%+!E%D./%6
MDE9OLES3RC0Q)?6IXA)P'*K01XI((X/4,4$!<^B(7VT<DB@]IF&&83N,4LIR
MM;C(A:EGU@)X@C6AI/"&X7`J#B-2OCH3WB50GAH*H:@(^#W3GA9]$XS>:3"9
M1`<42$[%9`JHY@K@,&(:OO>GK)"R/@L4/\1Z)R2TX]*NV=2'=&X&Q$\#?"+#
MQ3SX;@H!R#R""!0/JD0L&W&MREVPUDRNR_;]5!T7-8$^:'<8MSQQ;;09B>FY
M<)%L-K*\[Q#GT+E1"EV`9KZ`I?G?N3&&2S+F93MQ``LVUIX=AEMLB$;SN2_O
M"0O8V!*F?14U6W*#H_8>$)Z"*:!3PN>E4=?K4_)=HLE%*H.,"/4X.^A#EJL,
ML[*\`AL)T34^[)J$$:<00XNPY!6^B>#[6Z@A;$T<><^O5W8R`5`$$T2C?V,(
M$R6[;WEYV"0/YB/_C36>DO$OA8]:_*"0Y9>>(YM9PE/GJF-J:Q%()E/_#5&"
MMOT(2B3BQX2HL%34%`0+.WZ](;']-*Z)0\B1Y>([E@`$'",IW.;1`3/O#XO+
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M`7^.5[,D%HXY3UDA&3VF/3K\YYH8\QG8W>KLZTGTXU*]#"7-#_,E?_CJ)'=W
M!OHH'6@:5."E&E\%GVU:^DJTJNJ9=L:?G]:C_9;YTE_'%Q]?YORAB-WN]6J-
MAM$1/J6;>[0VO7A+VV//9C:VQYX]]K`]]NPJQ-Y'S<\@:L8W][%Q\E(>,29F
M<U_>JH>9GC:KW3NN(D=>D^/Z<?QY`0ZLV>S6#AO=O0/[T1JUQZ#-;&R/07L,
M*O-FCT$/X-K+K%-O9<OM;4?EU`UV51E['/F>P*,*:FPL[O%#H$Z+P_]>>)'[
MH?KS4JU[&_YT]89M;".K_.T;89[1V3Z$>49G_,3L:_5JASVC-W[.SKC23O++
MU\,]].W.>O?0]]:AKWE8.^KU]]#WG/1P7^)_&<G$C0S-KR@G?\SO`NPK_2\!
MW?=5M@V\W_.JLG7;K5JKO]^J_N$:M<>@S6QLCT$O'X-:C5J[W]ECT#..I?>5
M_E<8G`^*+_Z6YU_Y]N^^PO^,K7I?YMJ7N1[$OH-V][#6Z)G]\+-VQ,^PU/5N
MB^7"/>SMSG+WL/?F8:]UU*SUN^T][#T/V'LVE?V5B-G9)Q@5U*%X.%%Y^ES5
MOP:#FA\;>LDYA4%5WHA_J.Y<@4?,D='(Y16\Z].R[YF\X?8@MBWQJT^\;7YT
M6&LU#E]<6:_L5JN"_8LRX3WP[<Z"]\"W$=M>"?"U.KU:IV,\NFL/?,]RET/]
MAJ=`TL_N<SY7-+^N#;A?_6S1<SS_WZ%'_4V=3_!L73K=EWMTY"[&\M@X0OAQ
M2]VIY4_4L>4R;6FH-U'1QA(>->!UZ"!AEZ<=&]51TOI+P/HIH/H(MC6G0VO_
MCYM[$ISI.QG48&PVC_`P5&PZ-M&;+.NC!J%O(:;4D9%LQL.I=!AV@J3#AI.6
M!3@('T<N<\4M3UI_ETT^[NZ@CDKV+6_"D_X'>/8[MOV$VXNZO>"6;SX[?:!M
MQ>"<;O(Z=9Y?29<[C56EI:]9I\]1SJ:VR-@3.FE)X7/:2E)TK)=!VG1"8Y"^
MHKC[!#6?_ZG7J37Q0-B?^IU:KW>D^M'^=`C_Z#?+C-;Z51#[&*=>N:6C96OQ
MN;)TP&RC7S-I`.C^')M78P_=-].H64'";HZ"UM\ORL@8D&VL])FOAKN[Y62,
M,MH![MAXA_KM($@(FZS*F@#F*(!`'%\"?Y%J4QAR>^I)5TY@B%%\F'O<)I>,
M3`1!1"Y@&?+%+;B3+CW-HV,"X!F8>1`"\U=T:8\)-E&GK8%Z`"OTP*;8@"XI
MI#&"M!&V^XP1C7LEIE5$V023$JA372=2ZHRD$7ZU$+8.$V#B%CB`&#4U@"J-
ML@ZPE',,B"P[3#J$E-G_4[-?Z[?:`)_-!IY,HW^H-^HQFL(GT@6-NJ(Z>_P^
M)"^ER*ZM1\=79[R[A,;A#*,GK1E>1@O(XU)ZD_HEL-I9@9:OCM\[;=_C\UL!
M][K(69<X&Z,GVH%(I4&->#AB1]S<799A%YN`3[CJBR9\.YH%(4(B?N%@E\6X
M87VH][!0O;A,LL;^Z4@)]<KR9)B:M4Z[C7"&68L1N+XEOPM7M1Q*UJ;:"$VY
M6XZ_/(ID"5-F$,5%?M*U@QK&^B)0D>;R1>1700USTTFI;5F$V036^;.>\F;\
MR@92_>+B5L!!A&U&:$QS9_LQ-J5/VS+AY4L#<<4()69,/<B594)7Q%3727-3
M\24I+$IOXJ&W,J9#>?X3'XG-^"^5/QAD8&PKE4J`W]N<.X%*7!*&F^6!64DY
MU$^'VK>R?#0:#6S;CXS]-BZSOG]O@\U;8^FJ[JRHO)`3V]CO!/ZI&ERBY6#;
M5E-_RUI)_^^R?#_KC$B8?H>M8ET!O@$_4NO8K)XQBLH`3Y<@JB]XJ+K,@LC=
MK-=Y.!6^0[0O&#@<1T)LRFZFY4P^69+P;J6+I0<`/2\48P*%@/NWPD[:6Z:-
M:(GFXD!9O]LY][&IIX:V,04852-Q(SZUW+'6,S(;)>9/DGN[V`X7831%K(5Q
M(M-0,=I(K!9PA]K5I$PE[TRDQ4N,6\=@X&I"TUQ/*-5%4WA+)?^>G=\#9KL\
M:UV36V,B>B1"+>R.VL*#/:>=XL<\O@`$-`8!0>Y@Z(>9$Q#=(N^4$\0>H3Z(
M#-R_%XWA`X"T'VC-V'.1A_3^'7G4Q#UI+\_U&Y$UMT`@&)<B"E9>*@F!Z4&4
M`M+R@1O`@S\Y]4U5Z8W6*G5$G0BCN322`LN%Q$?9F*9Q6KJ4K"R"N>0(D$.5
M!4V1B*#NLBKQ`G?)*3ZC@EEB$_MRS.-A\\K<M?%2@A2_0@1U/<6"Z_+J^ZMA
M\K88>F(%PBX7!*@/L$ME5^Q0CO"7ED"F5+[P>5:9568F/7,YY8YC80.1$P/\
M"?B2B,H$U%TX&Q+,,`HQ#<&>5N_9P"VU#,P1H#?".U#(EA21L+_Y/*W'&PB"
M0-2"^][1*B#21!1TDNIVLJZT4JTSHCP8<D91I+JT4\"JFC'?R<AU,&B'R42=
MA@%4>(_UI5FYBWUY6<FJ<)2Y#-%74F%,$41%(ML`^9:/Q>]`HRSN-JC"9U4_
M27R!QH`B057XD4T""0F^/6V,$ENUHWZOUFM@1:C6:+9KW59+D=&L]0X/:]UN
M`[N\E0M(19+R!?!]M7O;\/I-]=@VB/";R@"7ODCSZMB\XTI.G$\G7<W11+'U
ML.]0[)<&1M?GI[DR]'5HC4MI\R!K7'\2060.G]B5?`^$@!UMJD-+E,*H$4A]
MUEKW6DM+=%7!N->:J<VMT:+D<VAI*];2V?I:S(LI$'V0\+_5.+X>G"`AZ3?-
MXW?O6?*E.<"\A1PG8)-(*,&BF.=SES*>3X/!5PPR$Q7P-1,K\!JW+'B@(!,A
M3XPQ_`578#D.1K`4M99&P?"YM-)H#KA.3Z]*S^?CR'.HGR0%]&G<BF5!Z7D\
M"].-2AR`KR$/Y;JJI0SME*:;">9=5;6IH,%[P5?D(1[SGF1IL7_'4&/,)NC"
M&=)OVNE-5Y)U!$[=V=7P,SL(.'P`GVHBH?UN28E2D1$/)'`?A_;%J?XF3`F]
MUJ$7*.#803BI+6*.&&1)8KPWDG07+V48=*F<4?*H;U^K89235T.9'.&K0^?=
M.D&EU\9-/`\WYB'>D*H+[+G*K]]*[/%4+'8T%B>[F)DEQS@0J`P"/JQZ1B<)
M?AT1T`[#HJ:/#E$K5@NP*.T9:]M998+J;V,")#!J)[*Q"`WH@Q4:*GA1Z2&N
MMQBPP-BC_$"\4]`[MT2\02M\IZZ*:7'%Q5!&0Z_BTY9`7)>J,<@H1"C]N'R6
MO"J-]2,K`8M2N5W&J^%I024((T?$-9Y"E:4&Q`*U.L-UO$UK)L$<%BJ1\ZF#
MR%P"#0*CI`AHH`G+A%@(0AKTPA"B*%$2[_IX*87E>EQ*\>T[YJ;MSE@0@?--
MU@?CTF93/<<>4_%,58)(Y#G=P5$.8(;`<D&B/*@9Q#[B'A^+\/_;^Q;FMHTE
MW;\R-]>GRJF%9()O)CFIDBW;43:Q'4NQ-[MU:VL(#$DD(,#@(8GY];=[\"!`
M#$B*X@,@6W6.0XGD8*:G^^OG]"3*&UVEB\A?1K<*QN=Y59WS+'U4PO:*>H,%
M_&?JUQ*)X07JDH[8U47F/!"J-.(;R=.4Z7Y"65"H;-\L,M6<$;K(.+T;E_3$
MB(U8$:"5"K_.Y)848[-JV<`<>2;O(5'32T/B9AJ\7D[LVM%'S2G,`6MV,/B0
M#$HE)<\6*P!X5Q&Q@XV+WHIJLV1JGQ*.NY"SN-89Y`<$+;1C99(M<1C9(29`
MP)9847H';X$Z$I$K*<.,TB("!]/%T.!,;MY%X%Y$KS(5&HJ0JC^1(<^HD`2%
MWXJ3..C\@+5B6C+FMZCDC2:N\G;CBH'HJ6J'](WP$%'0+H/U8:587*#@R_2?
M,D6'&4&TFKCO@RN>YHK0$DO].T06)X@&3#-WQ:Q:$BS!A?GP7VD.4#!S%_5I
MTF$NLM<=?U17*YP<=?<:P^11I"XJ/HMB$P%2-E.G;UM)/5=4HW_)?G=,11&P
M#*9$'T'O;"2DXP:C)=5`J'/M1:G)XE2%(J1J)CB5.?`0PP".B&Z8^#L46.U6
ML!4"<!R&H3Q;@W)L6B.8B_PHR'SP@&(O$RG%1'R1S9;*G:*<_Z,5>YLEZW)4
MZ1-XI.5EDAUR'>A#E$38B@0L\[.7:+HHXXKV4#A<:@%/)M,!(Z/$5A%E8X)+
MK(./Q1448CH#Q\N;Y^BXI%Z*=!N*I%@0`WT>>,%!8)<>DU'PBHHWP'=+B@/O
MN1W&D4K;=A]D6#9T;.&#BQ;'"MP96'<RV558*@@*CR)^\.E`EKZ!A@-"_H41
MOF#"':FW9*6-CS(QPX)L',LK+A4FD"@Q%=<_6/"^)$=R4HBTPK.Q[!8K^"]>
MHP>N<M\6+KF:V"='ZX/I"'ET(@Y]@.,$5#:B'/T",$`.DK,71707\K1:6H4D
MH_"`,+8[%Y@:,2WX3"`KOSSFXEF3L@HD\1A5/T?'!_X.43]9#CAS870$(EO-
MP$8<H!<A0ZC00-9]/7#/9'&Q=)25P)"@VM;,AGPP=J.@&<Y*CNEG*R20>/+P
M1*K3<M,$X]4H9K5B;`E1Z48YI]QP\7=EB=FB>&PI[83XN-E:%KN<EE\4@UI)
M[45^+07J+5:7*9/+QK&2[<IE1W&S+J+-`D_!X+81]8N,JY*+\OX:SV=?W!H3
M5Q;0R5E+6B*MIJY9$GO[*A;F1J&,(\/F1H%$W%^<RN%H9\SE\1^%6Y`]X9@]
M#B0='F!:WP(J)16%L5>E""*F'*I<R&V<!6/=B.WB<ZS2L$F7H2C#6:PJ4_9&
MX8_GIT4,I2F928I_\EP'7AOK[Q@^&8KOBKHR'J&N;I8.O>-*-0-/YPMZSW+T
M1MVR.#JC,.A*OYC6WD:V+WH7\LE<I:&23(<\WP$?=LOK?S&/[S'3A:%5IG14
MYRVM4="J\?H`=&1!053OG99V1\8]:%EE7CZS-%FD)Q64-4KB'+(6`0`44"\J
M>\NO3K&VN$ANQ=JVR%+\\"KT+\:<S[Z[!9Z391).L!"?3R[(*S@[=^(Q>(UL
M_&.RR!_&[OWC=^\18QU\^'NII=+/R4I@^.6S&/W[&Z/YO^_`^M!_Y@Z6,=RY
M+?U:&/CRFQ_/3;Q6GB9J*97._EXMMJ_(=]&&GD?,>*\5V#<_J>!!DI?4T9/"
MDPJ+^U8`A,H:V&:CT=/2>B5IPLFX#!ZVO`$L&GO*G/6G13+_U9LD@7]U<WW+
MOD2'*G+E*R]O/KVY^G+];5%<(E,<T_GA#$,8$J1_NOGR2HX5']!05";`]Z9E
M^6I\_T_$_(6YFC'[9<BG&)*3![@O9&0I_EI2%CV=8D3)9!_![5M03)9.<J7C
MQ\=C3XS1NXA\-G"/7C0;EVTVM6Q;&K"J$_72#4M*DY>GMSCJCAXG]A98JOEZ
MT;H<)./C0*$3^LH:Z44]F[_H8!(E&^^Y94>9%2`8-CE(NAE<A>/0+X;CXDDU
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MSP3`I\&NDW)$].C+L/@E;OJWB5I-TS&8!<^<%/X$V(#*_%-<"Z,^[(A2?34:
MX0D#5"5O$,^N##D(+KM49R_XCK&BJI?]8F13-3/*@L?%B0B5>%[I7N;1_"FW
M[:+RE$4`#N:>'B:N!-B1:T29)QE9<MS[J+XF6!!N>8RDK-,J289%6B&J!8_.
M0-GVH@%!63E#'(A,@;6AQ59'ID0;MR&!/E3,LG!=%120(3@C6JSD@S=8(&G+
MPE%S<5I"T0_A8P;XMW!<?GBUVJG],1[BA\1GQH-I5B#U#O*G[6(R\"1\X-R&
M'-H-;A_8#<YLXUDHAWVJW5^P/6#!%+U*"YK/@L![S1'*!HQ+7E-?:S<:S/\[
ME$H!^R"@&3P:65'C3A5D9ZN\9QP^!S22``LV]NUT[CE<8^^%ZXTMSEY.1>"Y
M,\#@@!?J/*\"&U"2?WO)/F>/'V1K'%0M&A4K4_5`D_W5='V@-3MH=NMZ7QOT
M$Z.[V]):G<8&C1T50O\N*G'!NM1I.(VI.N/SJ:HH=ME(Z3;Q_`#8[-'7Y$E>
MF%Q3USI=5&K2G=2*J@T^TM'T?O*15K0,O0F+:B9_;%/9PMZZ)ZY!^M,C\5[]
M`)0$![.9-AZZ]Z)NDD,T2&5QT(.0_<V`V`*KG$!T[KEGN:&RNFID>5,4,V/"
MY3&-=)^R1V46$0TI./%1I**8Q<>.DK!)DD+1TE,I6"BP?%JG!"=E:41Z-"<Y
M^Y+I?W+)\B&OY=/X^=8.;,+-Y9!7N]?'=HU1N"LUES/='53^A(I4\0&EI*5/
M%&(9)DU97&SIJ"C*6$ZU+<^NW9&SBU$M#G>T\&^*.@,):ULBV"(9M=JP_C%O
MA?\JO+'P_"LCRO*C^7_EF/"]F1O_NACC-#)4QS3..P<VSL$*Z!;X+-IRR8J?
M1=H;G,K0MDKRJU`O+BN3YE<2!<<TN`/@A$6JL:'X<PCPJH-!%M5,9<(#64/S
M0>+CC0T3=3'@[[-K'LXF\/V[M/6PQFX<X[+(WMEV`O&W<NT$E`'>>/0'7CQX
M&3I^:&!7-6SH+@^18\QXT<!>1K*P[SFL.%YD/I>1-U@;ZI3MC9//3'6U=,D8
MU["%5"'%8MF(K64:(K/NB-NSRXX"QF">?^&/$>4B%%<HBH?X*'RZ;>E.I3N3
MF/GQABHM\X9>ENWA\8&2)+P6S5;+A8HRD7H\T(EM[+'>,'KV8@U)I:$9EW`G
M?8X4C=IRA7GH:V3HNW@#-SC[!%7)A\&Q2P"&U(##+]P';'\-6M.W3`MKL96%
M?O'#5G)?@"?FDO4@ESGX(%#1T826I?P7/O1C,L17+=C<B+\9>7*Q1E\4;I;T
MF0@F;F2*Y5:NJF:#5<K2_M2OB?=.A0B98E.P87Q9!1.;4[(=PSRU_&*3"6N[
M"QQ>G%)<BKCX\BA)<V'H;Q).%:,D_>Y*@["Q?D#>C^MPXF,.2S"EL*>2VQ%&
MV0H>'K$Y)EPQ-ID:&HICC\M=:;!K27R.(WMN(_\`A:F8`3$P406/`]E1<!0F
MX,7UDDAY8(MB1\MH(C`XIIVP<GY1,I3MO1<=XXKW?ZFTM:!PXS-7BRX!N3BM
MD8W3+A_A4F;K-"8/P\2>!!Z:P*RPY6BXU`>!H6=D^KF"RSV1'I&0G@&N8H'C
MF@R/+TO"\EZ5"<9-K-D`]OI:CO-5*@4GO!)?96.BH+1J^!I<B@>8[K/*M[8S
M@G^,A?R'_W-QP?[GZZ]?6O_O?_[+F(6/?SB=@?E/[W[\Q]SY_3I\>-_S!KW_
M;/[Y^]W<MWOWQC\-^^>@__N;7SZ9?_RWW>HX_S7\^.;Z9O[^[F]]-OAM\/KC
M'U^LYOM/G^]^<O]C-O[3_?"IW]6=P8<OG^][;YKO^_W)J];#P^2GOW[^A<_?
MC`?#+].?7_\U>]^8#;X*-Y@WWHUO7G?OIC<W'VX^??GX\Q\__V3/FE//^/5V
M^.?7/YWKX<!Z=?/XUT_!V]O;UON^_ND?_OZ/U_;5#1^W_WCOWHGA7]W@G__X
M\.>'#Z+=^HM/>^\_#SO#3O/OT!\-)W_^VOFO_Y[-NX/.+]W__*?9&8?_3'H/
MUOR_?^W]_9OQWFSS/_YT__W_V)O;SQ<7BZJWM%H.U4NLQM[*DG@L"SZ]),`1
M'8WN@1V-[)9F5-,R9D2[?1[1HWT&Z+)-'7,57=)PN\L<>#F7<.A>8W7OQ-`+
MT9Y-<_9123/3FS*ZDYK:,H*4-:)509[HC&&<A<4*NT6SW[A9LJEH4-E0I/\3
M.R+-,+\8R+M+SN-PQ*ZV/"II4AB1R09$J178=1]O$,/[)]+:/J!YM]/7.LU&
MT=_*!4*7^"*ZTFP4"-D8!.ANF=BN#;=?F%9D(]X+'ST5A5L?-0Z1QX;D#%/6
M&[IQJ>'"SXD;&\7G2(N#75PDW>G8X-OH8$YV@:EI+P]]21YKMW6MJ3>*1O.+
M5E?K1Z'8."S*\VW^0'4G8M2,F]`M[W20]'%`&]461EK0%HTCRTE>ROP$>Q,W
M/9`WOGR[/)#*QL[50KR.6Y_?RM;G?+%S"@Y(HM*EA8JV[R:8$'D#*F&--W1Q
M+`UM[X2^RVPUZ/>T7K^E<`!2L,E[Z["&S";IE[`1F7ZYN0C'8C#Q.+.BGKU9
M;N^>1<NF7>''N_1*D`P;6U&X`O^[4!@K%$5:T)J-TC@8&N+Q4:#TF&GN3.GR
MEY(CJYL5;V92Q8E.4Z@_O3G0FNV.!NO6.HVHXI.UHY?Y`LWD]@%5["J>V/=1
M1^A,:6AYKZ/EQ27I<<G@G>2:KDY+Z^NMI)14QWEE;Q-3N)QI;X.XR'OYSK+T
M+*JZ%.KD)&'O1^`+>_!QML(Z/3GZ[M4XC2+D>-%&?"0.U5X4L\G&1?%CB?]5
M'.0FK:#\!%JQ$$2/_(IHT^0G<O'TD:K=1%KN'K>R_%N6IEK2$$B>E3N_O3I]
M<7/[,1ORS#Y?=A=>#)\;M&BD@/0'H"6#])/)\7>O^-;0Q0,4OK)S2*8;0!)A
MSO0%T'+H'2';O>7+C@&*"&$F2E8:EA6/PC.LU!*+++5YO%#%EDKB"S-S31K#
MOB-1VY!,IX&7NM[X%^[0XF_%">+3EK8@?0"VHXK:6A6(G1))G6N*42`=:1']
MRZ#&,FA$'!J=^(3%/<H*I$`XT;$=>>LNTCO6*C9>$^2K[F"+#KCC]<+E-US>
M+<7M,8+KW:O/9(!1W&@LN8-6X!>3+>F5H,MIOX(CGUGPV=0U[>S.*X7E'$ZG
M458JJ4"9+[-<CL<R/L$JIR"R/)*3VDL7+$>9K,P=IAF'P,^D!(;"=A^^V\[L
MCEI(&<*V9]A4P1G'I&S$.X+O8)EB\9T'RPPF\=_T1N-?\9\+ML&FU].7_:'D
M^RL+IZ,E9Z^ES[X7OVLB8"WX;>@&`1CCQ55\NKJ^OOGP_N+UQ[N[C[]^QYJS
MQ\+#\\-OQ9[KZ)-YIOKNP[*%O@K,4C(1*8JD,%SD^(06S9@,FQ'H]<?/UV\_
MI_098ML6I!*3L8/5<?[%)':`NN7(F3YH0;KRC4M1H_PCYS;9;?69(>LQ5U64
M'41B/L@[K58[3T34)Q)5H>J3'WG1F\I9?3*Q-P8PQWWP^"Q>8O3+DT!,;M;5
M+S?O/WS'T`K[GFV`^[6'?=*`IZ4!:PXI7^/+""]611%S.TM`O9ZJ5]'-CFL<
M8B+K$\GZ-HXO[4+-$4VCQWZ2G3)7E;ML3%*R',AR(,OA7("#+`>R'&I#UL])
M!S%BUAU2]4U\\C3D-D5Z=DK9.^%-2ZG(V,NYYW^[*XP@LXW,-C+;*(M001B\
M2LI-26WOD*HWH+4MQ[<,HNH.J?I%EB51(*6R:BAZWRNA>E3)D5O#$%3,V'-#
MQ[P`S>5ZW['_^Z;Q#GZ^7TV2>'/454;E.U-="5M=(W40/OBXW"VG^'P>I*<W
MXK*G`TOCCC>\#C+U1"MW&6\49ML94L+#0-JF%NS>:*%K>JNGM3K=C?S*HZFH
MH]-I'SQ#R%$WY'BQWG8^><3H7+9:!!;5$9C3TJ-/#!;5WS\A*2`I("D@*=B`
M2)N$,B@Z<;BM?1^=#CQX1H[\AKKY#=6@1#7\AV9+'D;=($I'2H.B#80:QZ9$
M-5`C'=PRDSE>O=8OF@-=,?V<1='J+H^34K)Q.5!G"PB)R(DC)XZ<.)("D@*2
M@B.%,J@JHZ)QC^1`GC+R06&/:ICMY,!4RX'9X,`4:1:*=Q!<')L2U8"+TGA'
M4S']3>,=A$%5X;[3$C+R\4@*2`I("D@**E&T\>0CIB7D/>\HQSO7&PF\\:04
MH1CVYHXNJJA^$<BNF*(.,O=$ZW_U(>.8R5?`$Y&I0":U$W500KULMP::KK?5
MDED135>]HY?*!A.$4742/L*HNF!4:92G]8PH3_.R7_&JENJA'K6`J9)KO(<6
M,+4B%\D;R1O)&\E;):FV24#KF*4[N;N#.DW5U4'+N]/>$`/..R"V63.6PBU4
MU8^,Y2Z;VI)?ZBK-&VC/M>11:@R@$3/=<&B+]<[I":B0S<@W>#;YRJH3#DK`
M0;.O-=M-I60?4`6O9<SU>GE3Y*\5+Q(`[D^"3P(`#]/&Y@2!KW/9KD#O&\(]
MPCW"O5J1[T3PKS1?T58L;]-\1?>R<_0<+4$J02I!*IF2AR/<14-9C4^H5^W(
M-@6KZQ&LCL^H<A!^"E:3@JVO@B6?Y;DQFUY?:[8VN16`="UY&#6AVAD!('D8
M6Q*N=]D94+"ZJA),N+<_`3X)W"/#;U_!ZHYB>9L&J]N7?0K;5)2["5+WAPDG
M`:ED2E*P^E10;U6P.GI/QCYC_37T7B4O*Q87SJ]K"^K?2>I_`.I_7G>OL&E:
M@>4ZW"Y0S')&KC?E^"XS7,<0GF,Y8^:&6,H.*V;N#-_S&7R,!1/!YH)[?A'$
MA&,*LQA6EO\V&'=,>-$8,,MG7/'MD6O;[H/_W1JO+1=]SF^NW'1F"-N><1,K
MM6,2-N+=P'?\&3>*[^3$J]%0"=B3F+[L#R7?7X-P&R5?Z``0D:)(BN.?A:);
MLLM2:_O+J]&1KFVH1K!!L%$MV%#>$T2P42U9(=@@V*@4;#24B2^"C4K(RJK(
M1>+I5>8`>;?]KPV#;Q6+JQQ8YKX*C%,NFB4JRNWNA<?'@HVXY2'Q0\'<41I7
M&4=W:3(S]##P$DQ$.<HQ-A.>Y:IZ+E:\4.\,DXD;A6HWU6VGGAE8&_@_*%$:
ME[TZ%I"<BIXDZ'FFB!'TU!9ZFI>#DD.!!#T$/00]!#U[(TKW4B?HJ79T@!S^
MXSO\-TX`GKIO&:4T8D4O7R0W1V;\_')GOH3NY,^39JLN?6J@X8Y]#=S9ZC8"
MGV<*%X$/@4^&*`0^VU"-P&<[X2+P(?#)$(7`YPE4HYS_"88`[MP@/4JA(!`K
M2?7?"U^5Z:<L?Y4$EG3CN>G&3KNAM5KJA#^I2++/*R]CA$&UQZ#V8*!U.CW"
MH&-S%&'0=C)&&%1[#-(UO=W26LTN%0%4,EP0O4?-#0H%^`I*AKZ0*?;7>)3H
MXM:8N#8,-W5-8<M.!J8(A#>UG"05+ZOPF<D#42#[DB^_U!@A^J9_F>&!]-7=
MQ/*7F2":0AA8MO4/S,@07L`M)]N&06-^:$P8]^7$+#Q8)/Q`158/ILM@"AS`
MP__K8N0)P7QAA)X5S$&$`AB$X3+96#C"X[8]5U!*_!U:L#H!RP]<^4CQ.!,&
M!BIL:R37C'^,5SL42#%)#;-`*>SRX.%X7F9E+GS;@]7XX30*@^36IUI6^GP^
M=4.8%LX`N`&&3V;Q8-DV3`4V([V8C\$G+;NH=*T`>TXLRB]@[V%\F*&IX7H-
M;ANAC73$1>:VNK"\?#^,^-Q&R<;#1H"`6"/+@$\M\T"&&.Q!(*^:#"D%K)69
M03*U^&.>6'3.R#`G-<Y8@:34.&,79LS9D8*.LE;A*"LUSJB#K!!L$&Q4"S:H
M<48-9(5@@V"C4K!!C3,J+"M41'."132;-\Y81+>2:)@,??F'E5C*#"U3A#)#
MYY(9NFRK`XR4$BJAV+_68Q,!#P$/`<^Z;A@ER6@"'@*>R@H6`<\)`$\-;SNJ
M._!LXN:3YWY\S_UM7*!1[KD#?2Q3.":;6\*F#A<UP6726[776XU+9?J+]!89
MS!46+`(>`IXEPA#P/(5:!#S;"18!#P'/$F$(>#:@5M43\FL2PN2^KW;?DX,?
MT5F'JKOO:S:[5K"<+P9KK46>)^'R1K)0&.5[ME_Q6#&_/6]@KTS\YIZRMH1X
MGGB^[CS?O>R5XS[Q/?']B?+]\;&>LENG8A[?NW@LU[:"N=HTKA!>4J"'`CTG
M$NC1=8">W=&%XCQ/H1;ASG9R1;AS`KC3O%0=#B/<(=RIK%P1[IP$[K0(=RJ3
MUXK>H_9K2U2_Q:Y8%T/NJSQFPYW.A./+)E:RKY?C"^8);+AE)NW&Y`#L8]39
MZY/-'?;`"VW37K2[+:W7:6KL1:?7T;I=>(7MQE[H6K.I:[UN.WNQVEQPSV?"
M,9,Y+0:Z%H:8#H7'6KK&L,F,_+<A!\-3X%IAWSWA8T#`NA?V7-GMZS;;#BY9
MI.7#)L&V\DPD(3LJ+!X&AGEB*S1XMBE@?'<VQ3YLR1BNAQ^+F[?AIPISXR;V
ML/,#C^/\TB_*W<#.<$B,A-QB.K/=N2@TG3=L[ONR4UG4:@QG8[@>+MMU3#_9
MIG@UN,:D-]IBC&1LYG.;>Y90]\-[APN:8*LU/,M;V*35N^2KJ`R<LB#SHC]:
MCM+4(FT5VE&+M%V8%F='"FI:4H6F)=0BK0ZR0K!!L%$MV*`6:360%8(-@HU*
MP0:U2*NPK&Q274(MTFI6BO(^"OV45DQAJ$8=`EK+3U24<AS=7;\DS8L=IO-.
M)CG3[+>U5D=5CD('CPXJ:80]V\D884]ML:?5'6AZ5QGZ(^PA["'L(>S9&U$&
M>D_3U?%#PIZ*N/D'\=QW$H0\;^_^<US_41[0*RD,V4#Z*N?>/Y5?ZBJ@NU"%
MJT/6L4RL4I5G0CREOGP*\=0G)P]<YMD;:.U&_33J1M'T^G,B@=_^Y)?`[]S!
MK]GH:IU&_4(9!'X$?L^47P*_<P>_5J.M=3OJFW4(_*H<8:E>(<5*D&U3.&8#
M'KIS@[340@$%3'D"12F\]0[&*+BEKK*\-Y4,-&*F&PYML8%./LNTQ9/(5J*-
M#TNX^(3A":CC3?&^5B),P+<_"2;@VXIL)P)\\8%J`KYJBC`!W_XDF(!O*[*=
M"/"EO2,V\N((_*H1A(G>HSXL2]2_\A64=$>J5AK!1'A1[XP7'1UT_Z"''PP=
M3QCNV+'^47<L6=?+Q5\T@LE]5C46]SSNC`46M:A;A=Q-1&Y"BA$7HV5ZKHBX
M>2M.:(C32P=P[X$&G#T(1)YB7Q@.;_,Q?F/*+0<;R<R$9[DF4J9YV8BZE5RN
M`8I<F*?2C+F&*2,NN_OC%V`S*X#!C,QDGLFH;Y*==+VY@F6_2MX(U$V93Y#4
MNR+K.X#GY0<B=LO^/?!?#5@?),0/11S(G(6>,>&RB4Y$<?ADT7XQ7,</[4"^
M[WK,1>SP8:X@:?!MD&$V@C_[PKNW#.%?LBOFA],I3[8V!T5NZ"WD&'8_>3+C
MV%[)"N8,(&D)LA0<$H&8;%,D9^`OMW["%T[460@Q88:-EAR%S`^%[3ZH^P)M
MP&;4%8@.IQ,I<J0XB7/ZZUQA>-""=.4;MS+=<YZ3K7D'A`\A*B6U74)$W9*H
M22]!Q7-O)QPT]UITVF5VE5I.;$,UTH"GI0%K#BE?8Q?_8GU<E(!Z8ZI>10&2
M716\$%FCQ[Y]%)YA[:9A"]$T>NPGSS(.?4B.+(=MJ$:6`UD.%0(.LAS(<J@-
M63\GF2IBUAU2]0T,['$C"+E-D9Z=4O9.>--2*C+V<N[YW^X*(\AL([.-S#;*
M(E00!J_&8T^,>:"TAXBJ6U+U!K2VY?B6053=(56_<#ND0$J%U="J.LFDDN.8
MAU6K*V$5.'#Z,0S\@#M8.E3V?!ZPG[D3<F_.XNK-`TOCCC>\#C+U1"MW@[Z5
M9TB)LOK^P]*B4]I:JR+*Z>@4JL*!)<*,8V/&84X051LK>I<E3?@(+(XB,*>E
M09\8)JJ_9T)20%)`4D!2L`&1-@EB4%SB<%O['L]D"?/@N3CR&^KF-U2#$A7Q
M'TI"#:0P*-)0#3DAQ*@68J2#6V8RQZO7^D5ST%5,/V=-M+K+XZ24U"_;%,:H
M$`^>EJB1`T=20%)`4D!20+48)Q7S2([A*:,>%/*HAME.#DRU')@-CDF19J%X
M!\'%L2E1#;@HC7?TGA'O(`RJ"O>=EI"1CT=20%)`4D!24(F"C2<?+"TA[WE'
M.=ZYWDA80::_=W$"KH=-M"VO!@4@NV**.LC<$ZW_YUXD2F3:\,K0@Q+J9;/B
MYUFJ=]A2V5*"\*E.@D?X5!=\*HWP])\1X:G^P9SJH1XU?:F26[R'IB^U(A?)
M&\D;R1O)6R6IMDDPZYAE.[G;@CK-+>_SI&#8ENU7"M?G53\J1O>_GM?]K\<C
MWXG<`]MM5R"L1C?`$OP1_%6V><T)PEXU`FN$>X1[A'NU(M^)X%]IMF*@6-ZF
MV8K&95>-J02I1^=N@M3]8<))0"J9DMN>!&HHZ_`)]:H=UZ90=3U"U?'I5`["
M3Z%J4K#U5;#DLSRWHWE?ZW<H5%U-3B3XVY_\G@3\D7]!H6K"/<*]<\,],OOV
M$ZIN`2H6E[=YJ+I'09N*<C=!ZOXPX20@E4Q)"E6?"NJM"E5'[\G(9ZR_AMZK
MY&7%HL+Y=6U!_3M)_0]`_<_K;A$V32NP7(?;!8I9SLCUIAS?98;K&,)S+&?,
MW-"#7Z<SX?@\<+TY>^`>7O3@,_@X"R9"M8:YX)[/A&,*LQA>EO\V&'=,>-$8
M,,MGW%=L\,BU;??!_VZ-`Y<+0^?W6>X_,X1MS[B)!=LQ-1/K!]_Q9]PHOI.3
MM$9#)6M/XO^R/Y1\?PW8;92%H7-`1(HB*8Y_)(JNQR[+L>TOP48GN[:A&L$&
MP4:U8&.##![!QK%EA6"#8*-2L-$8$&Q45E96!3$23Z\RY\B[[7]M&(>K6(CE
MP#+W56#(<M$O45%W=R\\/A9LQ"T/B1\*YHX6L95Q=)<F,T,/@S!IF*4XT$QX
MEJOJN5CQ<KTS3"IN%++=5+&=>H9@;0+@H$1I7`Y*SN=4.OY_*DJ2H.>9(D;0
M4UOH.?9-%00Z!#K;"1>!3FU!IWW9ZY"]4^F@`/GYQ_?S;YP`_'/?,DIIQ!3.
MO4@NC2RX]^H1R,4GE7<B]*F!ZB-[^]BL1."SG7`1^!#X9(A"X+,-U0A\MA,N
M`A\"GPQ1"'R>0#6J`3C!V,"=&Z2G+!0$8F6I_WOAJS+_%!>HE,B2=CPW[:AK
MO;ZJ_I84)%GGE9<OPI_ZX\]`:[;Z9*(3`E6,(H1`9X)`7:VMM\@"JER(('J/
M>AT4BO`5E`Q]@3XU>XW'B2YNC8EKPW!3UQ2V;&A@BD!X4\N)?>^H$)^9/"BZ
MX7G_O;1/PF6&"])7=PJWW@?*62/+P`=RWP^G,^S%X+,'@;,V@1SR(8O'%C6(
MP6TCM'GR/4_`0*OZ*"3?S`4(\OQ#/13H*!^1(D<*.M58A5.-U$.A#K)"L$&P
M42W8H!X*-9`5@@V"C4K!!O50J+"L4/W$"=9/;-Y#P;/\ORY&GA#P2$`+X0?,
MXX'P#RNQE!A8I@@E!LXD,="X'"@3D\J%4VY`/O)?.\SD$O1L)UH$/;6''JI9
M/C8K$?AL)UP$/K4''_VRTR:[Y^!VSR;N/GGPQ_?@WS[.A+'2@P?Z6*9P3#:W
MA*TZR5!"5_+827-5ESXUT%R-RY)[,4EOD;]>6<$BX*D]\)"_?FQ6(O#93K@(
M?&H//F3U5-1;/V9R?DURF%SXU2Z\;8VR_0LV"H<=TXE?L]VU`N9\:5AK+?8\
M"9DWDH;"*-^S_0K(BOGM>0-;H#Q*I6#N*:M-B.^/6!VZ@6UVAI0HNTS[O-S`
ML[/ASQDN2$T><`.KH28I17@J_L6]B^>9;2N85]ZUH$@91<I.)%*FZYW+MO+&
M,PJ548*PLI)%R%-[Y#FV9U@OT*F"JTC@0^!S(N"CZ\U+55L1PI_CY`>C]ZBS
MF<)K=GQ5>S/N^ZYA<6P@_F`%$W5',GCALQ<]3=<'&GNA-W6MT>EI1;3FCLE>
MM#M:NZ%GVI&SN>">SX1CPD.NA2&F0^&QEJXQ[,DC_VT4-A*'PD/T&O.$CRZ_
M=2_LN;(UVI5M,S\T)DQ$J\39%L>S8?OD,@.7C84C/&[+AW`3F[?Y@<?Q$<4U
MQ8.JG^QC(E.Q)%BU)^<!$JT@>NAXPG#'CO6/,!<4MUPG78(G[&2RV1U9%MAX
M@YC\SUA,A6P?MRI@E@MV5%H\UHA&Q.MW?_P"S&X%,)B1F<PSQ>7&P9[Z2,T"
M'WV-16)-;.EDR+P[DJK`QS0MR?;`YFX8^`$()(*&'\`BF1NW,T0I+0H!*XJ!
MKV'W0I5$8DO$";\7C,.C@%G@0\NKU[5^HZOIG8%B)K/0,R9<(DL,B);OAU(\
M%:NR)/>X`'F6`Q-W'$0O6*3$UY'E<`=['Q8X"Q`(%B@_JFX!F;`>+A((-NCW
MM%Z_%:_+*8R77!K)9IYER(J+%_IEHX&70#!_PK'5(Q`6`,?RL`]"2C25<@(:
M=K]?K#Z:0%_O:ZU>-YE`\8'%C7JA=R\[C9('XU/:RI5?%V^]7(PY<D,/"/MW
MR+T`!H%U1AC\@"AJN!YJG0S@+^]['O]3`);DZC0UO=DMZ,C,/++D#N"+N,_9
MNSD>)A8H)ME8TPP%4FVQ;LF8"0?E:-U28O@:;/GA5>A?C#F??7>+3#MQ;5-X
M_MN_0RN8?W`#<6WYANWZH2?N8*ZO$4=^C`;](?GBIV@%5X[Y$378)Q?((@*8
M+D+A:Z#AR`I\Q3C(Y0'\\EF,_OV-T?S?=V`%ZC]S!U=XY[9TV&%\^<V/%<2_
M/#/M`0/C/WR-5SB$?5G,H:?D]_V]^IQN9Y&#/]F`(N6N#*FT3=H%SP"%+,.:
M`5J@C',V#>W`NA#3F>W.!;8+!@T@K3Z\"7@8(MPOSWHA<VP&>\)>HA$=[6&_
MV6Q\#^;U7]%N)7_3O_\V!3+`&E/%VL,Y:K^)Y9ERDG/F"^\>@7KFN7BHSOM>
MXC(^ZPUH6^[,%<M+IRVD"L`/I[-A@'U#,>'V""'0PGN+HU4+7S'2D&.+XG#F
M2B+QP)@@Q(]<#PC&UVB!R*-0+7*EDY$Z%7'OY<4.^!E-GM'(N=5)$'_1Z6J#
M9A^\(-`-W593BWR>9J?$(\H[+UO9C`M<WQ:>EV'^Q@%S2MSQQU.#\N/A>/_`
M.!YMH4*L8%=7][$B&%^"\:M`048%@BQ<"!`1V0Y16H0C84K3TA%%9]$%6QO,
M2@`MD#*?O<Q@^(>/O^30VP"+<0[H!Y:CN3"=,V;J#&#ZT0*@!"1A+WKZ98M-
M+=L&/``,NN>6+=NNHR,U&ODB8'S,+<</5"`Y"@,0>1;P1_D=2_)2;*I&YJET
M7>ZY-\>Y\ZD;2I^GH*B`,$U`2<\-QQ/XI:6KHR2QE\=M>YZ241$\6EIAMZTU
MP%V!B<!\`.]A<HBUI@`L=6=9$R8S2);$G^5K_/]UCM2P;F:`DD0-%4QXD#/)
MF\WE16;7QT+'%K"3(1:88/`&YF5;PE.N^X,;DU:U!P'*:<100R$<4,F6C/8@
M4ZD4!8EOF?BJC`N./`.&%QHBJ,5_%=X8C2_0=Z$?7XV`/A'K:-(60&E4;%).
M*&$O/2&-%C\<8H`@L)"C$[\.'Y/&,U2^[\3"H(!E`%;`XW)C^_(FB6L>SL`(
M8G?"F#BN[8[GVC(E`?:5K/:3^P!BX6GL-HXUM/K-9.TWV.+0R=PLN1CN,WS)
M"='>,X54_`@9D3WH1U81BL>4SYEM3:T`2:4B4R0-/%ZY7!U*:D;^,C*WM/`B
MJ(#AR<9@,#G2RL-80W8WLW=>&!,,>JK&<!_`W_<GUBQM\!BO10J<:QBAYT5<
M,.-^$-^+Z3/76QX(URX_CI^-<3/^]);FW/E*ZK48":_$.8EU4(2*GAC9P,>2
M>T&M,C$:X:_(S^!1N!Y/8X"+`4P+/N0)QX#O#T7P@)B*WY?<EM5B,`H'"`C\
M13`H.XYM\2$6#UHB$LHX7@="ZPEXM%3FL]";N;[P$W^IP,'QH^0E+#C(8G7+
M'TV&4DKU;9;7P25S'1&O`#'+S)$SIUDR*\PM".9AA^@@(66B6UXD:8+E,8H!
MU,AUTANJ2V$V8WJZ%X;:DQ,I<J2@3NU5Z-1.]\+4058(-@@VJ@4;="],=65E
M58T8]9"H^!FO94>Q^/B%C[/JDLK=R^`F^WE^"J;^<$%'PTD*2`I("C8@TB:6
MQ=;!H&RDJ]?=I)A?90@D=EVD^=O_VJX-P-,;%43S.52?@@,;)1^$HF0J^5E*
M]&93'(=U$N@HUG;"5H^C6"_6,]..Z5*#(UC-MM;O=?!LRG$58+W.8=$Y4`(?
M`I_G@P\"3U<;=%37V1'X5,,</V:@;P.3?ME<W](2/Z\8X>>X)K#<)E\J%BPK
M05I=SY!C,[+024E6ECXU4):];DOK#M0=U4E7DJ%>>1DC#*H_!K5TK4D85&E[
M_7@F>*82HAA&WU2PS]LPEX?/+^3ISK+GJSJ>J,WPJMOA3ZT]JZO4[D)/KJX\
MBV5BE1X]$^(IE>A3B%?2L/^@Y-.UP4#7>EU53%Y-G^JHVHT*X^K/C02`^Y-A
M`D`"P%YOH`TZ)??'$0!6V@.AC,'I.29WV/BMW+-@Z8'*3'4Q)0?JH3(H,+>%
M2JU68*[9T[JMAM;I42;]%!P#`B$"H7J"4+.OZ0,"H>H:YVOL[2<:UO6GV98P
M=9881!A=>XRNRH&GL\5HPAO"&\(;PILJV835"]A2-'8'/1XRS>L.7B!"VHVT
MVS/I0]J-M!OA#>$-X0WA356HMH,(*Q5@5]NRGGD"KRO#FX4.;3134>$V5*.B
M0BHJW(1\+UM]K=/O*:6ZRKJS@@6%WZJ(2*!7.;DET#M[T.OHVJ#=(="K!.C5
M,QA/OD85:JK71O/)+ZFCEB$5??8JFOR2"JEH`CT"O6H3[S1`C_R2"H'>#M(:
M5#B^&7>=96J54L];0#JEGBGU3'CSK,43WA#>9(A#>/,$JM4S5KTV(GK>(>>5
M]_!0"X_J2!\IO'-3>,V>UAG(SG^D\*B%1[4H0B!T1B#4ZVK-3HM`J+)6=R6*
M/@IR3,;V,EM\X788%9*7&<X,IFR[#]PQ2EIX5]S2IO0FI3<IO:E*;ZZTYBNM
M24\SPTFX1[A7;>*=#NZ5.A"$>Y6L[-AE%'^77D9;0?\3@(/]:R`%X6I/M5UK
M(*`1,]UP:(L-5-!AR5>1NZ*?1+82Y7-8PEW47^>H,*_VLDN(MS_1)<3;BFR$
M>`7"$>+M-7H?O<>!C^3;\-O0>Y6\K%B@/+^N+:A_)ZG_`:C_>0WUOPH%)2?\
M7C#A([4L?R)`@[!1:-O(B%%$?1$W9^+OD-LL<%DP$:K9\RDX,P%S1\P-/6"(
M0%7GPLQ0X!@AC.@%W'+D,<OE+7RP@@GSA#\31H"?Q@&C0YES_'4L'.'Q0#`_
M'(TLPQ+P6'B$W/+EH2S'<*?RD9Z`W?A'X/1]D4S'<O!W6'00>N+R*3OP-6::
MH6N;:WG\2D%[3QBN8\"B(D(#W7`FR7R!8D-8YL@"BCK,=F&Z/N/!@OB+@7Z_
MO+UD(V$"36R8.`_"P/7F3%(HVBYXULSU`MB)Q?!%_1/?<<HL>)#/1B[NO/_=
MZGQ)+D^2%S4I@LP0MCWCIFDYXYB<C5@V\!U_QHWB.SFP:S14</<D""K[0\GW
MU^B:C7*#Y4B^BW1?'2":2%$DA>$BQR>T:*[5^IM'*%<KEL4DCJC_#(!IX:TW
M@/==>='0-T@5[3(#O(V]]^P`:NUEA6"#8*-:L*&\))5@HUJR0K!!L%$IV&@H
M+Y<GV*B$K!PZ:_NL`'V7KE#>B#\P'K*B$K0D4L)G,]O"6)7+9IY8!$B*`V`P
M9G54),=>U:DB/5K:H6)9F\H=E:A(6J9:1R1>]@8];=!4.NO5SKT<E6R5J^$D
MU"'4J1'J#%IMK3%H$NH0ZA#J$.H<AB@O=4W7NUJWW=T=TQ#H;$"M30(`Y-,?
MWZ?_)#SX@'""4AHQ9EJCD?"$8R@;=Y-O3OJJ7O2I@=Y*![?,9'Y7K_6+5D-7
M3#T'/JWFI=Y9'BJE;DOKM%2J4$E0TH;5+B@G:"-HJQ^TO>SUM&9#F?,G#*(P
M0'5EB["G]MA3:E8U%5//F55-_;)?:E7IW8'6[BKK$90D)5"C>@.*3:SEC\_"
M%]PS)N4E1MPQF2GNA>W.IGA8Q?"$:94T?:4X1=44!BG4TU6HK;4*M7/97A&G
M:&KM$A^!%"I%*FH@O`1NM0>WSD`;=#:H,B8$(@2JH(01`M4>@4K-J_:SXQ7=
MKOK"5@*WJL0K#A*"V,GIK?,.4[R9<&=<:!Z1_%B.JNG'>J.B<@&*IW)*745S
M%UJ66L:>4<O84B7=6:>D]?X*)=WKZMJ@K[Y@N-I*NH*-:"OKEQ"J$JH2JBK(
M-^CH6JNE;,)-X'=\3B3PVY_\$OB=._B5FI3==2;ERKA/K]?3.NIV.TJB$ZI6
M)QI4O>J5E>B]:5/<\PX=?8[;AY97N&3:EL9M1.M8W/)45JFK(.]-T5/K<VI]
M7D$E?$JMSPGQ"/$(\0CQ"/$(\0CQ"/$(\4X/\58%6J+W%-?;_/`J]"_&G,^^
MNY'.^!U_O+9\PW;]T!-WXC%XC5&('^-'_9!\^+.P.;CVG[@7S.\\[OC<P!H0
M7_%=9L":X)?/8O3O;XSF_[X#DN@_<P=;ZM^Y+?U:&/CRFQ\K&#%9HN`3N6#=
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MX\-SL`:E+-W!(,GM18H'^**XI(2.T9(E.1>[A@OQ<8'1[D4W6\F=5<SM1;,]
MT`:-GL9>Z(.6UNVU-4G;%_T._-**"`(3G`ON^4PXIEHT`3S%=`B[WM(UAC`J
M_VU$8V$;<2VY$0M8R9Y?DN#N[/XS[!0O[\;"V[(>7.1PU'0>0*0?,5'$!_%.
M%GAZ%GHSD"N4(/B>&<(6`6=Y\;'0PNE/1-Y[:W'Q6;EPX+UG8P!KD"I0M9*+
M/MS\Q%[Z`EZX07$FK6^5\G$=>C@C-5<]"'D5F;?@RPQOZYK>:VJ]3A^Y6VL-
M=*W9:"7\C1WK.GJ>+S6@0E':5@IGCM[*^5_9MDID(KGT088M<R&MH8/861RY
M!%H2H9>WE>'-=#[NIQ\BU>/;TY#F<AN40D<25R)Q=Q//#<<3!<T_N/<1UJ4<
M:`ON`U.X>)^?D.QE\Z'K<=F?'6^)$W@-'E^>_Q3F/KD(W`OY@@VY;_F1K+R=
MHA)BKRUWH8P`8U,IU(I,"F;S);`V<(2TGX"MT%A:8MGE&4B>4S+M9Y3U<L:'
MB<I%*\@3N`&WX9,OVBU-UYLY#1(ID)RV6)X2$I4X]2F<>N,H=N%7"=Y`S+[D
MT)R6X`CT?FA+H%_8/@L&R8UT[3K<-ME/%EAU0\`1$[D,-G4*^S>-MC&^-?.U
MRSTS@Z#902Q`:1`'7TH'?C@>X1/`KV7BXR7OX?_9FXDE1NSMH[3U[E4\]E%*
MFJ?EP.YA8L&2?_4N,W-%F_$>QO?9,/312O,5]B%\3(H9&(DVX^:]Y4NY%=X]
M/,3/7QJZ^%ILV)::=$#P:6($J^BM*=;%@3Y3*2,:&XHQ=Q`WKF:>93.I^QI]
M.5OXA(_O%.6(Y21);^Y"H2Z9BUJC`5]XT>EIW4;\S?2795V:IM-52RV:TBHR
MJ4U%`H.G@$'*)]&61U+K)V(+`_)Q!`&XF4M2K))AU"V68<UX="FKW#M@TGN\
MB61F@[J3@[G8T!3W4F53X8,-=PJ:+W(:Y:,?N(>&B@\&IV]XUC`:'6U%U@7.
MG`"$#8M.&3Q]CD!@3*06!J'A8^`>=&=QB:U61QMTVLR?@`F5+CIZ=G%>T610
M9_%(DZ4CXPHC1_-%L]G1&OV!G#/01`"_F\N[/((_7DB=EZX*+V=)!L-9FJ:%
M3BD\HP-FZ:#5C.>HH-:H2##Q*#S#BBP_'H"!>]EHL!ELLAQD*[%9!.&>$%?[
M,>&U-"CW6PA?$YX]?V>A<VYQ^\9!N)<N.,7CGA>/TQL'#LC="AO$7N%>I=O,
MTGUFUSS@[&7H\!!X6YC*CGH$WF7@?:7`HW`ZY6"-``+X\4:POU/"CU+"FTAX
MA"V4&02FHEVM-]9?CKW!UM#-V'1!(Y$B1XK\795ZTC=@'Y=55JR\MS(75>IZ
M:>XYU53LK0Q?'[:TEVZT?`+5-JG1)X0FA'XR*>@VX>.#]*_9-J.JI[>4MR42
M-%=+E`A5"%4JA"H_AXXJO)S\M)0',0E3JB5(A"F$*17"E%LQ"V2.A("EYM)$
MP$+`4B%@21*QY8\G'ZC"LK1)>*HR+20Z3;H`9;/V$/?""8OU/<F/+,B3!91T
M,6M5E7G].G)7Y+!?M3IQ]P<MK=%H;I"AV:M^.]N&V80]SY0QPI[:8H^N]3J`
M/B7-,`E_"'\(?PA_]HD_S4$/K)^2B^,)?PA_"'\(?_;8"KRK]=MM\KTJ'%ND
M<.'QPX4?A*+%1/)CNWY)3Q**$Y*NJA=]:J"S7G8;7:W95P<,26N5D4UY*HO0
MA]"G0O2I`_HT=5UKE9C,A#Z$/M65+D*?^J-/J]?1^AVR?0A]ZB9=A#[U1Q]=
MTSLML'[ZNR,.@<\&U-HD3$@EB*<64UST]:'H8CTPG'1<_75<X[*A<NY)O9%M
M75FY(MPY"=Q1G0(BW"'<J:Q<$>Z<!.ZHPHF$.X0[E94KPIV3P!T*(U8GC!B]
MI[BC31+X=+J_/KF^DII)$"F*I*#FK^M,CSUO*G:V+HV$4_/7VDC4)JDM0FA"
MZ">3@CH?'1^DJ?EKG:&94*5("D*5XZ,*-7\E3"%,(4S9Y;Y2\U<"%@(6`I:=
M[RLU?ZTUK&P2GJ+*ZYI57E/SUXI+W4F6`U`#(F4#M%:KKW6Z2M-:N7HJ!]B;
MM!'^;"=GA#\UQI]>JZ?IW0'AS_&EC?!G.SDC_*DQ_NC=EM;LJTHAU:LG_"'\
M(?PA_-E1`]AV5VNVU=X784\UXHL4,CQ^R)`:P%95@DY25]'1H55'A[J#AM;K
ME[CLI+7HX&)EI8O0I_[H,VBUM`:A#Z%/[:2+T*?^Z--MM[5NM^2^*$(?0I_*
M2A>A3_W1I]WK@^=%S>\KU;J!ZA!/-:A('6#K!N*DY.JOY*@#+!G7=9,KPIV3
MP!V57T^X0[A36;DBW#D)W"%[AW"G5G)%N',2N-,BW*E,&#%Z3]$!]H=7H7\Q
MYGSV7=Q5T9Z_LQSN&!:W;YR1ZTUY8+G.G7@,7F-$[L?XH3\D7[L-A[[X.Q1.
M\/8>_O'33S(#%@._?!:C?W]C-/_W'9!`_YD[S8:NW[DM_5H8^/*;'RL8*V3+
MM'OBOM_)??\`^_YY5:?;K_$"AZZ=Z;J@ZY<9;#G`J\46*E8?[:HR1)E\*!>9
M7+!6!?=US:9&NW3WQR^P358`@QF9R6RUT8L)?/*L>QZH>EM]LKDAID!EYH[8
M&W<Z=1UV&Z`$<<=D7[E7=EB=G>(>[(K>UZ%G.>.BY00(!$`W9X`]38T]".QY
M`J::P_AX[(DQ;!%N0[O1TP:#012?]_$O;JAH\V%$N^7+W0I<%CP(^U[`U('F
MEAERFW'#\(1I!<*$O]X+^*3G%\=Y:3F&'6+S;=;N:(U&(WFPG!P,/)5]1I*)
M`&!PSX1?5*:/:7G"P,=(]@$B\;'DKF\9H'E^H;/0,R;<AQ>>98CE[8%GO6CV
M6EJKVU`"TE<!>^V[S/+]4,A9!A-16.5BO(>8D_&3Z9.7"=^%76DT]`7AUQ"=
M!XQ'TY?SU2^!=FEB!?9W8AD3)AYG0!28VDIVZ%V>BXSM$^=N@!O`?!`JUI3X
M!OSA!1;VG/_DB9'P0#P([IY-]H^.0K/(%JVLJ6M+:)=#-78K/`M^NT*#+=F;
M@O#.TKU*P<Z`SW++@9G[@16$:"8"X*7R'\/-,A7*T">"F\LFFUJV#4,I(>=N
M(HHBO#PUR\^N1"*$,Y>F.$P.YKT$+1GV!&(L@\N+QF6OLT`4]K*I88UHJ]5*
MQEF@2G92"(7I4K_5F!\._P18EMCG^GXT,_//T`^DYN<^+,,%G2',`NF!Q#@:
MDML:648,E*;P@?&D<:["+1*4,CLL]!"@`N6F12H,O*"IE`[\Q1<&6!(!2LA"
M:<&^2IVJX4>*'+F0`:D@01\+ZQ[X<P3_7LP%S\A<1BDJ.+M,2Q:8,!;EB'L5
M2+#@Y[R&+).RX@15]$*!L*93L&]@7O8<]*SP#,M'-S,S,$L,!=EU*;445`-F
M",=<)Z85WDH2@TM*$!GAT)A`B0%E8RZS4"PSZ+\B;>+5O$Y7H^6,D'"6(7]V
M/@LZYP@<DQ,!#F;)Y"P?K&""^Q330(E3"<SE,463BJ_`&V^62)]CT_S4U_!#
MNOO+`SV1&1;DPYU7[M]:9E`.O+S4W)BN`X,A6T@R#06L260'1ZZ64@L0$)&R
MG+_$8Q!+;?PEY<K2/32W0-9%0*4T,O+C4@3%F`@SM,7'T1=NAQ+1KQSS-_`>
MK-$<7((KPW!#^/ZUY1NVZX>>J%V,I:Q?XS'#++=O?GI[_?LO;Q4L=W/#(C[M
M-W7]>_;EZI??K^YN/GY@5Q^NV6^_7_UR\^Z/FP_OV=6;-Q]__W!W6TMC=7T/
MS4/OR#M7U:$7Q?0/P$4_NN^%)4TW62NR:Z-_&U+RFXW&NF8_*S;CA&["4E20
MKBD*I=:Z1(HB*9[397@3`IT`B:CE+LG8#F6L^R3FH4[>N]G7J]C'5,8=]U>)
M3]BQ#=4(.T@_DXR1C)&,585$)&-/H-JJ.JT-G?4G5Y9N;S/NR5Y<]QC&,A3?
MT@P[S\G6^,SLM?`-SYJA(:Z.XNW/$B=]MQ-]1_[H;O;U-;<S133%A_-@)XXJ
MD3LFMQA;CH/U@D35W5'UXZB4?S\)SW+-M9A%L99C*P/2BZ07*P0I;R;<&RMJ
MY)*?P"4$WR6Y75]=^97\<$<%XD3QK2G^]G$F'%\<]FY"4HW;4(U4(ZG&"B$'
MJ<:#DOMC,(%9D.[;(4F30E?2?94'?-)]I/LJA!PO=57_!`+BK?,P9FB4ED,1
M&%<,@0B,"8PKA!Z4NSHHN=\J0W!$3DI:G9M"W*2P*K>&`_?1W['L70S6"M_@
M64VP#BQYGX4OO/MRO1%9I;*1CCP4&.L9=CL1(J]2]CM//&1;'F6#B5WYOI"=
M'K[*[C-6P*YF,]L2_G?JJJ9CE#6M+:NJ@\!O:_;5'^KVIB`V-7-K1222`I("
MD@*2`I("D@*2`I("D@*2`I*"LY6"3>)$:T(_9R(_9[),@@F""9("D@*2`I("
MD@*2`I("D@*2`I("D@*2@K,O,SFM%C-7MNT^Y.ZG*4X`^_I?)W>*W/''J*#C
MT+70A+&$L6>+L20%)`4D!20%)`4D!20%)`4D!20%)`4D!9O$7G8<3LE=[M1.
M[G9:*VSG'69)![?,A"NO7NL7K49/P;#+1Y;RPZ3\@I>`E85=&!/JR\$.'+1Y
M%G/I"MZJJZ"N5U?*I5<;R%ZHN&FO=!FLHXN\"/6H*K#9TSJ]KM;LM(ZK`I_-
M3K47-0*?[82,P*>VX-/O#[16L[F!EB?L(>PA["'LV1U1+G9(%`*=;:A&H+.=
M<!'HU!9T7O9[+:W3;RLM'D*?,K*IVD,2ZA#J$.IL'.,9Z-I@H(JG$NA4(^]Q
MS)I32I+L,DG25W#V'I,D#4J2D`(E!;IG!=H`!=IJ]4F!4LR@6A0A\#EQ\-$U
M8!BMW>BH@P:$/X0_A#^$/Y0H(=`AT"'0.0W0>=GM=;3V0!W;(/2A1`FA#J$.
M%<-6`G3H@(A+N8\X]S%0,.O^<A_P.,I]D$XDG;A/G=C1NKVVUN^KRK1))U(8
M@,"'P&=_N8^VWM7:G2[E/HXO;80_V\D9X4]M\8=R'\<6,0*=[82+0(=`AT"'
M0(=`AT"'2EQK(&JK4A_1>WQHBR1J/O1>)2_EWW.090@G$%Y,NZ'KF<*+WVG$
M?S2$;<^X:5K.6/&./^-&\9TTU#_ASMC"_YGPG`M=[ZFVKM%0;=Z3R%SVAY+O
M%W"EF#K*\UW@SA13+"9R5G-8S.O9(;[>7-_]!%_NSQ1@5Y),VG$JYT[2Y@/0
MYO-S6'B?N93G4JR("KE<V\:YM56/VC/M7^JJ@HV]D7P3HJY+-!Z>2-?"#(W`
M<AV_W%Y@S!,S3_@`2"R8""9&(V$$S!TQ\3BS/$`K]N'C+\S@GC<?N=X#]TQ?
M24K\&0&<L)EGN1Z;"^[YE^OMA1ULTE;X_\.KT+\8<S[[[M:8`)UL\7'TA=LA
M1WI=.>9O(>SG:`[KOS(,-W0"_]KR#=OU0T_<B<?@->:A?XRF\L.KQZ%G_RA?
M_W]02P,$%`````@`BUI^0$I%6\=/"```6%,``!4`'`!G;W9X+3(P,3$Q,C,Q
M7V-A;"YX;6Q55`D``S;/=4\VSW5/=7@+``$$)0X```0Y`0``Y5QM<]JX%OY^
M9^Y_\+)?[LX.-2\A"9FF,X2TE)0`!9(VN[.S(VP!2FS+E6Q>\NNO9$QJP,+&
M6#%M^Z7$R'J.SG/T2$<OO/TMGU<:T(($.%!7A@L%U?_GF'\H>:6.3;NO(:5I
M.>Q;S4%3R)Y94TC8W^S[B>/8%ZHZF\W>:*PHU1"!%+M$@Y0_4/+Y=PK_]]__
MO.4@=0(YQ(4RF+C*+2!*J:H4"A<G)Q>5@G(WJ"NE0K&T?(F]82#K:0@H5.:F
M8='+7`!L/B3&&TS&:JE0**NK@KEER8LY?[!6?E;V2A>KU:KJ??M2E**P@JS:
MHOKUMM77)M`$>611!U@:!Z#H@GH/6U@##L)6#+L480G^5WY5+,\?Y8NE?+GX
M9D[UW+NEYQ3E+<$&[,&1XIE^X2QL>)FCR+0-;I'W;$+@Z#(WQM,YJZ58+):6
M=?S.G_S+&*/80#KW_14P>$OZ$PB=G,(KONLU7]HPAG@*YIPZE7^E"M]4WZ5O
M6M-BN+#OL,\FM/:T;O-E;F#J%M8!G7PP\&P_TU[>4K\SJ@%#<PTO@%K,A#7C
MX-R!E@[UE7F\POT96K6?@1E86P,P>.ABLJK?`$-H7.9<FA\#8/];HQ0ZM.X2
MXI$0=)%O@Q?#(T"'7B#[[ZG<=2HT'+IZXCDS7RCZ\?Q[.("Z4H@$IG+/UBS/
MP>^_N6@*#%8CK3EU0,@"6>-[8+A01A/B`:L!#@*$U\AZ&P'15C:RCVML;RN&
M7T*EKFEZM>41B_C5^R."S0@F';RW_S#1(;G,%7/*#*+QQ.$?6=L24=8@@$'T
MH`89W'"S#Z;#SA;&=V./DH9MG_@>+VUX/'%'Z1)H`Z2_G]O0HI!1WG$FD$CO
MZ7%@OXOBL=(3RWD^8^5MQA(1%H!H8TN31U$X4-+>_0%9S-$M-DUD`S*;,HT1
M"V>_=BC%_@C$S*-K)Y'!*(MRG4"$D_%T#4>06:(S4#YCJ&,:-$\25=&@ZQ)W
MU'3%\&#:(GX-;4P1&Y]?01:$6(&0.W)^1,X2*/4!<V5YD^2CF+F$N3=\]-L2
MI^3S%6Q#XBRZ+*%QV(C+9Z>V*4^:=N)EKTIB'G8[*EJ!CJLU@MXMG%LEBJT6
M`D-D(`=!F5/?$)1#.D1-T[#+DH0N6/`,069V'HZ4=2XK9FU-E@1N2C.#91C$
MA?KKA)$8+/.9;6Q&1-X2JU.RZ9$+![@'#;X2U@5$,C$[T+(=L^/1LLM9XE0V
M&3%]!VM/$VRP6BD?GYR%#$)"4`Y:6L2FB2VO4GFKB)L8V4:.F*>U-<,MQZ0]
M^:OI.N*F`J,+$$N&Z\!&#C`"P%*4-AHUX]PG'C]QO"=4WH1YZ10:V)MU]ATP
MAN_Y9J%-$(4L248:<M@8X)JNIS77+D'6>/,-.1GLP5;]"-TQ#>=O"WX^^?0H
M,/ZP?.1UM#\2\XAFKSN=$F1VQY1),(_]45H65DH@2=YFJ;JQ6_I.XA[JYCYR
MPE[0L?EI"M;;_%T#*6M$VR#)1;P'*62\\^W`@$#X%<LP?C=@ULN,(OJ"81SA
MLE07[)?'<PP&5=--9"'J</NF4")!49#9ZDXLAB*]EG(*^F+44D5:F,KM]P&8
M961YIZS^_G)[7_[G[Z^:[<X?K$I5?SZ;CA\6UMVU.VN<D>K9I]+CW6!!C;.I
M]EPP;ISSNWJKJS_\990KUM=AIW[=7#0&WXIV]7/UJO-PCTJ-;F_P$?]ICQ]Q
MNWM^6K2J[?O>]*Q>:IR?3]3R;#;Y^'33`HOZN#J\-V^NGNQ&P:Y^@=A9%#Z,
MFU>G`[/9;#>[]YV;AYN/AETRB7;;'SY^>;2NAU6D-N=/'YWW_7ZY<5[L/H/&
MPY51:X+QR4,##^#PZ=1Y_K/]V&[#D_(3,,\:O6%E6"E]<^EH.'F\K7S]RUZ<
M5BNMTT_/I8II?ZY4R^73QH-FG)Q^-B;G[?+L\A^EWN_YA]$2RN,46B[\P&)P
MN5LO1Q(W0;*>M^P(Z'4EW/).A/H=<6-"E&5;)O*')$QM;.%U6R3*N!CL`*%K
M6E-('3[<+:OTSH>R)S(:(,3*.)PB60P&E=AA::^>K&J6&%*;$)DO1>])Q8:#
MA+T[6>>&CMS1?QT@^^V\T`:'"FJPF##LC[DE.^)L]TSR55/8E_/&R?6]IC^Z
M2[FB?)M`PY:&#+CFGP'F.%V"IX@9>;6XHSQY?N&ZQB\+>,L"<A9K4[0OZ4K7
M-;0)U)#''OML0"]86:YA8N*@9^^YI+,YT;@9'QR1$#\;IWMBN#Y*8_8^0[L\
M\N4M7_%]30^U,^I!'9JV9PJBWOZSI+.TL>&S'Q1D!\!>9*1]$*\_`01>`68O
MOQ_%]%]:5Q<@93U0RF97Y."4#UD'U:(S6IWHK#/PL:1A:R=@QOF,;%(CO.US
M>Y+&$1UF,8&`;X$M_V]:&P>#^%"Q=3!%3JJ4R)*?/!22\N/'2$5.C'R_@/-*
MH1`$_.487_.V3^QI.BGX-IA_A6<E.J%7>5Z'\UB6_'+!$(\?/TK.9$6)?V?@
MU6,B!/?G3M_BN=ZG^WQ[U3WQRER&2Q9[H!^PL_`++CX>$(<;[CJ^TS6'-2_=
M;ISR7KF@:<N-DJQZ8QCZ(2M&6(-0IWQ?M`\,V!D)K^O(63&*#W^T/7E'/&S<
M@XKOZC1O@["$Q>]@-8TA$/BZ%,='SWK-Z$!^]W"S:#\O39E:7OO-2J;"T-.1
MJ2:E+K_/W!E)/FX?#7JTDK2#>Y$D"=R:JA"%PFVLDUOZ\@'D/Q/TNM1&6I+U
M<0X)9$=[7S2I.F@LZHR\VE=V>+]-('/T"<7[X;OO3F>*KDRD^3M674@0UC=S
M91E$[H6?<3]-XJN-G&_?E.>8#C%*:G[H-"Q"G'ZBYH=J@FBW47B@Y^W++SYZ
MI?X/4$L#!!0````(`(M:?D!+&KO.>Q0``&)1`0`5`!P`9V]V>"TR,#$Q,3(S
M,5]D968N>&UL550)``,VSW5/-L]U3W5X"P`!!"4.```$.0$``.U=6W/;.+)^
M/U7['[3>EW-J2B/Y%MNI9*MD^3+*.);64I+);FVE(!*2X%"$!B!E*[_^`+S8
MI,0[`9+*8%[&D41T\^L&ON[&[=W?V^W6+30A`1;46]--"_7_UUK^7ZO=ZN/E
M:JRAUL"TV+>:A=:0?6:N(6'_9M\O+&OUMM-Y>GKZ56,_I1HBD&*;:)#R#UKM
M]C];_+^__<\[+J1/(!?QMC59V*V/@+2.+EK=[MN3D[>GW=:G2;]UU#T\<A]B
M3QC(_#X%%+:>EX9)WQ\$A#U/B?$K)O/.4;=[W/%_>.#^\NTS_R#T^Z=CY]>'
M%Q<7'>?;EY]2%/5#UNQAYX^/=V-M`9>@C4QJ`5/C`BAZ2YT/[[`&+(3-#'JU
M8G_!_]7V?];F'[4/C]K'A[\^4_U%1?8;W7H1$VS@M.-^>>``UFJ](]B`#W#6
M<M[QK;59P?<'%"U7!E?=^6Q!X.S]P1ROGYFXP\/#(U?8/_@GWYAI*3:0SHUT
M"0S^RN,%A-9!BS?\Z6'PHL4<XC5XYC;N\*\ZL4]V)*OV;00(-*T%M)`&#%I<
MT^V&9"@^,)D:<&RQOY=,5CYEMQ_F"@K1<+Q@;[[`A@X)O?[31M9FPIHXPN0X
M7<&$9YE^HO'K`[JX,?!3/N!>GG(0$Z+4/;9@NA+.KT3Y$6^LFTUF5_";=K/*
M[8HRNMM:9K%=<9W!:S"[:!]LH=)SB.^*];"\TL7[6FX-1'M=?@4D^%\!)>1X
M8A%%Q/DD#\!TV\@PV+[\4@P(5UBS.<WV3/W:M!BO#<P9)DLGY$M7)O'IH(*`
M:%EUC`DB_1B01X^GCNHZ8J(ID]36X0S8!HLS/#%!E5_:0*;588]TO-]T=A_W
MNY=D9?$2(+.PKN[3@<%(AK8+U@31["ELOTC.IW!4`]+]P8&FO83+*20Y\0T]
M^CK(R5`3&$8^Y?@#KRHQ9T4FXAWLC@D/J06?+6CJ4/<5XT_GSV2\$8V),K`6
M:M_@J2`F?O,&F$+C_8%-VW,`5M]>(G:F%QRP/VDD0,YKS@"=.N_J/=SA8U('
M&A;U/W%&J7;WT$L2_Y$@)>!7Q96>@&F,144I[$KHO,+[:LD>">O,+.^KXCE!
M-B_QGID1O,QB%PO'`X$)2W7>'S!&=/WWK89-BSG8M>'\BO4!./?3LW+(CS5H
M`H)P[QG)]9B0H%>UQ9HA<N1,-$O(\R)-$D;HQ3(O8T)^[+T&/YET!34T0U"_
M\EA)`OZQPEY)3+@9=NDVT091/A@R13Q@07.(-<:W;N7FD&T+/TZ38PP.F&>.
MP[!SY;-(CU)HT=Z46KP6+,,(6Q*DD<)62%2<'K8A*0.S6^ZR"2]#)D$=5RB+
M?%*:\Z8C&/T.'+VD-PT/X\4<E5?\6.K%_\>+DFM@,$&T9_4!(1MDSC\#PY82
MU&03'"2HRJR2[EU!O\Z(8,A8A4QU2P!K^`%JD`F1%&KNR*BA4^2#?Q>5X,!2
M".@1@2N`].OG%2,=R&P[M!:0N*IX>LG`/HM8F?&.*(MD@L\STE&IU$NZ2:+`
MKXTD<KCE+N]N`]\M!?R(8):C6)L12_J=RAT;^%8\`KB'DKI&@KR:S9*E0R2A
M)2+<#'B"S)@S2DR=@6<Z])'`"!E[;OBKPCNTYM/-%C#GB)&/*TE2)TB16`\U
M9/#`H#W24"N="E_!&60CG<X$\7ID'U/6,C8U=_B39)ETH36/41FMDP$\$:/5
M%5QABI@JKMU?!,@Q38RL.L>MS.:(PTG("!;00JX-H@75F&ZG.6`,@T18H$0Z
MY[8I+VK=%X!]'$(C2R%$[Q"8(H.])Z0LRAI;6/L>6F\E,S3*++M>FLY6JLL.
M9*F!*)A6!D46*.5%/5ZC_^?UQ.U*7R0:0C*WGJ9AV[3H"&QXM41F[APMJ?:*
M7H*GA8:E&*`$#/R:1FRH!_20:X488?67DK);(@ZOK6BT8#AJPPE^@`9?QC`"
M1+)!$J357&O-:(XDN()T4);")=H@MC?4%S"E^F`,/T>.2\5F@O!RB:RE,WEA
MZGUL6LB<0U-C0J3,_R2(JX4CRG!W)@Q%I,[5!K7)8>P^&BA[+%NX#V'3$2)O
MXG1;1HVFR-\[PNB(F,'NZ;KSRL`8`:0/S#Y8(0L8`6%2XJITJ?4NR<ACF"P0
MED_/K^`:&MB9^&!IZ!Q>\YV2*X(HO&+P:,AB@9Z]M!T.O+()&SFWGY!3("RM
MU=YT0!$6V,KX!;%8->Q5>Y0GK`<D<YJ`:#"-9.NHH=4;%\HQ7CK.43GNNTYX
M#7_@&]F+^[<W_ZJU_FJMOUKKK];ZJ[7^U:SU3UA!$2"@WA(3"_WP]F"*MU(!
M+?9AXJL(N$)JT(%4B_'KD#CJZDZ6/(+$.3I"<BTA5NP^V"T3?$(6300D.<W2
MGFTM,$$_7L,J20;:$5=K-)S;+KMH>?8X+EY1V&E^0*E=D2$\435GE`7-X./D
MF>!$3,G3;7MH6_P(*)TE0)48(BAO/ZT10LPSR6E@OW:UR=[VX4DBTB65XZD<
M3^5X*L=3.5XF8SS`-31M>,,T<[>WR3#"KI`]""@CD"D_,35<\?,\&?MZ6ZOD
M[J&)%;8/B58"5$+2JP=((5.:;Z@-5,\]87)Z09+`6C<)I'EEN%\DXE9Z1'+/
MO#58\SU]R7#@FO`C;B5:)DUDC;.NF;PTM$DY#;[RJTIWW*62P:M>SLAMAPB0
MPN6[<M"[J=,=IG+!#XAI_K$?D>"$2C]%=@TXNW+<%OW]T'EV#20\7NMBCB1`
M4]];0#%G8*XA==8ONC*<P\S9)S+<.596'3Z=T:F"CAV/E8A5;7YK$@EV6T2-
M&P+R(K^%C9`IF'MLXO!8)1'[>&%[8X4$O(2D`O?0DLNG80%[43K>PF2W5IR/
M12\!11H/GI!A\WG-/!0:]VRC<4Q^:P_.-Z7<]AH0D_4(ZL\[;DF3X<AI(NO:
M5Y3B7D''3D5-0(GS"T3S!==CS4:M.;RWN=K#V<X<C"-;AIWR*5`C$>0P7$Y0
M=XIU%4QN)5R\468)LYK:4E-;^9%W'9!?%H5-9YN8["FN2('2[")CKBL:LM(E
MS:UFY<UV10NJX*C<+--<2?X8(NAHM(2<21!8$/$Q1$F2UHU\W#JCOXXX-='[
M8E:+^."(.0@B>L^7/`,D"ZRSD)G9%BF8%9^)="]P<58$V5.J$;3B8EX/-8VR
M2MPU,*FMU)RAI:*=%0P!^W4?H,6$0]U//^1Y?XRD_1B#XF#:*N,+Y&$Y!]?'
M,K'\)2>9CJTO1<:[1]?G'X)Z^J/MUK3I!,?M"O8W!YL605/;P8I7I>!J=[-!
MS!@E0$RSIVE$X"A@8M(91-VUONZ.Q!$D"+OKXN_AD_.-I.PCB^`]6&^4$<$0
M%8DTE5M'J<-6VY(;7=?-BV*8N(3W+6<BI>I^Y0K=9S,%L1,PF9WH#%6;*"BU
M^8LVLD`7GGPJFN_$>,$-)OQ"C4\LP+E^AD1#%`YG[OXNFV@+0.$70/@"T.PY
M46E)S36;2#B#DV#";.HZ3B5&S2NJR:MNA4+J&?:L3'4BQKT&YAV"]G#&51F!
MS7+GV+X"_3*JS08'C,4P\FQR+GH,]7;YB35+?*.-#CH*XN29YJ)DD34]#_3G
MNZ'.$WIH4F=?N:/PT$D%Z0-D^3Y%%AQ#LD8:='5_@!J>NSC+*==6HWJC?:=R
M._I)?\D3\=*U]6A!WH;I_$HT-[XJ`:QOT')K$Y.()=KOJLX^8[1H<G15!ES?
MK,5/.DYDI-IMFJA&8VNOI;#U35KB/(I,-.%,;*T,).>X]WP:--Z2>1'UC7@B
MJ1++]Y\2"E]%5E^2C5"AP7E1851]2Q99W)QI9`\$9G[J+"40RJ]$\P.A`L#Z
M]BRWNCIY9*_9I$E:['$@E`BN;]:SPH%0YMQJNLW9J?F4M#/8I>O\<Q!S*:OY
MGG4NH6#IW=F=L,BH=/TR@X@&T[80!'T+%JNAI=?MY%HQLXQ&5[#$H.BO;RB^
MVGI$L`:A3OG)+5P3?I[T<";YDH9TH8VV70[L?`.5OUPFKK]CD\?H#!HNF?]M
M\;-1QU!CO[0DW1%43J'&<VA)O'V;RUIUU"239]6HP90J"G/?[+(6+_4T-S[C
M@7[5G3HD>X]3I@@@?;.=R*D8UV2U".'[.NQ&X>@;[512#F)`2KT)(S^G%I)X
M1+7;6+L41\HWSYLB44^VR%BPA9(;;C![E4#+M]*9M"E0?ZW3<";O4O5<\O>[
M@KL+IV_"<WG%VQIM&*/`'L<?<9#Z=KPH'(2H4WEVC1!]*L]QJ34\?]4K\G*X
M??0]:<?E2B"2KY'8O3NBX4!'71=Q'-AR&W=^R[N_M]NM_WSY^/GXO__Y0UO9
MSU_-TPO]Q]EZ_G5C?KJRGV[/R,79[T>/GR8;:IRMM1]=XX-U_JE_-]*__MLX
M/C7_F`[[5X/-[>3/P]7%ORXNAU\_HZ/;T</D-_S+:OZ([T?G;P[-B_O/#^NS
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MS(TU.4W)"4OYJQS^&NE)(6]+SU@*G#Z_>]H!7\AA:LB`3`9O?8+9'\X>-<KO
MEBK;+43)JNM,S")6$PMR^4YV!5>$#9S.:A[VMP$=\$SIEXYFDEN7805W@F!O
MS89WZ0/Q1LQ4D!#H+@7I:1IQ!`UG#U"'2V=-R!6B&K:WMQ&*6JR177R=XZY$
M0^>R@(CS8:K;9I*P/>AGLV+*!I,2RS6"'7XXN_*<I<_DS>6LQD@66-M%#1*-
MEP)QZ8M+6$OFG&\Y]FZ5-O4[!*;(*)`@9&KII^IA>1`,'R!3]!(.-@*SCGP%
MW?\/`HLBI?2W9(&U];=<3AN^J2,10"$'F>[*8#2Z`DCW.Z]_EX6I.R?7R)M>
M+*C)SV#6;)`+N:=E5SB+B3%%5N76C9!;6UHISI11:)8/77;EL/"6![)T!#9\
M..#Y#`MX;1C4O!H[9M+D9^BEV2`7<JIK+/N_UITFV#EPA>`UTJ%^N8D-!:1$
MMB+UV[M>+]8ZH5"K:-FV1E_((;V^<+IDN3>O,?,?;+&KI7M#GJ`ID*3&]FL*
M)!&6\DSKG6#%MV7RM<P$,K,S0UN;D0%,BXT1?,',:O<P,$%5O.S2&]*7,GAI
MJ$:7`UX!)=G7G5]C8,#AK%ICYA#?F*FPO/;,`[&0"<JHH3A"Z0J9+DKZ?O;.
M//`*9+H;9`(60HEANJ3&]HOI$F$)I1EJ3[&$OI/!*XMM,RYQ37VTD*V)+U-W
M/X#LRXH-F:I)?74`X:9-1UW`'*,?+WG'$OO2^YC**=,ERMO;KID(8OF<(88V
M([2L,"J)DMZ0J"2G^?+`&Z3%0K;TSO/@_^.1ZYK%M+SDY^P+VBX)RK!F+OG-
MWRB7#TX1LX[1$GO,A0C9,&^1=JI5-L%[L&LE(X*A&RP*[!VV5RMW`3TP^+(<
M`U.;0/<8<3Y2#,P9)DMG)4&N9*!(NPW?W%T$J?!M[`4GG2P6SE"+GTHF9RHI
MT'Y]U%3"$</S14&T=D+]"F[JOL<6/"A^EHW:LJ2V+.5'7FU94EN6_HI;EEZ2
M$V`Y;.'-!DHZ/RA"RE[L-(]"9[<J4A$W=M6&7L6.BAT5.RIVK(H=QVANLA8U
M/A7LKI[CA^Q@`VD(T@GK<I>&I/F)C)+W@D6SHE@?L[K4JKA5<:OB5L6MBEME
M<JM3M+S%:TA,KL(M/RXRCDMC:N3Q3S=^A4S"B^\L+ZN,_3SZ4_RG^$_QG^(_
MQ7]5Y)9\:1UR=^&\3MM)S2E3)#:9.[."%K7'M#H:Y3RJ.%1QJ.)0Q:&*0RO@
MT(^0S"$)7=O1,W7&#,XF=O[/5Y:06Z\MJ$GS5T`6A7B+B2LFXJY:2*2H6%&Q
MHF)%Q55-E>Y<RL#'XHHRV^S"&[M4N@".08JMFE_58B3%L(IA%<,JAJV,84>N
MHOZQ>B-,+7Y",'$4NX0FPZ6R4G)A71K/O\51KI6.U0HF1<B*D!4A*T*NCI#=
MXQ(GX+DBTDV4MQ<K@9,1JW'];Y!#%8DJ$E4DJDA4D6@5)/H`#7YIZ0@0:S,A
MP*1`VYI5E,JI><3O!<7FPK-VQE4KIA3=*KI5=*OHMB*Z_9?-B`$28^,=/P>,
MP/E`4IDVH^2](-FL*-;/KVHAE&)8Q;"*817#5K80RIY2^*?-M+A>P_BMK8*,
M$2ML'W;S)$!5TT:>L;:`NFU`E98JTE2DJ4A3D69%I.F-N\,9/YT9>%?<LS3+
M0+.-<T:Z>W=A5>N)2ZC3_"T]I<"N9U_/%=9L_E[\0B;30M8FD&__);A:A^B;
M^^8/<([X,<ZF=0^6"6Q-H?;K'*^9;9"K+?MC6\G85IOKQ/%`%!Z$>).^@TW8
M[\IC&FJML4L>=]^[Q(TOO+&^30AKZX:-&\#X"@&Y-O4KID%Y0&-;;G2Y,!F3
MT,4MQ<>#P!5-XP4@D`YMBUK`U-E(+FIT2)31>!-DP:G4M<>O0D;VU$#:C8%!
MPI6,^;`/-MGHH20"@?"%*+DQ[3%Y.I=Y8P`!OAQNKL$WF42\>^BVDC)07D&J
M$;2R`CF9`$2#K38[=H@&(GC=2-%QF+5)^$20#I]_AQMA0^]6LTVNZR6`X0%\
M%O2.W`B[5/H`5YCP(V2Y,G9"T)X3Z.C6&SY,)"/CH7Y>=-1P6_^,#98.`K*Y
M008DP@#?;G8_/'L'#`_CBS*>[;359PK,,1$V<H0;W9,H;0L)/R$IEM2Y37Z!
MAO&[B9_,,004FU#G%RB^ZED6YKCF]P3P6'1\Z`]+Y=/N57G"\L#H9IL^<L2`
MX2-\5#`\]IM]S2UOV"<"QN>XAAO.A;%X^$`7S^["3;MVE`)VL.EF!]()D/AX
MGZ0>9?RNP]N<`@J='_X_4$L#!!0````(`(M:?D!)###P5"D``/P&`@`5`!P`
M9V]V>"TR,#$Q,3(S,5]L86(N>&UL550)``,VSW5/-L]U3W5X"P`!!"4.```$
M.0$``.T]:7/<-K+?MVK_`S;9VK)K)>OP*>>H&NMP)E$DK23'\;JVMC@D9H8V
MAYR0'$GC7_]PD!QR"(``2`)T]KVJ?58DHKO1W6AT-QJ-[_^VNPO>PA#&3@H]
M,%D#__A1NG@,=L%QM%C>N#X8ARGZJYOZ=Q#]+KR#,?IO]/=YFBY?[^W=W]\_
M<=&GB>O',(E6L0L3_`NPN_LCP/_WU[]\CY$<QQ"C>`UNYROPJQ.#PR.PO__Z
MV;/7S_?!N]MC<+A_<$@'H1&!'WZ>.`D$#XL@3'[XIH3L81('3Z)XMG>XO_]T
M+__P&_KEZP?\B\KW]T_)UP='1T=[Y*_%IXG/^A"!/=C[_=?S&W<.%\ZN'R:I
M$[H80>*_3L@OSR/72?THE*`+<+_`_[6;?[:+?[5[<+C[].#)0^)]\R/E'`#?
MQU$`K^$4$-)?I^LE_.&;Q%\L`TP1^=T\AE,V)4$<[^'Q>R&<8>9C+$<8R\$+
MC.7;[-?GS@0&WP#\Y;OK,7=21Q58=-#>AM``_^(<$50A%3ZD,/2@EQ.+00C8
M1C`0(16`,>C(K0`-,/^C.(=),/_PS2RZ>_@OTM`D"GP/D_C&";#D;N80ILEH
MDJ18C:M<PV,05PX.#@XIY[^5A+*7*S<E$%-0(3%?"RKS1NLJ@9DP-&;VWV`2
M$-U&P\(98GVX^^[FFQ_+XT`V$-"1W^\1!#]6YS&*J]QV8C>G!_W8,)'LBSTW
M0FB6Z6Y0GLXTCA:J<DHCI?GO_=BQ4()6\MA7$PCXF`_^ST8V?Q[I[--EH[2J
M5\GNS'&6_QTE"7<59_,E<YTZR81,.!NXAU?W'@S2)/\-6>^[^P>9K?V6@Z%S
M3>(N;S8!G.4\NKDYO;TI:X=1]1"+`ZN#8#9]&$W6^N23P%J/E*/,I?>U<)8L
M+(W-<A7',$Q%2XNW03)'EH@PL2&R:.!M@O1;X)"/7Y>6CWG;*F+ZQIYR)[>W
M376/6QR/".:V5F4Q9RO[ZOB]7_)QE3>M8R>9CT(/_W/ZQ\J_<P*$(QFEQTX<
MK_UP]IL3K-A^?,N]3`ZQ&552HHFW?M$@X(0></$/<#/<KJU6DF_9A,OS0M6P
MYQC>Q@Z">`U=B*!/.-%B2RVKX>AZ`Q"ITS9RCN:0S\!T%7H)B(N/+6T`3<(I
MJPAS?BULT54,EX[OG3XL89A`I'R7Z1S&U.!EUJ\/'9%!NU>+<GK5'`F2.,J4
MC020#DV(28KP:.!6MK]"OVQHEX*DRPHGRY9R8*01PO6H:RRMZM@CC5(G:([A
MQ%ITBX'P%,9FT"%0#K8:Z%JB:`GC='V%N)(B/<,[X'*!X%[`GDR0`)_IF%1$
M#-?JT"'$VL#\^QT0PA1$4^"X[FJQ"D@ZR8-+M,GY)#M-/G<649SZ7\@OK"<-
M9`1?M4@-O-+7P9)MZS.GQ$)C/K'$H(*C:N3+>I1L0UD$$BKK"&]NIM<UAPY6
MI%QA\@!2OMUP7#T'E0,\\T,_A>?^'?3&88HXY2-WER+H:4=HP&C8'Q53PUFI
MY[Y+7%#F-E"V^OAO?S_<?[5S]/0IV1+^?O#JV<[^LY?`2<$)"B\6$Z2-3P]V
M\`GL`?D"_;"/@J5D"<FQ;["VK9ER&E)64@F>:ONQ)W`*D1_D(1SXG.,X2A!0
M-`GJ'/6DLLU(35N\1HHXFIN/0XJ)?O##&7#Q4*LAD[1(RSHFQP!]'^4$+J/$
M1U:6JFT!N1_UXN`R<J#:1`57D^CGI3"\%DU94B>QY*I:))CSUIK6=7'[U1TV
MHLX/@YI";R89PA!\2"HCE!;'_6(J2XO43'\Y&?/:0/$*Q3^@S`L_Y=)6LN>^
M,_$#/_5A@B+HFS1R/\^CP$,A(XZFTW6?T:\T[AX<[L:@6)8XGO\]'KT9GX]O
MQZ<W8'1Q`FYN+X]_^>GR_.3T^N8?W[XZ/'CY'3C]U[OQ[0>[8;2J_,L:J,0B
MHXZ""F6L$%Q>>@.*STV)4J=,JWR(7L:E453"&FZELH1!2$-Y2;`9,80:$X$@
MM@L?>',U7VW"H414<E)F^]#J3MK+H%4%RLAUHU68)E?.&A\B]WGXQL9DML:$
M302OE#+[&"SIU[8]0:&H*IXA?Y:Z.5@$,EY!KZ2"_:H*!YGAS"N7$+[&X.^+
M\W^K.:M&D6VIC&"F^JG0%;R-KB').E\Y<<]Z(\!FLO*(3P9/;185.P/2")PN
MHG@-WH7^'?)$D/\%'CD@IB#19W&Z?FS;VVP6;26+)>9)-P%LCZK%M46&TQ;2
MIJA:1%+R@"SO8G+F2&"'-"MMH\7"3Q>DBC+TCJ,P]<,9#%V$H`]U$:$S7%7+
MIX1[(:P8`1Y=1"D$SQY;+J-M%EZE>+9ARKH^D-GDF#@=9C87IIS]*@_(\R60
M#+05]\H+L:Q*$CDM@VM9/8\ED,,0`N$^A++?ZE`,VXXH)!CZNWRQC<.D<[J-
M7+`)1"%(\'<[X.]/]O</L-\)[O"8'?!L?V=_G_P/)',GQI7.JW0>Q?X7Z'T'
M#E[L/'MVN/,B*Q<Y>+[SXOFSG5?/7N0?^TF"PR1R++M*\05Z#Y_S"PM.=M@5
M)[;V(Y:2;&]"-3ZW2=1XGH_+=9S@RO&]<7CL+'WDX970]!*)-V,UFM=OIH<7
M8A4#`2YBW_5#X-*QUHV?O&0K`;L<)]K8PA.(5EI$"FIO4F<&3W&GCV7L)_`$
M3GW73T>;DK*3%:[4V1[13R5*:ZHZL[>LEA=]\9)?+86'5ZN\"0"0SB'P-E"0
M,4=@+)=1=:51U0J93GC;PCC7/1(S$8&='$2=#F$.(N'ZH-9-+U]N8G^S93*B
MZ;#51JU%#VD)E606DR:A6I526L1''+":R<I;Y4"^529#4/U<LI6C4I5X'RJI
M0<5P*N\Y%#96XW/+\!\AE_0D"@(G3BRGV_2U0[+"7L0[[:.FDN=[Y<27,=K8
M$7P2>UW!^`8'GCT'\URTAK56@B2IJ+^(]\NZ"98H."=A_..AQ.!-XN:$Y4+>
M=*&&!%HR*A(C/:M?#9WY@P8.)5+:5LLC64X42PB2HUC,Z>MNU36X8Y([,Z)+
M&2K3%X<X=*AH$4TP6G?\&H0GU)_2I-L=>U:@7F[2K494J(S/NAZ5B%%1IE**
M>G@:Q1"H4*VV>:!;REOJYTCV4'+<>CF]7.)6P<B9TV^HV@"NASA5NJ^JF#29
M!JL;"/C>[0:&%5]*4Y+,IIX2K#&U_C5H:^S#RI,;^Q3USRM$_5O\U_`.ABMX
MAHBFK:OZV'_J2,PZP37\PJYC,?W:^J;"%4UY)V%/35<;,NT*9UD[J7Z[K'"1
MV;A8QJ6&UW,E_[XH*WYMN_:S47J5"ZG"^1H]/A:2PFS%4N<]R^)_W3)HTW;[
M&B80$8V;598.U3(L_5AX$4*CVB0DA;.8\S'DR*)T.&LYV2$EQNINT#3W-I4'
M],61``$?>0L_]+&NXKJ?'O6J":71UJ5B6G@^!1U%V[I5QMD]3I`49J6WJ00#
M6AS7UZRA$:?#Q@EKC0B.[EANY<:3AW`+Z\;_'(=NM(#G4=*O$I30=-_?3UH+
M-E3PSBG1GP`6#HCJJ0G;SF9=5$S]V)JDSCY$`F/22(4"RWO>JJ2T!,/-WE;G
M$R)L\NB3$>!1YO@^?FTO1=4LB2*;T3!9@]?5Q93P^S[6^#Z0%%-G0FAU7WT<
MWL&$W.VA\,GK<^@W?1AO+BZC40:/"L[BS?^<Z9%MX]TDK[(%%\ZT33B1`^HQ
M?-A&T65B2;[*>(N*)A7)3(SEV),CG:IFU.>E7:%Q$851U5?H42_XR/I(/38Y
M@EQJ&L,"2[K1**NREHAGIZ\O,.TW2*@BL%+272&!HPSH&Q"@/UO->C*%45&"
MVDPT3[C?.(GOXO26'ZQPH:**[\\;:_Y54`XE'!&3KVEJDGYOM4M5@P0*=U,T
M1W/O?0JH8#G[=58/X4)N5WQO<Z1PZL0ALN!)7H^YA:8/"]R$TF3RMX$64>(&
ME^:Z6043'MI4MVMK5Y>4<-FLRW"E15CY'OJS.=;A.^0_S.#%"M]!OIS62J8(
MVCXT4(T`PP7E2L1Q%#2'`1P*A%%<1]25`K5\`T)+'<KJJLXQ9?=46+Q3OR]$
MKT+"T.4T+5$LS)-"8+*ZHC6UZM5[E>8:SC)*O@,4.'BT`6])DSO3CL8Z,6G>
MFMA$.Z%4L1A03@T&T"=X>#JQKVGV1MZG%<T4)K<1KQ-"WA`A3&-_LL)?C'!H
MB)A3N\_(,7X=H.E:Z;W(76&"*M?NNF4-MW)EB0@F2N^';@P=_+XEVK"=:F<-
ML.FL`9R4PL^;&N:_=TN(<=,7/T?]Q**Q[$ZGBN71D2P,'EIU0S'3@#;)'CSZ
M>15"</@2]_W9/WAL,_,P6%W8/COKW?6OI=-8LJUE!K^2U&`OW$1QMA_AW3!.
M11E7]HU^=J8HP,]'V65NFTX9/;+Y-!2>A['I.9!ALJ742!L^'[1J8=/SY=+Z
MC5)S;1.;+Y%FXF=F(*RH0<-M4=854?W.110.;8UT1=85N1!_`>_)7WHY]))#
M;%A19&CB=3QUD(^+HD&W=(,43*,8.;W)W*XNJ8BX9F6DV-&Q]E'MMJ%^VYB-
M'MBIT::CA^P,J\6=3EKV$GK)XH_^*91(^:^0R.<H_KV<]O<NGA)^HP5I*I3Q
M*I#0:++?LA0UA>X\C()HM@8!;9LT6//)4P19*\ID5YM*-^'2L*BV'`)L7+]4
MHK`;_?UJS&X+?1;P3R_'*UHWQV@OR[OBW:PFB1O[)$5R#5WHW^%THU1^MR6*
M[IW3QNQN.XHYVDQ&8U7.CV2GF39G;;I+[61IU+WQ)XK&BR`I801Q@?*)W5*6
M;I2H2.)UP'ZC33#:T\M\5$#H8C:JA,W$[N#T0;V?A@@Q-<+]6D=I''UHNJZ!
ME"6:5_I*ZC?Z-Y%#60^J>M2T()38W_W]2&'-2`<D]V`DK6<BAZH>;2I+K^+(
MA=!+<`^;W(6_G/;\A$8S4M-]\1HIXI5"8<U=.FM:^4)U%=F^0KN'M=\K"[T<
MY,BQJ)_LTG$4DD<?HQ!CQ#^GN'7R#731EVE/#]:U(\AD?70K2OE%?MDX;+*7
MB*\PCF%NHG'E2LF*#S8;):TXLNDI.7:V?3>#NQ\,:!W(4F2P.64W%'>Q(+Z:
M]%:7"T2%OWT<SH[</U9^0JJ(C&\(%=PVWD"4H$NBP6\>O.&*Q2@,\=-RZ$_W
M?CH'"QC/8#R,:A`%!9`U[#5&:5^.%:X.2SK*0&[GQ509TKK04XX!'I#&\O5!
MVM0R=;:/@X4`)LE[)\8]3D\?8.SZVYT!-$\36'"-EX=K$-GYJ0'&`>XI$@`S
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M?-YLF_NR&]9H^JTZ0"U)-VW:#<U+U27:I?V?LM@C^5I<HV[T5LM#ZD`^^CN1
M#)59$JR_7@CJ1!C-22F3I[YF<..P59#B#&N6:4VLIZ.T54-U%=1YUT,ZBB;`
MF.O->)J53<6`"H?8%*JKM?!L(:$6S?I[2OH*(YUWY;.SGT(CZWHN)&-8Q4=&
M=7TX+7U;Z(]\"E:L]UT7*YU%,3ZW>[>,PCSAF[7>S*]A9SM-Z_(E>4R=.RJM
M*IJDZ>[^9C0YEBA.(HJ!18">N3U#+"/04RZI,ADU@1CR$+JE6OTRH*2J#+-`
M;@!ZLJ_E/S<711BQKZJH>E@3[<JPVMK8-G>K-8SL<,RLII+)%?0H&]JA5',-
MP]8.X4K3UZ$[NBW<1=9_')[[<'4YQ51<T?O&K5U8%LSA5+3R2.S,+T7J'"#@
M9&&4KG$/M.I>H`!2[@./DX-IOL,A4*E>E2/2H084/<FTCP8Z'=L?/M#AM<B1
MMT$:?ENC$1J.RC8J@MQ6*C)$0_&X>K1%U@L-[(FX39\:J:-43-/-,O![>?I<
MD8+!U406I'&,UUE,*VF<('LI$2ELM$II>!!#?*<?@@0#^!H.]&NJH'PN7^57
M7QT]KBEC-]C,WPIGD#"TGAUU$ELKL74[W%(]I$]@.+S3<A%YCYMA0W\61/=)
M)P\IUJ&93<9(TZ7^/B+I%T9@V,V_*0NR\7T[-G,,WN56(DSQ/<.-V)AO%OY9
MQ:=_3;L`A[O%7:)8!X5>X6R$;/,=Z0&D9B=D@9E_7%62,E'WP"E1*RQ<$.40
M@%.`>&TUUZHJQXV>J7#&W#.H"E2Q7^R3$!C+1/PY!=?)6Z6XD#5T_0!>P!2_
M0G<;H1](LCV!R!UO:SRZPF76!>F(:H[=*4''UR7B'#X(LU<+\6_QS_1\**&-
MEIJLD]TG*=NK$?M=RI;,M_50:3NR6;:O0Z7A//S\_QK$M;&:J8<3_$"QZY.\
M-_HY@.3]U-`;+:(X];_T5A(JA==DADR&((ZQ+`\E3<J=TACK%?HJ$BZG#*09
MTD+[KO(>J23W,'+=F&"YG%Y##R[(Y983/W&CU?994E==QN71F^\W+DT;;P_/
MQ["ZT<8%%'"'#PJM]QM75H1JYW$U9K6XE&NN:%YP`:13+;R#\21J2+UV4OZ^
MW0C!VANQ<D7KPKKTO_[E^[_M[H*/[W_][>E_/O[N+E</'\+G1]Z7EW>S#^OP
MW<GJ_NW+^.CE+X>?WMVND^#EG?ME/_@Y??7N^/S*^_#OX.GS\/?)Y?')>/WV
M]H^#Y=&_CMY<?OC-/WQ[=7W[4_3/Y>Q3=''UZL5!>'3QV_7=R^/#MZ]>S?>>
MWM_/?_K\\[FS/IX=37Y;_/SF\_+M_O+H/8S2]?[9;/SFQ>UB/+X87_UV^?.'
MGW\*EH>+V/WU9O+I_:?P9'+D[XT?/O^4GM[</'W[ZN#JB_/VPYM@-'9FSSZ\
MC6[AY/.+],L_+SY=7,!G3S\[BY=OKR?/)\\/_U@ET\G\TZ_/?__W<OWBZ/GY
MBU^^''YQ9[,W/Q\NWM_-YNGIV7QQ_T_G^/,/_P''-]>[N_J;0GF#N9R>9"O[
M&(ECUD_[<C%"L[<(1:1PUMO[V$_A;C2=8COOY68>_3<DI01NE`SAGJ",4"LG
M<(V<T*Y?1D#"&3Z#IL_M(9_FW'<F?J"1=Y2"9/"L3)XJ7L*1CL6!F4-&$X<V
MV(RW&L\K26Z3L)+FA]%2-VFRF'G&1CD-)H3N66CZK1;'(?(3T09_`NF_X]*K
M2;UL-&*$W6TT1U3S0CC#AS@BQTY($<=$O"6UWM-5Z"7#>;!(2I;E_:5YYFWN
ME]>AHQ!EZ?A>OI&=4E\8J37IO=+?V\*:E`Q#&65(Y6AI-C0/.JA]C/`PX*X0
M,*3"U'#:O6';3E'$"BW-O6XU_00NH\1/C>LU`V]G"<0V2ERGBY]'Q!\F5@-D
M%7F*U8\S[Q;IPCJ.D4N2.LF5L\:&&Z<G73=>P;*S8$;[I"CI/):4R-WHD<K/
M*9*AN&J.O+A)TMUT=&%J!^<*J&B)6*>E6==9'[7RV1"B)UI`>D)$*J?CZ,[W
MH/=FS3THZB5?TB5]G9^:1ZD3B-9#E]3SN@YB&H"S032D>NB.%(I;+=T%2UOL
M$=G)J:6EH8"]AZQ0D^K+4\>[OB1S>&^[59.Z!I1U69%'>D72Y0JJ<7@'DZYJ
M'T7`[-8^"BB3K'WT<PC#K'V4D".[A*Z),W9J'QNHDJE]9`IL>+6/?0E.H_:Q
M.,_.W@N_C<@#?C%$Y@@9H'1]A1B>(J_S%/UV6;]BVU%9A#SV#C<Q^1!;GCY>
M;BAO7$$*(^A8$LG`?*#M<@AE^5>J(=3XHYL^+S_WCON'7$[-:JD">O/%.]*T
M<=.7%`*UI$G6GJ5)6>V4[BBK0;5T1XU5^J4[',^.8<4-1@8L[,.)#!C4-44&
MRPP$>(1CA,=@LF;Z`=8+$M2U02)*X/&K?91PYH<.BJJ[B1)$P.Q&"0+*)*.$
M:0YAF%&"A!S9SF839^Q$"0U4R40)3($-+TKH2W#[5@X%RKMNWI_D<DK?3R?U
MFSSIL?V2<EL3ZY:]<6Y-;HB`(:UJW5D8MBJ70X_^`J(_5FCMRW-6H,1H(:0>
MC8K.=*4DWNJI:SOE:%9D*<:U.;/*8\ZLYV&.^1@7G_:9HV#BZS3<4\]+L&CB
M'ODWE>O:3#^(A,E*.'`GWGG0QMA4#09M+.S#"=H8U$D';2A:8_ECEO5170DD
M8C4>FW3381@',JSX'YRQN$.[#"X4('UVM@L)^M!5)?S=M])K4E85\@3JZF>?
M@D=>]O%C?`Y)M!@GQ<@/<(/`ZJZNHQ)ES57F61]Y3MJ&\B9UXE1=OB.T].)X
MC599\6`K-R9DB0\X*9C`F1^&V"!AIXU08S?C*355>7DR>=3Y`J6,.PV%'HPT
M@0>J0H2X^K8NOC^K``]T&WROELN`=%QR`GQC-8B250PWS9?&X32*%^12E%+Z
M3P>NX?[VZA3R[I^6(`&O`%6T6<6Y)[1G%.`L]EC5E_:FS:HFWPRV'=$DD?E.
M@:)LV9>@_I<$W2IG-0[1HH5)BON>]N&S5N";T4@6:HXAR3\!^!:%];0F2Q;5
M8N6M"6D=.ETX*=&JK-XM"I-;^)"^"7#62&7#D8%C\J4J"7IX44>40G``=@$%
M@4W-FU7BAS"Q5NFH*JG"ALAR03<&KL/O)2M3QV*ZP*-.`D]["J79?`H^8JX#
MPG8[QUO-\JHD4-B354_JT7W,GX7^U'=Q<0>]38';$4>![_I0T]@H@C1V5*I&
ME\C^'.(GTU>+A1.OL2Z5`(,-9)"#MOOXDI9\-VZ..L]:=/.10M:'#9/$;-JN
MR9'%"[S$6LDV>W:Z`"G)O=(52)Y!FO;Q;70'XQ#[^>2BO:9);(9BM-=%(SDB
MX_<4&;\-`$`AV(O:I054V#2YV>MEC+BPVZF)E2<SN=3P3D\K"0!G8W*6>$&N
MR0.&^$F'<`5)-U*T=#'J)V`\)2\L(41^N@9S)P&>/R7GX2D=B\T5'KWY-9XV
MZ?2>`T2""Q.'O"61[-`'FS98H>/.`0K&8>P[`1F+AY:&`#\!,Q@BARH(UGDF
M`WJ$-(>4*"25SS&-BU60^LL`T4WS`(`\*#C+FM`_(G@?G`7Z8@=X,/`1,XFW
M4(Q;QI&W<E-$;O'4.!J#28_]V9QV;5TE,&N,\)C\I91D63BXEM-#Q@\M2OPW
M-L?)W%>(U5M"03.XAT&`_YU']^2+9/L3A,6#B&L+%%]Y))E,NA,BOMS6:8'X
M=N$2$0O\Q3**4[SO?%IY,\H;,AMGB4NFD1!2B`,V6O;AARYF!^Y>$I!6_EFS
MVDP]2D*NH76")*KS@>K1/YQEE'R'Q08=<AF23"Y<HYE")\;SP0J5'_@7:C1W
ML"!]W**"E*=@@"7)6WQLL-&T-!LX"P^E"FEAY11K6PO'4?EJ!:#;A!U7O_GT
M6N_&TNJY(Y*@S/;?DJ))Y)@\0XY)"8KM!UM4I%5Z[D.:"]K7V<0X>BF&$&,T
ME'F4HX;[1E`Q")0<'8YMLG20*B78R@EJ,ROTC-6O,)ZA?8'<>$O(/HY[QB$<
MI`D-_L\-/LV8JB4*@R=N[2@5F;SGR.0A`EX`BH*X:-?0I2_BV6YYWJ$B%/:Q
M`U:VJ:O50]^'2=6DQ&C5N!Z-''W/@.V`,CBB\&6`)=L\I`Q7.[TI6^P6/-7N
MT$O*B.=1X"'$N-`F76/CT]8)58=J1'GU:!,9Z1?XM*`$D$:F@,*U:YVU)5M]
M5UB94VU?9Y5!V,LY@31RDX^E2%,E>B*`I9R`Z.]0W5UE3:@]P2K-,]UG%:]@
MF-!W6DC?Q:L(K0&8^C%)$KZ!(9SZ[:/YUDC,V=6VI(K,[$MD9J\+8`#W*[!K
M7+L2?F%K.^%>FSN3FOC[L,3:M)@TS+I$\BY.4G#$Z24`014BR$$VFFPKU]A:
M:D_EBEL;QNH:<]H^\=9Y:&NPI0`9*XN1H49D=U\ANTMA``3$<KF+BHP*NRK-
M`?W2%A&*/LRC$)_I,A81,=QBWURAFMU/2UV-&^6YU;M8S`+-\I1K>F9ZY<3I
M^K9T!-[61.G`-6:Q-(@3&;`CXCC2LV<"$Y2!VCQQ;"'=PKCI,DO?UBE@[,/T
MJ:`W;0D5:.-H+%]1)>)T&Y920QO*AE.58YIV]%\KA`#&P3J[A^X$I0L\>B94
M$:0QZZE&E_`:QC[.;,(`NE@C"[B@``Q.G-0!CU:AL_)\],UCF\943\2%'=5@
MF[X)E4/6A_64Q&S:<,J1Q5%6EF:.R[<2!^-6JLF];"<5&*1[4V0U2>`?*Q1@
MG]Y![4KH9BA&JXX:R1':OP-R#R2'`"@(.QJD)J+2-5:9^6N7&G'!]W(XPT5F
MN,"(2PCWBOR6"@WLG*5)B)5S%>'<-=LPN'/HK7`S8MS1@=ZI#CUD\0)_NB8M
M@^@S0*U/I#O`8_(B?WMR>0J900;C,;)P!722>-[`SV\56;S\T:%F;$QB1VQM
M4V?4@H9>+&L+<HQ6'+4@M&DI1-/FA3#0$+P#;:J8^)9,;K,P2BU@?X6+"8S[
M4/<Z$K/-,&KX!37)2!G)A^`C_=2VKG$%M%UV7)^@;IN#&Q>&3NQ'[\)D"5U_
MZD/O)%HX?MB/*>0A,^UD\@CA&C+Z_0XHC0`?Z9@!.)E-0JQ:(-'<]:.5U$G)
M"7(.?_3@]](R@XW(;,D8@P)N>5CV[0[(OP8?\?>VKXV+Q%6M]>)-MD4QS,CS
M2+VM$^`6/^/PF!;=][<KB1$:=;.$I/#>JBW&`#QHUP]!-HRU=5E1*"F15E_:
M;.)#JR`@5UM:GX@VS644D@Z'?9LE)D*SCKR(E&8[E96O;H;5#)9EDR42*=-T
M<?G01L.N8>K@J]VG3HP[NB;]&2\.)K-^-9L([D$K_1CD7P_%PQ8+K7IVRIVO
M5C>ZJ]B_0^IX%3@NT<FZ'>)5*+,&FNPWQR*`^SH%^104WVZ;#O-UQ`*V;VJ#
M>3,T>]V?1P;[\9H&3G]EK-:]V)^_?SF:Q9``O/?3^=DJF2//(O,HY%>:)"R#
M)?]R%#6]#5H9#K+Q&P_2]A)5$^%&E1288_PI.`7BF,N[)CH@(SL;J[Y_Z>UK
M^6F;&W;X6,V-_26.-JZA"Y$%F@20Y:^);EL*H9@]=V\B1W15#90'@LU(VQZ:
MFKBJ5R@;>=']&R'B!O`R1#%[@JM*Z$\CHGW=RAH).Z*PTN6A&2LYE":II1?`
M4*Y![B8<+5-C4P]/7+5U!\260=HAJ(GQSRI#K=<`")J3K'DC?I";M+O3?8I$
M"I`Q0R%##:_[9#:4G,W3P=4B3];3$Q942T5RA59)\\5D^5'^N"#T3E;XL43Z
M$M;-W$%HSJ(8OX3Q;AF%IP\P=OT$9L\1Y@OD/6F7F?*>+^H&NG5'L/4,V*Y(
M1VPWEP40=D1DR9\[X$_0`=(DXX7J,@[/?;BBC]9DKX9JK4<&'/L.O@*Q:HN,
MR[6A&-_L731!T*(EY6:PPQ5Z,^UJ.B#+XB&I1`"3)#/_^>:@K0<,6#;O/6B0
MJRYO+O],%NZ,2#/PXU4<9V:'%6G1CW9`]IGM4^\*S<PZBOJD-`(C#_K_I=YQ
MJ;Z0BN]RE28I"@R05/FGVPETGR!-V$-PZ,$V^F'[/%L2AZE<JAPYG(@I"Y+*
M5:0[@`X&I=&VM$=-G%B=%+AAN)A%8%FNX1U.NU!:EX&?<@]4:&:5P@$4$*"0
M<K'M@`Q:5A-,X=E>_HK39Y?!:'#0J(Q5'X<6OKM,?BB!V<GD#,;%>]LY+%M7
MJG7FS9*L.M^,=U;DZ1WY_V\071XNRX)A0M(Q;58O^7=W@D&",LP=@!];CZ8`
MQ?=3Z./WWRQ=,VW!&.5U+>*OZ?OG69R7W$:D\VX,K^)H">-TC=L,DK0<^NUR
M(?#)<@CX>9,,!LB![)!NA>D.S5WFD"RO;/DILR2KRC##]<N?5DF:T8="-L0,
M/X!HC=$V3>=1@GY/POLXNO,]Z+U9OT-J.`ZS-Q?Q':?4O_-3'W)WZQ(.+/("
M"UG*67NK1QC38_QG8O%S;&"R!H\P0N"'CT&!$VR06K^NT24'F1%!YQ+2J;\H
M.92(DACW5/#@PR]PW5D0L0764$TDEX"&2(%^#,C7`'UNI>"J42A;H0!CAB9=
MB'/?F?@!4<2&J+WTY6!"]SKUK-7*FZ/A*W'%VC]]P.X"WS9O3&K^I=7.J#6Z
M63SF3,[HOHGL+\OFCL,[F,CMBGCS$^QU!23.7F=#.O*39HE-E67#24P<1R&.
MJY'+?3FE/Z?^)(`WT$6?BF0L$^EL@..PI@0>;.!;=W+:L4<YWI%D^!!6O((?
MW+#BF[S;`:UX2==5E67#6?'DCY?D'"O)3S@\[BKGY"K`:/,,*A9U^;LL*`2C
M>R=&QB!#M0-R9`E2B<Q46-V0U;FDGMS@\]KLI3@AE7G5R.64'M&T,?E%^1\R
M^!3:L`W\]MR51<QFGGJ-,(YE\@(P"O\T]$Z<M%`!_2B4#=9@%,HDH*G"+TN&
MG^*WO]#GUJ)0H5#R*)0_0Y-1Z'8J?1SF77J03<;E"J/00[^)D2*7@CG><F<<
M0V#+7;1!RF"2=&8&%93`6DYLZO&"M?S;<-7H,8;:205G9[=\XB!_J-!P;F!Q
MT5W%<.GXWDGV['@6RN?/F(CW6,ZBRT#FF8S2XS`#V63UN""WW.3YJ7KA'9ON
M$;+;'K;=9X'30=U(%9P9+Z^&E]>=)?\&X(\L&6@NS_.]M#X3T^>`G.`N:[K<
M03Q<0!I^/,R8M$(\S&6991.]J>!4M<2ED;8E)IR6G&FM\4''@N;.[RWZKKMH
MA4`SX3]M(VT*3/`WUJ.1,J^W@Y!B$F9S#&+'IN:GV*M191Y%;P?O&N%[L7&=
MP*)4O$.'H@S5B/GD86_T+DK?V@DGFJ11<S6V9V?X3/,B"J,\<TQK'S(GE^M?
ME`84=2;9F,?6@P'N=)B>@WCN[3)I9W[B.@'-RIRAWPDZZJGN3W70QA8EEX2F
MK8L.R%-K9(C-PN]&*6WO;.P):]XBR(H8*,P/T(D[2[AR(9N\,<`C@M=FFGZ>
MJP@>4,^]FE>1)B'E&B*<[7`.WTC&HLWY"@$PW&,S0I[R&4J)*Y:*MO);?I6W
MXB5*N(I:WG1M?==MF@Y++'(L&,[ZN8#WY$^MSB@1$/J%_;2IW&25%]06FVQ5
MZ&W*>)MK]"K%TI;#1,8$6"+@SG,PEU=(57Y"NE>W6C%E.,->,V5*E9=-G5WM
MZLE_BX)5F#KQ^LP/D$EM[UBRP1JO)]\B0%Q/7GP,Z-?6]*=1+M62<M8DS1[F
MIQ#!3!LR`?EG^=&@[1?3*T2SD]",>>E%^5105ZM)X+MG0>2D7:VP,DA3*>@:
M9O&RHA\"\J6])!M7`M6UM#TKLXGI_)9:UB0)6W\'S>HX2OCIZN(B7S0%FQT2
M#P-DG-403#0AUI)K9H!I#W%S<'^!IBN^,5.N<T#.>_&]W=L<K!DPG43^5$T?
M:]>/_T[@,D+^CGY=2@:`484RC`/1^@3ESD5YC&GG#Q)/XMA)X2R*.[M=6`5J
MOB=)!;]XSR*?@OQ;R_<*F<*H;EOUJ2GW_J]GKW%RLI>CB`U@<U5''`HDSR%(
MDKEV"F'Y&*(F'_8A1'6NIDTY.U-WR`OOLR__X2"K]EW^;M(H36-_LDI)$6\:
M@2NG>A?56FS?F+7DS;Y5.ZGW,`A^":/[\`9M`5$(/9(E$+R3I&:F>>#-&VP.
M)6+3C0?M?L:C0#Z,YHQBBX=#4H*KFG31Y(VFN4_@'0PBTAOC)G5F\!2'Q<O8
MQU[(U'?]=.0B<[,*T.Z39:JV1_!<M=)W@'P(-K!W0`8=E,#G6;_:0*L>=GL&
ML4Q'5VQOYPA>PYF/^SF'Z86SZ.#`F0G56#D""[O8FFR^!?ACZR:$+8^JY6#,
MKUW[0AH*7J-((\:'"/@1P"Z<0B%T<YZAB(R&!B19)4(Q"-!1`T@<BV6VU9*$
M/_5.W@N]+?>S[>6!4(K!SHN@MWEW7:9+FWT$/I+/[#P))A8(\WG/S:0ZT8!S
M/X1C]&._S\1NL)@/<K9):%8(_"D@WP[@M7.NH)C:49UE8:FS::"_?LZG@GZ%
M_@O?W2-K\_\`4$L#!!0````(`(M:?D!5W84-0!8```Z"`0`5`!P`9V]V>"TR
M,#$Q,3(S,5]P<F4N>&UL550)``,VSW5/-L]U3W5X"P`!!"4.```$.0$``.U=
M6W/;.+)^WZKS'[3>E]W:<B3;N3F53)4C7T89Q]9:3C*9K:TIBH0D)!2A@*1L
MY=<?@!>;DD@*``$"]#`OL66JN_EUH_&A<7O[]_W]S@7P`+8"X'3&JP[L_S.8
M_ZNSW^FC^6)DP\[`"\A?[0`N`?G,6P),?B=_GP7!XDVW>W=W]\PFC_HVQ,!'
M(;:!3S_H[.__TJ'__N]O;ZF2/@94Q9O.[2SL?+1PY_"XT^N]>?[\S8M>Y]-M
MOW/8.SB,OT2^X4+O^]CR0>=^[GK^N[V,LOLQ=I\A/.T>]GI'W?3!O?C)-_?T
M@[7G[XZBIP^.CX^[T5\?'O5AWH-$[$'W]X^7(WL&YM8^]/S`\FRJP(=O_.C#
M2V1;`40>@UV=PB?H;_OI8_OTH_V#P_VC@V?WOK/W2XQ<I_,6(Q?<@$DG,OU-
ML%J`=WL^G"]<:E'TV0R#R;N]*5K>$RD'!P>'L8Q_T$_^)![SD0L=BOU[RZ5O
M,IH!$.QUJ.!/-X.'=Y@"M+3NJ>NZ]$_=PF]V?U%KVI]#"P,OF($`VI;KBUNZ
M*4B%X0./F`%&`?EY3G3Q&;OY96J@%`M',_+F,^0Z`/MG/T(8K&Z)B$.$CW8;
M6/)=8I]L_/J6/SMWT1T?<`_?ZDIK*%<H`+N-B)Z2%4=46(]-9T_RF_98]?9D
M.3V6QJRV)Z\Q)`+95:=@2]7.H;XG-\)XM<N/-6X+9$<=OP$*XD_`"#61*&*(
MO)BDO,H)789D^_"D'!!.D1W2;O;$<\Z\@/1K`V^"\#QB<KN-*?UVUL`%H<'D
MN>@/E\2>-4O!?0`\!SBIK50T/P-[:)Y$G8OL-0TNY:8(IPI<:PS<=WM%HOR3
ML1]0=E^)L3U*R0#!;%OH[T\M:_'G`P^ZM<:;WDP0BACTQ/+'$8U.OMBEAG:!
M&_CI)Y'I^[V#A$W_HT!#&M'BEA+_@@'YT5=J[:.6=7BSD7:"UU_`PG9J$_EQ
M+<RVAR+)$]U%Q)?W[1ET'R)T@M&<(WX"5.Q0A`FG?+=W\*PG)TY&-O`L#-')
M/53K@#5%2<]4+_[E;207]'5TUK$7PST1^,GS%\"&$PB<4S2WH*<$^T)EW5_T
M-`&F\%OS1#%>B3=ZSWK9)&1V/&5R76+^X;,,2^(.IQ/?+^Q_Y,30A@9#D-[J
M,[)H;X*2"90.,7H",`;.90QDH5&110$9OH/H2>X&WP\Q?9LR!Q41A-QO:LV8
M^6]!,2]X32V0I];2P@9AF/0_6GM96BZQT#\)^A;&*^A-/UMNJ(0:L2G.MO8Z
MV4=90&:;#R-\XBYV4^^*9KT+;!&+;H`-B'6*:.Z6#BT-D-EIVY!DR(JX?X3<
M,\1@84'G['X!/!^04+H.9@#'[Y"\D`J/L:C5Q7N8_<B$788Z"+NV`MU0Z,,\
M;VGL]S@B>9N`;+I+I#-$@>5>5O/9$*,%P,%J2`:<4>&%Y/0%Y5!70%$S+-&G
MW:,L+;`,+PE95<B+F<!3R?;SU.BE_+L=E@N->(I<)Z!BWCJ''@S`)5S2Z<G`
M\J:0=,FQB8I:W0Z-NL?[)>&;=>4NW*1P3B&/GB;*B(6T;M='/C$)>7:<XQ4Y
M=;=2[?F4T;$,\.G*K*=@@7Q(S(_#[,$H-0XMT*4WQS([L0@I;80T8[E:S^4K
MTEJ4V16X!7UDCM^J,]-*XPEU`XGF."A%0CP+RO'();3&T(4!!#[AOJ,`V=_7
MEC&I))_,NG6S&;8R-#N4%9Q>@:PFX].LF0)EZKRO:VUUO!&<J6+G0B&KE"V8
M(6T;A5[@#ZT5+>NI++WD:]);K2X)SK7L68"2QAHU,0F'1-GC"ZCU78$RS05/
M=O\5@26CC"TV+@C!+;H!+EVM,;2P8@^6:-,Y\<#HOS*L9(P-*G,9A9XK;'0Z
MF>?.V"T@*O)KUH)3N&@^A\$\FGCTG#[R`NA-@6<3$Y5,W):HT]0!5J$S3"CJ
MJK?4.Z8H'T4TTZT,0XGJ=>\J+1=YD8GJUEELZM"\G)"W3:[C(X&DBC%4QX$4
M)LL=6M`9>'UK`4GJSABHA*KNUJI[C1F/.UE`E+(20[2XO00NBJ8O1X$U!6=T
M'^H"0Q^<@@FT84"8=S@/(Z)P&F+2/6Q^0TT9O+)5#6KQ,GP@D-:/XQ#RP)0*
MKDK(ME^YGM[:`"XMK0F5]^':.?<N2J*CY*N;?:MQ_FZDI4T#1+NINIO;J=(_
MJ-]FM;E]O-UUU>ZZ:G==M;NN2D%O=UVUNZY,WG55LDPMPP=.Y@@'\&>R-5I^
MG`E884P`;O4^C*L`"^&5,=-7M=Y%J,XUCE[1B4H[0X"C<V`4E\`*U3;#VTP`
M:IL%S%@7F>*?A,$,8?CSD1<K<NN6.LU#(6YO;N,E92I0DA\'OA_6Y,-$E?9*
MAJ`'4Z02[QU5\YXD]UV'`3U2SB$C[EI\F-775$>N899X\[D$;]9=7]@\\8U[
MX5M&UH,4_WIRO:`G.!)3Q4L+.\15J;^V%88F5!C8XHFKU-!6&MI*0UMI,.%E
MZJ\TW(`E\$)P3NR)=_BK"*-M)8T8:N1@HW&];Y+LO6FR65SM-MU"9<8T_%+7
ME8"E9R_$8TSY@+PL/?\D,Y&76*FF[94IU+PM<%=(K[?&4N3T[=R-#V9WB5TG
MSAQZD+X"/8==H5-WJ=3*CIA"?.UHF5T`FI1U:\FVNOM';A?FP"1QHV%%U\7#
M^4ODJW5>1HTA=)*MB\S"4V%U[YK3N!P6[1V.K4@/PN$ICY1\W8Q18JX;REY:
MO!`J:8WUP%L"/UK7'UL8W2Y"/E'1?@IUZ6E$NX,QVXB*@=*UZ#JU0"'[V%2A
M:TC`ZZH-8`0ZJ,(EKV*^ND(>6L_""KU6K*P9_BL!2U:O)>A%$*AE&.L*&C(Y
MM(&*^&Q013;XWO*A37DL=$.ZJ(.'611]UW`7%+YRXH07>DH?9Q;V2-OUTT47
M&V:J:#F[5&KAASLB,MN(=D(F9V0LYL\O`$YG]`66)"M/P54X'P-\/=F:"HZ,
M5N%=/@-T]7(<[N9$5-ZVKSHFV$MN+.,]^;Q@.G1[GT.\AP)X=L$68,X)=R8%
M,N94VSGXQLS!\P0=QZQ\-:_$AM"[09%'S50^-Y^KT)`JV.Y)U7RXY*R3R"R2
M^@AH/E>\FBQ18LH$:UDD%JPE2V'*GYZ7L@5=G2?*%1K2(EB=L@.]:@TD7C<8
MCGT;PP75\GBW0)Y[BNZIVRG%G,':+M@9$)%W^H;@['5@D:[82<<EZMI1@::F
MI;4BP#(5?O'Q]+H-ZE:!Y2LR8VZ%U1$%8&7*4F:\3WTKP$Z<;V$\=>'?HJ)3
M1M+#1KP`PW$8`4++>F"QO>>L($%+4&.&9W)+;3)`U%G#B;J<>/]%?+K`$&"(
MXLU15^`N^HNBD0.+8E/2?6FEFQ%#C8?T%%@8UY5TN'E3LSD<3<336SAJ/R.M
M+"2C6;>ZFW2LM-ENSJ*G<ZM::136[=VL5D-&M^)->-VY(G.5XG=+E@7=.<+T
MLL1/A+N>W0-L0Q\DA<=AB.V9Y8,O%J8KU-F'S)4UF>QL25B*3Y>*+BDNC<Y:
MHH!7E=G;`63AF43"2PD=NK2D,/`N(0BO)_0=AM8JVJA:M?GGR32:@W,#E'CR
M55W+\DHC4+(+BX4:3KSX04K<^%K3G1D,H_YTO09P:-$)>'X$=_2FU]'`W[\!
M/T+HPP",`%Y"&\0O?0-L-/6@JC-]ZC+=\(BKW9-)P![K&#"PO&32U:D[M(3?
M"),99@5HTSI0_2=)E766^4%>=YF@P`JS2685>--@T'")>FFGJST<2LTP>$*@
M$KII-,@H'*HC-M$L]<*%:BZ:XK.@`9'`BVD:!!5KB_)S`CT.@039HZWUSQCD
MF&#T\%08US0(*M<@E4PA9+EO6CI10AKYC6@":12`-HV'2K5(!31!<R"46=%H
MTE@*;QH,$LJ1:LL?XTV*LW.@K.Q&)^4V/Q4F4LEO:616*:_*K)'3FF%Z`4;^
MPLK*)7,&%493E*KPI2X7*,4*]DRE*5.MQYEU&%[^K`QAZG6!>J:4+FB(D0V`
MX].SV>A[T$LWKB>*;Y;;K=1PMW.@ERYAJOW\BM)\A#PZ5")P4FOISP$]N7\$
M;/)DH.CJUFH&-8`65$0\C13C%C::%"VL%AE-%62AGD:,F>LC3^R8Z])!5]WY
M9$UWHP>P.5"F;J]6V)2?)S0Y/$=Y<SN+/"13?\NH84H=$;K`]Y-)V;2J(F48
MF"?78)<*P90ZM4HA4NYH3[(WRP4;W3^+095ZM'HU47I7G*[#O)[$EW/5W1UO
MZ6_Z[,(VH*GW*U7LY/?)&CU?8$"CV5@1J*GWJZ^C;(_.4WUTWF&5M8/B+?0O
M>24[1V/+OU?[2*!NMHB;:F#AH&J?JO@"NNU;YXQW5>Y%<Q5+5K):U9^]&MN5
M\9[*A2?UF$#)*&Y69YZSWJCJOE..\N]S%]WM"81.T=ECJ4PYU\EM2Q/O.-IS
M[)IVCEUA+/%<)=?>)-?>)-?>)&?"R]1WCM!#XJ"SR0^7BIS8`5Q&\SU\?1.K
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MI(L3/1NZ@'B/^NT6D1^B_?X^O>"Y:J*2I4L+^Q!I#-+`E7;_HF#&.P5$JPTC
MG,G/+H@`]YR3.<(!_*ELHQN37BWA(+G=9%,G&]CZ[FX<IMJBLL.);>/(PNO)
M#7#`/%KV>`I]&X6;)S/(6E'(KEY;UZDP/+C@EW.`7H6*:CW[84NV0#\IW^_8
M!"M0Z5L"/$:BYV\];)+(9*;KR6FBOT^,G:I9,5BN4,]P4J';=^`KX6`]OM'K
MS/*F])"9>$J4=$V7T!I#5V#HRB3IZ;1C1N2T'*:7!AL9MF%`4LPIB/\?9#8Q
M*&G,Y0KU-&:N$%^_,;$4/0'6)OG^Q&T#":%86-!)TTIZK:#G1$<[JEM+(FA)
MXP."#6_]-VUN6TY&(\B'0>UQD:-73PU`7A#D02G`X@I<+LG?9'!!AQ'^T%K1
M_$7'H&2X$8+L:]<3`4R6-#XSL.$M3O<VR;YH9BAD1H\EWUL4G3V(T1(ZP'F_
M*J1)2H8',NUK5J:1ZQJ)-]"*SK1H#",.[9J&*!5G:'CCH/IET16F2>-KXR5-
MDY8):]`T:2DFNB<-DH-GZ;D9=(\3!B342'`%JZ%K>0%):72IVF+[`%])96)V
M[28T7H;H7BL"<V`K=<Q9_>B!D>6"ZTF]L<"AWHS9=MYPX,%7XZ4Z!7U.SMO6
MV)_G:6]@2N#!UH3^_!QZ%B&G<OKS,F$-ZL]+,9%X0U)[?HSLQLH0S6*GR0A,
M\$N9T\NW<&/RV7/B#P#Y8\TAL-,23=4@Z4&Q&W*=D_PI$4UN@4G-[B-?37&X
M5%\S4T$I@IIKP@6D(N<5:R1L>=I-(&R<CN?!5KSF6XFPI:8FQ]O1_^A`8DF&
M&+1,'>T2VRQCJP@$+OV&[";(97MB@,KROD3?GY#8Q7A%PE39\;-LBANQE981
M0_%R>^X^:+FM?<-:-1MP.7S^1+R>V:DK<#Y0SD9=7J^/PL7"C5[&<NG"41?Y
M(0:/FQL'W@3A>8PNS_A<1*X9^PISG2H$D\0[$$7G](D@X`?TO&HU,_49^9I2
M<84`7I^.ST(E:\-2/9OFKU``]O@K.U=6$"&5S/DAS[\E:M^[=)S)T]19Y%0Z
ML;3=&F_JUGB.$.+8%-_NB6_WQ+=[XDUXF?KVQ#^41;8RBI+2TK:6AHPJ\O"1
MPU9JI2L]D4-]1G#JD09CTSGM>*TD/:X/N="&0)"[<(ILC_=Y>AQ&+*K:,W[,
MZ']:/M/R&9/Y#%MV41);;)H;PGM8<6PB%Z)DB"NX+M`28(]B=D%/)A?D/KNE
M5#NTLZ4\IE(>YOCA83DMSVEY3LMS_FH\IS"55.N"S(F+7%92\M:2CR>LCX1$
M)1G.0Y;G<QCO-GR<>1/C(HRB6D+R-`D)7R2UK,247J1E)2TK,9&5/*S!*LTK
M2I:PE6LT)K!*BRV[8)-19*F9W,033EQ!]!'@*:%DV2L:3SR'`!*=W4)_?01'
ML`13486$V866#!E'AN3$'1=):CE2RY%:CF3"R]3/D<32C8I8$[3$$,^5,BI1
MD"4PK;J)5D]@*?+V%6946M6B$K_4ZBREY5/&\2GAX&*G4"U_:OE3RY],>!D-
M*WQ8TXN:ILVJW(SF7DJ2.)"4=O])K<Q(:-7S$'A^?`5,=%SP$)%."@001WB^
M!QZ8P.KS;Y65M,SI"3(G6:'7$BD3.KZ62+5$RF0B)9IM5$2;L"UF)(-2FB6.
M<T-9%_?ZZOBT]%OKOBJM8A+4;BI[>LR))X+:K61F]&<M/VKYD<G\J"RGJ(BH
M4GT-V396CEDC-XL]5I*XHN@&N/1`T*&%@]4MMCR?]$#K\XYB%$=$;LMXGA[C
MJ1!?+0$RH\-J"5!+@$PF0!PI1D6`\:AO"#WB0K3!;$E@]?=_0@(*P.XJ.9';
M<C,G28I1)4Z1+4MZ>BQ)+*I:@F1&A]82I)8@F4R0V+*+BMABU-P06L2*8Y,9
MD=`R[7#L@Q\AL>9L"83/'=HMI=WF_S39#W/\M#O\3>FB6LK34AZ3*4]A2E$2
M3H7*C`FG4EY3`E:3MO2/[!EP0A?P%W72;UY/Z.T[L8,\A]`]%TY6T:5KT=&2
ME2?%9.AI-_<_20HD+P+;'?Z&]&DM1VHYDM$<23SGJ`DX<7,,\6$YRZH"=X,V
M_)\B.Z1@D)<[\P(8K#)%,GYJ5B:-BWLQ">+-S`Z`?\;2;L`44B%><&7-2\B5
M#^QGQ)XN^6;<-,@/FRVB4*J>,.=Q`0WX8E`JUFBHX-286_)<=937I&GA%2+@
MKF.PT1=P(]H/,37NG*0=R_T*+'SF.:<DH55'MU"R-IHM@G8Q/ID;F`78]&,S
MH>?J(2_:YCR:$=O]ZS#P`\MS2*\@*Y.4ZFB4/U@PR]R97,DSPW#L0OO<158@
MRQ%9D8W).#EH9*XG%DH[)\0&A]IQ[EH2HGQ=7)84&P[M!@Z9RX'YF?V:O%/@
MVQ@N(MHE#]ZLU.;0D7Q0$JQ?5:`C23(BDC&=#7;`_6]@)2UG;XC5-?"ND*4W
M@4D@?RU0!<E(C7OD&[!`F-[W0\=?84D!BA/U?.D-2BGE*"4N.!;.,+'XS\@E
MHU4+K\ZA"[`T]#?%-B_FMX!)1ST]T:XREAN)ZQ/B.4586HI9%]I`'KB!2HIU
ME2%F+/@+<-W?/'3GC8#E(P\X`]\/`98%?)'X!KJ@$*G4&8<2QOM#@"%RI`U-
M\\4V*=D4`)-B?B2:;%*YC^/=<_*)A/Q>)+A!'6LA-BGJ%0:<Z[)CKRI!/BNZ
M.0R^!)X4_!>/I+*@SOVV2V6.+1]$O_X_4$L#!!0````(`(M:?D"4IS:BXPD`
M`+5/```1`!P`9V]V>"TR,#$Q,3(S,2YX<V155`D``S;/=4\VSW5/=7@+``$$
M)0X```0Y`0``[5QM<]JX%OY^9_8_Z/+E=F>'FI>0!*;)#"$)I4T(#21MNK/3
M$;8`);;D2#*!_/HKR1CS8AN39+ON+/ME@ZQS=,[S'$E'TMG]\-]\'C0100P*
M9('^%.#&.^'\#O*@01VW:V+0(D)^-04>(]E&QHC)W_+[2`BW9AA/3T_O3=F5
MFY@A3CUF(JX:0#Y_#-0_O_WG@QJDP9`:H@9Z(P]<0@9*55`HU/;V:I4"N.DU
M0*E0+/E"4F+":]P<(0>"B6,37IOTF8V/<@MCJI;WE`V-4J%0-C#A`A(3Y6;]
MB>=$][8$,\3418;L@1@V<T!`-D2B#1W$76BBN=@0T3&<*%?D$,5BL50N!MHG
M?$GY4SDPI&A\N[SH:L/GEE"2PAA*\G.#?+DA'4_2V.+QO%(16C2`O*^U!U^T
M2+Y0S"\X8&/R$.5#L5JM&OIKT'6MYS+PZG,?<@D\LI&#B#BGS#E%`^C9XBCW
MZ$$;#S"R<@L\6F*N;U%7Q?`_YHYE``"@0@`20@44F))C'4@JG'2[ZV(RH,=!
MFVQ5=M0"8Z[1`&@G:@J`HQS'CFNKV-!M(X8&1SF%;SX`\X<-^^^EA4$7R$Q&
M;92,D.$RZLK9@"7$(0R^@C7I9=349T..B>R+T.2<<?QF_K@,_71_Y)A<!H#F
M:\6MMR/*0H.?[I@<$Q,<X=9;.65"^Z<[)<<T/3N2K&6W5.^>=`2H/VZN6U&+
MDM8H-P=.;6RI9?X$VFHY[HX0$CF`+=_C'[%=@JT"@,6A0^"/Y=HJ]YRNC"Z]
MRNC]*=0%9LJ`UL8_&*OB4=H]CJPK<JS_7HW=F899EV39Y?!8E=PP\`H-*])S
M)HPE*M8GU*M)^M&!3`(P0@)+DW@*SE8E4E!82D\A>+>L_O<(3G>$KA#:(K(9
MS1&.(7&UUSJ02Z25DTB;?^"`#L"5J_)(*;:;@?&$=4<RL$?4MA#C9X\>%E,E
M5J*LO,!70J=())<8VTO/6%=0\V$VSO^`/Q)X)_,W;&)$S&G4M-O1N#KO&I"/
MSFWZ%#/AYI\C_%\BKI*>.*43**6[J1;/49L*M,")_IEBF]J7T)]B;MJ4>PS)
M'TH0J/RC#85JD?B?>!P3Q&/0W\$?P%]8P;^P<1(<1**O4P?/<2";ZG4+#XD\
M6)I0SI.Z:5*/"$R&H"-GBURX=G-B`REKK!12;"N'D<2H]*!)QX@1O6@UF:1D
MA_\F_-<)*&S*PZJ1\._Y-W4.%GIKB`1^AWN(>P3P?NPG85\L1&*OMNN2VBXN
M$1LB!B"QP#4RH8L%M/&S]FTW$S8R$D5)(<4^72Q&LK*ODZCUM':7R6[B(9*(
MC1NVNK6/H$%MX]?R\,[\9+8C#_?_!@;T6\>?7R]ORW_]^<UTO<D=J52MYX/Q
M\&Y*;DZ]I^8!JQY\+MW?]*;</AB;SP7[DSB\:5QTK+OO=KE"OO6O&J>M:;/W
M6'2K7ZHG5W>WN-3L7/<^TC_<X3UM=P[WBZ3:OKT>'S1*S</#D5%^>AI]?/AT
M`:>-8;5_ZWPZ>7";!;?Z%5$Q+9P/6R?[/:?5:K<ZMU>?[CY]M-V2P\S+;O_^
MZSTY[5>QT9H\?!1GW6ZY>5CL/,/FW8E=;\'AWEV3]E#_85\\_]&^;[?17OD!
M.@?-ZWZE7RD]>GS0']U?5KY]=Z?[U<K%_N?G4OGPR2I^QX?6;?O*9ORS.7`/
M.3_Z"S2ZU[,GH5?':72@ILAABN7(6%69C7\K`GIPLDL?TY$0P\*F1*:X%\E!
M5:\7MC[J=B`34]"3J217#X]Q]TD[0E8(B6,D1893B3[SJL2GBVQD*EJ^>%"]
M_=I3<(X))":&-CB%`H)W'H&>A66?R/NB'5%K1,4RE2KQB;F@T"\D7I^C1T]M
MN6?CV!/!CA+_*M8<(<NS%^^(YDT;9\S:/44@"EHM^>L6VI[V1!\+ONB'\*FZ
MHYA=5^R(22#FE)J>2AOKQ#HC0B;O+3*@S-$&^&0E]MC$76'M/!>H`U(?\!6"
M!8W_GH3@@[%47^&78AAKM1CS$@WLN)0)0-;*9Y)J=/S2G@MJ:GT)(NI7/I#+
MJZ9\L90O%]]/N#5_JM[2#.6X_UB^G1F!W(O,2"[*B3%$&[$H.830U8(&L@6?
MZ\J'NN86;8G,>EE4&G!6I10T505-<?_UABR61&UG#"7M!'M26!19EI0V7`(!
M-7AE'899F90>]2@7][C.ZWTN5-5=#OA%)+H`KB;;Y!;2$LA1LS8'X*S744XP
M3Y5_Z%ZN])U:/2UG>6RV:A)LV["O"D/\OEQF"G*=\]37)J.>&PPB\S@GQ?M_
M:.(*K"L>>DR]X]<YSY97D689Q\E>7&#8QS9613>9<R7*MGA_%D@-'Q:O!N$+
M?H;\2V]KPDR[$B/$_$/^V<1%A*/L>)A@6RR#)Y!C4V8KI]CV)##9<2;.L.15
M(H;CQ8M<_QHWK$W(CLNOLMXXCH>E;MU[W'_9Z=&Z9>FD$-H=B*T6:?@/#<&_
M*)&>][6M=2&#";F^4XO@.)0@`=DT"IX!M/D&?/QO?7\3.,J9#$F+7@[;&WBW
MF'PM0Z>Q;W'N(>O44R'1T2ZI8QE2Q1,R0G47=6`V&=;JKI&)\%BYDF787NE9
M4KS%J-;52'Q;U+B6>B%F;PQ.:@]BU]M-J-N(\Z^0J>?OLPEB)N:_=!!%N;/U
M9`M1_[O1^=O")0:'[6/DG#*E[\:E)%`TVR`Z'C-'\F`Y&^97C9KT#B9D:8E\
MO!#"[*U#6T+UDBVN12XP\JX&:IP.G/KEP+]F8$6Y\N)-;",NV8N6&/^W2Z2#
M&M1?X%RW;FJ\MT'7<T:=V7F0#.OJ/U;,VB$]K:6ICP,R::'$Q#9J(W%!N6R1
M?^AEA:L:_TRC\5:.Q`?&")*AFCJS"QYB9?/J)I692?>'BV'5(F/$LTIY:DN3
M)L"2DMDC]"_@;I*EB3N9Y[I^`[3#YZIPA5QXH<J.YR\Q.G8>^P7WBW=]/301
M)[;<+K/C<1HC$VD.B]G#6O:@E#V#_FYI;RRY8=FX7S6>05<WFYB8H<>*!Y[Y
M_W>`F@C:?W+>&6]?XBH<UIN'$SR#Y*6T,Y%!O[2;U\U'#W/LOS:HNVWNTMG/
M4'46`_B5]F\ZJB]=;JLJI$P'Q/8FQU]Y=1#A:@LCEGZ]Z5`I,2]W/D$$#7#&
MI\>K/8@'QW_+ZL%)I@%(967L[C4K5M6UJHNEJIEV^25&QR(PKP>=EX,NY'89
M='Y+>^.O>><UEGZ)909=W6QB\LWBK)3Q:C`O8Y3+1%C$&-0P9CK6W\*)A/VO
MP_!8SJ6.#4W=7)]@_M.=MD3-PHZ_D+=6EO<H^Y+2NN#NN3YD2+<_83$Z]_A(
MZIX]PV;.QY0F;WBYBGX+O$1.'[&53-VB#L3DG[@>3C0R(4_9#%%V'$UO;,+$
M3"H-SL[JE,I*O07I\EN_^-!W^O]02P$"'@,4````"`"+6GY`@SCOA]=U``#J
MV`<`$0`8```````!````I($`````9V]V>"TR,#$Q,3(S,2YX;6Q55`4``S;/
M=4]U>`L``00E#@``!#D!``!02P$"'@,4````"`"+6GY`2D5;QT\(``!84P``
M%0`8```````!````I($B=@``9V]V>"TR,#$Q,3(S,5]C86PN>&UL550%``,V
MSW5/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`BUI^0$L:N\Y[%```8E$!
M`!4`&````````0```*2!P'X``&=O=G@M,C`Q,3$R,S%?9&5F+GAM;%54!0`#
M-L]U3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(M:?D!)###P5"D``/P&
M`@`5`!@```````$```"D@8J3``!G;W9X+3(P,3$Q,C,Q7VQA8BYX;6Q55`4`
M`S;/=4]U>`L``00E#@``!#D!``!02P$"'@,4````"`"+6GY`5=V%#4`6```.
M@@$`%0`8```````!````I($MO0``9V]V>"TR,#$Q,3(S,5]P<F4N>&UL550%
M``,VSW5/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`BUI^0)2G-J+C"0``
MM4\``!$`&````````0```*2!O-,``&=O=G@M,C`Q,3$R,S$N>'-D550%``,V
HSW5/=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``.K=````````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 1 - Nature of Business<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nature

        of Business</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax

        Labs, Inc. (&#8220;GeoVax&#8221; or the

        &#8220;Company&#8221;), is a biotechnology company

        developing vaccines that prevent and fight Human

        Immunodeficiency Virus (&#8220;HIV&#8221;)

        infections.&#160;&#160;HIV infections result in Acquired

        Immunodeficiency Syndrome

        (&#8220;AIDS&#8221;).&#160;&#160;We have exclusively

        licensed from Emory University (&#8220;Emory&#8221;)

        vaccine technology which was developed in collaboration

        with the National Institutes of Health (&#8220;NIH&#8221;)

        and the Centers for Disease Control and Prevention

        (&#8220;CDC&#8221;).&#160;&#160;GeoVax is incorporated

        under the laws of the State of Delaware and our principal

        offices are located in Smyrna, Georgia (metropolitan

        Atlanta area).</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

        current vaccines under development address the clade B

        subtype of the HIV virus that is most prevalent in the

        United States and the developed world.&#160;&#160;Our

        vaccines are being evaluated to determine their potential

        to (a) prevent HIV infection and (b) to serve as a therapy

        for individuals who are already infected with

        HIV.&#160;&#160;These vaccines are currently being

        evaluated in humans -- both in those infected with HIV and

        those who are not.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

        discussed in Note 2, the Company is a development-stage

        enterprise and we are devoting substantially all of our

        present efforts to research and development.&#160;&#160;We

        have funded our activities to date almost exclusively from

        equity financings and government grants, and we will

        continue to require substantial funds to continue these

        activities.&#160;&#160;We anticipate that our existing cash

        resources, combined with the proceeds from the NIH grant

        discussed in Note 3 and the financing events discussed in

        Note 11, should be sufficient to fund our planned

        activities into the first quarter of 2013.&#160;&#160;In

        order to meet our operating cash flow requirements, we may

        plan additional offerings of our equity securities, debt or

        convertible debt instruments. We are also seeking

        additional funding for our research programs through

        government grant funding mechanisms.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Name Statement of Position (SOP)<br><br> -Publisher AICPA<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Licenses, accumulated amortization (in Dollars)</a></td>
        <td class="nump">$ 208,933<span></span></td>
        <td class="nump">$ 184,047<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">40,000,000<span></span></td>
        <td class="nump">40,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">16,442,611<span></span></td>
        <td class="nump">15,654,846<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">16,442,611<span></span></td>
        <td class="nump">15,632,564<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The accumulated amount of amortization of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 45<br><br> -Subparagraph a(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 11 - Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent

        Events</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Private

        Placement of Common Stock and Warrants</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During

        January 2012, we sold an aggregate of 407,999 shares of our

        common stock to twelve individual accredited investors

        (including 45,000 shares sold to members of our board of

        directors and management) for an aggregate purchase price

        of $273,360.&#160;&#160;We also issued to the investors

        warrants to purchase an aggregate of 612,001 shares of

        common stock at a price of $1.00 per share, which expire in

        January 2017.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Issuance

        of Convertible Preferred Stock and Warrants</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On

        March 21, 2012, we sold shares of our Series A convertible

        preferred stock to certain institutional investors for an

        aggregate purchase price of $2.2 million.&#160;&#160;The

        preferred stock is convertible at any time into shares of

        our common stock at $0.75 per share (2,933,333 shares in

        the aggregate), subject to possible adjustment as provided

        in the certificate of designation.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant

        to the terms of the securities purchase agreement, the

        investors also received five-year Series A warrants to

        purchase an aggregate of 2,933,333 shares of our common

        stock at $1.00 per share.&#160;&#160;The Series A warrants

        are immediately exercisable.&#160; We also granted to the

        investors a one-year additional purchase right, evidenced

        in the form of Series B warrants, to purchase up to

        2,933,333 of our common stock for one year with an exercise

        price of $0.75 per share, and five-year Series C warrants

        to purchase up to 2,933,333 shares of our common stock at

        $1.00 per share.&#160;&#160;The Series B warrants are

        immediately exercisable.&#160;&#160;The Series C warrants

        only vest and become exercisable at the time, and to the

        extent, that the Series B warrants are exercised.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EVRAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">GeoVax Labs, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-K<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16,850,610<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 8,741,870<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000832489<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Dec. 31,
         2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">FY<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document as an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE

        II &#8211; VALUATION AND QUALIFYING ACCOUNTS</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For

        the Years Ended December 31, 2011, 2010 and 2009</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font>

              </div>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance

                at</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of

                Period</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged

                to</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Costs

                and</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expenses</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged

                to</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deductions</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance

                at</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">End</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of

                Period</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve

                Deducted in the Balance Sheet</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From

                the Asset to Which it Applies:</font>

              </div>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowance

                for Deferred Tax Assets</font>

              </div>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="40%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-307" style="MARGIN-LEFT: 9pt"></font>Year

                ended December 31, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">889,322</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(873,584</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,991</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="40%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-308" style="MARGIN-LEFT: 9pt"></font>Year

                ended December 31, 2010</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,160,405</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(675,490</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="40%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-309" style="MARGIN-LEFT: 9pt"></font>Year

                ended December 31, 2009</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,674,882</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,416,456</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-117" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr valign="top" style="LINE-HEIGHT: 1.25;">

            <td style="WIDTH: 18pt">

              <div>

                <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

              </div>

            </td>

            <td style="WIDTH: 18pt">

              <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font>

              </div>

            </td>

            <td>

              <div align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deductions

                represent the effect of expiring NOL carryforwards

                from prior years.</font>

              </div>

            </td>

          </tr>

        </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 09<br><br> -Article 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e24092-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1EAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">126 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grant revenue</a></td>
        <td class="nump">$ 4,899,885<span></span></td>
        <td class="nump">$ 5,185,257<span></span></td>
        <td class="nump">$ 3,668,195<span></span></td>
        <td class="nump">$ 20,311,692<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">4,276,375<span></span></td>
        <td class="nump">4,793,956<span></span></td>
        <td class="nump">4,068,682<span></span></td>
        <td class="nump">25,630,676<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">2,972,555<span></span></td>
        <td class="nump">3,162,134<span></span></td>
        <td class="nump">2,914,845<span></span></td>
        <td class="nump">17,647,659<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );"></a></td>
        <td class="nump">7,248,930<span></span></td>
        <td class="nump">7,956,090<span></span></td>
        <td class="nump">6,983,527<span></span></td>
        <td class="nump">43,278,335<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(2,349,045)<span></span></td>
        <td class="num">(2,770,833)<span></span></td>
        <td class="num">(3,315,332)<span></span></td>
        <td class="num">(22,966,643)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_OtherIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">2,219<span></span></td>
        <td class="nump">23,505<span></span></td>
        <td class="nump">31,080<span></span></td>
        <td class="nump">340,310<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,669)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );"></a></td>
        <td class="nump">2,219<span></span></td>
        <td class="nump">23,505<span></span></td>
        <td class="nump">31,080<span></span></td>
        <td class="nump">334,641<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,346,826)<span></span></td>
        <td class="num">$ (2,747,328)<span></span></td>
        <td class="num">$ (3,284,252)<span></span></td>
        <td class="num">$ (22,632,002)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_BasicAndDilutedAbstract', window );"><strong>Basic and diluted:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share (in Dollars per share)</a></td>
        <td class="num">$ (0.15)<span></span></td>
        <td class="num">$ (0.18)<span></span></td>
        <td class="num">$ (0.22)<span></span></td>
        <td class="num">$ (2.11)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in Shares)</a></td>
        <td class="nump">15,735,541<span></span></td>
        <td class="nump">15,651,308<span></span></td>
        <td class="nump">15,191,278<span></span></td>
        <td class="nump">10,704,803<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_BasicAndDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_BasicAndDilutedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_OtherIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_OtherIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 34<br><br><br><br> -Paragraph 21<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher OTS<br><br><br><br> -Name Federal Regulation (FR)<br><br><br><br> -Number Title 12<br><br><br><br> -Chapter V<br><br><br><br> -Section 563c.102<br><br><br><br> -Paragraph 9<br><br><br><br> -Subsection II<br><br><br><br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 5<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 115<br><br><br><br> -Paragraph 14<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph 38<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A7<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 130<br><br><br><br> -Paragraph 10, 15<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph 38<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Emerging Issues Task Force (EITF)<br><br><br><br> -Number 87-21<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 5<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br><br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 28, 29, 30<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 5<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141<br><br><br><br> -Paragraph 51<br><br><br><br> -Subparagraph g<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 2<br><br><br><br> -Paragraph 12, 13<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 86<br><br><br><br> -Paragraph 11, 12<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1448-109256<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 128<br><br><br><br> -Paragraph 171<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 128<br><br><br><br> -Paragraph 40<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 128<br><br><br><br> -Paragraph 8<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Emerging Issues Task Force (EITF)<br><br><br><br> -Number 07-4<br><br><br><br> -Paragraph 4<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholders&#8217;

        Equity</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Common

        Stock Transactions</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        February 2010, we issued 12,000 shares of our common stock

        in settlement of an obligation accrued at December 31, 2009

        in the amount of $90,000.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During

        December 2011, we sold an aggregate of 658,520 shares of

        our common stock to fifteen individual accredited investors

        (including members of our board of directors and management

        --see Note 9) for an aggregate purchase price of $441,210,

        $36,800 of which was received in January 2012 and is

        therefore reflected as a receivable (Other Current Asset)

        in the accompanying Consolidated Balance Sheet as of

        December 31, 2011.&#160;&#160;We also issued to the

        investors warrants to purchase an aggregate of 987,783

        shares of common stock at a price of $1.00 per share, which

        expire in December 2016.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From

        time to time, we issue shares of our common stock to

        consultants or others in exchange for

        services.&#160;&#160;During 2011, 2010 and 2009 we issued

        129,245, 10,500, and 4,500, respectively, for such

        services; and we recorded general and administrative

        expense of $150,000, $53,813, and $31,500 during each

        respective period related to these issuances.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock

        Options</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        2006, we adopted the GeoVax Labs, Inc. 2006 Equity

        Incentive Plan (the &#8220;Stock Option Plan&#8221;) for

        the granting of qualified incentive stock options

        (&#8220;ISO&#8217;s&#8221;), nonqualified stock options,

        restricted stock awards or restricted stock bonuses to

        employees, officers, directors, consultants and advisors of

        the Company.&#160;&#160;The exercise price for any option

        granted may not be less than fair value (110% of fair value

        for ISO&#8217;s granted to certain

        employees).&#160;&#160;Options granted under the Stock

        Option Plan have a maximum ten-year term and generally vest

        over three years.&#160;&#160;The Company has reserved

        1,200,000 shares of its common stock for issuance under the

        Stock Option Plan.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A

        summary of activity under the Stock Option Plan as of

        December 31, 2011, and changes during the year then ended

        is presented below:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of

                Shares</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term

                (yrs)</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

                at January 1, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,137,356</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.33</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,000</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-291" style="MARGIN-LEFT: 36pt"></font>0.91</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-292" style="MARGIN-LEFT: 36pt"></font>-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

                or expired</font>

              </div>

            </td>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(439,114</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-293" style="MARGIN-LEFT: 36pt"></font>2.81</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

                at December 31, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">928,242</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-294" style="MARGIN-LEFT: 36pt"></font>6.5</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

                at December 31, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">578,231</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.59</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-295" style="MARGIN-LEFT: 36pt"></font>4.8</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional

        information concerning our stock options for the years

        ended December 31, 2011, 2010 and 2009 is as

        follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

                average fair value of options granted during the

                period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.79</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.95</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.15</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic

                value of options exercised during the period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                fair value of options vested during the

                period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">540,339</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,557</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,143,326</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        use the Black-Scholes model for determining the grant date

        fair value of our stock option grants.&#160;&#160;This

        model utilizes certain information, such as the interest

        rate on a risk-free security with a term generally

        equivalent to the expected life of the option being valued

        and requires certain other assumptions, such as the

        expected amount of time an option will be outstanding until

        it is exercised or expired, to calculate the fair value of

        stock options granted.&#160;&#160;The significant

        assumptions we used in our fair value calculations were as

        follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

                average risk-free interest rates</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.8</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                dividend yield</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                life of option</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="3" valign="bottom" style="TEXT-ALIGN: right">

              <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7

                yrs</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="3" valign="bottom" style="TEXT-ALIGN: right">

              <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7

                yrs</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="3" valign="bottom" style="TEXT-ALIGN: right">

              <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7

                yrs</font>

              </div>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                volatility</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111.2</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.9</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.3</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based

        compensation expense related to the Stock Option Plan was

        $463,752, $575,662, and $1,221,764 during the years ended

        December 31, 2011, 2010 and 2009,

        respectively.&#160;&#160;Stock option expense is allocated

        to research and development expense or to general and

        administrative expense based on the related employee

        classifications and corresponds to the allocation of

        employee salaries.&#160;&#160;For the three years ended

        December 31, 2011, stock option expense was allocated as

        follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General

                and administrative expense</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284,352</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369,161</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">917,110</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

                and development expense</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304,654</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                stock option expense</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221,764</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

        of December 31, 2011, there was $515,697 of unrecognized

        compensation expense related to stock-based compensation

        arrangements.&#160;&#160;The unrecognized compensation

        expense is expected to be recognized over a weighted

        average remaining period of 2.0 years.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensatory

        Warrants</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From

        time to time, we issue stock purchase warrants to

        consultants or others in exchange for services. A summary

        of our compensatory warrant activity as of December 31,

        2011, and changes during the year then ended is presented

        below:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of

                Shares</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term

                (yrs)</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">

                &#160;

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font>

              </div>

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

                at January 1, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-296" style="MARGIN-LEFT: 36pt"></font>1.40</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-297" style="MARGIN-LEFT: 36pt"></font>-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

                or expired</font>

              </div>

            </td>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-298" style="MARGIN-LEFT: 36pt"></font>7.00</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

                at December 31, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-299" style="MARGIN-LEFT: 36pt"></font>0.6</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

                at December 31, 2011</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,850</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-300" style="MARGIN-LEFT: 36pt"></font>0.7</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional

        information concerning our compensatory warrants for the

        years ended December 31, 2011, 2010 and 2009 is as

        follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

                average fair value of warrants granted during the

                period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.75</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic

                value of warrants exercised during the

                period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                fair value of warrants vested during the

                period</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,780</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,238</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,413</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        use the Black-Scholes model for determining the grant date

        fair value of our compensatory warrants.&#160;&#160;The

        significant assumptions we used in our fair value

        calculations were as follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

                average risk-free interest rates</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.98</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.54</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                dividend yield</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                life of warrant</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="3" valign="bottom" style="TEXT-ALIGN: right">

              <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.0

                yrs</font>

              </div>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="3" valign="bottom" style="TEXT-ALIGN: right">

              <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.0

                yrs</font>

              </div>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

                volatility</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115.46</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.1</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expense

        associated with compensatory warrants was $7,119, $121,057,

        and $45,401 during the years ended December 31, 2011, 2010

        and 2009, respectively.&#160;&#160;All such expense was

        allocated to general and administrative

        expense.&#160;&#160;As of December 31, 2011, there was no

        unrecognized compensation expense related to compensatory

        warrant arrangements.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investment

        Warrants</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        addition to outstanding stock options and compensatory

        warrants, as of December 31, 2011 we have a total of

        1,806,159 outstanding stock purchase warrants issued to

        investors in connection with financing

        transactions.&#160;&#160;Warrants as to 987,783 have an

        exercise price of $1.00 per share and expire in December

        2016; warrants as to 818,376 have an exercise price of

        $16.50 and expire in December 2014.&#160;&#160;During the

        fourth quarter of 2011, we recorded general and

        administrative expense of $152,126 associated with the

        extension of warrants which were due to expire in 2011 to

        2013.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph d<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Chapter 1<br><br> -Section B<br><br> -Paragraph 7, 11A<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 21: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 22: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 23: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - 2006 Merger and Recapitalization<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2006

        Merger and Recapitalization</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

        Company was originally incorporated in June 1988 under the

        laws of Illinois as Dauphin Technology, Inc.

        (&#8220;Dauphin&#8221;).&#160;&#160;Dauphin was

        unsuccessful and its operations were terminated in December

        2003.&#160;&#160;In September 2006, Dauphin completed a

        merger (the &#8220;Merger&#8221;) with GeoVax, Inc. which

        was incorporated under the laws of Georgia in June

        2001.&#160;&#160;As a result of the Merger, the

        shareholders of GeoVax, Inc. exchanged their shares of

        common stock for Dauphin common stock and GeoVax, Inc.

        became a wholly-owned subsidiary of

        Dauphin.&#160;&#160;Dauphin then changed its name to GeoVax

        Labs, Inc. and replaced its officers and directors with

        those of GeoVax, Inc.&#160;&#160;Subsequent to the Merger,

        the Company has not conducted any business other than

        GeoVax, Inc.&#8217;s business of developing human

        vaccines.&#160;&#160;The Merger was accounted for under the

        purchase method of accounting as a reverse acquisition in

        accordance with GAAP. Under this method of accounting,

        Dauphin was treated as the acquired company and,

        accordingly, all financial information prior to the date of

        Merger presented in the accompanying consolidated financial

        statements, or in the notes herein, as well as any

        references to prior operations, are those of GeoVax,

        Inc.&#160;&#160;In June 2008, the Company was

        reincorporated under the laws of the State of

        Delaware.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 9 - Related Party Transactions<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related

        Party Transactions</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        are obligated to reimburse Emory University (a significant

        stockholder of the Company) for ongoing costs in connection

        with the filing, prosecution and maintenance of patent

        applications subject to a license agreement for technology

        associated with the vaccines we are

        developing.&#160;&#160;The expense associated with these

        ongoing patent cost reimbursements to Emory amounted to

        $249,907, $193,674, and $85,673 for the years ended

        December 31, 2011, 2010, and 2009, respectively.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        have entered into two subcontracts with Emory for the

        purpose of conducting research and development activities

        associated with our grant from the NIH (see Note

        3).&#160;&#160;During 2011, 2010, and 2009, we recorded

        $1,172,758, $1,391,203, and $816,651, respectively, of

        expense associated with these subcontracts.&#160;&#160;All

        amounts paid to Emory under these subcontracts are

        reimbursable to us pursuant to the NIH grant.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through

        November 2009, we leased office and laboratory space on a

        month-to-month basis from Emtech Biotechnology Development,

        Inc., a related party associated with

        Emory.&#160;&#160;Rent expense associated with this lease

        totaled $43,112 for the year ended December 31,

        2009.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        March 2008, we entered into a consulting agreement with

        Donald Hildebrand, a former member of our Board of

        Directors and our former President &amp; Chief Executive

        Officer, pursuant to which Mr. Hildebrand provides business

        and technical advisory services to the

        Company.&#160;&#160;The term of the consulting agreement,

        as amended, began on April 1, 2008 and ends on December 31,

        2012.&#160;&#160;During 2011, 2010, and 2009, we recorded

        $24,000, $57,600, and $57,600, respectively, of expense

        associated with the consulting agreement.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        December 2011, members of our management and Board of

        Directors participated in the private placement offering of

        our common stock and warrants described in Note 6, whereby

        they purchased an aggregate of 335,954 shares of our common

        stock for a total purchase price of $225,089 and received

        five-year warrants to purchase an additional 503,932 shares

        of our common stock exercisable at $1.00 per share.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 3A<br><br> -Section 04<br><br> -Paragraph b<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 1-4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 4<br><br> -Section 08<br><br> -Paragraph k<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 7 - Retirement Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Postretirement Benefits Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retirement

        Plan</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        participate in a multi-employer defined contribution

        retirement plan (the &#8220;401k Plan&#8221;) administered

        by a third party service provider; and the Company

        contributes to the 401k Plan on behalf of its employees

        based upon a matching formula.&#160;&#160;During the years

        ended December 31, 2011, 2010 and 2009 our contributions to

        the 401k Plan were $56,928, $52,632, and $25,057,

        respectively.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 87<br><br> -Paragraph 264<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 158<br><br> -Paragraph 7, 21, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS106-2<br><br> -Paragraph 20, 21, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Implementation Guide (Q and A)<br><br> -Number FAS88<br><br> -Paragraph 63<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph h<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 30<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 03-2<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 8<br><br> -Subparagraph m<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph q<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 106<br><br> -Paragraph 518<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income

        Taxes</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At

        December 31, 2011, we have a consolidated federal net

        operating loss (&#8220;NOL&#8221;) carryforward of

        approximately $71.3 million, available to offset against

        future taxable income which expires in varying amounts in

        2012 through 2031.&#160;&#160;Additionally, we have

        approximately $764,000 in research and development

        (&#8220;R&amp;D&#8221;) tax credits that expire in 2022

        through 2031 unless utilized earlier.&#160;&#160;No income

        taxes have been paid to date.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

        a result of the Merger discussed in Note 5, our NOL

        carryforward increased substantially due to the addition of

        historical NOL carryforwards for Dauphin Technology,

        Inc.&#160;&#160;However, Section 382 of the Internal

        Revenue Code contains provisions that may limit our

        utilization of NOL and R&amp;D tax credit carryforwards in

        any given year as a result of significant changes in

        ownership interests that have occurred in past periods or

        may occur in future periods.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred

        income taxes reflect the net effect of temporary

        differences between the carrying amounts of assets and

        liabilities for financial reporting purposes and the

        amounts used for income tax

        purposes.&#160;&#160;Significant components of our deferred

        tax assets and liabilities included the following at

        December 31, 2011 and 2010:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

                tax assets:</font>

              </div>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 4%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                operating loss carryforward</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,875,119</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,116,958</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 4%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

                and development tax credit carryforward</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,690</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">731,290</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based

                compensation expense</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,991,769</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,779,950</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 4%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                deferred tax assets</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,630,578</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,628,198</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom" width="76%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

                tax liabilities</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38,587</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,945</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

                deferred tax liabilities</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38,587</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,945</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom" width="76%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="76%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                deferred tax assets</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,991</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation

                allowance</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,591,991</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,576,253</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        have established a full valuation allowance equal to the

        amount of our net deferred tax assets due to uncertainties

        with respect to our ability to generate sufficient taxable

        income to realize these assets in the future. <font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A

        reconciliation of the income tax benefit on losses at the

        U.S. federal statutory rate to the reported income tax

        expense is as follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S.

                federal statutory rate applied to pretax

                loss</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(797,921</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(934,092</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,116,646</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permanent

                differences</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-301" style="MARGIN-LEFT: 32.15pt"></font>3,536</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77,200</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-302" style="MARGIN-LEFT: 21.8pt"></font>169,469</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

                and development credits</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-303" style="MARGIN-LEFT: 25.45pt"></font>32,400</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,959</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-304" style="MARGIN-LEFT: 21.8pt"></font>169,667</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change

                in valuation allowance</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-305" style="MARGIN-LEFT: 18.8pt"></font>761,985</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">951,333</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-306" style="MARGIN-LEFT: 21.8pt"></font>777,510</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reported

                income tax expense</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

        </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 136, 172<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 44, 45, 46, 47, 48, 49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Selected Quarterly Financial Data (unaudited)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected

        Quarterly Financial Data (unaudited)</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A

        summary of selected quarterly financial data for 2011 and

        2010 is as follows:</font>

      </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011

                Quarter Ended</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

                31</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

                30</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

                30</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

                31</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

                from grants</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,002</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,753,033</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,297,006</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,844</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                loss</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(606,282</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211,344</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(375,852</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,153,348</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                loss per share</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.08</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

        </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010

                Quarter Ended</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

                31</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

                30</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

                30</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" style="PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

                31</font>

              </div>

            </td>

            <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

                from grants</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,338,560</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,737,169</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,163,288</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">946,240</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                loss</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(690,789</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(933,089</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(644,666</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(478,784</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="52%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                loss per share</font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

            <td align="left" valign="bottom" width="1%">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

            </td>

            <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

        </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the quarterly financial data in the annual financial statements.  The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section G<br><br> -Subsection 1<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e725-108305<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 28<br><br> -Paragraph 23, 24<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e765-108305<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 28<br><br> -Paragraph 30<br><br> -Subparagraph a-j<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-K (SK)<br><br> -Number 229<br><br> -Section 302<br><br> -Paragraph a<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952194&amp;loc=d3e1280-108306<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPHHK">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficiency) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital [Member]</div>
        </th>
        <th class="th">
          <div>Stock Subscription Receivable [Member]</div>
        </th>
        <th class="th">
          <div>Retained Earnings [Member]</div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 26, 2001</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception', window );">Capital contribution at inception (June 27, 2001)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(170,592)<span></span></td>
        <td class="num">(170,592)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2001</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(170,592)<span></span></td>
        <td class="num">(170,582)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock for cash</a></td>
        <td class="nump">2,790<span></span></td>
        <td class="num">(2,320)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">470<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock for cash (in Shares)</a></td>
        <td class="nump">2,789,954<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for technology license</a></td>
        <td class="nump">705<span></span></td>
        <td class="nump">148,151<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">148,856<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for technology license (in Shares)</a></td>
        <td class="nump">704,534<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(618,137)<span></span></td>
        <td class="num">(618,137)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">3,494,488<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2002</a></td>
        <td class="nump">3,495<span></span></td>
        <td class="nump">145,841<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(788,729)<span></span></td>
        <td class="num">(639,393)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock for cash</a></td>
        <td class="nump">1,229<span></span></td>
        <td class="nump">2,458,380<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,459,609<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock for cash (in Shares)</a></td>
        <td class="nump">1,229,278<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(947,804)<span></span></td>
        <td class="num">(947,804)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">4,723,766<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2003</a></td>
        <td class="nump">4,724<span></span></td>
        <td class="nump">2,604,221<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,736,533)<span></span></td>
        <td class="nump">872,412<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable', window );">Sale of common stock for cash and stock subscription receivable</a></td>
        <td class="nump">1,483<span></span></td>
        <td class="nump">2,988,436<span></span></td>
        <td class="num">(2,750,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">239,919<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable', window );">Sale of common stock for cash and stock subscription receivable (in Shares)</a></td>
        <td class="nump">1,482,605<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for technology license</a></td>
        <td class="nump">49<span></span></td>
        <td class="nump">99,951<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for technology license (in Shares)</a></td>
        <td class="nump">49,420<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,351,828)<span></span></td>
        <td class="num">(2,351,828)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">6,255,791<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2004</a></td>
        <td class="nump">6,256<span></span></td>
        <td class="nump">5,692,608<span></span></td>
        <td class="num">(2,000,000)<span></span></td>
        <td class="num">(4,088,361)<span></span></td>
        <td class="num">(389,497)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,611,086)<span></span></td>
        <td class="num">(1,611,086)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">6,255,791<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2005</a></td>
        <td class="nump">6,256<span></span></td>
        <td class="nump">5,692,608<span></span></td>
        <td class="num">(500,000)<span></span></td>
        <td class="num">(5,699,447)<span></span></td>
        <td class="num">(500,583)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
        <td class="nump">3,551<span></span></td>
        <td class="nump">1,071,565<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,075,116<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in Shares)</a></td>
        <td class="nump">3,550,851<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued in connection with merger</a></td>
        <td class="nump">4,360<span></span></td>
        <td class="nump">1,708,489<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,712,849<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued in connection with merger (in Shares)</a></td>
        <td class="nump">4,359,891<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodValueCashlessWarrantExercise', window );">Issuance of common stock for cashless warrant exercise</a></td>
        <td class="nump">57<span></span></td>
        <td class="num">(57)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise', window );">Issuance of common stock for cashless warrant exercise</a></td>
        <td class="nump">56,825<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(584,166)<span></span></td>
        <td class="num">(584,166)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">14,223,358<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2006</a></td>
        <td class="nump">14,224<span></span></td>
        <td class="nump">8,472,605<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6,283,613)<span></span></td>
        <td class="nump">2,203,216<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock for cash</a></td>
        <td class="nump">407<span></span></td>
        <td class="nump">3,162,543<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,162,950<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock for cash (in Shares)</a></td>
        <td class="nump">406,729<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon stock option exercise</a></td>
        <td class="nump">2<span></span></td>
        <td class="nump">4,998<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon stock option exercise (in Shares)</a></td>
        <td class="nump">2,471<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,518,496<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,518,496<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,241,796)<span></span></td>
        <td class="num">(4,241,796)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">14,632,558<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2007</a></td>
        <td class="nump">14,633<span></span></td>
        <td class="nump">13,158,642<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(10,525,409)<span></span></td>
        <td class="nump">2,647,866<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock for cash</a></td>
        <td class="nump">176<span></span></td>
        <td class="nump">1,364,824<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,365,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock for cash (in Shares)</a></td>
        <td class="nump">176,129<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Transactions related to common stock purchase agreement with Fusion Capital</a></td>
        <td class="nump">130<span></span></td>
        <td class="nump">405,961<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">406,091<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Transactions related to common stock purchase agreement with Fusion Capital (in Shares)</a></td>
        <td class="nump">130,290<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation - Stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,798,169<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,798,169<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock-based compensation - Consultant warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">146,880<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">146,880<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services</a></td>
        <td class="nump">10<span></span></td>
        <td class="nump">73,990<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">74,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services (in Shares)</a></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,728,187)<span></span></td>
        <td class="num">(3,728,187)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">14,948,977<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2008</a></td>
        <td class="nump">14,949<span></span></td>
        <td class="nump">16,948,466<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(14,253,596)<span></span></td>
        <td class="nump">2,709,819<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Transactions related to common stock purchase agreement with Fusion Capital</a></td>
        <td class="nump">216<span></span></td>
        <td class="nump">1,519,784<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,520,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Transactions related to common stock purchase agreement with Fusion Capital (in Shares)</a></td>
        <td class="nump">216,261<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant', window );">Sale of common stock for cash upon exercise of stock purchase warrant</a></td>
        <td class="nump">463<span></span></td>
        <td class="nump">1,499,537<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant', window );">Sale of common stock for cash upon exercise of stock purchase warrant (in Shares)</a></td>
        <td class="nump">462,826<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation - Stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,221,764<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,221,764<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock-based compensation - Consultant warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">45,401<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">45,401<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services</a></td>
        <td class="nump">5<span></span></td>
        <td class="nump">31,495<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,500<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services (in Shares)</a></td>
        <td class="nump">4,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,020,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,284,252)<span></span></td>
        <td class="num">(3,284,252)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">15,632,564<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2009</a></td>
        <td class="nump">15,633<span></span></td>
        <td class="nump">21,266,447<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(17,537,848)<span></span></td>
        <td class="nump">3,744,232<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodValueInLieuOfCashPayment', window );">Issuance of common stock in lieu of cash payment</a></td>
        <td class="nump">12<span></span></td>
        <td class="nump">89,988<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">90,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment', window );">Issuance of common stock in lieu of cash payment (in Shares)</a></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation - Stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">575,662<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">575,662<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock-based compensation - Consultant warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">121,057<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">121,057<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services</a></td>
        <td class="nump">10<span></span></td>
        <td class="nump">53,803<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">53,813<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services (in Shares)</a></td>
        <td class="nump">10,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit', window );">Fractional share payout upon reverse split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,210)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,210)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Fractional share payout upon reverse split (in Shares)</a></td>
        <td class="num">(218)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,747,328)<span></span></td>
        <td class="num">(2,747,328)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">15,654,846<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2010</a></td>
        <td class="nump">15,655<span></span></td>
        <td class="nump">22,105,747<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(20,285,176)<span></span></td>
        <td class="nump">1,836,226<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock for cash</a></td>
        <td class="nump">659<span></span></td>
        <td class="nump">440,551<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">441,210<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock for cash (in Shares)</a></td>
        <td class="nump">658,520<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation - Stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">463,752<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">463,752<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock-based compensation - Consultant warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">159,245<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">159,245<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services</a></td>
        <td class="nump">129<span></span></td>
        <td class="nump">149,871<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">150,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation - Issuance of common stock for services (in Shares)</a></td>
        <td class="nump">129,245<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">404,410<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,346,826)<span></span></td>
        <td class="num">(2,346,826)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares)</a></td>
        <td class="nump">16,442,611<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2011</a></td>
        <td class="nump">$ 16,443<span></span></td>
        <td class="nump">$ 23,319,166<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (22,632,002)<span></span></td>
        <td class="nump">$ 703,607<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents increases in additional paid in capital attributable to capital contribution at inception.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period for cash and stock subscription receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodSharesCashAndStockSubscriptionReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period for cashless warrant exercise.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodSharesCashlessWarrantExercise</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period for cash upon exercise of stock purchase warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodSharesForCashUponExerciseOfStockPurchaseWarrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period in lieu of cash payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodSharesInLieuOfCashPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period for cash and stock subscription receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodValueCashAndStockSubscriptionReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodValueCashlessWarrantExercise">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period for cashless warrant exercise.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodValueCashlessWarrantExercise</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period for cash upon exercise of stock purchase warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodValueForCashUponExerciseOfStockPurchaseWarrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_StockIssuedDuringPeriodValueInLieuOfCashPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period in lieu of cash payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_StockIssuedDuringPeriodValueInLieuOfCashPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6576910&amp;loc=d3e11149-113907<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A91<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6576910&amp;loc=d3e11178-113907<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 39<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation related to stock options during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate adjustment to additional paid in capital for stock to account for a stock split in the case where the per-share par value or stated value is not reduced or increased proportionately such that the total par value or stated value remains the same for all shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase in additional paid in capital due to warrants issued during the period. Includes also the proceeds of debt securities issued with detachable stock purchase warrants that are allocable to the warrants. These warrants qualify for equity classification and provide the holder with a right to purchase stock from the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Warrant<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6923874&amp;loc=d3e4724-112606<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 14<br><br> -Paragraph 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e565-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 5<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A3<br><br> -Appendix A<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period pursuant to acquisitions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 53<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 51<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reduction in the number of shares during the period as a result of a reverse stock split.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued pursuant to acquisitions during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value stock issued during the period as a result of the exercise of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Commitments<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments Disclosure [Text Block]</a></td>
        <td class="text"><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease

        Agreements</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

        lease approximately 8,400 square feet of office and

        laboratory space located in Smyrna, Georgia (metropolitan

        Atlanta). Rent expense for the years ended December 31,

        2011, 2010 and 2009 was $119,255, $118,988, and $63,350,

        respectively.&#160;&#160;Future minimum lease payments

        pursuant to the 62 month lease total $121,560 in 2012,

        $125,180 in 2013 and $128,920 in 2014.</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

        Commitments</font>

      </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

        <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

        the normal course of business, we may enter into various

        firm purchase commitments related to production and testing

        of our vaccine material, conduct of clinical trials, and

        other research-related activities. As of December 31, 2011,

        we had approximately $478,000 of unrecorded outstanding

        purchase commitments to our vendors and subcontractors, of

        which we expect approximately $445,000 in 2012 and $33,000

        in 2013.</font>

      </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.17)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 25<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.(a)(19))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 17<br><br> -Article 9<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 7<br><br> -Section 03<br><br> -Paragraph 19<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>92</ContextCount>
  <ElementCount>110</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficiency)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Note 1 - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note</Role>
      <ShortName>Note 1 - Nature of Business</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Note 2 - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0</Role>
      <ShortName>Note 2 - Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 3 - Government Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00</Role>
      <ShortName>Note 3 - Government Grants</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 4 - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000</Role>
      <ShortName>Note 4 - Commitments</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Note 5 - 2006 Merger and Recapitalization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000</Role>
      <ShortName>Note 5 - 2006 Merger and Recapitalization</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 6 - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00000</Role>
      <ShortName>Note 6 - Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 7 - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000000</Role>
      <ShortName>Note 7 - Retirement Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 8 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000000</Role>
      <ShortName>Note 8 - Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 9 - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00000000</Role>
      <ShortName>Note 9 - Related Party Transactions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000000000</Role>
      <ShortName>Note 10 - Selected Quarterly Financial Data (unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 11 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000000000</Role>
      <ShortName>Note 11 - Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Schedule</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 001 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2002'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2001'</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals)</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Consolidated Statements of Operations</Log>
    <Log type="Info">	Process Flow-Through: Removing column '6 Months Ended
Dec. 31, 2001'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2002'</Log>
    <Log type="Info">Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows</Log>
  </Logs>
  <InputFiles>
    <File>govx-20111231.xml</File>
    <File>govx-20111231.xsd</File>
    <File>govx-20111231_cal.xml</File>
    <File>govx-20111231_def.xml</File>
    <File>govx-20111231_lab.xml</File>
    <File>govx-20111231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
